This value set has >1000 codes in it. In order to keep the publication size manageable, only a selection (1000 codes) of the whole set of codes is shown
| Code | Display |
| 1-8 | Acyclovir [Susceptibility] |
| 10-9 | Amdinocillin [Susceptibility] by Serum bactericidal titer |
| 100-8 | Cefoperazone [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 1000-9 | DBG Ab [Presence] in Serum or Plasma from Blood product unit |
| 10000-8 | R wave duration in lead AVR |
| 10001-6 | R wave duration in lead I |
| 10002-4 | R wave duration in lead II |
| 10003-2 | R wave duration in lead III |
| 10004-0 | R wave duration in lead V1 |
| 10005-7 | R wave duration in lead V2 |
| 10006-5 | R wave duration in lead V3 |
| 10007-3 | R wave duration in lead V4 |
| 10008-1 | R wave duration in lead V5 |
| 10009-9 | R wave duration in lead V6 |
| 1001-7 | DBG Ab [Presence] in Serum or Plasma from donor |
| 10010-7 | R' wave amplitude in lead AVF |
| 10011-5 | R' wave amplitude in lead AVL |
| 10012-3 | R' wave amplitude in lead AVR |
| 10013-1 | R' wave amplitude in lead I |
| 10014-9 | R' wave amplitude in lead II |
| 10015-6 | R' wave amplitude in lead III |
| 10016-4 | R' wave amplitude in lead V1 |
| 10017-2 | R' wave amplitude in lead V2 |
| 10018-0 | R' wave amplitude in lead V3 |
| 10019-8 | R' wave amplitude in lead V4 |
| 1002-5 | DBG Ab [Presence] in Serum or Plasma |
| 10020-6 | R' wave amplitude in lead V5 |
| 10021-4 | R' wave amplitude in lead V6 |
| 10022-2 | R' wave duration in lead AVF |
| 10023-0 | R' wave duration in lead AVL |
| 10024-8 | R' wave duration in lead AVR |
| 10025-5 | R' wave duration in lead I |
| 10026-3 | R' wave duration in lead II |
| 10027-1 | R' wave duration in lead III |
| 10028-9 | R' wave duration in lead V1 |
| 10029-7 | R' wave duration in lead V2 |
| 1003-3 | Indirect antiglobulin test.complement specific reagent [Presence] in Serum or Plasma |
| 10030-5 | R' wave duration in lead V3 |
| 10031-3 | R' wave duration in lead V4 |
| 10032-1 | R' wave duration in lead V5 |
| 10033-9 | R' wave duration in lead V6 |
| 10034-7 | S wave amplitude in lead AVF |
| 10035-4 | S wave amplitude in lead AVL |
| 10036-2 | S wave amplitude in lead AVR |
| 10037-0 | S wave amplitude in lead I |
| 10038-8 | S wave amplitude in lead II |
| 10039-6 | S wave amplitude in lead III |
| 1004-1 | Direct antiglobulin test.complement specific reagent [Presence] on Red Blood Cells |
| 10040-4 | S wave amplitude in lead V1 |
| 10041-2 | S wave amplitude in lead V2 |
| 10042-0 | S wave amplitude in lead V3 |
| 10043-8 | S wave amplitude in lead V4 |
| 10044-6 | S wave amplitude in lead V5 |
| 10045-3 | S wave amplitude in lead V6 |
| 10046-1 | S wave duration in lead AVF |
| 10047-9 | S wave duration in lead AVL |
| 10048-7 | S wave duration in lead AVR |
| 10049-5 | S wave duration in lead I |
| 1005-8 | Indirect antiglobulin test.IgG specific reagent [Presence] in Serum or Plasma |
| 10050-3 | S wave duration in lead II |
| 10051-1 | S wave duration in lead III |
| 10052-9 | S wave duration in lead V1 |
| 10053-7 | S wave duration in lead V2 |
| 10054-5 | S wave duration in lead V3 |
| 10055-2 | S wave duration in lead V4 |
| 10056-0 | S wave duration in lead V5 |
| 10057-8 | S wave duration in lead V6 |
| 10058-6 | S' wave amplitude in lead AVF |
| 10059-4 | S' wave amplitude in lead AVL |
| 1006-6 | Direct antiglobulin test.IgG specific reagent [Interpretation] on Red Blood Cells |
| 10060-2 | S' wave amplitude in lead AVR |
| 10061-0 | S' wave amplitude in lead I |
| 10062-8 | S' wave amplitude in lead II |
| 10063-6 | S' wave amplitude in lead III |
| 10064-4 | S' wave amplitude in lead V1 |
| 10065-1 | S' wave amplitude in lead V2 |
| 10066-9 | S' wave amplitude in lead V3 |
| 10067-7 | S' wave amplitude in lead V4 |
| 10068-5 | S' wave amplitude in lead V5 |
| 10069-3 | S' wave amplitude in lead V6 |
| 1007-4 | Direct antiglobulin test.poly specific reagent [Presence] on Red Blood Cells |
| 10070-1 | S' wave duration in lead AVF |
| 10071-9 | S' wave duration in lead AVL |
| 10072-7 | S' wave duration in lead AVR |
| 10073-5 | S' wave duration in lead I |
| 10074-3 | S' wave duration in lead II |
| 10075-0 | S' wave duration in lead III |
| 10076-8 | S' wave duration in lead V1 |
| 10077-6 | S' wave duration in lead V2 |
| 10078-4 | S' wave duration in lead V3 |
| 10079-2 | S' wave duration in lead V4 |
| 1008-2 | Indirect antiglobulin test.poly specific reagent [Presence] in Serum or Plasma |
| 10080-0 | S' wave duration in lead V5 |
| 10081-8 | S' wave duration in lead V6 |
| 10082-6 | ST initial amplitude 6 ms in lead AVF |
| 10083-4 | ST initial amplitude 6 ms in lead AVL |
| 10084-2 | ST initial amplitude 6 ms in lead AVR |
| 10085-9 | ST initial amplitude 6 ms in lead I |
| 10086-7 | ST initial amplitude 6 ms in lead II |
| 10087-5 | ST initial amplitude 6 ms in lead III |
| 10088-3 | ST initial amplitude 6 ms in lead V1 |
| 10089-1 | ST initial amplitude 6 ms in lead V2 |
| 1009-0 | Deprecated Direct antiglobulin test.poly specific reagent [Presence] on Red Blood Cells |
| 10090-9 | ST initial amplitude 6 ms in lead V3 |
| 10091-7 | ST initial amplitude 6 ms in lead V4 |
| 10092-5 | ST initial amplitude 6 ms in lead V5 |
| 10093-3 | ST initial amplitude 6 ms in lead V6 |
| 10094-1 | ST slope in lead AVF |
| 10095-8 | ST slope in lead AVL |
| 10096-6 | ST slope in lead AVR |
| 10097-4 | ST slope in lead I |
| 10098-2 | ST slope in lead II |
| 10099-0 | ST slope in lead III |
| 101-6 | Cefoperazone [Susceptibility] by Disk diffusion (KB) |
| 1010-8 | Ew Ab [Presence] in Serum or Plasma from Blood product unit |
| 10100-6 | ST slope in lead V1 |
| 10101-4 | ST slope in lead V2 |
| 10102-2 | ST slope in lead V3 |
| 10103-0 | ST slope in lead V4 |
| 10104-8 | ST slope in lead V5 |
| 10105-5 | ST slope in lead V6 |
| 10106-3 | ST wave end displacement in lead AVF |
| 10107-1 | ST wave end displacement in lead AVL |
| 10108-9 | ST wave end displacement in lead AVR |
| 10109-7 | ST wave end displacement in lead I |
| 1011-6 | Ew Ab [Presence] in Serum or Plasma from donor |
| 10110-5 | ST wave end displacement in lead II |
| 10111-3 | ST wave end displacement in lead III |
| 10112-1 | ST wave end displacement in lead V1 |
| 10113-9 | ST wave end displacement in lead V2 |
| 10114-7 | ST wave end displacement in lead V3 |
| 10115-4 | ST wave end displacement in lead V4 |
| 10116-2 | ST wave end displacement in lead V5 |
| 10117-0 | ST wave end displacement in lead V6 |
| 10118-8 | ST wave mid displacement in lead AVF |
| 10119-6 | ST wave mid displacement in lead AVL |
| 1012-4 | Ew Ab [Presence] in Serum or Plasma |
| 10120-4 | ST wave mid displacement in lead AVR |
| 10121-2 | ST wave mid displacement in lead I |
| 10122-0 | ST wave mid displacement in lead II |
| 10123-8 | ST wave mid displacement in lead III |
| 10124-6 | ST wave mid displacement in lead V1 |
| 10125-3 | ST wave mid displacement in lead V2 |
| 10126-1 | ST wave mid displacement in lead V3 |
| 10127-9 | ST wave mid displacement in lead V4 |
| 10128-7 | ST wave mid displacement in lead V5 |
| 10129-5 | ST wave mid displacement in lead V6 |
| 1013-2 | Ew Ag [Presence] on Red Blood Cells from Blood product unit |
| 10130-3 | T' wave amplitude in lead AVF |
| 10131-1 | T' wave amplitude in lead AVL |
| 10132-9 | T' wave amplitude in lead AVR |
| 10133-7 | T' wave amplitude in lead I |
| 10134-5 | T' wave amplitude in lead II |
| 10135-2 | T' wave amplitude in lead III |
| 10136-0 | T' wave amplitude in lead V1 |
| 10137-8 | T' wave amplitude in lead V2 |
| 10138-6 | T' wave amplitude in lead V3 |
| 10139-4 | T' wave amplitude in lead V4 |
| 1014-0 | Ew Ag [Presence] on Red Blood Cells from donor |
| 10140-2 | T' wave amplitude in lead V5 |
| 10141-0 | T' wave amplitude in lead V6 |
| 10142-8 | T wave amplitude in lead AVF |
| 10143-6 | T wave amplitude in lead AVL |
| 10144-4 | T wave amplitude in lead AVR |
| 10145-1 | T wave amplitude in lead I |
| 10146-9 | T wave amplitude in lead II |
| 10147-7 | T wave amplitude in lead III |
| 10148-5 | T wave amplitude in lead V1 |
| 10149-3 | T wave amplitude in lead V2 |
| 1015-7 | Ew Ag [Presence] on Red Blood Cells |
| 10150-1 | T wave amplitude in lead V3 |
| 10151-9 | T wave amplitude in lead V4 |
| 10152-7 | T wave amplitude in lead V5 |
| 10153-5 | T wave amplitude in lead V6 |
| 10154-3 | Chief complaint Narrative - Reported |
| 10155-0 | History of allergies, reported |
| 10156-8 | History of Childhood diseases Narrative |
| 10157-6 | History of family member diseases Narrative |
| 10158-4 | History of Functional status Narrative |
| 10159-2 | History of Industrial exposure Narrative |
| 1016-5 | E Ab [Presence] in Serum or Plasma from Blood product unit |
| 10160-0 | History of Medication use Narrative |
| 10161-8 | History of Occupational exposure Narrative |
| 10162-6 | History of pregnancies Narrative |
| 10163-4 | History of pregnancies |
| 10164-2 | History of Present illness Narrative |
| 10165-9 | Deprecated History of psychiatric symptoms and diseases Narrative |
| 10166-7 | History of Social function Narrative |
| 10167-5 | History of Surgical procedures Narrative |
| 10168-3 | History of Cardiovascular system disorders Narrative |
| 10169-1 | History of Ear disorders Narrative |
| 1017-3 | E Ab [Presence] in Serum or Plasma from donor |
| 10170-9 | History of Endocrine system disorders Narrative |
| 10171-7 | History of Eyes disorders Narrative |
| 10172-5 | History of Hematologic system disorders Narrative |
| 10173-3 | History of Musculoskeletal system disorders Narrative |
| 10174-1 | History of Nose disorders Narrative |
| 10175-8 | History of Oral cavity disorders Narrative |
| 10176-6 | History of Reproductive system disorders Narrative |
| 10177-4 | History of Respiratory system disorders Narrative |
| 10178-2 | History of Skin disorders Narrative |
| 10179-0 | History of Throat and Neck disorders Narrative |
| 1018-1 | E Ab [Presence] in Serum or Plasma |
| 10180-8 | History of Throat and Neck disorders |
| 10181-6 | History of Urinary tract disorders Narrative |
| 10182-4 | History of Travel Narrative |
| 10183-2 | Hospital discharge medications Narrative |
| 10184-0 | Hospital discharge physical findings Narrative |
| 10185-7 | Hospital discharge procedures Narrative |
| 10186-5 | Identifying information Narrative Observed |
| 10187-3 | Review of systems Narrative - Reported |
| 10188-1 | Review of systems overview Narrative - Reported |
| 10189-9 | Review of systems overview - Reported |
| 1019-9 | E Ag [Presence] on Red Blood Cells from Blood product unit |
| 10190-7 | Mental status Narrative |
| 10191-5 | Physical findings of Abdomen Narrative |
| 10192-3 | Physical findings of Back Narrative |
| 10193-1 | Physical findings of Breasts Narrative |
| 10194-9 | Physical findings of Neurologic deep tendon reflexes Narrative |
| 10195-6 | Physical findings of Ear Narrative |
| 10196-4 | Physical findings of Extremities Narrative |
| 10197-2 | Physical findings of Eye Narrative |
| 10198-0 | Physical findings of Genitourinary tract Narrative |
| 10199-8 | Physical findings of Head Narrative |
| 102-4 | Cefoperazone [Susceptibility] by Serum bactericidal titer |
| 1020-7 | E Ag [Presence] on Red Blood Cells from donor |
| 10200-4 | Physical findings of Heart Narrative |
| 10201-2 | Physical findings of Mouth and Throat and Teeth Narrative |
| 10202-0 | Physical findings of Nervous system Narrative |
| 10203-8 | Physical findings of Nose Narrative |
| 10204-6 | Physical findings of Pelvis Narrative |
| 10205-3 | Physical findings of Rectum Narrative |
| 10206-1 | Physical findings of Skin Narrative |
| 10207-9 | Physical findings of Thorax and Lungs Narrative |
| 10208-7 | Physical findings of Vessels Narrative |
| 10209-5 | Physical findings of Neurologic balance and Coordination Narrative |
| 1021-5 | E Ag [Presence] on Red Blood Cells |
| 10210-3 | Physical findings of General status Narrative |
| 10211-1 | Physical findings of Sense of touch Narrative |
| 10212-9 | Physical findings of Strength Narrative |
| 10213-7 | Surgical operation note anesthesia Narrative |
| 10214-5 | Surgical operation note anesthesia duration |
| 10215-2 | Surgical operation note findings Narrative |
| 10216-0 | Surgical operation note fluids Narrative |
| 10217-8 | Surgical operation note indications [Interpretation] Narrative |
| 10218-6 | Surgical operation note postoperative diagnosis Narrative |
| 10219-4 | Surgical operation note preoperative diagnosis Narrative |
| 1022-3 | Fy sup(a) Ab [Presence] in Serum or Plasma from Blood product unit |
| 10220-2 | Surgical operation note prep time duration |
| 10221-0 | Surgical operation note specimens taken Narrative |
| 10222-8 | Surgical operation note surgical complications [Interpretation] Narrative |
| 10223-6 | Surgical operation note surgical procedure Narrative |
| 10224-4 | Hemodynamic method special circumstances |
| 10225-1 | Cardiac measurement device Institution inventory number |
| 10226-9 | Oxygen content in Intravascular space |
| 10227-7 | Cardiac measurement device Vendor model number |
| 10228-5 | Cardiac measurement device Vendor serial number |
| 10229-3 | Hemodynamic method Type of |
| 1023-1 | Fy sup(a) Ab [Presence] in Serum or Plasma from donor |
| 10230-1 | Left ventricular Ejection fraction |
| 10231-9 | Right ventricular Ejection fraction |
| 10232-7 | Oxygen content in Aorta root |
| 10233-5 | Oxygen content in Left atrium |
| 10234-3 | Oxygen content in Right atrium |
| 10235-0 | Oxygen content in High right atrium |
| 10236-8 | Oxygen content in Low right atrium |
| 10237-6 | Oxygen content in Mid right atrium |
| 10238-4 | Oxygen content in Left ventricle |
| 10239-2 | Oxygen content in Right ventricular outflow tract |
| 1024-9 | Fy sup(a) Ab [Presence] in Serum or Plasma |
| 10240-0 | Oxygen content in Right ventricle |
| 10241-8 | Oxygen content in Coronary sinus |
| 10242-6 | Oxygen content in Ductus arteriosus |
| 10243-4 | Oxygen content in Inferior vena cava |
| 10244-2 | Oxygen content in Left pulmonary artery |
| 10245-9 | Oxygen content in Main pulmonary artery |
| 10246-7 | Oxygen content in Right pulmonary artery |
| 10247-5 | Oxygen content in Pulmonary wedge |
| 10248-3 | Oxygen content in Superior vena cava |
| 10249-1 | Heart rate device Institution inventory number |
| 1025-6 | Fy sup(a) Ag [Presence] on Red Blood Cells from Blood product unit |
| 10250-9 | Heart rate device Vendor model number |
| 10251-7 | Heart rate device Vendor serial number |
| 10252-5 | Biliary drain site |
| 10253-3 | Type of Biliary drain |
| 10254-1 | Type of Peritoneal drain |
| 10255-8 | Type of Subarachnoid drain |
| 10256-6 | Biliary drain Institution inventory number |
| 10257-4 | Chest tube Institution inventory number |
| 10258-2 | Enteral tube Institution inventory number |
| 10259-0 | Gastrostomy tube Institution inventory number |
| 1026-4 | Fy sup(a) Ag [Presence] on Red Blood Cells from donor |
| 10260-8 | GI tube Institution inventory number |
| 10261-6 | Intravascular tube Institution inventory number |
| 10262-4 | IO tube Institution inventory number |
| 10263-2 | Nasogastric tube Institution inventory number |
| 10264-0 | Oral tube Institution inventory number |
| 10265-7 | Peritoneal drain Institution inventory number |
| 10266-5 | Peritoneal tube Institution inventory number |
| 10267-3 | Rate control device Institution inventory number |
| 10268-1 | Stool collection device Institution inventory number |
| 10269-9 | Subarachnoid drain Institution inventory number |
| 1027-2 | Fy sup(a) Ag [Presence] on Red Blood Cells |
| 10270-7 | Synovial drain Institution inventory number |
| 10271-5 | Tube or drain Institution inventory number |
| 10272-3 | Upper GI tube Institution inventory number |
| 10273-1 | Bladder irrigation tube Institution inventory number |
| 10274-9 | Urine tube Institution inventory number |
| 10275-6 | Wound drain device Institution inventory number |
| 10276-4 | Peritoneal drain site |
| 10277-2 | Stool collection site |
| 10278-0 | Subarachnoid drain site |
| 10279-8 | Biliary drain Vendor model number |
| 1028-0 | Fy sup(b) Ab [Presence] in Serum or Plasma from Blood product unit |
| 10280-6 | Chest tube Vendor model number |
| 10281-4 | Enteral tube Vendor model number |
| 10282-2 | Gastrostomy tube Vendor model number |
| 10283-0 | GI tube Vendor model number |
| 10284-8 | Intravascular tube Vendor model number |
| 10285-5 | IO tube Vendor model number |
| 10286-3 | Nasogastric tube Vendor model number |
| 10287-1 | Oral tube Vendor model number |
| 10288-9 | Peritoneal drain Vendor model number |
| 10289-7 | Peritoneal tube Vendor model number |
| 1029-8 | Fy sup(b) Ab [Presence] in Serum or Plasma from donor |
| 10290-5 | Rate control device Vendor model number |
| 10291-3 | Stool collection device Vendor model number |
| 10292-1 | Subarachnoid drain Vendor model number |
| 10293-9 | Synovial drain Vendor model number |
| 10294-7 | Tube or drain Vendor model number |
| 10295-4 | Upper GI tube Vendor model number |
| 10296-2 | Bladder irrigation tube Vendor model number |
| 10297-0 | Urine tube Vendor model number |
| 10298-8 | Wound drain device Vendor model number |
| 10299-6 | Biliary drain Vendor serial number |
| 103-2 | Ceforanide [Susceptibility] by Minimum lethal concentration (MLC) |
| 1030-6 | Fy sup(b) Ab [Presence] in Serum or Plasma |
| 10300-2 | Chest tube Vendor serial number |
| 10301-0 | Enteral tube Vendor serial number |
| 10302-8 | Gastrostomy tube Vendor serial number |
| 10303-6 | GI tube Vendor serial number |
| 10304-4 | Intravascular tube Vendor serial number |
| 10305-1 | IO tube Vendor serial number |
| 10306-9 | Nasogastric tube Vendor serial number |
| 10307-7 | Oral tube Vendor serial number |
| 10308-5 | Peritoneal drain Vendor serial number |
| 10309-3 | Peritoneal tube Vendor serial number |
| 1031-4 | Fy sup(b) Ag [Presence] on Red Blood Cells from Blood product unit |
| 10310-1 | Rate control device Vendor serial number |
| 10311-9 | Stool collection device Vendor serial number |
| 10312-7 | Subarachnoid drain Vendor serial number |
| 10313-5 | Synovial drain Vendor serial number |
| 10314-3 | Tube or drain Vendor serial number |
| 10315-0 | Upper GI tube Vendor serial number |
| 10316-8 | Bladder irrigation tube Vendor serial number |
| 10317-6 | Urine tube Vendor serial number |
| 10318-4 | Wound drain device Vendor serial number |
| 10319-2 | Enema device Institution inventory number |
| 1032-2 | Fy sup(b) Ag [Presence] on Red Blood Cells from donor |
| 10320-0 | Enema device Vendor model number |
| 10321-8 | Enema device Vendor serial number |
| 10322-6 | Potassium intake 24 hour |
| 10323-4 | Wound drain fluid [Appearance] Lower GI tract |
| 10324-2 | Breath rate device Institution inventory number |
| 10325-9 | Breath rate device Vendor model number |
| 10326-7 | Breath rate device Vendor serial number |
| 10327-5 | Eosinophils/100 leukocytes in Sputum by Manual count |
| 10328-3 | Lymphocytes/100 leukocytes in Cerebral spinal fluid by Manual count |
| 10329-1 | Monocytes/100 leukocytes in Cerebral spinal fluid by Manual count |
| 1033-0 | Fy sup(b) Ag [Presence] on Red Blood Cells |
| 10330-9 | Monocytes/100 leukocytes in Body fluid by Manual count |
| 10331-7 | Rh [Type] in Blood |
| 10332-5 | Cortisol [Mass/volume] in Serum or Plasma --pre 250 ug corticotropin IM |
| 10333-3 | Appearance of Cerebral spinal fluid |
| 10334-1 | Cancer Ag 125 [Units/volume] in Serum or Plasma |
| 10335-8 | Color of Cerebral spinal fluid |
| 10336-6 | Gonadotropin peptide [Mass/volume] in Urine |
| 10337-4 | Procollagen type I [Mass/volume] in Serum |
| 10338-2 | Barbiturates [Mass/volume] in Serum or Plasma |
| 10339-0 | Fluoxetine+Norfluoxetine [Mass/volume] in Serum or Plasma |
| 1034-8 | Fetal cell screen [Interpretation] in Blood |
| 10340-8 | Molindone [Mass/volume] in Serum or Plasma |
| 10341-6 | Norpropoxyphene [Mass/volume] in Serum or Plasma |
| 10342-4 | Sulfamethoxazole [Mass/volume] in Serum or Plasma |
| 10343-2 | Temazepam [Mass/volume] in Serum or Plasma |
| 10344-0 | Tranylcypromine [Mass/volume] in Serum or Plasma |
| 10345-7 | Trihexyphenidyl [Mass/volume] in Urine |
| 10346-5 | Hemoglobin A [Units/volume] in Blood by Electrophoresis |
| 10347-3 | Babesia microti identified in Blood by Light microscopy |
| 10348-1 | Bordetella parapertussis Ab [Presence] in Serum |
| 10349-9 | Brucella sp Ab [Units/volume] in Serum |
| 1035-5 | Fresh frozen plasma given [Volume] |
| 10350-7 | Herpes simplex virus IgM Ab [Titer] in Serum by Immunoassay |
| 10351-5 | HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification |
| 10352-3 | Bacteria identified in Genital specimen by Aerobe culture |
| 10353-1 | Bacteria identified in Nose by Aerobe culture |
| 10354-9 | Bacteria identified in Urethra by Culture |
| 10355-6 | Microscopic observation [Identifier] in Bone marrow by Wright Giemsa stain |
| 10356-4 | Deprecated Microscopic observation [Identifier] in Stool by Trichrome stain |
| 10357-2 | Microscopic observation [Identifier] in Wound by Gram stain |
| 10358-0 | Teichoate Ab [Titer] in Serum by Immune diffusion (ID) |
| 10359-8 | Asialoganglioside GM1 IgM Ab [Titer] in Serum |
| 1036-3 | G Ab [Presence] in Serum or Plasma from Blood product unit |
| 10360-6 | DNA single strand IgG Ab [Units/volume] in Serum |
| 10361-4 | DNA single strand IgM Ab [Units/volume] in Serum |
| 10362-2 | Endomysium IgA Ab [Presence] in Serum |
| 10363-0 | Barbiturates [Presence] in Unspecified specimen |
| 10364-8 | Cotinine [Mass/mass] in Hair |
| 10365-5 | Cotinine [Mass/volume] in Serum or Plasma |
| 10366-3 | Cotinine [Mass/volume] in Urine |
| 10367-1 | Ethanol [Mass/volume] in Gastric fluid |
| 10368-9 | Lead [Mass/volume] in Capillary blood |
| 10369-7 | Opiates [Mass/mass] in Hair |
| 1037-1 | G Ab [Presence] in Serum or Plasma from donor |
| 10370-5 | Phencyclidine [Mass/mass] in Hair |
| 10371-3 | Bite cells [Presence] in Blood by Light microscopy |
| 10372-1 | Blister cells [Presence] in Blood by Light microscopy |
| 10373-9 | Fragments [Presence] in Blood by Light microscopy |
| 10374-7 | Helmet cells [Presence] in Blood by Light microscopy |
| 10375-4 | Irregularly contracted cells [Presence] in Blood by Light microscopy |
| 10376-2 | Oval macrocytes [Presence] in Blood by Light microscopy |
| 10377-0 | Pencil cells [Presence] in Blood by Light microscopy |
| 10378-8 | Polychromasia [Presence] in Blood by Light microscopy |
| 10379-6 | Erythrocytes.dual population [Presence] in Blood by Light microscopy |
| 1038-9 | G Ab [Presence] in Serum or Plasma |
| 10380-4 | Stomatocytes [Presence] in Blood by Light microscopy |
| 10381-2 | Target cells [Presence] in Blood by Light microscopy |
| 10382-0 | A,B variant NOS Ag [Presence] on Red Blood Cells from Blood product unit |
| 10383-8 | A,B variant NOS Ag [Presence] on Red Blood Cells from donor |
| 10384-6 | A,B variant NOS Ag [Presence] on Red Blood Cells |
| 10385-3 | Albumin concentration given |
| 10386-1 | Albumin given [Volume] |
| 10387-9 | Autologous erythrocytes given [Volume] |
| 10388-7 | Autologous whole blood given [Volume] |
| 10389-5 | Blood product.other [Type] |
| 1039-7 | G Ag [Presence] on Red Blood Cells from Blood product unit |
| 10390-3 | Blood product special preparation [Type] |
| 10391-1 | Cytomegalovirus immune globulin given [Volume] |
| 10392-9 | Cryoprecipitate given [Volume] |
| 10393-7 | Factor IX given [Type] |
| 10394-5 | Factor IX given [Volume] |
| 10395-2 | Factor VIII given [Type] |
| 10396-0 | Factor VIII given [Volume] |
| 10397-8 | Hepatitis B immune globulin given [Volume] |
| 10398-6 | I Ag [Presence] on Red Blood Cells from Blood product unit |
| 10399-4 | I Ag [Presence] on Red Blood Cells from donor |
| 104-0 | Ceforanide [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 1040-5 | G Ag [Presence] on Red Blood Cells from donor |
| 10400-0 | I Ag [Presence] on Red Blood Cells |
| 10401-8 | Immune serum globulin given [Type] |
| 10402-6 | Immune serum globulin given [Volume] |
| 10403-4 | Inject immune serum globulin [Volume] |
| 10404-2 | Inject Rh immune globulin [Volume] |
| 10405-9 | Inject varicella zoster virus immune globulin [Volume] |
| 10406-7 | little i Ag [Presence] on Red Blood Cells from Blood product unit |
| 10407-5 | little i Ag [Presence] on Red Blood Cells from donor |
| 10408-3 | little i Ag [Presence] on Red Blood Cells |
| 10409-1 | Pentaspan given [Volume] |
| 1041-3 | G Ag [Presence] on Red Blood Cells |
| 10410-9 | Plasma given [Type] |
| 10411-7 | Plasma given [Volume] |
| 10412-5 | Platelets given [Type] |
| 10413-3 | Rh immune globulin given [Volume] |
| 10414-1 | Transfuse albumin [Volume] |
| 10415-8 | Transfuse blood exchange transfusion [Volume] |
| 10416-6 | Transfuse blood product other [Volume] |
| 10417-4 | Transfuse cryoprecipitate [Volume] |
| 10418-2 | Transfuse factor IX [Volume] |
| 10419-0 | Transfuse factor VIII [Volume] |
| 1042-1 | H Ab [Presence] in Serum or Plasma from Blood product unit |
| 10420-8 | Transfuse immune serum globulin [Volume] |
| 10421-6 | Transfuse Pentaspan [Volume] |
| 10422-4 | Transfuse plasma [Volume] |
| 10423-2 | Transfuse platelets [Volume] |
| 10424-0 | Transfuse erythrocytes [Volume] |
| 10425-7 | Transfuse Rh immune globulin [Volume] |
| 10426-5 | Transfuse whole blood [Volume] |
| 10427-3 | Transfuse whole blood autologous [Volume] |
| 10428-1 | Varicella zoster virus immune globulin given [Volume] |
| 10429-9 | AE 1 Ag [Presence] in Tissue by Immune stain |
| 1043-9 | H Ab [Presence] in Serum or Plasma from donor |
| 10430-7 | AE 3 Ag [Presence] in Tissue by Immune stain |
| 10431-5 | B-cell Ag [Presence] in Tissue by Immune stain |
| 10432-3 | CD30 Ag [Presence] in Tissue by Immune stain |
| 10433-1 | BR-2 Ag [Presence] in Tissue by Immune stain |
| 10434-9 | Complement C3 Ag [Presence] in Tissue by Immune stain |
| 10435-6 | C5B-9 Ag [Presence] in Tissue by Immune stain |
| 10436-4 | CD15 Ag [Presence] in Tissue by Immune stain |
| 10437-2 | CD16 Ag [Presence] in Tissue by Immune stain |
| 10438-0 | CD20 Ag [Presence] in Tissue by Immune stain |
| 10439-8 | CD3 Ag [Presence] in Tissue by Immune stain |
| 1044-7 | H Ab [Presence] in Serum |
| 10440-6 | Deprecated CD30 Ag [Presence] in Tissue by Immune stain |
| 10441-4 | CD34 Ag [Presence] in Tissue by Immune stain |
| 10442-2 | CD56 Ag [Presence] in Tissue by Immune stain |
| 10443-0 | CD43 T-cell monocyte+myeloid cell Ag [Presence] in Tissue by Immune stain |
| 10444-8 | CD57 Ag [Presence] in Tissue by Immune stain |
| 10445-5 | CD11c Ag [Presence] in Tissue by Immune stain |
| 10446-3 | Leukocyte common Ag [Presence] in Tissue by Immune stain |
| 10447-1 | M-5 Ag [Presence] in Tissue by Immune stain |
| 10448-9 | T-cell Ag [Presence] in Tissue by Immune stain |
| 10449-7 | Glucose [Mass/volume] in Serum or Plasma --1 hour post meal |
| 1045-4 | H NOS Ab [Presence] in Serum or Plasma from Blood product unit |
| 10450-5 | Glucose [Mass/volume] in Serum or Plasma --10 hours fasting |
| 10451-3 | Proinsulin [Moles/volume] in Serum or Plasma --12 hours fasting |
| 10452-1 | Xylose [Mass/volume] in Serum or Plasma --1 hour post 25 g xylose PO |
| 10453-9 | Xylose [Mass/volume] in Serum or Plasma --1 hour post dose xylose PO |
| 10454-7 | Xylose [Mass/volume] in Serum or Plasma --2 hours post 25 g xylose PO |
| 10455-4 | Xylose [Mass/volume] in Serum or Plasma --30 minutes post 25 g xylose PO |
| 10456-2 | Xylose [Mass/volume] in Serum or Plasma --6 hours fasting |
| 10457-0 | Actin Ag [Presence] in Tissue by Immune stain |
| 10458-8 | Alkaline phosphatase.placental Ag [Presence] in Tissue by Immune stain |
| 10459-6 | Alpha-1-Fetoprotein Ag [Presence] in Tissue by Immune stain |
| 1046-2 | H NOS Ab [Presence] in Serum or Plasma from donor |
| 10460-4 | Lactalbumin alpha Ag [Presence] in Tissue by Immune stain |
| 10461-2 | Alpha-1-Antichymotrypsin Ag [Presence] in Tissue by Immune stain |
| 10462-0 | Alpha 1 antitrypsin Ag [Presence] in Tissue by Immune stain |
| 10463-8 | Amyloid A component Ag [Presence] in Tissue by Immune stain |
| 10464-6 | Amyloid P component Ag [Presence] in Tissue by Immune stain |
| 10465-3 | Amyloid.prealbumin Ag [Presence] in Tissue by Immune stain |
| 10466-1 | Anion gap 3 in Serum or Plasma |
| 10467-9 | Beta-2-Microglobulin amyloid Ag [Presence] in Tissue by Immune stain |
| 10468-7 | Calcitonin Ag [Presence] in Tissue by Immune stain |
| 10469-5 | Carcinoembryonic Ag [Presence] in Tissue by Immune stain |
| 1047-0 | H NOS Ab [Presence] in Serum or Plasma |
| 10470-3 | Choriogonadotropin Ag [Presence] in Tissue by Immune stain |
| 10471-1 | Chromogranin A Ag [Presence] in Tissue by Immune stain |
| 10472-9 | Chromogranin Ag [Presence] in Tissue by Immune stain |
| 10473-7 | Chymotrypsin Ag [Presence] in Tissue by Immune stain |
| 10474-5 | Collagen type 4 Ag [Presence] in Tissue by Immune stain |
| 10475-2 | Corticotropin Ag [Presence] in Tissue by Immune stain |
| 10476-0 | Desmin Ag [Presence] in Tissue by Immune stain |
| 10477-8 | Enolase.neuron specific Ag [Presence] in Tissue by Immune stain |
| 10478-6 | Eosinophil major basic protein Ag [Presence] in Tissue by Immune stain |
| 10479-4 | CD227 Ag [Presence] in Tissue by Immune stain |
| 1048-8 | H NOS Ag [Presence] on Red Blood Cells from Blood product unit |
| 10480-2 | Estrogen+Progesterone receptor Ag [Presence] in Tissue by Immune stain |
| 10481-0 | Follitropin.alpha subunit Ag [Presence] in Tissue by Immune stain |
| 10482-8 | Follitropin.beta subunit Ag [Presence] in Tissue by Immune stain |
| 10483-6 | Gastrin Ag [Presence] in Tissue by Immune stain |
| 10484-4 | Glial fibrillary acidic protein Ag [Presence] in Tissue by Immune stain |
| 10485-1 | Glucagon Ag [Presence] in Tissue by Immune stain |
| 10486-9 | Hemoglobin Ag [Presence] in Tissue by Immune stain |
| 10487-7 | HMB-45 Ag [Presence] in Tissue by Immune stain |
| 10488-5 | IgA Ag [Presence] in Tissue by Immune stain |
| 10489-3 | IgA.heavy chain Ag [Presence] in Tissue by Immune stain |
| 1049-6 | H NOS Ag [Presence] on Red Blood Cells from donor |
| 10490-1 | IgE Ag [Presence] in Tissue by Immune stain |
| 10491-9 | IgG Ag [Presence] in Tissue by Immune stain |
| 10492-7 | IgG.heavy chain Ag [Presence] in Tissue by Immune stain |
| 10493-5 | IgM Ag [Presence] in Tissue by Immune stain |
| 10494-3 | IgM.heavy chain Ag [Presence] in Tissue by Immune stain |
| 10495-0 | Insulin Ag [Presence] in Tissue by Immune stain |
| 10496-8 | Immunoglobulin light chains.kappa Ag [Presence] in Tissue by Immune stain |
| 10497-6 | Immunoglobulin light chains.kappa amyloid Ag [Presence] in Tissue by Immune stain |
| 10498-4 | Keratin Ag [Presence] in Tissue by Immune stain |
| 10499-2 | Immunoglobulin light chains.lambda Ag [Presence] in Tissue by Immune stain |
| 105-7 | Ceforanide [Susceptibility] by Disk diffusion (KB) |
| 1050-4 | H NOS Ag [Presence] on Red Blood Cells |
| 10500-7 | Immunoglobulin light chains.lambda amyloid Ag [Presence] in Tissue by Immune stain |
| 10501-5 | Lutropin [Units/volume] in Serum or Plasma |
| 10502-3 | Lutropin Ag [Presence] in Tissue by Immune stain |
| 10503-1 | Lysozyme Ag [Presence] in Tissue by Immune stain |
| 10504-9 | Myelin basic protein Ag [Presence] in Tissue by Immune stain |
| 10505-6 | Myoglobin Ag [Presence] in Tissue by Immune stain |
| 10506-4 | Peanut agglutinin Ag [Presence] in Tissue by Immune stain |
| 10507-2 | Prolactin Ag [Presence] in Tissue by Immune stain |
| 10508-0 | Prostate specific Ag [Presence] in Tissue by Immune stain |
| 10509-8 | Prostatic acid phosphatase Ag [Presence] in Tissue by Immune stain |
| 1051-2 | Hemolytic disease of newborn screen [Interpretation] in Blood |
| 10510-6 | S-100 Ag Ag [Presence] in Tissue by Immune stain |
| 10511-4 | Serotonin Ag [Presence] in Tissue by Immune stain |
| 10512-2 | Somatostatin Ag [Presence] in Tissue by Immune stain |
| 10513-0 | Somatotropin Ag [Presence] in Tissue by Immune stain |
| 10514-8 | Synaptophysin Ag [Presence] in Tissue by Immune stain |
| 10515-5 | Thyroglobulin Ag [Presence] in Tissue by Immune stain |
| 10516-3 | Thyrotropin Ag [Presence] in Tissue by Immune stain |
| 10517-1 | Trypsin Ag [Presence] in Tissue by Immune stain |
| 10518-9 | Ulex europaeus I lectin Ag [Presence] in Tissue by Immune stain |
| 10519-7 | Vimentin Ag [Presence] in Tissue by Immune stain |
| 1052-0 | Deprecated I (intermediate) subtype [Presence] in Serum or Plasma from Blood product unit |
| 10520-5 | Coagulation factor VI Ag [Presence] in Tissue by Immune stain |
| 10521-3 | Coagulation factor VIII Ag [Presence] in Tissue by Immune stain |
| 10522-1 | Coagulation factor XIII Ag [Presence] in Tissue by Immune stain |
| 10523-9 | Fibrinogen Ag [Presence] in Tissue by Immune stain |
| 10524-7 | Microscopic observation [Identifier] in Cervix by Cyto stain |
| 10525-4 | Microscopic observation [Identifier] in Unspecified specimen by Cyto stain |
| 10526-2 | Microscopic observation [Identifier] in Sputum by Cyto stain |
| 10527-0 | Microscopic observation [Identifier] in Tissue by Cyto stain |
| 10528-8 | Acetophenazine [Mass/volume] in Serum or Plasma |
| 10529-6 | Amoxapine metabolite [Mass/volume] in Serum or Plasma |
| 1053-8 | Deprecated I (intermediate) subtype [Presence] in serum or plasma from donor |
| 10530-4 | Aprobarbital [Mass/volume] in Serum or Plasma |
| 10531-2 | Bretylium [Mass/volume] in Serum or Plasma |
| 10532-0 | Deprecated Desethylamiodarone [Mass/volume] in Serum or Plasma |
| 10533-8 | Propoxyphene+Acetaminophen [Mass/volume] in Serum or Plasma |
| 10534-6 | Diazoxide [Mass/volume] in Serum or Plasma |
| 10535-3 | Digoxin [Mass/volume] in Serum or Plasma |
| 10536-1 | Dipyridamole [Mass/volume] in Serum or Plasma |
| 10537-9 | Deprecated Doxepin+Nordoxepin [Mass/volume] in Serum or Plasma |
| 10538-7 | Deprecated Fluoxetine+Norfluoxetine [Mass/volume] in Serum or Plasma |
| 10539-5 | Glipizide [Mass/volume] in Serum or Plasma |
| 1054-6 | Deprecated I (intermediate) subtype [Presence] in srum |
| 10540-3 | Glyburide [Mass/volume] in Serum or Plasma |
| 10541-1 | Mepivacaine [Mass/volume] in Serum or Plasma |
| 10542-9 | Metharbital [Mass/volume] in Serum or Plasma |
| 10543-7 | Methsuximide+Normethsuximide [Mass/volume] in Serum or Plasma |
| 10544-5 | Normeperidine [Presence] in Serum or Plasma |
| 10545-2 | Normephenytoin [Mass/volume] in Serum or Plasma |
| 10546-0 | Normethsuximide [Mass/volume] in Serum or Plasma |
| 10547-8 | Primidone+Phenobarbital [Mass/volume] in Serum or Plasma |
| 10548-6 | Phenytoin Free/Phenytoin.total in Serum or Plasma |
| 10549-4 | Pirmenol [Mass/volume] in Serum or Plasma |
| 1055-3 | Deprecated I (intermediate) subtype [Presence] on Red Blood Cells from Blood product unit |
| 10550-2 | Deprecated Temazepam [Mass/volume] in Serum or Plasma |
| 10551-0 | Triamterene [Mass/volume] in Serum or Plasma |
| 10552-8 | Tricyclic antidepressants [Mass/volume] in Serum or Plasma |
| 10553-6 | Prostatic acid phosphatase [Enzymatic activity/volume] in Genital fluid |
| 10554-4 | Deprecated Prostatic acid phosphatase [Enzymatic activity/volume] in Seminal plasma |
| 10555-1 | Acrosin [Entitic Catalytic Activity] in Spermatozoa |
| 10556-9 | Deprecated Adenosine triphosphatase [Enzymatic activity/volume] in Seminal plasma |
| 10557-7 | Adenosine triphosphate [Moles/volume] in Semen |
| 10558-5 | Albumin [Moles/volume] in Semen |
| 10559-3 | Deprecated Calcium [Molecules/volume] in Semen |
| 1056-1 | Deprecated I (intermediate) subtype [Presence] on Red Blood Cells from donor |
| 10560-1 | Carcinoembryonic Ag [Units/volume] in Semen |
| 10561-9 | Carnitine [Moles/volume] in Semen |
| 10562-7 | Cells [#/volume] in Cervical mucus |
| 10563-5 | Cells other than spermatozoa [#/volume] in Semen |
| 10564-3 | Cervical mucus [Volume] |
| 10565-0 | Choriogonadotropin [Units/volume] in Semen |
| 10566-8 | Deprecated Choriogonadotropin [Molecules/volume] in Semen |
| 10567-6 | Citrate [Moles/volume] in Semen |
| 10568-4 | Clarity of Semen |
| 10569-2 | Color of Semen |
| 1057-9 | Deprecated I (intermediate) subtype [Presence] on Red Blood Cells |
| 10570-0 | Consistency of Cervical mucus |
| 10571-8 | Deprecated Consistency of Semen |
| 10572-6 | Deprecated Duration^post ejaculation |
| 10573-4 | Ferning [Type] in Cervical mucus |
| 10574-2 | Fructose [Moles/volume] in Semen |
| 10575-9 | Deprecated Gamma glutamyl transferase [Enzymatic activity/volume] in Semen |
| 10576-7 | Germ cells.immature [#/volume] in Semen |
| 10577-5 | Glucosidase [Enzymatic activity/volume] in Seminal plasma |
| 10578-3 | Glycerophosphocholine [Moles/volume] in Seminal plasma |
| 10579-1 | Leukocytes [#/volume] in Semen |
| 1058-7 | I Ab [Presence] in Serum or Plasma from Blood product unit |
| 10580-9 | Liquefaction [Time] in Semen |
| 10581-7 | Deprecated Number of entities [#] in Spermatozoa |
| 10582-5 | pH of Cervical mucus |
| 10583-3 | Prostaglandin F1 alpha [Moles/volume] in Semen |
| 10584-1 | Deprecated Protein [Mass/volume] in Semen |
| 10585-8 | Round cells [#/volume] in Semen |
| 10586-6 | Deprecated Volume of Semen |
| 10587-4 | Sexual abstinence duration |
| 10588-2 | Spermatogonia [#/volume] in Semen |
| 10589-0 | Spermatids [#/volume] in Semen by Streptoavidin-biotin method (SAB) |
| 1059-5 | I Ab [Presence] in Serum or Plasma from donor |
| 10590-8 | Spermatids [#/volume] in Semen by Sertoli cell barrier method (SCB) |
| 10591-6 | Primary Spermatocytes [#/volume] in Semen |
| 10592-4 | Secondary Spermatocytes [#/volume] in Semen |
| 10593-2 | Spermatozoa Pyriform Head/100 spermatozoa in Semen |
| 10594-0 | Spermatozoa Tapering Head/100 spermatozoa in Semen |
| 10595-7 | Deprecated Spermatozoa [#/volume] in Semen |
| 10596-5 | Deprecated Spermatozoa Ab in cervical mucosa |
| 10597-3 | Deprecated Spermatozoa Ab in semen |
| 10598-1 | Deprecated Spermatozoa Ab in serum |
| 10599-9 | Spermatozoa penetration [Presence] in Seminal fluid and Cervical mucosa by Kremer test |
| 106-5 | Ceforanide [Susceptibility] by Serum bactericidal titer |
| 1060-3 | I Ab [Presence] in Serum or Plasma |
| 10600-5 | Spermatozoa penetration [Presence] in Seminal fluid and Cervical mucosa |
| 10601-3 | Spermatozoa penetration [Presence] in Seminal fluid and Cervical mucosa --post coitus |
| 10602-1 | Spermatozoa Abnormal Head/100 spermatozoa in Semen |
| 10603-9 | Spermatozoa Abnormal Midpiece/100 spermatozoa in Semen |
| 10604-7 | Spermatozoa Abnormal Tail/100 spermatozoa in Semen |
| 10605-4 | Spermatozoa Agglutinated/100 spermatozoa in Semen |
| 10606-2 | Spermatozoa Amorphous Head/100 spermatozoa in Semen |
| 10607-0 | Spermatozoa Coiled Tail/100 spermatozoa in Semen |
| 10608-8 | Spermatozoa Cytoplasmic Droplet/100 spermatozoa in Semen |
| 10609-6 | Spermatozoa Duplicate Head/100 spermatozoa in Semen |
| 1061-1 | I NOS Ab [Presence] in Serum or Plasma from Blood product unit |
| 10610-4 | Spermatozoa Duplicate Tail/100 spermatozoa in Semen |
| 10611-2 | Spermatozoa Immotile/100 spermatozoa in Semen |
| 10612-0 | Spermatozoa Large Oval Head/100 spermatozoa in Semen |
| 10613-8 | Spermatozoa Viable/100 spermatozoa in Semen |
| 10614-6 | Spermatozoa Motile w IgA/100 spermatozoa in Semen by Immunobead |
| 10615-3 | Spermatozoa Motile w IgA/100 spermatozoa in Semen by Mixed antiglobulin reaction |
| 10616-1 | Spermatozoa Motile w IgG/100 spermatozoa in Semen by Immunobead |
| 10617-9 | Spermatozoa Motile w IgG/100 spermatozoa in Semen by Mixed antiglobulin reaction |
| 10618-7 | Spermatozoa Motile w IgM/100 spermatozoa in Semen by Immunobead |
| 10619-5 | Spermatozoa Motile w IgM/100 spermatozoa in Semen by Mixed antiglobulin reaction |
| 1062-9 | I NOS Ab [Presence] in Serum or Plasma from donor |
| 10620-3 | Spermatozoa Nonprogressive/100 spermatozoa in Semen |
| 10621-1 | Spermatozoa Normal Head/100 spermatozoa in Semen |
| 10622-9 | Spermatozoa Normal/100 spermatozoa in Semen |
| 10623-7 | Spermatozoa Pin Head/100 spermatozoa in Semen |
| 10624-5 | Spermatozoa Rapid/100 spermatozoa in Semen |
| 10625-2 | Spermatozoa Round Head/100 spermatozoa in Semen |
| 10626-0 | Spermatozoa Slow/100 spermatozoa in Semen |
| 10627-8 | Spermatozoa Small Oval Head/100 spermatozoa in Semen |
| 10628-6 | Spermatozoa Tail Swelling/100 spermatozoa in Semen |
| 10629-4 | Spermatozoa Vacuolated Head/100 spermatozoa in Semen |
| 1063-7 | I NOS Ab [Presence] in Serum or Plasma |
| 10630-2 | Spinnbarkeit [Length] in Cervical mucus |
| 10631-0 | Testosterone [Moles/volume] in Semen |
| 10632-8 | Time until next menstrual period |
| 10633-6 | Zinc [Moles/volume] in Semen |
| 10634-4 | Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma |
| 10635-1 | Acanthamoeba sp identified in Eye by Organism specific culture |
| 10636-9 | Acanthamoeba sp identified in Eye by Wet preparation |
| 10637-7 | Microscopic observation [Identifier] in Tissue by Night blue stain |
| 10638-5 | Thermophilic Actinomycetes colony count [#/volume] in Unspecified specimen by Organism specific culture |
| 10639-3 | Thermophilic Actinomycetes identified in Unspecified specimen by Organism specific culture |
| 1064-5 | I NOS Ag [Presence] on Red Blood Cells from Blood product unit |
| 10640-1 | Deprecated Adenovirus 40+41 [Identifier] in Stool by Electron microscopy |
| 10641-9 | Amoeba identified in Aspirate by Immune stain |
| 10642-7 | Amoeba identified in Aspirate by Wet preparation |
| 10643-5 | Amoeba identified in Stool by Organism specific culture |
| 10644-3 | Arthropod identified in Unspecified specimen |
| 10645-0 | Aspergillus fumigatus Ag [Presence] in Tissue by Immunofluorescence |
| 10646-8 | Astrovirus [Identifier] in Stool by Electron microscopy |
| 10647-6 | Babesia sp identified in Blood by Thick film |
| 10648-4 | Babesia sp identified in Blood by Thin film |
| 10649-2 | Calicivirus [Identifier] in Stool by Electron microscopy |
| 1065-2 | I NOS Ag [Presence] on Red Blood Cells from donor |
| 10650-0 | Candida sp DNA [Presence] in Blood by Probe with amplification |
| 10651-8 | Chlamydophila pneumoniae Ag [Presence] in Sputum or Bronchial |
| 10652-6 | Chlamydophila pneumoniae DNA [Presence] in Sputum or Bronchial by Probe with amplification |
| 10653-4 | Clotrimazole [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 10654-2 | Clotrimazole [Susceptibility] by Minimum lethal concentration (MLC) |
| 10655-9 | Coccidia identified in Duodenal fluid by Acid fast stain |
| 10656-7 | Coccidia identified in Stool by Acid fast stain |
| 10657-5 | Deprecated Cryptococcus neoformans Ag [Presence] in Tissue by Immunofluorescence |
| 10658-3 | Cyanobacterium identified in Water by Light microscopy |
| 10659-1 | Cyclospora sp identified in Stool by Acid fast stain |
| 1066-0 | I NOS Ag [Presence] on Red Blood Cells |
| 10660-9 | Cytomegalovirus Ag [Presence] in Tissue by Immune stain |
| 10661-7 | Dinoflagellate identified in Water by Light microscopy |
| 10662-5 | Filaria identified in Blood by Concentration |
| 10663-3 | Filaria identified in Blood by Thick film |
| 10664-1 | Filaria identified in Blood by Thin film |
| 10665-8 | Fungus colony count [#/volume] in Unspecified specimen by Environmental culture |
| 10666-6 | Fungus identified in Tissue by Fontana-Masson stain |
| 10667-4 | Fungus identified in Unspecified specimen by Animal inoculation |
| 10668-2 | Fungus identified in Unspecified specimen by Environmental culture |
| 10669-0 | Fungus identified in Unspecified specimen by Sticky tape for environmental fungus |
| 1067-8 | Jk sup(a) Ab [Presence] in Serum or Plasma from Blood product unit |
| 10670-8 | Giardia lamblia [Presence] in Stool by Organism specific culture |
| 10671-6 | Helminth identified in Unspecified specimen |
| 10672-4 | Helminth+Arthropod identified in Unspecified specimen |
| 10673-2 | Hepatitis B virus core Ag [Presence] in Tissue by Immune stain |
| 10674-0 | Hepatitis B virus surface Ag [Presence] in Tissue by Immune stain |
| 10675-7 | Hepatitis B virus surface Ag [Presence] in Tissue by Orcein stain |
| 10676-5 | Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification |
| 10677-3 | Herpes simplex virus 1 Ag [Presence] in Tissue by Immune stain |
| 10678-1 | Herpes simplex virus 1+2 Ag [Presence] in Tissue by Immune stain |
| 10679-9 | Herpes simplex virus 2 Ag [Presence] in Tissue by Immune stain |
| 1068-6 | Jk sup(a) Ab [Presence] in Serum or Plasma from donor |
| 10680-7 | Herpes simplex virus identified in Cerebral spinal fluid by Electron microscopy |
| 10681-5 | Herpes simplex virus identified in Tissue by Electron microscopy |
| 10682-3 | Deprecated HIV 1 RNA [Units/volume] in Serum or Plasma by Probe with amplification |
| 10683-1 | Hydatid cyst identified in Aspirate by Immune stain |
| 10684-9 | Hydatid cyst identified in Liver by Wet preparation |
| 10685-6 | Hydatid cyst identified in Lung tissue by Wet preparation |
| 10686-4 | Leishmania sp identified in Tissue by Giemsa stain |
| 10687-2 | Leishmania sp identified in Tissue by Organism specific culture |
| 10688-0 | Microscopic observation [Identifier] in Hair by KOH preparation |
| 10689-8 | Microscopic observation [Identifier] in Nail by KOH preparation |
| 1069-4 | Jk sup(a) Ab [Presence] in Serum or Plasma |
| 10690-6 | Microsporidia identified in Duodenal fluid by Trichrome stain modified |
| 10691-4 | Mushroom.toxic identified by Inspection |
| 10692-2 | Mushroom.toxic identified in Food by Light microscopy |
| 10693-0 | Mushroom.toxic identified in Vomitus by Light microscopy |
| 10694-8 | Naegleria sp identified in Tissue by Organism specific culture |
| 10695-5 | Naegleria sp identified in Tissue by Wet preparation |
| 10696-3 | Norovirus [Identifier] in Stool by Electron microscopy |
| 10697-1 | Nystatin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 10698-9 | Nystatin [Susceptibility] by Minimum lethal concentration (MLC) |
| 10699-7 | Onchocerca sp identified in Tissue by Wet preparation |
| 107-3 | Cefotaxime [Susceptibility] by Minimum lethal concentration (MLC) |
| 1070-2 | Jk sup(a) Ag [Presence] on Red Blood Cells from Blood product unit |
| 10700-3 | Orthopoxvirus [Identifier] in Skin by Electron microscopy |
| 10701-1 | Ova and parasites identified in Stool by Concentration |
| 10702-9 | Ova and parasites identified in Stool by Immune stain |
| 10703-7 | Ova and parasites identified in Stool by Kinyoun iron hematoxylin stain |
| 10704-5 | Ova and parasites identified in Stool by Light microscopy |
| 10705-2 | Human papilloma virus Ag [Presence] in Tissue by Immune stain |
| 10706-0 | Picornavirus [Identifier] in Stool by Electron microscopy |
| 10707-8 | Toxic Plant identified in plant specimen by Inspection |
| 10708-6 | Toxic Plant identified in Vomitus by Light microscopy |
| 10709-4 | Plasmodium falciparum Ag [Units/volume] in Blood by Immunofluorescence |
| 1071-0 | Jk sup(a) Ag [Presence] on Red Blood Cells from donor |
| 10710-2 | Plasmodium sp identified in Blood by Thin film |
| 10711-0 | Plasmodium vivax Ag [Units/volume] in Blood by Immunofluorescence |
| 10712-8 | Pneumocystis sp identified in Lung tissue |
| 10713-6 | Prototheca identified in Unspecified specimen by Culture |
| 10714-4 | Deprecated Rotavirus [Identifier] in Stool by Electron microscopy |
| 10715-1 | Schistosoma sp identified in Urine sediment by Light microscopy |
| 10716-9 | Schistosoma sp identified in Unspecified specimen by Organism specific culture |
| 10717-7 | Streptococcus pneumoniae Ab [Units/volume] in Serum by Latex agglutination |
| 10718-5 | Strongyloides sp Ab [Units/volume] in Serum by Immunoassay |
| 10719-3 | Taenia solium adult Ab [Units/volume] in Serum by Immunoblot (IB) |
| 1072-8 | Jk sup(a) Ag [Presence] on Red Blood Cells |
| 10720-1 | Terbinafine [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 10721-9 | Terbinafine [Susceptibility] by Minimum lethal concentration (MLC) |
| 10722-7 | Torovirus [Identifier] in Stool by Electron microscopy |
| 10723-5 | Toxoplasma gondii IgA Ab [Units/volume] in Serum by Immunoassay |
| 10724-3 | Toxoplasma gondii IgE Ab [Units/volume] in Serum by Immunoassay |
| 10725-0 | Toxoplasma gondii DNA [Units/volume] in Body fluid by Probe with amplification |
| 10726-8 | Toxoplasma gondii [Presence] in Tissue by Giemsa stain |
| 10727-6 | Toxoplasma gondii identified in Tissue |
| 10728-4 | Trichomonas sp identified in Genital specimen by Organism specific culture |
| 10729-2 | Trypanosoma sp identified in Blood by Light microscopy |
| 1073-6 | Jk sup(b) Ab [Presence] in Serum or Plasma from Blood product unit |
| 10730-0 | Trypanosoma sp identified in Blood by Organism specific culture |
| 10731-8 | Trypanosoma sp identified in Blood by Thick film |
| 10732-6 | Trypanosoma sp identified in Blood by Thin film |
| 10733-4 | Trypanosoma sp identified in Blood by Wet preparation |
| 10734-2 | Varicella zoster virus identified in Skin by Electron microscopy |
| 10735-9 | Viral sequencing [Identifier] in Serum by Sequencing |
| 10736-7 | Virus identified in Cerebral spinal fluid by Electron microscopy |
| 10737-5 | Virus identified in Stool by Electron microscopy |
| 10738-3 | Virus identified in Tissue by Electron microscopy |
| 10739-1 | Virus identified in Unspecified specimen by Electron microscopy |
| 1074-4 | Jk sup(b) Ab [Presence] in Serum or Plasma from donor |
| 10740-9 | Aluminum.microscopic observation [Identifier] in Bone by Histomorphometry stain |
| 10741-7 | Amyloid.microscopic observation [Identifier] in Brain by Thioflavine-S stain |
| 10742-5 | Amyloid.microscopic observation [Identifier] in Tissue by Bennhold stain.Putchler modified |
| 10743-3 | Amyloid.microscopic observation [Identifier] in Tissue by Highman stain |
| 10744-1 | Amyloid.microscopic observation [Identifier] in Tissue by Vassar-culling stain |
| 10745-8 | Bile.microscopic observation [Identifier] in Tissue by Fouchet stain |
| 10746-6 | Calcium.microscopic observation [Identifier] in Tissue by Von Kossa stain |
| 10747-4 | Collagen fibers+Elastic fibers.microscopic observation [Identifier] in Tissue by Lawson-Van Gieson stain |
| 10748-2 | Collagen fibers+Elastic fibers.microscopic observation [Identifier] in Tissue by Verhoeff-Van Gieson stain |
| 10749-0 | Collagen fibers.microscopic observation [Identifier] in Tissue by Van Gieson stain |
| 1075-1 | Jk sup(b) Ab [Presence] in Serum or Plasma |
| 10750-8 | Connective tissue.microscopic observation [Identifier] in Tissue by Trichrome stain.Masson |
| 10751-6 | Copper.microscopic observation [Identifier] in Tissue by Rhodamine stain |
| 10752-4 | Fat.microscopic observation [Identifier] in Milk by Sudan IV stain |
| 10753-2 | Fat.microscopic observation [Identifier] in Stool by Sudan IV stain |
| 10754-0 | Fat.microscopic observation [Identifier] in Tissue by Sudan IV stain |
| 10755-7 | Fungus.microscopic observation [Identifier] in Tissue by Methenamine silver stain.Grocott |
| 10756-5 | Glial fibers.microscopic observation [Identifier] in Tissue by Holzer stain |
| 10757-3 | Hematologic+Nuclear elements.microscopic observation [Identifier] in Tissue by Giemsa stain.May-Grunwald |
| 10758-1 | Iron.microscopic observation [Identifier] in Bone by Histomorphometry stain |
| 10759-9 | Iron.microscopic observation [Identifier] in Sputum by Gomori stain |
| 1076-9 | Jk sup(b) Ag [Presence] on Red Blood Cells from Blood product unit |
| 10760-7 | Iron.microscopic observation [Identifier] in Tissue by Gomori stain |
| 10761-5 | Iron.microscopic observation [Identifier] in Tissue by Other stain |
| 10762-3 | Microscopic observation [Identifier] in Blood by Hemosiderin stain |
| 10763-1 | Microscopic observation [Identifier] in Body fluid by Sudan black stain |
| 10764-9 | Microscopic observation [Identifier] in Sputum by Silver stain |
| 10765-6 | Microscopic observation [Identifier] in Tissue by Acetate esterase stain |
| 10766-4 | Microscopic observation [Identifier] in Tissue by Alcian blue stain |
| 10767-2 | Microscopic observation [Identifier] in Tissue by Alcian blue stain.sulfated |
| 10768-0 | Microscopic observation [Identifier] in Tissue by Alcian blue stain.with periodic acid-Schiff |
| 10769-8 | Microscopic observation [Identifier] in Tissue by Alizarin red S stain |
| 1077-7 | Jk sup(b) Ag [Presence] on Red Blood Cells from donor |
| 10770-6 | Microscopic observation [Identifier] in Tissue by Argentaffin stain |
| 10771-4 | Deprecated Microscopic observation [Identifier] in Tissue by Rhodamine-auramine fluorochrome stain |
| 10772-2 | Microscopic observation [Identifier] in Tissue by Azure-eosin stain |
| 10773-0 | Microscopic observation [Identifier] in Tissue by Basic fuchsin stain |
| 10774-8 | Microscopic observation [Identifier] in Tissue by Bielschowsky stain |
| 10775-5 | Microscopic observation [Identifier] in Tissue by Bleach stain |
| 10776-3 | Microscopic observation [Identifier] in Tissue by Bodian stain |
| 10777-1 | Microscopic observation [Identifier] in Tissue by Brown and Brenn stain |
| 10778-9 | Microscopic observation [Identifier] in Tissue by Butyrate esterase stain |
| 10779-7 | Microscopic observation [Identifier] in Tissue by Carmine stain.Best |
| 1078-5 | Jk sup(b) Ag [Presence] on Red Blood Cells |
| 10780-5 | Microscopic observation [Identifier] in Tissue by Chloracetate esterase stain |
| 10781-3 | Microscopic observation [Identifier] in Tissue by Churukian-Schenk stain |
| 10782-1 | Microscopic observation [Identifier] in Tissue by Congo red stain |
| 10783-9 | Microscopic observation [Identifier] in Tissue by Crystal violet stain |
| 10784-7 | Microscopic observation [Identifier] in Tissue by Esterase stain.non-specific |
| 10785-4 | Microscopic observation [Identifier] in Tissue by Fite-Faraco stain |
| 10786-2 | Microscopic observation [Identifier] in Tissue by Giemsa stain.3 micron |
| 10787-0 | Microscopic observation [Identifier] in Tissue by Gridley stain |
| 10788-8 | Microscopic observation [Identifier] in Tissue by Hansel stain |
| 10789-6 | Microscopic observation [Identifier] in Tissue by Hematoxylin-eosin-Harris regressive stain |
| 1079-3 | Js sup(a) Ab [Presence] in Serum or Plasma from Blood product unit |
| 10790-4 | Microscopic observation [Identifier] in Tissue by Hematoxylin-eosin-Mayers progressive stain |
| 10791-2 | Microscopic observation [Identifier] in Tissue by Mallory-Heidenhain stain |
| 10792-0 | Microscopic observation [Identifier] in Tissue by Methenamine silver stain.Jones |
| 10793-8 | Microscopic observation [Identifier] in Tissue by Methyl green stain |
| 10794-6 | Microscopic observation [Identifier] in Tissue by Methyl green-pyronine Y stain |
| 10795-3 | Microscopic observation [Identifier] in Tissue by Methyl violet stain |
| 10796-1 | Microscopic observation [Identifier] in Tissue by Mucicarmine stain |
| 10797-9 | Microscopic observation [Identifier] in Tissue by Neutral red stain |
| 10798-7 | Microscopic observation [Identifier] in Tissue by Oil red O stain |
| 10799-5 | Microscopic observation [Identifier] in Tissue by Pentachrome stain.Movat |
| 108-1 | Cefotaxime [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 1080-1 | Js sup(a) Ab [Presence] in Serum or Plasma from donor |
| 10800-1 | Microscopic observation [Identifier] in Tissue by Periodic acid-Schiff stain with diatase digestion |
| 10801-9 | Microscopic observation [Identifier] in Tissue by Phosphotungstic acid Hematoxylin (PTAH) Stain |
| 10802-7 | Microscopic observation [Identifier] in Tissue by Prussian blue stain |
| 10803-5 | Microscopic observation [Identifier] in Tissue by Quinacrine fluorescent stain |
| 10804-3 | Microscopic observation [Identifier] in Tissue by Reticulin stain |
| 10805-0 | Microscopic observation [Identifier] in Tissue by Safranin stain |
| 10806-8 | Microscopic observation [Identifier] in Tissue by Schmorl stain |
| 10807-6 | Microscopic observation [Identifier] in Tissue by Sevier-Munger stain |
| 10808-4 | Microscopic observation [Identifier] in Tissue by Silver impregnation stain.Dieterle |
| 10809-2 | Microscopic observation [Identifier] in Tissue by Silver nitrate stain |
| 1081-9 | Js sup(a) Ab [Presence] in Serum or Plasma |
| 10810-0 | Microscopic observation [Identifier] in Tissue by Silver stain.Fontana-Masson |
| 10811-8 | Microscopic observation [Identifier] in Tissue by Silver stain.Grimelius |
| 10812-6 | Microscopic observation [Identifier] in Tissue by Steiner stain |
| 10813-4 | Microscopic observation [Identifier] in Tissue by Sudan black stain |
| 10814-2 | Microscopic observation [Identifier] in Tissue by Supravital stain |
| 10815-9 | Microscopic observation [Identifier] in Tissue by Tetrachrome stain |
| 10816-7 | Deprecated Microscopic observation [Identifier] in Tissue by Toluidine blue O stain |
| 10817-5 | Microscopic observation [Identifier] in Tissue by Trichrome stain.Gomori-Wheatley |
| 10818-3 | Microscopic observation [Identifier] in Tissue by Trichrome stain.Masson modified |
| 10819-1 | Microscopic observation [Identifier] in Tissue by Wade stain |
| 1082-7 | Js sup(a) Ag [Presence] on Red Blood Cells from Blood product unit |
| 10820-9 | Deprecated Microscopic observation [Identifier] in Tissue by Warthin-Starry stain |
| 10821-7 | Deprecated Microscopic observation [Identifier] in Tissue by Wright Giemsa stain |
| 10822-5 | Mucin.microscopic observation [Identifier] in Tissue by Mucicarmine stain.Mayer |
| 10823-3 | Mucopolysaccharides.microscopic observation [Identifier] in Tissue by Colloidal ferric oxide stain.Hale |
| 10824-1 | Myelin+Myelin breakdown products.microscopic observation [Identifier] in Tissue by Luxol fast blue/Periodic acid-Schiff stain |
| 10825-8 | Myelin+Nerve cells.microscopic observation [Identifier] in Tissue by Luxol fast blue/Cresyl violet stain |
| 10826-6 | Nissel.microscopic observation [Identifier] in Tissue by Cresyl echt violet stain |
| 10827-4 | Reticulum.microscopic observation [Identifier] in Tissue by Gomori stain |
| 10828-2 | Urate crystals.microscopic observation [type] in Tissue by De Galantha stain |
| 10829-0 | Silicon [Mass/volume] in Serum or Plasma |
| 1083-5 | Js sup(a) Ag [Presence] on Red Blood Cells from donor |
| 10830-8 | Deprecated Surgical operation note complications |
| 10831-6 | Surgical operation note complications [Interpretation] |
| 10832-4 | Glucose [Mass/volume] in Serum or Plasma --15 minutes post 50 g lactose PO |
| 10833-2 | Insulin [Mass/volume] in Serum or Plasma --7 hours post 75 g glucose PO |
| 10834-0 | Globulin [Mass/volume] in Serum by calculation |
| 10835-7 | Lipoprotein a [Mass/volume] in Serum or Plasma |
| 10836-5 | Niacin [Mass/volume] in Blood |
| 10837-3 | Organic acids [Presence] in Serum or Plasma |
| 10838-1 | Phosphoserine [Mass/volume] in Serum or Plasma |
| 10839-9 | Troponin I.cardiac [Mass/volume] in Serum or Plasma |
| 1084-3 | Js sup(a) Ag [Presence] on Red Blood Cells |
| 10840-7 | Atropine [Mass/volume] in Urine |
| 10841-5 | Methazolamide [Mass/volume] in Serum or Plasma |
| 10842-3 | Deprecated HLA-DQ1 [Presence] |
| 10843-1 | Deprecated HLA-DQ2 [Presence] |
| 10844-9 | Deprecated HLA-DQ3 [Presence] |
| 10845-6 | Deprecated HLA-DQ4 [Presence] |
| 10846-4 | Borrelia burgdorferi DNA [Presence] in Blood by Probe with amplification |
| 10847-2 | Borrelia burgdorferi DNA [Presence] in Body fluid by Probe with amplification |
| 10848-0 | Chlamydia sp IgG Ab [Titer] in Serum by Immunofluorescence |
| 10849-8 | Chlamydia sp IgM Ab [Titer] in Serum by Immunofluorescence |
| 1085-0 | Js sup(b) Ab [Presence] in Serum or Plasma from Blood product unit |
| 10850-6 | Cyclospora cayetanensis [Presence] in Unspecified specimen |
| 10851-4 | Escherichia coli O157:H7 [Presence] in Stool by Organism specific culture |
| 10852-2 | Deprecated Fungus identified in Blood by Culture |
| 10853-0 | Isospora belli [Presence] in Unspecified specimen by Acid fast stain.Kinyoun modified |
| 10854-8 | Deprecated Midrofilaria identified in Blood by Concentration |
| 10855-5 | Ova and parasites identified in Duodenal fluid or Gastric fluid by Light microscopy |
| 10856-3 | Microscopic observation [Identifier] in Genital mucus by Gram stain |
| 10857-1 | Microsporidia identified in Unspecified specimen by Light microscopy |
| 10858-9 | Teichoate Ab [Presence] in Serum |
| 10859-7 | Trypanosoma sp [Identifier] in Blood by Acridine Orange + Giemsa Stain |
| 1086-8 | Js sup(b) Ab [Presence] in Serum or Plasma from donor |
| 10860-5 | Varicella zoster virus [Presence] in Unspecified specimen by Organism specific culture |
| 10861-3 | Progesterone receptor [Mass/mass] in Tissue |
| 10862-1 | Basement membrane Ab [Titer] in Serum |
| 10863-9 | Endomysium IgA Ab [Titer] in Serum |
| 10864-7 | Immune complex [Units/volume] in Serum or Plasma by Raji cell assay |
| 10865-4 | Intercellular substance Ab [Presence] in Serum |
| 10866-2 | Sulfatide IgG Ab [Titer] in Serum |
| 10867-0 | Sulfatide IgM Ab [Titer] in Serum |
| 10868-8 | Bacitracin [Susceptibility] by Disk diffusion (KB) |
| 10869-6 | Xylose [Mass/volume] in Blood --3 hours post 25 g xylose PO |
| 1087-6 | Js sup(b) Ab [Presence] in Serum or Plasma |
| 10870-4 | Xylose [Mass/volume] in Blood --4 hours post 25 g xylose PO |
| 10871-2 | Xylose [Mass/volume] in Blood --5 hours post 25 g xylose PO |
| 10872-0 | Xylose [Mass/volume] in Blood --baseline |
| 10873-8 | Beta-2-Microglobulin [Mass/time] in 24 hour Urine |
| 10874-6 | Bombesin [Mass/volume] in Plasma |
| 10875-3 | Carnitine esters [Mass/volume] in Urine |
| 10876-1 | Carnitine esters [Mass/volume] in Serum or Plasma |
| 10877-9 | Carnitine free (C0) [Mass/volume] in Urine |
| 10878-7 | Iodine.protein bound [Mass/volume] in Serum or Plasma |
| 10879-5 | Isovalerylglycine [Mass/volume] in Urine |
| 1088-4 | Js sup(b) Ag [Presence] on Red Blood Cells from Blood product unit |
| 10880-3 | Magnesium [Mass/mass] in Stool |
| 10881-1 | Pentacarboxylporphyrins [Mass/volume] in Red Blood Cells |
| 10882-9 | Pentacarboxylporphyrins [Mass/volume] in Serum or Plasma |
| 10883-7 | Phenolphthalein [Mass/mass] in Stool |
| 10884-5 | Phosphate [Mass/mass] in Stool |
| 10885-2 | Porphyrins [Mass/time] in 24 hour Urine |
| 10886-0 | Prostate Specific Ag Free [Mass/volume] in Serum or Plasma |
| 10887-8 | Pyridinoline [Mass/time] in 24 hour Urine |
| 10888-6 | Lipase [Enzymatic activity/volume] in Urine |
| 10889-4 | Bisacodyl [Mass/mass] in Stool |
| 1089-2 | Js sup(b) Ag [Presence] on Red Blood Cells from donor |
| 10890-2 | Deprecated Normethsuximide [Mass/volume] in Serum or Plasma |
| 10891-0 | Oxyphenisatin [Mass/mass] in Stool |
| 10892-8 | Pentoxifylline [Mass/volume] in Serum or Plasma |
| 10893-6 | Trenbolone [Mass/volume] in Urine |
| 10894-4 | Aspergillus niger Ab [Presence] in Serum by Immune diffusion (ID) |
| 10895-1 | Clostridium difficile toxin B [Presence] in Stool |
| 10896-9 | Eastern equine encephalitis virus IgG Ab [Titer] in Serum by Immunofluorescence |
| 10897-7 | Eastern equine encephalitis virus IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 10898-5 | Eastern equine encephalitis virus IgM Ab [Titer] in Serum by Immunofluorescence |
| 10899-3 | Eastern equine encephalitis virus IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 109-9 | Cefotaxime [Susceptibility] by Disk diffusion (KB) |
| 1090-0 | Js sup(b) Ag [Presence] on Red Blood Cells |
| 10900-9 | Hepatitis B virus surface Ab [Presence] in Serum by Immunoassay |
| 10901-7 | HIV 2 gp125 Ab [Presence] in Serum by Immunoblot (IB) |
| 10902-5 | HIV 2 gp36 Ab [Presence] in Serum by Immunoblot (IB) |
| 10903-3 | Hyaluronidase Ab [Titer] in Serum |
| 10904-1 | La Crosse virus IgG Ab [Titer] in Serum by Immunofluorescence |
| 10905-8 | La Crosse virus IgM Ab [Titer] in Serum by Immunofluorescence |
| 10906-6 | Saint Louis encephalitis virus IgG Ab [Titer] in Serum by Immunofluorescence |
| 10907-4 | Saint Louis encephalitis virus IgM Ab [Titer] in Serum by Immunofluorescence |
| 10908-2 | Streptococcus pneumoniae 7 IgG Ab [Units/volume] in Serum by Immunoassay |
| 10909-0 | Benzidine [Mass/volume] in Urine |
| 1091-8 | K Ab [Presence] in Serum or Plasma from Blood product unit |
| 10910-8 | Borate [Mass/volume] in Urine |
| 10911-6 | Dichlorobenzidine [Mass/volume] in Urine |
| 10912-4 | Lead [Mass/volume] in Serum or Plasma |
| 10913-2 | 4,4'-Methylene bis(2-Chloroaniline) [Mass/volume] in Urine |
| 10914-0 | Methylenediamine [Mass/volume] in Urine |
| 10915-7 | Phencyclidine [Mass/volume] in Unspecified specimen |
| 10916-5 | Platinum [Mass/volume] in Blood |
| 10917-3 | Zinc [Mass/mass] in Stool |
| 10918-1 | Zinc [Mass/volume] in Unspecified specimen |
| 10919-9 | Anisakis IgE Ab [Units/volume] in Serum |
| 1092-6 | K Ab [Presence] in Serum or Plasma from donor |
| 10920-7 | Bamboo shoot IgE Ab [Units/volume] in Serum |
| 10921-5 | Blomia tropicalis IgE Ab [Units/volume] in Serum |
| 10922-3 | Bovine serum albumin (BSA) IgE Ab [Units/volume] in Serum |
| 10923-1 | Bromelin IgE Ab [Units/volume] in Serum |
| 10924-9 | Starfruit IgE Ab [Units/volume] in Serum |
| 10925-6 | Chub Mackerel IgE Ab [Units/volume] in Serum |
| 10926-4 | Deer epithelium IgE Ab [Units/volume] in Serum |
| 10927-2 | Elk or Moose Meat IgE Ab [Units/volume] in Serum |
| 10928-0 | Fennel Fresh IgE Ab [Units/volume] in Serum |
| 10929-8 | Fennel Seed IgE Ab [Units/volume] in Serum |
| 1093-4 | K Ab [Presence] in Serum or Plasma |
| 10930-6 | Fish Feed IgE Ab [Units/volume] in Serum |
| 10931-4 | Daphnia (fish feed) IgE Ab [Units/volume] in Serum |
| 10932-2 | Tetramin IgE Ab [Units/volume] in Serum |
| 10933-0 | Guar gum IgE Ab [Units/volume] in Serum |
| 10934-8 | Guava IgE Ab [Units/volume] in Serum |
| 10935-5 | Horse serum proteins IgE Ab [Units/volume] in Serum |
| 10936-3 | Mare milk IgE Ab [Units/volume] in Serum |
| 10937-1 | Marjoram IgE Ab [Units/volume] in Serum |
| 10938-9 | Mediterranean flour moth IgE Ab [Units/volume] in Serum |
| 10939-7 | Whiff IgE Ab [Units/volume] in Serum |
| 1094-2 | K Ag [Presence] on Red Blood Cells from Blood product unit |
| 10940-5 | Cow milk boiled IgE Ab [Units/volume] in Serum |
| 10941-3 | Milk powder IgE Ab [Units/volume] in Serum |
| 10942-1 | Cockspur IgE Ab [Units/volume] in Serum |
| 10943-9 | Mink epithelium IgE Ab [Units/volume] in Serum |
| 10944-7 | Octopus IgE Ab [Units/volume] in Serum |
| 10945-4 | Papain IgE Ab [Units/volume] in Serum |
| 10946-2 | Passion fruit IgE Ab [Units/volume] in Serum |
| 10947-0 | Persimmon IgE Ab [Units/volume] in Serum |
| 10948-8 | Pigeon feather IgE Ab [Units/volume] in Serum |
| 10949-6 | Malassezia furfur IgE Ab [Units/volume] in Serum |
| 1095-9 | K Ag [Presence] on Red Blood Cells from donor |
| 10950-4 | Reindeer epithelium IgE Ab [Units/volume] in Serum |
| 10951-2 | Sericin IgE Ab [Units/volume] in Serum |
| 10952-0 | Swine urine proteins IgE Ab [Units/volume] in Serum |
| 10953-8 | Timothy IgG Ab [Units/volume] in Serum |
| 10954-6 | Pine Nut IgE Ab [Units/volume] in Serum |
| 10955-3 | Long Leaf Pine IgE Ab [Units/volume] in Serum |
| 10956-1 | Short Leaf Pine IgE Ab [Units/volume] in Serum |
| 10957-9 | Slash Pine IgE Ab [Units/volume] in Serum |
| 10958-7 | Virginia Scrub Pine IgE Ab [Units/volume] in Serum |
| 10959-5 | Plaice IgE Ab [Units/volume] in Serum |
| 1096-7 | K Ag [Presence] on Red Blood Cells |
| 10960-3 | Rabbit serum proteins IgE Ab [Units/volume] in Serum |
| 10961-1 | Rabbit urine proteins IgE Ab [Units/volume] in Serum |
| 10962-9 | Deprecated Sagebrush tridenda IgE Ab [Units/volume] in Serum |
| 10963-7 | Spondylocladium citrovirens IgE Ab [Units/volume] in Serum |
| 10964-5 | 17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --15 minutes post 250 ug corticotropin IM |
| 10965-2 | 17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin IM |
| 10966-0 | Glucose [Presence] in Urine by Test strip --2.5 hours post 75 g glucose PO |
| 10967-8 | Glucose [Presence] in Urine by Test strip --3.5 hours post 75 g glucose PO |
| 10968-6 | Glucose [Presence] in Urine by Test strip --4.5 hours post 75 g glucose PO |
| 10969-4 | Cystine+Homocysteine [Presence] in Urine |
| 1097-5 | Kp sup(a) Ab [Presence] in Serum or Plasma from Blood product unit |
| 10970-2 | Galactose 1 phosphate uridyl transferase [Enzymatic activity/volume] in Blood |
| 10971-0 | Lysozyme [Mass/volume] in Urine |
| 10972-8 | Organic acids [Mass/volume] in Urine |
| 10973-6 | 3 methoxy O desmethylencainide [Mass/volume] in Serum or Plasma |
| 10974-4 | 5-Fluorocytosine [Mass/volume] in Urine |
| 10975-1 | 6-Monoacetylmorphine (6-MAM) [Mass/volume] in Urine |
| 10976-9 | 6-Monoacetylmorphine (6-MAM) [Presence] in Urine |
| 10977-7 | Alprazolam [Mass/volume] in Blood |
| 10978-5 | Amitriptyline+Nortriptyline [Mass/volume] in Urine |
| 10979-3 | Carisoprodol [Mass/volume] in Urine |
| 1098-3 | Kp sup(a) Ab [Presence] in Serum or Plasma from donor |
| 10980-1 | Cephapirin [Mass/volume] in Serum or Plasma |
| 10981-9 | Clonidine [Mass/volume] in Urine |
| 10982-7 | Demeclocycline [Mass/volume] in Serum or Plasma |
| 10983-5 | Norparamethadione [Mass/volume] in Serum or Plasma |
| 10984-3 | Dicloxacillin [Mass/volume] in Serum or Plasma |
| 10985-0 | Doxapram [Mass/volume] in Serum or Plasma |
| 10986-8 | Doxycycline [Mass/volume] in Serum or Plasma |
| 10987-6 | Fluconazole [Mass/volume] in Serum or Plasma |
| 10988-4 | Fluvoxamine [Mass/volume] in Serum or Plasma |
| 10989-2 | Itraconazole [Mass/volume] in Serum or Plasma |
| 1099-1 | Kp sup(a) Ab [Presence] in Serum or Plasma |
| 10990-0 | Ketoconazole [Mass/volume] in Serum or Plasma |
| 10991-8 | Metronidazole [Mass/volume] in Serum or Plasma |
| 10992-6 | Norclozapine [Mass/volume] in Serum or Plasma |
| 10993-4 | Nafcillin [Mass/volume] in Serum or Plasma |
| 10994-2 | Naltrexone [Mass/volume] in Serum or Plasma |
| 10995-9 | Neomycin [Mass/volume] in Serum or Plasma |
| 10996-7 | Normeperidine [Mass/volume] in Serum or Plasma |
| 10997-5 | O-desmethylencainide [Mass/volume] in Serum or Plasma |
| 10998-3 | Oxycodone [Presence] in Urine |
| 10999-1 | Paramethadione [Mass/volume] in Serum or Plasma |
| 11-7 | Amikacin [Susceptibility] by Minimum lethal concentration (MLC) |
| 110-7 | Cefotaxime [Susceptibility] by Serum bactericidal titer |
| 1100-7 | Kp sup(a) Ag [Presence] on Red Blood Cells from Blood product unit |
| 11000-7 | Promethazine [Presence] in Urine |
| 11001-5 | Pyrazinamide [Mass/volume] in Serum or Plasma |
| 11002-3 | Scopolamine [Presence] in Urine |
| 11003-1 | Ticlopidine [Mass/volume] in Serum or Plasma |
| 11004-9 | Tricyclic antidepressants [Presence] in Urine |
| 11005-6 | Trimethoprim [Mass/volume] in Serum or Plasma |
| 11006-4 | Borrelia burgdorferi Ab [Presence] in Serum |
| 11007-2 | Borrelia burgdorferi Ag [Units/volume] in Urine |
| 11008-0 | Cytomegalovirus IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 11009-8 | Epstein Barr virus capsid IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 1101-5 | Kp sup(a) Ag [Presence] on Red Blood Cells from donor |
| 11010-6 | Epstein Barr virus capsid IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 11011-4 | Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method |
| 11012-2 | Reovirus Ab [Titer] in Serum by Complement fixation |
| 11013-0 | DNA double strand Ab [Titer] in Serum |
| 11014-8 | Somatotropin Ab [Titer] in Serum or Plasma |
| 11015-5 | Somatotropin binding protein [Moles/volume] in Serum or Plasma |
| 11016-3 | Microscopic observation [Identifier] in Blood or Marrow by Esterase stain.non-specific |
| 11017-1 | Microscopic observation [Identifier] in Blood or Marrow by Chloracetate esterase stain |
| 11018-9 | Microscopic observation [Identifier] in Blood or Marrow by Peroxidase stain |
| 11019-7 | Microscopic observation [Identifier] in Blood or Marrow by Sudan black B stain |
| 1102-3 | Kp sup(a) Ag [Presence] on Red Blood Cells |
| 11020-5 | Microscopic observation [Identifier] in Blood or Marrow by Tartrate-resistant acid phosphatase stain |
| 11021-3 | Microscopic observation [Identifier] in Blood or Marrow by Terminal deoxynucleotidyl transferase stain |
| 11022-1 | Barbiturates [Mass/volume] in Meconium |
| 11023-9 | Benzodiazepines [Mass/volume] in Meconium |
| 11024-7 | Benzodiazepines [Mass/volume] in Serum or Plasma |
| 11025-4 | Methadone [Mass/volume] in Meconium |
| 11026-2 | Methaqualone [Mass/volume] in Meconium |
| 11027-0 | Propoxyphene [Mass/volume] in Meconium |
| 11028-8 | Zinc [Mass/volume] in Body fluid |
| 11029-6 | Consistency of Stool |
| 1103-1 | Kp sup(b) Ab [Presence] in Serum or Plasma from Blood product unit |
| 11030-4 | Aspergillus fumigatus+Aspergillus niger IgE Ab [Units/volume] in Serum |
| 11031-2 | Lymphocytes/100 leukocytes in Body fluid |
| 11032-0 | Glucose [Mass/volume] in Serum or Plasma --45 minutes post 50 g lactose PO |
| 11033-8 | Thyrotropin [Mass/volume] in Serum or Plasma --45 minutes post dose TRH IV |
| 11034-6 | Acetylcholine receptor binding Ab [Moles/volume] in Serum |
| 11035-3 | Adenylate kinase [Enzymatic activity/volume] in Red Blood Cells |
| 11036-1 | Deprecated Aldolase [Enzymatic activity/volume] in Red Blood Cells |
| 11037-9 | Alpha-N-acetylgalactosaminidase [Enzymatic activity/volume] in Serum or Plasma |
| 11038-7 | Beta+gamma tocopherol [Mass/volume] in Serum or Plasma |
| 11039-5 | C reactive protein [Presence] in Serum or Plasma |
| 1104-9 | Kp sup(b) Ab [Presence] in Serum or Plasma from donor |
| 11040-3 | Cortisol Free [Mass/volume] in Urine |
| 11041-1 | Creatinine [Mass/volume] in Serum or Plasma --post dialysis |
| 11042-9 | Creatinine [Mass/volume] in Serum or Plasma --pre dialysis |
| 11043-7 | Cryofibrinogen [Presence] in Plasma |
| 11044-5 | Diphosphoglycerate mutase [Enzymatic activity/volume] in Red Blood Cells |
| 11045-2 | Enolase [Enzymatic activity/volume] in Red Blood Cells |
| 11046-0 | Epinephrine [Mass/volume] in Urine |
| 11047-8 | Glucose phosphate isomerase [Enzymatic activity/volume] in Red Blood Cells |
| 11048-6 | Glyceraldehyde 3 phosphate dehydrogenase [Enzymatic activity/volume] in Red Blood Cells |
| 11049-4 | Deprecated Hydroxyproline [Mass/volume] in Urine |
| 1105-6 | Kp sup(b) Ab [Presence] in Serum or Plasma |
| 11050-2 | Immunoglobulin light chains.kappa [Mass/volume] in Serum or Plasma |
| 11051-0 | Immunoglobulin light chains.lambda [Mass/volume] in Serum or Plasma |
| 11052-8 | Ketamine [Mass/volume] in Urine |
| 11053-6 | Lactate dehydrogenase [Enzymatic activity/volume] in Red Blood Cells |
| 11054-4 | Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma |
| 11055-1 | Melatonin [Mass/volume] in Serum or Plasma |
| 11056-9 | Melatonin [Flow] in 24 hour Urine |
| 11057-7 | Monophosphoglyceromutase [Enzymatic activity/volume] in Red Blood Cells |
| 11058-5 | Phosphofructokinase [Enzymatic activity/volume] in Red Blood Cells |
| 11059-3 | Phosphoglycerate kinase [Enzymatic activity/volume] in Red Blood Cells |
| 1106-4 | Kp sup(b) Ag [Presence] on Red Blood Cells from Blood product unit |
| 11060-1 | Reducing substances [Presence] in Stool |
| 11061-9 | Thromboxane beta 2 [Mass/time] in 24 hour Urine |
| 11062-7 | Thyroxine (T4).albumin bound [Mass/volume] in Serum or Plasma |
| 11063-5 | Triosephosphate isomerase [Enzymatic activity/volume] in Red Blood Cells |
| 11064-3 | Urea nitrogen [Mass/volume] in Serum or Plasma --post dialysis |
| 11065-0 | Urea nitrogen [Mass/volume] in Serum or Plasma --pre dialysis |
| 11066-8 | Uroporphyrinogen III synthase [Enzymatic activity/volume] in Red Blood Cells |
| 11067-6 | Bleeding time |
| 11068-4 | Microscopic observation [Identifier] in Body fluid by Cyto stain |
| 11069-2 | Microscopic observation [Identifier] in Gastric fluid by Cyto stain |
| 1107-2 | Kp sup(b) Ag [Presence] on Red Blood Cells from donor |
| 11070-0 | Microscopic observation [Identifier] in Urine by Cyto stain |
| 11071-8 | Butalbital [Mass/volume] in Urine |
| 11072-6 | Despropionylfentanyl [Mass/volume] in Serum or Plasma |
| 11073-4 | Despropionylfentanyl [Mass/volume] in Urine |
| 11074-2 | Norfentanyl [Mass/volume] in Serum or Plasma |
| 11075-9 | Norfentanyl [Mass/volume] in Urine |
| 11076-7 | Hepatitis C virus 5-1-1 Ab [Presence] in Serum by Immunoblot (IB) |
| 11077-5 | Hepatitis C virus superoxide dismutase Ab [Presence] in Serum by Immunoblot (IB) |
| 11078-3 | HIV 2 gp80 Ab [Presence] in Serum by Immunoblot (IB) |
| 11079-1 | HIV 2 p26 Ab [Presence] in Serum by Immunoblot (IB) |
| 1108-0 | Kp sup(b) Ag [Presence] on Red Blood Cells |
| 11080-9 | HIV 2 p53 Ab [Presence] in Serum by Immunoblot (IB) |
| 11081-7 | HIV 2 p56 Ab [Presence] in Serum by Immunoblot (IB) |
| 11082-5 | HIV 2 p68 Ab [Presence] in Serum by Immunoblot (IB) |
| 11083-3 | Human papilloma virus identified in Cervix |
| 11084-1 | Reagin Ab [Titer] in Serum |
| 11085-8 | Schistosoma sp identified in Stool by Concentration |
| 11086-6 | Streptococcus pneumoniae Ag [Presence] in Serum |
| 11087-4 | Insulin Ab [Titer] in Serum |
| 11088-2 | Neuronal nuclear Ab [Presence] in Serum |
| 11089-0 | Neuronal nuclear Ab [Presence] in Cerebral spinal fluid |
| 1109-8 | Deprecated L little b |
| 11090-8 | Smith extractable nuclear Ab [Units/volume] in Serum |
| 11091-6 | Alpha chlordane [Mass/volume] in Serum or Plasma |
| 11092-4 | Barbiturates [Mass/mass] in Hair |
| 11093-2 | Dichlorodiphenyldichloroethylene [Mass/volume] in Serum or Plasma |
| 11094-0 | Dichlorodiphenyltrichloroethane [Mass/volume] in Serum or Plasma |
| 11095-7 | Dieldrin [Mass/volume] in Serum or Plasma |
| 11096-5 | Gamma chlordane [Mass/volume] in Serum or Plasma |
| 11097-3 | Lindane [Mass/volume] in Serum or Plasma |
| 11098-1 | Malaoxon [Mass/volume] in Serum or Plasma |
| 11099-9 | Methoxychlor [Mass/volume] in Serum or Plasma |
| 111-5 | Cefotetan [Susceptibility] by Minimum lethal concentration (MLC) |
| 1110-6 | Le sup(a) Ab [Presence] in Serum or Plasma from Blood product unit |
| 11100-5 | Tetrachloroethylene [Mass/volume] in Blood |
| 11101-3 | Bacteria [#/area] in Synovial fluid by Microscopy high power field |
| 11102-1 | Charcot-leyden crystals [type] in Unspecified specimen by Trichrome stain |
| 11103-9 | Band form neutrophils/100 cells in Bone marrow by Manual count |
| 11104-7 | Normoblasts Basophilic/100 cells in Bone marrow by Manual count |
| 11105-4 | Basophils/100 cells in Bone marrow by Manual count |
| 11106-2 | Eosinophils/100 cells in Bone marrow by Manual count |
| 11107-0 | Variant lymphocytes/100 cells in Bone marrow by Manual count |
| 11108-8 | Lymphocytes/100 cells in Bone marrow by Manual count |
| 11109-6 | Mast cells/100 cells in Bone marrow by Manual count |
| 1111-4 | Le sup(a) Ab [Presence] in Serum or Plasma from donor |
| 11110-4 | Megakaryocytes/100 cells in Bone marrow by Manual count |
| 11111-2 | Metamyelocytes/100 cells in Bone marrow by Manual count |
| 11112-0 | Monocytes/100 cells in Bone marrow by Manual count |
| 11113-8 | Myeloblasts/100 cells in Bone marrow by Manual count |
| 11114-6 | Myelocytes/100 cells in Bone marrow by Manual count |
| 11115-3 | Neutrophils/100 cells in Bone marrow by Manual count |
| 11116-1 | Normoblasts Orthochromic/100 cells in Bone marrow by Manual count |
| 11117-9 | Plasma cells immature/100 cells in Bone marrow by Manual count |
| 11118-7 | Plasma cells/100 cells in Bone marrow by Manual count |
| 11119-5 | Normoblasts Polychromatophilic/100 cells in Bone marrow by Manual count |
| 1112-2 | Le sup(a) Ab [Presence] in Serum or Plasma |
| 11120-3 | Promyelocytes/100 cells in Bone marrow by Manual count |
| 11121-1 | Prolymphocytes/100 cells in Bone marrow by Manual count |
| 11122-9 | Promonocytes/100 cells in Bone marrow by Manual count |
| 11123-7 | Deprecated Promyelocytes/100 cells in Bone marrow by Microscopy |
| 11124-5 | Pronormoblasts/100 cells in Bone marrow by Manual count |
| 11125-2 | Platelet morphology finding [Identifier] in Blood |
| 11126-0 | Platelets [Morphology] in Bone marrow |
| 11127-8 | Erythrocytes [Morphology] in Bone marrow |
| 11128-6 | Segmented neutrophils/100 cells in Bone marrow |
| 11129-4 | Pronormoblasts [#/volume] in Blood |
| 1113-0 | Le sup(a) Ag [Presence] on Red Blood Cells from Blood product unit |
| 11130-2 | B lymphocytes [#/volume] in Blood |
| 11131-0 | Deprecated Normoblasts Basophilic/100 cells in Bone marrow by Microscopy |
| 11132-8 | Deprecated Bilirubin [Mass/volume] in Body fluid |
| 11133-6 | Catecholamines Free [Mass/volume] in Urine |
| 11134-4 | Appearance of Spun Body fluid |
| 11135-1 | Appearance of Spun Cerebral spinal fluid |
| 11136-9 | Deprecated Normoblasts Orthochromic/100 cells in Bone marrow by Microscopy |
| 11137-7 | Deprecated Normoblasts Polychromatophilic/100 cells in Bone marrow by Microscopy |
| 11138-5 | Myeloid cells/Erythroid cells [# Ratio] in Bone marrow |
| 11139-3 | Metanephrine [Mass/volume] in Urine |
| 1114-8 | Le sup(a) Ag [Presence] on Red Blood Cells from donor |
| 11140-1 | Metanephrine [Moles/time] in 24 hour Urine |
| 11141-9 | Phosphate/Creatinine [Mass Ratio] in Urine |
| 11142-7 | Glucose [Mass/volume] in Serum or Plasma --15 minutes post 100 g glucose PO |
| 11143-5 | Glucose [Mass/volume] in Serum or Plasma --45 minutes post 100 g glucose PO |
| 11144-3 | Homovanillate [Mass/volume] in Urine |
| 11145-0 | 5-Hydroxyindoleacetate/Creatinine [Mass Ratio] in Urine |
| 11146-8 | Homovanillate/Creatinine [Mass Ratio] in Urine |
| 11147-6 | Myoglobin/Creatinine [Mass Ratio] in Urine |
| 11148-4 | Potassium/Creatinine [Mass Ratio] in Urine |
| 11149-2 | Sodium/Creatinine [Mass Ratio] in Urine |
| 1115-5 | Le sup(a) Ag [Presence] on Red Blood Cells |
| 11150-0 | Blasts/100 cells in Bone marrow |
| 11151-8 | Hematocrit [Volume Fraction] of Cord blood |
| 11152-6 | Eosinophils/100 cells in Bone marrow |
| 11153-4 | Hematocrit [Volume Fraction] of Body fluid |
| 11154-2 | Cholinesterase [Enzymatic activity/volume] in Blood |
| 11155-9 | Cortisol/Creatinine [Mass Ratio] in Urine |
| 11156-7 | Leukocyte morphology finding [Identifier] in Blood |
| 11157-5 | Leukocytes [Morphology] in Bone marrow |
| 11158-3 | Appearance of Serum |
| 11159-1 | Alkalase IgE Ab [Units/volume] in Serum |
| 1116-3 | Le sup(b) Ab [Presence] in Serum or Plasma from Blood product unit |
| 11160-9 | Beta lactoglobulin IgG Ab [Units/volume] in Serum |
| 11161-7 | Wheat Bran IgE Ab [Units/volume] in Serum |
| 11162-5 | Deprecated Cocoa IgE Ab [Units/volume] in Serum |
| 11163-3 | Carageenan IgE Ab [Units/volume] in Serum |
| 11164-1 | Cream Cheese IgE Ab [Units/volume] in Serum |
| 11165-8 | Chinchilla IgE Ab [Units/volume] in Serum |
| 11166-6 | Chortoglyphus arcuatus IgE Ab [Units/volume] in Serum |
| 11167-4 | Cockatiel feather IgE Ab [Units/volume] in Serum |
| 11168-2 | Arizona Cypress IgE Ab [Units/volume] in Serum |
| 11169-0 | Deer hair IgE Ab [Units/volume] in Serum |
| 1117-1 | Le sup(b) Ab [Presence] in Serum or Plasma from donor |
| 11170-8 | Dematiaceae IgE Ab [Units/volume] in Serum |
| 11171-6 | Erythromycin IgE Ab [Units/volume] in Serum |
| 11172-4 | Ferret epithelium IgE Ab [Units/volume] in Serum |
| 11173-2 | Fig IgE Ab [Units/volume] in Serum |
| 11174-0 | Grain weevel IgE Ab [Units/volume] in Serum |
| 11175-7 | Helminthosporium sativum IgE Ab [Units/volume] in Serum |
| 11176-5 | Lactalbumin alpha IgG Ab [Units/volume] in Serum |
| 11177-3 | Lactalbumin beta IgE Ab [Units/volume] in Serum |
| 11178-1 | Beta galactosidase IgE Ab [Units/volume] in Serum |
| 11179-9 | Linden IgE Ab [Units/volume] in Serum |
| 1118-9 | Le sup(b) Ab [Presence] in Serum or Plasma |
| 11180-7 | Lupin IgE Ab [Units/volume] in Serum |
| 11181-5 | Lycopodium spp IgE Ab [Units/volume] in Serum |
| 11182-3 | Lysozyme IgE Ab [Units/volume] in Serum |
| 11183-1 | Macadamia IgE Ab [Units/volume] in Serum |
| 11184-9 | Scad IgE Ab [Units/volume] in Serum |
| 11185-6 | Maxatase IgE Ab [Units/volume] in Serum |
| 11186-4 | Foxtail Millet IgE Ab [Units/volume] in Serum |
| 11187-2 | Penicillium frequentans IgE Ab [Units/volume] in Serum |
| 11188-0 | Cayenne IgE Ab [Units/volume] in Serum |
| 11189-8 | Jalepeno Pepper IgE Ab [Units/volume] in Serum |
| 1119-7 | Le sup(b) Ag [Presence] on Red Blood Cells from Blood product unit |
| 11190-6 | Mint IgE Ab [Units/volume] in Serum |
| 11191-4 | Pollock IgE Ab [Units/volume] in Serum |
| 11192-2 | Protamine IgE Ab [Units/volume] in Serum |
| 11193-0 | Pumpkin Seed IgE Ab [Units/volume] in Serum |
| 11194-8 | Rape Pollen IgE Ab [Units/volume] in Serum |
| 11195-5 | Rapeseed IgE Ab [Units/volume] in Serum |
| 11196-3 | Orange roughy IgE Ab [Units/volume] in Serum |
| 11197-1 | Sardine (pilchard) IgE Ab [Units/volume] in Serum |
| 11198-9 | Shark IgE Ab [Units/volume] in Serum |
| 11199-7 | Silver IgE Ab [Units/volume] in Serum |
| 112-3 | Cefotetan [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 1120-5 | Le sup(b) Ag [Presence] on Red Blood Cells from donor |
| 11200-3 | Escargot IgE Ab [Units/volume] in Serum |
| 11201-1 | Succinylcholine IgE Ab [Units/volume] in Serum |
| 11202-9 | Tarragon IgE Ab [Units/volume] in Serum |
| 11203-7 | Trichosporon pullulans IgE Ab [Units/volume] in Serum |
| 11204-5 | Ulocladium chartarum IgE Ab [Units/volume] in Serum |
| 11205-2 | Deprecated Paper Wasp IgE Ab [Units/volume] in Serum |
| 11206-0 | 18-Hydroxydeoxycorticosterone [Mass/volume] in Serum or Plasma |
| 11207-8 | Alpha-1-Fetoprotein [Mass/volume] in Body fluid |
| 11208-6 | Atrial natriuretic factor [Mass/volume] in Plasma |
| 11209-4 | Beta glucuronidase [Enzymatic activity/volume] in Cerebral spinal fluid |
| 1121-3 | Le sup(b) Ag [Presence] on Red Blood Cells |
| 11210-2 | Cancer Ag 125 [Units/volume] in Body fluid |
| 11211-0 | Carbon dioxide, total [Moles/volume] in Body fluid |
| 11212-8 | Coproporphyrin [Mass/volume] in Urine |
| 11213-6 | Corticotropin releasing hormone [Mass/volume] in Serum or Plasma |
| 11214-4 | Deprecated Creatinine |
| 11215-1 | Delta aminolevulinate [Mass/volume] in Urine |
| 11216-9 | Deoxypyridinoline [Mass/volume] in Urine |
| 11217-7 | Deprecated Hexaporphyrin [Mass/time] in 24 hour Urine |
| 11218-5 | Microalbumin [Mass/volume] in Urine by Test strip |
| 11219-3 | Immunoglobulin light chains [Presence] in Serum |
| 1122-1 | Le sup(x) Ab [Presence] in Serum or Plasma from Blood product unit |
| 11220-1 | Iodine Free [Mass/time] in 24 hour Urine |
| 11221-9 | Pentacarboxylporphyrins [Mass/volume] in Urine |
| 11222-7 | Pentacarboxylporphyrins [Presence] in Urine |
| 11223-5 | Deprecated Phenolphthalein |
| 11224-3 | Phosphoethanolamine [Mass/volume] in Cerebral spinal fluid |
| 11225-0 | Porphyrins [Mass/volume] in Urine |
| 11226-8 | Prorenin [Units/volume] in Plasma |
| 11227-6 | Pyruvate kinase [Presence] in Blood |
| 11228-4 | Uroporphyrin [Mass/volume] in Urine |
| 11229-2 | 3-O-Methyldopa [Mass/volume] in Serum or Plasma |
| 1123-9 | Le sup(x) Ab [Presence] in Serum or Plasma from donor |
| 11230-0 | Amobarbital [Mass/volume] in Urine |
| 11231-8 | Astemizole [Mass/volume] in Serum or Plasma |
| 11232-6 | Bromocriptine [Mass/volume] in Serum or Plasma |
| 11233-4 | Brompheniramine [Mass/volume] in Serum or Plasma |
| 11234-2 | Propoxyphene [Mass/mass] in Hair |
| 11235-9 | Fentanyl [Presence] in Urine |
| 11236-7 | Gemfibrozil [Mass/volume] in Serum or Plasma |
| 11237-5 | Hydralazine [Mass/volume] in Serum or Plasma |
| 11238-3 | Hydroxyalprazolam [Mass/volume] in Urine |
| 11239-1 | Deprecated Hydroxyzine |
| 1124-7 | Le sup(x) Ab [Presence] in Serum or Plasma |
| 11240-9 | Hydroxyzine [Mass/volume] in Urine |
| 11241-7 | Hyoscyamine [Mass/volume] in Serum or Plasma |
| 11242-5 | Mercaptopurine [Mass/volume] in Serum or Plasma |
| 11243-3 | Methadone [Mass/mass] in Hair |
| 11244-1 | Morphine Free [Mass/volume] in Serum or Plasma |
| 11245-8 | Deprecated Orphenadrine |
| 11246-6 | Oxycodone [Mass/volume] in Urine |
| 11247-4 | Oxymorphone [Presence] in Urine |
| 11248-2 | Pergolide [Mass/volume] in Serum or Plasma |
| 11249-0 | Phenacemide [Mass/volume] in Serum or Plasma |
| 1125-4 | Le Ab [Presence] in Serum or Plasma from Blood product unit |
| 11250-8 | Phenylethylmalonate [Mass/volume] in Serum or Plasma |
| 11251-6 | Piroxicam [Mass/volume] in Serum or Plasma |
| 11252-4 | Scopolamine [Mass/volume] in Serum or Plasma |
| 11253-2 | Tacrolimus [Mass/volume] in Blood |
| 11254-0 | Chlamydophila pneumoniae Ab [Titer] in Serum |
| 11255-7 | Haemophilus ducreyi [Presence] in Unspecified specimen by Organism specific culture |
| 11256-5 | Haemophilus influenzae B IgG Ab [Mass/volume] in Serum |
| 11257-3 | Haemophilus influenzae B IgG Ab [Mass/volume] in Serum by Immunoassay |
| 11258-1 | Hepatitis B virus DNA [Units/volume] in Serum |
| 11259-9 | Hepatitis C virus RNA [Presence] in Serum or Plasma by Probe and target amplification method |
| 1126-2 | Le Ab [Presence] in Serum or Plasma from donor |
| 11260-7 | HTLV I Ab [Presence] in Serum by Immunoassay |
| 11261-5 | Bacteria identified in Vaginal fluid by Aerobe culture |
| 11262-3 | Parainfluenza virus 3 IgG Ab [Titer] in Serum |
| 11263-1 | Parainfluenza virus 3 IgM Ab [Titer] in Serum |
| 11264-9 | Salmonella paratyphi A Ab [Presence] in Serum by Agglutination |
| 11265-6 | Salmonella paratyphi B Ab [Presence] in Serum by Agglutination |
| 11266-4 | Streptococcus agalactiae Ag [Presence] in Unspecified specimen |
| 11267-2 | Streptococcus.beta-hemolytic [Presence] in Genital specimen by Organism specific culture |
| 11268-0 | Streptococcus pyogenes [Presence] in Throat by Organism specific culture |
| 11269-8 | Streptococcus pyogenes Ag [Presence] in Serum by Agglutination |
| 1127-0 | Le NOS Ab [Presence] in Serum or Plasma from Blood product unit |
| 11270-6 | Viral inclusion bodies [Identifier] in Unspecified specimen by Cyto stain |
| 11271-4 | Hematocrit [Volume Fraction] of Cord blood by Automated count |
| 11272-2 | Erythrocyte mean corpuscular volume [Entitic volume] in Cord blood by Automated count |
| 11273-0 | Erythrocytes [Morphology] in Blood by Automated count |
| 11274-8 | Elliptocytes [Presence] in Blood by Light microscopy |
| 11275-5 | Large granular lymphocytes/100 leukocytes in Blood by Manual count |
| 11276-3 | Tubular cells [Presence] in Urine sediment by Light microscopy |
| 11277-1 | Epithelial cells.squamous [#/area] in Urine sediment by Microscopy high power field |
| 11278-9 | Bladder cells [#/area] in Urine sediment by Microscopy high power field |
| 11279-7 | Urine sediment comments by Light microscopy Narrative |
| 1128-8 | Le NOS Ab [Presence] in Serum or Plasma from donor |
| 11280-5 | Cabot rings [Presence] in Blood by Light microscopy |
| 11281-3 | Auer rods [Presence] in Blood by Light microscopy |
| 11282-1 | Cells Counted Total [#] in Blood |
| 11283-9 | Acuity assessment [Function] at First encounter |
| 11284-7 | Acuity assessment practitioner identification |
| 11285-4 | Acuity assessment practitioner profession |
| 11286-2 | Alcohol binge episodes per month - Reported |
| 11287-0 | Alcoholic drinks per drinking day - Reported |
| 11288-8 | Arrival time documented |
| 11289-6 | Body temperature at First encounter |
| 1129-6 | Le NOS Ab [Presence] in Serum or Plasma |
| 11290-4 | Body temperature measurement site at First encounter |
| 11291-2 | Respiratory rate at First encounter |
| 11292-0 | Deprecated Chief complaint: Prid: Pt: ^Patient: Nom: Reported |
| 11293-8 | Type of Referral source |
| 11294-6 | Current employment Narrative - Reported |
| 11295-3 | Current employment - Reported |
| 11296-1 | ED clinical finding practitioner identifier |
| 11297-9 | ED clinical finding practitioner profession |
| 11298-7 | ED consultant practitioner identifier |
| 11299-5 | ED consultant practitioner profession |
| 113-1 | Cefotetan [Susceptibility] by Disk diffusion (KB) |
| 1130-4 | Le NOS Ag [Presence] on Red Blood Cells from Blood product unit |
| 11300-1 | ED diagnosis |
| 11301-9 | ED diagnosis type |
| 11302-7 | ED discharge disposition |
| 11303-5 | ED disposition consult/referral |
| 11304-3 | ED disposition diagnosis practitioner identification |
| 11305-0 | ED disposition diagnosis practitioner profession |
| 11306-8 | ED medication practitioner identification |
| 11307-6 | ED medication practitioner profession |
| 11308-4 | ED outcome observation practitioner identification |
| 11309-2 | ED outcome observation practitioner profession |
| 1131-2 | Le NOS Ag [Presence] on Red Blood Cells from donor |
| 11310-0 | ED patient satisfaction report type |
| 11311-8 | ED procedure practitioner profession |
| 11312-6 | ED procedure practitioner identifier |
| 11313-4 | ED procedure result observation [Interpretation] |
| 11314-2 | ED procedure result type |
| 11315-9 | ED service level |
| 11316-7 | ED service level practitioner profession |
| 11317-5 | ED service level practitioner identification |
| 11318-3 | Ambulance transport agency EMS system |
| 11319-1 | Ambulance transport unit [Identifier] EMS system |
| 1132-0 | Le NOS Ag [Presence] on Red Blood Cells |
| 11320-9 | Feeding and dietary status Narrative - Reported |
| 11321-7 | Feeding and dietary status - Reported |
| 11322-5 | History of General health Narrative |
| 11323-3 | General health - Reported |
| 11324-1 | Glasgow coma score eye opening at First encounter |
| 11325-8 | Glasgow coma score motor at First encounter |
| 11326-6 | Glasgow coma score verbal at First encounter |
| 11327-4 | Heart rate method at First encounter |
| 11328-2 | Heart rate at First encounter |
| 11329-0 | History general Narrative - Reported |
| 1133-8 | Lu sup(a) Ab [Presence] in Serum or Plasma from Blood product unit |
| 11330-8 | History of Alcohol use Narrative |
| 11331-6 | History of Alcohol use |
| 11332-4 | History of Cognitive function Narrative |
| 11333-2 | History of Cognitive function |
| 11334-0 | History of Growth+Development Narrative |
| 11335-7 | History of Growth+Development |
| 11336-5 | History of Hospitalization Narrative |
| 11337-3 | History of Hospitalization |
| 11338-1 | History of Major illnesses and injuries Narrative |
| 11339-9 | History of Major illnesses and injuries |
| 1134-6 | Lu sup(a) Ab [Presence] in Serum or Plasma from donor |
| 11340-7 | History of Occupation Narrative |
| 11341-5 | History of Occupation |
| 11342-3 | History of Other nonmedical drug use Narrative |
| 11343-1 | History of Other nonmedical drug use |
| 11344-9 | History of Other social factors Narrative |
| 11345-6 | History of Other social factors |
| 11346-4 | History of Outpatient visits Narrative |
| 11347-2 | History of Outpatient visits |
| 11348-0 | History of Past illness Narrative |
| 11349-8 | History of Past illness |
| 1135-3 | Lu sup(a) Ab [Presence] in Serum or Plasma |
| 11350-6 | History of Sexual behavior Narrative |
| 11351-4 | History of Sexual behavior |
| 11352-2 | History of Allergenic and Immunologic disorders Narrative |
| 11353-0 | History of Breasts disorders Narrative |
| 11354-8 | History of Ears and Nose and Sinuses and Mouth and Throat disorders Narrative |
| 11355-5 | History of Gastrointestinal system disorders Narrative |
| 11356-3 | History of Genitourinary systems disorders Narrative |
| 11357-1 | History of Integumentary system disorders Narrative |
| 11358-9 | History of Psychiatric disorders Narrative |
| 11359-7 | History of Allergenic and Immunologic disorders |
| 1136-1 | Lu sup(a) Ag [Presence] on Red Blood Cells from Blood product unit |
| 11360-5 | History of Breasts disorders |
| 11361-3 | History of Ears and Nose and Sinuses and Mouth and Throat disorders |
| 11362-1 | History of Gastrointestinal system disorders |
| 11363-9 | History of Genitourinary systems disorders |
| 11364-7 | History of Integumentary system disorders |
| 11365-4 | History of Psychiatric disorders |
| 11366-2 | History of Tobacco use Narrative |
| 11367-0 | History of Tobacco use |
| 11368-8 | Illness or injury onset date and time |
| 11369-6 | History of Immunization Narrative |
| 1137-9 | Lu sup(a) Ag [Presence] on Red Blood Cells from donor |
| 11370-4 | Immunization status - Reported |
| 11371-2 | Initial visit for chief complaint |
| 11372-0 | Injury associated activity |
| 11373-8 | Injury cause |
| 11374-6 | Injury incident description Narrative |
| 11375-3 | Injury intent |
| 11376-1 | Injury location |
| 11377-9 | Diastolic blood pressure at First encounter |
| 11378-7 | Systolic blood pressure at First encounter |
| 11379-5 | Highest level of education [Time] - Reported |
| 1138-7 | Lu sup(a) Ag [Presence] on Red Blood Cells |
| 11380-3 | Marital status and living arrangements Narrative - Reported |
| 11381-1 | Marital status and living arrangements - Reported |
| 11382-9 | Medication allergy - Reported |
| 11383-7 | Patient problem outcome Narrative |
| 11384-5 | Physical examination by organ systems |
| 11385-2 | Physical findings of Ankle Narrative |
| 11386-0 | Physical findings of Upper arm Narrative |
| 11387-8 | Physical findings of Axilla Narrative |
| 11388-6 | Physical findings of Buttocks Narrative |
| 11389-4 | Physical findings of Calf Narrative |
| 1139-5 | Lu sup(ab) Ab [Presence] in Serum or Plasma from Blood product unit |
| 11390-2 | Physical findings of Cardiovascular system Narrative |
| 11391-0 | Physical findings of Chest Narrative |
| 11392-8 | Physical findings of Chest wall Narrative |
| 11393-6 | Physical findings of Ears and Nose and Mouth and Throat Narrative |
| 11394-4 | Physical findings of Elbow Narrative |
| 11395-1 | Deprecated Physical findings: Find: Pt: Extremities: Nar: Observed |
| 11396-9 | Deprecated Physical findings: Find: Pt: Extremities: Nar: Observed. |
| 11397-7 | Physical findings of Foot Narrative |
| 11398-5 | Physical findings of Forearm Narrative |
| 11399-3 | Physical findings of Gastrointestinal system Narrative |
| 114-9 | Cefotetan [Susceptibility] by Serum bactericidal titer |
| 1140-3 | Lu sup(ab) Ab [Presence] in Serum or Plasma from donor |
| 11400-9 | Physical findings of Genitalia Narrative |
| 11401-7 | Physical findings of Female genitalia Narrative |
| 11402-5 | Physical findings of Male genitalia Narrative |
| 11403-3 | Physical findings of Groin Narrative |
| 11404-1 | Physical findings of Hand Narrative |
| 11405-8 | Deprecated Physical findings: Find: Pt: Heart: Nar: Observed |
| 11406-6 | Physical findings of Hip Narrative |
| 11407-4 | Physical findings of Knee Narrative |
| 11408-2 | Deprecated Physical findings: Find: Pt: Mouth & Throat & Teeth: Nar: Observed |
| 11409-0 | Deprecated Physical findings: Find: Pt: Mouth & Throat & Teeth: Nar: Observed. |
| 1141-1 | Lu sup(ab) Ab [Presence] in Serum or Plasma |
| 11410-8 | Physical findings of Musculoskeletal system Narrative |
| 11411-6 | Physical findings of Neck Narrative |
| 11412-4 | Physical findings of Respiratory system Narrative |
| 11413-2 | Physical findings of Shoulder Narrative |
| 11414-0 | Physical findings of Thigh Narrative |
| 11415-7 | Physical findings of Wrist Narrative |
| 11416-5 | Physical findings of Ankle |
| 11417-3 | Physical findings of Upper arm |
| 11418-1 | Physical findings of Axilla |
| 11419-9 | Physical findings of Buttocks |
| 1142-9 | Lu sup(b) Ab [Presence] in Serum or Plasma from Blood product unit |
| 11420-7 | Physical findings of Calf |
| 11421-5 | Physical findings of Cardiovascular system |
| 11422-3 | Physical findings of Chest |
| 11423-1 | Physical findings of Chest wall |
| 11424-9 | Physical findings of Ears and Nose and Mouth and Throat |
| 11425-6 | Physical findings of Elbow |
| 11426-4 | Deprecated Physical findings: Find: Pt: Extremities: Nom: Observed |
| 11427-2 | Deprecated Physical findings: Find: Pt: Extremities: Nom: Observed. |
| 11428-0 | Physical findings of Foot |
| 11429-8 | Physical findings of Forearm |
| 1143-7 | Lu sup(b) Ab [Presence] in Serum or Plasma from donor |
| 11430-6 | Physical findings of Gastrointestinal system |
| 11431-4 | Physical findings of Genitalia |
| 11432-2 | Physical findings of Female genitalia |
| 11433-0 | Physical findings of Male genitalia |
| 11434-8 | Physical findings of Groin |
| 11435-5 | Physical findings of Hand |
| 11436-3 | Deprecated Physical findings: Find: Pt: Heart: Nom: Observed |
| 11437-1 | Physical findings of Hip |
| 11438-9 | Physical findings of Knee |
| 11439-7 | Deprecated Physical findings: Find: Pt: Mouth & Throat & Teeth: Nom: Observed. |
| 1144-5 | Lu sup(b) Ab [Presence] in Serum or Plasma |
| 11440-5 | Deprecated Physical findings: Find: Pt: Mouth & Throat & Teeth: Nom: Observed |
| 11441-3 | Physical findings of Musculoskeletal system |
| 11442-1 | Physical findings of Neck |
| 11443-9 | Physical findings of Respiratory system |
| 11444-7 | Physical findings of Shoulder |
| 11445-4 | Physical findings of Thigh |
| 11446-2 | Physical findings of Wrist |
| 11447-0 | Physical findings of Hematologic and Lymphatic and Immunologic System Narrative |
| 11448-8 | Physical findings of Hematologic and Lymphatic and Immunologic System |
| 11449-6 | Pregnancy status [Interpretation] - Reported |
| 1145-2 | Lu sup(b) Ag [Presence] on Red Blood Cells from Blood product unit |
| 11450-4 | Problem list - Reported |
| 11451-2 | Psychiatric findings Narrative |
| 11452-0 | Psychiatric findings |
| 11453-8 | Receiving facility EMS system |
| 11454-6 | Responsiveness assessment at First encounter |
| 11455-3 | Deprecated Review of symptoms and diseases: Find: Pt: ^Patient: Nar: Reported |
| 11456-1 | Deprecated Review of symptoms and diseases: Find: Pt: ^Patient: Nom: Reported |
| 11457-9 | Safety equipment used |
| 11458-7 | Clostridium tetani immunization status |
| 11459-5 | Transport mode EMS system |
| 1146-0 | Lu sup(b) Ag [Presence] on Red Blood Cells from donor |
| 11467-8 | Bacillus anthracis Ab [Units/volume] in Serum by Immunoblot (IB) |
| 11468-6 | Bacillus anthracis Ab [Units/volume] in Unspecified specimen by Immunofluorescence |
| 11469-4 | Bacillus anthracis [Presence] in Unspecified specimen by Organism specific culture |
| 1147-8 | Lu sup(b) Ag [Presence] on Red Blood Cells |
| 11470-2 | Clostridium botulinum toxin [Units/volume] in Stool |
| 11471-0 | Deprecated Cryptococcus neoformans Ag [Titer] in Unspecified specimen |
| 11472-8 | Deprecated Cryptococcus neoformans Ag [Presence] in Unspecified specimen |
| 11473-6 | Cryptococcus sp Ag [Titer] in Unspecified specimen |
| 11474-4 | Hydatid cyst identified in Unspecified specimen by Wet preparation |
| 11475-1 | Microorganism identified in Unspecified specimen by Culture |
| 11476-9 | Microscopic observation [Identifier] in Gastric fluid by Acid fast stain |
| 11477-7 | Microscopic observation [Identifier] in Sputum by Acid fast stain |
| 11478-5 | Microscopic observation [Identifier] in Stool by Acid fast stain |
| 11479-3 | Microscopic observation [Identifier] in Tissue by Acid fast stain |
| 1148-6 | Lu NOS Ab [Presence] in Serum or Plasma from Blood product unit |
| 11480-1 | Microscopic observation [Identifier] in Urine by Acid fast stain |
| 11481-9 | Human papilloma virus identified in Unspecified specimen |
| 11482-7 | Rickettsia rickettsii RNA [Presence] in Tissue by Probe and target amplification method |
| 11483-5 | Varicella zoster virus DNA [Presence] in Unspecified specimen by Probe and target amplification method |
| 11484-3 | Virus identified in Amniotic fluid by Culture |
| 11485-0 | Anesthesia records |
| 11486-8 | Chemotherapy records |
| 11487-6 | Consultation request (narrative) |
| 11488-4 | Consult note |
| 11489-2 | Dictating practitioner identifier |
| 1149-4 | Lu NOS Ab [Presence] in Serum or Plasma from donor |
| 11490-0 | Physician Discharge summary |
| 11491-6 | Deprecated Provider-unspecified ED visit note |
| 11492-6 | Provider-unspecifed, History and physical note |
| 11493-4 | Hospital discharge studies summary Narrative |
| 11494-2 | Deprecated Physician Initial assessment note at First encounter |
| 11495-9 | Deprecated Physical therapy Initial assessment note at First encounter |
| 11496-7 | Deprecated Podiatry Initial assessment note at First encounter |
| 11497-5 | Deprecated Psychology Initial assessment note at First encounter |
| 11498-3 | Deprecated Social work Initial assessment note at First encounter |
| 11499-1 | Deprecated Speech therapy Initial assessment note at First encounter |
| 115-6 | Cefoxitin [Susceptibility] by Minimum lethal concentration (MLC) |
| 1150-2 | Lu NOS Ab [Presence] in Serum or Plasma |
| 11500-6 | Deprecated Occupational therapy Initial assessment note at First encounter |
| 11501-6 | Deprecated Labor and delivery records |
| 11502-2 | Laboratory report |
| 11503-0 | Medical records |
| 11504-8 | Provider-unspecified Operation note |
| 11505-5 | Physician Procedure note |
| 11506-3 | Provider-unspecified Progress note |
| 11507-1 | Occupational therapy Progress note |
| 11508-9 | Physical therapy Progress note |
| 11509-7 | Podiatry Progress note |
| 1151-0 | Lu NOS Ag [Presence] on Red Blood Cells from Blood product unit |
| 11510-5 | Psychology Progress note |
| 11511-3 | Deprecated Provider-unspecified progress note |
| 11512-1 | Speech-language pathology Progress note |
| 11513-9 | Provider.signing [Identifier] Report |
| 11514-7 | Chiropractic Records total Encounter |
| 11515-4 | Physical therapy Records total Encounter |
| 11516-2 | Physician Records total Encounter |
| 11517-0 | Podiatry Records total Encounter |
| 11518-8 | Psychology Records total Encounter |
| 11519-6 | Social service Records total Encounter |
| 1152-8 | Lu NOS Ag [Presence] on Red Blood Cells from donor |
| 11520-4 | Speech therapy Records total Encounter |
| 11521-2 | Occupational therapy Records total Encounter |
| 11522-0 | Deprecated Cardiac echo study |
| 11523-8 | EEG study |
| 11524-6 | EKG Study |
| 11525-3 | US Pelvis Fetus for pregnancy |
| 11526-1 | Pathology study |
| 11527-9 | Psychiatry study |
| 11528-7 | Deprecated Radiology Unspecified site and modality Study |
| 11529-5 | Surgical pathology study |
| 1153-6 | Lu NOS Ag [Presence] on Red Blood Cells |
| 11530-3 | Surgeon.assisting [Identifier] |
| 11531-1 | Surgeon.resident [Identifier] |
| 11532-9 | Surgeon.staff [Identifier] |
| 11533-7 | Surgical drains |
| 11534-5 | Temperature charts |
| 11535-2 | Hospital discharge Dx Narrative |
| 11536-0 | Nurse Notes |
| 11537-8 | Surgical drains Narrative |
| 11538-6 | Deprecated CT Chest study |
| 11539-4 | Deprecated CT Head study |
| 1154-4 | little c Ab [Presence] in Serum or Plasma from Blood product unit |
| 11540-2 | Deprecated CT Abdomen study |
| 11541-0 | Deprecated MRI Brain study |
| 11542-8 | Deprecated Provider-unspecified visit note |
| 11543-6 | Nursery records |
| 11544-4 | Hospital discharge follow-up Narrative |
| 11545-1 | Microscopic observation [Identifier] in Unspecified specimen by Acid fast stain |
| 11546-9 | Microscopic observation [Identifier] in Unspecified specimen by Other stain |
| 1155-1 | little c Ab [Presence] in Serum or Plasma from donor |
| 11550-1 | Borrelia burgdorferi [Presence] in Unspecified specimen by Organism specific culture |
| 11551-9 | Borrelia burgdorferi DNA [Presence] in Cerebral spinal fluid by Probe with amplification |
| 11552-7 | Microscopic exam [Interpretation] of Tissue fine needle aspirate by Cytology |
| 11553-5 | Microscopic exam [Interpretation] of Sputum by Cytology |
| 11554-3 | Deprecated Magnesium [Molecules/volume] in Serum or Plasma |
| 11555-0 | Base excess in Blood by calculation |
| 11556-8 | Oxygen [Partial pressure] in Blood |
| 11557-6 | Carbon dioxide [Partial pressure] in Blood |
| 11558-4 | pH of Blood |
| 11559-2 | Fractional oxyhemoglobin in Blood |
| 1156-9 | little c Ab [Presence] in Serum or Plasma |
| 11560-0 | Acetylcholine receptor binding Ab [Units/volume] in Serum |
| 11561-8 | Acetylcholine receptor blocking Ab [Units/volume] in Serum |
| 11562-6 | Acetylcholine receptor modulation Ab [Units/volume] in Serum |
| 11563-4 | Deprecated DNA double strand Ab [Units/volume] in Serum |
| 11564-2 | Intrinsic factor Ab [Units/volume] in Serum |
| 11565-9 | Jo-1 extractable nuclear Ab [Units/volume] in Serum |
| 11566-7 | Liver kidney microsomal Ab [Units/volume] in Serum |
| 11567-5 | Deprecated Neutrophil cytoplasmic Ab [Units/volume] in Serum |
| 11568-3 | Phosphatidylserine IgG Ab [Presence] in Serum |
| 11569-1 | Phosphatidylserine IgM Ab [Presence] in Serum |
| 1157-7 | little c Ag [Presence] on Red Blood Cells from Blood product unit |
| 11570-9 | Platelet IgG Ab [Units/volume] in Serum |
| 11571-7 | Rheumatoid arthritis nuclear Ab [Units/volume] in Serum |
| 11572-5 | Rheumatoid factor [Units/volume] in Serum or Plasma |
| 11573-3 | Rheumatoid factor IgM [Units/volume] in Serum |
| 11574-1 | Deprecated Thyroperoxidase Ab [Units/volume] in Serum |
| 11575-8 | Cefmetazole [Susceptibility] by Gradient strip |
| 11576-6 | Erythromycin+Sulfisoxazole [Susceptibility] by Gradient strip |
| 11577-4 | Sulfamethoxazole [Susceptibility] by Gradient strip |
| 11578-2 | Sulfisoxazole [Susceptibility] by Gradient strip |
| 11579-0 | Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L |
| 1158-5 | little c Ag [Presence] on Red Blood Cells from donor |
| 11580-8 | Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.005 mIU/L |
| 11581-6 | Ebola virus Ab [Units/volume] in Serum |
| 11582-4 | Wuchereria bancrofti Ab [Units/volume] in Serum |
| 11583-2 | Aspergillus fumigatus 1 Ab [Presence] in Serum |
| 11584-0 | Aureobasidium pullulans Ab [Presence] in Serum |
| 11585-7 | Bordetella pertussis Ab [Units/volume] in Serum |
| 11586-5 | Brucella abortus Ab [Units/volume] in Serum |
| 11587-3 | Brucella canis Ab [Units/volume] in Serum |
| 11588-1 | Brucella melitensis Ab [Units/volume] in Serum |
| 11589-9 | Brucella suis Ab [Units/volume] in Serum |
| 1159-3 | little c Ag [Presence] on Red Blood Cells |
| 11590-7 | Coxsackievirus A10 Ab [Units/volume] in Serum |
| 11591-5 | Coxsackievirus A2 Ab [Units/volume] in Serum |
| 11592-3 | Aspergillus fumigatus 6 Ab [Presence] in Serum |
| 11593-1 | Coxsackievirus A4 Ab [Units/volume] in Serum |
| 11594-9 | Echovirus 16 Ab [Units/volume] in Serum |
| 11595-6 | Echovirus 18 Ab [Units/volume] in Serum |
| 11596-4 | Shigella dysenteriae Ab [Units/volume] in Serum |
| 11597-2 | Treponema pallidum Ab [Units/volume] in Serum |
| 11598-0 | Toxoplasma gondii Ab [Units/volume] in Serum |
| 11599-8 | Coxsackievirus A21 Ab [Units/volume] in Serum |
| 116-4 | Cefoxitin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 1160-1 | little e Ab [Presence] in Serum or Plasma from Blood product unit |
| 11600-4 | Shigella flexneri Ab [Units/volume] in Serum |
| 11601-2 | Echovirus 7 Ab [Units/volume] in Serum |
| 11602-0 | Shigella boydii Ab [Units/volume] in Serum |
| 11603-8 | Salmonella sp Ab [Units/volume] in Serum |
| 11604-6 | Burkholderia pseudomallei Ab [Units/volume] in Serum |
| 11605-3 | Lymphocytic choriomeningitis virus Ab [Units/volume] in Serum |
| 11606-1 | Leptospira interrogans Ab [Units/volume] in Serum |
| 11607-9 | Junin virus Ab [Units/volume] in Serum |
| 11608-7 | Japanese encephalitis virus Ab [Units/volume] in Serum |
| 11609-5 | HTLV I Ab [Units/volume] in Serum |
| 1161-9 | little e Ab [Presence] in Serum or Plasma from donor |
| 11610-3 | Heterophile Ab [Units/volume] in Serum |
| 11611-1 | Shigella sonnei Ab [Units/volume] in Serum |
| 11612-9 | [#] Abortions |
| 11613-7 | [#] Abortions.induced |
| 11614-5 | [#] Abortions.spontaneous |
| 11615-2 | Fetal Heart Activity US |
| 11616-0 | Fetal Heart Narrative Activity US |
| 11617-8 | Fetal Limbs Activity US |
| 11618-6 | Fetal Limbs Narrative Activity US |
| 11619-4 | Fetal Respiratory Activity US |
| 1162-7 | little e Ab [Presence] in Serum or Plasma |
| 11620-2 | Fetal Respiratory Narrative Activity US |
| 11621-0 | Fetal Trunk Activity US |
| 11622-8 | Fetal Trunk Narrative Activity US |
| 11623-6 | Fetal Quadrant four Amniotic fluid index derived by US |
| 11624-4 | Fetal Quadrant four one Amniotic fluid index derived by US |
| 11625-1 | Fetal Quadrant three Amniotic fluid index derived by US |
| 11626-9 | Fetal Quadrant two Amniotic fluid index derived by US |
| 11627-7 | Fetal Amniotic fluid index.sum derived by US |
| 11628-5 | Fetal Head Binocular distance estimated from Biparietal diameter on US |
| 11629-3 | Fetal Head Binocular distance US |
| 1163-5 | little e Ag [Presence] on Red Blood Cells from Blood product unit |
| 11630-1 | Fetal Biophysical profile.amniotic fluid volume US |
| 11631-9 | Fetal Biophysical profile.body movement US |
| 11632-7 | Fetal Biophysical profile.breathing movement US |
| 11633-5 | Fetal Biophysical profile.heart rate reactivity US |
| 11634-3 | Fetal Biophysical profile.sum Derived |
| 11635-0 | Fetal Biophysical profile.tone US |
| 11636-8 | [#] Births.live |
| 11637-6 | [#] Births.preterm |
| 11638-4 | [#] Births.still living |
| 11639-2 | [#] Births.term |
| 1164-3 | little e Ag [Presence] on Red Blood Cells from donor |
| 11640-0 | [#] Births total |
| 11641-8 | Fetal Mitral valve Peak A wave US.doppler |
| 11642-6 | Deprecated Mitral valve Blood flow.diastolic.atrial wave.max by US.doppler |
| 11643-4 | Fetal Tricuspid valve Peak A wave US.doppler |
| 11644-2 | Deprecated Tricuspid valve Peak A velocity US.doppler |
| 11645-9 | Fetal Mitral valve Peak E wave US.doppler |
| 11646-7 | Deprecated Mitral valve Peak E velocity US.doppler |
| 11647-5 | Fetal Tricuspid valve Peak E wave US.doppler |
| 11648-3 | Deprecated Tricuspid valve Peak E velocity US.doppler |
| 11649-1 | Fetal Mitral valve E-wave/A-wave US.doppler |
| 1165-0 | little e Ag [Presence] on Red Blood Cells |
| 11650-9 | Deprecated Mitral valve Blood flow.diastolic.early wave/Atrial wave Doppler.measured |
| 11651-7 | Fetal Tricuspid valve E-wave/A-wave US.doppler |
| 11652-5 | Deprecated Tricuspid valve Blood flow.diastolic.early wave/Atrial wave Doppler.measured |
| 11653-3 | Circulatory system End diastolic blood flow US.doppler |
| 11654-1 | Fetal Cerebral artery anterior Minimal flow velocity US.doppler |
| 11655-8 | Cerebral artery anterior Minimal flow velocity US.doppler |
| 11656-6 | Fetal Cerebral artery middle Minimal flow velocity US.doppler |
| 11657-4 | Cerebral artery middle Minimal flow velocity US.doppler |
| 11658-2 | Ovarian artery - left Minimal flow velocity US.doppler |
| 11659-0 | Ovarian artery - right Minimal flow velocity US.doppler |
| 1166-8 | little f Ab [Presence] in Serum or Plasma from Blood product unit |
| 11660-8 | Fetal Umbilical artery at fetus Minimal flow velocity US.doppler |
| 11661-6 | Fetal Umbilical artery at placenta Minimal flow velocity US.doppler |
| 11662-4 | Fetal Umbilical artery between fetus and placenta Minimal flow velocity US.doppler |
| 11663-2 | Uterine artery - left Minimal flow velocity US.doppler |
| 11664-0 | Uterine artery - right Minimal flow velocity US.doppler |
| 11665-7 | Circulatory system Minimal flow velocity US.doppler |
| 11666-5 | Fetal Aorta ascending Mean blood flow US.doppler |
| 11667-3 | Aorta ascending Mean blood flow US.doppler |
| 11668-1 | Fetal Aorta descending Mean blood flow US.doppler |
| 11669-9 | Aorta descending Mean blood flow US.doppler |
| 1167-6 | little f Ab [Presence] in Serum or Plasma from donor |
| 11670-7 | Fetal Aortic arch Mean blood flow US.doppler |
| 11671-5 | Aortic arch Mean blood flow US.doppler |
| 11672-3 | Fetal Cerebral artery anterior Mean blood flow US.doppler |
| 11673-1 | Cerebral artery anterior Mean blood flow US.doppler |
| 11674-9 | Cerebral artery middle Mean blood flow US.doppler |
| 11675-6 | Fetal Ductus arteriosus Mean blood flow US.doppler |
| 11676-4 | Ductus arteriosus Mean blood flow US.doppler |
| 11677-2 | Fetal Pulmonary valve Mean blood flow US.doppler |
| 11678-0 | Pulmonary valve Mean blood flow by US.doppler |
| 11679-8 | Fetal Left ventricular outflow tract Mean blood flow US.doppler |
| 1168-4 | little f Ab [Presence] in Serum or Plasma |
| 11680-6 | Deprecated Left ventricular outflow tract Mean blood flow Doppler.measured |
| 11681-4 | Fetal Right ventricular outflow tract Mean blood flow US.doppler |
| 11682-2 | Deprecated Right ventricular outflow tract Mean blood flow Doppler.measured |
| 11683-0 | Ovarian artery - left Mean blood flow US.doppler |
| 11684-8 | Ovarian artery - right Mean blood flow US.doppler |
| 11685-5 | Fetal Main pulmonary artery Mean blood flow US.doppler |
| 11686-3 | Main pulmonary artery Mean blood flow US.doppler |
| 11687-1 | Fetal Umbilical artery at fetus Mean blood flow US.doppler |
| 11688-9 | Fetal Umbilical artery at placenta Mean blood flow US.doppler |
| 11689-7 | Fetal Umbilical artery between fetus and placenta Mean blood flow US.doppler |
| 1169-2 | little f Ag [Presence] on Red Blood Cells from Blood product unit |
| 11690-5 | Uterine artery - left Mean blood flow US.doppler |
| 11691-3 | Uterine artery - right Mean blood flow US.doppler |
| 11692-1 | Circulatory system Maximum blood flow mean US.doppler |
| 11693-9 | Fetal Aorta ascending Peak systolic flow US.doppler |
| 11694-7 | Aorta ascending Peak systolic flow US.doppler |
| 11695-4 | Fetal Aorta descending Peak systolic flow US.doppler |
| 11696-2 | Aorta descending Peak systolic flow US.doppler |
| 11697-0 | Fetal Aortic arch Peak systolic flow US.doppler |
| 11698-8 | Aortic arch Peak systolic flow US.doppler |
| 11699-6 | Fetal Cerebral artery anterior Peak systolic flow US.doppler |
| 117-2 | Cefoxitin [Susceptibility] by Disk diffusion (KB) |
| 1170-0 | little f Ag [Presence] on Red Blood Cells from donor |
| 11700-2 | Cerebral artery anterior Peak systolic flow US.doppler |
| 11701-0 | Fetal Cerebral artery middle Peak systolic flow US.doppler |
| 11702-8 | Cerebral artery middle Peak systolic flow US.doppler |
| 11703-6 | Fetal Ductus arteriosus Peak systolic flow US.doppler |
| 11704-4 | Ductus arteriosus Peak systolic flow US.doppler |
| 11705-1 | Fetal Aortic valve Peak systolic flow US.doppler |
| 11706-9 | Aortic valve Peak systolic flow by US.doppler |
| 11707-7 | Fetal Mitral valve Peak systolic flow US.doppler |
| 11708-5 | Mitral valve Peak systolic flow by US.doppler |
| 11709-3 | Fetal Pulmonary valve Peak systolic flow US.doppler |
| 1171-8 | little f Ag [Presence] on Red Blood Cells |
| 11710-1 | Pulmonary valve Peak systolic flow by US.doppler |
| 11711-9 | Fetal Tricuspid valve Peak systolic flow US.doppler |
| 11712-7 | Tricuspid valve Peak systolic flow by US.doppler |
| 11713-5 | Fetal Left ventricular outflow tract Peak systolic flow US.doppler |
| 11714-3 | Deprecated Left ventricular outflow tract Peak systolic flow Doppler.measured |
| 11715-0 | Fetal Right ventricular outflow tract Peak systolic flow US.doppler |
| 11716-8 | Deprecated Right ventricular outflow tract Peak systolic flow Doppler.measured |
| 11717-6 | Ovarian artery - left Peak systolic flow US.doppler |
| 11718-4 | Ovarian artery - right Peak systolic flow US.doppler |
| 11719-2 | Fetal Main pulmonary artery Peak systolic flow US.doppler |
| 1172-6 | Deprecated little i-1 subtype [Presence] in Serum or Plasma from Blood product unit |
| 11720-0 | Main pulmonary artery Peak systolic flow US.doppler |
| 11721-8 | Fetal Umbilical artery at fetus Peak systolic flow US.doppler |
| 11722-6 | Fetal Umbilical artery at placenta Peak systolic flow US.doppler |
| 11723-4 | Fetal Umbilical artery between fetus and placenta Peak systolic flow US.doppler |
| 11724-2 | Uterine artery - left Peak systolic flow US.doppler |
| 11725-9 | Uterine artery - right Peak systolic flow US.doppler |
| 11726-7 | Circulatory system Peak systolic flow US.doppler |
| 11727-5 | Fetal Body weight estimated by US |
| 11728-3 | Fetal Body weight estimated from Abdominal circumference on US |
| 11729-1 | Fetal Body weight estimated from Abdominal circumference and Biparietal diameter on US |
| 1173-4 | Deprecated little i-1 subtype [Presence] in serum or plasma from donor |
| 11730-9 | Fetal Body weight estimated from Abdominal circumference and Biparietal diameter and Femur length on US |
| 11731-7 | Fetal Body weight estimated from Abdominal circumference and Biparietal diameter and Femur length and Head circumference on US |
| 11732-5 | Fetal Body weight estimated from Abdominal circumference and Biparietal diameter and Femur length and Head circumference on US by Hadlock 1985 method |
| 11733-3 | Fetal Body weight estimated from Abdominal circumference and Biparietal diameter and Femur length and Head circumference on US by Roberts 1985 method |
| 11734-1 | Fetal Body weight estimated from Abdominal circumference and Biparietal diameter and Femur length on US by Hadlock 1984 method |
| 11735-8 | Fetal Body weight estimated from Abdominal circumference and Biparietal diameter and Femur length on US by Hadlock 1985 method |
| 11736-6 | Fetal Body weight estimated from Abdominal circumference and Biparietal diameter and Femur length on US by Woo 1985 method |
| 11737-4 | Fetal Body weight estimated from Abdominal circumference and Biparietal diameter on US by Eik-Nes 1982 method |
| 11738-2 | Fetal Body weight estimated from Abdominal circumference and Biparietal diameter on US by Hadlock 1984 method |
| 11739-0 | Fetal Body weight estimated from Abdominal circumference and Biparietal diameter on US by Shepard 1982 method |
| 1174-2 | Deprecated little i-1 subtype [Presence] in serum |
| 11740-8 | Fetal Body weight estimated from Abdominal circumference and Biparietal diameter on US by Thurnau 1983 method |
| 11741-6 | Fetal Body weight estimated from Abdominal circumference and Biparietal diameter on US by Warsof 1977 method |
| 11742-4 | Fetal Body weight estimated from Abdominal circumference and Biparietal diameter on US by Weinberger 1984 method |
| 11743-2 | Fetal Body weight estimated from Abdominal circumference and Femur length on US |
| 11744-0 | Fetal Body weight estimated from Abdominal circumference and Femur length and Head circumference on US |
| 11745-7 | Fetal Body weight estimated from Abdominal circumference and Femur length and Head circumference on US by Hadlock 1984 method |
| 11746-5 | Fetal Body weight estimated from Abdominal circumference and Femur length and Head circumference on US by Hadlock 1985 method |
| 11747-3 | Fetal Body weight estimated from Abdominal circumference and Femur length and Head circumference on US by Ott 1986 method |
| 11748-1 | Fetal Body weight estimated from Abdominal circumference and Femur length and Head circumference on US by Vintzileos 1987 method |
| 11749-9 | Fetal Body weight estimated from Abdominal circumference and Femur length and Head circumference on US by Weiner 1985 method |
| 1175-9 | Deprecated little i-1 subtype [Presence] on Red Blood Cells from Blood product unit |
| 11750-7 | Fetal Body weight estimated from Abdominal circumference and Femur length on US by Hadlock 1984 method |
| 11751-5 | Fetal Body weight estimated from Abdominal circumference and Femur length on US by Hadlock 1985 method |
| 11752-3 | Fetal Body weight estimated from Abdominal circumference and Femur length on US by Woo 1985 method |
| 11753-1 | Fetal Body weight estimated from Abdominal circumference and Head circumference on US |
| 11754-9 | Fetal Body weight estimated from Abdominal circumference and Head circumference on US by Hadlock 1984 method |
| 11755-6 | Fetal Body weight estimated from Abdominal circumference and Head circumference on US by Jordaan 1983 method |
| 11756-4 | Fetal Body weight estimated from Abdominal circumference on US by Campbell 1975 method |
| 11757-2 | Fetal Body weight estimated from Abdominal circumference on US by Vintzileos 1987 method |
| 11758-0 | Fetal Body weight estimated from Abdominal circumference on US by Warsof 1977 method |
| 11759-8 | Fetal Body weight estimated from Abdominal diameter and Biparietal diameter on US |
| 1176-7 | Deprecated little i-1 subtype [Presence] on Red Blood Cells from donor |
| 11760-6 | Fetal Body weight estimated from Abdominal diameter and Biparietal diameter and Femur length on US |
| 11761-4 | Fetal Body weight estimated from Abdominal diameter and Biparietal diameter and Femur length on US by Rose 1987 method |
| 11762-2 | Fetal Body weight estimated from Abdominal diameter and Biparietal diameter on US by Rose 1987 method |
| 11763-0 | Fetal Body weight estimated from Abdominal diameter and Biparietal diameter on US by Vintzileos 1987 method |
| 11764-8 | Fetal Body weight estimated from Abdominal diameter and Femur length on US |
| 11765-5 | Fetal Body weight estimated from Abdominal diameter and Femur length on US by Rose 1987 method |
| 11766-3 | Fetal Body weight percentile Comparison of estimated fetal weight with standard population distribution at same estimated gestational age |
| 11767-1 | Body weight percentile Comparison of estimated fetal weight with standard population distribution at same estimated gestational age |
| 11768-9 | Fetal Body weight percentile range Categorization by comparison with standards |
| 11769-7 | Body weight percentile range Categorization by comparison with standards |
| 1177-5 | Deprecated little i-1 subtype [Presence] on Red Blood Cells |
| 11770-5 | [Percentile] Body weight.10th Estimated.pop birth wgt gestational age corr.ref |
| 11771-3 | [Percentile] Body weight.25th Estimated.pop birth wgt gestational age corr.ref |
| 11772-1 | [Percentile] Body weight.50th Estimated.pop birth wgt gestational age corr.ref |
| 11773-9 | [Percentile] Body weight.75th Estimated.pop birth wgt gestational age corr.ref |
| 11774-7 | [Percentile] Body weight.90th Estimated.pop birth wgt gestational age corr.ref |
| 11775-4 | Fetal body weight estimation formula Narrative [Bibliographic Citation] Citation |
| 11776-2 | Gestational age estimation formula Narrative [Bibliographic Citation] Citation |
| 11777-0 | Fetal Abdomen [Area] Cross section derived by US |
| 11778-8 | Delivery date Estimated |
| 11779-6 | Delivery date Estimated from last menstrual period |
| 1178-3 | Deprecated little i-2 subtype [Presence] in Serum or Plasma from Blood product unit |
| 11780-4 | Delivery date Estimated from ovulation date |
| 11781-2 | Delivery date US composite estimate |
| 11782-0 | Fetal Bowel Diameter US |
| 11783-8 | Bowel Diameter US |
| 11784-6 | Cervical canal external os Diameter palpation |
| 11785-3 | Cervical canal external os Diameter US |
| 11786-1 | Cervical canal internal os Diameter palpation |
| 11787-9 | Cervical canal internal os Diameter US |
| 11788-7 | Cervical canal Diameter Probe insertion.Hagar |
| 11789-5 | Cervical canal Diameter Probe insertion.Pratt |
| 1179-1 | Deprecated little i-2 subtype [Presence] in serum or plasmafrom donor |
| 11790-3 | Fetal Colon lumen Diameter US |
| 11791-1 | Colon lumen Diameter US |
| 11792-9 | Fetal Eye Diameter US |
| 11793-7 | Follicle Diameter US |
| 11794-5 | Fetal Aortic valve Diameter US |
| 11795-2 | Aortic valve Diameter by US |
| 11796-0 | Fetal Mitral valve Diameter US |
| 11797-8 | Deprecated Mitral valve Diameter by US |
| 11798-6 | Fetal Pulmonary valve Diameter US |
| 11799-4 | Pulmonary valve Diameter by US |
| 118-0 | Cefoxitin [Susceptibility] by Serum bactericidal titer |
| 1180-9 | Deprecated little i-2 subtype [Presence] in serum |
| 11800-0 | Fetal Tricuspid valve Diameter US |
| 11801-8 | Tricuspid valve Diameter by US |
| 11802-6 | Fetal Left ventricular outflow tract Diameter US.doppler |
| 11803-4 | Left ventricular outflow tract Diameter US.doppler |
| 11804-2 | Fetal Right ventricular outflow tract Diameter US |
| 11805-9 | Right ventricular outflow tract Diameter US |
| 11806-7 | Fetal Pulmonary artery Diameter US |
| 11807-5 | Pulmonary artery Diameter US |
| 11808-3 | Fetal Renal pelvis - left Diameter US |
| 11809-1 | Renal pelvis - left Diameter US |
| 1181-7 | Deprecated little i-2 subtype [Presence] on Red Blood Cells from Blood product unit |
| 11810-9 | Fetal Renal pelvis - right Diameter US |
| 11811-7 | Renal pelvis - right Diameter US |
| 11812-5 | Fetal Small bowel Diameter US |
| 11813-3 | Small bowel Diameter US |
| 11814-1 | Fetal Umbilical vein Diameter US |
| 11815-8 | Fetal Urinary bladder Diameter US |
| 11816-6 | Fetal Yolk sac Diameter US |
| 11817-4 | Fetal Amniotic fluid space Diameter largest pocket US |
| 11818-2 | Fetal Abdomen Diameter.anterior-posterior US |
| 11819-0 | Fetal Thorax Diameter.anterior-posterior US |
| 1182-5 | Deprecated little i-2 subtype [Presence] on Red Blood Cells from donor |
| 11820-8 | Fetal Head Diameter.biparietal US |
| 11821-6 | Fetal Head Mean biparietal diameter Estimated from gestational age |
| 11822-4 | Fetal Head Mean biparietal diameter estimated from Cerebellar diameter (US) |
| 11823-2 | Fetal Head Diameter.biparietal/Diameter.occipital derived by US |
| 11824-0 | Fetal Head Diameter.BPD.area-corrected derived by US |
| 11825-7 | Fetal Kidney - left Hilum-cortex diameter US |
| 11826-5 | Kidney - left Hilum-cortex diameter US |
| 11827-3 | Fetal Kidney - right Hilum-cortex diameter US |
| 11828-1 | Kidney - right Hilum-cortex diameter US |
| 11829-9 | Ovary - left Hilum-cortex diameter US |
| 1183-3 | Deprecated little i-2 subtype [Presence] on Red Blood Cells |
| 11830-7 | Ovary - right Hilum-cortex diameter US |
| 11831-5 | Fetal Kidney Mean width Estimated from gestational age |
| 11832-3 | Fetal Amniotic fluid space Maximum diameter largest pocket US |
| 11833-1 | Fetal Amniotic fluid space Mean diameter largest pocket US |
| 11834-9 | Fetal Kidney - left Longitudinal diameter US |
| 11835-6 | Kidney - left Longitudinal diameter US |
| 11836-4 | Fetal Kidney - right Longitudinal diameter US |
| 11837-2 | Kidney - right Longitudinal diameter US |
| 11838-0 | Fetal Liver Longitudinal diameter US |
| 11839-8 | Liver Longitudinal diameter US |
| 1184-1 | little i Ab [Presence] in Serum or Plasma from Blood product unit |
| 11840-6 | Ovary - left Longitudinal diameter US |
| 11841-4 | Ovary - right Longitudinal diameter US |
| 11842-2 | Uterus Longitudinal diameter US |
| 11843-0 | Fetal Kidney Mean longitudinal diameter Estimated from gestational age |
| 11844-8 | Fetal Liver Mean longitudinal diameter Estimated from abdominal circumference |
| 11845-5 | Fetal Liver Mean longitudinal diameter Estimated from gestational age |
| 11846-3 | Ovary largest follicle Maximum diameter US |
| 11847-1 | Ovary - left largest follicle Maximum diameter US |
| 11848-9 | Ovary - right largest follicle Maximum diameter US |
| 11849-7 | Fetal Abdomen Mean diameter Estimated from gestational age |
| 1185-8 | little i Ab [Presence] in Serum or Plasma from donor |
| 11850-5 | Gestational sac Mean diameter US |
| 11851-3 | Fetal Head Diameter.occipito-frontal US |
| 11852-1 | Fetal Head Diameter.outer to outer US |
| 11853-9 | Fetal Kidney - left Thickeness US |
| 11854-7 | Kidney - left Thickeness US |
| 11855-4 | Fetal Kidney - right Thickeness US |
| 11856-2 | Kidney - right Thickeness US |
| 11857-0 | Ovary - left Thickeness US |
| 11858-8 | Ovary - right Thickeness US |
| 11859-6 | Uterus Thickeness US |
| 1186-6 | little i Ab [Presence] in Serum or Plasma |
| 11860-4 | Fetal Cisterna magna Diameter.sagittal US |
| 11861-2 | Fetal Cisterna magna Mean sagittal diameter Estimated from gestational age |
| 11862-0 | Fetal Abdomen Diameter transverse US |
| 11863-8 | Fetal Cerebellum Diameter transverse US |
| 11864-6 | Fetal Thorax Diameter transverse US |
| 11865-3 | Uterus Diameter transverse US |
| 11866-1 | Fetal Cerebellum Mean transverse diameter Estimated from gestational age |
| 11867-9 | Effacement Cervix |
| 11868-7 | Fetal body weight estimation formula Narrative [Equation] Equation |
| 11869-5 | Gestational age estimation formula Narrative [Equation] Equation |
| 1187-4 | little i NOS Ag [Presence] on Red Blood Cells from Blood product unit |
| 11870-3 | Examination level ultrasound |
| 11871-1 | Fetal Femur length/Abdominal circumference derived by US |
| 11872-9 | Fetal Femur length/Biparietal diameter derived by US |
| 11873-7 | Fetal Femur length/Head circumference derived by US |
| 11874-5 | Fetal position palpation |
| 11875-2 | Fetal position US |
| 11876-0 | Fetal presentation palpation |
| 11877-8 | Fetal presentation US |
| 11878-6 | Number of fetuses by US |
| 11879-4 | Ovary - left [#] Follicles US |
| 1188-2 | little i NOS Ag [Presence] on Red Blood Cells from donor |
| 11880-2 | Ovary - right [#] Follicles US |
| 11881-0 | Uterus Fundal height Tape measure |
| 11882-8 | Fetal Sex US |
| 11883-6 | Fetal Narrative Sex US |
| 11884-4 | Gestational age Estimated |
| 11885-1 | Gestational age Estimated from last menstrual period |
| 11886-9 | Gestational age Estimated from ovulation date |
| 11887-7 | Gestational age Estimated from selected delivery date |
| 11888-5 | Gestational age US composite estimate |
| 11889-3 | Gestational age estimated from Abdominal circumference on US |
| 1189-0 | little i NOS Ag [Presence] on Red Blood Cells |
| 11890-1 | Gestational age estimated from Abdominal circumference on US by Campbell 1975 method |
| 11891-9 | Gestational age estimated from Abdominal circumference on US by Hadlock 1982 method |
| 11892-7 | Gestational age estimated from Abdominal circumference on US by Hadlock 1984 method |
| 11893-5 | Gestational age estimated from Abdominal circumference on US by Jeanty 1984 method |
| 11894-3 | Gestational age estimated from area corrected Biparietal circumference (US) |
| 11895-0 | Gestational age estimated from Binocular distance on US |
| 11896-8 | Gestational age estimated from Binocular distance on US by Jeanty 1984 method |
| 11897-6 | Gestational age estimated from Biparietal circumference (US) |
| 11898-4 | Gestational age estimated from Biparietal diameter on US |
| 11899-2 | Gestational age estimated from Biparietal diameter on US by Campbell 1975 method |
| 119-8 | Cefpodoxime [Susceptibility] by Minimum lethal concentration (MLC) |
| 1190-8 | little k Ab [Presence] in Serum or Plasma from Blood product unit |
| 11900-8 | Gestational age estimated from Biparietal diameter on US by Doubilet 1993 method |
| 11901-6 | Gestational age estimated from Biparietal diameter on US by Hadlock 1982 method |
| 11902-4 | Gestational age estimated from Biparietal diameter on US by Hadlock 1984 method |
| 11903-2 | Gestational age estimated from Biparietal diameter on US by Hansmann 1985 method |
| 11904-0 | Gestational age estimated from Biparietal diameter on US by Hobbins 1983 method |
| 11905-7 | Gestational age estimated from Biparietal diameter on US by Jeanty 1984 method |
| 11906-5 | Gestational age estimated from Biparietal diameter on US by Kurtz 1980 method |
| 11907-3 | Gestational age estimated from Biparietal diameter on US by Sabbagha 1978 method |
| 11908-1 | Gestational age estimated from Cerebellar diameter by method of Goldstein 1987 (US) |
| 11909-9 | Gestational age estimated from Crown rump length on US |
| 1191-6 | little k Ab [Presence] in Serum or Plasma from donor |
| 11910-7 | Gestational age estimated from Crown rump length on US by Hadlock 1992 method |
| 11911-5 | Gestational age estimated from Crown rump length on US by Hansmann 1985 method |
| 11912-3 | Gestational age estimated from Crown rump length on US by Jeanty 1984 method |
| 11913-1 | Gestational age estimated from Crown rump length on US by Nelson 1981 method |
| 11914-9 | Gestational age estimated from Crown rump length on US by Robinson 1975 method |
| 11915-6 | Gestational age estimated from Crown rump length on US by Yeh 1988 method |
| 11916-4 | Gestational age estimated from Fibula length (US) |
| 11917-2 | Gestational age estimated from Fibula length by method of Jeanty 1984 (US) |
| 11918-0 | Gestational age estimated from Fibula length by method of Merz 1987 (US) |
| 11919-8 | Gestational age estimated from Femur length on US |
| 1192-4 | little k Ab [Presence] in Serum or Plasma |
| 11920-6 | Gestational age estimated from Femur length on US by Hadlock 1984 method |
| 11921-4 | Gestational age estimated from Femur length on US by Hansmann 1985 method |
| 11922-2 | Gestational age estimated from Femur length on US by Hohler 1982 method |
| 11923-0 | Gestational age estimated from Femur length on US by Jeanty 1984 method |
| 11924-8 | Gestational age estimated from Femur length on US by Merz 1987 method |
| 11925-5 | Gestational age estimated from Femur length on US by Obrien 1982 method |
| 11926-3 | Gestational age estimated from Foot length on US by Mercer 1987 method |
| 11927-1 | Gestational age estimated from Gestational sac diameter on US |
| 11928-9 | Gestational age estimated from Gestational sac diameter on US by Hellman 1969 method |
| 11929-7 | Gestational age estimated from Gestational sac diameter on US by Rempen 1991 method |
| 1193-2 | little k Ag [Presence] on Red Blood Cells from Blood product unit |
| 11930-5 | Gestational age estimated from Head circumference on US |
| 11931-3 | Gestational age estimated from Head circumference on US by Hadlock 1982 method |
| 11932-1 | Gestational age estimated from Head circumference on US by Hadlock 1984 method |
| 11933-9 | Gestational age estimated from Head circumference on US by Hoffbauer 1979 method |
| 11934-7 | Gestational age estimated from Head circumference on US by Jeanty 1984 method |
| 11935-4 | Gestational age estimated from Humerus length on US |
| 11936-2 | Gestational age estimated from Humerus length on US by Jeanty 1984 method |
| 11937-0 | Gestational age estimated from Humerus length on US by Merz 1987 method |
| 11938-8 | Gestational age estimated from Radius length (US) |
| 11939-6 | Gestational age estimated from Radius length by method of Merz 1987 (US) |
| 1194-0 | little k Ag [Presence] on Red Blood Cells from donor |
| 11940-4 | Gestational age estimated from Tibia length on US |
| 11941-2 | Gestational age estimated from Tibia length on US by Jeanty 1984 method |
| 11942-0 | Gestational age estimated from Tibia length on US by Merz 1987 method |
| 11943-8 | Gestational age estimated from Ulna length (US) |
| 11944-6 | Gestational age estimated from Ulna length by method of Jeanty 1984 (US) |
| 11945-3 | Gestational age estimated from Ulna length by method of Merz 1987 (US) |
| 11946-1 | Fetal Placenta Grade US |
| 11947-9 | Head circumference/Abdominal circumference derived by US |
| 11948-7 | Fetal Heart rate US |
| 11949-5 | Fetal Identification criteria US |
| 1195-7 | little k Ag [Presence] on Red Blood Cells |
| 11950-3 | Fetal Narrative Identification criteria US |
| 11951-1 | Fetal [Identifier] Identifier |
| 11952-9 | Fetal Umbilical cord.placenta Narrative Insertion site US |
| 11953-7 | OB ultrasound imaging device Institution inventory number |
| 11954-5 | Fetal Kidney length/Abdominal circumference derived by US |
| 11955-2 | Deprecated Last menstrual period |
| 11956-0 | Fetal Head Lateral ventricular body width/Hemispheric width derived by US |
| 11957-8 | Fetal Crown Rump length US |
| 11958-6 | Cervical canal [Length] palpation |
| 11959-4 | Cervical canal [Length] US |
| 1196-5 | Little NOS Ab [Presence] in Serum or Plasma from Blood product unit |
| 11960-2 | Cervix externally palpable surface [Length] palpation |
| 11961-0 | Cervix [Length] US |
| 11962-8 | Fetal Clavicle diaphysis [Length] US |
| 11963-6 | Fetal Femur diaphysis [Length] US |
| 11964-4 | Fetal Fibula diaphysis [Length] US |
| 11965-1 | Fetal Foot [Length] US |
| 11966-9 | Fetal Humerus diaphysis [Length] US |
| 11967-7 | Fetal Radius diaphysis [Length] US |
| 11968-5 | Fetal Tibia diaphysis [Length] US |
| 11969-3 | Fetal Ulna diaphysis [Length] US |
| 1197-3 | Little NOS Ab [Presence] in Serum or Plasma from donor |
| 11970-1 | Fetal Femur diaphysis [Length] mean Estimated from gestational age.Merz. 1987 |
| 11971-9 | Fetal Fibula diaphysis [Length] mean Estimated from gestational age.Merz. 1987 |
| 11972-7 | Fetal Humerus diaphysis [Length] mean Estimated from gestational age.Merz. 1987 |
| 11973-5 | Fetal Radius diaphysis [Length] mean Estimated from gestational age.Merz. 1987 |
| 11974-3 | Fetal Tibia diaphysis [Length] mean Estimated from gestational age.Merz. 1987 |
| 11975-0 | Fetal Ulna diaphysis [Length] mean Estimated from gestational age.Merz. 1987 |
| 11976-8 | Ovulation date |
| 11977-6 | [#] Parity |
| 11978-4 | Fetal Abdomen Circumference derived by US |
| 11979-2 | Fetal Abdomen Circumference US |
| 1198-1 | Little NOS Ab [Presence] in Serum or Plasma |
| 11980-0 | Fetal Abdomen Circumference measured by ellipse overlay (US) |
| 11981-8 | Fetal Abdomen Circumference US.traced |
| 11982-6 | Fetal Head Circumference derived from occipital-frontal diameter and outer-outer transaxial diameter (US) |
| 11983-4 | Fetal Head Circumference derived from occipital-frontal diameter and outer-inner biparietal diameter (US) |
| 11984-2 | Fetal Head Circumference US |
| 11985-9 | Fetal Head Circumference measured by ellipse overlay (US) |
| 11986-7 | Fetal Head Circumference US.traced |
| 11987-5 | Fetal Thorax Circumference derived by US |
| 11988-3 | Fetal Thorax Circumference US |
| 11989-1 | Fetal Thorax Circumference measured by ellipse overlay (US) |
| 1199-9 | pk Ab [Presence] in Serum or Plasma from Blood product unit |
| 11990-9 | Fetal Thorax Circumference US.traced |
| 11991-7 | Fetal Abdomen Mean perimeter Estimated from gestational age |
| 11992-5 | Fetal Heart position US |
| 11993-3 | Fetal Narrative Heart position US |
| 11994-1 | Placenta position US |
| 11995-8 | Narrative Placenta position US |
| 11996-6 | [#] Pregnancies |
| 11997-4 | Fetal Cerebral artery anterior Pulsatility index US.doppler |
| 11998-2 | Cerebral artery anterior Pulsatility index US.doppler |
| 11999-0 | Fetal Cerebral artery middle Pulsatility index US.doppler |
| 12-5 | Amikacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 120-6 | Cefpodoxime [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 1200-5 | pk Ab [Presence] in Serum or Plasma from donor |
| 12000-6 | Cerebral artery middle Pulsatility index US.doppler |
| 12001-4 | Ovarian artery - left Pulsatility index US.doppler |
| 12002-2 | Ovarian artery - right Pulsatility index US.doppler |
| 12003-0 | Fetal Umbilical artery at fetus Pulsatility index US.doppler |
| 12004-8 | Fetal Umbilical artery at placenta Pulsatility index US.doppler |
| 12005-5 | Fetal Umbilical artery between fetus and placenta Pulsatility index US.doppler |
| 12006-3 | Uterine artery - left Pulsatility index US.doppler |
| 12007-1 | Uterine artery - right Pulsatility index US.doppler |
| 12008-9 | Pulsatility index US.doppler |
| 12009-7 | Fetal Heart R-R duration US |
| 1201-3 | pk Ab [Presence] in Serum or Plasma |
| 12010-5 | R-R duration US |
| 12011-3 | Replicate summarization |
| 12012-1 | Fetal Cerebral artery anterior Resistivity index US.doppler |
| 12013-9 | Deprecated Fetal Cerebral artery anterior Resistivity index Doppler.calculated |
| 12014-7 | Cerebral artery middle Resistivity index US.doppler |
| 12015-4 | Deprecated Resistivity index of Cerebral artery middle Doppler.calculated |
| 12016-2 | Ovarian artery - left Resistivity index US.doppler |
| 12017-0 | Ovarian artery - right Resistivity index US.doppler |
| 12018-8 | Fetal Umbilical artery at fetus Resistivity index US.doppler |
| 12019-6 | Fetal Umbilical artery at placenta Resistivity index US.doppler |
| 1202-1 | pk Ag [Presence] on Red Blood Cells from Blood product unit |
| 12020-4 | Fetal Umbilical artery between fetus and placenta Resistivity index US.doppler |
| 12021-2 | Uterine artery - left Resistivity index US.doppler |
| 12022-0 | Uterine artery - right Resistivity index US.doppler |
| 12023-8 | Resistivity index US.doppler |
| 12024-6 | Left ventricle [Length] Short axis during diastole US.M-mode+Measured |
| 12025-3 | Left ventricle [Length] Short axis during diastole Measured by real time two dimension US |
| 12026-1 | Left ventricle [Length] Short axis during systole US.M-mode+Measured |
| 12027-9 | Left ventricle [Length] Short axis during systole Measured by real time two dimension US |
| 12028-7 | Fetal Abdomen Study observation US |
| 12029-5 | Fetal Abdomen Narrative Study observation US |
| 1203-9 | pk Ag [Presence] on Red Blood Cells from donor |
| 12030-3 | Fetal Abdominal wall Study observation US |
| 12031-1 | Fetal Abdominal wall Narrative Study observation US |
| 12032-9 | Fetal Aorta ascending Study observation US |
| 12033-7 | Fetal Aorta ascending Narrative Study observation US |
| 12034-5 | Fetal Aorta descending Study observation US |
| 12035-2 | Fetal Aorta descending Narrative Study observation US |
| 12036-0 | Fetal Aorta Study observation US |
| 12037-8 | Fetal Aorta Narrative Study observation US |
| 12038-6 | Fetal Aortic arch Study observation US |
| 12039-4 | Fetal Aortic arch Narrative Study observation US |
| 1204-7 | pk Ag [Presence] on Red Blood Cells |
| 12040-2 | Fetal Cerebellum Study observation US |
| 12041-0 | Fetal Cerebellum Narrative Study observation US |
| 12042-8 | Fetal Cerebrum Study observation US |
| 12043-6 | Fetal Cerebrum Narrative Study observation US |
| 12044-4 | Inspection Cervix Study observation |
| 12045-1 | palpation Cervix Study observation |
| 12046-9 | US Cervix Study observation |
| 12047-7 | Fetal Colon Study observation US |
| 12048-5 | Fetal Colon Narrative Study observation US |
| 12049-3 | Fetal Cranium Study observation US |
| 1205-4 | little p Ag [Presence] on Red Blood Cells from Blood product unit |
| 12050-1 | Fetal Cranium Narrative Study observation US |
| 12051-9 | Fetal Diaphragm Study observation US |
| 12052-7 | Fetal Diaphragm Narrative Study observation US |
| 12053-5 | Fetal ductal arch Study observation US |
| 12054-3 | Fetal ductal arch Narrative Study observation US |
| 12055-0 | Fetal Face Study observation US |
| 12056-8 | Fetal Face Narrative Study observation US |
| 12057-6 | Fetal Choroid plexus Study observation US |
| 12058-4 | Fetal Choroid plexus Narrative Study observation US |
| 12059-2 | Fetal Fourth ventricle Study observation US |
| 1206-2 | little p Ag [Presence] on Red Blood Cells from donor |
| 12060-0 | Fetal Fourth ventricle Narrative Study observation US |
| 12061-8 | Fetal Intracranial anatomy Study observation US |
| 12062-6 | Fetal Intracranial anatomy Narrative Study observation US |
| 12063-4 | Fetal Lateral cerebral ventricles Study observation US |
| 12064-2 | Fetal Lateral cerebral ventricles Narrative Study observation US |
| 12065-9 | Fetal Posterior fossa Study observation US |
| 12066-7 | Fetal Posterior fossa Narrative Study observation US |
| 12067-5 | Fetal Head Third Ventricle Study observation US |
| 12068-3 | Fetal Head Third Ventricle Narrative Study observation US |
| 12069-1 | Fetal Head Study observation US |
| 1207-0 | little p Ag [Presence] on Red Blood Cells |
| 12070-9 | Fetal Head Narrative Study observation US |
| 12071-7 | Fetal Aortic valve Study observation US |
| 12072-5 | Fetal Aortic valve Narrative Study observation US |
| 12073-3 | Fetal Atrium Study observation US |
| 12074-1 | Fetal Atrium Narrative Study observation US |
| 12075-8 | Fetal Heart chambers Study observation US |
| 12076-6 | Fetal Heart chambers Narrative Study observation US |
| 12077-4 | Fetal Heart great vessels Study observation US |
| 12078-2 | Fetal Heart great vessels Narrative Study observation US |
| 12079-0 | Fetal Interventricular septum Study observation US |
| 1208-8 | little s Ab [Presence] in Serum or Plasma from Blood product unit |
| 12080-8 | Fetal Interventricular septum Narrative Study observation US |
| 12081-6 | Fetal Mitral valve Study observation US |
| 12082-4 | Fetal Mitral valve Narrative Study observation US |
| 12083-2 | Fetal Pulmonary valve Study observation US |
| 12084-0 | Fetal Tricuspid valve Study observation US |
| 12085-7 | Fetal Tricuspid valve Narrative Study observation US |
| 12086-5 | Fetal Heart valves Study observation US |
| 12087-3 | Fetal Heart valves Narrative Study observation US |
| 12088-1 | Fetal Left ventricular outflow tract Study observation US |
| 12089-9 | Fetal Left ventricular outflow tract Narrative Study observation US |
| 1209-6 | little s Ab [Presence] in Serum or Plasma from donor |
| 12090-7 | Fetal Right ventricular outflow tract Study observation US |
| 12091-5 | Fetal Right ventricular outflow tract Narrative Study observation US |
| 12092-3 | Fetal Intestine Study observation US |
| 12093-1 | Fetal Intestine Narrative Study observation US |
| 12094-9 | Fetal Kidney - left Study observation US |
| 12095-6 | Fetal Kidney - left Narrative Study observation US |
| 12096-4 | Fetal Kidney - right Study observation US |
| 12097-2 | Fetal Kidney - right Narrative Study observation US |
| 12098-0 | Fetal Kidney Study observation US |
| 12099-8 | Fetal Kidney Narrative Study observation US |
| 121-4 | Cefpodoxime [Susceptibility] by Disk diffusion (KB) |
| 1210-4 | little s Ab [Presence] in Serum or Plasma |
| 12100-4 | Fetal Limbs Study observation US |
| 12101-2 | Fetal Limbs Narrative Study observation US |
| 12102-0 | Fetal Nuchal fold Study observation US |
| 12103-8 | Fetal Nuchal fold Narrative Study observation US |
| 12104-6 | Fetal Pulmonary artery Study observation US |
| 12105-3 | Fetal Pulmonary artery Narrative Study observation US |
| 12106-1 | Fetal Pulmonary vein Study observation US |
| 12107-9 | Fetal Pulmonary vein Narrative Study observation US |
| 12108-7 | Fetal Small bowel Study observation US |
| 12109-5 | Fetal Small bowel Narrative Study observation US |
| 1211-2 | little s Ag [Presence] on Red Blood Cells from Blood product unit |
| 12110-3 | Fetal Spine Study observation US |
| 12111-1 | Fetal Spine Narrative Study observation US |
| 12112-9 | Fetal Stomach Study observation US |
| 12113-7 | Fetal Stomach Narrative Study observation US |
| 12114-5 | Fetal Thorax Study observation US |
| 12115-2 | Fetal Thorax Narrative Study observation US |
| 12116-0 | Fetal Umbilical cord Study observation US |
| 12117-8 | Fetal Umbilical cord Narrative Study observation US |
| 12118-6 | Fetal Urinary bladder Study observation US |
| 12119-4 | Fetal Urinary bladder Narrative Study observation US |
| 1212-0 | little s Ag [Presence] on Red Blood Cells from donor |
| 12120-2 | Fetal Inferior vena cava Study observation US |
| 12121-0 | Fetal Inferior vena cava Narrative Study observation US |
| 12122-8 | Fetal Superior vena cava Study observation US |
| 12123-6 | Fetal Superior vena cava Narrative Study observation US |
| 12124-4 | Fetal Vena cava Study observation US |
| 12125-1 | Fetal Vena cava Narrative Study observation US |
| 12126-9 | US Unspecified body region Study observation Narrative |
| 12127-7 | Deprecated Fetal Yolk sac Quantitative Study observation US |
| 12128-5 | Fetal Yolk sac Narrative Study observation US |
| 12129-3 | Fetal [Interpretation] Study observation general US |
| 1213-8 | little s Ag [Presence] on Red Blood Cells |
| 12130-1 | Fetal Narrative [Interpretation] Study observation general US |
| 12131-9 | US Study observation general [Interpretation] |
| 12132-7 | US Study observation general [Interpretation] Narrative |
| 12133-5 | Fetal Cerebral artery anterior Systolic flow/Diastolic flow US.doppler |
| 12134-3 | Cerebral artery anterior Systolic flow/Diastolic flow US.doppler |
| 12135-0 | Fetal Cerebral artery middle Systolic flow/Diastolic flow US.doppler |
| 12136-8 | Cerebral artery middle Systolic flow/Diastolic flow US.doppler |
| 12137-6 | Ovarian artery - left Systolic flow/Diastolic flow US.doppler |
| 12138-4 | Ovarian artery - right Systolic flow/Diastolic flow US.doppler |
| 12139-2 | Fetal Umbilical artery at fetus Systolic flow/Diastolic flow US.doppler |
| 1214-6 | LW Ab [Presence] in Serum or Plasma from Blood product unit |
| 12140-0 | Fetal Umbilical artery at placenta Systolic flow/Diastolic flow US.doppler |
| 12141-8 | Fetal Umbilical artery between fetus and placenta Systolic flow/Diastolic flow US.doppler |
| 12142-6 | Uterine artery - left Systolic flow/Diastolic flow US.doppler |
| 12143-4 | Uterine artery - right Systolic flow/Diastolic flow US.doppler |
| 12144-2 | Systolic flow/Diastolic flow US.doppler |
| 12145-9 | Endometrium Thickness US |
| 12146-7 | Fetal Nuchal fold Thickness US |
| 12147-5 | Fetal Placenta Thickness US |
| 12148-3 | Fetal Interventricular septum Thickness diastolic US.M-mode+Measured |
| 12149-1 | Fetal Interventricular septum Thickness diastolic Measured by real time two dimension US |
| 1215-3 | LW Ab [Presence] in Serum or Plasma from donor |
| 12150-9 | Fetal Left ventricular posterior wall Thickness diastolic US.M-mode+Measured |
| 12151-7 | Fetal Left ventricular posterior wall Thickness diastolic Measured by real time two dimension US |
| 12152-5 | Fetal Interventricular septum Thickness.systolic US.M-mode+Measured |
| 12153-3 | Fetal Interventricular septum Thickness.systolic Measured by real time two dimension US |
| 12154-1 | Fetal Left ventricular posterior wall Thickness.systolic US.M-mode+Measured |
| 12155-8 | Fetal Left ventricular posterior wall Thickness.systolic Measured by real time two dimension US |
| 12156-6 | Transducer site |
| 12157-4 | Ultrasonographer gravidity number |
| 12158-2 | OB ultrasound imaging device Class |
| 12159-0 | Ultrasound scan quality |
| 1216-1 | LW Ab [Presence] in Serum or Plasma |
| 12160-8 | OB ultrasound imaging device Vendor model number |
| 12161-6 | OB ultrasound imaging device Vendor serial number |
| 12162-4 | Fetal Kidney - left Volume derived by US |
| 12163-2 | Fetal Kidney - right Volume derived by US |
| 12164-0 | Ovary - left Volume derived by US |
| 12165-7 | Ovary - right Volume derived by US |
| 12166-5 | Fetal Yolk sac Volume US |
| 12167-3 | Fetal Amniotic fluid space [Interpretation] Volume.amniotic fluid US |
| 12168-1 | Fetal Urinary bladder Volume post void US |
| 12169-9 | Fetal Urinary bladder Volume.pre void US |
| 1217-9 | LW Ag [Presence] on Red Blood Cells from Blood product unit |
| 12170-7 | Fetal Head Hemisphere width US |
| 12171-5 | Fetal Lateral cerebral ventricles Transverse width US |
| 12172-3 | 5-Hydroxyindoleacetate [Presence] in 24 hour Urine |
| 12173-1 | Non prostatic acid phosphatase [Enzymatic activity/volume] in Serum or Plasma |
| 12174-9 | Albumin/Globulin [Mass Ratio] in Body fluid |
| 12175-6 | Deprecated Albumin/Globulin [Mass ratio] in Serum |
| 12176-4 | Amino acids [Moles/volume] in Serum or Plasma |
| 12177-2 | Amino acids/Creatinine [Ratio] in Urine |
| 12178-0 | Bacteria [Presence] in Genital specimen by Wet preparation |
| 12179-8 | Basophils/100 leukocytes in Body fluid by Manual count |
| 1218-7 | LW Ag [Presence] on Red Blood Cells from donor |
| 12180-6 | Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE) |
| 12181-4 | Calcium [Moles/volume] in Body fluid |
| 12182-2 | Cells [#/volume] in Body fluid by Manual count |
| 12183-0 | Cholesterol [Mass/volume] in Body fluid |
| 12184-8 | Choriogonadotropin [Presence] in Body fluid |
| 12185-5 | aPTT in control Blood by Coagulation assay |
| 12186-3 | Colloid oncotic pressure [Partial pressure] in Plasma |
| 12187-1 | Creatine kinase.MB/Creatine kinase.total in Serum or Plasma by Electrophoresis |
| 12188-9 | Deprecated Creatine kinase.MB/Creatine kinase.total |
| 12189-7 | Creatine kinase.MB/Creatine kinase.total in Serum or Plasma by calculation |
| 1219-5 | LW Ag [Presence] on Red Blood Cells |
| 12190-5 | Creatinine [Mass/volume] in Body fluid |
| 12191-3 | Creatinine [Mass/volume] in Peritoneal fluid |
| 12192-1 | Creatinine [Mass/volume] in Peritoneal fluid --2 hours post peritoneal dialysis |
| 12193-9 | Creatinine [Mass/volume] in Peritoneal fluid --4 hours post peritoneal dialysis |
| 12194-7 | Creatinine [Mass/volume] in Peritoneal fluid --12 hours post peritoneal dialysis |
| 12195-4 | Creatinine renal clearance/1.73 sq M in 24 hour |
| 12196-2 | Cryofibrinogen [Presence] in Plasma by 4 hour cold incubation |
| 12197-0 | Cryofibrinogen [Presence] in Plasma by 1 day cold incubation |
| 12198-8 | Cryofibrinogen [Presence] in Plasma by 2 day cold incubation |
| 12199-6 | Cryofibrinogen [Presence] in Plasma by 3 day cold incubation |
| 122-2 | Cefpodoxime [Susceptibility] by Serum bactericidal titer |
| 1220-3 | Mg Ab [Presence] in Serum or Plasma from Blood product unit |
| 12200-2 | Cryoglobulin [Presence] in Serum by 4 hour cold incubation |
| 12201-0 | Cryoglobulin [Presence] in Serum by 1 day cold incubation |
| 12202-8 | Cryoglobulin [Presence] in Serum by 2 day cold incubation |
| 12203-6 | Cryoglobulin [Presence] in Serum by 3 day cold incubation |
| 12204-4 | Cryoglobulin [Presence] in Serum by 4 day cold incubation |
| 12205-1 | Cryoglobulin [Presence] in Serum by 5 day cold incubation |
| 12206-9 | Cryoglobulin [Presence] in Serum by 6 day cold incubation |
| 12207-7 | Cryoglobulin [Presence] in Serum by 1 week cold incubation |
| 12208-5 | Eosinophils/100 leukocytes in Cerebral spinal fluid by Manual count |
| 12209-3 | Eosinophils/100 leukocytes in Body fluid by Manual count |
| 1221-1 | Mg Ab [Presence] in Serum or Plasma from donor |
| 12210-1 | Eosinophils/100 leukocytes in Urine sediment by Manual count |
| 12211-9 | Epithelial cells [Presence] in Vaginal fluid by Wet preparation |
| 12212-7 | Epstein Barr virus nuclear IgG Ab [Titer] in Serum by Immunofluorescence |
| 12213-5 | Deprecated Estradiol [Mass/volume] in Serum or Plasma by RIA |
| 12214-3 | Deprecated Estradiol [Mass/volume] in Serum or Plasma by MEIA |
| 12215-0 | Fatty acids.very long chain [Moles/volume] in Serum or Plasma |
| 12216-8 | Deprecated Gastrin [Mass/volume] in Serum or Plasma |
| 12217-6 | Globulin [Mass/volume] in Body fluid |
| 12218-4 | Glucose [Mass/volume] in Peritoneal fluid --2 hours post peritoneal dialysis |
| 12219-2 | Glucose [Mass/volume] in Peritoneal fluid --4 hours post peritoneal dialysis |
| 1222-9 | Mg Ab [Presence] in Serum or Plasma |
| 12220-0 | Glucose [Mass/volume] in Peritoneal fluid --12 hours post peritoneal dialysis |
| 12221-8 | Heterophile Ab [Presence] in Serum by Sheep Cell Agglutination |
| 12222-6 | Human papilloma virus Ag [Presence] in Genital specimen |
| 12223-4 | Human papilloma virus 16+18 Ag [Presence] in Genital specimen |
| 12224-2 | Leukocytes [#/area] in Nose by Microscopy high power field |
| 12225-9 | Leukocytes [#/area] in Sputum by Microscopy high power field |
| 12226-7 | Leukocytes [Presence] in Vaginal fluid by Wet preparation |
| 12227-5 | Leukocytes [#/volume] corrected for nucleated erythrocytes in Blood |
| 12228-3 | Triglyceride [Mass/volume] in Body fluid |
| 12229-1 | Macrophages/100 leukocytes in Cerebral spinal fluid by Manual count |
| 1223-7 | Mg Ag [Presence] on Red Blood Cells from Blood product unit |
| 12230-9 | Macrophages/100 leukocytes in Body fluid by Manual count |
| 12231-7 | Prolactin [Mass/volume] in Serum or Plasma --baseline |
| 12232-5 | Measles virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
| 12233-3 | Mesothelial cells/100 leukocytes in Cerebral spinal fluid by Manual count |
| 12234-1 | Mesothelial cells/100 leukocytes in Body fluid by Manual count |
| 12235-8 | Microscopic observation [Identifier] in Urine sediment by Light microscopy |
| 12236-6 | Mononuclear cells/100 leukocytes in Cerebral spinal fluid by Manual count |
| 12237-4 | Mumps virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
| 12238-2 | Neutrophils/100 leukocytes in Body fluid by Manual count |
| 12239-0 | Oligosaccharides [Presence] in Urine |
| 1224-5 | Mg Ag [Presence] on Red Blood Cells from donor |
| 12240-8 | Orotidine [Moles/volume] in Urine |
| 12241-6 | Osmotic fragility of Red Blood Cells by Diluted RBC |
| 12242-4 | Phosphate [Mass/volume] in Body fluid |
| 12243-2 | Deprecated Platelets [Morphology] in Blood |
| 12244-0 | Polymorphonuclear cells/100 leukocytes in Cerebral spinal fluid by Manual count |
| 12245-7 | Porphobilinogen [Presence] in 24 hour Urine |
| 12246-5 | Porphyrins [Presence] in 24 hour Urine |
| 12247-3 | Pyruvate [Mass/volume] in Serum or Plasma |
| 12248-1 | Epithelial cells.renal [Presence] in Urine sediment by Light microscopy |
| 12249-9 | Deprecated Renin [Enzymatic activity/volume] in Plasma |
| 1225-2 | Mg Ag [Presence] on Red Blood Cells |
| 12250-7 | Reticulocytes/1000 erythrocytes hematocrit adjusted in Blood |
| 12251-5 | Rubella virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
| 12252-3 | Deprecated Insulin-Like growth factor-I [Mass/volume] in Serum or Plasma |
| 12253-1 | Somatotropin [Mass/volume] in Serum or Plasma --baseline |
| 12254-9 | Volume of Body fluid |
| 12255-6 | Volume of 5 hour Urine |
| 12256-4 | Spermatozoa [#/area] in Semen by Microscopy high power field --post vasectomy |
| 12257-2 | Spermatozoa Motile/100 spermatozoa in Semen by Microscopy high power field --post vasectomy |
| 12258-0 | Epithelial cells.squamous [Presence] in Urine sediment by Light microscopy |
| 12259-8 | Streptococcus pyogenes enzyme Ab [Presence] in Serum by Sheep Cell Agglutination |
| 1226-0 | M Ab [Presence] in Serum or Plasma from Blood product unit |
| 12260-6 | Sucrose hemolysis [Presence] of Red Blood Cells |
| 12261-4 | Toxoplasma gondii IgG Ab [Titer] in Serum by Immunoassay |
| 12262-2 | Toxoplasma gondii IgM Ab [Titer] in Serum by Immunoassay |
| 12263-0 | Deprecated EBV [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 12264-8 | Deprecated Epstein Barr virus early restricted Ab [Mass/volume] in Body fluid |
| 12265-5 | Urea nitrogen [Mass/volume] in Peritoneal fluid |
| 12266-3 | Urea nitrogen [Mass/volume] in Peritoneal fluid --2 hours post peritoneal dialysis |
| 12267-1 | Urea nitrogen [Mass/volume] in Peritoneal fluid --4 hours post peritoneal dialysis |
| 12268-9 | Urea nitrogen [Mass/volume] in Peritoneal fluid --12 hours post peritoneal dialysis |
| 12269-7 | Urobilinogen [Presence] in 24 hour Urine |
| 1227-8 | M Ab [Presence] in Serum or Plasma from donor |
| 12270-5 | Uroporphyrin [Presence] in 24 hour Urine |
| 12271-3 | Varicella zoster virus Ab [Presence] in Serum by Latex agglutination |
| 12272-1 | Virus identified in Unspecified specimen by Immunofluorescence |
| 12273-9 | Xanthochromia [Presence] of Body fluid Qualitative |
| 12274-7 | Xylose [Mass/time] in 5 hour Urine |
| 12275-4 | Yeast [Presence] in Genital specimen by Wet preparation |
| 12276-2 | Deprecated Escherichia coli O157:H7 identified in Stool by Organism specific culture |
| 12277-0 | DNA double strand Ab [Presence] in Serum by Farr method |
| 12278-8 | Band form neutrophils/100 leukocytes in Cerebral spinal fluid by Manual count |
| 12279-6 | Deprecated Spermatozoa Ab [Units/volume] in Semen |
| 1228-6 | M Ab [Presence] in Serum or Plasma |
| 12280-4 | Alanine [Mass/volume] in Amniotic fluid |
| 12281-2 | Bacteria identified in Cervix by Anaerobe culture |
| 12282-0 | Warfarin [Presence] in Urine |
| 12283-8 | Corticotropin releasing hormone [Units/volume] in Serum or Plasma |
| 12284-6 | Growth hormone-releasing hormone [Units/volume] in Serum or Plasma |
| 12285-3 | HLA-DP [Type] |
| 12286-1 | Drugs identified in Urine by Screen method |
| 12287-9 | Drugs identified in Gastric fluid by Screen method |
| 12288-7 | Diuretics [Identifier] in Urine |
| 12289-5 | Drugs identified in Vitreous fluid by Screen method |
| 1229-4 | M Ag [Presence] on Red Blood Cells from Blood product unit |
| 12290-3 | Procyclidine [Presence] in Urine |
| 12291-1 | Mephentermine [Presence] in Urine |
| 12292-9 | Dimethyltryptamine [Presence] in Urine |
| 12293-7 | Cotinine [Presence] in Urine |
| 12294-5 | Nicotine [Presence] in Urine |
| 12295-2 | Hallucinogens [Identifier] in Urine |
| 12296-0 | Mescaline [Presence] in Urine |
| 12297-8 | Chlorate [Presence] in Blood |
| 12298-6 | Erythromycin [Presence] in Urine |
| 12299-4 | Ethinamate [Presence] in Urine |
| 123-0 | Cefprozil [Susceptibility] by Minimum lethal concentration (MLC) |
| 1230-2 | M Ag [Presence] on Red Blood Cells from donor |
| 12300-0 | Polythiazide [Presence] in Urine |
| 12301-8 | Procaine [Presence] in Urine |
| 12302-6 | Theobromine [Presence] in Serum or Plasma |
| 12303-4 | Theobromine [Presence] in Urine |
| 12304-2 | Benzyl alcohol [Presence] in Serum or Plasma |
| 12305-9 | Chlordecone [Presence] in Blood |
| 12306-7 | Cyclohexane [Mass/volume] in Blood |
| 12307-5 | Dichloroethane [Mass/volume] in Blood |
| 12308-3 | Hydrocodone [Presence] in Urine |
| 12309-1 | Naltrexone [Presence] in Urine |
| 1231-0 | M Ag [Presence] on Red Blood Cells |
| 12310-9 | Phenytoin [Presence] in Urine |
| 12311-7 | Prazepam [Mass/volume] in Urine |
| 12312-5 | Cyclopropane [Mass/volume] in Blood |
| 12313-3 | Aprobarbital [Presence] in Urine |
| 12314-1 | Clorazepate [Presence] in Urine |
| 12315-8 | Mephobarbital [Presence] in Urine |
| 12316-6 | Deprecated Methapyrilene [Presence] in Urine |
| 12317-4 | Phenolphthalein [Presence] in Urine |
| 12318-2 | Spironolactone [Presence] in Urine |
| 12319-0 | Thioridazine [Presence] in Urine |
| 1232-8 | Mi sup(a) Ag [Presence] on Red Blood Cells from Blood product unit |
| 12320-8 | Thiothixene [Presence] in Urine |
| 12321-6 | Trifluoperazine [Presence] in Urine |
| 12322-4 | Triflupromazine [Presence] in Urine |
| 12323-2 | Trimeprazine [Presence] in Urine |
| 12324-0 | Hydroxyzine [Presence] in Urine |
| 12325-7 | Tetrahydrocortisone [Presence] in Urine |
| 12326-5 | Diamorphine [Presence] in Unknown substance |
| 12327-3 | Ketamine [Presence] in Urine |
| 12328-1 | Beta blockers [Identifier] in Urine |
| 12329-9 | Chlorpropamide [Presence] in Urine |
| 1233-6 | Mi sup(a) Ag [Presence] on Red Blood Cells from donor |
| 12330-7 | Hypoglycemics.oral [Identifier] in Urine |
| 12331-5 | Phenethylamine [Presence] in Urine |
| 12332-3 | Antihistamines [Identifier] in Urine |
| 12333-1 | Butorphanol [Presence] in Urine |
| 12334-9 | Para aminophenol [Mass/volume] in Urine |
| 12335-6 | Halothane [Presence] in Blood |
| 12336-4 | Hydralazine [Presence] in Serum or Plasma |
| 12337-2 | Dimethylsulfoxide [Presence] in Serum or Plasma |
| 12338-0 | Pentachlorophenol [Presence] in Serum or Plasma |
| 12339-8 | Diquat [Presence] in Urine |
| 1234-4 | Mi sup(a) Ag [Presence] on Red Blood Cells |
| 12340-6 | Ethylene [Presence] in Blood |
| 12341-4 | Mazindol [Presence] in Serum or Plasma |
| 12342-2 | Oxymorphone [Presence] in Serum or Plasma |
| 12343-0 | Thiazides [Identifier] in Urine |
| 12344-8 | Antipsychotics [Identifier] in Serum or Plasma |
| 12345-5 | Cyclothiazide [Presence] in Urine |
| 12346-3 | Methyclothiazide [Presence] in Urine |
| 12347-1 | Metolazone [Presence] in Urine |
| 12348-9 | Quinethazone [Presence] in Urine |
| 12349-7 | Trichlormethiazide [Presence] in Urine |
| 1235-1 | Mi sup(a) Ab [Presence] in Serum or Plasma from Blood product unit |
| 12350-5 | Amphetamines [Presence] in Stool |
| 12351-3 | Tetrahydrocannabinol [Presence] in Stool |
| 12352-1 | Benzoylecgonine [Presence] in Stool |
| 12353-9 | Methaqualone [Presence] in Stool |
| 12354-7 | Opiates [Presence] in Stool |
| 12355-4 | Phencyclidine [Presence] in Stool |
| 12356-2 | Methadone [Presence] in Stool |
| 12357-0 | Propoxyphene [Presence] in Stool |
| 12358-8 | Barbiturates [Presence] in Stool |
| 12359-6 | Benzodiazepines [Presence] in Stool |
| 1236-9 | Mi sup(a) Ab [Presence] in Serum or Plasma from donor |
| 12360-4 | Barbital [Presence] in Urine |
| 12361-2 | Oxazepam [Presence] in Urine |
| 12362-0 | Oxazepam [Presence] in Serum or Plasma |
| 12363-8 | Carbamazepine [Presence] in Urine |
| 12364-6 | Benzodiazepines [Presence] in Gastric fluid |
| 12365-3 | Dimenhydrinate [Presence] in Urine |
| 12366-1 | Disopyramide [Presence] in Urine |
| 12367-9 | Mesoridazine [Presence] in Urine |
| 12368-7 | Phenacetin [Presence] in Urine |
| 12369-5 | Sympathomimetics [Identifier] in Urine |
| 1237-7 | Mi sup(a) Ab [Presence] in Serum or Plasma |
| 12370-3 | Thiopental [Mass/volume] in Urine |
| 12371-1 | Isopropyl ether [Mass/volume] in Blood |
| 12372-9 | Dimethylacetamide [Mass/volume] in Urine |
| 12373-7 | Deprecated Norchlordiazepoxide [Mass/volume] in Serum or Plasma |
| 12374-5 | Clobazam [Mass/volume] in Urine |
| 12375-2 | Clozapine+Norclozapine [Mass/volume] in Serum or Plasma |
| 12376-0 | Deprecated Norclozapine [Mass/volume] in Serum or Plasma |
| 12377-8 | Demoxepam [Mass/volume] in Serum or Plasma |
| 12378-6 | Diazepam [Presence] in Stool |
| 12379-4 | Halazepam [Mass/volume] in Serum or Plasma |
| 1238-5 | M NOS Ab [Presence] in Serum or Plasma from Blood product unit |
| 12380-2 | Lorazepam [Presence] in Stool |
| 12381-0 | Oxazepam [Presence] in Stool |
| 12382-8 | Temazepam [Mass/volume] in Urine |
| 12383-6 | Hydroxytriazolam [Presence] in Stool |
| 12384-4 | Triazolam [Presence] in Stool |
| 12385-1 | Deprecated Nordoxepin [Mass/volume] in Serum or Plasma |
| 12386-9 | Nordoxepin [Mass/volume] in Urine |
| 12387-7 | Primidone [Mass/volume] in Urine |
| 12388-5 | Phenylethylmalonamide [Mass/volume] in Serum or Plasma |
| 12389-3 | Olanzapine [Mass/volume] in Serum or Plasma |
| 1239-3 | M NOS Ab [Presence] in Serum or Plasma from donor |
| 12390-1 | Sulfasalazine [Mass/volume] in Serum or Plasma |
| 12391-9 | Dimenhydrinate [Mass/volume] in Serum or Plasma |
| 12392-7 | Deprecated Itraconazole [Mass/volume] in Serum or Plasma |
| 12393-5 | Deprecated Ketoconazole [Mass/volume] in Serum or Plasma |
| 12394-3 | Butorphanol [Mass/volume] in Serum or Plasma |
| 12395-0 | Butorphanol [Mass/volume] in Urine |
| 12396-8 | Chlorpropamide [Mass/volume] in Urine |
| 12397-6 | Colchicine [Mass/volume] in Serum or Plasma |
| 12398-4 | Diphenoxylate [Mass/volume] in Serum or Plasma |
| 12399-2 | Emetine [Mass/volume] in Serum or Plasma |
| 124-8 | Cefprozil [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 1240-1 | M NOS Ab [Presence] in Serum or Plasma |
| 12400-8 | Emetine [Mass/volume] in Urine |
| 12401-6 | Ethinamate [Mass/volume] in Serum or Plasma |
| 12402-4 | Griseofulvin [Mass/volume] in Serum or Plasma |
| 12403-2 | Mephentermine [Mass/volume] in Blood |
| 12404-0 | Nitroglycerin [Mass/volume] in Serum or Plasma |
| 12405-7 | Nabumetone [Mass/volume] in Serum or Plasma |
| 12406-5 | Nadolol [Mass/volume] in Serum or Plasma |
| 12407-3 | 6-Beta naltrexone [Mass/volume] in Serum or Plasma |
| 12408-1 | Oxybutynin [Mass/volume] in Serum or Plasma |
| 12409-9 | Deprecated Pentoxyfylline [Mass/volume] in Serum or Plasma |
| 1241-9 | M NOS Ag [Presence] on Red Blood Cells from Blood product unit |
| 12410-7 | Pimozide [Mass/volume] in Serum or Plasma |
| 12411-5 | Promazine [Mass/volume] in Serum or Plasma |
| 12412-3 | Pyridine [Mass/volume] in Serum or Plasma |
| 12413-1 | Resperine [Mass/volume] in Serum or Plasma |
| 12414-9 | Resperine [Mass/volume] in Urine |
| 12415-6 | Selegiline [Mass/volume] in Serum or Plasma |
| 12416-4 | Sotalol [Mass/volume] in Serum or Plasma |
| 12417-2 | Sulindac [Mass/volume] in Serum or Plasma |
| 12418-0 | Terfenadine [Mass/volume] in Serum or Plasma |
| 12419-8 | Terfenadine [Mass/volume] in Urine |
| 1242-7 | M NOS Ag [Presence] on Red Blood Cells from donor |
| 12420-6 | Thiosulfate [Mass/volume] in Urine |
| 12421-4 | Thiosulfate/Creatinine [Mass Ratio] in Urine |
| 12422-2 | Triflupromazine [Mass/volume] in Serum or Plasma |
| 12423-0 | Trimeprazine [Mass/volume] in Serum or Plasma |
| 12424-8 | Triprolidine [Mass/volume] in Serum or Plasma |
| 12425-5 | Chlorzoxazone [Mass/volume] in Serum or Plasma |
| 12426-3 | Brodifacoum [Mass/volume] in Serum or Plasma |
| 12427-1 | Chlormezanone [Mass/volume] in Serum or Plasma |
| 12428-9 | Flurbiprofen [Mass/volume] in Serum or Plasma |
| 12429-7 | Succinylcholine [Mass/volume] in Urine |
| 1243-5 | M NOS Ag [Presence] on Red Blood Cells |
| 12430-5 | Cumene [Mass/volume] in Serum or Plasma |
| 12431-3 | Norfenfluramine [Mass/volume] in Serum or Plasma |
| 12432-1 | Hydroxytriazolam [Mass/volume] in Urine |
| 12433-9 | Bufotenine [Mass/volume] in Serum or Plasma |
| 12434-7 | Prednisone [Mass/volume] in Serum or Plasma |
| 12435-4 | Naphthalene [Mass/volume] in Serum or Plasma |
| 12436-2 | Naphthol [Mass/volume] in Serum or Plasma |
| 12437-0 | Tramadol [Mass/volume] in Serum or Plasma |
| 12438-8 | Nortramadol [Mass/volume] in Serum or Plasma |
| 12439-6 | Fluoxetine [Mass/volume] in Urine |
| 1244-3 | M1 Ab [Presence] in Serum or Plasma from Blood product unit |
| 12440-4 | Midazolam [Presence] in Stool |
| 12441-2 | Tolmetin [Mass/volume] in Serum or Plasma |
| 12442-0 | Acetaminophen [Mass/volume] in Unspecified specimen |
| 12443-8 | Trimipramine [Mass/volume] in Urine |
| 12444-6 | Nortrimipramine [Mass/volume] in Urine |
| 12445-3 | Norfluoxetine [Mass/volume] in Urine |
| 12446-1 | Halogenated organic molecules [Identifier] in Urine |
| 12447-9 | Deprecated Phenylethylmalonamide |
| 12448-7 | Ketones [Mass/volume] in Urine by Test strip --fasting |
| 12449-5 | Ketones [Mass/volume] in Urine by Test strip --1 hour post XXX challenge |
| 1245-0 | M1 Ab [Presence] in Serum or Plasma from donor |
| 12450-3 | Ketones [Mass/volume] in Urine by Test strip --2 hours post XXX challenge |
| 12451-1 | Ketones [Mass/volume] in Urine by Test strip --3 hours post XXX challenge |
| 12452-9 | Epithelial cells [Presence] in Semen by Light microscopy |
| 12453-7 | Phosphate crystals amorphous [Presence] in Urine sediment by Light microscopy |
| 12454-5 | Urate crystals amorphous [Presence] in Urine sediment by Light microscopy |
| 12455-2 | Histoplasma capsulatum yeast phase Ab [Presence] in Cerebral spinal fluid |
| 12456-0 | Histoplasma capsulatum mycelial phase Ab [Presence] in Cerebral spinal fluid |
| 12457-8 | Volume of Dialysis fluid |
| 12458-6 | Corticotropin [Mass/volume] in Plasma --2nd specimen post XXX challenge |
| 12459-4 | Corticotropin [Mass/volume] in Plasma --3rd specimen post XXX challenge |
| 1246-8 | M1 Ab [Presence] in Serum or Plasma |
| 12460-2 | Corticotropin [Mass/volume] in Plasma --4th specimen post XXX challenge |
| 12461-0 | Corticotropin [Mass/volume] in Plasma --5th specimen post XXX challenge |
| 12462-8 | Corticotropin [Mass/volume] in Plasma --6th specimen post XXX challenge |
| 12463-6 | Corticotropin [Mass/volume] in Plasma --7th specimen post XXX challenge |
| 12464-4 | Corticotropin [Mass/volume] in Plasma --8th specimen post XXX challenge |
| 12465-1 | Ethanol [Mass/volume] in Vitreous fluid |
| 12466-9 | Alpha 1 antitrypsin [Mass/volume] in Amniotic fluid by Nephelometry |
| 12467-7 | Amino acids [Identifier] in Urine |
| 12468-5 | Amino acids [Identifier] in Serum or Plasma |
| 12469-3 | Cystine crystals [type] in Stone by Light microscopy |
| 1247-6 | M1 Ag [Presence] on Red Blood Cells from Blood product unit |
| 12470-1 | Homocysteine [Mass/volume] in Urine |
| 12471-9 | Amino beta guanidinopropionate [Mass/volume] in Urine |
| 12472-7 | Amino beta guanidinopropionate [Mass/volume] in 24 hour Urine |
| 12473-5 | Phosphoethanolamine [Mass/time] in Urine |
| 12474-3 | Carnosine [Mass/volume] in 24 hour Urine |
| 12475-0 | Delta aminolevulinate [Mass/time] in Urine |
| 12476-8 | Bilirubin.total [Mass/volume] in Amniotic fluid by Spectrophotometry direct |
| 12477-6 | Dextromethamphetamine [Mass/volume] in Urine |
| 12478-4 | Levomethamphetamine [Mass/volume] in Urine |
| 12479-2 | Androsterone [Mass/time] in Urine |
| 1248-4 | M1 Ag [Presence] on Red Blood Cells from donor |
| 12480-0 | Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid |
| 12481-8 | Arsenic.inorganic [Mass/volume] in Urine |
| 12482-6 | Ascorbate [Mass/volume] in Leukocytes |
| 12483-4 | Tungsten [Presence] in Serum or Plasma |
| 12484-2 | Phenobarbital [Presence] in Gastric fluid |
| 12485-9 | Amobarbital [Presence] in Gastric fluid |
| 12486-7 | Butabarbital [Presence] in Gastric fluid |
| 12487-5 | Butalbital [Presence] in Gastric fluid |
| 12488-3 | Pentobarbital [Presence] in Gastric fluid |
| 12489-1 | Secobarbital [Presence] in Gastric fluid |
| 1249-2 | M1 Ag [Presence] on Red Blood Cells |
| 12490-9 | Allyl-sec-butyl-barbiturate [Mass/volume] in Serum or Plasma |
| 12491-7 | Methohexital [Presence] in Serum or Plasma |
| 12492-5 | Thiamylal [Presence] in Serum or Plasma |
| 12493-3 | Hexobarbital [Mass/volume] in Serum or Plasma |
| 12494-1 | Amobarbital [Presence] in Stool |
| 12495-8 | Barbital [Presence] in Stool |
| 12496-6 | Butabarbital [Presence] in Stool |
| 12497-4 | Butalbital [Presence] in Stool |
| 12498-2 | Metharbital [Presence] in Stool |
| 12499-0 | Pentobarbital [Presence] in Stool |
| 125-5 | Cefprozil [Susceptibility] by Disk diffusion (KB) |
| 1250-0 | Major crossmatch [Interpretation] |
| 12500-5 | Secobarbital [Presence] in Stool |
| 12501-3 | Phenobarbital [Presence] in Stool |
| 12502-1 | Allobarbital [Presence] in Stool |
| 12503-9 | Hemoglobin.gastrointestinal [Presence] in Stool --4th specimen |
| 12504-7 | Hemoglobin.gastrointestinal [Presence] in Stool --5th specimen |
| 12505-4 | Cadmium [Mass/volume] in Red Blood Cells |
| 12506-2 | Calcitonin [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
| 12507-0 | Calcitonin [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
| 12508-8 | Calcitonin [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
| 12509-6 | Calcitonin [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
| 1251-8 | Major crossmatch [Interpretation] by Immediate spin |
| 12510-4 | Calcitonin [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
| 12511-2 | Calcium [Mass/volume] in 4 hour Urine |
| 12512-0 | Calcium hydrogen phosphate dihydrate crystals [Presence] in Urine sediment by Light microscopy |
| 12513-8 | Bicarbonate [Moles/volume] in Water |
| 12514-6 | Bicarbonate [Moles/volume] in Dialysis fluid |
| 12515-3 | Carcinoembryonic Ag [Mass/volume] in Body fluid |
| 12516-1 | Catecholamines [Mass/volume] in Urine --2nd specimen post XXX challenge |
| 12517-9 | Catecholamines [Mass/volume] in Urine --3rd specimen post XXX challenge |
| 12518-7 | Catecholamines [Mass/volume] in Urine --4th specimen post XXX challenge |
| 12519-5 | Catecholamines [Mass/volume] in Urine --5th specimen post XXX challenge |
| 1252-6 | Major crossmatch [Interpretation] --post immediate spin |
| 12520-3 | Catecholamines [Mass/volume] in Urine --6th specimen post XXX challenge |
| 12521-1 | Catecholamines [Mass/volume] in Urine --7th specimen post XXX challenge |
| 12522-9 | Catecholamines [Mass/volume] in Plasma --2nd specimen post XXX challenge |
| 12523-7 | Catecholamines [Mass/volume] in Plasma --3rd specimen post XXX challenge |
| 12524-5 | Catecholamines [Mass/volume] in Plasma --4th specimen post XXX challenge |
| 12525-2 | Norepinephrine [Mass/volume] in Plasma --1 hour post XXX challenge |
| 12526-0 | Norepinephrine [Mass/volume] in Plasma --2 hours post XXX challenge |
| 12527-8 | Norepinephrine [Mass/volume] in Plasma --3 hours post XXX challenge |
| 12528-6 | Norepinephrine [Mass/volume] in Plasma --4 hours post XXX challenge |
| 12529-4 | Epinephrine [Mass/volume] in Plasma --2 hours post XXX challenge |
| 1253-4 | Major crossmatch [Interpretation] by Prewarmed |
| 12530-2 | Chloride [Moles/volume] in Water |
| 12531-0 | Deprecated Cholesterol [Mass/volume] in Body fluid |
| 12532-8 | Meclizine [Presence] in Serum or Plasma |
| 12533-6 | Thiazolidine-2-Thione-4-Carboxylic acid [Mass/volume] in Urine |
| 12534-4 | Thiazolidine-2-Thione-4-Carboxylic acid/Creatinine [Mass Ratio] in Urine |
| 12535-1 | Amyl nitrite [Presence] in Blood |
| 12536-9 | Butyl nitrate [Presence] in Blood |
| 12537-7 | Phenylglyoxylate [Mass/volume] in Urine |
| 12538-5 | Nitrate [Mass/volume] in Blood |
| 12539-3 | 2-Methylcitrate [Mass/volume] in Urine |
| 1254-2 | Major crossmatch.re-crossmatch [Interpretation] |
| 12540-1 | 2-Methylcitrate [Mass/volume] in Serum or Plasma |
| 12541-9 | Meta methylhippurate+Para methylhippurate [Mass/volume] in Urine |
| 12542-7 | N-methylacetamide [Mass/volume] in Urine |
| 12543-5 | Methyl formamide [Mass/volume] in Urine |
| 12544-3 | Nefazodone [Mass/volume] in Serum or Plasma |
| 12545-0 | Zomepirac [Mass/volume] in Serum or Plasma |
| 12546-8 | Quinethazone [Presence] in Serum or Plasma |
| 12547-6 | Phorate [Mass/volume] in Serum or Plasma |
| 12548-4 | Tybamate [Mass/volume] in Serum or Plasma |
| 12549-2 | Turpentine [Mass/volume] in Serum or Plasma |
| 1255-9 | Minor crossmatch [Interpretation] |
| 12550-0 | Papaverine [Mass/volume] in Serum or Plasma |
| 12551-8 | Isocarboxazid [Mass/volume] in Serum or Plasma |
| 12552-6 | Propylene glycol [Mass/volume] in Serum or Plasma |
| 12553-4 | Stimulants [Identifier] in Urine |
| 12554-2 | Narcotics and opioids [Identifier] in Urine |
| 12555-9 | Turpentine [Mass/volume] in Urine |
| 12556-7 | Copper [Mass/volume] in Blood |
| 12557-5 | Cortisol [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
| 12558-3 | Cortisol [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
| 12559-1 | Cortisol [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
| 1256-7 | N Ab [Presence] in Serum or Plasma from Blood product unit |
| 12560-9 | Cortisol [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
| 12561-7 | Cortisol [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
| 12562-5 | Cortisol [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
| 12563-3 | Cortisol [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge |
| 12564-1 | Cortisol [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge |
| 12565-8 | Cortisol [Mass/volume] in Serum or Plasma --10th specimen post XXX challenge |
| 12566-6 | Cortisol [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge |
| 12567-4 | Cortisol [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
| 12568-2 | Cortisol [Mass/volume] in Serum or Plasma --20 minutes post XXX challenge |
| 12569-0 | Cortisol [Mass/volume] in Serum or Plasma --2.5 hours post XXX challenge |
| 1257-5 | N Ab [Presence] in Serum or Plasma from donor |
| 12570-8 | Cortisol [Mass/volume] in Serum or Plasma --post XXX challenge |
| 12571-6 | Deprecated Creatinine [Mass/volume] in Body fluid |
| 12572-4 | Creatinine [Mass/volume] in Peritoneal dialysis fluid --2 hour dwell specimen |
| 12573-2 | Creatinine [Mass/volume] in Peritoneal dialysis fluid --4 hour dwell specimen |
| 12574-0 | Creatinine [Mass/volume] in Peritoneal dialysis fluid --24 hour specimen |
| 12575-7 | Creatinine [Mass/volume] in Peritoneal dialysis fluid --baseline |
| 12576-5 | Creatinine [Mass/volume] in Peritoneal dialysis fluid --1st specimen |
| 12577-3 | Creatinine [Mass/volume] in Peritoneal dialysis fluid --2nd specimen |
| 12578-1 | Creatinine [Mass/volume] in Peritoneal dialysis fluid --3rd specimen |
| 12579-9 | Creatinine [Mass/volume] in Peritoneal dialysis fluid --4th specimen |
| 1258-3 | N Ab [Presence] in Serum or Plasma |
| 12580-7 | Creatinine [Mass/volume] in Peritoneal dialysis fluid --5th specimen |
| 12581-5 | Creatinine [Mass/volume] in Peritoneal dialysis fluid --6th specimen |
| 12582-3 | Creatinine [Mass/volume] in Peritoneal dialysis fluid --7th specimen |
| 12583-1 | Creatinine [Mass/volume] in Peritoneal dialysis fluid --8th specimen |
| 12584-9 | Creatinine [Mass/volume] in Vitreous fluid |
| 12585-6 | Creatinine [Mass/time] in 2 hour Urine |
| 12586-4 | Creatinine [Mass/time] in 4 hour Urine |
| 12587-2 | Creatinine [Mass/time] in 6 hour Urine |
| 12588-0 | Creatinine [Mass/time] in 8 hour Urine |
| 12589-8 | Creatinine [Mass/time] in 12 hour Urine |
| 1259-1 | N Ag [Presence] on Red Blood Cells from Blood product unit |
| 12590-6 | Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
| 12591-4 | Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
| 12592-2 | Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
| 12593-0 | Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
| 12594-8 | Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
| 12595-5 | Estradiol (E2) [Mass/volume] in Urine |
| 12596-3 | Estradiol (E2) [Mass/volume] in Serum or Plasma --3 hours post XXX challenge |
| 12597-1 | Estrogen [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
| 12598-9 | Fat.neutral [Presence] in Stool |
| 12599-7 | Pristanate (C15:0(CH3)4) [Mass/volume] in Serum or Plasma |
| 126-3 | Cefprozil [Susceptibility] by Serum bactericidal titer |
| 1260-9 | N Ag [Presence] on Red Blood Cells from donor |
| 12600-3 | Pristanate (C15:0(CH3)4)/Phytanate (C16:0(CH3)4) [Mass Ratio] in Serum or Plasma |
| 12601-1 | Fluoride [Mass/volume] in Dialysis fluid |
| 12602-9 | Hydroxyethylflurazepam [Mass/volume] in Urine |
| 12603-7 | N-desalkylflurazepam [Presence] in Stool |
| 12604-5 | Hydroxyethylflurazepam [Presence] in Stool |
| 12605-2 | Flurazepam [Presence] in Stool |
| 12606-0 | Dolichol [Mass/volume] in Serum or Plasma |
| 12607-8 | Glucose [Mass/volume] in Peritoneal dialysis fluid --pre dialysis |
| 12608-6 | Glucose [Mass/volume] in Peritoneal dialysis fluid --2 hour dwell specimen |
| 12609-4 | Glucose [Mass/volume] in Peritoneal dialysis fluid --4 hour dwell specimen |
| 1261-7 | N Ag [Presence] on Red Blood Cells |
| 12610-2 | Glucose [Mass/volume] in Serum or Plasma --2 hours post XXX challenge |
| 12611-0 | Glucose [Mass/volume] in Serum or Plasma --4 hour specimen |
| 12612-8 | Glucose [Mass/volume] in Dialysis fluid --2 hour specimen |
| 12613-6 | Glucose [Mass/volume] in Dialysis fluid --4 hour specimen |
| 12614-4 | Glucose [Mass/volume] in Serum or Plasma --7 hours post meal |
| 12615-1 | Glucose [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge |
| 12616-9 | Glucose [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
| 12617-7 | Glucose [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
| 12618-5 | Glucose [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
| 12619-3 | Glucose [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
| 1262-5 | N NOS Ab [Presence] in Serum or Plasma from Blood product unit |
| 12620-1 | Glucose [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
| 12621-9 | Glucose [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge |
| 12622-7 | Glucose [Mass/volume] in Serum or Plasma --10th specimen post XXX challenge |
| 12623-5 | Glucose [Mass/volume] in Serum or Plasma --11th specimen post XXX challenge |
| 12624-3 | Glucose [Mass/volume] in Serum or Plasma --12th specimen post XXX challenge |
| 12625-0 | Glucose [Mass/volume] in Serum or Plasma --13th specimen post XXX challenge |
| 12626-8 | Glucose [Mass/volume] in Serum or Plasma --14th specimen post XXX challenge |
| 12627-6 | Glucose [Mass/volume] in Serum or Plasma --15th specimen post XXX challenge |
| 12628-4 | Glucose [Mass/volume] in Peritoneal dialysis fluid |
| 12629-2 | Glucose [Mass/volume] in 24 hour Peritoneal dialysis fluid |
| 1263-3 | N NOS Ab [Presence] in Serum or Plasma from donor |
| 12630-0 | Glucose [Mass/volume] in Peritoneal dialysis fluid --1st specimen |
| 12631-8 | Glucose [Mass/volume] in Peritoneal dialysis fluid --2nd specimen |
| 12632-6 | Glucose [Mass/volume] in Peritoneal dialysis fluid --3rd specimen |
| 12633-4 | Glucose [Mass/volume] in Peritoneal dialysis fluid --4th specimen |
| 12634-2 | Glucose [Mass/volume] in Peritoneal dialysis fluid --5th specimen |
| 12635-9 | Glucose [Mass/volume] in Peritoneal dialysis fluid --6th specimen |
| 12636-7 | Glucose [Mass/volume] in Peritoneal dialysis fluid --7th specimen |
| 12637-5 | Glucose [Mass/volume] in Peritoneal dialysis fluid --8th specimen post XXX challenge |
| 12638-3 | Glucose [Mass/volume] in Serum or Plasma --pre dose lactose PO |
| 12639-1 | Glucose [Mass/volume] in Serum or Plasma --15 minutes post XXX challenge |
| 1264-1 | N NOS Ab [Presence] in Serum or Plasma |
| 12640-9 | Glucose [Mass/volume] in Serum or Plasma --6.5 hours post XXX challenge |
| 12641-7 | Glucose [Mass/volume] in Serum or Plasma --7 hours post XXX challenge |
| 12642-5 | Glucose [Mass/volume] in Serum or Plasma --7.5 hours post XXX challenge |
| 12643-3 | Glucose [Mass/volume] in Serum or Plasma --8 hours post XXX challenge |
| 12644-1 | Glucose [Mass/volume] in Serum or Plasma --9 hours post XXX challenge |
| 12645-8 | Glucose [Mass/volume] in Serum or Plasma --10 hours post XXX challenge |
| 12646-6 | Glucose [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
| 12647-4 | Glucose [Mass/volume] in Serum or Plasma --12 hours post XXX challenge |
| 12648-2 | Glucose [Mass/volume] in Serum or Plasma --15 minutes post dose lactose PO |
| 12649-0 | Glucose [Mass/volume] in Serum or Plasma --6th specimen post dose lactose |
| 1265-8 | N NOS Ag [Presence] on Red Blood Cells from Blood product unit |
| 12650-8 | Glucose [Mass/volume] in Serum or Plasma --3.5 hours post dose lactose PO |
| 12651-6 | Glucose [Mass/volume] in Serum or Plasma --10 minutes pre XXX challenge |
| 12652-4 | Glucose [Mass/volume] in Serum or Plasma --2 minutes post XXX challenge |
| 12653-2 | Glucose [Mass/volume] in Serum or Plasma --8 minutes post XXX challenge |
| 12654-0 | Glucose [Mass/volume] in Serum or Plasma --10 minutes post XXX challenge |
| 12655-7 | Glucose [Mass/volume] in Serum or Plasma --20 minutes post XXX challenge |
| 12656-5 | Glucose [Mass/volume] in Serum or Plasma --4 minutes post XXX challenge |
| 12657-3 | Glucose [Mass/volume] in Serum or Plasma --40 minutes post XXX challenge |
| 12658-1 | Glucose [Mass/volume] in Serum or Plasma --50 minutes post XXX challenge |
| 12659-9 | Glucose [Mass/volume] in Serum or Plasma --70 minutes post XXX challenge |
| 1266-6 | N NOS Ag [Presence] on Red Blood Cells from donor |
| 12660-7 | Follitropin [Moles/volume] in Serum or Plasma --3 hours post XXX challenge |
| 12661-5 | Follitropin [Moles/volume] in Serum or Plasma --10 minutes post XXX challenge |
| 12662-3 | Follitropin [Moles/volume] in Serum or Plasma --20 minutes post XXX challenge |
| 12663-1 | Follitropin [Moles/volume] in Serum or Plasma --40 minutes post XXX challenge |
| 12664-9 | Follitropin [Moles/volume] in Serum or Plasma --2nd specimen post XXX challenge |
| 12665-6 | Follitropin [Moles/volume] in Serum or Plasma --3rd specimen post XXX challenge |
| 12666-4 | Follitropin [Moles/volume] in Serum or Plasma --4th specimen post XXX challenge |
| 12667-2 | Follitropin [Moles/volume] in Serum or Plasma --5th specimen post XXX challenge |
| 12668-0 | Follitropin [Moles/volume] in Serum or Plasma --6th specimen post XXX challenge |
| 12669-8 | Follitropin [Moles/volume] in Serum or Plasma --7th specimen post XXX challenge |
| 1267-4 | N NOS Ag [Presence] on Red Blood Cells |
| 12670-6 | Follitropin [Moles/volume] in Serum or Plasma --8th specimen post XXX challenge |
| 12671-4 | Follitropin [Moles/volume] in Serum or Plasma --9th specimen post XXX challenge |
| 12672-2 | Lutropin [Moles/volume] in Serum or Plasma --10 minutes post XXX challenge |
| 12673-0 | Lutropin [Moles/volume] in Serum or Plasma --3 hours post XXX challenge |
| 12674-8 | Lutropin [Moles/volume] in Serum or Plasma --15 minutes pre XXX challenge |
| 12675-5 | Lutropin [Moles/volume] in Serum or Plasma --20 minutes post XXX challenge |
| 12676-3 | Lutropin [Moles/volume] in Serum or Plasma --40 minutes post XXX challenge |
| 12677-1 | Lutropin [Moles/volume] in Serum or Plasma --2nd specimen post XXX challenge |
| 12678-9 | Lutropin [Moles/volume] in Serum or Plasma --3rd specimen post XXX challenge |
| 12679-7 | Lutropin [Moles/volume] in Serum or Plasma --4th specimen post XXX challenge |
| 1268-2 | Not otherwise specified Ab [Presence] in Serum or Plasma from Blood product unit |
| 12680-5 | Lutropin [Moles/volume] in Serum or Plasma --5th specimen post XXX challenge |
| 12681-3 | Lutropin [Moles/volume] in Serum or Plasma --6th specimen post XXX challenge |
| 12682-1 | Lutropin [Moles/volume] in Serum or Plasma --7th specimen post XXX challenge |
| 12683-9 | Lutropin [Moles/volume] in Serum or Plasma --8th specimen post XXX challenge |
| 12684-7 | Lutropin [Moles/volume] in Serum or Plasma --9th specimen post XXX challenge |
| 12685-4 | Somatotropin [Moles/volume] in Serum or Plasma --2nd specimen post XXX challenge |
| 12686-2 | Somatotropin [Moles/volume] in Serum or Plasma --3rd specimen post XXX challenge |
| 12687-0 | Somatotropin [Moles/volume] in Serum or Plasma --4th specimen post XXX challenge |
| 12688-8 | Somatotropin [Moles/volume] in Serum or Plasma --5th specimen post XXX challenge |
| 12689-6 | Somatotropin [Moles/volume] in Serum or Plasma --6th specimen post XXX challenge |
| 1269-0 | Not otherwise specified Ab [Presence] in Serum or Plasma from donor |
| 12690-4 | Somatotropin [Moles/volume] in Serum or Plasma --7th specimen post XXX challenge |
| 12691-2 | Somatotropin [Moles/volume] in Serum or Plasma --8th specimen post XXX challenge |
| 12692-0 | Somatotropin [Moles/volume] in Serum or Plasma --9th specimen post XXX challenge |
| 12693-8 | Somatotropin [Moles/volume] in Serum or Plasma --10th specimen post XXX challenge |
| 12694-6 | Somatotropin [Moles/volume] in Serum or Plasma --post XXX challenge |
| 12695-3 | Somatotropin [Moles/volume] in Serum or Plasma --15 minutes pre XXX challenge |
| 12696-1 | Somatotropin [Moles/volume] in Serum or Plasma --pre XXX challenge |
| 12697-9 | Somatotropin [Moles/volume] in Serum or Plasma --10 minutes post XXX challenge |
| 12698-7 | Somatotropin [Moles/volume] in Serum or Plasma --15 minutes post XXX challenge |
| 12699-5 | Somatotropin [Moles/volume] in Serum or Plasma --20 minutes post XXX challenge |
| 127-1 | Cefsulodin [Susceptibility] by Minimum lethal concentration (MLC) |
| 1270-8 | Unidentified Ab [Presence] in Serum or Plasma |
| 12700-1 | Somatotropin [Moles/volume] in Serum or Plasma --45 minutes post XXX challenge |
| 12701-9 | Somatotropin [Moles/volume] in Serum or Plasma --2.5 hours post XXX challenge |
| 12702-7 | Antimony [Presence] in Serum or Plasma |
| 12703-5 | Gallium [Mass/volume] in Serum or Plasma |
| 12704-3 | Length of Hair |
| 12705-0 | Strontium [Mass/volume] in Urine |
| 12706-8 | Tellurium [Mass/volume] in Serum or Plasma |
| 12707-6 | Thorium [Mass/volume] in Serum or Plasma |
| 12708-4 | Tin [Mass/volume] in Urine |
| 12709-2 | Norastemizole [Mass/volume] in Serum or Plasma |
| 1271-6 | Deprecated O group [Presence] [Presence] in Serum or Plasma from Blood product unit |
| 12710-0 | Hemoglobin pattern [Interpretation] in Blood |
| 12711-8 | Hemoglobin A region [Presence] in Blood by Electrophoresis alkaline (pH 8.9) |
| 12712-6 | Hemoglobin S+D+G region [Presence] in Blood by Electrophoresis alkaline (pH 8.9) |
| 12713-4 | Hemoglobin C+E+O+A2 region [Presence] in Blood by Electrophoresis alkaline (pH 8.9) |
| 12714-2 | N-methylhistamine [Mass/volume] in Urine |
| 12715-9 | Homovanillate [Mass/time] in Urine |
| 12716-7 | 17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
| 12717-5 | 17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
| 12718-3 | 17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
| 12719-1 | 17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
| 1272-4 | Deprecated O group [Presence] in serum or plasma from donor |
| 12720-9 | Hydroxyproline [Mass/volume] in 2 hour Urine |
| 12721-7 | Melatonin [Units/volume] in Serum or Plasma |
| 12722-5 | Insulin-like growth factor binding protein 1 [Mass/volume] in Serum or Plasma |
| 12723-3 | Insulin-like growth factor binding protein 2 [Mass/volume] in Serum or Plasma |
| 12724-1 | Voltage-gated calcium channel IgG Ab [Units/volume] in Serum |
| 12725-8 | IgA.secretory [Units/volume] in Serum or Plasma |
| 12726-6 | Leucine-enkephalin [Units/volume] in Serum or Plasma |
| 12727-4 | Prednisolone [Mass/volume] in Serum or Plasma |
| 12728-2 | Alpha subunit [Units/volume] in Serum or Plasma |
| 12729-0 | Interferon gamma [Units/volume] in Serum or Plasma |
| 1273-2 | Deprecated O group [Presence] in serum |
| 12730-8 | Interferon beta [Units/volume] in Serum or Plasma |
| 12731-6 | Interferon alpha [Units/volume] in Serum or Plasma |
| 12732-4 | Interleukin 12 [Units/volume] in Serum or Plasma |
| 12733-2 | Tryptase [Enzymatic activity/volume] in Serum or Plasma |
| 12734-0 | Cytokeratin Ab [Units/volume] in Serum |
| 12735-7 | Collagen Ab [Units/volume] in Urine |
| 12736-5 | Hyaluronate [Mass/volume] in Serum or Plasma |
| 12737-3 | Endothelin [Units/volume] in Serum or Plasma |
| 12738-1 | Insulin [Mass/volume] in Serum or Plasma --pre XXX challenge |
| 12739-9 | Insulin [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
| 1274-0 | Deprecated O group [Presence] on Red Blood Cells from Blood product unit |
| 12740-7 | Insulin [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
| 12741-5 | Insulin [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
| 12742-3 | Insulin [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
| 12743-1 | Insulin [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
| 12744-9 | Insulin [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
| 12745-6 | Insulin [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge |
| 12746-4 | Insulin [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge |
| 12747-2 | Insulin [Mass/volume] in Serum or Plasma --3.5 hours post XXX challenge |
| 12748-0 | Insulin [Mass/volume] in Serum or Plasma --4.5 hours post XXX challenge |
| 12749-8 | Insulin [Mass/volume] in Serum or Plasma --5.5 hours post XXX challenge |
| 1275-7 | Deprecated O group [Presence] on Red Blood Cells from donor |
| 12750-6 | Insulin [Mass/volume] in Serum or Plasma --7 hours post XXX challenge |
| 12751-4 | Insulin [Mass/volume] in Serum or Plasma --7.5 hours post XXX challenge |
| 12752-2 | Insulin [Mass/volume] in Serum or Plasma --8 hours post XXX challenge |
| 12753-0 | Insulin [Mass/volume] in Serum or Plasma --9 hours post XXX challenge |
| 12754-8 | Insulin [Mass/volume] in Serum or Plasma --10 hours post XXX challenge |
| 12755-5 | Insulin [Mass/volume] in Serum or Plasma --11 hour post XXX challenge |
| 12756-3 | Insulin [Mass/volume] in Serum or Plasma --12 hours post XXX challenge |
| 12757-1 | Insulin [Mass/volume] in Serum or Plasma --30 minutes pre XXX challenge |
| 12758-9 | Insulin [Mass/volume] in Serum or Plasma --15 minutes pre XXX challenge |
| 12759-7 | Insulin [Mass/volume] in Serum or Plasma --2 minutes post XXX challenge |
| 1276-5 | Deprecated O group [Presence] on Red Blood Cells |
| 12760-5 | Insulin [Mass/volume] in Serum or Plasma --4 minutes post XXX challenge |
| 12761-3 | Insulin [Mass/volume] in Serum or Plasma --8 minutes post XXX challenge |
| 12762-1 | Insulin [Mass/volume] in Serum or Plasma --15 minutes post XXX challenge |
| 12763-9 | Insulin [Mass/volume] in Serum or Plasma --19 minutes post XXX challenge |
| 12764-7 | Insulin [Mass/volume] in Serum or Plasma --22 minutes post XXX challenge |
| 12765-4 | Insulin [Mass/volume] in Serum or Plasma --40 minutes post XXX challenge |
| 12766-2 | Insulin [Mass/volume] in Serum or Plasma --45 minutes post XXX challenge |
| 12767-0 | Insulin [Mass/volume] in Serum or Plasma --50 minutes post XXX challenge |
| 12768-8 | Insulin [Mass/volume] in Serum or Plasma --70 minutes post XXX challenge |
| 12769-6 | 17-Ketosteroids.total neutral [Mass/time] in 24 hour Urine |
| 1277-3 | P Ab [Presence] in Serum or Plasma from Blood product unit |
| 12770-4 | Lead [Mass/mass] in Tissue |
| 12771-2 | Cholesterol in HDL [Presence] in Serum or Plasma by Electrophoresis |
| 12772-0 | Cholesterol in HDL [Units/volume] in Serum or Plasma by Electrophoresis |
| 12773-8 | Cholesterol in LDL [Units/volume] in Serum or Plasma by Electrophoresis |
| 12774-6 | Mercury [Mass/volume] in Red Blood Cells |
| 12775-3 | Mercury [Mass/volume] in Dentin |
| 12776-1 | Mucin-like carcinoma associated Ag [Units/volume] in Serum or Plasma |
| 12777-9 | Immunoglobulin light chains.kappa.free [Units/volume] in Urine |
| 12778-7 | Immunoglobulin light chains.lambda.free [Units/volume] in Urine |
| 12779-5 | Nickel [Mass/time] in Urine |
| 1278-1 | P Ab [Presence] in Serum or Plasma from donor |
| 12780-3 | Nickel [Mass/volume] in Red Blood Cells |
| 12781-1 | Borrelia burgdorferi Ab band pattern [Interpretation] in Serum by Immunoblot (IB) |
| 12782-9 | Oligoclonal bands [Interpretation] in Cerebral spinal fluid by Electrophoresis |
| 12783-7 | Oligoclonal bands [Interpretation] in Serum or Plasma |
| 12784-5 | Codeine Free [Mass/volume] in Serum or Plasma |
| 12785-2 | Dihydrocodeine Free [Mass/volume] in Serum or Plasma |
| 12786-0 | Hydrocodone Free [Mass/volume] in Serum or Plasma |
| 12787-8 | Hydromorphone Free [Mass/volume] in Serum or Plasma |
| 12788-6 | 6-Monoacetylmorphine (6-MAM) [Mass/volume] in Serum or Plasma |
| 12789-4 | Oxycodone Free [Mass/volume] in Serum or Plasma |
| 1279-9 | P Ab [Presence] in Serum or Plasma |
| 12790-2 | Oxalate [Mass/volume] in Urine --2nd specimen post XXX challenge |
| 12791-0 | Oxalate [Mass/volume] in Urine --3rd specimen post XXX challenge |
| 12792-8 | Oxalate [Mass/volume] in Urine --4th specimen post XXX challenge |
| 12793-6 | Oxalate [Mass/volume] in Urine --5th specimen post XXX challenge |
| 12794-4 | Oxalate [Mass/volume] in Urine --6th specimen post XXX challenge |
| 12795-1 | Oxalate [Mass/volume] in Urine --7th specimen post XXX challenge |
| 12796-9 | Oxalate [Mass/volume] in Urine --8th specimen post XXX challenge |
| 12797-7 | Oxalate [Mass/volume] in Urine --9th specimen post XXX challenge |
| 12798-5 | Oxalate [Mass/volume] in Urine --10th specimen post XXX challenge |
| 12799-3 | Parathyrin Ab [Units/volume] in Serum |
| 128-9 | Cefsulodin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 1280-7 | P NOS Ab [Presence] in Serum or Plasma from Blood product unit |
| 12800-9 | Deprecated Trimeprazine |
| 12801-7 | Methdilazine [Mass/volume] in Serum or Plasma |
| 12802-5 | Propiomazine [Mass/volume] in Serum or Plasma |
| 12803-3 | Phenylalanine [Presence] in Blood by Guthrie test |
| 12804-1 | Acid phosphatase [Enzymatic activity/volume] in Body fluid |
| 12805-8 | Alkaline phosphatase isoenzyme [Units/volume] in Serum or Plasma |
| 12806-6 | Alkaline phosphatase.lung [Enzymatic activity/volume] in Serum or Plasma |
| 12807-4 | Phosphoserine [Mass/volume] in Cerebral spinal fluid |
| 12808-2 | Uroporphyrin [Mass/time] in Urine |
| 12809-0 | Coproporphyrin [Mass/time] in Urine |
| 1281-5 | P NOS Ab [Presence] in Serum or Plasma from donor |
| 12810-8 | Porphobilinogen deaminase [Enzymatic activity/volume] in Blood |
| 12811-6 | Uroporphyrinogen III synthase [Enzymatic activity/volume] in Blood |
| 12812-4 | Potassium [Moles/volume] in Serum or Plasma --2nd specimen |
| 12813-2 | Potassium [Moles/volume] in Serum or Plasma --3rd specimen |
| 12814-0 | Potassium [Moles/volume] in Vitreous fluid |
| 12815-7 | Progesterone [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
| 12816-5 | Progesterone [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
| 12817-3 | Progesterone [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
| 12818-1 | Progesterone [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
| 12819-9 | Progesterone [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
| 1282-3 | P NOS Ab [Presence] in Serum or Plasma |
| 12820-7 | Progesterone [Mass/volume] in 24 hour Urine |
| 12821-5 | Progesterone [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge |
| 12822-3 | Progesterone [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
| 12823-1 | Prolactin [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
| 12824-9 | Prolactin [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
| 12825-6 | Prolactin [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
| 12826-4 | Prolactin [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
| 12827-2 | Prolactin [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
| 12828-0 | Prolactin [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
| 12829-8 | Prolactin [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge |
| 1283-1 | P NOS Ag [Presence] on Red Blood Cells from Blood product unit |
| 12830-6 | Prolactin [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge |
| 12831-4 | Prolactin [Mass/volume] in Serum or Plasma --10th specimen post XXX challenge |
| 12832-2 | Prolactin [Mass/volume] in Serum or Plasma --10 minutes post XXX challenge |
| 12833-0 | Prolactin [Mass/volume] in Serum or Plasma --20 minutes post XXX challenge |
| 12834-8 | Prolactin [Mass/volume] in Serum or Plasma --15 minutes post XXX challenge |
| 12835-5 | Prolactin [Mass/volume] in Serum or Plasma --45 minutes post XXX challenge |
| 12836-3 | Prostaglandin E2 [Mass/volume] in 24 hour Urine |
| 12837-1 | Prostaglandin E1 [Mass/volume] in 24 hour Urine |
| 12838-9 | Prostaglandin D2 [Mass/volume] in Urine |
| 12839-7 | Prostaglandin D2 [Mass/volume] in Serum or Plasma |
| 1284-9 | P NOS Ag [Presence] on Red Blood Cells from donor |
| 12840-5 | Prostaglandin F2 alpha [Moles/volume] in Urine |
| 12841-3 | Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma |
| 12842-1 | Protein [Mass/volume] in 12 hour Urine |
| 12843-9 | Protein [Mass/volume] in Peritoneal dialysis fluid |
| 12844-7 | Protein [Mass/volume] in Peritoneal dialysis fluid --2nd specimen |
| 12845-4 | Protein [Mass/volume] in Peritoneal dialysis fluid --3rd specimen |
| 12846-2 | Protein [Mass/volume] in Peritoneal dialysis fluid --4th specimen |
| 12847-0 | Protein [Mass/volume] in Peritoneal dialysis fluid --5th specimen |
| 12848-8 | Protein [Mass/volume] in Peritoneal dialysis fluid --6th specimen |
| 12849-6 | Protein [Mass/volume] in Peritoneal dialysis fluid --7th specimen |
| 1285-6 | P NOS Ag [Presence] on Red Blood Cells |
| 12850-4 | Protein [Mass/volume] in Peritoneal dialysis fluid --8th specimen |
| 12851-2 | Protein Fractions [Interpretation] in Serum or Plasma by Electrophoresis |
| 12852-0 | Bovine inner ear Ag [Presence] in Serum or Plasma by Immunoblot (IB) |
| 12853-8 | Purkinje cells Ab [Presence] in Serum by Immunoblot (IB) |
| 12854-6 | Neuronal nuclear type 1 Ab [Units/volume] in Serum |
| 12855-3 | HIV 1 p23 Ab [Presence] in Serum by Immunoblot (IB) |
| 12856-1 | HIV 1 p65 Ab [Presence] in Serum by Immunoblot (IB) |
| 12857-9 | HIV 1 p28 Ab [Presence] in Serum by Immunoblot (IB) |
| 12858-7 | HIV 1 p32 Ab [Presence] in Serum by Immunoblot (IB) |
| 12859-5 | HIV 1 p18 Ab [Presence] in Serum by Immunoblot (IB) |
| 1286-4 | P1 Ab [Presence] in Serum or Plasma from Blood product unit |
| 12860-3 | Borrelia burgdorferi 39kD Ab [Presence] in Cerebral spinal fluid by Immunoblot (IB) |
| 12861-1 | Borrelia burgdorferi 88kD Ab [Presence] in Cerebral spinal fluid by Immunoblot (IB) |
| 12862-9 | Borrelia burgdorferi 66kD Ab [Presence] in Cerebral spinal fluid by Immunoblot (IB) |
| 12863-7 | Borrelia burgdorferi 41kD Ab [Presence] in Cerebral spinal fluid by Immunoblot (IB) |
| 12864-5 | Borrelia burgdorferi 25kD Ab [Presence] in Cerebral spinal fluid by Immunoblot (IB) |
| 12865-2 | Borrelia burgdorferi 29kD Ab [Presence] in Cerebral spinal fluid by Immunoblot (IB) |
| 12866-0 | Borrelia burgdorferi 18kD Ab [Presence] in Cerebral spinal fluid by Immunoblot (IB) |
| 12867-8 | Borrelia burgdorferi 58kD Ab [Presence] in Cerebral spinal fluid by Immunoblot (IB) |
| 12868-6 | Borrelia burgdorferi 47kD Ab [Presence] in Cerebral spinal fluid by Immunoblot (IB) |
| 12869-4 | Borrelia burgdorferi 30kD Ab [Presence] in Cerebral spinal fluid by Immunoblot (IB) |
| 1287-2 | P1 Ab [Presence] in Serum or Plasma from donor |
| 12870-2 | HIV 1 gp34 Ab [Presence] in Serum by Immunoblot (IB) |
| 12871-0 | HIV 1 p26 Ab [Presence] in Serum by Immunoblot (IB) |
| 12872-8 | HIV 1 p15 Ab [Presence] in Serum by Immunoblot (IB) |
| 12873-6 | Borrelia burgdorferi 88kD Ab [Presence] in Serum by Immunoblot (IB) |
| 12874-4 | Borrelia burgdorferi 93kD Ab [Presence] in Serum by Immunoblot (IB) |
| 12875-1 | HIV 1 p64 Ab [Presence] in Serum by Immunoblot (IB) |
| 12876-9 | HIV 1 p53 Ab [Presence] in Serum by Immunoblot (IB) |
| 12877-7 | Borrelia burgdorferi 47kD Ab [Presence] in Serum by Immunoblot (IB) |
| 12878-5 | Borrelia burgdorferi 29kD Ab [Presence] in Serum by Immunoblot (IB) |
| 12879-3 | Borrelia burgdorferi 25kD Ab [Presence] in Serum by Immunoblot (IB) |
| 1288-0 | P1 Ab [Presence] in Serum or Plasma |
| 12880-1 | Borrelia burgdorferi 58kD Ab [Presence] in Body fluid by Immunoblot (IB) |
| 12881-9 | Borrelia burgdorferi 47kD Ab [Presence] in Body fluid by Immunoblot (IB) |
| 12882-7 | Borrelia burgdorferi 29kD Ab [Presence] in Body fluid by Immunoblot (IB) |
| 12883-5 | Borrelia burgdorferi 18kD Ab [Presence] in Body fluid by Immunoblot (IB) |
| 12884-3 | Borrelia burgdorferi 39kD Ab [Presence] in Body fluid by Immunoblot (IB) |
| 12885-0 | Borrelia burgdorferi 88kD Ab [Presence] in Body fluid by Immunoblot (IB) |
| 12886-8 | Borrelia burgdorferi 66kD Ab [Presence] in Body fluid by Immunoblot (IB) |
| 12887-6 | Borrelia burgdorferi 41kD Ab [Presence] in Body fluid by Immunoblot (IB) |
| 12888-4 | Borrelia burgdorferi 25kD Ab [Presence] in Body fluid by Immunoblot (IB) |
| 12889-2 | Borrelia burgdorferi 30kD Ab [Presence] in Body fluid by Immunoblot (IB) |
| 1289-8 | P1 Ag [Presence] on Red Blood Cells from Blood product unit |
| 12890-0 | Borrelia burgdorferi 45kD Ab [Presence] in Serum by Immunoblot (IB) |
| 12891-8 | Borrelia burgdorferi 41kD Ab [Presence] in Serum by Immunoblot (IB) |
| 12892-6 | Borrelia burgdorferi 30kD Ab [Presence] in Serum by Immunoblot (IB) |
| 12893-4 | HIV 1 gp105 Ab [Presence] in Serum by Immunoblot (IB) |
| 12894-2 | HIV 1 p68 Ab [Presence] in Serum by Immunoblot (IB) |
| 12895-9 | HIV 1 p58 Ab [Presence] in Serum by Immunoblot (IB) |
| 12896-7 | Borrelia burgdorferi 58kD Ab [Presence] in Serum by Immunoblot (IB) |
| 12897-5 | Myelin associated glycoprotein Ab [Presence] in Cerebral spinal fluid by Immunoblot (IB) |
| 12898-3 | Chloride [Moles/volume] in Vitreous fluid |
| 12899-1 | Acetylene [Mass/volume] in Serum or Plasma |
| 129-7 | Cefsulodin [Susceptibility] by Disk diffusion (KB) |
| 1290-6 | P1 Ag [Presence] on Red Blood Cells from donor |
| 12900-7 | Renin [Enzymatic activity/volume] in Plasma --2nd specimen post XXX challenge |
| 12901-5 | Renin [Enzymatic activity/volume] in Plasma --3rd specimen post XXX challenge |
| 12902-3 | Renin [Enzymatic activity/volume] in Plasma --4th specimen post XXX challenge |
| 12903-1 | Renin [Enzymatic activity/volume] in Plasma --5th specimen post XXX challenge |
| 12904-9 | Renin [Enzymatic activity/volume] in Plasma --6th specimen post XXX challenge |
| 12905-6 | Renin [Enzymatic activity/volume] in Plasma --7th specimen post XXX challenge |
| 12906-4 | Renin [Enzymatic activity/volume] in Plasma --8th specimen post XXX challenge |
| 12907-2 | Sodium [Moles/volume] in Red Blood Cells |
| 12908-0 | Sodium [Moles/volume] in Vitreous fluid |
| 12909-8 | Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge |
| 1291-4 | P1 Ag [Presence] on Red Blood Cells |
| 12910-6 | Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
| 12911-4 | Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge |
| 12912-2 | Lipids [Mass/volume] in Body fluid |
| 12913-0 | Beta-N-acetylhexosaminidase [Enzymatic activity/volume] in Leukocytes |
| 12914-8 | Beta-N-acetylhexosaminidase.A/Beta-n-acetylhexosaminidase.total in Serum |
| 12915-5 | Beta galactosidase [Enzymatic activity/volume] in Leukocytes |
| 12916-3 | Porphobilinogen synthase [Enzymatic activity/volume] in Blood |
| 12917-1 | Porphobilinogen synthase [Enzymatic activity/volume] in Serum or Plasma |
| 12918-9 | Monoamine oxidase [Enzymatic activity/volume] in Platelet rich plasma |
| 12919-7 | Monoamine oxidase [Enzymatic activity/volume] in Blood |
| 1292-2 | Deprecated P2 Ab [Presence] in Serum or Plasma from Blood product unit |
| 12920-5 | Sulfate [Mass/volume] in 24 hour Urine |
| 12921-3 | Testosterone [Mass/volume] in Serum or Plasma --3 hours post XXX challenge |
| 12922-1 | Testosterone [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
| 12923-9 | Thyroxine (T4) [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
| 12924-7 | Thyroxine (T4) [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
| 12925-4 | Thyroxine (T4) [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
| 12926-2 | Thyroxine (T4) [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
| 12927-0 | Thyroxine (T4) [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
| 12928-8 | Thyroxine (T4) [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
| 12929-6 | Thyroxine (T4) [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge |
| 1293-0 | Deprecated P2 Ab [Presence] on Red Blood Cells from donor |
| 12930-4 | Thyroxine (T4) [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge |
| 12931-2 | Thyroxine (T4) [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
| 12932-0 | Thyrotropin [Units/volume] in Serum or Plasma --post XXX challenge |
| 12933-8 | Thyrotropin [Units/volume] in Serum or Plasma --10 minutes post XXX challenge |
| 12934-6 | Thyrotropin [Units/volume] in Serum or Plasma --15 minutes post XXX challenge |
| 12935-3 | Thyrotropin [Units/volume] in Serum or Plasma --20 minutes post XXX challenge |
| 12936-1 | Thyrotropin [Units/volume] in Serum or Plasma --40 minutes post XXX challenge |
| 12937-9 | Thyrotropin [Units/volume] in Serum or Plasma --45 minutes post XXX challenge |
| 12938-7 | Thyrotropin [Units/volume] in Serum or Plasma --1.5 hours post XXX challenge |
| 12939-5 | Thyrotropin [Units/volume] in Serum or Plasma --2 hours post XXX challenge |
| 1294-8 | Deprecated P2 Ab |
| 12940-3 | Thyrotropin [Units/volume] in Serum or Plasma --30 minutes pre XXX challenge |
| 12941-1 | Thyrotropin [Units/volume] in Serum or Plasma --2nd specimen post XXX challenge |
| 12942-9 | Thyrotropin [Units/volume] in Serum or Plasma --3rd specimen post XXX challenge |
| 12943-7 | Thyrotropin [Units/volume] in Serum or Plasma --4th specimen post XXX challenge |
| 12944-5 | Thyrotropin [Units/volume] in Serum or Plasma --5th specimen post XXX challenge |
| 12945-2 | Thyrotropin [Units/volume] in Serum or Plasma --6th specimen post XXX challenge |
| 12946-0 | Thyrotropin [Units/volume] in Serum or Plasma --7th specimen post XXX challenge |
| 12947-8 | Thyrotropin [Units/volume] in Serum or Plasma --8th specimen post XXX challenge |
| 12948-6 | Thyrotropin [Units/volume] in Serum or Plasma --9th specimen post XXX challenge |
| 12949-4 | Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma |
| 1295-5 | P2 Ag [Presence] on Red Blood Cells from Blood product unit |
| 12950-2 | Deprecated Triglyceride [Mass/volume] in Body fluid |
| 12951-0 | Triglyceride [Mass/volume] in Serum or Plasma by calculation |
| 12952-8 | Deprecated Thyroxine (T4) uptake [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
| 12953-6 | Triiodothyronine (T3) [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
| 12954-4 | Triiodothyronine (T3) [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
| 12955-1 | Triiodothyronine (T3) [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
| 12956-9 | Triiodothyronine (T3) [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
| 12957-7 | Triiodothyronine (T3) [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
| 12958-5 | Triiodothyronine (T3) [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
| 12959-3 | Triiodothyronine (T3) [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge |
| 1296-3 | P2 Ag [Presence] on Red Blood Cells from donor |
| 12960-1 | Alpha 1 antitrypsin fecal clearance |
| 12961-9 | Urea nitrogen [Mass/volume] in Arterial blood |
| 12962-7 | Urea nitrogen [Mass/volume] in Venous blood |
| 12963-5 | Urea nitrogen [Mass/volume] in Peripheral blood |
| 12964-3 | Urea nitrogen [Mass/volume] in Blood --baseline |
| 12965-0 | Urea nitrogen [Mass/volume] in Serum or Plasma --70 minute specimen |
| 12966-8 | Urea nitrogen [Mass/volume] in Serum or Plasma --2 hour specimen |
| 12967-6 | Urea nitrogen [Mass/volume] in 24 hour Urine |
| 12968-4 | Urea nitrogen [Mass/volume] in Dialysis fluid --4 hour specimen |
| 12969-2 | Urea nitrogen [Mass/volume] in Peritoneal dialysis fluid --baseline |
| 1297-1 | P2 Ag [Presence] on Red Blood Cells |
| 12970-0 | Urea nitrogen [Mass/volume] in Peritoneal dialysis fluid --2 hour dwell specimen |
| 12971-8 | Urea nitrogen [Mass/volume] in Peritoneal dialysis fluid --4 hour dwell specimen |
| 12972-6 | Urea nitrogen [Mass/volume] in Peritoneal dialysis fluid --1st specimen |
| 12973-4 | Urea nitrogen [Mass/volume] in Peritoneal dialysis fluid --4th specimen |
| 12974-2 | Urea nitrogen [Mass/volume] in Peritoneal dialysis fluid --3rd specimen |
| 12975-9 | Urea nitrogen [Mass/volume] in Peritoneal dialysis fluid --5th specimen |
| 12976-7 | Urea nitrogen [Mass/volume] in Peritoneal dialysis fluid --6th specimen |
| 12977-5 | Urea nitrogen [Mass/volume] in Peritoneal dialysis fluid --8th specimen |
| 12978-3 | Urea nitrogen [Mass/volume] in Peritoneal dialysis fluid --7th specimen |
| 12979-1 | Urea nitrogen [Mass/volume] in Peritoneal dialysis fluid --24 hour specimen |
| 1298-9 | Packed erythrocytes given [Volume] |
| 12980-9 | Deprecated Urate [Mass/volume] in Body fluid |
| 12981-7 | Urea nitrogen [Mass Ratio] in Peritoneal dialysis fluid --post dialysis/pre dialysis |
| 12982-5 | Vasopressin [Mass/volume] in Plasma --2nd specimen post XXX challenge |
| 12983-3 | Volatiles and gases [Identifier] in Urine |
| 12984-1 | 2,4 toluenediamine [Mass/volume] in Blood |
| 12985-8 | 2,6 toluenediamine [Mass/volume] in Blood |
| 12986-6 | 2,5-Hexanedione [Mass/volume] in Blood |
| 12987-4 | Acetonitrile [Mass/volume] in Urine |
| 12988-2 | Acrylamide [Mass/volume] in Blood |
| 12989-0 | Allyl alcohol [Mass/volume] in Serum or Plasma |
| 1299-7 | Platelets given [Volume] |
| 12990-8 | Polychlorinated biphenyl.Aroclor 1260 [Mass/volume] in Serum or Plasma |
| 12991-6 | Polychlorinated biphenyl.Aroclor 1254 [Mass/volume] in Serum or Plasma |
| 12992-4 | Isobutane [Mass/volume] in Blood |
| 12993-2 | Hydrocarbons.chlorinated [Identifier] in Blood |
| 12994-0 | Oxychlordane [Mass/volume] in Blood |
| 12995-7 | Cyclohexanone [Mass/volume] in Blood |
| 12996-5 | Dichlorodifluoroethane [Mass/volume] in Blood |
| 12997-3 | 1,4-Dioxane [Mass/volume] in Serum or Plasma |
| 12998-1 | Methylene chloride [Mass/volume] in Blood |
| 12999-9 | Epichlorohydrin [Mass/volume] in Serum or Plasma |
| 13-3 | Amikacin [Susceptibility] by Disk diffusion (KB) |
| 130-5 | Cefsulodin [Susceptibility] by Serum bactericidal titer |
| 1300-3 | Deprecated PP1 Ab [Presence] in Serum or Plasma from Blood product unit |
| 13000-5 | Mandelate [Mass/volume] in Urine |
| 13001-3 | Mandelate/Creatinine [Mass Ratio] in Urine |
| 13002-1 | Mesityl oxide [Mass/volume] in Blood |
| 13003-9 | Halogenated organic molecules [Identifier] in Blood |
| 13004-7 | Hydrocarbons.halogenated.volatile [Identifier] in Blood |
| 13005-4 | 2,4,5-Trichlorophenoxyacetate [Type] in Serum or Plasma |
| 13006-2 | 1,4-Dichlorobenzene [Mass/volume] in Serum or Plasma |
| 13007-0 | Ethane [Mass/volume] in Blood |
| 13008-8 | Methyl propyl ketone [Mass/volume] in Blood |
| 13009-6 | Methyl ethyl ketone [Mass/volume] in Urine |
| 1301-1 | Deprecated PP1 Ab [Presence] serum or plasma from donor |
| 13010-4 | Methyl amyl ketone [Mass/volume] in Blood |
| 13011-2 | Methyl ethyl ketone [Mass/volume] in Blood |
| 13012-0 | Methyl isoamyl ketone [Mass/volume] in Blood |
| 13013-8 | Methyl isobutyl ketone [Mass/volume] in Blood |
| 13014-6 | Methyl butyl ketone [Mass/volume] in Blood |
| 13015-3 | Diisobutylketone [Mass/volume] in Blood |
| 13016-1 | Nitrophenol [Units/volume] in Blood |
| 13017-9 | Deprecated Tetrachloroethylene [Mass/volume] in Blood |
| 13018-7 | Pesticides [Identifier] in Urine |
| 13019-5 | Pesticides [Identifier] in Serum or Plasma |
| 1302-9 | Deprecated PP1 Ab |
| 13020-3 | Pesticides [Identifier] in Blood |
| 13021-1 | Pesticides [Identifier] in Gastric fluid |
| 13022-9 | Propane [Mass/volume] in Blood |
| 13023-7 | Trichlorofluoromethane [Mass/volume] in Blood |
| 13024-5 | Trichlorofluoroethane [Mass/volume] in Blood |
| 13025-2 | Trichlorotrifluoroethane [Mass/volume] in Blood |
| 13026-0 | Orthocresol [Mass/volume] in Urine |
| 13027-8 | Ethyl acetate [Mass/volume] in Serum or Plasma |
| 13028-6 | Xylose [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge |
| 13029-4 | Xylose [Mass/volume] in Serum or Plasma --3 hours post XXX challenge |
| 1303-7 | Reverse ABO group [Type] |
| 13030-2 | Xylose [Mass/volume] in Serum or Plasma --4 hours post XXX challenge |
| 13031-0 | Xylose [Mass/volume] in Serum or Plasma --5 hours post XXX challenge |
| 13032-8 | C peptide [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
| 13033-6 | C peptide [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
| 13034-4 | C peptide [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
| 13035-1 | C peptide [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
| 13036-9 | C peptide [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
| 13037-7 | C peptide [Mass/volume] in Serum or Plasma --fasting |
| 13038-5 | C peptide [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge |
| 13039-3 | C peptide [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
| 1304-5 | D Ab [Titer] in Serum or Plasma |
| 13040-1 | C peptide [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge |
| 13041-9 | C peptide [Mass/volume] in Serum or Plasma --2 hours post XXX challenge |
| 13042-7 | C peptide [Mass/volume] in Serum or Plasma --2.5 hours post XXX challenge |
| 13043-5 | C peptide [Mass/volume] in Serum or Plasma --3 hours post XXX challenge |
| 13044-3 | C peptide [Mass/volume] in Serum or Plasma --5 hours post XXX challenge |
| 13045-0 | C peptide [Mass/volume] in Serum or Plasma --6 hours post XXX challenge |
| 13046-8 | Variant lymphocytes/100 leukocytes in Blood |
| 13047-6 | Plasma cells/100 leukocytes in Blood |
| 13048-4 | Sezary cells [Presence] in Blood by Light microscopy |
| 13049-2 | Deprecated von Willebrand factor (vWf) Ag [Units/volume] in Platelet poor plasma by Immunologic method |
| 1305-2 | D Ag [Presence] in Blood |
| 13050-0 | Protein C/Coagulation factor IX [Mass Ratio] in Platelet poor plasma |
| 13051-8 | Deprecated Protein S [Units/volume] in Platelet poor plasma |
| 13052-6 | Protein S/Coagulation factor IX [Mass Ratio] in Platelet poor plasma by Coagulation assay |
| 13053-4 | Kaolin activated time [Units/volume] in Platelet poor plasma |
| 13054-2 | Fibrin+Fibrinogen fragments [Units/volume] in Urine |
| 13055-9 | Heparin [Units/volume] in Platelet poor plasma |
| 13056-7 | Platelets [#/volume] in Plasma by Automated count |
| 13057-5 | Platelets [Units/volume] in Dialysis fluid |
| 13058-3 | aPTT in Platelet poor plasma by Coagulation assay --2nd specimen |
| 13059-1 | aPTT in Platelet poor plasma by Coagulation assay --3rd specimen |
| 1306-0 | D NOS Ab [Presence] in Serum or Plasma |
| 13060-9 | aPTT in Platelet poor plasma by Coagulation assay --4th specimen |
| 13061-7 | Platelet IgM Ab [Units/volume] in Serum |
| 13062-5 | Platelet IgA Ab [Units/volume] in Serum |
| 13063-3 | Drug induced platelet Ab [Units/volume] in Serum |
| 13064-1 | Platelet associated IgA Ab [Units/volume] in Blood |
| 13065-8 | Deprecated Platelet Ab [Units/volume] in Serum |
| 13066-6 | Nuclear Ab [Units/volume] in Body fluid by Immunofluorescence |
| 13067-4 | Nuclear Ab pattern [Interpretation] in Body fluid by Immunofluorescence |
| 13068-2 | Nuclear Ab pattern [Interpretation] in Serum by Immunofluorescence |
| 13069-0 | Phosphatidylserine IgA Ab [Units/volume] in Serum |
| 1307-8 | D NOS Ab [Presence] in Serum or Plasma from Blood product unit |
| 13070-8 | Phosphatidate IgG Ab [Units/volume] in Serum |
| 13071-6 | Phosphatidate IgM Ab [Units/volume] in Serum |
| 13072-4 | Phosphatidate IgA Ab [Units/volume] in Serum |
| 13073-2 | Phosphatidylcholine IgG Ab [Units/volume] in Serum |
| 13074-0 | Phosphatidylcholine IgM Ab [Units/volume] in Serum |
| 13075-7 | Phosphatidylcholine IgA Ab [Units/volume] in Serum |
| 13076-5 | Phosphatidylethanolamine IgG Ab [Units/volume] in Serum |
| 13077-3 | Phosphatidylethanolamine IgM Ab [Units/volume] in Serum |
| 13078-1 | Phosphatidylethanolamine IgA Ab [Units/volume] in Serum |
| 13079-9 | Phosphatidylglycerol IgG Ab [Units/volume] in Serum |
| 1308-6 | D NOS Ab [Presence] in Serum or Plasma from donor |
| 13080-7 | Phosphatidylglycerol IgM Ab [Units/volume] in Serum |
| 13081-5 | Phosphatidylglycerol IgA Ab [Units/volume] in Serum |
| 13082-3 | Phosphatidylinositol IgG Ab [Units/volume] in Serum |
| 13083-1 | Phosphatidylinositol IgM Ab [Units/volume] in Serum |
| 13084-9 | Phosphatidylinositol IgA Ab [Units/volume] in Serum |
| 13085-6 | Complement C4 Nephritic [Mass/volume] in Serum or Plasma |
| 13086-4 | Complement C3 Nephritic [Mass/volume] in Serum or Plasma |
| 13087-2 | Complement alternate pathway AH50 [Units/volume] in Serum or Plasma |
| 13088-0 | Complement total hemolytic CH100 [Units/volume] in Serum or Plasma |
| 13089-8 | Deprecated Asialoganglioside GM1 Ab |
| 1309-4 | Deprecated D NOS Ab [Presence] in Serum or Plasma |
| 13090-6 | Deprecated Asialoganglioside GM1 Ab.IgG |
| 13091-4 | Deoxyribonucleoprotein Ab [Units/volume] in Serum |
| 13092-2 | Endomysium Ab [Units/volume] in Serum |
| 13093-0 | Deprecated Monosialoganglioside GM1 Ab.IgM |
| 13094-8 | Deprecated Monosialoganglioside GM1 Ab.IgA in serum |
| 13095-5 | Deprecated Monosialoganglioside GM1 Ab.IgA in serum or plasma |
| 13096-3 | Deprecated Myelin associated glycoprotein Ab.IgM in serum |
| 13097-1 | Deprecated PM-SCL extractable nuclear Ab |
| 13098-9 | Deprecated Sulfatide Ab.IgG |
| 13099-7 | Deprecated Sulfatide Ab.IgM in serum |
| 131-3 | Cefsulodin [Mass/volume] in Serum or Plasma |
| 1310-2 | D NOS Ag [Presence] on Red Blood Cells from Blood product unit |
| 13100-3 | Deprecated Sulfate-3-Glucuronyl paragloboside Ab.IgM in serum |
| 13101-1 | Deprecated Sulfate-3-Glucuronyl paragloboside Ab.IgM in CSF |
| 13102-9 | Deprecated Disialylganglioside GD1b Ab in serum |
| 13103-7 | Deprecated Disialylganglioside GD1b Ab.IgG |
| 13104-5 | Deprecated Disialylganglioside GD1b Ab.IgM |
| 13105-2 | Deprecated Tetrasialylganglioside GQ1b Ab.IgG |
| 13106-0 | Deprecated Tetrasialylganglioside GQ1b Ab in serum |
| 13107-8 | Deprecated Disialylganglioside GD1a Ab |
| 13108-6 | Deprecated Tetrasialylganglioside GQ1b Ab in serum or plasma |
| 13109-4 | Deprecated Disialylganglioside GD1b Ab in serum or plasma |
| 1311-0 | D NOS Ag [Presence] on Red Blood Cells from donor |
| 13110-2 | Deprecated Beta tubulin Ab.IgM |
| 13111-0 | Deprecated Nuclear Ab by Immunofluorescence |
| 13112-8 | Deprecated Nuclear Ab Immunofluorescence (rat kidney substrate) |
| 13113-6 | Deprecated Myelin associated glycoprotein Ab.IgM in serum or plasma |
| 13114-4 | Deprecated Neuronal nuclear type 2 Ab |
| 13115-1 | Deprecated Neuronal nuclear type 1 Ab |
| 13116-9 | Deprecated Reticulin Ab.IgG |
| 13117-7 | Complement Sc5b-9 Ab [Units/volume] in Serum or Plasma |
| 13118-5 | Deprecated Myelin associated glycoprotein Ab |
| 13119-3 | Myelin associated glycoprotein Ab [Presence] in Serum by Immunoblot (IB) |
| 1312-8 | D NOS Ag [Presence] on Red Blood Cells |
| 13120-1 | Ovary Ab [Units/volume] in Serum |
| 13121-9 | Deprecated Ribosomal P protein Ab |
| 13122-7 | Deprecated Sulfatide Ab.IgM in serum or plasma |
| 13123-5 | Deprecated Sulfate-3-Glucuronyl paragloboside Ab in serum |
| 13124-3 | Deprecated Sulfate-3-Glucuronyl paragloboside Ab in serum or plasma |
| 13125-0 | Deprecated Hepatitis C virus c33c Ab [Presence] in Serum by Immunoblot (IB) |
| 13126-8 | Deprecated Hepatitis B virus DNA [Presence] in Blood by Immunoblot (IB) |
| 13127-6 | Cancer Ag DM/70K [Units/volume] in Serum or Plasma |
| 13128-4 | Protein.immunoacidic [Units/volume] in Serum or Plasma |
| 13129-2 | Pancreatic oncofetal Ag [Units/volume] in Serum or Plasma |
| 1313-6 | Rh immune globulin dosage.vials recommended [#] |
| 13130-0 | Motilin [Units/volume] in Serum or Plasma |
| 13131-8 | Streptococcus pneumoniae 1 Ab [Units/volume] in Serum |
| 13132-6 | Streptococcus pneumoniae 4 Ab [Units/volume] in Serum |
| 13133-4 | Streptococcus pneumoniae 26 Ab [Units/volume] in Serum |
| 13134-2 | Streptococcus pneumoniae 8 Ab [Units/volume] in Serum |
| 13135-9 | Streptococcus pneumoniae 12 Ab [Units/volume] in Serum |
| 13136-7 | Streptococcus pneumoniae 56 Ab [Units/volume] in Serum |
| 13137-5 | Streptococcus pneumoniae 19 Ab [Units/volume] in Serum |
| 13138-3 | Streptococcus pneumoniae 23 Ab [Units/volume] in Serum |
| 13139-1 | Streptococcus pneumoniae 1 Ab [Units/volume] in Serum --1st specimen |
| 1314-4 | Rh immune globulin screen [interpretation] |
| 13140-9 | Streptococcus pneumoniae 1 Ab [Units/volume] in Serum --2nd specimen |
| 13141-7 | Streptococcus pneumoniae 3 Ab [Units/volume] in Serum --1st specimen |
| 13142-5 | Streptococcus pneumoniae 3 Ab [Units/volume] in Serum --2nd specimen |
| 13143-3 | Streptococcus pneumoniae 4 Ab [Units/volume] in Serum --1st specimen |
| 13144-1 | Streptococcus pneumoniae 4 Ab [Units/volume] in Serum --2nd specimen |
| 13145-8 | Streptococcus pneumoniae 26 Ab [Units/volume] in Serum --1st specimen |
| 13146-6 | Streptococcus pneumoniae 26 Ab [Units/volume] in Serum --2nd specimen |
| 13147-4 | Streptococcus pneumoniae 51 Ab [Units/volume] in Serum --1st specimen |
| 13148-2 | Streptococcus pneumoniae 51 Ab [Units/volume] in Serum --2nd specimen |
| 13149-0 | Streptococcus pneumoniae 8 Ab [Units/volume] in Serum --1st specimen |
| 1315-1 | S Ab [Presence] in Serum or Plasma from Blood product unit |
| 13150-8 | Streptococcus pneumoniae 8 Ab [Units/volume] in Serum --2nd specimen |
| 13151-6 | Streptococcus pneumoniae 9 Ab [Units/volume] in Serum --1st specimen |
| 13152-4 | Streptococcus pneumoniae 9 Ab [Units/volume] in Serum --2nd specimen |
| 13153-2 | Streptococcus pneumoniae 12 Ab [Units/volume] in Serum --1st specimen |
| 13154-0 | Streptococcus pneumoniae 12 Ab [Ratio] in Serum --2nd specimen/1st specimen |
| 13155-7 | Streptococcus pneumoniae 14 Ab [Units/volume] in Serum --1st specimen |
| 13156-5 | Streptococcus pneumoniae 14 Ab [Ratio] in Serum --2nd specimen/1st specimen |
| 13157-3 | Streptococcus pneumoniae 56 Ab [Units/volume] in Serum --1st specimen |
| 13158-1 | Streptococcus pneumoniae 56 Ab [Units/volume] in Serum --2nd specimen |
| 13159-9 | Streptococcus pneumoniae 19 Ab [Units/volume] in Serum --1st specimen |
| 1316-9 | S Ab [Presence] in Serum or Plasma from donor |
| 13160-7 | Streptococcus pneumoniae 19 Ab [Units/volume] in Serum --2nd specimen |
| 13161-5 | Streptococcus pneumoniae 23 Ab [Units/volume] in Serum --1st specimen |
| 13162-3 | Streptococcus pneumoniae 23 Ab [Units/volume] in Serum --2nd specimen |
| 13163-1 | Deprecated Streptococcus pneumoniae 12 Ab [Units/volume] in Serum |
| 13164-9 | Human antimouse Ab [Units/volume] in Serum |
| 13165-6 | Deprecated Streptococcus pneumoniae 19 Ab [Units/volume] in Serum |
| 13166-4 | Deprecated Streptococcus pneumoniae 23 Ab [Units/volume] in Serum |
| 13167-2 | Streptococcus pneumoniae 51 Ab [Units/volume] in Serum |
| 13168-0 | Streptococcus pneumoniae 6+26 Ab [Units/volume] in Serum |
| 13169-8 | Immunoelectrophoresis for Serum or Plasma |
| 1317-7 | S Ab [Presence] in Serum or Plasma |
| 13170-6 | Immune complex [Units/volume] in Serum or Plasma by Conglutinin assay |
| 13171-4 | Immune complex [Units/volume] in Serum or Plasma by Polyethylene glycol (PEG) assay |
| 13172-2 | Complement C1q Ag [Units/volume] in Serum or Plasma by Raji cell assay |
| 13173-0 | Fibronectin aggregate IgA Ab [Units/volume] in Serum |
| 13174-8 | Immunofixation for Cerebral spinal fluid |
| 13175-5 | Liver cytosol Ab [Presence] in Serum |
| 13176-3 | Wasp venom IgE Ab [Units/volume] in Serum |
| 13177-1 | Russian olive IgE Ab [Units/volume] in Serum |
| 13178-9 | Wasp venom IgG Ab [Units/volume] in Serum |
| 13179-7 | English Walnut IgG Ab [Units/volume] in Serum |
| 1318-5 | S Ag [Presence] on Red Blood Cells from Blood product unit |
| 13180-5 | Formaldehyde IgG Ab [Units/volume] in Serum |
| 13181-3 | Bahia grass IgG Ab [Units/volume] in Serum |
| 13182-1 | Mesquite IgG Ab [Units/volume] in Serum |
| 13183-9 | White Elm IgG Ab [Units/volume] in Serum |
| 13184-7 | Cottonwood IgG Ab [Units/volume] in Serum |
| 13185-4 | Nettle IgG Ab [Units/volume] in Serum |
| 13186-2 | Yellow Dock IgG Ab [Units/volume] in Serum |
| 13187-0 | False ragweed IgG Ab [Units/volume] in Serum |
| 13188-8 | Mugwort IgG Ab [Units/volume] in Serum |
| 13189-6 | English plantain IgG Ab [Units/volume] in Serum |
| 1319-3 | S Ag [Presence] on Red Blood Cells from donor |
| 13190-4 | Formaldehyde IgM Ab [Units/volume] in Serum or Plasma |
| 13191-2 | Deprecated Rheumatoid factor [Units/volume] in Serum |
| 13192-0 | Adenovirus Ab [Units/volume] in Cerebral spinal fluid |
| 13193-8 | Aspergillus flavus Ab [Units/volume] in Cerebral spinal fluid |
| 13194-6 | Aspergillus glaucus Ab [Units/volume] in Serum |
| 13195-3 | Ehrlichia chaffeensis Ab [Units/volume] in Serum |
| 13196-1 | Ehrlichia sp IgG Ab [Presence] in Serum |
| 13197-9 | Ehrlichia sp IgM Ab [Presence] in Serum |
| 13198-7 | Thermoactinomyces Ab [Units/volume] in Serum |
| 13199-5 | Rickettsia conorii IgG Ab [Units/volume] in Serum |
| 132-1 | Ceftazidime [Susceptibility] by Minimum lethal concentration (MLC) |
| 1320-1 | S Ag [Presence] on Red Blood Cells |
| 13200-1 | Rickettsia conorii IgM Ab [Units/volume] in Serum |
| 13201-9 | Blastomyces dermatitidis Ab [Units/volume] in Cerebral spinal fluid |
| 13202-7 | Borrelia burgdorferi IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot (IB) |
| 13203-5 | Borrelia burgdorferi IgM Ab [Presence] in Cerebral spinal fluid by Immunoblot (IB) |
| 13204-3 | Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence |
| 13205-0 | Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence |
| 13206-8 | Borrelia burgdorferi IgG Ab [Presence] in Synovial fluid by Immunoblot (IB) |
| 13207-6 | Borrelia burgdorferi IgM Ab [Presence] in Synovial fluid by Immunoblot (IB) |
| 13208-4 | Borrelia hermsii IgG Ab [Units/volume] in Serum |
| 13209-2 | Borrelia hermsii IgM Ab [Units/volume] in Serum |
| 1321-9 | Transfusion duration |
| 13210-0 | Brucella sp IgG Ab [Units/volume] in Serum |
| 13211-8 | Brucella sp IgA Ab [Units/volume] in Serum |
| 13212-6 | Brucella abortus IgG Ab [Units/volume] in Cerebral spinal fluid |
| 13213-4 | Brucella abortus IgM Ab [Units/volume] in Cerebral spinal fluid |
| 13214-2 | Brucella canis IgG Ab [Units/volume] in Cerebral spinal fluid |
| 13215-9 | Brucella canis IgM Ab [Units/volume] in Cerebral spinal fluid |
| 13216-7 | Candida albicans immune complex [Units/volume] in Serum or Plasma |
| 13217-5 | Chlamydia trachomatis B Ab [Units/volume] in Serum |
| 13218-3 | Chlamydia trachomatis C Ab [Units/volume] in Serum |
| 13219-1 | Chlamydia trachomatis G+F+K Ab [Units/volume] in Serum |
| 1322-7 | Transfusion volume |
| 13220-9 | Chlamydia trachomatis C IgM Ab [Units/volume] in Serum |
| 13221-7 | Chlamydia trachomatis G+F+K IgM Ab [Units/volume] in Serum |
| 13222-5 | Deprecated Chlamydia trachomatis C Ab [Units/volume] in Serum |
| 13223-3 | Deprecated Chlamydia trachomatis B Ab [Units/volume] in Serum |
| 13224-1 | Deprecated Chlamydia trachomatis G+F+K Ab [Units/volume] in Serum |
| 13225-8 | Cytomegalovirus IgG Ab [Units/volume] in Serum --1st specimen |
| 13226-6 | Cytomegalovirus IgM Ab [Units/volume] in Cerebral spinal fluid |
| 13227-4 | Corynebacterium diphtheriae IgG Ab [Units/volume] in Serum |
| 13228-2 | Eastern equine encephalitis virus IgG Ab [Units/volume] in Cerebral spinal fluid |
| 13229-0 | Eastern equine encephalitis virus IgM Ab [Units/volume] in Cerebral spinal fluid |
| 1323-5 | U Ab [Presence] in Serum or Plasma from Blood product unit |
| 13230-8 | Saint Louis encephalitis virus IgG Ab [Units/volume] in Cerebral spinal fluid |
| 13231-6 | Saint Louis encephalitis virus IgM Ab [Units/volume] in Cerebral spinal fluid |
| 13232-4 | Coxsackievirus A Ab [Units/volume] in Cerebral spinal fluid |
| 13233-2 | Coxsackievirus A2 Ab [Units/volume] in Cerebral spinal fluid |
| 13234-0 | Coxsackievirus A4 Ab [Units/volume] in Cerebral spinal fluid |
| 13235-7 | Coxsackievirus A16 Ab [Units/volume] in Cerebral spinal fluid |
| 13236-5 | Epstein Barr virus early diffuse Ab [Presence] in Serum by Immunofluorescence |
| 13237-3 | Epstein Barr virus early restricted Ab [Presence] in Serum by Immunofluorescence |
| 13238-1 | Epstein Barr virus Ab [Units/volume] in Serum |
| 13239-9 | Deprecated Epstein Barr virus nuclear IgG Ab [Presence] in Serum |
| 1324-3 | U Ab [Presence] in Serum or Plasma from donor |
| 13240-7 | Phoma herbarum IgE Ab [Units/volume] in Serum |
| 13241-5 | Sporothrix schenckii IgG Ab [Units/volume] in Serum |
| 13242-3 | Sporothrix schenckii IgM Ab [Units/volume] in Serum |
| 13243-1 | Sporothrix schenckii IgA Ab [Units/volume] in Serum |
| 13244-9 | Filaria IgG Ab [Units/volume] in Serum |
| 13245-6 | Filaria IgM Ab [Units/volume] in Serum |
| 13246-4 | Haemophilus influenzae B Ab [Units/volume] in Serum |
| 13247-2 | HTLV I+II Ab [Units/volume] in Cerebral spinal fluid |
| 13248-0 | Hepatitis D virus Ab [Presence] in Serum |
| 13249-8 | Herpes simplex virus 1+2 IgG Ab [Units/volume] in Cerebral spinal fluid |
| 1325-0 | U Ab [Presence] in Serum or Plasma |
| 13250-6 | Herpes virus 6 IgG+IgM Ab [Units/volume] in Serum |
| 13251-4 | Herpes simplex virus 1 IgM Ab [Units/volume] in Cerebral spinal fluid |
| 13252-2 | Herpes simplex virus 2 IgM Ab [Units/volume] in Cerebral spinal fluid |
| 13253-0 | Legionella non-pneumophila Ab [Presence] in Serum |
| 13254-8 | Legionella pneumophila atypical Ab [Presence] in Serum |
| 13255-5 | Legionella longbeachae 1+2 Ab [Presence] in Serum |
| 13256-3 | Leishmania donovani IgG Ab [Units/volume] in Serum |
| 13257-1 | Leishmania donovani IgM Ab [Units/volume] in Serum |
| 13258-9 | Leishmania brasilensis IgG Ab [Units/volume] in Serum |
| 13259-7 | Leishmania brasilensis IgM Ab [Units/volume] in Serum |
| 1326-8 | U Ag [Presence] on Red Blood Cells from Blood product unit |
| 13260-5 | Leishmania mexicana IgG Ab [Units/volume] in Serum |
| 13261-3 | Leishmania mexicana IgM Ab [Units/volume] in Serum |
| 13262-1 | Leishmania tropica IgG Ab [Units/volume] in Serum |
| 13263-9 | Leishmania tropica IgM Ab [Units/volume] in Serum |
| 13264-7 | Leptospira sp IgG Ab [Titer] in Serum |
| 13265-4 | Leptospira sp IgM Ab [Titer] in Serum |
| 13266-2 | Mumps virus IgG Ab [Units/volume] in Cerebral spinal fluid |
| 13267-0 | Mumps virus IgM Ab [Units/volume] in Cerebral spinal fluid |
| 13268-8 | Mycoplasma pneumoniae Ab [Units/volume] in Serum --1st specimen |
| 13269-6 | Mycoplasma pneumoniae Ab [Units/volume] in Serum --2nd specimen |
| 1327-6 | U Ag [Presence] on Red Blood Cells from donor |
| 13270-4 | Mycoplasma pneumoniae IgA Ab [Units/volume] in Serum |
| 13271-2 | Neisseria meningitidis A Ab [Units/volume] in Serum |
| 13272-0 | Neisseria meningitidis C Ab [Units/volume] in Serum |
| 13273-8 | Sporothrix schenckii Ab [Presence] in Serum |
| 13274-6 | Toxocara canis Ab [Units/volume] in Cerebral spinal fluid |
| 13275-3 | Toxocara canis IgM Ab [Units/volume] in Serum |
| 13276-1 | Toxocara canis IgA Ab [Units/volume] in Serum |
| 13277-9 | Schistosoma sp IgG Ab [Units/volume] in Serum |
| 13278-7 | Schistosoma sp IgM Ab [Units/volume] in Serum |
| 13279-5 | Rubella virus IgG Ab [Units/volume] in Serum --1st specimen |
| 1328-4 | U Ag [Presence] on Red Blood Cells |
| 13280-3 | Rubella virus IgG Ab [Units/volume] in Serum --2nd specimen |
| 13281-1 | Rubella virus IgG Ab [Units/volume] in Cerebral spinal fluid |
| 13282-9 | Rubella virus IgM Ab [Units/volume] in Cerebral spinal fluid |
| 13283-7 | Measles virus IgM Ab [Units/volume] in Cerebral spinal fluid |
| 13284-5 | Salmonella typhi H D Ab [Presence] in Serum |
| 13285-2 | Salmonella typhi O D Ab [Presence] in Serum |
| 13286-0 | Toxoplasma gondii IgG Ab [Units/volume] in Serum --2nd specimen |
| 13287-8 | Toxoplasma gondii Ab [Units/volume] in Cerebral spinal fluid |
| 13288-6 | Treponema pallidum Ab [Units/volume] in Blood by Immunofluorescence |
| 13289-4 | Hantavirus hantaan Ab [Units/volume] in Serum |
| 1329-2 | V Ab [Presence] in Serum or Plasma from Blood product unit |
| 13290-2 | Trypanosoma cruzi IgM Ab [Units/volume] in Serum |
| 13291-0 | Trypanosoma cruzi IgG Ab [Units/volume] in Serum |
| 13292-8 | Colorado tick fever virus IgG Ab [Units/volume] in Serum |
| 13293-6 | Colorado tick fever virus IgM Ab [Units/volume] in Serum |
| 13294-4 | Hepatitis E virus Ab [Presence] in Serum |
| 13295-1 | Coxsackievirus A10 Ab [Units/volume] in Cerebral spinal fluid |
| 13296-9 | Deprecated Coxsackievirus A10 Ab [Units/volume] in Serum |
| 13297-7 | Coxsackievirus A1 Ab [Units/volume] in Serum |
| 13298-5 | HLA-A [Type] |
| 13299-3 | HLA-B [Type] |
| 133-9 | Ceftazidime [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 1330-0 | V Ab [Presence] in Serum or Plasma from donor |
| 13300-9 | HLA-A+B [Type] |
| 13301-7 | HLA-A+B+Bw [Type] |
| 13302-5 | HLA-C [Type] |
| 13303-3 | HLA-A+B+C (class I) [Type] |
| 13304-1 | HLA-DR [Type] |
| 13305-8 | HLA-DQ [Type] |
| 13306-6 | HLA-DR beta [Type] |
| 13307-4 | HLA-DQ alpha [Type] |
| 13308-2 | Deprecated DNA |
| 13309-0 | Duffy group Ag [Type] on Red Blood Cells |
| 1331-8 | V Ab [Presence] in Serum or Plasma |
| 13310-8 | Kell group Ag [Type] on Red Blood Cells |
| 13311-6 | MNS group Ag [Type] on Red Blood Cells |
| 13312-4 | IgA IgG Ab [Units/volume] in Serum or Plasma |
| 13313-2 | IgM IgM Ab [Units/volume] in Serum or Plasma |
| 13314-0 | Bacteria identified in Semen |
| 13315-7 | Bacteria identified in 24 hour Urine by Culture |
| 13316-5 | Vancomycin resistant enterococcus [Presence] in Unspecified specimen by Organism specific culture |
| 13317-3 | Methicillin resistant Staphylococcus aureus [Presence] in Unspecified specimen by Organism specific culture |
| 13318-1 | Escherichia coli enteroinvasive identified in Stool by Organism specific culture |
| 13319-9 | Ova and parasites identified in Stool by Light microscopy--2nd specimen |
| 1332-6 | V Ag [Presence] on Red Blood Cells from Blood product unit |
| 13320-7 | Ova and parasites identified in Stool by Light microscopy--3rd specimen |
| 13321-5 | Human papilloma virus IgG Ab [Presence] in Serum |
| 13322-3 | Human papilloma virus IgM Ab [Presence] in Serum |
| 13323-1 | Herpes simplex virus 2 Ab [Units/volume] in Serum by Immunofluorescence |
| 13324-9 | Herpes simplex virus 1 Ab [Units/volume] in Serum by Immunofluorescence |
| 13325-6 | Bartonella sp identified in Blood by Light microscopy |
| 13326-4 | Pneumocystis sp identified in Unspecified specimen by Light microscopy |
| 13327-2 | Parainfluenza virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
| 13328-0 | Measles virus Ag [Presence] in Serum or Plasma by Immunofluorescence |
| 13329-8 | Escherichia coli labile toxin [Presence] in Unspecified specimen |
| 1333-4 | V Ag [Presence] on Red Blood Cells from donor |
| 13330-6 | Barr bodies [Presence] in Cervix by Light microscopy |
| 13331-4 | CD2+CD26+ cells/100 cells in Blood |
| 13332-2 | CD4+CD25+ cells/100 cells in Blood |
| 13333-0 | CD3+CD25+ cells/100 cells in Blood |
| 13334-8 | CD8+CD25+ cells/100 cells in Blood |
| 13335-5 | CD4+CD29+ cells/100 cells in Blood |
| 13336-3 | CD4+CD45RA+ cells/100 cells in Blood |
| 13337-1 | CD8+HLA-DR+ cells/100 cells in Blood |
| 13338-9 | CD8+CD57+ cells/100 cells in Blood |
| 13339-7 | CD8+CD56+ cells/100 cells in Blood |
| 1334-2 | V Ag [Presence] on Red Blood Cells |
| 13340-5 | CD3+CD38+ cells/100 cells in Blood |
| 13341-3 | CD3+CD25+ cells/100 cells in Tissue |
| 13342-1 | CD3+CD26+ cells/100 cells in Blood |
| 13343-9 | CD4+HLA-DR+ cells/100 cells in Blood |
| 13344-7 | CD8+CD38+ cells/100 cells in Blood |
| 13345-4 | CD8+CD11b+ cells/100 cells in Blood |
| 13346-2 | CD35 cells/100 cells in Blood |
| 13347-0 | RNA polymerase I+II+III Ab [Presence] in Serum |
| 13348-8 | Monoclonal band observed [Identifier] in Serum or Plasma |
| 13349-6 | Leukocytes [#/volume] in Stool by Manual count |
| 1335-9 | Whole blood given [Volume] |
| 13350-4 | Deprecated Eosinophils/100 leukocytes in Cerebral spinal fluid by Manual count |
| 13351-2 | Leukocytes other [#/volume] in Cerebral spinal fluid by Manual count |
| 13352-0 | Deprecated Neutrophils/100 leukocytes in Body fluid by Manual count |
| 13353-8 | Deprecated Eosinophils/100 leukocytes in Body fluid by Manual count |
| 13354-6 | Band form neutrophils/100 leukocytes in Body fluid by Manual count |
| 13355-3 | Unspecified cells/100 leukocytes in Body fluid by Manual count |
| 13356-1 | Fat [Presence] in Body fluid |
| 13357-9 | Synovial cells [Units/volume] in Body fluid |
| 13358-7 | Collection time of Semen |
| 13359-5 | Character of Semen |
| 1336-7 | Xg sup(a) Ab [Presence] in Serum or Plasma from Blood product unit |
| 13360-3 | Deprecated Color of Semen - impression |
| 13361-1 | Semen analysis panel |
| 13362-9 | Collection duration of Urine |
| 13363-7 | Collection duration of Stool |
| 13364-5 | Amino beta guanidinopropionate [Mass/volume] in Plasma |
| 13365-2 | Amino beta guanidinopropionate [Mass/volume] in Cerebral spinal fluid |
| 13366-0 | Alpha aminoadipate [Mass/volume] in Cerebral spinal fluid |
| 13367-8 | Beta aminoisobutyrate [Mass/volume] in Cerebral spinal fluid |
| 13368-6 | Beta alanine [Mass/volume] in Cerebral spinal fluid |
| 13369-4 | Carnosine [Mass/volume] in Cerebral spinal fluid |
| 1337-5 | Xg sup(a) Ab [Presence] in Serum or Plasma from donor |
| 13370-2 | Cystathionine [Mass/volume] in Cerebral spinal fluid |
| 13371-0 | Cystine [Mass/volume] in Cerebral spinal fluid |
| 13372-8 | Homocystine [Mass/volume] in Cerebral spinal fluid |
| 13373-6 | Hydroxylysine [Mass/volume] in Cerebral spinal fluid |
| 13374-4 | Hydroxyproline [Mass/volume] in Cerebral spinal fluid |
| 13375-1 | Lysine [Mass/volume] in Cerebral spinal fluid |
| 13376-9 | Methionine [Mass/volume] in Cerebral spinal fluid |
| 13377-7 | 1-Methylhistidine [Mass/volume] in Cerebral spinal fluid |
| 13378-5 | 3-Methylhistidine [Mass/volume] in Cerebral spinal fluid |
| 13379-3 | Ornithine [Mass/volume] in Cerebral spinal fluid |
| 1338-3 | Xg sup(a) Ab [Presence] in Serum or Plasma |
| 13380-1 | Sarcosine [Mass/volume] in Cerebral spinal fluid |
| 13381-9 | Tyrosine [Mass/volume] in Cerebral spinal fluid |
| 13382-7 | Amino beta guanidinopropionate [Mass/volume] in Amniotic fluid |
| 13383-5 | Alpha aminobutyrate [Mass/volume] in Amniotic fluid |
| 13384-3 | Alpha aminoadipate [Mass/volume] in Amniotic fluid |
| 13385-0 | Beta aminoisobutyrate [Mass/volume] in Amniotic fluid |
| 13386-8 | Anserine [Mass/volume] in Amniotic fluid |
| 13387-6 | Arginine [Mass/volume] in Amniotic fluid |
| 13388-4 | Asparagine [Mass/volume] in Amniotic fluid |
| 13389-2 | Aspartate [Mass/volume] in Amniotic fluid |
| 1339-1 | Xg sup(a) Ag [Presence] on Red Blood Cells from Blood product unit |
| 13390-0 | Beta alanine [Mass/volume] in Amniotic fluid |
| 13391-8 | Carnosine [Mass/volume] in Amniotic fluid |
| 13392-6 | Citrulline [Mass/volume] in Amniotic fluid |
| 13393-4 | Cystathionine [Mass/volume] in Amniotic fluid |
| 13394-2 | Cystine [Mass/volume] in Amniotic fluid |
| 13395-9 | Glutamate [Mass/volume] in Amniotic fluid |
| 13396-7 | Glutamine [Mass/volume] in Amniotic fluid |
| 13397-5 | Glycine [Mass/volume] in Amniotic fluid |
| 13398-3 | Histidine [Mass/volume] in Amniotic fluid |
| 13399-1 | Homocystine [Mass/volume] in Amniotic fluid |
| 134-7 | Ceftazidime [Susceptibility] by Disk diffusion (KB) |
| 1340-9 | Xg sup(a) Ag [Presence] on Red Blood Cells from donor |
| 13400-7 | Hydroxylysine [Mass/volume] in Amniotic fluid |
| 13401-5 | Hydroxyproline [Mass/volume] in Amniotic fluid |
| 13402-3 | Isoleucine [Mass/volume] in Amniotic fluid |
| 13403-1 | Leucine [Mass/volume] in Amniotic fluid |
| 13404-9 | Lysine [Mass/volume] in Amniotic fluid |
| 13405-6 | Methionine [Mass/volume] in Amniotic fluid |
| 13406-4 | 1-Methylhistidine [Mass/volume] in Amniotic fluid |
| 13407-2 | 3-Methylhistidine [Mass/volume] in Amniotic fluid |
| 13408-0 | Ornithine [Mass/volume] in Amniotic fluid |
| 13409-8 | Phenylalanine [Mass/volume] in Amniotic fluid |
| 1341-7 | Xg sup(a) Ag [Presence] on Red Blood Cells |
| 13410-6 | Phosphoethanolamine [Mass/volume] in Amniotic fluid |
| 13411-4 | Phosphoserine [Mass/volume] in Amniotic fluid |
| 13412-2 | Proline [Mass/volume] in Amniotic fluid |
| 13413-0 | Sarcosine [Mass/volume] in Amniotic fluid |
| 13414-8 | Serine [Mass/volume] in Amniotic fluid |
| 13415-5 | Taurine [Mass/volume] in Amniotic fluid |
| 13416-3 | Threonine [Mass/volume] in Amniotic fluid |
| 13417-1 | Tyrosine [Mass/volume] in Amniotic fluid |
| 13418-9 | Tryptophan [Mass/volume] in Amniotic fluid |
| 13419-7 | Valine [Mass/volume] in Amniotic fluid |
| 1342-5 | Yt sup(a) Ab [Presence] in Serum or Plasma from Blood product unit |
| 13420-5 | Epinephrine [Mass/volume] in Plasma --2nd specimen post XXX challenge |
| 13421-3 | Epinephrine [Mass/volume] in Plasma --3rd specimen post XXX challenge |
| 13422-1 | Epinephrine [Mass/volume] in Plasma --4th specimen post XXX challenge |
| 13423-9 | Epinephrine [Mass/volume] in Plasma --5th specimen post XXX challenge |
| 13424-7 | Epinephrine [Mass/volume] in Plasma --6th specimen post XXX challenge |
| 13425-4 | Epinephrine [Mass/volume] in Plasma --7th specimen post XXX challenge |
| 13426-2 | Norepinephrine [Mass/volume] in Plasma --2nd specimen post XXX challenge |
| 13427-0 | Norepinephrine [Mass/volume] in Plasma --3rd specimen post XXX challenge |
| 13428-8 | Norepinephrine [Mass/volume] in Plasma --4th specimen post XXX challenge |
| 13429-6 | Norepinephrine [Mass/volume] in Plasma --5th specimen post XXX challenge |
| 1343-3 | Yt sup(a) Ab [Presence] in Serum or Plasma from donor |
| 13430-4 | Norepinephrine [Mass/volume] in Plasma --6th specimen post XXX challenge |
| 13431-2 | Norepinephrine [Mass/volume] in Plasma --7th specimen post XXX challenge |
| 13432-0 | Dopamine [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
| 13433-8 | Dopamine [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
| 13434-6 | Dopamine [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
| 13435-3 | Dopamine [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
| 13436-1 | Dopamine [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
| 13437-9 | Dopamine [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
| 13438-7 | Protein Fractions [Interpretation] in Urine by Electrophoresis |
| 13439-5 | Protein Fractions [Interpretation] in Cerebral spinal fluid by Electrophoresis |
| 1344-1 | Yt sup(a) Ab [Presence] in Serum or Plasma |
| 13440-3 | Immunofixation for Urine |
| 13441-1 | Creatinine renal clearance in 4 hour |
| 13442-9 | Creatinine renal clearance in 6 hour |
| 13443-7 | Creatinine renal clearance in 8 hour |
| 13444-5 | Calcium/Albumin [Mass Ratio] in Serum or Plasma |
| 13445-2 | Deprecated Creatinine renal clearance/1.73 sq M in 24 hour |
| 13446-0 | Creatinine renal clearance/1.73 sq M in 4 hour |
| 13447-8 | Creatinine renal clearance/1.73 sq M in 6 hour |
| 13448-6 | Calcium/Osmolality [Mass Ratio] in Serum or Plasma |
| 13449-4 | Creatinine renal clearance/1.73 sq M in 8 hour |
| 1345-8 | Yt sup(a) Ag [Presence] on Red Blood Cells from Blood product unit |
| 13450-2 | Creatinine renal clearance/1.73 sq M in 12 hour |
| 13451-0 | Creatinine dialysis fluid clearance |
| 13452-8 | Iron/Transferrin [Mass Ratio] in Serum or Plasma |
| 13453-6 | Deprecated Glucose mean value |
| 13454-4 | Calcium-phosphorus product [(Moles/volume)*2] in Serum or Plasma |
| 13455-1 | Lithium.plasma/Lithium.RBC [Mass Ratio] in Blood |
| 13456-9 | IgG synthesis rate [Units/volume] in Serum and CSF |
| 13457-7 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation |
| 13458-5 | Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation |
| 13459-3 | Cholesterol in LDL/Cholesterol.total [Mass Ratio] in Serum or Plasma |
| 1346-6 | Yt sup(a) Ag [Presence] on Red Blood Cells from donor |
| 13460-1 | Deprecated Cholesterol.in LDL/Cholesterol.in HDL [Mass ratio] in Serum or Plasma |
| 13461-9 | Monoacetyldapsone/Dapsone [Mass Ratio] in Serum or Plasma |
| 13462-7 | Apolipoprotein A-I/Apolipoprotein B [Mass Ratio] in Serum or Plasma |
| 13463-5 | Arsenic/Creatinine [Mass Ratio] in Urine |
| 13464-3 | Chromium/Creatinine [Mass Ratio] in Urine |
| 13465-0 | Mercury/Creatinine [Mass Ratio] in Urine |
| 13466-8 | Lead/Creatinine [Mass Ratio] in Urine |
| 13467-6 | Selenium/Creatinine [Mass Ratio] in Urine |
| 13468-4 | Cobalt/Creatinine [Mass Ratio] in Urine |
| 13469-2 | Thallium/Creatinine [Mass Ratio] in Urine |
| 1347-4 | Yt sup(a) Ag [Presence] on Red Blood Cells |
| 13470-0 | Aluminum/Creatinine [Mass Ratio] in Urine |
| 13471-8 | Cadmium/Creatinine [Mass Ratio] in Urine |
| 13472-6 | Nickel/Creatinine [Mass Ratio] in Urine |
| 13473-4 | Zinc/Creatinine [Mass Ratio] in Urine |
| 13474-2 | Magnesium/Creatinine [Mass Ratio] in Urine |
| 13475-9 | Fluoride/Creatinine [Mass Ratio] in Urine |
| 13476-7 | Silver/Creatinine [Mass Ratio] in Urine |
| 13477-5 | Orthocresol/Creatinine [Mass Ratio] in Urine |
| 13478-3 | Tetrahydrocannabinol/Creatinine [Mass Ratio] in Urine |
| 13479-1 | Benzoylecgonine/Creatinine [Mass Ratio] in Urine |
| 1348-2 | Yt sup(b) Ab [Presence] in Serum or Plasma from Blood product unit |
| 13480-9 | 18-Hydroxydeoxycortisol/Creatinine [Mass Ratio] in Urine |
| 13481-7 | Gonadotropin peptide/Creatinine [Mass Ratio] in Urine |
| 13482-5 | Aldosterone/Creatinine [Mass Ratio] in Urine |
| 13483-3 | Oxalate/Creatinine [Mass Ratio] in Urine |
| 13484-1 | Creatine/Creatinine [Mass Ratio] in Urine |
| 13485-8 | Beta-2-Microglobulin/Creatinine [Mass Ratio] in Urine |
| 13486-6 | Testosterone/Creatinine [Mass Ratio] in Urine |
| 13487-4 | Phenol/Creatinine [Mass Ratio] in Urine |
| 13488-2 | aPTT in control Platelet poor plasma by Coagulation assay |
| 13489-0 | Follitropin/Creatinine [Mass Ratio] in Urine |
| 1349-0 | Yt sup(b) Ab [Presence] in Serum or Plasma from donor |
| 13490-8 | Lutropin/Creatinine [Mass Ratio] in Urine |
| 13491-6 | Deprecated CD4+CD25+ cells/100 cells in Blood |
| 13492-4 | Deprecated CD4+HLA-DR+ cells/100 cells in Blood |
| 13493-2 | Deprecated CD8+CD25+ cells/100 cells in Blood |
| 13494-0 | Volume of 4 hour Dialysis fluid |
| 13495-7 | Volume of 24 hour Dialysis fluid |
| 13496-5 | Triple phosphate crystals [type] in Stone by Light microscopy |
| 13497-3 | Dextroamphetamine/Levoamphetamine [Mass Ratio] in Urine |
| 13498-1 | Dextromethamphetamine/Levomethamphetamine [Mass Ratio] in Urine |
| 13499-9 | HIV 1 Ab band pattern [Interpretation] in Serum by Immunoblot (IB) |
| 135-4 | Ceftazidime [Susceptibility] by Serum bactericidal titer |
| 1350-8 | Yt sup(b) Ab [Presence] in Serum or Plasma |
| 13500-4 | Amino acid pattern [Interpretation] in Serum or Plasma |
| 13501-2 | Herpes simplex virus 2 Ab pattern [Interpretation] in Serum |
| 13502-0 | Borrelia burgdorferi Ab.IgG band pattern [Interpretation] in Serum by Immunoblot (IB) |
| 13503-8 | Borrelia burgdorferi Ab.IgM band pattern [Interpretation] in Serum by Immunoblot (IB) |
| 13504-6 | Deprecated Borrelia burgdorferi Ab [interpretation] in Serum |
| 13505-3 | Herpes simplex virus 1+2 Ab pattern [Interpretation] in Serum |
| 13506-1 | Urea nitrogen renal clearance |
| 13507-9 | Lupus erythematosus cells [Presence] in Blood |
| 13508-7 | Hematocrit [Volume Fraction] of Cerebral spinal fluid by Centrifugation |
| 13509-5 | Microscopic observation [Identifier] in Blood by Crystal violet stain |
| 1351-6 | Yt sup(b) Ag [Presence] on Red Blood Cells from Blood product unit |
| 13510-3 | Microscopic observation [Identifier] in Bone marrow by Myeloperoxidase stain |
| 13511-1 | Cyanide ascorbate screen [Presence] in Blood |
| 13512-9 | Microscopic observation [Identifier] in Bone marrow by Butyrate esterase stain |
| 13513-7 | Iron.microscopic observation [Identifier] in Bone marrow by Potassium ferrocyanide stain |
| 13514-5 | Hemoglobin pattern [Interpretation] in Blood by Electrophoresis Narrative |
| 13515-2 | Hemoglobin pattern [Interpretation] in Blood by Electrophesis citrate agar Narrative |
| 13516-0 | Neutrophils/100 leukocytes in Cerebral spinal fluid by Manual count |
| 13517-8 | Variant lymphocytes/100 leukocytes in Cerebral spinal fluid by Manual count |
| 13518-6 | Variant lymphocytes/100 leukocytes in Body fluid by Manual count |
| 13519-4 | Basophils/100 leukocytes in Cerebral spinal fluid by Manual count |
| 1352-4 | Yt sup(b) Ag [Presence] on Red Blood Cells from donor |
| 13520-2 | Deprecated Basophils/100 leukocytes in Body fluid by Manual count |
| 13521-0 | Blasts/100 leukocytes in Cerebral spinal fluid by Manual count |
| 13522-8 | Blasts/100 leukocytes in Body fluid by Manual count |
| 13523-6 | Leukocytes other/100 leukocytes in Cerebral spinal fluid by Manual count |
| 13524-4 | Leukocytes other/100 leukocytes in Body fluid by Manual count |
| 13525-1 | Nonhematic cells/100 leukocytes in Cerebral spinal fluid by Manual count |
| 13526-9 | Nonhematic cells/100 leukocytes in Body fluid by Manual count |
| 13527-7 | Unidentified cells/100 leukocytes in Cerebral spinal fluid by Manual count |
| 13528-5 | Unidentified cells/100 leukocytes in Body fluid by Manual count |
| 13529-3 | Nucleated erythrocytes [#/volume] in Cerebral spinal fluid by Manual count |
| 1353-2 | Yt sup(b) Ag [Presence] on Red Blood Cells |
| 13530-1 | Nucleated erythrocytes [#/volume] in Body fluid by Manual count |
| 13531-9 | Fat.microscopic observation [Presence] in Sputum by Sudan III stain |
| 13532-7 | Xanthochromia [Presence] of Cerebral spinal fluid Qualitative |
| 13533-5 | Acid hemolysis [Presence] of Blood |
| 13534-3 | Sucrose hemolysis [Presence] of Blood |
| 13535-0 | Sucrose hemolysis of Red Blood Cells |
| 13536-8 | Globulin [Mass/volume] in Plasma |
| 13537-6 | Deprecated Protein [Mass/volume] in Plasma. |
| 13538-4 | Carbon dioxide, total [Moles/volume] in Urine |
| 13539-2 | Phosphate [Moles/volume] in Urine |
| 1354-0 | 11-Deoxycorticosteroids [Mass/volume] in Plasma --9 hours post 3 g metyrapone PO overnight |
| 13540-0 | Carbon dioxide, total [Moles/volume] in Cerebral spinal fluid |
| 13541-8 | Deprecated Carbon dioxide [Molecules/volume] in Body fluid |
| 13542-6 | Phosphate [Mass/volume] in Cerebral spinal fluid |
| 13543-4 | Deprecated Phosphate [Mass/volume] in Body fluid |
| 13544-2 | 4-Hydroxyglutethimide [Presence] in Serum or Plasma |
| 13545-9 | Alprazolam [Presence] in Serum or Plasma |
| 13546-7 | Amikacin [Mass/volume] in Body fluid |
| 13547-5 | Butriptyline [Presence] in Serum or Plasma |
| 13548-3 | Chlorpromazine [Presence] in Serum or Plasma |
| 13549-1 | Clomipramine [Presence] in Serum or Plasma |
| 1355-7 | 11-Deoxycorticosteroids [Mass/volume] in Plasma --pre 3 g metyrapone PO overnight |
| 13550-9 | Clonazepam [Presence] in Serum or Plasma |
| 13551-7 | Clorazepate [Presence] in Serum or Plasma |
| 13552-5 | Clozapine [Presence] in Serum or Plasma |
| 13553-3 | Cocaethylene [Presence] in Serum or Plasma |
| 13554-1 | Cyclobenzaprine [Presence] in Serum or Plasma |
| 13555-8 | D-pseudoephedrine [Presence] in Serum or Plasma |
| 13556-6 | Demoxepam [Presence] in Serum or Plasma |
| 13557-4 | Norsertraline [Presence] in Serum or Plasma |
| 13558-2 | Disopyramide [Presence] in Serum or Plasma |
| 13559-0 | Flecainide [Presence] in Serum or Plasma |
| 1356-5 | 11-Deoxycortisol [Mass/volume] in Serum or Plasma --8 hours post 30 mg/kg metyrapone PO |
| 13560-8 | Fluvoxamine [Presence] in Serum or Plasma |
| 13561-6 | Gentamicin [Mass/volume] in Cerebral spinal fluid |
| 13562-4 | Gentamicin [Mass/volume] in Body fluid |
| 13563-2 | Glutethimide [Presence] in Serum or Plasma |
| 13564-0 | Ibuprofen [Presence] in Serum or Plasma |
| 13565-7 | Lorazepam [Presence] in Serum or Plasma |
| 13566-5 | Mesoridazine [Presence] in Serum or Plasma |
| 13567-3 | Mexiletine [Presence] in Serum or Plasma |
| 13568-1 | N-desalkylflurazepam [Presence] in Serum or Plasma |
| 13569-9 | Norchlordiazepoxide [Presence] in Serum or Plasma |
| 1357-3 | 11-Deoxycortisol [Mass/volume] in Serum or Plasma --post 750 mg metyrapone q4h X 6 |
| 13570-7 | Norclomipramine [Presence] in Serum or Plasma |
| 13571-5 | Norclozapine [Presence] in Serum or Plasma |
| 13572-3 | Nordiazepam [Presence] in Serum or Plasma |
| 13573-1 | Nordoxepin [Presence] in Serum or Plasma |
| 13574-9 | Norfluoxetine [Presence] in Serum or Plasma |
| 13575-6 | Normaprotiline [Presence] in Serum or Plasma |
| 13576-4 | Oxycodone [Presence] in Serum or Plasma |
| 13577-2 | Paroxetine [Presence] in Serum or Plasma |
| 13578-0 | Promazine [Presence] in Serum or Plasma |
| 13579-8 | Sertraline [Presence] in Serum or Plasma |
| 1358-1 | Corticotropin [Mass/volume] in Plasma --1.5 hours post dose insulin IV |
| 13580-6 | Temazepam [Presence] in Serum or Plasma |
| 13581-4 | Theophylline [Mass/volume] in Cerebral spinal fluid |
| 13582-2 | Theophylline [Mass/volume] in Body fluid |
| 13583-0 | Thioridazine [Presence] in Serum or Plasma |
| 13584-8 | Tobramycin [Mass/volume] in Body fluid |
| 13585-5 | Trifluoperazine [Presence] in Serum or Plasma |
| 13586-3 | Vancomycin [Mass/volume] in Cerebral spinal fluid |
| 13587-1 | Vancomycin [Mass/volume] in Body fluid |
| 13588-9 | Venlafaxine [Presence] in Serum or Plasma |
| 13589-7 | Activated protein C resistance [Presence] in Blood by Probe and target amplification method |
| 1359-9 | Corticotropin [Mass/volume] in Plasma --1 hour post 1 ug/kg CRH IV |
| 13590-5 | Activated protein C resistance [Time Ratio] in Platelet poor plasma by Coagulation assay |
| 13591-3 | Factor inhibitor XXX [Units/volume] in Platelet poor plasma by Coagulation assay |
| 13592-1 | Platelet aggregation XXX induced in Platelet rich plasma |
| 13593-9 | Platelet aggregation prostaglandin induced in Platelet rich plasma |
| 13594-7 | Prekallikrein (Fletcher Factor) [Presence] in Platelet poor plasma |
| 13595-4 | Basophils/100 leukocytes in Nose |
| 13596-2 | Histiocytes [Presence] in Nose by Light microscopy |
| 13597-0 | Neutrophils/100 leukocytes in Nose |
| 13598-8 | Deprecated Promyelocytes/100 leukocytes in Blood by Manual count |
| 13599-6 | Promonocytes/100 leukocytes in Blood by Manual count |
| 136-2 | Ceftizoxime [Susceptibility] by Minimum lethal concentration (MLC) |
| 1360-7 | Corticotropin [Mass/volume] in Plasma --1 hour post dose insulin IV |
| 13600-2 | 11-Deoxycortisol [Mass/volume] in Serum or Plasma --15 minutes post 250 ug corticotropin |
| 13601-0 | 11-Deoxycortisol [Mass/volume] in Serum or Plasma --1 hour post 250 ug corticotropin |
| 13602-8 | 11-Deoxycortisol [Mass/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin |
| 13603-6 | 17-Hydroxypregnenolone [Mass/volume] in Serum or Plasma --15 minutes post 250 ug corticotropin |
| 13604-4 | 17-Hydroxypregnenolone [Mass/volume] in Serum or Plasma --1 hour post 250 ug corticotropin |
| 13605-1 | 17-Hydroxypregnenolone [Mass/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin |
| 13606-9 | Glucose [Mass/volume] in Serum or Plasma --3 hours post 50 g lactose PO |
| 13607-7 | Glucose [Mass/volume] in Serum or Plasma --4 hours post 50 g lactose PO |
| 13608-5 | Insulin [Mass/volume] in Serum or Plasma --1.5 hours post 75 g glucose PO |
| 13609-3 | Insulin [Mass/volume] in Serum or Plasma --2.5 hours post 75 g glucose PO |
| 1361-5 | Corticotropin [Mass/volume] in Plasma --1 minute post 1 ug/kg CRH IV |
| 13610-1 | 3-Beta-Androstanediol [Mass/volume] in Serum or Plasma |
| 13611-9 | 6-Beta-Hydroxycortisol [Mass/time] in 24 hour Urine |
| 13612-7 | Dehydroepiandrosterone (DHEA) [Mass/time] in 24 hour Urine |
| 13613-5 | Ethanolamine [Mass/volume] in Cerebral spinal fluid |
| 13614-3 | Etiocholanolone [Mass/volume] in Serum or Plasma |
| 13615-0 | Gamma aminobutyrate [Mass/volume] in Cerebral spinal fluid |
| 13616-8 | Nitrite [Mass/volume] in Water |
| 13617-6 | Deprecated Prostaglandin D2 [Mass/volume] in Serum or Plasma |
| 13618-4 | Tetrahydroaldosterone [Mass/time] in 24 hour Urine |
| 13619-2 | Volume of 2 hour Urine |
| 1362-3 | Corticotropin [Mass/volume] in Plasma --30 minutes post 1 ug/kg CRH IV |
| 13620-0 | Volume of 12 hour Urine |
| 13621-8 | Deprecated Thrombin time in Platelet poor plasma from control by Coagulation assay |
| 13622-6 | Acetaminophen [Mass/volume] in Urine |
| 13623-4 | Dextromethorphan [Mass/volume] in Serum or Plasma |
| 13624-2 | Doxorubicin [Mass/volume] in Serum or Plasma |
| 13625-9 | Methoxsalen [Mass/volume] in Serum or Plasma |
| 13626-7 | Mitotane [Mass/volume] in Serum or Plasma |
| 13627-5 | Erythrocytes [Presence] in Semen by Light microscopy |
| 13628-3 | Deprecated Spermatozoa Motile/100 spermatozoa in Semen |
| 13629-1 | Interleukin 1 beta [Mass/volume] in Serum or Plasma |
| 1363-1 | Corticotropin [Mass/volume] in Plasma --30 minutes post dose insulin IV |
| 13630-9 | Deprecated Immune complex [Units/volume] in Serum or Plasma by Conglutinin assay |
| 13631-7 | Immune complex [Mass/volume] in Serum or Plasma by Polyethylene glycol (PEG) assay |
| 13632-5 | Insulin receptor Ab [Titer] in Serum |
| 13633-3 | Insulin receptor Ab [Presence] in Serum |
| 13634-1 | Rheumatoid factor [Units/volume] in Synovial fluid |
| 13635-8 | Ribosomal Ab [Titer] in Serum |
| 13636-6 | Ribosomal P Ab [Units/volume] in Serum |
| 13637-4 | Trichloroethane [Mass/volume] in Serum or Plasma |
| 13638-2 | Chlordecone [Mass/volume] in Blood |
| 13639-0 | Chlordecone [Mass/volume] in Serum or Plasma |
| 1364-9 | Corticotropin [Mass/volume] in Plasma --45 minutes post 1 ug/kg CRH IV |
| 13640-8 | Vinyl chloride [Mass/volume] in Urine |
| 13641-6 | Codeine [Presence] in Urine by SAMHSA confirm method |
| 13642-4 | Deprecated Ethylene glycol |
| 13643-2 | Lindane [Mass/volume] in Urine |
| 13644-0 | 1,3-Dimethylbenzene [Mass/volume] in Blood |
| 13645-7 | Manganese [Mass/volume] in Water |
| 13646-5 | Methaqualone [Mass/mass] in Hair |
| 13647-3 | Deprecated Methylene chloride [Mass/volume] in Blood |
| 13648-1 | Morphine [Presence] in Urine by SAMHSA confirm method |
| 13649-9 | Nickel [Mass/volume] in Water |
| 1365-6 | Corticotropin [Mass/volume] in Plasma --45 minutes post dose insulin IV |
| 13650-7 | 1,2-Dimethylbenzene [Mass/volume] in Blood |
| 13651-5 | 1,4-Dimethylbenzene [Mass/volume] in Blood |
| 13652-3 | Zinc [Mass/mass] in Hair |
| 13653-1 | Epithelial cells.renal [#/volume] in Urine sediment |
| 13654-9 | Epithelial cells.squamous [#/volume] in Urine sediment |
| 13655-6 | Leukocytes [Presence] in Stool by Light microscopy |
| 13656-4 | Phosphate crystals amorphous [#/volume] in Urine sediment |
| 13657-2 | Urate crystals amorphous [#/volume] in Urine sediment |
| 13658-0 | Urobilinogen [Presence] in Urine |
| 13659-8 | Epidermal growth factor receptor [Mass/mass] in Tissue |
| 1366-4 | Corticotropin [Mass/volume] in Plasma --5 minutes post 1 ug/kg CRH IV |
| 13660-6 | Gonadotropin releasing hormone [Mass/volume] in Serum or Plasma |
| 13661-4 | Ganglioside GD1b IgM Ab [Titer] in Serum |
| 13662-2 | Ganglioside GD1b IgG Ab [Titer] in Serum |
| 13663-0 | Asialoganglioside GM1 IgG Ab [Titer] in Serum |
| 13664-8 | Myelin associated glycoprotein/Sulfated glucuronic paragloboside IgM Ab [Titer] in Serum |
| 13665-5 | 1-Methylhistidine/Creatinine [Mass Ratio] in Urine |
| 13666-3 | Alpha aminoadipate/Creatinine [Mass Ratio] in Urine |
| 13667-1 | Alpha aminobutyrate/Creatinine [Mass Ratio] in Urine |
| 13668-9 | 2-Ethyl-3-Hydroxypropionate/Creatinine [Mass Ratio] in Urine |
| 13669-7 | 2-Hydroxy-3-Methylvalerate/Creatinine [Mass Ratio] in Urine |
| 1367-2 | Corticotropin [Mass/volume] in Plasma --pre 1 ug/kg CRH IV |
| 13670-5 | 2-Hydroxyadipate/Creatinine [Mass Ratio] in Urine |
| 13671-3 | Alpha hydroxybutyrate/Creatinine [Mass Ratio] in Urine |
| 13672-1 | 2-Hydroxyglutarate/Creatinine [Mass Ratio] in Urine |
| 13673-9 | 2-Hydroxyisocaproate/Creatinine [Mass Ratio] in Urine |
| 13674-7 | 2-Hydroxyisovalerate/Creatinine [Mass Ratio] in Urine |
| 13675-4 | 2-methyl-3-hydroxybutyrate (C5-OH)/Creatinine [Mass Ratio] in Urine |
| 13676-2 | 2-Oxo,3-Methylvalerate/Creatinine [Mass Ratio] in Urine |
| 13677-0 | 2-Oxoadipate/Creatinine [Mass Ratio] in Urine |
| 13678-8 | Alpha ketoglutarate/Creatinine [Mass Ratio] in Urine |
| 13679-6 | 2-Oxoisocaproate/Creatinine [Mass Ratio] in Urine |
| 1368-0 | Corticotropin [Mass/volume] in Plasma --pre dose insulin IV |
| 13680-4 | 2-Oxoisovalerate/Creatinine [Mass Ratio] in Urine |
| 13681-2 | Beta aminoisobutyrate/Creatinine [Mass Ratio] in Urine |
| 13682-0 | 3-Hydroxy,3-Methylglutarate/Creatinine [Mass Ratio] in Urine |
| 13683-8 | 3-Hydroxyadipate/Creatinine [Mass Ratio] in Urine |
| 13684-6 | Beta hydroxybutyrate/Creatinine [Mass Ratio] in Urine |
| 13685-3 | 3-Hydroxyglutarate/Creatinine [Mass Ratio] in Urine |
| 13686-1 | 3-Hydroxyisobutyrate/Creatinine [Mass Ratio] in Urine |
| 13687-9 | 3-Hydroxyisovalerate/Creatinine [Mass Ratio] in Urine |
| 13688-7 | 3-Hydroxypropionate (3-OH-C3)/Creatinine [Mass Ratio] in Urine |
| 13689-5 | 3-Hydroxyvalerate/Creatinine [Mass Ratio] in Urine |
| 1369-8 | Ascorbate [Mass/time] in 24 hour Urine --post dose PO |
| 13690-3 | Deprecated Vanillylmandelate/Creatinine [Mass ratio] in Urine |
| 13691-1 | 3-Methylcrotonylglycine/Creatinine [Mass Ratio] in Urine |
| 13692-9 | 3-Methylglutaconate/Creatinine [Mass Ratio] in Urine |
| 13693-7 | 3-Methylglutarate/Creatinine [Mass Ratio] in Urine |
| 13694-5 | 3-Methylhistidine/Creatinine [Mass Ratio] in Urine |
| 13695-2 | Gamma aminobutyrate/Creatinine [Mass Ratio] in Urine |
| 13696-0 | 4-Hydroxyphenylacetate/Creatinine [Mass Ratio] in Urine |
| 13697-8 | 4-Hydroxyphenyllactate/Creatinine [Mass Ratio] in Urine |
| 13698-6 | 4-Hydroxyphenylpyruvate/Creatinine [Mass Ratio] in Urine |
| 13699-4 | 5-Hydroxyhexanoate/Creatinine [Mass Ratio] in Urine |
| 137-0 | Ceftizoxime [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 1370-6 | Carotene [Mass/volume] in Serum --post 15000 U carotene QDx3 for 3 day poly |
| 13700-0 | 5-Oxoproline/Creatinine [Mass Ratio] in Urine |
| 13701-8 | Acetoacetate/Creatinine [Mass Ratio] in Urine |
| 13702-6 | Aconitate/Creatinine [Mass Ratio] in Urine |
| 13703-4 | Adipate/Creatinine [Mass Ratio] in Urine |
| 13704-2 | Alanine/Creatinine [Mass Ratio] in Urine |
| 13705-9 | Albumin/Creatinine [Mass Ratio] in 24 hour Urine |
| 13706-7 | Amylase/Creatinine [Mass Ratio] in Urine |
| 13707-5 | Anserine/Creatinine [Mass Ratio] in Urine |
| 13708-3 | Arginine/Creatinine [Mass Ratio] in Urine |
| 13709-1 | Argininosuccinate/Creatinine [Mass Ratio] in Urine |
| 1371-4 | Bromsulphthalein [Mass/volume] in Serum or Plasma |
| 13710-9 | Asparagine/Creatinine [Mass Ratio] in Urine |
| 13711-7 | Aspartate/Creatinine [Mass Ratio] in Urine |
| 13712-5 | Azelate/Creatinine [Mass Ratio] in Urine |
| 13713-3 | Benzoate/Creatinine [Mass Ratio] in Urine |
| 13714-1 | Beta alanine/Creatinine [Mass Ratio] in Urine |
| 13715-8 | C peptide/Creatinine [Mass Ratio] in 24 hour Urine |
| 13716-6 | C peptide/Creatinine [Mass Ratio] in Urine |
| 13717-4 | Calcium/Creatinine [Mass Ratio] in 24 hour Urine |
| 13718-2 | Carnitine free (C0)/Creatinine [Mass Ratio] in Urine |
| 13719-0 | Carnitine/Creatinine [Mass Ratio] in Urine |
| 1372-2 | Calcitonin [Mass/volume] in Serum or Plasma --90 seconds post 0.5 ug/kg pentagastrin IV |
| 13720-8 | Carnosine/Creatinine [Mass Ratio] in Urine |
| 13721-6 | Chloride/Creatinine [Mass Ratio] in 24 hour Urine |
| 13722-4 | Citrate/Creatinine [Mass Ratio] in Urine |
| 13723-2 | Citrulline/Creatinine [Mass Ratio] in Urine |
| 13724-0 | Cystathionine/Creatinine [Mass Ratio] in Urine |
| 13725-7 | Cystine/Creatinine [Mass Ratio] in Urine |
| 13726-5 | Decadienediate/Creatinine [Mass Ratio] in Urine |
| 13727-3 | Decenedioate/Creatinine [Mass Ratio] in Urine |
| 13728-1 | Delta aminolevulinate/Creatinine [Mass Ratio] in Urine |
| 13729-9 | Deoxypyridinoline/Creatinine [Mass Ratio] in Urine |
| 1373-0 | Calcitonin [Mass/volume] in Serum or Plasma --10 minutes post 2.4 mg/kg calcium short IV |
| 13730-7 | Deoxypyridinoline/Creatinine [Mass Ratio] in 24 hour Urine |
| 13731-5 | Deoxypyridinoline/Creatinine [Mass Ratio] in 2 hour Urine |
| 13732-3 | Dodecanedioate/Creatinine [Mass Ratio] in Urine |
| 13733-1 | Dopamine/Creatinine [Mass Ratio] in Urine |
| 13734-9 | Epinephrine/Creatinine [Mass Ratio] in Urine |
| 13735-6 | Epinephrine+Norepinephrine/Creatinine [Mass Ratio] in Urine |
| 13736-4 | Estradiol (E2)/Creatinine [Mass Ratio] in 24 hour Urine |
| 13737-2 | Estriol (E3)/Creatinine [Mass Ratio] in 24 hour Urine |
| 13738-0 | Estrogen/Creatinine [Mass Ratio] in 24 hour Urine |
| 13739-8 | Estrone (E1)/Creatinine [Mass Ratio] in 24 hour Urine |
| 1374-8 | Calcitonin [Mass/volume] in Serum or Plasma --3 hours post 15 mg/kg calcium gluconate IV |
| 13740-6 | Ethanolamine/Creatinine [Mass Ratio] in Urine |
| 13741-4 | Ethylmalonate/Creatinine [Mass Ratio] in Urine |
| 13742-2 | Formate/Creatinine [Mass Ratio] in Urine |
| 13743-0 | Fumarate/Creatinine [Mass Ratio] in Urine |
| 13744-8 | Galactose/Creatinine [Mass Ratio] in Urine |
| 13745-5 | Glutaconate/Creatinine [Mass Ratio] in Urine |
| 13746-3 | Glutamate/Creatinine [Mass Ratio] in Urine |
| 13747-1 | Glutamine/Creatinine [Mass Ratio] in Urine |
| 13748-9 | Glutarate/Creatinine [Mass Ratio] in Urine |
| 13749-7 | Glycerate/Creatinine [Mass Ratio] in Urine |
| 1375-5 | Calcitonin [Mass/volume] in Serum or Plasma --4 hours post 15 mg/kg calcium gluconate IV |
| 13750-5 | Glycine/Creatinine [Mass Ratio] in Urine |
| 13751-3 | Glycolate/Creatinine [Mass Ratio] in Urine |
| 13752-1 | Glyoxylate/Creatinine [Mass Ratio] in Urine |
| 13753-9 | Hexanoylglycine/Creatinine [Mass Ratio] in Urine |
| 13754-7 | Hippurate/Creatinine [Mass Ratio] in Urine |
| 13755-4 | Histamine/Creatinine [Mass Ratio] in Urine |
| 13756-2 | Histamine/Creatinine [Mass Ratio] in 24 hour Urine |
| 13757-0 | Histidine/Creatinine [Mass Ratio] in Urine |
| 13758-8 | Homocysteine/Creatinine [Mass Ratio] in Urine |
| 13759-6 | Homocystine/Creatinine [Mass Ratio] in Urine |
| 1376-3 | Calcitonin [Mass/volume] in Serum or Plasma --5 minutes post 0.5 ug/kg pentagastrin IV |
| 13760-4 | Homovanillate/Creatinine [Mass Ratio] in 24 hour Urine |
| 13761-2 | Hydroxydecanedioate/Creatinine [Mass Ratio] in Urine |
| 13762-0 | Hydroxylysine/Creatinine [Mass Ratio] in Urine |
| 13763-8 | Hydroxyproline/Creatinine [Mass Ratio] in Urine |
| 13764-6 | Isocitrate/Creatinine [Mass Ratio] in Urine |
| 13765-3 | Isoleucine/Creatinine [Mass Ratio] in Urine |
| 13766-1 | Isovalerylglycine/Creatinine [Mass Ratio] in Urine |
| 13767-9 | Lactate/Creatinine [Mass Ratio] in Urine |
| 13768-7 | Leucine/Creatinine [Mass Ratio] in Urine |
| 13769-5 | Lysine/Creatinine [Mass Ratio] in Urine |
| 1377-1 | Calcitonin [Mass/volume] in Serum or Plasma --5 minutes post 2.4 mg/kg calcium short IV |
| 13770-3 | Malate/Creatinine [Mass Ratio] in Urine |
| 13771-1 | Metanephrines/Creatinine [Mass Ratio] in Urine |
| 13772-9 | Methionine/Creatinine [Mass Ratio] in Urine |
| 13773-7 | 2-Methylcitrate/Creatinine [Mass Ratio] in Urine |
| 13774-5 | Methylhippurate/Creatinine [Mass Ratio] in Urine |
| 13775-2 | Methylmalonate/Creatinine [Mass Ratio] in 24 hour Urine |
| 13776-0 | Methylmalonate/Creatinine [Mass Ratio] in Urine |
| 13777-8 | Methylsuccinate/Creatinine [Mass Ratio] in Urine |
| 13778-6 | Mevalonate/Creatinine [Mass Ratio] in Urine |
| 13779-4 | N-acetyl-L-aspartate/Creatinine [Mass Ratio] in Urine |
| 1378-9 | Calcitonin [Mass/volume] in Serum or Plasma --pre 0.5 ug/kg pentagastrin IV |
| 13780-2 | N-acetyltyrosine/Creatinine [Mass Ratio] in Urine |
| 13781-0 | N-methylhistamine/Creatinine [Mass Ratio] in Urine |
| 13782-8 | Norepinephrine/Creatinine [Mass Ratio] in Urine |
| 13783-6 | Normetanephrine/Creatinine [Mass Ratio] in Urine |
| 13784-4 | Octanoate (C8:0)/Creatinine [Mass Ratio] in Urine |
| 13785-1 | Octenedioate (C8:1)/Creatinine [Mass Ratio] in Urine |
| 13786-9 | Ornithine/Creatinine [Mass Ratio] in Urine |
| 13787-7 | Orotate/Creatinine [Mass Ratio] in Urine |
| 13788-5 | Oxalate/Creatinine [Mass Ratio] in 24 hour Urine |
| 13789-3 | Phosphoethanolamine/Creatinine [Mass Ratio] in Urine |
| 1379-7 | Calcitonin [Mass/volume] in Serum or Plasma --pre 2.4 mg/kg calcium short IV |
| 13790-1 | Para nitrophenol/Creatinine [Mass Ratio] in Urine |
| 13791-9 | Phenylacetate/Creatinine [Mass Ratio] in Urine |
| 13792-7 | Phenyllactate/Creatinine [Mass Ratio] in Urine |
| 13793-5 | Phenylpropionylglycine/Creatinine [Mass Ratio] in Urine |
| 13794-3 | Phenylpyruvate/Creatinine [Mass Ratio] in Urine |
| 13795-0 | Phosphate/Creatinine [Mass Ratio] in 24 hour Urine |
| 13796-8 | Phosphoserine/Creatinine [Mass Ratio] in Urine |
| 13797-6 | Porphobilinogen/Creatinine [Mass Ratio] in Urine |
| 13798-4 | Potassium/Creatinine [Mass Ratio] in 24 hour Urine |
| 13799-2 | Proline/Creatinine [Mass Ratio] in Urine |
| 138-8 | Ceftizoxime [Susceptibility] by Disk diffusion (KB) |
| 1380-5 | Calcium/Phosphate parathyroid-challenge test [Mass Ratio] in Serum |
| 13800-8 | Propionylglycine/Creatinine [Mass Ratio] in Urine |
| 13801-6 | Protein/Creatinine [Mass Ratio] in 24 hour Urine |
| 13802-4 | Pyridinoline/Creatinine [Mass Ratio] in Urine |
| 13803-2 | Pyridinoline/Creatinine [Mass Ratio] in 24 hour Urine |
| 13804-0 | Pyridinoline/Creatinine [Mass Ratio] in 2 hour Urine |
| 13805-7 | Pyruvate/Creatinine [Mass Ratio] in Urine |
| 13806-5 | Sarcosine/Creatinine [Mass Ratio] in Urine |
| 13807-3 | Sebacate (C8)/Creatinine [Mass Ratio] in Urine |
| 13808-1 | Serine/Creatinine [Mass Ratio] in Urine |
| 13809-9 | Sodium/Creatinine [Mass Ratio] in 24 hour Urine |
| 1381-3 | Calcium [Moles/volume] in Serum or Plasma --10 minutes post 2.4 mg/kg calcium short IV |
| 13810-7 | Suberate/Creatinine [Mass Ratio] in Urine |
| 13811-5 | Suberylglycine/Creatinine [Mass Ratio] in Urine |
| 13812-3 | Succinate/Creatinine [Mass Ratio] in Urine |
| 13813-1 | Succinylacetone/Creatinine [Mass Ratio] in Urine |
| 13814-9 | Taurine/Creatinine [Mass Ratio] in Urine |
| 13815-6 | Threonine/Creatinine [Mass Ratio] in Urine |
| 13816-4 | Tiglylglycine/Creatinine [Mass Ratio] in Urine |
| 13817-2 | Tryptophan/Creatinine [Mass Ratio] in Urine |
| 13818-0 | Tyrosine/Creatinine [Mass Ratio] in Urine |
| 13819-8 | Uracil/Creatinine [Mass Ratio] in Urine |
| 1382-1 | Calcium [Moles/volume] in Serum or Plasma --5 minutes post 2.4 mg/kg calcium short IV |
| 13820-6 | Urate/Creatinine [Mass Ratio] in 24 hour Urine |
| 13821-4 | Urea nitrogen/Creatinine [Mass Ratio] in 24 hour Urine |
| 13822-2 | Valine/Creatinine [Mass Ratio] in Urine |
| 13823-0 | Antimony/Creatinine [Mass Ratio] in Urine |
| 13824-8 | Arsenic/Creatinine [Mass Ratio] in 24 hour Urine |
| 13825-5 | Arsenic.inorganic/Creatinine [Mass Ratio] in Urine |
| 13826-3 | Barium/Creatinine [Mass Ratio] in Urine |
| 13827-1 | Beryllium/Creatinine [Mass Ratio] in Urine |
| 13828-9 | Cadmium/Creatinine [Mass Ratio] in 24 hour Urine |
| 13829-7 | Copper/Creatinine [Mass Ratio] in Urine |
| 1383-9 | Calcium [Moles/volume] in Serum or Plasma --pre 2.4 mg/kg calcium short IV |
| 13830-5 | Phenylglyoxylate/Creatinine [Mass Ratio] in Urine |
| 13831-3 | Vanadium/Creatinine [Mass Ratio] in Urine |
| 13832-1 | Dimethylbenzene/Creatinine [Mass Ratio] in Urine |
| 13833-9 | Finch feather IgE Ab [Units/volume] in Serum |
| 13834-7 | Total IgE [Units/volume] in Serum by Radioallergosorbent test (RAST) |
| 13835-4 | Monocytes/100 leukocytes in Peritoneal fluid by Manual count |
| 13836-2 | Neutrophils/100 leukocytes in Peritoneal fluid by Manual count |
| 13837-0 | CD10 blasts/100 blasts in Blood |
| 13838-8 | CD13 blasts/100 blasts in Blood |
| 13839-6 | CD14 blasts/100 blasts in Blood |
| 1384-7 | Calcium [Moles/volume] in Blood --post calcium infusion |
| 13840-4 | CD19 blasts/100 blasts in Blood |
| 13841-2 | CD2 blasts/100 blasts in Blood |
| 13842-0 | CD20 blasts/100 blasts in Blood |
| 13843-8 | CD33 blasts/100 blasts in Blood |
| 13844-6 | CD34 blasts/100 blasts in Blood |
| 13845-3 | CD5 blasts/100 blasts in Blood |
| 13846-1 | CD7 blasts/100 blasts in Blood |
| 13847-9 | Terminal Deoxyribonucleotidyl Transferase blasts/100 blasts in Blood by Immunoperoxidase stain |
| 13848-7 | CD3+CD26+ cells [#/volume] in Blood |
| 13849-5 | Deprecated CD3+CD26+ cells/100 cells in Blood |
| 1385-4 | Catecholamines Free fractionated [Mass/volume] in Plasma --1 hour post 300 ug clonidine PO |
| 13850-3 | CD5+CD25+ cells [#/volume] in Blood |
| 13851-1 | CD5+CD25+ cells/100 cells in Blood |
| 13852-9 | Aldosterone [Mass/volume] in Serum or Plasma --1 hour post 250 ug corticotropin IM |
| 13853-7 | Aldosterone [Mass/volume] in Serum or Plasma --1 hour post 25 mg captopril PO |
| 13854-5 | Aldosterone [Mass/volume] in Serum or Plasma --2 hours post 25 mg captopril PO |
| 13855-2 | Aldosterone [Mass/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin IM |
| 13856-0 | Androstenedione [Mass/volume] in Serum or Plasma --15 minutes post 250 ug corticotropin IM |
| 13857-8 | Androstenedione [Mass/volume] in Serum or Plasma --1 hour post 250 ug corticotropin IM |
| 13858-6 | Androstenedione [Mass/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin IM |
| 13859-4 | C peptide [Mass/volume] in Serum or Plasma --10 minutes post 1 mg glucagon IV |
| 1386-2 | Catecholamines Free fractionated [Mass/volume] in Plasma --2 hours post 300 ug clonidine PO |
| 13860-2 | C peptide [Mass/volume] in Serum or Plasma --15 minutes post 1 mg glucagon IV |
| 13861-0 | C peptide [Mass/volume] in Serum or Plasma --5 minutes post 1 mg glucagon IV |
| 13862-8 | Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --15 minutes post 250 ug corticotropin |
| 13863-6 | Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --1 hour post 250 ug corticotropin |
| 13864-4 | Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin |
| 13865-1 | Glucose [Mass/volume] in Serum or Plasma --2.5 hours post 50 g lactose PO |
| 13866-9 | Glucose [Mass/volume] in Serum or Plasma --5 hours post 50 g lactose PO |
| 13867-7 | Renin [Enzymatic activity/volume] in Plasma --1 hour post 25 mg captopril PO |
| 13868-5 | Renin [Enzymatic activity/volume] in Plasma --2 hours post 25 mg captopril PO |
| 13869-3 | Thyrotropin [Mass/volume] in Serum or Plasma --1.5 hours post dose TRH IV |
| 1387-0 | Catecholamines Free fractionated [Mass/volume] in Plasma --3 hours post 300 ug clonidine PO |
| 13870-1 | Thyrotropin [Mass/volume] in Serum or Plasma --15 minutes post dose TRH IV |
| 13871-9 | Thyrotropin [Mass/volume] in Serum or Plasma --2 hours post dose TRH IV |
| 13872-7 | 11-Deoxycortisol [Mass/time] in 24 hour Urine |
| 13873-5 | Albumin.glycated/Albumin.total in Serum or Plasma |
| 13874-3 | Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma |
| 13875-0 | Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma |
| 13876-8 | Beta-2 transferrin [Presence] in Body fluid |
| 13877-6 | Bilirubin.total [Presence] in Amniotic fluid |
| 13878-4 | Collagen type 1 IgG Ab [Units/volume] in Serum |
| 13879-2 | Collagen type 2 IgG Ab [Units/volume] in Serum |
| 1388-8 | Catecholamines Free fractionated [Mass/volume] in Plasma --pre 300 ug clonidine PO |
| 13880-0 | Collagen type 4 IgG Ab [Units/volume] in Serum |
| 13881-8 | Deoxypyridinoline Free/Creatinine [Molar ratio] in Urine |
| 13882-6 | Androstanolone Free/Androstanolone.total in Serum or Plasma |
| 13883-4 | Estradiol (E2).bioavailable/Estradiol (E2).total in Serum or Plasma |
| 13884-2 | Estradiol (E2).bioavailable [Mass/volume] in Serum or Plasma |
| 13885-9 | Deprecated Estrogen/Creatinine [Mass ratio] in 24 hour Urine |
| 13886-7 | Lactate dehydrogenase 1/Lactate dehydrogenase.total in Urine by Electrophoresis |
| 13887-5 | Lactate dehydrogenase 2/Lactate dehydrogenase.total in Urine by Electrophoresis |
| 13888-3 | Lactate dehydrogenase 3/Lactate dehydrogenase.total in Urine by Electrophoresis |
| 13889-1 | Lactate dehydrogenase 4/Lactate dehydrogenase.total in Urine by Electrophoresis |
| 1389-6 | Cortisol Free [Mass/volume] in 24 hour Urine --24 hours post 40 ug corticotropin IM BID 3 day |
| 13890-9 | Lactate dehydrogenase 5/Lactate dehydrogenase.total in Urine by Electrophoresis |
| 13891-7 | Motilin [Mass/volume] in Serum or Plasma |
| 13892-5 | Nitrosonaphthol [Presence] in Urine |
| 13893-3 | Phenylalanine [Presence] in Urine |
| 13894-1 | Pregnenolone [Mass/time] in 24 hour Urine |
| 13895-8 | Sodium [Moles/volume] in Milk |
| 13896-6 | Insulin-like growth factor-I [Units/volume] in Blood |
| 13897-4 | Thyrotropin.beta subunit [Mass/volume] in Serum or Plasma |
| 13898-2 | Trichloroacetate [Mass/volume] in Serum or Plasma |
| 13899-0 | Deprecated Triglyceride [Mass/volume] in fluid |
| 139-6 | Ceftizoxime [Susceptibility] by Serum bactericidal titer |
| 1390-4 | Cortisol Free [Mass/volume] in 24 hour Urine --48 hours post 40 ug corticotropin IM BID 3 day |
| 13900-6 | Deprecated Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma |
| 13901-4 | Tyrosine [Presence] in Urine |
| 13902-2 | Urate [Mass/volume] in Cerebral spinal fluid |
| 13903-0 | Vasopressin [Mass/volume] in Urine |
| 13904-8 | Meclizine [Mass/volume] in Serum or Plasma |
| 13905-5 | Meclofenamate [Mass/volume] in Serum or Plasma |
| 13906-3 | Deprecated Mesoridazine |
| 13907-1 | Norethindrone [Mass/volume] in Serum or Plasma |
| 13908-9 | Oxipurinol [Mass/volume] in Serum or Plasma |
| 13909-7 | Tamoxifen [Mass/volume] in Serum or Plasma |
| 1391-2 | Cortisol Free [Mass/volume] in 24 hour Urine --48 hours post 500 ug dexamethasone PO 2.5 day low dose q6h |
| 13910-5 | Deprecated HLA-B22 [Presence] |
| 13911-3 | HLA-B27 related Ag [Presence] |
| 13912-1 | Deprecated HLA-B42 [Presence] |
| 13913-9 | Adenovirus Ab [Titer] in Serum by Immunofluorescence |
| 13914-7 | Adenovirus IgG Ab [Units/volume] in Serum |
| 13915-4 | Adenovirus IgM Ab [Titer] in Serum |
| 13916-2 | Bordetella parapertussis Ag [Presence] in Unspecified specimen by Immunofluorescence |
| 13917-0 | Coccidioides immitis Ab [Titer] in Cerebral spinal fluid by Complement fixation |
| 13918-8 | Eastern equine encephalitis virus Ab [Titer] in Serum by Immunofluorescence |
| 13919-6 | Hepatitis B virus core IgG Ab [Units/volume] in Serum by Immunoassay |
| 1392-0 | Cortisol Free [Mass/volume] in 24 hour Urine --48 hours post 2 mg dexamethasone PO 2.5 day high dose q6h |
| 13920-4 | HIV 2 p41 Ab [Presence] in Serum by Immunoblot (IB) |
| 13921-2 | Mumps virus [Presence] in Unspecified specimen by Organism specific culture |
| 13922-0 | Trichinella spiralis IgA Ab [Presence] in Serum by Immunoassay |
| 13923-8 | Trichinella spiralis IgM Ab [Presence] in Serum by Immunoassay |
| 13924-6 | Calcitonin Ab [Presence] in Serum |
| 13925-3 | Cytokeratin Ab [Presence] in Serum |
| 13926-1 | Glutamate decarboxylase 65 Ab [Units/volume] in Serum |
| 13927-9 | Pancreatic islet cell Ab [Titer] in Serum |
| 13928-7 | Parathyrin Ab [Presence] in Serum |
| 13929-5 | Rheumatoid factor [Titer] in Synovial fluid by Sheep Cell Agglutination |
| 1393-8 | Cortisol Free [Mass/volume] in 24 hour Urine --72 hours post 40 ug corticotropin IM BID 3 day |
| 13930-3 | Rheumatoid factor [Titer] in Synovial fluid by Agglutination |
| 13931-1 | Striated muscle Ab [Presence] in Serum |
| 13932-9 | Testes IgG Ab [Titer] in Serum |
| 13933-7 | Benzodiazepines [Mass/mass] in Hair |
| 13934-5 | Butanol [Mass/volume] in Blood |
| 13935-2 | Dichlorodifluoromethane [Mass/volume] in Blood |
| 13936-0 | Diethyl ether [Mass/volume] in Blood |
| 13937-8 | Ethyl acetate [Mass/volume] in Blood |
| 13938-6 | Trichloroethane [Mass/volume] in Blood |
| 13939-4 | Deprecated Trichlorotrifluoroethane [Mass/volume] in Blood |
| 1394-6 | Cortisol Free [Mass/volume] in 24 hour Urine --pre 50 ug corticotropin IM 3 day |
| 13940-2 | Dimethylbenzene [Mass/volume] in Blood |
| 13941-0 | Lymphocytes/100 leukocytes in Body fluid by Manual count |
| 13942-8 | Spermatozoa Motile [Presence] in Semen by Light microscopy |
| 13943-6 | Fructose [Presence] in Semen |
| 13944-4 | Leukocyte phosphatase [Enzymatic activity/volume] in control Leukocytes by Light microscopy |
| 13945-1 | Erythrocytes [#/area] in Urine sediment by Microscopy high power field |
| 13946-9 | Complement+Immunoglobulin [Presence] in Red Blood Cells |
| 13947-7 | Coccidioides immitis IgG Ab [Presence] in Serum by Immunoassay |
| 13948-5 | Coccidioides immitis IgM Ab [Presence] in Serum by Immunoassay |
| 13949-3 | Cytomegalovirus IgG Ab [Presence] in Serum by Immunoassay |
| 1395-3 | Cortisol Free [Mass/volume] in 24 hour Urine --pre 500 ug dexamethasone PO 2.5 day low dose q6h |
| 13950-1 | Hepatitis A virus IgM Ab [Presence] in Serum or Plasma by Immunoassay |
| 13951-9 | Hepatitis A virus Ab [Presence] in Serum by Immunoassay |
| 13952-7 | Hepatitis B virus core Ab [Presence] in Serum or Plasma by Immunoassay |
| 13953-5 | Hepatitis B virus e Ab [Presence] in Serum or Plasma by Immunoassay |
| 13954-3 | Hepatitis B virus e Ag [Presence] in Serum or Plasma by Immunoassay |
| 13955-0 | Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay |
| 13956-8 | Mycobacterium tuberculosis DNA [Presence] in Unspecified specimen by Probe and target amplification method |
| 13957-6 | Clostridium difficile toxin A [Presence] in Stool by Immunoassay |
| 13958-4 | Arsenic [Presence] in 24 hour Urine |
| 13959-2 | Calcium.ionized [Moles/volume] in Serum or Plasma by calculation |
| 1396-1 | Cortisol Free [Mass/volume] in 24 hour Urine --pre 2 mg dexamethasone PO 2.5 day high dose q6h |
| 13960-0 | Coproporphyrin [Presence] in 24 hour Urine |
| 13961-8 | Mercury [Presence] in 24 hour Urine |
| 13962-6 | Beta glucuronidase [Enzymatic activity/volume] in Serum or Plasma |
| 13963-4 | Orotate [Moles/volume] in Urine |
| 13964-2 | Methylmalonate [Moles/volume] in Serum or Plasma |
| 13965-9 | Homocysteine [Moles/volume] in Serum or Plasma |
| 13966-7 | Cystine [Moles/time] in 24 hour Urine |
| 13967-5 | Sex hormone binding globulin [Moles/volume] in Serum or Plasma |
| 13968-3 | Penicillin [Susceptibility] by Disk diffusion (KB) |
| 13969-1 | Creatine kinase.MB [Mass/volume] in Serum or Plasma |
| 1397-9 | Cortisol [Mass/volume] in Serum or Plasma --1.5 hours post 0.05-0.15 U insulin/kg IV 12 hours fasting |
| 13970-9 | Delta tocopherol [Mass/volume] in Serum or Plasma |
| 13971-7 | Histoplasma capsulatum Ag [Units/volume] in Urine by Immunoassay |
| 13972-5 | Alpha 1 globulin/Protein.total in Cerebral spinal fluid by Electrophoresis |
| 13973-3 | Prealbumin/Protein.total in Cerebral spinal fluid by Electrophoresis |
| 13974-1 | Albumin/Protein.total in Cerebral spinal fluid by Electrophoresis |
| 13975-8 | Alpha 2 globulin/Protein.total in Cerebral spinal fluid by Electrophoresis |
| 13976-6 | Beta globulin/Protein.total in Cerebral spinal fluid by Electrophoresis |
| 13977-4 | Gamma globulin/Protein.total in Cerebral spinal fluid by Electrophoresis |
| 13978-2 | Alpha 1 globulin/Protein.total in Serum or Plasma by Electrophoresis |
| 13979-0 | Prealbumin/Protein.total in Serum or Plasma by Electrophoresis |
| 1398-7 | Cortisol [Mass/volume] in Serum or Plasma --1.5 hours post dose insulin IV |
| 13980-8 | Albumin/Protein.total in Serum or Plasma by Electrophoresis |
| 13981-6 | Alpha 2 globulin/Protein.total in Serum or Plasma by Electrophoresis |
| 13982-4 | Beta globulin/Protein.total in Serum or Plasma by Electrophoresis |
| 13983-2 | Gamma globulin/Protein.total in Serum or Plasma by Electrophoresis |
| 13984-0 | Alpha 1 globulin/Protein.total in 24 hour Urine by Electrophoresis |
| 13985-7 | Prealbumin/Protein.total in 24 hour Urine by Electrophoresis |
| 13986-5 | Albumin/Protein.total in 24 hour Urine by Electrophoresis |
| 13987-3 | Alpha 2 globulin/Protein.total in 24 hour Urine by Electrophoresis |
| 13988-1 | Beta globulin/Protein.total in 24 hour Urine by Electrophoresis |
| 13989-9 | Gamma globulin/Protein.total in 24 hour Urine by Electrophoresis |
| 1399-5 | Cortisol [Mass/volume] in Serum or Plasma --1 hour post 0.05-0.15 U insulin/kg IV post 12H CFst |
| 13990-7 | Alpha 1 globulin/Protein.total in Urine by Electrophoresis |
| 13991-5 | Prealbumin/Protein.total in Urine by Electrophoresis |
| 13992-3 | Albumin/Protein.total in Urine by Electrophoresis |
| 13993-1 | Alpha 2 globulin/Protein.total in Urine by Electrophoresis |
| 13994-9 | Beta globulin/Protein.total in Urine by Electrophoresis |
| 13995-6 | Gamma globulin/Protein.total in Urine by Electrophoresis |
| 13996-4 | Hydroxyproline/Creatinine [Molar ratio] in 24 hour Urine |
| 13997-2 | Neuronal nuclear type 1 Ab [Titer] in Serum |
| 13998-0 | Neuronal nuclear type 2 Ab [Titer] in Serum |
| 13999-8 | Transferrin.carbohydrate deficient [Units/volume] in Serum or Plasma |
| 14-1 | Amikacin [Susceptibility] by Serum bactericidal titer |
| 140-4 | Ceftriaxone [Susceptibility] by Minimum lethal concentration (MLC) |
| 1400-1 | Cortisol [Mass/volume] in Serum or Plasma --1 hour post 1 ug/kg CRH IV |
| 14000-4 | Urea nitrogen [Mass/volume] in Cerebral spinal fluid |
| 14001-2 | IgE [Units/volume] in Cord blood |
| 14002-0 | IgM [Units/volume] in Cord blood |
| 14003-8 | Carbon dioxide [Partial pressure] in Cord blood |
| 14004-6 | Prostaglandin A [Mass/time] in 24 hour Urine |
| 14005-3 | Prostaglandin E1 [Mass/time] in 24 hour Urine |
| 14006-1 | Prostaglandin E2 [Mass/time] in 24 hour Urine |
| 14007-9 | Prostaglandin F2 alpha [Mass/time] in 24 hour Urine |
| 14008-7 | Phosphatidylcholine IgG Ab [Units/volume] in Serum by Immunoassay |
| 14009-5 | Phosphatidylcholine IgM Ab [Units/volume] in Serum by Immunoassay |
| 1401-9 | Cortisol [Mass/volume] in Serum or Plasma --1 hour post 250 ug corticotropin IM rapid |
| 14010-3 | Phosphatidylcholine IgA Ab [Units/volume] in Serum by Immunoassay |
| 14011-1 | Deprecated Platelet associated IgA Ab [Units/volume] in Blood |
| 14012-9 | Platelet associated IgG Ab [Units/volume] in Blood by Flow cytometry (FC) |
| 14013-7 | Platelet associated IgM Ab [Units/volume] in Blood by Flow cytometry (FC) |
| 14014-5 | Thyroxine (T4).prealbumin bound [Mass/volume] in Serum or Plasma |
| 14015-2 | Thyroxine (T4).prealbumin bound/Prealbumin [Mass Ratio] in Serum or Plasma |
| 14016-0 | Thyroxine.thyroxine binding globulin bound [Mass/volume] in Serum or Plasma |
| 14017-8 | CD22 cells/100 cells in Blood |
| 14018-6 | CD23 cells/100 cells in Blood |
| 14019-4 | HTLV I+II gp46 Ab [Presence] in Serum or Plasma by Immunoblot (IB) |
| 1402-7 | Cortisol [Mass/volume] in Serum or Plasma --1 hour post 250 ug corticotropin IV rapid |
| 14020-2 | HTLV I+II p19 Ab [Presence] in Serum or Plasma by Immunoblot (IB) |
| 14021-0 | HTLV I+II p24 Ab [Presence] in Serum or Plasma by Immunoblot (IB) |
| 14022-8 | HTLV I+II p26 Ab [Presence] in Serum by Immunoblot (IB) |
| 14023-6 | HTLV I+II p28 Ab [Presence] in Serum by Immunoblot (IB) |
| 14024-4 | HTLV I+II p32 Ab [Presence] in Serum by Immunoblot (IB) |
| 14025-1 | HTLV I+II p36 Ab [Presence] in Serum by Immunoblot (IB) |
| 14026-9 | HTLV I+II p53 Ab [Presence] in Serum by Immunoblot (IB) |
| 14027-7 | HTLV I+II rgp21 Ab [Presence] in Serum or Plasma by Immunoblot (IB) |
| 14028-5 | Deprecated HTLV I+II rgp46-I Ab [Presence] in Serum by Immunoblot (IB) |
| 14029-3 | Deprecated HTLV I+II rgp46-II Ab [Presence] in Serum by Immunoblot (IB) |
| 1403-5 | Cortisol [Mass/volume] in Serum or Plasma --1 hour post 250 ug corticotropin IM |
| 14030-1 | Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum by Immunoassay |
| 14031-9 | Ciprofloxacin [Mass/volume] in Serum or Plasma --peak |
| 14032-7 | Ciprofloxacin [Mass/volume] in Serum or Plasma --trough |
| 14033-5 | 1,4-Dioxane [Mass/volume] in Blood by Gas chromatography |
| 14034-3 | Rheumatoid factor [Units/volume] in Cerebral spinal fluid |
| 14035-0 | Japanese Cedar IgE Ab [Units/volume] in Serum |
| 14036-8 | Dermatophagoides microceras IgE Ab [Units/volume] in Serum |
| 14037-6 | Fox IgE Ab [Units/volume] in Serum |
| 14038-4 | Pacific Squid IgE Ab [Units/volume] in Serum |
| 14039-2 | Neutrophils/100 leukocytes in Cerebral spinal fluid by Microscopy |
| 1404-3 | Cortisol [Mass/volume] in Serum or Plasma --1 hour post dose insulin IV |
| 14040-0 | Carbon dioxide, total [Moles/volume] in Stool |
| 14041-8 | Choriogonadotropin.beta subunit [Units/volume] in Cerebral spinal fluid |
| 14042-6 | Corticosterone [Mass/time] in 24 hour Urine |
| 14043-4 | Cortisol Free [Mass/time] in 12 hour Urine |
| 14044-2 | Cortisone [Mass/time] in 24 hour Urine |
| 14045-9 | D-Lactate [Moles/volume] in Serum or Plasma |
| 14046-7 | D-Lactate [Moles/volume] in Urine |
| 14047-5 | Androstanolone Free [Mass/volume] in Serum or Plasma |
| 14048-3 | Elastase.pancreatic [Mass/volume] in Serum |
| 14049-1 | Epidermal growth factor [Mass/volume] in Serum or Plasma |
| 1405-0 | Deprecated Cortisol [Mass/volume] in Serum or Plasma --1 hour post dose insulin IV |
| 14050-9 | Epidermal growth factor receptor [Moles/mass] in Tissue |
| 14051-7 | Estrogen binding protein [Mass/volume] in Serum or Plasma |
| 14052-5 | Formate [Mass/volume] in Urine |
| 14053-3 | Homocystine [Presence] in Urine |
| 14054-1 | Prostaglandin D2 [Mass/time] in 24 hour Urine |
| 14055-8 | Sodium [Moles/mass] in Stool |
| 14056-6 | Carbamazepine 10,11-epoxide free [Mass/volume] in Serum or Plasma |
| 14057-4 | Carbamazepine free [Mass/volume] in Saliva (oral fluid) |
| 14058-2 | Deprecated Ciprofloxacin [Mass/volume] in Serum or Plasma --peak |
| 14059-0 | Deprecated Ciprofloxacin [Mass/volume] in Serum or Plasma --trough |
| 1406-8 | Cortisol [Mass/volume] in Serum or Plasma --1 minute post 1 ug/kg CRH IV |
| 14060-8 | Cyclobenzaprine [Presence] in Urine |
| 14061-6 | Cyclobenzaprine [Mass/volume] in Urine |
| 14062-4 | Dexamethasone [Mass/volume] in Serum or Plasma |
| 14063-2 | Dezocine [Presence] in Urine |
| 14064-0 | Diethylstilbestrol [Mass/volume] in Serum or Plasma |
| 14065-7 | Diflunisal [Mass/volume] in Serum or Plasma |
| 14066-5 | Dihydrocodeine [Presence] in Urine |
| 14067-3 | Dihydrocodeine [Mass/volume] in Blood |
| 14068-1 | Triamterene+Hydrochlorothiazide [Mass/volume] in Serum or Plasma |
| 14069-9 | Estazolam [Mass/volume] in Serum or Plasma |
| 1407-6 | Cortisol [Mass/volume] in Serum or Plasma --24 hours post 2 mg dexamethasone PO 2.5 day high dose q6h |
| 14070-7 | Fluphenazine [Presence] in Urine |
| 14071-5 | Ibuprofen [Presence] in Urine |
| 14072-3 | Monoacetyldapsone [Mass/volume] in Serum or Plasma |
| 14073-1 | Phenytoin [Mass/volume] in Saliva (oral fluid) |
| 14074-9 | Spironolactone [Mass/volume] in Serum or Plasma |
| 14075-6 | Sulfapyridine [Mass/volume] in Serum or Plasma |
| 14076-4 | Complement total hemolytic CH100 [Presence] in Serum or Plasma by Immune diffusion (ID) |
| 14077-2 | Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 14078-0 | Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 14079-8 | Brucella canis IgG Ab [Titer] in Serum by Immunofluorescence |
| 1408-4 | Cortisol [Mass/volume] in Serum or Plasma --24 hours post 40 ug corticotropin IM BID 3 day |
| 14080-6 | Brucella canis IgM Ab [Titer] in Serum by Immunofluorescence |
| 14081-4 | Coliform bacteria [Presence] in Water |
| 14082-2 | Echinococcus sp IgG Ab [Units/volume] in Serum by Immunoblot (IB) |
| 14083-0 | Epstein Barr virus early Ab [Titer] in Serum by Immunofluorescence |
| 14084-8 | Herpes simplex virus 1 [Presence] in Isolate by Immunofluorescence |
| 14085-5 | Herpes simplex virus 2 [Presence] in Isolate by Immunofluorescence |
| 14086-3 | Herpes simplex virus 1 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 14087-1 | Herpes simplex virus 1 IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 14088-9 | Deprecated Herpes simplex virus 1 IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 14089-7 | Herpes simplex virus 2 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 1409-2 | Cortisol [Mass/volume] in Serum or Plasma --24 hours post 500 ug corticotropin IM |
| 14090-5 | Herpes simplex virus 2 IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 14091-3 | Deprecated Herpes simplex virus 2 IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 14092-1 | HIV 1 Ab [Presence] in Serum by Immunofluorescence |
| 14093-9 | Bacteria identified in Water by Culture |
| 14094-7 | Trypanosoma cruzi IgG Ab [Titer] in Serum |
| 14095-4 | Fibronectin aggregate IgG Ab [Units/volume] in Serum |
| 14096-2 | Intercalated disk Ab [Titer] in Serum by Immunofluorescence |
| 14097-0 | Antimony [Mass/time] in 24 hour Urine |
| 14098-8 | Dimethylsulfoxide [Mass/volume] in Serum or Plasma |
| 14099-6 | Nickel [Mass/volume] in Urine |
| 141-2 | Ceftriaxone [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 1410-0 | Cortisol [Mass/volume] in Serum or Plasma --24 hours post 500 ug dexamethasone PO 2.5 day low dose q6h |
| 14100-2 | Strontium [Presence] in Urine |
| 14101-0 | Strychnine [Mass/volume] in Gastric fluid |
| 14102-8 | Strychnine [Mass/volume] in Blood |
| 14103-6 | Epithelial cells [Presence] in Stool by Light microscopy |
| 14104-4 | Barley smut+Wheat smut IgE Ab [Units/volume] in Serum |
| 14105-1 | Leukocytes [Presence] in Nose by Light microscopy |
| 14106-9 | Lymphocytes [#/volume] in Cerebral spinal fluid by Manual count |
| 14107-7 | Segmented neutrophils/100 leukocytes in Cerebral spinal fluid by Manual count |
| 14108-5 | CD16C+CD56+ cells [#/volume] in Blood |
| 14109-3 | CD16C+CD56+ cells/100 cells in Blood |
| 1411-8 | Cortisol [Mass/volume] in Serum or Plasma --26 hours post 500 ug dexamethasone PO 2.5 day low dose q6h |
| 14110-1 | Deprecated CD22 cells/100 cells in Blood |
| 14111-9 | Deprecated CD23 cells/100 lymphocytes in Blood |
| 14112-7 | CD25+CD19+ cells/100 cells in Blood |
| 14113-5 | CD56 cells [#/volume] in Blood |
| 14114-3 | 17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --1 hour post 250 ug corticotropin IM |
| 14115-0 | Collagen crosslinked N-telopeptide/Creatinine [Molar ratio] in Urine |
| 14116-8 | IgG synthesis rate [Mass/time] in Serum and CSF by calculation |
| 14117-6 | IgG clearance/Albumin clearance [Ratio] in Serum and CSF |
| 14118-4 | Lactate [Mass/volume] in Serum or Plasma |
| 14119-2 | Lactate dehydrogenase 1/Lactate dehydrogenase 2 [Enzymatic activity ratio] in Serum or Plasma |
| 1412-6 | Cortisol [Mass/volume] in Serum or Plasma --26 hours post 2 mg dexamethasone PO 2.5 day high dose q6h |
| 14120-0 | Deprecated Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma |
| 14121-8 | Pyruvate [Moles/volume] in Blood |
| 14122-6 | Pyruvate [Moles/volume] in Cerebral spinal fluid |
| 14123-4 | Thyroxine (T4).albumin bound/Albumin [Mass Ratio] in Serum or Plasma |
| 14124-2 | Bacteria [Presence] in Semen by Light microscopy |
| 14125-9 | Entamoeba histolytica [Presence] in Stool by Trichrome stain |
| 14126-7 | HIV 1 gp120+gp160 Ab [Presence] in Serum by Immunoblot (IB) |
| 14127-5 | Neisseria gonorrhoeae [Presence] in Anal by Organism specific culture |
| 14128-3 | Rabies virus Ab [Titer] in Serum |
| 14129-1 | Respiratory syncytial virus [Presence] in Nose by Organism specific culture |
| 1413-4 | Cortisol [Mass/volume] in Serum or Plasma --2 days post 500 ug corticotropin IM |
| 14130-9 | Estrogen receptor [Moles/mass] in Tissue |
| 14131-7 | PM-1 Ab [Presence] in Serum |
| 14132-5 | Color of Gastric fluid |
| 14133-3 | Silver Maple IgE Ab [Units/volume] in Serum |
| 14134-1 | Deprecated Free Hemoglobin [Mass/volume] in Serum |
| 14135-8 | CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Blood |
| 14136-6 | CD34 cells [#/volume] in Blood |
| 14137-4 | Glucose [Mass/volume] in Serum or Plasma --5.5 hours post 75 g glucose PO |
| 14138-2 | Ketones [Presence] in Urine --30 minutes post XXX challenge |
| 14139-0 | Ketones [Presence] in Urine --4 hours post XXX challenge |
| 1414-2 | Cortisol [Mass/volume] in Serum or Plasma --30 minutes post 0.05-0.15 U insulin/kg IV post 12H CFst |
| 14140-8 | Ketones [Presence] in Urine --5 hours post XXX challenge |
| 14141-6 | Ketones [Presence] in Urine --6 hours post XXX challenge |
| 14142-4 | Somatotropin [Mass/volume] in Serum or Plasma --15 minutes post XXX challenge |
| 14143-2 | Somatotropin [Mass/volume] in Serum or Plasma --20 minutes post XXX challenge |
| 14144-0 | Somatotropin [Mass/volume] in Serum or Plasma --2 hours post XXX challenge |
| 14145-7 | Somatotropin [Mass/volume] in Serum or Plasma --40 minutes post XXX challenge |
| 14146-5 | Somatotropin [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
| 14147-3 | Somatotropin [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge |
| 14148-1 | 18-Hydroxycortisol [Mass/time] in 24 hour Urine |
| 14149-9 | Corticotropin Big Fragment [Mass/volume] in Serum or Plasma |
| 1415-9 | Cortisol [Mass/volume] in Serum or Plasma --30 minutes post 1 ug/kg CRH IV |
| 14150-7 | Deprecated Beta glucuronidase [Enzymatic activity/volume] in Serum or Plasma |
| 14151-5 | Bicarbonate [Moles/volume] in Cord blood |
| 14152-3 | Bilirubin.direct [Mass/volume] in Body fluid |
| 14153-1 | Carnitine esters/Creatinine [Mass Ratio] in Urine |
| 14154-9 | Cholesterol sulfate [Mass/volume] in Serum |
| 14155-6 | Cholesterol in LDL [Percentile] |
| 14156-4 | Coproporphyrin [Mass/mass] in 24 hour Stool |
| 14157-2 | Coproporphyrin [Mass/volume] in Serum or Plasma |
| 14158-0 | Cortisol [Mass/time] in 24 hour Urine |
| 14159-8 | Cortisone [Mass/volume] in Serum or Plasma |
| 1416-7 | Cortisol [Mass/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin IM rapid |
| 14160-6 | Estrone (E1).unconjugated/Estrone (E1).total in Serum or Plasma |
| 14161-4 | Deprecated Formaldehyde in Nonbiological fluid |
| 14162-2 | Gamma melanocyte stimulating hormone [Mass/volume] in Serum or Plasma |
| 14163-0 | IgA.secretory [Mass/volume] in Serum or Plasma |
| 14164-8 | Immunosuppressive acidic protein [Mass/volume] in Serum or Plasma |
| 14165-5 | Lactate [Moles/volume] in Body fluid |
| 14166-3 | Methane [Mass/volume] in Blood |
| 14167-1 | N-methylimidazoleacetate [Mass/time] in 24 hour Urine |
| 14168-9 | Palatinase [Enzymatic activity/mass] in Tissue |
| 14169-7 | Peptide histidine isoleucine [Mass/volume] in Plasma |
| 1417-5 | Cortisol [Mass/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin IV rapid |
| 14170-5 | Pituitary glucoprotein hormone.alpha subunit [Mass/volume] in Serum |
| 14171-3 | Porphyrins [Mass/mass] in 24 hour Stool |
| 14172-1 | Potassium [Moles/volume] in Synovial fluid |
| 14173-9 | Progesterone Free [Mass/time] in 24 hour Urine |
| 14174-7 | Prostaglandin F2 alpha [Mass/volume] in Serum or Plasma |
| 14175-4 | Protoporphyrin [Mass/mass] in 24 hour Stool |
| 14176-2 | Pyrroles [Mass/volume] in Urine |
| 14177-0 | Growth hormone-releasing hormone [Mass/volume] in Serum or Plasma |
| 14178-8 | Sucrase [Enzymatic activity/mass] in Tissue |
| 14179-6 | Tissue polypeptide Ag [Mass/volume] in Serum or Plasma |
| 1418-3 | Cortisol [Mass/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin IM |
| 14180-4 | Uroporphyrin [Mass/volume] in Red Blood Cells |
| 14181-2 | Uroporphyrin [Mass/mass] in 24 hour Stool |
| 14182-0 | Thrombin antithrombin complex Ag [Mass/volume] in Platelet poor plasma by Immunologic method |
| 14183-8 | Aprobarbital [Mass/volume] in Urine |
| 14184-6 | Atropine [Presence] in Urine |
| 14185-3 | Methimazole [Mass/volume] in Serum or Plasma |
| 14186-1 | Methylprednisolone [Mass/volume] in Serum or Plasma |
| 14187-9 | OKT3 [Mass/volume] in Serum or Plasma |
| 14188-7 | Omeprazole [Mass/volume] in Serum or Plasma |
| 14189-5 | Phenyltoloxamine [Mass/volume] in Urine |
| 1419-1 | Cortisol [Mass/volume] in Serum or Plasma --30 minutes post dose insulin IV |
| 14190-3 | Phenytoin Free [Mass/volume] in Saliva (oral fluid) |
| 14191-1 | Prazosin [Mass/volume] in Serum or Plasma |
| 14192-9 | Triazolam [Presence] in Urine |
| 14193-7 | Tripelennamine [Presence] in Urine |
| 14194-5 | Spermatozoa Progressive/100 spermatozoa in Semen |
| 14195-2 | Complement C3b Inactive [Mass/volume] in Plasma |
| 14196-0 | Reticulocytes [#/volume] in Blood |
| 14197-8 | Blastomyces dermatitidis exoantigen [Identifier] in Isolate |
| 14198-6 | Chlamydophila psittaci Ab [Titer] in Serum by Immunofluorescence |
| 14199-4 | Chlamydia trachomatis B IgA Ab [Titer] in Serum by Immunofluorescence |
| 142-0 | Ceftriaxone [Susceptibility] by Disk diffusion (KB) |
| 1420-9 | Deprecated Cortisol [Mass/volume] in Serum or Plasma --30 minutes post dose insulin IV |
| 14200-0 | Chlamydia trachomatis B IgG Ab [Titer] in Serum by Immunofluorescence |
| 14201-8 | Chlamydia trachomatis B IgM Ab [Titer] in Serum by Immunofluorescence |
| 14202-6 | Chlamydia trachomatis C IgA Ab [Titer] in Serum by Immunofluorescence |
| 14203-4 | Chlamydia trachomatis C IgG Ab [Titer] in Serum by Immunofluorescence |
| 14204-2 | Chlamydia trachomatis C IgM Ab [Titer] in Serum by Immunofluorescence |
| 14205-9 | Coccidioides immitis Ag [Presence] in Isolate by Immune diffusion (ID) |
| 14206-7 | Coccidioides immitis exoantigen [Identifier] in Isolate |
| 14207-5 | Streptococcal DNAse B [Titer] in Serum |
| 14208-3 | Filaria IgG4 Ab [Units/volume] in Serum |
| 14209-1 | Francisella tularensis IgA Ab [Presence] in Serum |
| 1421-7 | Cortisol [Mass/volume] in Serum or Plasma --32 hours post 40 ug corticotropin IM BID 3 day |
| 14210-9 | Giardia lamblia Ag [Presence] in Stool by Immunofluorescence |
| 14211-7 | Hepatitis E virus IgG Ab [Presence] in Serum |
| 14212-5 | Hepatitis E virus IgM Ab [Presence] in Serum |
| 14213-3 | Herpes simplex virus IgM Ab [Titer] in Serum by Immunofluorescence |
| 14214-1 | Histoplasma capsulatum exoantigen [Identifier] in Isolate |
| 14215-8 | HTLV I g46 Ab [Presence] in Serum |
| 14216-6 | HTLV 1 gp46 Ab [Presence] in Serum |
| 14217-4 | HTLV I p19 Ab [Presence] in Serum |
| 14218-2 | HTLV I p24 Ab [Presence] in Serum |
| 14219-0 | HTLV I p26 Ab [Presence] in Serum |
| 1422-5 | Cortisol [Mass/volume] in Serum or Plasma --3 days post 500 ug corticotropin IM |
| 14220-8 | HTLV I p28 Ab [Presence] in Serum |
| 14221-6 | HTLV I p32 Ab [Presence] in Serum |
| 14222-4 | HTLV I p36 Ab [Presence] in Serum |
| 14223-2 | HTLV I p53 Ab [Presence] in Serum |
| 14224-0 | HTLV I rgp21 Ab [Presence] in Serum |
| 14225-7 | HTLV II g46 Ab [Presence] in Serum |
| 14226-5 | Nocardia sp identified in Isolate by Organism specific culture |
| 14227-3 | Salmonella typhi H D Ab [Titer] in Serum |
| 14228-1 | Estrogen receptor/100 cells in Tissue by Immune stain |
| 14229-9 | P53 protein Ag [Presence] in Tissue by Immune stain |
| 1423-3 | Cortisol [Mass/volume] in Serum or Plasma --45 minutes post 1 ug/kg CRH IV |
| 14230-7 | Progesterone receptor/100 cells in Tissue by Immune stain |
| 14231-5 | H2a-H2b DNA IgG Ab [Units/volume] in Serum |
| 14232-3 | Adrenal Ab [Presence] in Serum |
| 14233-1 | Beta tubulin IgG Ab [Titer] in Serum |
| 14234-9 | Beta tubulin IgM Ab [Titer] in Serum |
| 14235-6 | Jo-1 extractable nuclear Ab [Titer] in Serum |
| 14236-4 | Mitochondria Ab [Presence] in Serum |
| 14237-2 | Myelin basic protein IgA Ab [Units/volume] in Serum |
| 14238-0 | Myelin basic protein IgG Ab [Units/volume] in Serum |
| 14239-8 | Myelin basic protein IgM Ab [Units/volume] in Serum |
| 1424-1 | Cortisol [Mass/volume] in Serum or Plasma --45 minutes post dose insulin IV |
| 14240-6 | Neuronal nuclear Ab [Units/volume] in Cerebral spinal fluid |
| 14241-4 | Parietal cell Ab [Presence] in Serum |
| 14242-2 | Phosphatidylcholine IgA Ab [Presence] in Serum |
| 14243-0 | Phosphatidylcholine IgG Ab [Presence] in Serum |
| 14244-8 | Phosphatidylcholine IgM Ab [Presence] in Serum |
| 14245-5 | Phosphatidylserine IgG Ab [Units/volume] in Serum |
| 14246-3 | Phosphatidylserine IgM Ab [Units/volume] in Serum |
| 14247-1 | Purkinje cells Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 14248-9 | Purkinje cells Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 14249-7 | Purkinje cells Ab [Presence] in Serum by Immunofluorescence |
| 1425-8 | Cortisol [Mass/volume] in Serum or Plasma --48 hours post 2 mg dexamethasone PO 2.5 day high dose q6h |
| 14250-5 | Purkinje cells IgG Ab [Units/volume] in Serum by Immunofluorescence |
| 14251-3 | Mitochondria M2 IgG Ab [Units/volume] in Serum |
| 14252-1 | Smooth muscle Ab [Presence] in Serum |
| 14253-9 | Somatotropin Ab [Presence] in Serum or Plasma |
| 14254-7 | Ganglioside GQ1b IgG Ab [Titer] in Serum |
| 14255-4 | Thyrotropin blocking Ab [Units/volume] in Serum |
| 14256-2 | Tetrachlorodiphenylethane [Mass/mass] in Tissue |
| 14257-0 | Tetrachlorodiphenylethane [Mass/volume] in Serum or Plasma |
| 14258-8 | 1,4-Dioxane [Mass/volume] in Blood |
| 14259-6 | 1-Pentanol [Mass/volume] in Blood |
| 1426-6 | Cortisol [Mass/volume] in Serum or Plasma --48 hours post 40 ug corticotropin IM BID 3 day |
| 14260-4 | Bromoform [Mass/volume] in Blood |
| 14261-2 | Codeine [Presence] in Gastric fluid |
| 14262-0 | Dichlorodiphenyldichloroethylene [Mass/mass] in Tissue |
| 14263-8 | Dichlorodiphenyltrichloroethane [Mass/mass] in Tissue |
| 14264-6 | Enflurane [Mass/volume] in Blood |
| 14265-3 | Isobutyl acetate [Mass/volume] in Blood |
| 14266-1 | Methoxyflurane [Mass/volume] in Blood |
| 14267-9 | Methylenedioxymethamphetamine [Presence] in Urine |
| 14268-7 | Butyl acetate [Mass/volume] in Blood |
| 14269-5 | Sec-butyl acetate [Mass/volume] in Blood |
| 1427-4 | Cortisol [Mass/volume] in Serum or Plasma --48 hours post 500 ug dexamethasone PO 2.5 day low dose q6h |
| 14270-3 | Tert-butyl acetate [Mass/volume] in Blood |
| 14271-1 | Character of Synovial fluid |
| 14272-9 | Liver kidney microsomal Ab [Presence] in Serum |
| 14273-7 | Reticulin IgA Ab [Presence] in Serum |
| 14274-5 | Uroporphyrin [Mass/volume] in Serum or Plasma |
| 14275-2 | Immune complex [Units/volume] in Serum or Plasma by C3b binding assay |
| 14276-0 | Hemoglobin F distribution [Interpretation] in Blood by Kleihauer-Betke method |
| 14277-8 | Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence |
| 14278-6 | Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence |
| 1428-2 | Cortisol [Mass/volume] in Serum or Plasma --50 hours post 500 ug dexamethasone PO 2.5 day low dose q6h |
| 14282-8 | Acylcarnitine [Moles/volume] in Serum or Plasma |
| 14283-6 | Acylcarnitine [Moles/volume] in Urine |
| 14284-4 | Beta glucuronidase [Moles/volume] in Serum or Plasma |
| 14285-1 | Carnitine free (C0) [Moles/volume] in Urine |
| 14286-9 | Carnitine free (C0) [Moles/volume] in Serum or Plasma |
| 14287-7 | Carnitine [Moles/volume] in Urine |
| 14288-5 | Carnitine [Moles/volume] in Serum or Plasma |
| 14289-3 | Deprecated Coproporphyrin [Presence] in 24 hour Urine |
| 1429-0 | Cortisol [Mass/volume] in Serum or Plasma --50 hours post 2 mg dexamethasone PO 2.5 day high dose q6h |
| 14290-1 | Deprecated Erythrocytes [Units/volume] in Urine sediment by Manual count |
| 14291-9 | Follitropin [Moles/volume] in Serum or Plasma --baseline |
| 14292-7 | IgE [Moles/volume] in Serum |
| 14293-5 | Insulin [Moles/volume] in Serum or Plasma --baseline |
| 14294-3 | Lysosomal enzymes screen [Identifier] in Plasma and Urine |
| 14295-0 | Organic acids/Creatinine [Molar ratio] in Urine |
| 14296-8 | Thyroperoxidase Ab [Moles/volume] in Serum or Plasma |
| 14297-6 | Thyrotropin [Moles/volume] in Serum or Plasma |
| 14298-4 | Plasma units available [#] |
| 14299-2 | Cryoprecipitate units available [#] |
| 143-8 | Ceftriaxone [Susceptibility] by Serum bactericidal titer |
| 1430-8 | Cortisol [Mass/volume] in Serum or Plasma --56 hours post 40 ug corticotropin IM BID 3 day |
| 14300-8 | Plateletpheresis units available [#] |
| 14301-6 | Platelet concentrate units available [#] |
| 14302-4 | Packed erythrocytes units available [#] |
| 14303-2 | Transfuse plateletpheresis [Volume] |
| 14304-0 | Measles virus IgG Ab [Units/volume] in Serum by Immunoassay --1st specimen |
| 14305-7 | Measles virus IgG Ab [Units/volume] in Serum by Immunoassay --2nd specimen |
| 14306-5 | Varicella zoster virus IgG Ab [Units/volume] in Serum by Immunoassay --1st specimen |
| 14307-3 | Varicella zoster virus IgG Ab [Units/volume] in Serum by Immunoassay --2nd specimen |
| 14308-1 | Amphetamines [Presence] in Urine by Screen method >1000 ng/mL |
| 14309-9 | Amphetamines [Presence] in Urine by Confirm method >200 ng/mL |
| 1431-6 | Cortisol [Mass/volume] in Serum or Plasma --5 minutes post 1 ug/kg CRH IV |
| 14310-7 | Phencyclidine [Presence] in Urine by Screen method >25 ng/mL |
| 14311-5 | Phencyclidine [Presence] in Urine by Confirm method >20 ng/mL |
| 14312-3 | Tetrahydrocannabinol [Presence] in Urine by Screen method >50 ng/mL |
| 14313-1 | Tetrahydrocannabinol [Mass/volume] in Urine by Confirmatory method |
| 14314-9 | Benzoylecgonine [Presence] in Urine by Screen method |
| 14315-6 | Benzoylecgonine [Presence] in Urine by Confirmatory method |
| 14316-4 | Benzodiazepines [Presence] in Urine by Screen method |
| 14317-2 | Microscopic observation [Identifier] in Genital specimen by Wet preparation |
| 14318-0 | Microscopic observation [Identifier] in Cervix by Wet preparation |
| 14319-8 | Microscopic observation [Identifier] in Vaginal fluid by Wet preparation |
| 1432-4 | Cortisol [Mass/volume] in Serum or Plasma --72 hours post 2 mg dexamethasone PO 2.5 day high dose q6h |
| 14320-6 | Deprecated Bacteria identified in Urine by Culture @1:100 |
| 14321-4 | Haemophilus influenzae B Ag [Presence] in Cerebral spinal fluid by Latex agglutination |
| 14322-2 | Streptococcus pneumoniae Ag [Presence] in Cerebral spinal fluid by Latex agglutination |
| 14323-0 | Streptococcus agalactiae Ag [Presence] in Cerebral spinal fluid by Latex agglutination |
| 14324-8 | Escherichia coli K1 Ag [Presence] in Cerebral spinal fluid by Latex agglutination |
| 14325-5 | Bacteria identified in Unspecified specimen by Environmental culture |
| 14326-3 | Eosinophils/100 leukocytes in Stool by Manual count |
| 14327-1 | Epithelial cells.squamous [Presence] in Sputum by Light microscopy |
| 14328-9 | Leukocytes [Presence] in Sputum by Light microscopy |
| 14329-7 | Mucus [Presence] in Sputum by Light microscopy |
| 1433-2 | Cortisol [Mass/volume] in Serum or Plasma --72 hours post 500 ug dexamethasone PO 2.5 day low dose q6h |
| 14330-5 | Polymorphonuclear cells/100 leukocytes in Stool by Manual count |
| 14331-3 | Erythrocytes [Units/volume] in Stool by Manual count |
| 14332-1 | Para aminosalicylate [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 14333-9 | Lead [Presence] in 24 hour Urine |
| 14334-7 | Lithium [Moles/volume] in Serum or Plasma |
| 14335-4 | Optical density of Amniotic fluid by Spectrophotometry |
| 14336-2 | Ethanol [Mass/volume] in Serum or Plasma by Gas chromatography |
| 14337-0 | Phenytoin.total/Phenytoin.free [Mass Ratio] in Serum or Plasma |
| 14338-8 | Prealbumin [Mass/volume] in Serum or Plasma |
| 14339-6 | IgG/Protein.total in Cerebral spinal fluid |
| 1434-0 | Cortisol [Mass/volume] in Serum or Plasma --8 hours post 1 mg dexamethasone PO overnight |
| 14340-4 | Gammopathy [Interpretation] in Serum or Plasma by Electrophoresis |
| 14341-2 | Globulin/Protein.total in 24 hour Urine by Electrophoresis |
| 14342-0 | Deprecated Catecholamines/Creatinine [Mass ratio] in Urine |
| 14343-8 | Eosinophils/100 leukocytes in Peritoneal fluid by Manual count |
| 14344-6 | Eosinophils/100 leukocytes in Pleural fluid by Manual count |
| 14345-3 | Specific gravity of Amniotic fluid by Refractometry |
| 14346-1 | Specific gravity of Cerebral spinal fluid by Refractometry |
| 14347-9 | Specific gravity of Gastric fluid by Refractometry |
| 14348-7 | Specific gravity of Peritoneal fluid by Refractometry |
| 14349-5 | Specific gravity of Pleural fluid by Refractometry |
| 1435-7 | Cortisol [Mass/volume] in Serum or Plasma --8 hours post 2 mg dexamethasone PO 2.5 day high dose q6h |
| 14350-3 | Specific gravity of Synovial fluid by Refractometry |
| 14351-1 | Specific gravity of Stool by Refractometry |
| 14352-9 | Specific gravity of Water by Refractometry |
| 14353-7 | Microscopic observation [Identifier] in Pleural fluid by Acid fast stain.Kinyoun modified |
| 14354-5 | Microscopic observation [Identifier] in Wound by Acid fast stain.Kinyoun modified |
| 14355-2 | Microscopic observation [Identifier] in Cervix by KOH preparation |
| 14356-0 | Microscopic observation [Identifier] in Vaginal fluid by KOH preparation |
| 14357-8 | Microscopic observation [Identifier] in Cerebral spinal fluid by Gram stain |
| 14358-6 | Microscopic observation [Identifier] in Aspirate by Gram stain |
| 14359-4 | Microscopic observation [Identifier] in Peritoneal fluid by Gram stain |
| 1436-5 | Cortisol [Mass/volume] in Serum or Plasma --8 hours post 30 mg/kg metyrapone PO |
| 14360-2 | Microscopic observation [Identifier] in Pleural fluid by Gram stain |
| 14361-0 | Microscopic observation [Identifier] in Vaginal fluid by Gram stain |
| 14362-8 | Microscopic observation [Identifier] in Throat by Gram stain |
| 14363-6 | Microscopic observation [Identifier] in Synovial fluid by Gram stain |
| 14364-4 | Microscopic observation [Identifier] in Eye by Gram stain |
| 14365-1 | Microscopic observation [Identifier] in Ear by Gram stain |
| 14366-9 | Trichomonas vaginalis [Presence] in Cervix by Wet preparation |
| 14367-7 | Trichomonas vaginalis [Presence] in Vaginal fluid by Wet preparation |
| 14368-5 | Trichomonas vaginalis [Presence] in Urethra by Wet preparation |
| 14369-3 | Yeast [Presence] in Cervix by Wet preparation |
| 1437-3 | Cortisol [Mass/volume] in Serum or Plasma --8 hours post 500 ug dexamethasone PO 2.5 day low dose q6h |
| 14370-1 | Yeast [Presence] in Vaginal fluid by Wet preparation |
| 14371-9 | Yeast [Presence] in Urethra by Wet preparation |
| 14372-7 | Erythrocytes [#/volume] in Gastric fluid by Manual count |
| 14373-5 | Leukocytes [#/volume] in Gastric fluid by Manual count |
| 14374-3 | Polymorphonuclear cells/100 leukocytes in Pleural fluid by Manual count |
| 14375-0 | Polymorphonuclear cells/100 leukocytes in Peritoneal fluid by Manual count |
| 14376-8 | Polymorphonuclear cells/100 leukocytes in Synovial fluid by Manual count |
| 14377-6 | Polymorphonuclear cells/100 leukocytes in Semen by Manual count |
| 14378-4 | Polymorphonuclear cells/100 leukocytes in Urine by Manual count |
| 14379-2 | Polymorphonuclear cells/100 leukocytes in Gastric fluid by Manual count |
| 1438-1 | Cortisol [Mass/volume] in Serum or Plasma --8 hours post 40 ug corticotropin IM BID 3 day |
| 14380-0 | Mononuclear cells/100 leukocytes in Pleural fluid by Manual count |
| 14381-8 | Mononuclear cells/100 leukocytes in Peritoneal fluid by Manual count |
| 14382-6 | Mononuclear cells/100 leukocytes in Synovial fluid by Manual count |
| 14383-4 | Mononuclear cells/100 leukocytes in Semen by Manual count |
| 14384-2 | Mononuclear cells/100 leukocytes in Urine sediment by Manual count |
| 14385-9 | Mononuclear cells/100 leukocytes in Gastric fluid by Manual count |
| 14386-7 | Glucose [Mass/volume] in Gastric fluid |
| 14387-5 | Protein [Mass/volume] in Gastric fluid |
| 14388-3 | Amylase [Enzymatic activity/volume] in Synovial fluid |
| 14389-1 | Amylase [Enzymatic activity/volume] in Cerebral spinal fluid |
| 1439-9 | Cortisol [Mass/volume] in Serum or Plasma --9.5 hours post 8 mg dexamethasone PO overnight high dose |
| 14390-9 | Amylase [Enzymatic activity/volume] in Dialysis fluid |
| 14391-7 | Amylase [Enzymatic activity/volume] in Gastric fluid |
| 14392-5 | Amylase [Enzymatic activity/volume] in Amniotic fluid |
| 14393-3 | Urea nitrogen [Mass/volume] in Amniotic fluid |
| 14394-1 | Urea nitrogen [Mass/volume] in Pleural fluid |
| 14395-8 | Deprecated Urea nitrogen [Mass/volume] in Peritoneal fluid |
| 14396-6 | Urea nitrogen [Mass/volume] in Synovial fluid |
| 14397-4 | Urea nitrogen [Mass/volume] in Gastric fluid |
| 14398-2 | Creatinine [Mass/volume] in Cerebral spinal fluid |
| 14399-0 | Creatinine [Mass/volume] in Pleural fluid |
| 144-6 | Cefuroxime Parenteral [Susceptibility] by Minimum lethal concentration (MLC) |
| 1440-7 | Cortisol [Mass/volume] in Serum or Plasma --9 hours post 1 mg dexamethasone PO overnight |
| 14400-6 | Deprecated Creatinine [Mass/volume] in Peritoneal fluid |
| 14401-4 | Creatinine [Mass/volume] in Synovial fluid |
| 14402-2 | Creatinine [Mass/volume] in Gastric fluid |
| 14403-0 | Lactate dehydrogenase [Enzymatic activity/volume] in Gastric fluid |
| 14404-8 | Phosphate [Mass/volume] in Pleural fluid |
| 14405-5 | Phosphate [Mass/volume] in Peritoneal fluid |
| 14406-3 | Phosphate [Mass/volume] in Synovial fluid |
| 14407-1 | Phosphate [Mass/volume] in Gastric fluid |
| 14408-9 | Phosphate [Mass/volume] in Amniotic fluid |
| 14409-7 | Aspartate aminotransferase [Enzymatic activity/volume] in Pleural fluid |
| 1441-5 | Cortisol [Mass/volume] in Serum or Plasma --9 hours post 3 g metyrapone PO overnight |
| 14410-5 | Aspartate aminotransferase [Enzymatic activity/volume] in Peritoneal fluid |
| 14411-3 | Aspartate aminotransferase [Enzymatic activity/volume] in Synovial fluid |
| 14412-1 | Aspartate aminotransferase [Enzymatic activity/volume] in Gastric fluid |
| 14413-9 | Aspartate aminotransferase [Enzymatic activity/volume] in Urine |
| 14414-7 | Aspartate aminotransferase [Enzymatic activity/volume] in Dialysis fluid |
| 14415-4 | Calcium [Moles/volume] in Amniotic fluid |
| 14416-2 | Calcium [Moles/volume] in Pleural fluid |
| 14417-0 | Calcium [Moles/volume] in Peritoneal fluid |
| 14418-8 | Calcium [Moles/volume] in Synovial fluid |
| 14419-6 | Calcium [Moles/volume] in Gastric fluid |
| 1442-3 | Cortisol [Mass/volume] in Serum or Plasma --9 hours post 8 mg dexamethasone PO overnight high dose |
| 14420-4 | Bilirubin.total [Mass/volume] in Dialysis fluid |
| 14421-2 | Bilirubin.total [Mass/volume] in Pleural fluid |
| 14422-0 | Bilirubin.total [Mass/volume] in Peritoneal fluid |
| 14423-8 | Bilirubin.total [Mass/volume] in Synovial fluid |
| 14424-6 | Bilirubin.total [Mass/volume] in Gastric fluid |
| 14425-3 | Globulin [Mass/volume] in Amniotic fluid |
| 14426-1 | Globulin [Mass/volume] in Cerebral spinal fluid |
| 14427-9 | Globulin [Mass/volume] in Pleural fluid |
| 14428-7 | Globulin [Mass/volume] in Peritoneal fluid |
| 14429-5 | Globulin [Mass/volume] in Semen |
| 1443-1 | Cortisol [Mass/volume] in Serum or Plasma --pre 1 ug/kg CRH IV |
| 14430-3 | Globulin [Mass/volume] in Synovial fluid |
| 14431-1 | Globulin [Mass/volume] in Urine |
| 14432-9 | Albumin/Globulin [Mass Ratio] in Amniotic fluid |
| 14433-7 | Albumin/Globulin [Mass Ratio] in Cerebral spinal fluid |
| 14434-5 | Albumin/Globulin [Mass Ratio] in Pleural fluid |
| 14435-2 | Albumin/Globulin [Mass Ratio] in Peritoneal fluid |
| 14436-0 | Albumin/Globulin [Mass Ratio] in Semen |
| 14437-8 | Albumin/Globulin [Mass Ratio] in Synovial fluid |
| 14438-6 | Cholesterol [Mass/volume] in Amniotic fluid |
| 14439-4 | Cholesterol [Mass/volume] in Cerebral spinal fluid |
| 1444-9 | Cortisol [Mass/volume] in Serum or Plasma --pre 12 hour fast |
| 14440-2 | Deprecated Cholesterol [Mass/volume] in Pleural fluid |
| 14441-0 | Cholesterol [Mass/volume] in Peritoneal fluid |
| 14442-8 | Cholesterol [Mass/volume] in Semen |
| 14443-6 | Cholesterol [Mass/volume] in Synovial fluid |
| 14444-4 | Cholesterol [Mass/volume] in Urine |
| 14445-1 | Triglyceride [Mass/volume] in Amniotic fluid |
| 14446-9 | Triglyceride [Mass/volume] in Cerebral spinal fluid |
| 14447-7 | Triglyceride [Mass/volume] in Peritoneal fluid |
| 14448-5 | Triglyceride [Mass/volume] in Semen |
| 14449-3 | Triglyceride [Mass/volume] in Synovial fluid |
| 1445-6 | Cortisol [Mass/volume] in Serum or Plasma --pre 1 mg dexamethasone PO overnight |
| 14450-1 | Triglyceride [Mass/volume] in Urine |
| 14451-9 | Virus identified in Eye by Culture |
| 14452-7 | Virus identified in Cervix by Culture |
| 14453-5 | Virus identified in Vaginal fluid by Culture |
| 14454-3 | Virus identified in Nose by Culture |
| 14455-0 | Virus identified in Pleural fluid by Culture |
| 14456-8 | Virus identified in Peritoneal fluid by Culture |
| 14457-6 | Virus identified in Urine by Culture |
| 14458-4 | Virus identified in Sputum by Culture |
| 14459-2 | Virus identified in Penis by Culture |
| 1446-4 | Cortisol [Mass/volume] in Serum or Plasma --pre 3 g metyrapone PO overnight |
| 14460-0 | Virus identified in Urethra by Culture |
| 14461-8 | Chlamydia trachomatis [Presence] in Blood by Organism specific culture |
| 14462-6 | Chlamydia trachomatis [Presence] in Cerebral spinal fluid by Organism specific culture |
| 14463-4 | Chlamydia trachomatis [Presence] in Cervix by Organism specific culture |
| 14464-2 | Chlamydia trachomatis [Presence] in Vaginal fluid by Organism specific culture |
| 14465-9 | Chlamydia trachomatis [Presence] in Urethra by Organism specific culture |
| 14466-7 | Deprecated Chlamydia trachomatis [Presence] in Penis by Organism specific culture |
| 14467-5 | Chlamydia trachomatis [Presence] in Urine sediment by Organism specific culture |
| 14468-3 | Chlamydia trachomatis Ag [Presence] in Blood by Immunoassay |
| 14469-1 | Chlamydia trachomatis Ag [Presence] in Cerebral spinal fluid by Immunoassay |
| 1447-2 | Cortisol [Mass/volume] in Serum or Plasma --pre 40 ug corticotropin IM 3 day |
| 14470-9 | Chlamydia trachomatis Ag [Presence] in Cervix by Immunoassay |
| 14471-7 | Chlamydia trachomatis Ag [Presence] in Vaginal fluid by Immunoassay |
| 14472-5 | Chlamydia trachomatis Ag [Presence] in Urethra by Immunoassay |
| 14473-3 | Deprecated Chlamydia trachomatis Ag [Presence] in Penis by Immunoassay |
| 14474-1 | Chlamydia trachomatis Ag [Presence] in Urine sediment by Immunoassay |
| 14475-8 | Bacteria identified in Cervix by Aerobe culture |
| 14476-6 | Deprecated Bacteria identified in Vaginal fluid by Aerobe culture |
| 14477-4 | Bacteria identified in Urethra by Aerobe culture |
| 14478-2 | Bacteria identified in Penis by Aerobe culture |
| 14479-0 | Diphtheria identified in Throat by Organism specific culture |
| 1448-0 | Cortisol [Mass/volume] in Serum or Plasma --pre 500 ug dexamethasone PO 2.5 day low dose q6h |
| 14480-8 | Diphtheria identified in Sputum by Organism specific culture |
| 14481-6 | Diphtheria identified in Nose by Organism specific culture |
| 14482-4 | Diphtheria identified in Skin by Organism specific culture |
| 14483-2 | Diphtheria identified in Bronchial specimen by Organism specific culture |
| 14484-0 | Mycoplasma sp and Ureaplasma sp [Identifier] in Cervix by Organism specific culture |
| 14485-7 | Mycoplasma sp and Ureaplasma sp [Identifier] in Vaginal fluid by Organism specific culture |
| 14486-5 | Mycoplasma sp and Ureaplasma sp [Identifier] in Penis by Organism specific culture |
| 14487-3 | Mycoplasma sp and Ureaplasma sp [Identifier] in Urethra by Organism specific culture |
| 14488-1 | Virus identified in Cerebral spinal fluid by Immunofluorescence |
| 14489-9 | Virus identified in Blood by Immunofluorescence |
| 1449-8 | Cortisol [Mass/volume] in Serum or Plasma --pre 8 mg dexamethasone PO overnight high dose |
| 14490-7 | Virus identified in Semen by Immunofluorescence |
| 14491-5 | Virus identified in Throat by Immunofluorescence |
| 14492-3 | Virus identified in Eye by Immunofluorescence |
| 14493-1 | Virus identified in Cervix by Immunofluorescence |
| 14494-9 | Virus identified in Vaginal fluid by Immunofluorescence |
| 14495-6 | Virus identified in Urine sediment by Immunofluorescence |
| 14496-4 | Virus identified in Sputum by Immunofluorescence |
| 14497-2 | Virus identified in Penis by Immunofluorescence |
| 14498-0 | Virus identified in Urethra by Immunofluorescence |
| 14499-8 | Human papilloma virus Ag [Presence] in Cervix |
| 145-3 | Cefuroxime Parenteral [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 1450-6 | Cortisol [Mass/volume] in Serum or Plasma --pre 2 mg dexamethasone PO 2.5 day high dose q6h |
| 14500-3 | Human papilloma virus Ag [Presence] in Vaginal fluid |
| 14501-1 | Human papilloma virus Ag [Presence] in Penis |
| 14502-9 | Human papilloma virus Ag [Presence] in Urethra |
| 14503-7 | Human papilloma virus 16+18 Ag [Presence] in Cervix |
| 14504-5 | Human papilloma virus 16+18 Ag [Presence] in Vaginal fluid |
| 14505-2 | Human papilloma virus 16+18 Ag [Presence] in Penis |
| 14506-0 | Human papilloma virus 16+18 Ag [Presence] in Urethra |
| 14507-8 | Chlamydia trachomatis Ag [Presence] in Blood by Immunofluorescence |
| 14508-6 | Chlamydia trachomatis Ag [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 14509-4 | Chlamydia trachomatis Ag [Presence] in Cervix by Immunofluorescence |
| 1451-4 | Cortisol [Mass/volume] in Serum or Plasma --pre dose insulin IV |
| 14510-2 | Chlamydia trachomatis Ag [Presence] in Vaginal fluid by Immunofluorescence |
| 14511-0 | Chlamydia trachomatis Ag [Presence] in Urethra by Immunofluorescence |
| 14512-8 | Deprecated Chlamydia trachomatis Ag [Presence] in Penis by Immunofluorescence |
| 14513-6 | Chlamydia trachomatis Ag [Presence] in Urine sediment by Immunofluorescence |
| 14514-4 | Pneumocystis jiroveci Ag [Presence] in Blood by Immunofluorescence |
| 14515-1 | Pneumocystis jiroveci Ag [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 14516-9 | Pneumocystis jiroveci Ag [Presence] in Semen by Immunofluorescence |
| 14517-7 | Pneumocystis jiroveci Ag [Presence] in Stool by Immunofluorescence |
| 14518-5 | Pneumocystis jiroveci Ag [Presence] in Throat by Immunofluorescence |
| 14519-3 | Pneumocystis jiroveci Ag [Presence] in Eye by Immunofluorescence |
| 1452-2 | Creatinine [Mass/volume] in 24 hour Urine --24 hours post 40 ug corticotropin IM BID 3 day |
| 14520-1 | Pneumocystis jiroveci Ag [Presence] in Nose by Immunofluorescence |
| 14521-9 | Pneumocystis jiroveci Ag [Presence] in Urine by Immunofluorescence |
| 14522-7 | Pneumocystis jiroveci Ag [Presence] in Bronchial specimen by Immunofluorescence |
| 14523-5 | Rubella virus Ag [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 14524-3 | Rubella virus Ag [Presence] in Throat by Immunofluorescence |
| 14525-0 | Rubella virus Ag [Presence] in Skin by Immunofluorescence |
| 14526-8 | Rubella virus Ag [Presence] in Eye by Immunofluorescence |
| 14527-6 | Rubella virus Ag [Presence] in Nose by Immunofluorescence |
| 14528-4 | Rubella virus Ag [Presence] in Sputum by Immunofluorescence |
| 14529-2 | Rubella virus Ag [Presence] in Cervix by Immunofluorescence |
| 1453-0 | Creatinine [Mass/volume] in 24 hour Urine --48 hours post 40 ug corticotropin IM BID 3 day |
| 14530-0 | Rubella virus Ag [Presence] in Vaginal fluid by Immunofluorescence |
| 14531-8 | Rubella virus Ag [Presence] in Urine sediment by Immunofluorescence |
| 14532-6 | Rubella virus Ag [Presence] in Penis by Immunofluorescence |
| 14533-4 | Rubella virus Ag [Presence] in Urethra by Immunofluorescence |
| 14534-2 | Measles virus Ag [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 14535-9 | Measles virus Ag [Presence] in Throat by Immunofluorescence |
| 14536-7 | Measles virus Ag [Presence] in Skin by Immunofluorescence |
| 14537-5 | Measles virus Ag [Presence] in Eye by Immunofluorescence |
| 14538-3 | Measles virus Ag [Presence] in Nose by Immunofluorescence |
| 14539-1 | Measles virus Ag [Presence] in Sputum by Immunofluorescence |
| 1454-8 | Creatinine [Mass/volume] in 24 hour Urine --48 hours post 500 ug dexamethasone PO 2.5 day low dose q6h |
| 14540-9 | Measles virus Ag [Presence] in Cervix by Immunofluorescence |
| 14541-7 | Measles virus Ag [Presence] in Vaginal fluid by Immunofluorescence |
| 14542-5 | Measles virus Ag [Presence] in Urine sediment by Immunofluorescence |
| 14543-3 | Measles virus Ag [Presence] in Penis by Immunofluorescence |
| 14544-1 | Measles virus Ag [Presence] in Urethra by Immunofluorescence |
| 14545-8 | Mumps virus Ag [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 14546-6 | Mumps virus Ag [Presence] in Throat by Immunofluorescence |
| 14547-4 | Mumps virus Ag [Presence] in Skin by Immunofluorescence |
| 14548-2 | Mumps virus Ag [Presence] in Eye by Immunofluorescence |
| 14549-0 | Mumps virus Ag [Presence] in Nose by Immunofluorescence |
| 1455-5 | Creatinine [Mass/volume] in 24 hour Urine --48 hours post 2 mg dexamethasone PO 2.5 day high dose q6h |
| 14550-8 | Mumps virus Ag [Presence] in Sputum by Immunofluorescence |
| 14551-6 | Mumps virus Ag [Presence] in Cervix by Immunofluorescence |
| 14552-4 | Mumps virus Ag [Presence] in Vaginal fluid by Immunofluorescence |
| 14553-2 | Mumps virus Ag [Presence] in Urine sediment by Immunofluorescence |
| 14554-0 | Mumps virus Ag [Presence] in Penis by Immunofluorescence |
| 14555-7 | Mumps virus Ag [Presence] in Urethra by Immunofluorescence |
| 14556-5 | Mycobacterium tuberculosis DNA [Presence] in Sputum by Probe and target amplification method |
| 14557-3 | Mycobacterium tuberculosis DNA [Presence] in Bronchial specimen by Probe and target amplification method |
| 14558-1 | Mycobacterium tuberculosis DNA [Presence] in Gastric fluid by Probe and target amplification method |
| 14559-9 | Mycobacterium tuberculosis DNA [Presence] in Pleural fluid by Probe and target amplification method |
| 1456-3 | Creatinine [Mass/volume] in 24 hour Urine --72 hours post 40 ug corticotropin IM BID 3 day |
| 14560-7 | Mycobacterium tuberculosis DNA [Presence] in Urine by Probe and target amplification method |
| 14561-5 | Mycobacterium tuberculosis DNA [Presence] in Cerebral spinal fluid by Probe and target amplification method |
| 14562-3 | Mycobacterium tuberculosis DNA [Presence] in Semen by Probe and target amplification method |
| 14563-1 | Hemoglobin.gastrointestinal [Presence] in Stool --1st specimen |
| 14564-9 | Hemoglobin.gastrointestinal [Presence] in Stool --2nd specimen |
| 14565-6 | Hemoglobin.gastrointestinal [Presence] in Stool --3rd specimen |
| 14566-4 | Calcitriol [Moles/volume] in Serum or Plasma |
| 14567-2 | 11-Deoxycortisol [Moles/volume] in Serum or Plasma |
| 14568-0 | 17-Hydroxycorticosteroids [Moles/time] in 24 hour Urine |
| 14569-8 | 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma |
| 1457-1 | Creatinine [Mass/volume] in 24 hour Urine --pre 40 ug corticotropin IM 3 day |
| 14570-6 | 17-Hydroxyprogesterone [Moles/volume] in Urine |
| 14571-4 | 17-Hydroxyprogesterone [Moles/time] in 24 hour Urine |
| 14572-2 | 17-Ketosteroids [Moles/time] in 24 hour Urine |
| 14573-0 | 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine |
| 14574-8 | 8-Hydroxyamoxapine [Moles/volume] in Serum or Plasma |
| 14575-5 | Blood group antibody investigation [Interpretation] in Plasma or RBC |
| 14576-3 | Blood group antibody investigation [Interpretation] in Plasma or RBC by Senior review |
| 14577-1 | ABO and Rh group [Type] in Blood from donor |
| 14578-9 | ABO group [Type] in Blood from Blood product unit |
| 14579-7 | ABO group [Type] in Blood from donor |
| 1458-9 | Creatinine [Mass/volume] in 24 hour Urine --pre 500 ug dexamethasone PO 2.5 day low dose q6h |
| 14580-5 | ABO group [Type] in Blood from newborn |
| 14581-3 | Acetaminophen [Moles/volume] in Serum or Plasma |
| 14582-1 | Acetone [Moles/volume] in Serum or Plasma |
| 14583-9 | Acidity.titratable [Mass/volume] in Gastric fluid |
| 14584-7 | Adenosine monophosphate.cyclic [Moles/time] in 24 hour Urine |
| 14585-4 | Albumin/Creatinine [Molar ratio] in Urine |
| 14586-2 | Aldosterone [Moles/volume] in Serum or Plasma |
| 14587-0 | Aldosterone [Moles/time] in 24 hour Urine |
| 14588-8 | Alkaline phosphatase isoenzymes [Interpretation] in Serum or Plasma |
| 14589-6 | Amylase isoenzymes [Interpretation] in Serum or Plasma |
| 1459-7 | Creatinine [Mass/volume] in 24 hour Urine --pre 2 mg dexamethasone PO 2.5 day high dose q6h |
| 14590-4 | Alpha tocopherol [Moles/volume] in Serum or Plasma |
| 14591-2 | Alprazolam [Moles/volume] in Serum or Plasma |
| 14592-0 | Aluminum [Moles/volume] in 24 hour Urine |
| 14593-8 | Aluminum [Moles/volume] in Serum or Plasma |
| 14594-6 | Amitriptyline+Nortriptyline [Presence] in Gastric fluid |
| 14595-3 | Amitriptyline+Nortriptyline [Presence] in Serum or Plasma |
| 14596-1 | Amitriptyline+Nortriptyline [Presence] in Urine |
| 14597-9 | Amitriptyline [Moles/volume] in Serum or Plasma |
| 14598-7 | Amitriptyline+Nortriptyline [Moles/volume] in Serum or Plasma |
| 14599-5 | Ammonium [Presence] in Stone |
| 146-1 | Cefuroxime Parenteral [Susceptibility] by Disk diffusion (KB) |
| 1460-5 | Cobalamin (Vitamin B12) [Mass/time] in 24 hour Urine --post dose cyanocobalamin |
| 14600-1 | Amoxapine [Moles/volume] in Serum or Plasma |
| 14601-9 | Amoxapine+8-Hydroxyamoxapine [Moles/volume] in Serum or Plasma |
| 14602-7 | Deprecated Amoxapine+8-Hydroxyamoxapine [Molecules/volume] in Serum or Plasma |
| 14603-5 | Androstenedione [Moles/volume] in Serum or Plasma |
| 14604-3 | Blood group antibodies identified in Serum or Plasma from Blood product unit |
| 14605-0 | Blood group antibodies identified in Serum or Plasma from donor |
| 14606-8 | Blood group antibody screen [Presence] in Serum or Plasma by Prewarmed |
| 14607-6 | Nuclear Ab [Presence] in Body fluid |
| 14608-4 | Nuclear Ab [Presence] in Pleural fluid |
| 14609-2 | Nuclear Ab [Presence] in Peritoneal fluid |
| 1461-3 | Epinephrine [Mass/volume] in Plasma --1 hour post 300 ug clonidine PO |
| 14610-0 | Nuclear Ab [Presence] in Synovial fluid |
| 14611-8 | Nuclear Ab pattern [Interpretation] in Serum |
| 14612-6 | Nuclear Ab [Titer] in Pericardial fluid |
| 14613-4 | Nuclear Ab [Titer] in Body fluid |
| 14614-2 | Nuclear Ab [Titer] in Pleural fluid |
| 14615-9 | Nuclear Ab [Titer] in Peritoneal fluid |
| 14616-7 | Nuclear Ab [Titer] in Synovial fluid |
| 14617-5 | Appearance of Pericardial fluid |
| 14618-3 | Appearance of Stone |
| 14619-1 | Appearance of Plasma |
| 1462-1 | Epinephrine [Mass/volume] in Plasma --2 hours post 300 ug clonidine PO |
| 14620-9 | Appearance of Pleural fluid |
| 14621-7 | Appearance of Peritoneal fluid |
| 14622-5 | Ascorbate [Moles/volume] in Serum or Plasma |
| 14623-3 | Barbital [Presence] in Serum or Plasma |
| 14624-1 | Barbiturates [Presence] in Gastric fluid |
| 14625-8 | Basophils/100 leukocytes in Bronchial specimen by Manual count |
| 14626-6 | Beta-2-Microglobulin [Moles/volume] in Serum |
| 14627-4 | Bicarbonate [Moles/volume] in Venous blood |
| 14628-2 | Bile acid [Moles/volume] in Serum |
| 14629-0 | Bilirubin.direct [Moles/volume] in Serum or Plasma |
| 1463-9 | Epinephrine [Mass/volume] in Plasma --3 hours post 300 ug clonidine PO |
| 14630-8 | Bilirubin.indirect [Moles/volume] in Serum or Plasma |
| 14631-6 | Bilirubin.total [Moles/volume] in Serum or Plasma |
| 14632-4 | Deprecated Buffy coat |
| 14633-2 | C peptide [Moles/volume] in Serum or Plasma |
| 14634-0 | C reactive protein [Titer] in Serum or Plasma |
| 14635-7 | Calcidiol [Moles/volume] in Serum or Plasma |
| 14636-5 | Calcium [Presence] in Stone |
| 14637-3 | Calcium [Moles/time] in 24 hour Urine |
| 14638-1 | Calculus analysis [Interpretation] in Stone |
| 14639-9 | Carbamazepine [Moles/volume] in Serum or Plasma |
| 1464-7 | Epinephrine [Mass/volume] in Plasma --pre 300 ug clonidine PO |
| 14640-7 | Carbon dioxide, total [Moles/volume] in Dialysis fluid |
| 14641-5 | Carbonate [Presence] in Stone |
| 14642-3 | Carotene [Moles/volume] in Serum |
| 14643-1 | Catecholamines Free [Moles/time] in 24 hour Urine |
| 14644-9 | Chlorpromazine [Presence] in Gastric fluid |
| 14645-6 | Chlorpromazine [Moles/volume] in Serum or Plasma |
| 14646-4 | Cholesterol in HDL [Moles/volume] in Serum or Plasma |
| 14647-2 | Cholesterol [Moles/volume] in Serum or Plasma |
| 14648-0 | Chylomicrons [Moles/volume] in Serum or Plasma |
| 14649-8 | Cimetidine [Presence] in Gastric fluid |
| 1465-4 | Epinephrine [Mass/volume] in Plasma --supine |
| 14650-6 | Citrate [Moles/time] in 24 hour Urine |
| 14651-4 | Clobazam [Moles/volume] in Serum or Plasma |
| 14652-2 | Clomipramine [Moles/volume] in Serum or Plasma |
| 14653-0 | Clomipramine [Moles/volume] in Urine |
| 14654-8 | Clomipramine+Norclomipramine [Moles/volume] in Serum or Plasma |
| 14655-5 | Clonazepam [Moles/volume] in Serum or Plasma |
| 14656-3 | Clozapine [Moles/volume] in Serum or Plasma |
| 14657-1 | Clozapine+Norclozapine [Moles/volume] in Serum or Plasma |
| 14658-9 | Cold agglutinin [Titer] in Serum or Plasma |
| 14659-7 | Deprecated Collection duration of Urine |
| 1466-2 | Deprecated Follitropin [Mass/volume] in Serum or Plasma --1.5 hours post 100 g lutropin IV |
| 14660-5 | Color of Peritoneal fluid |
| 14661-3 | Color of Pericardial fluid |
| 14662-1 | Color of Pleural fluid |
| 14663-9 | Deprecated Color of Semen by Visual |
| 14664-7 | Color of Synovial fluid |
| 14665-4 | Copper [Moles/volume] in Serum or Plasma |
| 14666-2 | Copper [Moles/time] in 24 hour Urine |
| 14667-0 | Coproporphyrin 1 [Moles/volume] in Serum or Plasma |
| 14668-8 | Coproporphyrin 1 [Moles/volume] in Stool |
| 14669-6 | Coproporphyrin 1 [Moles/volume] in Urine |
| 1467-0 | Follitropin [Mass/volume] in Serum or Plasma --1.5 hours post dose gonadotropin releasing hormone |
| 14670-4 | Coproporphyrin 1/Porphyrins.total in Urine |
| 14671-2 | Coproporphyrin 3 [Moles/volume] in Serum or Plasma |
| 14672-0 | Coproporphyrin 3 [Moles/volume] in Stool |
| 14673-8 | Coproporphyrin 3 [Moles/volume] in Urine |
| 14674-6 | Corticotropin [Moles/volume] in Plasma |
| 14675-3 | Cortisol [Moles/volume] in Serum or Plasma |
| 14676-1 | Cortisol Free [Moles/time] in 24 hour Urine |
| 14677-9 | Cortisol [Moles/volume] in Serum or Plasma --24 hours post 500 ug dexamethasone PO 2.5 day low dose q6h |
| 14678-7 | Cortisol [Moles/volume] in Serum or Plasma --PM trough specimen |
| 14679-5 | Cortisol [Moles/volume] in Serum or Plasma --AM peak specimen |
| 1468-8 | Follitropin [Mass/volume] in Serum or Plasma --105 minutes post 100 ug lutenizing releasing hormone IV |
| 14680-3 | Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis |
| 14681-1 | Creatinine [Moles/volume] in Peritoneal dialysis fluid |
| 14682-9 | Creatinine [Moles/volume] in Serum or Plasma |
| 14683-7 | Creatinine [Moles/volume] in Urine |
| 14684-5 | Creatinine [Moles/time] in 24 hour Urine |
| 14685-2 | Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma |
| 14686-0 | Cystine [Presence] in Stone |
| 14687-8 | Transfusion date |
| 14688-6 | Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma |
| 14689-4 | Delta aminolevulinate [Moles/time] in 24 hour Urine |
| 1469-6 | Follitropin [Mass/volume] in Serum or Plasma --15 minutes post 100 ug lutenizing releasing hormone IV |
| 14690-2 | N-desalkylflurazepam [Moles/volume] in Serum or Plasma |
| 14691-0 | Desipramine [Moles/volume] in Serum or Plasma |
| 14692-8 | Desipramine [Moles/volume] in Urine |
| 14693-6 | Norclobazam [Moles/volume] in Serum or Plasma |
| 14694-4 | Norclomipramine [Moles/volume] in Serum or Plasma |
| 14695-1 | Nordoxepin [Moles/volume] in Serum or Plasma |
| 14696-9 | Deuteroporphyrin [Moles/volume] in Stool |
| 14697-7 | Diazepam [Moles/volume] in Serum or Plasma |
| 14698-5 | Digoxin [Moles/volume] in Serum or Plasma |
| 14699-3 | Diphenhydramine+Dimenhydrinate [Presence] in Gastric fluid |
| 147-9 | Cefuroxime Parenteral [Susceptibility] by Serum bactericidal titer |
| 1470-4 | Follitropin [Mass/volume] in Serum or Plasma --1 hour post 100 ug lutenizing releasing hormone IV |
| 14700-9 | Diphenhydramine+Dimenhydrinate [Presence] in Serum or Plasma |
| 14701-7 | Diphenhydramine+Dimenhydrinate [Presence] in Urine |
| 14702-5 | Disopyramide [Moles/volume] in Serum or Plasma |
| 14703-3 | Dopamine [Moles/volume] in Serum or Plasma |
| 14704-1 | Doxepin [Presence] in Gastric fluid |
| 14705-8 | Doxepin [Moles/volume] in Serum or Plasma |
| 14706-6 | Doxepin [Moles/volume] in Urine |
| 14707-4 | Doxepin+Nordoxepin [Moles/volume] in Serum or Plasma |
| 14708-2 | Endomysium Ab [Titer] in Serum |
| 14709-0 | Eosinophils/100 leukocytes in Bronchial specimen by Manual count |
| 1471-2 | Follitropin [Mass/volume] in Serum or Plasma --1 hour post dose gonadotropin releasing hormone |
| 14710-8 | Ephedrine+Pseudoephedrine [Presence] in Gastric fluid |
| 14711-6 | Epinephrine [Moles/volume] in Plasma |
| 14712-4 | Epinephrine [Moles/time] in 24 hour Urine |
| 14713-2 | Erythrocytes [#/volume] in Pericardial fluid by Manual count |
| 14714-0 | Erythropoietin (EPO) [Moles/volume] in Serum or Plasma |
| 14715-7 | Estradiol (E2) [Moles/volume] in Serum or Plasma |
| 14716-5 | Estriol (E3) [Moles/volume] in Serum or Plasma |
| 14717-3 | Estriol (E3) [Moles/volume] in Urine |
| 14718-1 | Estriol (E3) [Moles/time] in 24 hour Urine |
| 14719-9 | Ethanol [Moles/volume] in Serum or Plasma |
| 1472-0 | Follitropin [Mass/volume] in Serum or Plasma --2 hours post 100 ug lutenizing releasing hormone IV |
| 14720-7 | Ethosuximide [Moles/volume] in Serum or Plasma |
| 14721-5 | Ethylene glycol [Moles/volume] in Serum or Plasma |
| 14722-3 | Extractable nuclear Ab [Presence] in Serum |
| 14723-1 | Ferritin [Moles/volume] in Serum or Plasma |
| 14724-9 | Ferritin [Interpretation] in Blood |
| 14725-6 | [Type] of Body fluid |
| 14726-4 | Fluoride [Moles/volume] in Serum or Plasma |
| 14727-2 | Fluoxetine [Presence] in Gastric fluid |
| 14728-0 | Fluoxetine [Moles/volume] in Serum or Plasma |
| 14729-8 | Flurazepam [Moles/volume] in Serum or Plasma |
| 1473-8 | Follitropin [Mass/volume] in Serum or Plasma --30 minutes post 100 ug lutenizing releasing hormone IV |
| 14730-6 | Flurazepam+N-desalkylflurazepam [Moles/volume] in Serum or Plasma |
| 14731-4 | Folate [Moles/volume] in Red Blood Cells |
| 14732-2 | Folate [Moles/volume] in Serum or Plasma |
| 14733-0 | Folate+Cyanocobalamin [Interpretation] in Serum or Blood |
| 14734-8 | Follitropin [Moles/time] in 24 hour Urine |
| 14735-5 | Gastrin [Moles/volume] in Serum or Plasma --10 minutes post 0.2 U/kg secretin |
| 14736-3 | Gastrin [Moles/volume] in Serum or Plasma --15 minutes post 0.2 U/kg secretin |
| 14737-1 | Gastrin [Moles/volume] in Serum or Plasma --20 minutes post 0.2 U/kg secretin |
| 14738-9 | Gastrin [Moles/volume] in Serum or Plasma --25 minutes post 0.2 U/kg secretin |
| 14739-7 | Gastrin [Moles/volume] in Serum or Plasma --2 minutes post 0.2 U/kg secretin |
| 1474-6 | Follitropin [Mass/volume] in Serum or Plasma --30 minutes post dose gonadotropin releasing hormone |
| 14740-5 | Gastrin [Moles/volume] in Serum or Plasma --30 minutes post 0.2 U/kg secretin |
| 14741-3 | Gastrin [Moles/volume] in Serum or Plasma --5 minutes post 0.2 U/kg secretin |
| 14742-1 | Gastrin [Moles/volume] in Serum or Plasma --pre 0.2 U/kg secretin |
| 14743-9 | Glucose [Moles/volume] in Capillary blood by Glucometer |
| 14744-7 | Glucose [Moles/volume] in Cerebral spinal fluid |
| 14745-4 | Glucose [Moles/volume] in Body fluid |
| 14746-2 | Glucose [Moles/volume] in Peritoneal dialysis fluid |
| 14747-0 | Glucose [Moles/volume] in Pleural fluid |
| 14748-8 | Glucose [Moles/volume] in Peritoneal fluid |
| 14749-6 | Glucose [Moles/volume] in Serum or Plasma |
| 1475-3 | Follitropin [Mass/volume] in Serum or Plasma --45 minutes post 100 ug lutenizing releasing hormone IV |
| 14750-4 | Glucose [Moles/volume] in Synovial fluid |
| 14751-2 | Glucose [Moles/volume] in Serum or Plasma --1.5 hours post 50 g lactose PO |
| 14752-0 | Glucose [Moles/volume] in Serum or Plasma --1.5 hours post dose glucose |
| 14753-8 | Glucose [Moles/volume] in Serum or Plasma --1 hour post 100 g glucose PO |
| 14754-6 | Glucose [Moles/volume] in Serum or Plasma --1 hour post 50 g glucose PO |
| 14755-3 | Glucose [Moles/volume] in Serum or Plasma --1 hour post 50 g lactose PO |
| 14756-1 | Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose |
| 14757-9 | Glucose [Moles/volume] in Serum or Plasma --2 hours post 100 g glucose PO |
| 14758-7 | Glucose [Moles/volume] in Serum or Plasma --2 hours post 50 g lactose PO |
| 14759-5 | Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose |
| 1476-1 | Follitropin [Mass/volume] in Serum or Plasma --75 minutes post 100 ug lutenizing releasing hormone IV |
| 14760-3 | Glucose [Moles/volume] in Capillary blood --2 hours post meal |
| 14761-1 | Glucose [Moles/volume] in Serum or Plasma --2 hours post meal |
| 14762-9 | Glucose [Moles/volume] in Serum or Plasma --30 minutes post 50 g lactose PO |
| 14763-7 | Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose |
| 14764-5 | Glucose [Moles/volume] in Serum or Plasma --3 hours post 100 g glucose PO |
| 14765-2 | Glucose [Moles/volume] in Serum or Plasma --3 hours post dose glucose |
| 14766-0 | Glucose [Moles/volume] in Serum or Plasma --4 hours post dose glucose |
| 14767-8 | Glucose [Moles/volume] in Serum or Plasma --5 hours post dose glucose |
| 14768-6 | Glucose [Moles/volume] in Serum or Plasma --baseline |
| 14769-4 | Glucose [Moles/volume] in Serum or Plasma --pre 12 hour fast |
| 1477-9 | Follitropin [Mass/volume] in Serum or Plasma --baseline |
| 14770-2 | Fasting glucose [Moles/volume] in Capillary blood by Glucometer |
| 14771-0 | Fasting glucose [Moles/volume] in Serum or Plasma |
| 14772-8 | Gold [Moles/volume] in Serum or Plasma |
| 14773-6 | Granulocytes/100 leukocytes in Bronchial specimen by Manual count |
| 14774-4 | Haloperidol [Moles/volume] in Serum or Plasma |
| 14775-1 | Hemoglobin [Mass/volume] in Arterial blood by Oximetry |
| 14776-9 | Heptacarboxylate [Moles/volume] in Plasma |
| 14777-7 | Heptacarboxylate [Moles/volume] in Stool |
| 14778-5 | Heptacarboxylate [Moles/volume] in Urine |
| 14779-3 | Hexacarboxylate [Moles/volume] in Plasma |
| 1478-7 | Follitropin [Mass/volume] in Serum or Plasma --pre dose gonadotropin releasing hormone |
| 14780-1 | Hexacarboxylate [Moles/volume] in Stool |
| 14781-9 | Hexacarboxylate [Moles/volume] in Urine |
| 14782-7 | Homovanillate [Moles/volume] in Urine |
| 14783-5 | Homovanillate [Moles/time] in 24 hour Urine |
| 14784-3 | Hydroxyproline Free [Moles/time] in 24 hour Urine |
| 14785-0 | Hydroxyproline [Moles/time] in 24 hour Urine |
| 14786-8 | Deprecated Arthropod identified in Unspecified specimen |
| 14787-6 | Arthropod identified in Unspecified specimen by Permanent mount |
| 14788-4 | Helminth+Arthropod identified in Unspecified specimen by Rearing/Culture |
| 14789-2 | Helminth identified in Unspecified specimen by Macro/micro identification |
| 1479-5 | Galactose [Mass/volume] in Blood --1.5 hours post 40 g galactose PO |
| 14790-0 | Helminth identified in Unspecified specimen by Permanent mount |
| 14791-8 | Imipramine+Desipramine [Presence] in Gastric fluid |
| 14792-6 | Imipramine+Desipramine [Presence] in Serum or Plasma |
| 14793-4 | Imipramine+Desipramine [Presence] in Urine |
| 14794-2 | Imipramine+Desipramine [Moles/volume] in Serum or Plasma |
| 14795-9 | Immunoglobulin light chains [Interpretation] in Urine |
| 14796-7 | Insulin [Moles/volume] in Serum or Plasma |
| 14797-5 | Iron [Interpretation] in Serum or Plasma |
| 14798-3 | Iron [Moles/volume] in Serum or Plasma |
| 14799-1 | Iron [Moles/time] in 24 hour Urine |
| 148-7 | Cephalexin [Susceptibility] by Minimum lethal concentration (MLC) |
| 1480-3 | Galactose [Mass/volume] in Blood --1 hour post 40 g galactose PO |
| 14800-7 | Iron binding capacity [Moles/volume] in Serum or Plasma |
| 14801-5 | Iron saturation [Molar fraction] in Serum or Plasma |
| 14802-3 | Isopropanol [Moles/volume] in Serum or Plasma |
| 14803-1 | Lactate dehydrogenase [Enzymatic activity/volume] in Body fluid by Lactate to pyruvate reaction |
| 14804-9 | Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction |
| 14805-6 | Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Pyruvate to lactate reaction |
| 14806-4 | Lactose.PO [Mass] of Dose |
| 14807-2 | Lead [Moles/volume] in Blood |
| 14808-0 | Lead [Moles/volume] in Urine |
| 14809-8 | Lead [Moles/time] in 24 hour Urine |
| 1481-1 | Galactose [Mass/volume] in Blood --2 hours post 40 g galactose PO |
| 14810-6 | Leukocytes [#/volume] in Bronchial specimen by Manual count |
| 14811-4 | Leukocytes [#/volume] in Pericardial fluid by Manual count |
| 14812-2 | Lidocaine [Moles/volume] in Serum or Plasma |
| 14813-0 | Lipoprotein.alpha [Moles/volume] in Serum or Plasma by Electrophoresis |
| 14814-8 | Lipoprotein.beta [Moles/volume] in Serum or Plasma by Electrophoresis |
| 14815-5 | Lipoprotein.beta [Moles/volume] in Serum or Plasma by calculation |
| 14816-3 | Lipoprotein.pre-beta [Moles/volume] in Serum or Plasma by Electrophoresis |
| 14817-1 | Lorazepam [Moles/volume] in Serum or Plasma |
| 14818-9 | Lymphocytes/100 leukocytes in Pericardial fluid by Manual count |
| 14819-7 | Lymphocytes/100 leukocytes in Bronchial specimen by Manual count |
| 1482-9 | Galactose [Mass/volume] in Blood --30 minutes post 40 g galactose PO |
| 14820-5 | Lymphocytes/100 leukocytes in Pleural fluid by Manual count |
| 14821-3 | Lymphocytes/100 leukocytes in Peritoneal fluid by Manual count |
| 14822-1 | Lymphocytes/100 leukocytes in Synovial fluid by Manual count |
| 14823-9 | Macrophages/100 leukocytes in Bronchial specimen by Manual count |
| 14824-7 | Magnesium [Presence] in Stone |
| 14825-4 | Maprotiline [Moles/volume] in Serum or Plasma |
| 14826-2 | Meperidine [Presence] in Gastric fluid |
| 14827-0 | Mesoporphyrin [Moles/volume] in Stool |
| 14828-8 | Mesothelial cells/100 leukocytes in Pericardial fluid by Manual count |
| 14829-6 | Mesothelial cells/100 leukocytes in Pleural fluid by Manual count |
| 1483-7 | Galactose [Mass/time] in 5 hour Urine --post 40 g dose PO |
| 14830-4 | Mesothelial cells/100 leukocytes in Peritoneal fluid by Manual count |
| 14831-2 | Metanephrine/Creatinine [Molar ratio] in Urine |
| 14832-0 | Metanephrines [Moles/volume] in Urine |
| 14833-8 | Metanephrines [Moles/time] in 24 hour Urine |
| 14834-6 | Methamphetamine [Presence] in Gastric fluid |
| 14835-3 | Methanol [Moles/volume] in Serum or Plasma |
| 14836-1 | Methotrexate [Moles/volume] in Serum or Plasma |
| 14837-9 | Methsuximide [Moles/volume] in Serum or Plasma |
| 14838-7 | Toxoplasma gondii [Presence] in Tissue by Organism specific culture |
| 14839-5 | Trypanosoma sp identified in Buffy Coat by Light microscopy |
| 1484-5 | Gastrin [Mass/volume] in Serum or Plasma --10 minutes post 0.2 U/kg secretin |
| 14840-3 | Trypanosoma sp identified in Cerebral spinal fluid by Wet preparation |
| 14841-1 | Microscopic observation [Identifier] in Unspecified specimen by Iron hematoxylin stain |
| 14842-9 | Microscopic observation [Identifier] in Unspecified specimen by Kinyoun iron hematoxylin stain |
| 14843-7 | 6-Monoacetylmorphine (6-MAM) [Presence] in Gastric fluid |
| 14844-5 | 6-Monoacetylmorphine (6-MAM) [Presence] in Serum or Plasma |
| 14845-2 | Deprecated Monoacetylmorphine [Presence] in Urine |
| 14846-0 | N-acetylprocainamide [Moles/volume] in Serum or Plasma |
| 14847-8 | Neutrophils/100 leukocytes in Pericardial fluid by Manual count |
| 14848-6 | Neutrophils/100 leukocytes in Pleural fluid by Manual count |
| 14849-4 | Nitrazepam [Moles/volume] in Serum or Plasma |
| 1485-2 | Gastrin [Mass/volume] in Serum or Plasma --15 minutes post 0.2 U/kg secretin |
| 14850-2 | Nitrazepam [Moles/volume] in Urine |
| 14851-0 | Norclozapine [Moles/volume] in Serum or Plasma |
| 14852-8 | Norepinephrine [Moles/volume] in Plasma |
| 14853-6 | Norepinephrine [Moles/volume] in Urine |
| 14854-4 | Norepinephrine [Moles/time] in 24 hour Urine |
| 14855-1 | Norfluoxetine [Moles/volume] in Serum or Plasma |
| 14856-9 | Nortriptyline [Moles/volume] in Serum or Plasma |
| 14857-7 | Leukocytes other/100 leukocytes in Pericardial fluid by Manual count |
| 14858-5 | Leukocytes other/100 leukocytes in Pleural fluid by Manual count |
| 14859-3 | Leukocytes other/100 leukocytes in Peritoneal fluid by Manual count |
| 1486-0 | Gastrin [Mass/volume] in Serum or Plasma --20 minutes post 0.2 U/kg secretin |
| 14860-1 | Leukocytes other/100 leukocytes in Synovial fluid by Manual count |
| 14861-9 | Oxalate [Presence] in Stone |
| 14862-7 | Oxalate [Moles/time] in 24 hour Urine |
| 14863-5 | Oxycodone [Presence] in Gastric fluid |
| 14864-3 | Oxygen [Partial pressure] in Cord blood |
| 14865-0 | Parathyrin [Interpretation] in Serum or Plasma |
| 14866-8 | Parathyrin.intact [Moles/volume] in Serum or Plasma |
| 14867-6 | Paroxetine [Moles/volume] in Serum or Plasma |
| 14868-4 | Pathologist report of Plasma or RBC tests |
| 14869-2 | Pathologist review of Blood tests |
| 1487-8 | Gastrin [Mass/volume] in Serum or Plasma --25 minutes post 0.2 U/kg secretin |
| 14870-0 | Pentacarboxylate [Moles/volume] in Plasma |
| 14871-8 | Pentacarboxylate [Moles/volume] in Stool |
| 14872-6 | Pentacarboxylate [Moles/volume] in Urine |
| 14873-4 | pH of Cord blood |
| 14874-2 | Phenobarbital [Moles/volume] in Serum or Plasma |
| 14875-9 | Phenylalanine [Moles/volume] in Serum or Plasma |
| 14876-7 | Phenylpropanolamine [Presence] in Gastric fluid |
| 14877-5 | Phenytoin [Moles/volume] in Serum or Plasma |
| 14878-3 | Phosphate [Presence] in Stone |
| 14879-1 | Phosphate [Moles/volume] in Serum or Plasma |
| 1488-6 | Gastrin [Mass/volume] in Serum or Plasma --30 minutes post 0.2 U/kg secretin |
| 14880-9 | Deprecated Phosphate [Molecules/volume] in Urine |
| 14881-7 | Phosphate [Moles/time] in 24 hour Urine |
| 14882-5 | Porphobilinogen [Moles/time] in 24 hour Urine |
| 14883-3 | Porphyrins [Interpretation] in Serum or Plasma |
| 14884-1 | Porphyrins [Interpretation] in Stool |
| 14885-8 | Pregnanediol [Moles/time] in 24 hour Urine |
| 14886-6 | Pregnanetriol [Moles/time] in 24 hour Urine |
| 14887-4 | Primidone [Moles/volume] in Serum or Plasma |
| 14888-2 | Procainamide [Moles/volume] in Serum or Plasma |
| 14889-0 | Procainamide+N-acetylprocainamide [Moles/volume] in Serum or Plasma |
| 1489-4 | Gastrin [Mass/volume] in Serum or Plasma --5 minutes post 0.2 U/kg secretin |
| 14890-8 | Progesterone [Moles/volume] in Serum or Plasma |
| 14891-6 | Propranolol [Moles/volume] in Serum or Plasma |
| 14892-4 | Propranolol [Moles/volume] in Urine |
| 14893-2 | Propranolol [Moles/time] in 24 hour Urine |
| 14894-0 | Propylene glycol [Presence] in Serum or Plasma |
| 14895-7 | Protein Fractions [Interpretation] in Serum or Plasma by Immunofixation |
| 14896-5 | Protein Fractions [Interpretation] in Urine by Immunofixation |
| 14897-3 | Deprecated Protein [Mass/volume] in Plasma |
| 14898-1 | Protriptyline [Moles/volume] in Serum or Plasma |
| 14899-9 | Quinidine [Moles/volume] in Serum or Plasma |
| 149-5 | Cephalexin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 1490-2 | Gastrin [Mass/volume] in Serum or Plasma --pre 0.2 U/kg secretin |
| 14900-5 | Ranitidine [Presence] in Gastric fluid |
| 14901-3 | Ranitidine [Presence] in Serum or Plasma |
| 14902-1 | Ranitidine [Presence] in Urine |
| 14903-9 | Folate [Interpretation] in Blood |
| 14904-7 | Reagin Ab [Presence] in Unspecified specimen by VDRL |
| 14905-4 | Retinol [Moles/volume] in Serum or Plasma |
| 14906-2 | Rh [Type] in Cord blood |
| 14907-0 | Rh [Type] in Blood from Blood product unit |
| 14908-8 | Rh [Type] in Blood from newborn |
| 14909-6 | Salicylates [Moles/volume] in Serum or Plasma |
| 1491-0 | Glucose [Mass/volume] in Urine --30 minutes post 100 g glucose PO |
| 14910-4 | Serotonin [Moles/volume] in Serum |
| 14911-2 | Sertraline [Moles/volume] in Serum or Plasma |
| 14912-0 | Smudge cells/100 leukocytes in Blood by Manual count |
| 14913-8 | Testosterone [Moles/volume] in Serum or Plasma |
| 14914-6 | Testosterone Free [Moles/volume] in Serum or Plasma |
| 14915-3 | Theophylline [Moles/volume] in Serum or Plasma |
| 14916-1 | Thiocyanate [Moles/volume] in Serum or Plasma |
| 14917-9 | Thioridazine [Moles/volume] in Serum or Plasma |
| 14918-7 | Thyroglobulin [Moles/volume] in Serum or Plasma |
| 14919-5 | Thyrotropin binding inhibitory immunoglobulins [Presence] in Serum |
| 1492-8 | Glucose [Mass/volume] in Serum or Plasma --1.5 hours post 0.5 g/kg glucose IV |
| 14920-3 | Thyroxine (T4) free [Moles/volume] in Serum or Plasma |
| 14921-1 | Thyroxine (T4) [Moles/volume] in Serum or Plasma |
| 14922-9 | Toxoplasma gondii IgA+IgE Ab [Units/volume] in Serum by Immunoassay |
| 14923-7 | Toxoplasma gondii Ab [Units/volume] in Unspecified specimen |
| 14924-5 | Transfusion reaction [Interpretation] in Plasma or RBC Narrative |
| 14925-2 | Trazodone [Moles/volume] in Serum or Plasma |
| 14926-0 | Triazolam [Moles/volume] in Serum or Plasma |
| 14927-8 | Triglyceride [Moles/volume] in Serum or Plasma |
| 14928-6 | Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma |
| 14929-4 | Triiodothyronine (T3).reverse [Moles/volume] in Serum or Plasma |
| 1493-6 | Glucose [Mass/volume] in Serum or Plasma --1.5 hours post 0.05-0.15 U insulin/kg IV 12 hours fasting |
| 14930-2 | Triiodothyronine (T3) [Moles/volume] in Serum or Plasma |
| 14931-0 | Trimipramine [Moles/volume] in Serum or Plasma |
| 14932-8 | Urate [Presence] in Stone |
| 14933-6 | Urate [Moles/volume] in Serum or Plasma |
| 14934-4 | Urate [Moles/volume] in Urine |
| 14935-1 | Urate [Moles/time] in 24 hour Urine |
| 14936-9 | Urea nitrogen [Moles/volume] in Peritoneal dialysis fluid |
| 14937-7 | Urea nitrogen [Moles/volume] in Serum or Plasma |
| 14938-5 | Urea nitrogen [Moles/volume] in Urine |
| 14939-3 | Urea nitrogen [Moles/time] in 24 hour Urine |
| 1494-4 | Glucose [Mass/volume] in Serum or Plasma --1.5 hours post 100 g glucose PO |
| 14940-1 | Uroporphyrin 1 isomer [Moles/volume] in Serum or Plasma |
| 14941-9 | Uroporphyrin 1 isomer [Moles/volume] in Stool |
| 14942-7 | Uroporphyrin 1 isomer [Moles/volume] in Urine |
| 14943-5 | Uroporphyrin 3 isomer [Moles/volume] in Serum or Plasma |
| 14944-3 | Uroporphyrin 3 isomer [Moles/volume] in Stool |
| 14945-0 | Uroporphyrin 3 isomer [Moles/volume] in Urine |
| 14946-8 | Valproate [Moles/volume] in Serum or Plasma |
| 14947-6 | Vanillylmandelate [Moles/time] in 24 hour Urine |
| 14948-4 | Vanillylmandelate/Creatinine [Molar ratio] in Urine |
| 14949-2 | Vasopressin [Moles/volume] in Plasma |
| 1495-1 | Glucose [Mass/volume] in Urine --1.5 hours post 100 g glucose PO |
| 14950-0 | Viscosity of Synovial fluid Qualitative |
| 14951-8 | Volatile drugs positive [Identifier] in Serum or Plasma by Screen method |
| 14952-6 | Xylose [Moles/volume] in Blood --1 hour post 25 g xylose PO |
| 14953-4 | Xylose [Moles/volume] in Blood --2 hours post 25 g xylose PO |
| 14954-2 | Xylose [Moles/time] in 5 hour Urine --post dose PO |
| 14955-9 | Zinc [Moles/volume] in Serum or Plasma |
| 14956-7 | Microalbumin [Mass/time] in 24 hour Urine |
| 14957-5 | Microalbumin [Mass/volume] in Urine |
| 14958-3 | Microalbumin/Creatinine [Mass Ratio] in 24 hour Urine |
| 14959-1 | Microalbumin/Creatinine [Mass Ratio] in Urine |
| 1496-9 | Glucose [Mass/volume] in Serum or Plasma --1.5 hours post 75 g glucose PO |
| 14960-9 | Estradiol (E2) Free/Estradiol (E2).total in Serum or Plasma |
| 14961-7 | CD10 Abnormal blood cells/Abnormal blood cells.total in Blood |
| 14962-5 | CD13 Abnormal blood cells/Abnormal blood cells.total in Blood |
| 14963-3 | CD14 Abnormal blood cells/Abnormal blood cells.total in Blood |
| 14964-1 | CD19 Abnormal blood cells/Abnormal blood cells.total in Blood |
| 14965-8 | CD2 Abnormal blood cells/Abnormal blood cells.total in Blood |
| 14966-6 | CD20 Abnormal blood cells/Abnormal blood cells.total in Blood |
| 14967-4 | CD33 Abnormal blood cells/Abnormal blood cells.total in Blood |
| 14968-2 | CD5 Abnormal blood cells/Abnormal blood cells.total in Blood |
| 14969-0 | CD7 Abnormal blood cells/Abnormal blood cells.total in Blood |
| 1497-7 | Glucose [Mass/volume] in Serum or Plasma --1.5 hours post dose insulin IV |
| 14970-8 | Estrone (E1).bioavailable [Mass/volume] in Serum or Plasma |
| 14971-6 | Estrone (E1).bioavailable/Estrone (E1).total in Serum or Plasma |
| 14972-4 | Mycobacterium sp DNA [Presence] in Cerebral spinal fluid by Probe and target amplification method |
| 14973-2 | Mycobacterium sp DNA [Presence] in Sputum by Probe and target amplification method |
| 14974-0 | Mycobacterium sp DNA [Presence] in Unspecified specimen by Probe and target amplification method |
| 14975-7 | Human antimouse Ab [Mass/volume] in Serum |
| 14976-5 | Lecithin/Sphingomyelin [Ratio] in Amniotic fluid |
| 14977-3 | Immunoglobulin light chains.free [Type] in Urine |
| 14978-1 | Cyclosporine [Mass/volume] in Blood by Immunoassay |
| 14979-9 | aPTT in Platelet poor plasma by Coagulation assay |
| 1498-5 | Glucose [Mass/volume] in Serum or Plasma --10 minutes post 0.5 g/kg glucose IV |
| 14980-7 | A variant subtype Ab [Presence] in Serum or Plasma from Blood product unit |
| 14981-5 | A variant subtype Ab [Presence] in Serum or Plasma from donor |
| 14982-3 | A variant subtype Ab [Presence] in Serum or Plasma |
| 14983-1 | I (intermediate) subtype [Presence] on Red Blood Cells from Blood product unit |
| 14984-9 | I (intermediate) subtype [Presence] on Red Blood Cells from donor |
| 14985-6 | I (intermediate) subtype [Presence] on Red Blood Cells |
| 14986-4 | little i-1 subtype [Presence] on Red Blood Cells from Blood product unit |
| 14987-2 | little i-1 subtype [Presence] on Red Blood Cells from donor |
| 14988-0 | little i-1 subtype [Presence] on Red Blood Cells |
| 14989-8 | little i-2 subtype [Presence] on Red Blood Cells from Blood product unit |
| 1499-3 | Glucose [Mass/volume] in Serum or Plasma --1 hour post 0.5 g/kg glucose IV |
| 14990-6 | little i-2 subtype [Presence] on Red Blood Cells from donor |
| 14991-4 | little i-2 subtype [Presence] on Red Blood Cells |
| 14992-2 | O group [Presence] on Red Blood Cells from Blood product unit |
| 14993-0 | O group [Presence] on Red Blood Cells from donor |
| 14994-8 | O group [Presence] on Red Blood Cells |
| 14995-5 | Glucose [Moles/volume] in Serum or Plasma --2 hours post 75 g glucose PO |
| 14996-3 | Glucose [Moles/volume] in Serum or Plasma --pre 75 g glucose PO |
| 14997-1 | Thyrotropin [Units/volume] in Serum or Plasma --30 minutes post dose TRH IV |
| 14998-9 | Thyrotropin [Units/volume] in Serum or Plasma --1 hour post dose TRH IV |
| 14999-7 | Thyrotropin [Units/volume] in Serum or Plasma --baseline |
| 15-8 | Amoxicillin [Susceptibility] by Minimum lethal concentration (MLC) |
| 150-3 | Cephalexin [Susceptibility] by Disk diffusion (KB) |
| 1500-8 | Glucose [Mass/volume] in Serum or Plasma --1 hour post 0.05-0.15 U insulin/kg IV post 12H CFst |
| 15000-3 | Thyrotropin [Units/volume] in Serum or Plasma --pre dose TRH IV |
| 15001-1 | Xylose [Moles/volume] in Serum or Plasma --1 hour post 25 g xylose PO |
| 15002-9 | Xylose [Moles/volume] in Serum or Plasma --2 hours post 25 g xylose PO |
| 15003-7 | 11-Hydroxyandrosterone [Moles/time] in 24 hour Urine |
| 15004-5 | 11-Hydroxyetiocholanolone [Moles/time] in 24 hour Urine |
| 15005-2 | 11-Ketoandrosterone [Moles/time] in 24 hour Urine |
| 15006-0 | 11-Ketoetiocholanolone [Moles/time] in 24 hour Urine |
| 15007-8 | 2,3-Diphosphoglycerate [Moles/volume] in Red Blood Cells |
| 15008-6 | 3-Alpha-Androstanediol glucuronide [Moles/volume] in Serum |
| 15009-4 | 5-Hydroxyindoleacetate [Moles/volume] in Urine |
| 1501-6 | Glucose [Mass/volume] in Serum or Plasma --1 hour post 100 g glucose PO |
| 15010-2 | Aldosterone [Moles/volume] in Urine |
| 15011-0 | Aldosterone [Moles/volume] in Serum or Plasma --supine |
| 15012-8 | Aldosterone [Moles/volume] in Serum or Plasma --upright |
| 15013-6 | Alkaline phosphatase.bone/Alkaline phosphatase.total in Serum or Plasma |
| 15014-4 | Alkaline phosphatase.intestinal/Alkaline phosphatase.total in Serum or Plasma |
| 15015-1 | Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma |
| 15016-9 | Alkaline phosphatase.placental/Alkaline phosphatase.total in Serum or Plasma |
| 15017-7 | Alkaline phosphatase.regan/Alkaline phosphatase.total in Serum or Plasma |
| 15018-5 | Alkaline phosphatase.renal/Alkaline phosphatase.total in Serum or Plasma |
| 15019-3 | Alpha-1-Fetoprotein [Moles/volume] in Amniotic fluid |
| 1502-4 | Deprecated Glucose [Mass/volume] in Serum or Plasma --1 hour post 100 g glucose PO |
| 15020-1 | Amylase.P1/Amylase.total in Serum or Plasma |
| 15021-9 | Amylase.P2/Amylase.total in Serum or Plasma |
| 15022-7 | Amylase.P3/Amylase.total in Serum or Plasma |
| 15023-5 | Amylase S1/Amylase.total in Serum or Plasma |
| 15024-3 | Amylase S2/Amylase.total in Serum or Plasma |
| 15025-0 | Amylase S3/Amylase.total in Serum or Plasma |
| 15026-8 | Androstanediol [Moles/volume] in Serum or Plasma |
| 15027-6 | Androstenedione [Moles/volume] in Urine |
| 15028-4 | Androstenedione [Moles/time] in 24 hour Urine |
| 15029-2 | Androsterone [Moles/volume] in Serum or Plasma |
| 1503-2 | Glucose [Mass/volume] in Urine --1 hour post 100 g glucose PO |
| 15030-0 | Androsterone [Moles/time] in 24 hour Urine |
| 15031-8 | Angiotensin I [Moles/volume] in Plasma |
| 15032-6 | Angiotensin II [Moles/volume] in Plasma |
| 15033-4 | Ascorbate [Moles/time] in 24 hour Urine |
| 15034-2 | Bromide [Moles/volume] in Serum or Plasma |
| 15035-9 | Calcitonin [Moles/volume] in Serum or Plasma |
| 15036-7 | Catecholamines [Moles/time] in 24 hour Urine |
| 15037-5 | Chymotrypsin [Moles/mass] in Stool |
| 15038-3 | Citrate [Moles/volume] in Serum or Plasma |
| 15039-1 | Deprecated Cobalamin [Molecules/volume] in Serum |
| 1504-0 | Glucose [Mass/volume] in Serum or Plasma --1 hour post 50 g glucose PO |
| 15040-9 | Coproporphyrin [Moles/time] in 24 hour Stool |
| 15041-7 | Coproporphyrin [Moles/time] in 24 hour Urine |
| 15042-5 | Corticotropin [Units/volume] in Serum |
| 15043-3 | Cortisol [Moles/volume] in Urine |
| 15044-1 | Cortisol Free [Moles/volume] in Serum or Plasma |
| 15045-8 | Creatine [Moles/volume] in Serum or Plasma |
| 15046-6 | Creatine [Moles/volume] in Urine |
| 15047-4 | Creatine [Moles/time] in 24 hour Urine |
| 15048-2 | Creatine kinase.BB/Creatine kinase.total in Serum or Plasma by Electrophoresis |
| 15049-0 | Creatine kinase.MM/Creatine kinase.total in Serum or Plasma by Electrophoresis |
| 1505-7 | Glucose [Mass/volume] in Urine --1 hour post 50 g glucose PO |
| 15050-8 | Creatinine [Moles/volume] in Amniotic fluid |
| 15051-6 | Creatinine [Moles/volume] in Dialysis fluid |
| 15052-4 | Cobalamin (Vitamin B12).unsaturated Binding Capacity [Moles/volume] in Serum or Plasma |
| 15053-2 | Dehydroepiandrosterone sulfate (DHEA-S) [Moles/time] in 24 hour Urine |
| 15054-0 | Dehydroepiandrosterone (DHEA) [Moles/volume] in Serum or Plasma |
| 15055-7 | Deoxypyridinoline [Moles/time] in 24 hour Urine |
| 15056-5 | Deprecated Deoxypyridinoline [Molecules/time] in 24 hour Urine |
| 15057-3 | Androstanolone [Moles/volume] in Serum or Plasma |
| 15058-1 | Dopamine [Moles/volume] in Urine |
| 15059-9 | Dopamine [Moles/time] in 24 hour Urine |
| 1506-5 | Glucose [Mass/volume] in Serum or Plasma --1 hour post 50 g lactose PO |
| 15060-7 | Enolase.neuron specific [Mass/volume] in Serum or Plasma |
| 15061-5 | Erythropoietin (EPO) [Units/volume] in Serum or Plasma |
| 15062-3 | Estradiol (E2).unconjugated [Moles/time] in 24 hour Urine |
| 15063-1 | Estriol (E3).conjugated [Moles/volume] in Serum or Plasma |
| 15064-9 | Estriol (E3).unconjugated [Moles/volume] in Serum or Plasma |
| 15065-6 | Etiocholanolone [Moles/time] in 24 hour Urine |
| 15066-4 | Fatty acids.nonesterified [Moles/volume] in Serum or Plasma |
| 15067-2 | Follitropin [Units/volume] in Serum or Plasma |
| 15068-0 | Follitropin [Units] in 24 hour Urine |
| 15069-8 | Fructosamine [Moles/volume] in Serum or Plasma |
| 1507-3 | Glucose [Mass/volume] in Serum or Plasma --1 hour post 75 g glucose PO |
| 15070-6 | Fructose [Moles/time] in 24 hour Urine |
| 15071-4 | Galactose [Moles/time] in 24 hour Urine |
| 15072-2 | Gastrin [Moles/volume] in Serum or Plasma |
| 15073-0 | Glucagon [Moles/volume] in Serum or Plasma |
| 15074-8 | Glucose [Moles/volume] in Blood |
| 15075-5 | Glucose [Moles/volume] in Dialysis fluid |
| 15076-3 | Glucose [Moles/volume] in Urine |
| 15077-1 | Glucose [Moles/time] in 24 hour Urine |
| 15078-9 | Lactate [Moles/time] in 24 hour Urine |
| 15079-7 | Lutropin [Units/volume] in Urine |
| 1508-1 | Deprecated Glucose [Mass/volume] in Serum or Plasma --1 hour post 75 g glucose PO |
| 15080-5 | Lutropin [Units] in 24 hour Urine |
| 15081-3 | Prolactin [Units/volume] in Serum or Plasma |
| 15082-1 | Methemoglobin [Mass/volume] in Blood |
| 15083-9 | Normetanephrine [Moles/time] in 24 hour Urine |
| 15084-7 | Osteocalcin [Moles/volume] in Serum or Plasma |
| 15085-4 | Oxalate [Moles/volume] in Serum or Plasma |
| 15086-2 | Oxalate [Moles/volume] in Urine |
| 15087-0 | Parathyrin related protein [Moles/volume] in Serum or Plasma |
| 15088-8 | Parathyrin.C-terminal [Moles/volume] in Serum or Plasma |
| 15089-6 | Phospholipid [Moles/volume] in Serum or Plasma |
| 1509-9 | Glucose [Mass/volume] in Urine --1 hour post 75 g glucose PO |
| 15090-4 | Porphyrins [Moles/time] in 24 hour Stool |
| 15091-2 | Pregnanediol [Moles/volume] in Urine |
| 15092-0 | Pregnanetriol [Moles/volume] in Urine |
| 15093-8 | Protoporphyrin Free [Moles/volume] in Blood |
| 15094-6 | Testosterone [Moles/volume] in Urine |
| 15095-3 | Testosterone [Moles/time] in 24 hour Urine |
| 15096-1 | Uroporphyrin [Moles/time] in 24 hour Urine |
| 15097-9 | Vanillylmandelate [Moles/volume] in Urine |
| 15098-7 | Amikacin [Moles/volume] in Serum or Plasma --random |
| 15099-5 | Amiodarone [Moles/volume] in Serum or Plasma |
| 151-1 | Cephalexin [Susceptibility] by Serum bactericidal titer |
| 1510-7 | Glucose [Mass/volume] in Serum or Plasma --1 hour post dose insulin IV |
| 15100-1 | Barbiturates [Moles/volume] in Serum or Plasma |
| 15101-9 | Chloramphenicol [Moles/volume] in Serum or Plasma |
| 15102-7 | Codeine [Moles/volume] in Serum or Plasma |
| 15103-5 | Cyclosporine [Moles/volume] in Serum |
| 15104-3 | Digitoxin [Moles/volume] in Serum or Plasma |
| 15105-0 | Flecainide [Moles/volume] in Serum or Plasma |
| 15106-8 | Gentamicin [Moles/volume] in Serum or Plasma --random |
| 15107-6 | Imipramine [Moles/volume] in Serum or Plasma |
| 15108-4 | Methadone [Moles/volume] in Serum or Plasma |
| 15109-2 | Midazolam [Moles/volume] in Serum or Plasma |
| 1511-5 | Deprecated Glucose [Mass/volume] in Serum or Plasma --1 hour post dose insulin IV |
| 15110-0 | Morphine [Moles/volume] in Serum or Plasma |
| 15111-8 | Tricyclic antidepressants [Moles/volume] in Serum or Plasma |
| 15112-6 | Leukocyte phosphatase [Units/volume] in Leukocytes |
| 15113-4 | Aluminum [Moles/volume] in Dialysis fluid |
| 15114-2 | Arsenic [Moles/volume] in Blood |
| 15115-9 | Arsenic [Moles/volume] in Urine |
| 15116-7 | Deprecated Arsenic [Molecules/volume] in Urine |
| 15117-5 | Cadmium [Moles/volume] in Blood |
| 15118-3 | Chromium [Moles/volume] in Blood |
| 15119-1 | Cobalt [Moles/volume] in Blood |
| 1512-3 | Glucose [Mass/volume] in Serum or Plasma --1 minute post 0.5 g/kg glucose IV |
| 15120-9 | Ethanol [Moles/volume] in Blood |
| 15121-7 | Lipoprotein.alpha/total Lipoprotein in Serum or Plasma |
| 15122-5 | Lipoprotein.beta/total Lipoprotein in Serum or Plasma |
| 15123-3 | Lipoprotein.pre-beta/total Lipoprotein in Serum or Plasma |
| 15124-1 | Albumin/Protein.total in Synovial fluid by Electrophoresis |
| 15125-8 | Alpha 1 globulin/Protein.total in Synovial fluid by Electrophoresis |
| 15126-6 | Alpha 2 globulin/Protein.total in Synovial fluid by Electrophoresis |
| 15127-4 | Beta globulin/Protein.total in Synovial fluid by Electrophoresis |
| 15128-2 | Gamma globulin/Protein.total in Synovial fluid by Electrophoresis |
| 15129-0 | Deprecated Fibrin D-dimer EIA |
| 1513-1 | Glucose [Mass/volume] in Serum or Plasma --20 minutes post 0.5 g/kg glucose IV |
| 15130-8 | Methionine+Tryptophan [Presence] in Serum or Plasma |
| 15131-6 | Isoleucine+Leucine [Presence] in Serum or Plasma |
| 15132-4 | Beta aminoisobutyrate+Proline [Presence] in Serum or Plasma |
| 15133-2 | Anserine+Carnosine+Cysteine+Histidine+Ornithine [Presence] in Serum or Plasma |
| 15134-0 | Glutamate+Glutamine+Threonine [Presence] in Serum or Plasma |
| 15135-7 | Aspartate+Citrulline+Glycine+Homocystine+Hydroxyproline [Presence] in Serum or Plasma |
| 15136-5 | Arginine+Argininosuccinate+Lysine+Serine+Taurine [Presence] in Serum or Plasma |
| 15137-3 | Alanine+Ethanolamine [Presence] in Serum or Plasma |
| 15138-1 | Isoleucine+Leucine [Presence] in Urine |
| 15139-9 | Anserine+Carnosine+Cysteine+Histidine+Ornithine [Presence] in Urine |
| 1514-9 | Glucose [Mass/volume] in Serum or Plasma --2 hours post 100 g glucose PO |
| 15140-7 | Arginine+Argininosuccinate+Lysine+Serine+Taurine [Presence] in Urine |
| 15141-5 | Beta aminoisobutyrate+Proline [Presence] in Urine |
| 15142-3 | Alanine+Ethanolamine [Presence] in Urine |
| 15143-1 | Aspartate+Citrulline+Glycine+Homocystine+Hydroxyproline [Presence] in Urine |
| 15144-9 | Glutamate+Glutamine+Threonine [Presence] in Urine |
| 15145-6 | Methionine+Tryptophan [Presence] in Urine |
| 15146-4 | Acetone [Units/volume] in Body fluid |
| 15147-2 | Deprecated Acetone [Units] in 24 hour Urine Qualitative |
| 15148-0 | Alkaline phosphatase [Enzymatic activity/volume] in Body fluid |
| 15149-8 | Ammonia [Moles/volume] in Body fluid |
| 1515-6 | Deprecated Glucose [Mass/volume] in Serum or Plasma --2 hours post 100 g glucose PO |
| 15150-6 | Anisocytosis [Presence] in Blood by Automated count |
| 15151-4 | Aspergillus fumigatus 3 Ab [Presence] in Serum by Immune diffusion (ID) |
| 15152-2 | Bilirubin.conjugated [Mass/volume] in Serum or Plasma |
| 15153-0 | Deprecated Indirect bilirubin [Mass/volume] in Serum or Plasma |
| 15154-8 | Blasts [Presence] in Blood by Automated count |
| 15155-5 | Calcium [Mass/volume] in Body fluid |
| 15156-3 | Cancer Ag 125 [Units/volume] in Body fluid by Dilution |
| 15157-1 | Cancer Ag 125 [Units/volume] in Serum or Plasma by Dilution |
| 15158-9 | Chloride [Moles/volume] in Stool |
| 15159-7 | Coagulation factor extrinsic pathway [Interpretation] in Platelet poor plasma Narrative |
| 1516-4 | Glucose [Mass/volume] in Urine --2 hours post 100 g glucose PO |
| 15160-5 | Coagulation factor Intrinsic Factor [Interpretation] in Platelet poor plasma Narrative |
| 15161-3 | Complement C1 esterase inhibitor.functional [Presence] in Serum or Plasma |
| 15162-1 | Complement C1q [Mass/volume] in Body fluid |
| 15163-9 | Complement C2 [Mass/volume] in Body fluid |
| 15164-7 | Complement C3 [Mass/volume] in Synovial fluid |
| 15165-4 | Complement C4 [Mass/volume] in Synovial fluid |
| 15166-2 | Complement C5 [Mass/volume] in Body fluid |
| 15167-0 | Complement C6 [Mass/volume] in Body fluid |
| 15168-8 | Complement total hemolytic C50 [Units/volume] in Body fluid by Immunoassay |
| 15169-6 | Complement total hemolytic C50 [Units/volume] in Serum or Plasma by Immunoassay |
| 1517-2 | Glucose [Mass/volume] in Serum or Plasma --2 hours post 50 g lactose PO |
| 15170-4 | Complement total hemolytic C50 [Units/volume] in Synovial fluid by Immunoassay |
| 15171-2 | Cryoglobulin.IgA [Units/volume] in Serum |
| 15172-0 | Cryoglobulin.IgG [Units/volume] in Serum |
| 15173-8 | Cryoglobulin.IgM [Units/volume] in Serum |
| 15174-6 | Cryocrit of Serum by Spun Westergren |
| 15175-3 | Cryoproteins [Interpretation] in Serum or Plasma by Electrophoresis agarose gel |
| 15176-1 | Cryoproteins identified in Serum or Plasma |
| 15177-9 | DNA double strand Ab [Units/volume] in Body fluid |
| 15178-7 | Complement factor B [Mass/volume] in Body fluid |
| 15179-5 | Fibrin D-dimer [Presence] in Platelet poor plasma |
| 1518-0 | Glucose [Mass/volume] in Serum or Plasma --2 hours post 75 g glucose PO |
| 15180-3 | Hypochromia [Presence] in Blood by Automated count |
| 15181-1 | IgA [Mass/volume] in Body fluid |
| 15182-9 | IgA [Presence] in Serum by Immunoelectrophoresis |
| 15183-7 | IgG [Mass/volume] in Body fluid |
| 15184-5 | IgG [Presence] in Serum by Immunoelectrophoresis |
| 15185-2 | IgM [Mass/volume] in Body fluid |
| 15186-0 | IgM [Presence] in Serum by Immunoelectrophoresis |
| 15187-8 | Immunoglobulin light chains.lambda [Mass/volume] in 24 hour Urine |
| 15188-6 | Immunoglobulin light chains.kappa [Mass/volume] in 24 hour Urine |
| 15189-4 | Immunoglobulin light chains.kappa/Immunoglobulin light chains.lambda [Mass Ratio] in Serum |
| 1519-8 | Deprecated Glucose [Mass/volume] in Serum or Plasma --2 hours post 75 g glucose PO |
| 15190-2 | Leukocytes other [Identifier] in Blood by Automated count |
| 15191-0 | Lupus anticoagulant neutralization dilute phospholipid [Presence] in Platelet poor plasma |
| 15192-8 | Variant lymphocytes [Presence] in Blood by Automated count |
| 15193-6 | CD3-CD16+ cells [#/volume] in Blood |
| 15194-4 | CD3-CD16+ cells/100 cells in Blood |
| 15195-1 | CD3-CD19+ cells [#/volume] in Blood |
| 15196-9 | CD3-CD19+ cells/100 cells in Blood |
| 15197-7 | Lymphocytes clefted/100 leukocytes in Blood by Manual count |
| 15198-5 | Macrocytes [Presence] in Blood by Automated count |
| 15199-3 | Microcytes [Presence] in Blood by Automated count |
| 152-9 | Cephaloglycin [Susceptibility] by Minimum lethal concentration (MLC) |
| 1520-6 | Glucose [Mass/volume] in Urine --2 hours post 75 g glucose PO |
| 15200-9 | Osmolality of Body fluid |
| 15201-7 | Platelets Large Fragments [#/volume] in Blood by Manual count |
| 15202-5 | Potassium [Moles/volume] in Stool |
| 15203-3 | Rheumatoid factor [Units/volume] in Body fluid by Nephelometry |
| 15204-1 | Rheumatoid factor [Titer] in Serum by Nephelometry |
| 15205-8 | Rheumatoid factor [Units/volume] in Serum by Nephelometry |
| 15206-6 | Rheumatoid factor [Units/volume] in Synovial fluid by Nephelometry |
| 15207-4 | Sodium [Moles/volume] in Stool |
| 15208-2 | Taurine [Presence] in Nose |
| 15209-0 | Saccharomonospora viridis Ab [Presence] in Serum by Immune diffusion (ID) |
| 1521-4 | Glucose [Mass/volume] in Serum or Plasma --2 hours post meal |
| 15210-8 | Thyroglobulin Ab [Presence] in Serum |
| 15211-6 | Biopsy [Interpretation] in Thyroid Narrative |
| 15212-4 | Lipase [Enzymatic activity/volume] in Body fluid |
| 15213-2 | Epidermal Allergen Mix 2 (Cat dander+Dog dander+Guinea pig epithelium+Mouse+Rat) IgE Ab [Presence] in Serum by Multidisk |
| 15214-0 | Epidermal Allergen Mix 70 (Guinea pig epithelium+Hamster epithelium+Mouse+Rabbit epithelium+Rat) IgE Ab [Presence] in Serum by Multidisk |
| 15215-7 | Epidermal Allergen Mix 71 (Chicken feather+Duck feather+Goose feather+Turkey feather) IgE Ab [Presence] in Serum by Multidisk |
| 15216-5 | Epidermal Allergen Mix 72 (Budgerigar feather+Canary feather+Finch feather+Parakeet feather+Parrot feather) IgE Ab [Presence] in Serum by Multidisk |
| 15217-3 | Food Allergen Mix 1 (Peanut+Brazil nut+Coconut+Hazelnut+Almond) IgE Ab [Presence] in Serum by Multidisk |
| 15218-1 | Food Allergen Mix 2 (Cod+Blue Mussel+Shrimp+Salmon+Tuna) IgE Ab [Presence] in Serum by Multidisk |
| 15219-9 | Food Allergen Mix 3 (Oat+Buckwheat+Sesame seed+Wheat+Corn) IgE Ab [Presence] in Serum by Multidisk |
| 1522-2 | Glucose [Mass/volume] in Serum or Plasma --30 minutes post 0.5 g/kg glucose IV |
| 15220-7 | Food Allergen Mix A (Peanut+Cow milk+Egg white+Soybean+Wheat) IgE Ab [Presence] in Serum by Multidisk |
| 15221-5 | Food Allergen Mix F (Buckwheat+Soybean+Rice+Sesame seed+Wheat) IgE Ab [Presence] in Serum by Multidisk |
| 15222-3 | Food Allergen Mix E (Crab+Buckwheat+Shrimp+Sesame seed+Corn) IgE Ab [Presence] in Serum by Multidisk |
| 15223-1 | Food Allergen Mix B (Tarragon+Lovage+Marjoram) IgE Ab [Presence] in Serum by Multidisk |
| 15224-9 | Food Allergen Mix 71 (Caraway+Cardamon+Mace+Clove) IgE Ab [Presence] in Serum by Multidisk |
| 15225-6 | Food Allergen Mix 72 (Fennel seed+Basil+Anise+Ginger) IgE Ab [Presence] in Serum by Multidisk |
| 15226-4 | Food Allergen Mix G (Beef+Chicken meat+Pork+Plaice) IgE Ab [Presence] in Serum by Multidisk |
| 15227-2 | Food Allergen Mix 74 (Herring+Cod+Plaice+Mackerel) IgE Ab [Presence] in Serum by Multidisk |
| 15228-0 | Grass Allergen Mix 4 (Sweet vernal grass+Velvet grass+Perennial rye grass+Common reed+Rye) IgE Ab [Presence] in Serum by Multidisk |
| 15229-8 | Grass Allergen Mix 3 (Sweet vernal grass+Perennial rye grass+Timothy+Rye+Velvet grass) IgE Ab [Presence] in Serum by Multidisk |
| 1523-0 | Glucose [Mass/volume] in Serum or Plasma --30 minutes post 0.05-0.15 U insulin/kg IV post 12H CFst |
| 15230-6 | Grass Allergen Mix C (Brome+Bermuda grass+Velvet grass+Bahia grass+Timothy+Johnson grass) IgE Ab [Presence] in Serum by Multidisk |
| 15231-4 | Dust Allergen Mix A (Cockroach+American house dust mite+European house dust mite+House dust Greer) IgE Ab [Presence] in Serum by Multidisk |
| 15232-2 | Regional Allergen Mix A (Common ragweed+Mugwort+Japenese cedar+Orchard grass+Timothy) IgE Ab [Presence] in Serum by Multidisk |
| 15233-0 | Mold Allergen Mix A (Alternaria alternata+Aspergillus fumigatus+Candida albicans+Setomelanomma rostrata+Penicillium notatum) IgE Ab [Presence] in Serum by Multidisk |
| 15234-8 | Mold Allergen Mix 2 (Alternaria alternata+Aspergillus fumigatus+Candida albicans+Cladosporium herbarum+Setomelanomma rostrata+Penicillium notatum) IgE Ab [Presence] in Serum by Multidisk |
| 15235-5 | Occupational Allergen Mix 1 (Chicken feather+Cow dander+Goose feather+Horse dander) IgE Ab [Presence] in Serum by Multidisk |
| 15236-3 | Occupational Allergen Mix 2 (Acarus siro+Lepidoglyphus destructor+Horse bot fly+Grain weevel) IgE Ab [Presence] in Serum by Multidisk |
| 15237-1 | Occupational Allergen Mix 3 (Alternaria alternata+Aspergillus fumigatus+rye pollen+wheat pollen) IgE Ab [Presence] in Serum by Multidisk |
| 15238-9 | Occupational Allergen Mix 4 (Amylase+Soybean+Grain weevel+Wheat) IgE Ab [Presence] in Serum by Multidisk |
| 15239-7 | Occupational Allergen Mix 5 (Isocyanate HDI+MDI+TDI+Phthalic anhydride) IgE Ab [Presence] in Serum by Multidisk |
| 1524-8 | Glucose [Mass/volume] in Serum or Plasma --30 minutes post 0.1 U/kg insulin |
| 15240-5 | Occupational Allergen Mix 6 (Chloramin T+Ethylene oxide+Formaldehyde+Phthalic anhydride) IgE Ab [Presence] in Serum by Multidisk |
| 15241-3 | Food Allergen Mix 10 (Beef+Chicken meat+Egg yolk+Pork+Turkey meat) IgE Ab [Presence] in Serum by Multidisk |
| 15242-1 | Food Allergen Mix 11 (Broccoli+Carrot+White bean+Peas+Corn) IgE Ab [Presence] in Serum by Multidisk |
| 15243-9 | Food Allergen Mix 12 (Mushroom+Pumpkin+Rice+Rye+Potato) IgE Ab [Presence] in Serum by Multidisk |
| 15244-7 | Food Allergen Mix 13 (Carrot+White bean+Peas+Potato) IgE Ab [Presence] in Serum by Multidisk |
| 15245-4 | Food Allergen Mix 14 (Cabbage+Paprika+Tomato+Spinach) IgE Ab [Presence] in Serum by Multidisk |
| 15246-2 | Food Allergen Mix 15 (Orange+Apple+Banana+Peach) IgE Ab [Presence] in Serum by Multidisk |
| 15247-0 | Food Allergen Mix H (Pineapple+Lemon+Strawberry+Avocado) IgE Ab [Presence] in Serum by Multidisk |
| 15248-8 | Food Allergen Mix 18 (Peanut+Soybean+Peas) IgE Ab [Presence] in Serum by Multidisk |
| 15249-6 | Food Allergen Mix 19 (Cucumber+Carrot+Potato+Spinach) IgE Ab [Presence] in Serum by Multidisk |
| 1525-5 | Glucose [Mass/volume] in Serum or Plasma --30 minutes post 100 g glucose PO |
| 15250-4 | Food Allergen Mix 20 (Barley+Rice+Rye+Wheat) IgE Ab [Presence] in Serum by Multidisk |
| 15251-2 | Food Allergen Mix 21 (Kiwi+Pineapple+Melon+Banana+Peach) IgE Ab [Presence] in Serum by Multidisk |
| 15252-0 | Food Allergen Mix 22 (Cashew+Pecan or Hickory nut+Walnut+Pistachio) IgE Ab [Presence] in Serum by Multidisk |
| 15253-8 | Food Allergen Mix 7 (Onion+Garlic+Celery+Tomato+Yeast) IgE Ab [Presence] in Serum by Multidisk |
| 15254-6 | Food Allergen Mix 8 (Brazil nut+Orange+Hazelnut+Apple+Cocoa) IgE Ab [Presence] in Serum by Multidisk |
| 15255-3 | Food Allergen Mix 9 (Kiwi+Melon+Banana+Almond+Grape) IgE Ab [Presence] in Serum by Multidisk |
| 15256-1 | Regional Allergen Mix 1 (Mugwort+Silver birch+Pellitory+Timothy+English plantain) IgE Ab [Presence] in Serum by Multidisk |
| 15257-9 | Regional Allergen Mix 2 (Alternaria alternata+Cat dander+American house dust mite+Dog dander+Horse dander) IgE Ab [Presence] in Serum by Multidisk |
| 15258-7 | Regional Allergen Mix B (Common ragweed+Goosefoot or Lambs quarters+Bermuda grass+Perennial rye grass+Bahia grass) IgE Ab [Presence] in Serum by Multidisk |
| 15259-5 | Regional Allergen Mix 4 (Bermuda grass+Perennial rye grass+Brome+Common ragweed+Mugwort+English plantain) IgE Ab [Presence] in Serum by Multidisk |
| 1526-3 | Glucose [Mass/volume] in Serum or Plasma --30 minutes post 50 g lactose PO |
| 15260-3 | Tree Allergen Mix 10 (Grey alder+Silver birch+Hazelnut+White ash) IgE Ab [Presence] in Serum by Multidisk |
| 15261-1 | Weed Allergen Mix 209 (Common ragweed+Western ragweed+Giant ragweed) IgE Ab [Presence] in Serum by Multidisk |
| 15262-9 | Tree Allergen Mix 1 (Boxelder+Silver birch+White oak+White elm+California walnut) IgE Ab [Presence] in Serum by Multidisk |
| 15263-7 | Tree Allergen Mix D (Cottonwood+Elm+Maple+Oak+Pecan tree) IgE Ab [Presence] in Serum by Multidisk |
| 15264-5 | Tree Allergen Mix 3 (Mountain juniper+White oak+White elm+Cottonwood+Mesquite) IgE Ab [Presence] in Serum by Multidisk |
| 15265-2 | Tree Allergen Mix E (American sycamore+Cottonwood+White oak+Willow+White elm) IgE Ab [Presence] in Serum by Multidisk |
| 15266-0 | Tree Allergen Mix 5 (Grey alder+Hazelnut+White elm+Willow+Cottonwood) IgE Ab [Presence] in Serum by Multidisk |
| 15267-8 | Tree Allergen Mix 6 (Boxelder+Silver birch+American beech+White oak+California walnut) IgE Ab [Presence] in Serum by Multidisk |
| 15268-6 | Tree Allergen Mix 7 (Olive+Willow+Eastern white pine+Eucalyptus spp+Wattle+Cajeput) IgE Ab [Presence] in Serum by Multidisk |
| 15269-4 | Tree Allergen Mix 9 (Grey alder+Silver birch+Hazelnut+White oak+Willow) IgE Ab [Presence] in Serum by Multidisk |
| 1527-1 | Glucose [Mass/volume] in Serum or Plasma --30 minutes post 75 g glucose PO |
| 15270-2 | Tree Allergen Mix 8 (Boxelder+Silver birch+Hazelnut+White oak+London plane or Maple leaf sycamore) IgE Ab [Presence] in Serum by Multidisk |
| 15271-0 | Weed Allergen Mix 1 (Common ragweed+Mugwort+Goosefoot or Lambs quarters+English plantain+Saltwort) IgE Ab [Presence] in Serum by Multidisk |
| 15272-8 | Weed Allergen Mix 2 (Western ragweed+Mugwort+Lenscale+Goosefoot or Lambs quarters+English plantain) IgE Ab [Presence] in Serum by Multidisk |
| 15273-6 | Weed Allergen Mix 3 (Mugwort+Goosefoot or Lambs quarters+English plantain+Goldenrod+Nettle) IgE Ab [Presence] in Serum by Multidisk |
| 15274-4 | Weed Allergen Mix 5 (Common ragweed+Mugwort+Ox-eye daisy+Dandelion+Goldenrod) IgE Ab [Presence] in Serum by Multidisk |
| 15275-1 | Weed Allergen Mix 6 (English plantain+Goosefoot or Lambs quarters+Saltwort+Sheep sorrel) IgE Ab [Presence] in Serum by Multidisk |
| 15276-9 | Weed Allergen Mix 7 (Ox-eye daisy+Dandelion+English plantain+Goosefoot or Lambs quarters+Goldenrod) IgE Ab [Presence] in Serum by Multidisk |
| 15277-7 | Deprecated Turkey feather IgE Ab [Units/volume] in Serum |
| 15278-5 | Lovage IgE Ab [Units/volume] in Serum |
| 15279-3 | Cardamon IgE Ab [Units/volume] in Serum |
| 1528-9 | Glucose [Mass/volume] in Serum or Plasma --30 minutes post dose insulin IV |
| 15280-1 | Mace IgE Ab [Units/volume] in Serum |
| 15281-9 | Horse Bot Fly IgE Ab [Units/volume] in Serum |
| 15282-7 | Deprecated Cultivated Rye IgE Ab [Units/volume] in Serum |
| 15283-5 | Silver Birch IgE Ab [Units/volume] in Serum |
| 15284-3 | Grey Alder IgE Ab [Units/volume] in Serum |
| 15285-0 | London Plane IgE Ab [Units/volume] in Serum |
| 15286-8 | Kidney - left Height by US |
| 15287-6 | Kidney - left Width by US |
| 15288-4 | Kidney - left Length by US |
| 15289-2 | Kidney - right Height by US |
| 1529-7 | Deprecated Glucose [Mass/volume] in Serum or Plasma --30 minutes post dose insulin IV |
| 15290-0 | Kidney - right Width by US |
| 15291-8 | Kidney - right Length by US |
| 15292-6 | Testis - left Height by US |
| 15293-4 | Testis - left Width by US |
| 15294-2 | Testis - left Length by US |
| 15295-9 | Testis - right Height by US |
| 15296-7 | Testis - right Width by US |
| 15297-5 | Testis - right Length by US |
| 15298-3 | Urinary bladder Height by US |
| 15299-1 | Urinary bladder Width by US |
| 153-7 | Cephaloglycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 1530-5 | Glucose [Mass/volume] in Serum or Plasma --3 hours post 100 g glucose PO |
| 15300-7 | Urinary bladder Length by US |
| 15301-5 | Prostate Height by US |
| 15302-3 | Prostate Width by US |
| 15303-1 | Prostate Length by US |
| 15304-9 | Kidney - left Volume by derived from height, width and length (US) |
| 15305-6 | Kidney - right Volume by derived from height, width and length (US) |
| 15306-4 | Testis - left Volume by derived from height, width and length (US) |
| 15307-2 | Testis - right Volume by derived from height, width and length (US) |
| 15308-0 | Prostate Volume by derived from height, width and length (US) |
| 15309-8 | Urinary bladder Volume by derived from height, width and length (US) |
| 1531-3 | Deprecated Glucose [Mass/volume] in Serum or Plasma --3 hours post 100 g glucose PO |
| 15310-6 | Kidney - left Volume by derived.from ROT (US) |
| 15311-4 | Kidney - right Volume by derived.from ROT (US) |
| 15312-2 | Testis - left Volume by derived.from ROT (US) |
| 15313-0 | Testis - right Volume by derived.from ROT (US) |
| 15314-8 | Prostate Volume by derived.from ROT (US) |
| 15315-5 | Prostate Volume by derived by planimetry (US) |
| 15316-3 | Volume planimetry Stepsize by - Reported |
| 15317-1 | Kidney - left Volume by derived by automated ultrasound testing (US) |
| 15318-9 | Kidney - right Volume by derived by automated ultrasound testing (US) |
| 15319-7 | Testis - left Volume by derived by automated ultrasound testing (US) |
| 1532-1 | Glucose [Mass/volume] in Urine --3 hours post 100 g glucose PO |
| 15320-5 | Testis - right Volume by derived by automated ultrasound testing (US) |
| 15321-3 | Urinary bladder Volume by derived by EMP (US) |
| 15323-9 | Prostate specific Ag/Prostate volume calculated from height, width and length |
| 15324-7 | Prostate specific Ag/Prostate volume calculated from planimetry |
| 15325-4 | Prostate specific Ag/Prostate volume calculated |
| 15326-2 | Prostate Adenoma Volume by derived from height, width and length (US) |
| 15327-0 | Prostate Adenoma Volume by derived by planimetry (US) |
| 15328-8 | Penile cavernosal artery Peak systolic flow-baseline- by US.doppler |
| 15329-6 | Penile cavernosal artery Peak systolic flow-post XXX challenge- by US.doppler |
| 1533-9 | Glucose [Mass/volume] in Serum or Plasma --3 hours post 75 g glucose PO |
| 15330-4 | Penile cavernosal artery End diastolic blood flow-baseline- by US.doppler |
| 15331-2 | Penile cavernosal artery End diastolic blood flow-post XXX challenge- by US.doppler |
| 15332-0 | Penile cavernosal artery Resistance index-baseline- by US.calculated |
| 15333-8 | Penile cavernosal artery Resistance index-post XXX challenge- by US.calculated |
| 15334-6 | Challenge |
| 15335-3 | Penile cavernosal artery Pulsativity index by US.calculated |
| 15336-1 | Other Antibiotic [Susceptibility] by Serum bactericidal titer |
| 15337-9 | Other Antibiotic [Susceptibility] by Serum bactericidal titer --peak |
| 15338-7 | Other Antibiotic [Susceptibility] by Serum bactericidal titer --trough |
| 15339-5 | Berlin Beetle IgE Ab [Units/volume] in Serum |
| 1534-7 | Glucose [Mass/volume] in Serum or Plasma --3 minutes post 0.5 g/kg glucose IV |
| 15340-3 | Italian Cedar IgE Ab [Units/volume] in Serum |
| 15341-1 | Black Fly IgE Ab [Units/volume] in Serum |
| 15342-9 | European Hornet IgE Ab [Units/volume] in Serum |
| 15343-7 | Blood group antibody screen [Titer] in Serum or Plasma |
| 15344-5 | little i Ab [Titer] in Serum or Plasma |
| 15345-2 | Aldosterone [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
| 15346-0 | Aldosterone [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge |
| 15347-8 | Somatotropin [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge |
| 15348-6 | Alkaline phosphatase.liver 1/Alkaline phosphatase.total in Serum or Plasma |
| 15349-4 | Alkaline phosphatase.liver 2/Alkaline phosphatase.total in Serum or Plasma |
| 1535-4 | Glucose [Mass/volume] in Serum or Plasma --40 minutes post 0.5 g/kg glucose IV |
| 15350-2 | Amylase [Enzymatic activity/time] in 2 hour Urine |
| 15351-0 | Apolipoprotein E2 [Presence] in Blood |
| 15352-8 | Apolipoprotein E3 [Presence] in Blood |
| 15353-6 | Apolipoprotein E4 [Presence] in Blood |
| 15354-4 | Bombesin Ag [Presence] in Tissue by Immune stain |
| 15355-1 | Estrone sulfate [Mass/volume] in Serum or Plasma |
| 15356-9 | Globulin [Mass/time] in 24 hour Urine |
| 15357-7 | Iron [Mass/mass] in Tissue |
| 15358-5 | Macroamylase [Presence] in Serum or Plasma |
| 15359-3 | dRVVT actual/normal (normalized LA screen) |
| 1536-2 | Glucose [Mass/volume] in Serum or Plasma --45 minutes post dose insulin IV |
| 15360-1 | dRVVT actual/normal [Presence] in Platelet poor plasma by Coagulation assay |
| 15361-9 | aPTT.factor substitution in Platelet poor plasma by Coagulation assay --immediately after 1:4 addition of normal plasma |
| 15362-7 | aPTT.inhibitor sensitive in Platelet poor plasma by Coagulation assay |
| 15363-5 | Busulfan [Mass/volume] in Serum or Plasma |
| 15364-3 | Codeine [Mass/volume] in Meconium |
| 15365-0 | Deprecated Codeine |
| 15366-8 | Dextroamphetamine [Mass/volume] in Urine |
| 15367-6 | Ganciclovir [Mass/volume] in Serum or Plasma |
| 15368-4 | Hypoglycemics.sulfonyluric [Identifier] in Serum or Plasma |
| 15369-2 | Lithium.saliva/Lithium.serum |
| 1537-0 | Glucose [Mass/volume] in Serum or Plasma --4 hours post 100 g glucose PO |
| 15370-0 | Morphine [Mass/volume] in Meconium |
| 15371-8 | Deprecated Morphine |
| 15372-6 | Nordiazepam [Mass/volume] in Urine |
| 15373-4 | Phenyltoloxamine [Mass/volume] in Blood |
| 15374-2 | Sulfonylurea [Presence] in Serum or Plasma |
| 15375-9 | Valproate Free [Mass/volume] in Saliva (oral fluid) |
| 15376-7 | Spermatozoa Abnormal/100 spermatozoa in Semen |
| 15377-5 | Cytomegalovirus Ab [Presence] in Serum by Latex agglutination |
| 15378-3 | Fungus identified in Isolate by Culture |
| 15379-1 | Haemophilus influenzae B Ag [Presence] in Urine |
| 1538-8 | Glucose [Mass/volume] in Urine --4 hours post 100 g glucose PO |
| 15380-9 | Leishmania brasilensis IgG Ab [Titer] in Serum |
| 15381-7 | Leishmania brasilensis IgM Ab [Titer] in Serum |
| 15382-5 | Leishmania donovani IgG Ab [Titer] in Serum |
| 15383-3 | Leishmania donovani IgM Ab [Titer] in Serum |
| 15384-1 | Leishmania mexicana IgG Ab [Titer] in Serum |
| 15385-8 | Leishmania mexicana IgM Ab [Titer] in Serum |
| 15386-6 | Leishmania tropica IgG Ab [Titer] in Serum |
| 15387-4 | Leishmania tropica IgM Ab [Titer] in Serum |
| 15388-2 | Mycoplasma hominis [Presence] in Unspecified specimen by Organism specific culture |
| 15389-0 | Parainfluenza virus 1 IgG Ab [Presence] in Serum |
| 1539-6 | Glucose [Mass/volume] in Serum or Plasma --4 hours post 75 g glucose PO |
| 15390-8 | Parainfluenza virus 1 IgM Ab [Presence] in Serum |
| 15391-6 | Parainfluenza virus 1 IgM Ab [Titer] in Serum |
| 15392-4 | Parainfluenza virus 2 IgG Ab [Presence] in Serum |
| 15393-2 | Parainfluenza virus 2 IgM Ab [Titer] in Serum |
| 15394-0 | Parainfluenza virus 3 IgG Ab [Presence] in Serum |
| 15395-7 | Parainfluenza virus 3 IgM Ab [Presence] in Serum |
| 15396-5 | Deprecated Toxoplasma gondii IgG Ab [Units/volume] in Serum |
| 15397-3 | Trypanosoma cruzi IgM Ab [Titer] in Serum |
| 15398-1 | Neuronal nuclear Ab [Titer] in Serum |
| 15399-9 | Neuronal nuclear IgG Ab [Units/volume] in Serum by Immunofluorescence |
| 154-5 | Cephaloglycin [Susceptibility] by Disk diffusion (KB) |
| 1540-4 | Glucose [Mass/volume] in Serum or Plasma --5 hours post 100 g glucose PO |
| 15400-5 | Platelet IgG Ab [Presence] in Serum |
| 15401-3 | Drugs identified in Blood by Screen method |
| 15402-1 | Ethanol [Presence] in Meconium |
| 15403-9 | Isopropanol [Presence] in Meconium |
| 15404-7 | Levomethamphetamine/Amphetamines.total in Urine |
| 15405-4 | Methamphetamine [Mass/volume] in Meconium |
| 15406-2 | Deprecated Methamphetamine |
| 15407-0 | Methanol [Presence] in Meconium |
| 15408-8 | Thallium [Mass/mass] in Hair |
| 15409-6 | Thallium [Mass/mass] in Nail |
| 1541-2 | Glucose [Mass/volume] in Urine --5 hours post 100 g glucose PO |
| 15410-4 | Varicella zoster virus IgG Ab [Presence] in Serum by Immunoassay |
| 15411-2 | Ergosterol [Mass/volume] in Serum or Plasma |
| 15412-0 | Service comment 21 |
| 15413-8 | Service comment 22 |
| 15414-6 | Service comment 23 |
| 15415-3 | Service comment 24 |
| 15416-1 | Service comment 25 |
| 15417-9 | Service comment 26 |
| 15418-7 | Service comment 27 |
| 15419-5 | Service comment 28 |
| 1542-0 | Glucose [Mass/volume] in Serum or Plasma --5 hours post 75 g glucose PO |
| 15420-3 | Service comment 29 |
| 15421-1 | Service comment 30 |
| 15422-9 | Service comment 31 |
| 15423-7 | Service comment 32 |
| 15424-5 | Service comment 33 |
| 15425-2 | Service comment 34 |
| 15426-0 | Service comment 35 |
| 15427-8 | Service comment 36 |
| 15428-6 | Service comment 37 |
| 15429-4 | Service comment 38 |
| 1543-8 | Glucose [Mass/volume] in Serum or Plasma --5 minutes post 0.5 g/kg glucose IV |
| 15430-2 | Service comment 39 |
| 15431-0 | Service comment 40 |
| 15432-8 | Testosterone Free/Testosterone.total in Serum or Plasma |
| 15433-6 | Anaplasma marginale Ab [Presence] in Serum by Agglutination |
| 15434-4 | Avian adenovirus Ab [Presence] in Serum by Immune diffusion (ID) |
| 15435-1 | Avian adenovirus 2 Ab [Presence] in Serum by Immune diffusion (ID) |
| 15436-9 | Avian encephalomyelitis virus Ab [Presence] in Serum by Immunoassay |
| 15437-7 | Avian encephalomyelitis virus Ab [Presence] in Serum by Immune diffusion (ID) |
| 15438-5 | Avian hemorrhagic enteritis virus Ab [Presence] in Serum by Immunoassay |
| 15439-3 | Infectious bronchitis virus Ark-99 Ab [Titer] in Serum by Hemagglutination inhibition |
| 1544-6 | Glucose [Mass/volume] in Serum or Plasma --6 hours post 100 g glucose PO |
| 15440-1 | Infectious bronchitis virus Mass-41 Ab [Titer] in Serum by Hemagglutination inhibition |
| 15441-9 | Infectious bronchitis virus Conn-42 Ab [Titer] in Serum by Hemagglutination inhibition |
| 15442-7 | Avian infectious laryngotracheitis virus Ab [Presence] in Serum by Immunoassay |
| 15443-5 | Avian infectious laryngotracheitis virus Ab [Presence] in Serum by Immune diffusion (ID) |
| 15444-3 | Influenza virus A Ab [Presence] in Serum by Immune diffusion (ID) |
| 15445-0 | Avian leukosis virus Ag [Titer] in Serum by Immunoassay |
| 15446-8 | Avian leukosis virus Ag [Titer] in Egg yolk by Immunoassay |
| 15447-6 | Avian paramyxovirus 1 Ab [Presence] in Serum by Immunoassay |
| 15448-4 | Avian paramyxovirus 1 Ab [Titer] in Serum by Hemagglutination inhibition |
| 15449-2 | Avian paramyxovirus 2 Ab [Titer] in Serum by Hemagglutination inhibition |
| 1545-3 | Deprecated Glucose [Mass/volume] in Serum or Plasma --6 hours post 100 g glucose PO |
| 15450-0 | Avian paramyxovirus 3 Ab [Titer] in Serum by Hemagglutination inhibition |
| 15451-8 | Avian pox virus Ab [Presence] in Serum by Immune diffusion (ID) |
| 15452-6 | Avian reovirus Ab [Presence] in Serum by Immune diffusion (ID) |
| 15453-4 | Avian reovirus Ab [Presence] in Serum by Immunoassay |
| 15454-2 | Reticuloendotheliosis virus Ab [Presence] in Serum by Immunoassay |
| 15455-9 | Bluetongue virus Ab [Presence] in Serum by Immune diffusion (ID) |
| 15456-7 | Bluetongue virus Ab [Presence] in Serum by Immunoassay |
| 15457-5 | Bordetella avium Ab [Titer] in Serum by Agglutination |
| 15458-3 | Bordetella avium Ab [Presence] in Serum by Immunoassay |
| 15459-1 | Bovine herpesvirus 1 Ab [Titer] in Serum by Neutralization test |
| 1546-1 | Glucose [Mass/volume] in Urine --6 hours post 100 g glucose PO |
| 15460-9 | Bovine leukemia virus Ab [Presence] in Serum by Immunoassay |
| 15461-7 | Bovine leukemia virus Ab [Presence] in Serum by Immune diffusion (ID) |
| 15462-5 | Bovine diarrhea virus 1 Ab [Titer] in Serum by Neutralization test |
| 15463-3 | Bovine diarrhea virus 2 Ab [Titer] in Serum by Neutralization test |
| 15464-1 | Caprine arthritis encephalitis virus Ab [Presence] in Serum by Immunoassay |
| 15465-8 | Caprine arthritis encephalitis virus Ab [Presence] in Serum by Immune diffusion (ID) |
| 15466-6 | Epizootic hemorrhagic disease virus Ab [Presence] in Serum by Immune diffusion (ID) |
| 15467-4 | Equine herpesvirus 1 Ab [Titer] in Serum by Neutralization test |
| 15468-2 | Equine infectious anemia virus Ab [Presence] in Serum by Immune diffusion (ID) |
| 15469-0 | Equine influenza virus A1 Ab [Titer] in Serum by Hemagglutination inhibition |
| 1547-9 | Glucose [Mass/volume] in Serum or Plasma --baseline |
| 15470-8 | Equine influenza virus A2 Ab [Presence] in Serum |
| 15471-6 | Equine influenza virus A2 Ab [Titer] in Serum by Hemagglutination inhibition |
| 15472-4 | Equine influenza virus Ag [Presence] in Nose by Immunoassay |
| 15473-2 | Equine arteritis virus Ab [Titer] in Serum by Neutralization test |
| 15474-0 | Infectious bursal disease virus Ab [Presence] in Serum by Immune diffusion (ID) |
| 15475-7 | Infectious bursal disease virus Ab [Presence] in Serum by Immunoassay |
| 15476-5 | Leptospira interrogans sv Bratislava Ab [Titer] in Serum by Agglutination |
| 15477-3 | Leptospira interrogans sv Canicola Ab [Titer] in Serum by Agglutination |
| 15478-1 | Leptospira interrogans sv Grippotyphosa Ab [Titer] in Serum by Agglutination |
| 15479-9 | Leptospira interrogans sv Hardjo Ab [Titer] in Serum by Agglutination |
| 1548-7 | Glucose [Mass/volume] in Serum or Plasma --pre 0.5 g/kg glucose IV |
| 15480-7 | Leptospira interrogans sv Icterohaemorrhagiae Ab [Titer] in Serum by Agglutination |
| 15481-5 | Leptospira interrogans sv Pomona Ab [Titer] in Serum by Agglutination |
| 15482-3 | Mycobacterium avium ss paratuberculosis Ab [Presence] in Serum by Immune diffusion (ID) |
| 15483-1 | Mycobacterium avium ss paratuberculosis Ab [Presence] in Serum by Immunoassay |
| 15484-9 | Mycoplasma gallisepticum Ab [Presence] in Serum by Agglutination |
| 15485-6 | Mycoplasma gallisepticum Ab [Presence] in Serum by Immunoassay |
| 15486-4 | Mycoplasma gallisepticum rRNA [Presence] in Nose or Trachea by DNA probe |
| 15487-2 | Mycoplasma meleagridis Ab [Presence] in Serum by Immunoassay |
| 15488-0 | Mycoplasma meleagridis Ab [Presence] in Serum by Agglutination |
| 15489-8 | Mycoplasma synoviae Ab [Presence] in Serum by Immunoassay |
| 1549-5 | Glucose [Mass/volume] in Serum or Plasma --pre 100 g glucose PO |
| 15490-6 | Mycoplasma synoviae Ab [Presence] in Serum by Agglutination |
| 15491-4 | Mycoplasma synoviae rRNA [Presence] in Serum by DNA probe |
| 15492-2 | Neospora caninum Ab [Presence] in Serum by Immunoassay |
| 15493-0 | Parainfluenza virus 3 Ab [Titer] in Serum by Hemagglutination inhibition |
| 15494-8 | Pasteurella multocida Ab [Presence] in Serum by Immunoassay |
| 15495-5 | Porcine reproductive and respiratory syndrome virus Ab [Presence] in Serum by Immunoassay |
| 15496-3 | Porcine reproductive and respiratory syndrome virus Ab [Presence] in Serum by Immunofluorescence |
| 15497-1 | Pseudorabies virus Ab [Presence] in Serum by Immunoassay |
| 15498-9 | Pseudorabies virus Ab [Presence] in Serum by Latex agglutination |
| 15499-7 | Pseudorabies virus Ab [Titer] in Serum by Neutralization test |
| 155-2 | Cephaloglycin [Susceptibility] by Serum bactericidal titer |
| 1550-3 | Glucose [Mass/volume] in Serum or Plasma --pre 12 hour fast |
| 15500-2 | Pseudorabies virus Clinease gene deletion Ab [Presence] in Serum by Immunoassay |
| 15501-0 | Pseudorabies virus Herdcheck gene deletion Ab [Presence] in Serum by Immunoassay |
| 15502-8 | Pseudorabies virus Omnimark gene deletion Ab [Presence] in Serum by Immunoassay |
| 15503-6 | Pseudorabies virus Tolvid gene deletion Ab [Presence] in Serum by Immunoassay |
| 15504-4 | Salmonella arizonae Ab [Presence] in Serum by Agglutination |
| 15505-1 | Salmonella pullorum Ab [Presence] in Serum by Agglutination |
| 15506-9 | Salmonella typhimurium Ab [Presence] in Serum by Agglutination |
| 15507-7 | Provider-unspecified ED Progress note |
| 15508-5 | Labor and delivery records |
| 15509-3 | Ambulance transport, Rationale for scheduled transport |
| 1551-1 | Glucose [Mass/volume] in Serum or Plasma --pre 50 g lactose PO |
| 15510-1 | Ambulance transport, Distance transported Length |
| 15511-9 | Ambulance transport, Origination site information Set |
| 15512-7 | Ambulance transport, Destination site information Set |
| 15513-5 | Ambulance transport, Reason for scheduled trip Set |
| 15514-3 | Ambulance transport, Ordering practitioner identifier type |
| 15515-0 | Ambulance transport, Medical reason for transport |
| 15516-8 | Ambulance transport, Justification for extra attendants |
| 15517-6 | Ambulance transport, Transport direction |
| 15518-4 | Abalone IgE Ab RAST class [Presence] in Serum |
| 15519-2 | Wattle IgE Ab RAST class [Presence] in Serum |
| 1552-9 | Glucose [Mass/volume] in Serum or Plasma --pre 75 g glucose PO |
| 15520-0 | Corticotropin IgE Ab RAST class [Presence] in Serum |
| 15521-8 | White Alder IgE Ab RAST class [Presence] in Serum |
| 15522-6 | Deprecated Alder Ab.IgE.RAST class |
| 15523-4 | Smooth Alder IgE Ab RAST class [Presence] in Serum |
| 15524-2 | Alfalfa IgE Ab RAST class [Presence] in Serum |
| 15525-9 | Alkalase IgE Ab RAST class [Presence] in Serum |
| 15526-7 | Allspice IgE Ab RAST class [Presence] in Serum |
| 15527-5 | Almond IgE Ab RAST class [Presence] in Serum |
| 15528-3 | Almond Tree IgE Ab RAST class [Presence] in Serum |
| 15529-1 | Lactalbumin alpha IgE Ab RAST class [Presence] in Serum |
| 1553-7 | Glucose [Mass/volume] in Serum or Plasma --pre dose insulin IV |
| 15530-9 | Alternaria alternata IgE Ab RAST class [Presence] in Serum |
| 15531-7 | Deprecated Alternaria alternata IgE Ab RAST class in Serum |
| 15532-5 | Amoxicillin IgE Ab RAST class [Presence] in Serum |
| 15533-3 | Ampicillin IgE Ab RAST class [Presence] in Serum |
| 15534-1 | Anchovy IgE Ab RAST class [Presence] in Serum |
| 15535-8 | Anisakis IgE Ab RAST class [Presence] in Serum |
| 15536-6 | Anise IgE Ab RAST class [Presence] in Serum |
| 15537-4 | Red Imported Fire Ant IgE Ab RAST class [Presence] in Serum |
| 15538-2 | Deprecated Red Imported Fire Ant IgE Ab RAST class in Serum |
| 15539-0 | Apple IgE Ab RAST class [Presence] in Serum |
| 1554-5 | Glucose [Mass/volume] in Serum or Plasma --12 hours fasting |
| 15540-8 | Apple Tree IgE Ab RAST class [Presence] in Serum |
| 15541-6 | Apricot IgE Ab RAST class [Presence] in Serum |
| 15542-4 | Arrowroot IgE Ab RAST class [Presence] in Serum |
| 15543-2 | Artichoke IgE Ab RAST class [Presence] in Serum |
| 15544-0 | Ascaris sp IgE Ab RAST class [Presence] in Serum |
| 15545-7 | Arizona Ash IgE Ab RAST class [Presence] in Serum |
| 15546-5 | White Ash IgE Ab RAST class [Presence] in Serum |
| 15547-3 | Asparagus IgE Ab RAST class [Presence] in Serum |
| 15548-1 | Aspen IgE Ab RAST class [Presence] in Serum |
| 15549-9 | Aspergillus fumigatus IgE Ab RAST class [Presence] in Serum |
| 1555-2 | Glucose [Mass/volume] in Urine --12 hours fasting |
| 15550-7 | Aspergillus niger IgE Ab RAST class [Presence] in Serum |
| 15551-5 | Avocado IgE Ab RAST class [Presence] in Serum |
| 15552-3 | Groundsel Tree IgE Ab RAST class [Presence] in Serum |
| 15553-1 | Bamboo shoot IgE Ab RAST class [Presence] in Serum |
| 15554-9 | Banana IgE Ab RAST class [Presence] in Serum |
| 15555-6 | Barley IgE Ab RAST class [Presence] in Serum |
| 15556-4 | Barley Pollen IgE Ab RAST class [Presence] in Serum |
| 15557-2 | Basil IgE Ab RAST class [Presence] in Serum |
| 15558-0 | Bass, Black IgE Ab RAST class [Presence] in Serum |
| 15559-8 | Fivehook Bassia IgE Ab RAST class [Presence] in Serum |
| 1556-0 | Fasting glucose [Mass/volume] in Capillary blood |
| 15560-6 | Bayberry IgE Ab RAST class [Presence] in Serum |
| 15561-4 | Bayleaf IgE Ab RAST class [Presence] in Serum |
| 15562-2 | Castor Bean IgE Ab RAST class [Presence] in Serum |
| 15563-0 | Green Coffee Bean IgE Ab RAST class [Presence] in Serum |
| 15564-8 | Green Bean IgE Ab RAST class [Presence] in Serum |
| 15565-5 | Red Kidney Bean IgE Ab RAST class [Presence] in Serum |
| 15566-3 | Lima Bean IgE Ab RAST class [Presence] in Serum |
| 15567-1 | Pinto Bean IgE Ab RAST class [Presence] in Serum |
| 15568-9 | Soybean IgE Ab RAST class [Presence] in Serum |
| 15569-7 | White Bean IgE Ab RAST class [Presence] in Serum |
| 1557-8 | Fasting glucose [Mass/volume] in Venous blood |
| 15570-5 | Honey bee IgE Ab RAST class [Presence] in Serum |
| 15571-3 | American Beech IgE Ab RAST class [Presence] in Serum |
| 15572-1 | Beef IgE Ab RAST class [Presence] in Serum |
| 15573-9 | Beet IgE Ab RAST class [Presence] in Serum |
| 15574-7 | Sugar Beet Seed (Beta vulgaris seed) IgE Ab RAST class [Presence] in Serum |
| 15575-4 | Berlin Beetle IgE Ab RAST class [Presence] in Serum |
| 15576-2 | Lactalbumin beta IgE Ab RAST class [Presence] in Serum |
| 15577-0 | Beta lactoglobulin IgE Ab RAST class [Presence] in Serum |
| 15578-8 | Deprecated Birch Ab.IgE.RAST class |
| 15579-6 | Silver Birch IgE Ab RAST class [Presence] in Serum |
| 1558-6 | Fasting glucose [Mass/volume] in Serum or Plasma |
| 15580-4 | Blackberry IgE Ab RAST class [Presence] in Serum |
| 15581-2 | Blomia tropicalis IgE Ab RAST class [Presence] in Serum |
| 15582-0 | Bloodworm IgE Ab RAST class [Presence] in Serum |
| 15583-8 | Blueberry IgE Ab RAST class [Presence] in Serum |
| 15584-6 | Botrytis cinerea IgE Ab RAST class [Presence] in Serum |
| 15585-3 | Boxelder IgE Ab RAST class [Presence] in Serum |
| 15586-1 | Brazil Nut IgE Ab RAST class [Presence] in Serum |
| 15587-9 | Broccoli IgE Ab RAST class [Presence] in Serum |
| 15588-7 | Bromelin IgE Ab RAST class [Presence] in Serum |
| 15589-5 | Brussel Sprouts IgE Ab RAST class [Presence] in Serum |
| 1559-4 | Insulin [Mass/volume] in Serum or Plasma --1.5 hours post dose tolbutamide IV |
| 15590-3 | Bovine serum albumin (BSA) IgE Ab RAST class [Presence] in Serum |
| 15591-1 | Buckwheat IgE Ab RAST class [Presence] in Serum |
| 15592-9 | Budgerigar feather IgE Ab RAST class [Presence] in Serum |
| 15593-7 | Bumble Bee IgE Ab RAST class [Presence] in Serum |
| 15594-5 | Burrobrush IgE Ab RAST class [Presence] in Serum |
| 15595-2 | Burweed marshelder IgE Ab RAST class [Presence] in Serum |
| 15596-0 | Cabbage IgE Ab RAST class [Presence] in Serum |
| 15597-8 | Cocoa IgE Ab RAST class [Presence] in Serum |
| 15598-6 | Canary feather IgE Ab RAST class [Presence] in Serum |
| 15599-4 | Candida albicans IgE Ab RAST class [Presence] in Serum |
| 156-0 | Cephaloridine [Susceptibility] by Minimum lethal concentration (MLC) |
| 1560-2 | Insulin [Mass/volume] in Serum or Plasma --1 hour post dose tolbutamide IV |
| 15600-0 | Deprecated Melon IgE Ab RAST class in Serum |
| 15601-8 | Starfruit IgE Ab RAST class [Presence] in Serum |
| 15602-6 | Caraway IgE Ab RAST class [Presence] in Serum |
| 15603-4 | Careless Weed IgE Ab RAST class [Presence] in Serum |
| 15604-2 | Carob IgE Ab RAST class [Presence] in Serum |
| 15605-9 | Carrot IgE Ab RAST class [Presence] in Serum |
| 15606-7 | Casein IgE Ab RAST class [Presence] in Serum |
| 15607-5 | Cashew Nut IgE Ab RAST class [Presence] in Serum |
| 15608-3 | Deprecated Cat IgE Ab RAST class in Serum |
| 15609-1 | Cat dander IgE Ab RAST class [Presence] in Serum |
| 1561-0 | Insulin [Mass/volume] in Serum or Plasma --1 hour post 75 g glucose PO |
| 15610-9 | Deprecated Cat epithelium IgE Ab RAST class in Serum |
| 15611-7 | Catfish IgE Ab RAST class [Presence] in Serum |
| 15612-5 | Cauliflower IgE Ab RAST class [Presence] in Serum |
| 15613-3 | Italian Cedar IgE Ab RAST class [Presence] in Serum |
| 15614-1 | Japanese Cedar IgE Ab RAST class [Presence] in Serum |
| 15615-8 | Mountain Juniper IgE Ab RAST class [Presence] in Serum |
| 15616-6 | Red Cedar IgE Ab RAST class [Presence] in Serum |
| 15617-4 | Saltcedar IgE Ab RAST class [Presence] in Serum |
| 15618-2 | Celery IgE Ab RAST class [Presence] in Serum |
| 15619-0 | Acremonium sp IgE Ab RAST class [Presence] in Serum |
| 1562-8 | Insulin [Mass/volume] in Serum or Plasma --2.5 hours post dose tolbutamide IV |
| 15620-8 | Chaetomium globosum IgE Ab RAST class [Presence] in Serum |
| 15621-6 | Chamomile IgE Ab RAST class [Presence] in Serum |
| 15622-4 | American Cheese IgE Ab RAST class [Presence] in Serum |
| 15623-2 | Cheese cheddar type IgE Ab RAST class [Presence] in Serum |
| 15624-0 | Cottage Cheese IgE Ab RAST class [Presence] in Serum |
| 15625-7 | Mozzarella Cheese IgE Ab RAST class [Presence] in Serum |
| 15626-5 | Parmesan Cheese IgE Ab RAST class [Presence] in Serum |
| 15627-3 | Swiss Cheese IgE Ab RAST class [Presence] in Serum |
| 15628-1 | Cherry IgE Ab RAST class [Presence] in Serum |
| 15629-9 | Chestnut IgE Ab RAST class [Presence] in Serum |
| 1563-6 | Insulin [Mass/volume] in Serum or Plasma --2 hours post dose tolbutamide IV |
| 15630-7 | Horse Chestnut IgE Ab RAST class [Presence] in Serum |
| 15631-5 | Deprecated Chestnut IgE Ab RAST class in Serum |
| 15632-3 | Chestnut Pollen IgE Ab RAST class [Presence] in Serum |
| 15633-1 | Chicken feather IgE Ab RAST class [Presence] in Serum |
| 15634-9 | Chicken meat IgE Ab RAST class [Presence] in Serum |
| 15635-6 | Chicory IgE Ab RAST class [Presence] in Serum |
| 15636-4 | Chinchilla IgE Ab RAST class [Presence] in Serum |
| 15637-2 | Chloramin T IgE Ab RAST class [Presence] in Serum |
| 15638-0 | Chortoglyphus arcuatus IgE Ab RAST class [Presence] in Serum |
| 15639-8 | Deprecated Chymofast IgE Ab RAST class in Serum |
| 1564-4 | Insulin [Mass/volume] in Serum or Plasma --2 hours post 75 g glucose PO |
| 15640-6 | Chymopapain IgE Ab RAST class [Presence] in Serum |
| 15641-4 | Cinnamon IgE Ab RAST class [Presence] in Serum |
| 15642-2 | Cladosporium herbarum IgE Ab RAST class [Presence] in Serum |
| 15643-0 | Clam IgE Ab RAST class [Presence] in Serum |
| 15644-8 | Clove IgE Ab RAST class [Presence] in Serum |
| 15645-5 | Clover IgE Ab RAST class [Presence] in Serum |
| 15646-3 | Cocklebur IgE Ab RAST class [Presence] in Serum |
| 15647-1 | Cockroach IgE Ab RAST class [Presence] in Serum |
| 15648-9 | Deprecated Cocoa IgE Ab RAST class in Serum |
| 15649-7 | Coconut IgE Ab RAST class [Presence] in Serum |
| 1565-1 | Insulin [Mass/volume] in Serum or Plasma --30 minutes post dose tolbutamide IV |
| 15650-5 | Codfish IgE Ab RAST class [Presence] in Serum |
| 15651-3 | Coffee IgE Ab RAST class [Presence] in Serum |
| 15652-1 | Cola IgE Ab RAST class [Presence] in Serum |
| 15653-9 | Corn IgE Ab RAST class [Presence] in Serum |
| 15654-7 | Cultivated Corn IgE Ab RAST class [Presence] in Serum |
| 15655-4 | Cultivated Cotton IgE Ab RAST class [Presence] in Serum |
| 15656-2 | Cotton fibers IgE Ab RAST class [Presence] in Serum |
| 15657-0 | Cotton western IgE Ab RAST class [Presence] in Serum |
| 15658-8 | Cottonseed IgE Ab RAST class [Presence] in Serum |
| 15659-6 | Cottonwood IgE Ab RAST class [Presence] in Serum |
| 1566-9 | Insulin [Mass/volume] in Serum or Plasma --3 hours post dose tolbutamide IV |
| 15660-4 | Western Cottonwood IgE Ab RAST class [Presence] in Serum |
| 15661-2 | Cow dander IgE Ab RAST class [Presence] in Serum |
| 15662-0 | Cow epithelium IgE Ab RAST class [Presence] in Serum |
| 15663-8 | Crab IgE Ab RAST class [Presence] in Serum |
| 15664-6 | Cranberry IgE Ab RAST class [Presence] in Serum |
| 15665-3 | Crawfish IgE Ab RAST class [Presence] in Serum |
| 15666-1 | Cryptococcus terreus IgE Ab RAST class [Presence] in Serum |
| 15667-9 | Cucumber IgE Ab RAST class [Presence] in Serum |
| 15668-7 | Curry IgE Ab RAST class [Presence] in Serum |
| 15669-5 | Curvularia lunata IgE Ab RAST class [Presence] in Serum |
| 1567-7 | Insulin [Mass/volume] in Serum or Plasma --3 hours post 75 g glucose PO |
| 15670-3 | Curvularia specifera IgE Ab RAST class [Presence] in Serum |
| 15671-1 | Arizona Cypress IgE Ab RAST class [Presence] in Serum |
| 15672-9 | Bald Cypress IgE Ab RAST class [Presence] in Serum |
| 15673-7 | Italian Cypress IgE Ab RAST class [Presence] in Serum |
| 15674-5 | Daisy IgE Ab RAST class [Presence] in Serum |
| 15675-2 | Ox-eye daisy IgE Ab RAST class [Presence] in Serum |
| 15676-0 | Dandelion IgE Ab RAST class [Presence] in Serum |
| 15677-8 | Daphnia (fish feed) IgE Ab RAST class [Presence] in Serum |
| 15678-6 | Date Palm Pollen IgE Ab RAST class [Presence] in Serum |
| 15679-4 | Deer epithelium IgE Ab RAST class [Presence] in Serum |
| 1568-5 | Insulin [Mass/volume] in Serum or Plasma --4 hours post 75 g glucose PO |
| 15680-2 | American house dust mite IgE Ab RAST class [Presence] in Serum |
| 15681-0 | Dermatophagoides microceras IgE Ab RAST class [Presence] in Serum |
| 15682-8 | European house dust mite IgE Ab RAST class [Presence] in Serum |
| 15683-6 | Dill IgE Ab RAST class [Presence] in Serum |
| 15684-4 | Yellow Dock IgE Ab RAST class [Presence] in Serum |
| 15685-1 | Dog dander IgE Ab RAST class [Presence] in Serum |
| 15686-9 | Dog epithelium IgE Ab RAST class [Presence] in Serum |
| 15687-7 | Duck feather IgE Ab RAST class [Presence] in Serum |
| 15688-5 | Echinococcus sp IgE Ab RAST class [Presence] in Serum |
| 15689-3 | Egg white IgE Ab RAST class [Presence] in Serum |
| 1569-3 | Insulin [Mass/volume] in Serum or Plasma --5 hours post 75 g glucose PO |
| 15690-1 | Whole Egg IgE Ab RAST class [Presence] in Serum |
| 15691-9 | Egg yolk IgE Ab RAST class [Presence] in Serum |
| 15692-7 | Eggplant IgE Ab RAST class [Presence] in Serum |
| 15693-5 | Marsh Elder IgE Ab RAST class [Presence] in Serum |
| 15694-3 | Elder IgE Ab RAST class [Presence] in Serum |
| 15695-0 | Deprecated Elderberry IgE Ab RAST class in Serum |
| 15696-8 | Elk or Moose Meat IgE Ab RAST class [Presence] in Serum |
| 15697-6 | White Elm IgE Ab RAST class [Presence] in Serum |
| 15698-4 | Chinese Elm IgE Ab RAST class [Presence] in Serum |
| 15699-2 | Endive IgE Ab RAST class [Presence] in Serum |
| 157-8 | Cephaloridine [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 1570-1 | Insulin [Mass/volume] in Serum or Plasma --baseline |
| 15700-8 | Epicoccum purpurascens IgE Ab RAST class [Presence] in Serum |
| 15701-6 | Epidermophyton floccosum IgE Ab RAST class [Presence] in Serum |
| 15702-4 | Ethylene oxide IgE Ab RAST class [Presence] in Serum |
| 15703-2 | Gum-Tree IgE Ab RAST class [Presence] in Serum |
| 15704-0 | Euroglyphus maynei IgE Ab RAST class [Presence] in Serum |
| 15705-7 | Dog Fennel IgE Ab RAST class [Presence] in Serum |
| 15706-5 | Fennel Fresh IgE Ab RAST class [Presence] in Serum |
| 15707-3 | Fennel Seed IgE Ab RAST class [Presence] in Serum |
| 15708-1 | Ferret epithelium IgE Ab RAST class [Presence] in Serum |
| 15709-9 | Meadow Fescue IgE Ab RAST class [Presence] in Serum |
| 1571-9 | Insulin [Mass/volume] in Serum or Plasma --pre dose tolbutamide IV |
| 15710-7 | Finch feather IgE Ab RAST class [Presence] in Serum |
| 15711-5 | Douglas Fir IgE Ab RAST class [Presence] in Serum |
| 15712-3 | Firebush IgE Ab RAST class [Presence] in Serum |
| 15713-1 | Fiscus sp IgE Ab RAST class [Presence] in Serum |
| 15714-9 | Flea IgE Ab RAST class [Presence] in Serum |
| 15715-6 | Flounder IgE Ab RAST class [Presence] in Serum |
| 15716-4 | Black Fly IgE Ab RAST class [Presence] in Serum |
| 15717-2 | Horse Fly IgE Ab RAST class [Presence] in Serum |
| 15718-0 | Formaldehyde IgE Ab RAST class [Presence] in Serum |
| 15719-8 | Fox IgE Ab RAST class [Presence] in Serum |
| 1572-7 | Insulin [Mass/volume] in Serum or Plasma --pre 75 g glucose PO |
| 15720-6 | Meadow Foxtail IgE Ab RAST class [Presence] in Serum |
| 15721-4 | Fusarium culmorum IgE Ab RAST class [Presence] in Serum |
| 15722-2 | Fusarium moniliforme IgE Ab RAST class [Presence] in Serum |
| 15723-0 | Fusarium solani IgE Ab RAST class [Presence] in Serum |
| 15724-8 | Garlic IgE Ab RAST class [Presence] in Serum |
| 15725-5 | Gelatin IgE Ab RAST class [Presence] in Serum |
| 15726-3 | Geotrichum candidum IgE Ab RAST class [Presence] in Serum |
| 15727-1 | Gerbil IgE Ab RAST class [Presence] in Serum |
| 15728-9 | Ginger IgE Ab RAST class [Presence] in Serum |
| 15729-7 | Gluten IgE Ab RAST class [Presence] in Serum |
| 1573-5 | Insulin [Mass/volume] in Serum or Plasma --12 hours fasting |
| 15730-5 | Glycyphagus domesticus IgE Ab RAST class [Presence] in Serum |
| 15731-3 | Goat epithelium IgE Ab RAST class [Presence] in Serum |
| 15732-1 | Goat milk IgE Ab RAST class [Presence] in Serum |
| 15733-9 | Goldenrod IgE Ab RAST class [Presence] in Serum |
| 15734-7 | Goose feather IgE Ab RAST class [Presence] in Serum |
| 15735-4 | Grape IgE Ab RAST class [Presence] in Serum |
| 15736-2 | Grapefruit IgE Ab RAST class [Presence] in Serum |
| 15737-0 | Bahia grass IgE Ab RAST class [Presence] in Serum |
| 15738-8 | Bermuda grass IgE Ab RAST class [Presence] in Serum |
| 15739-6 | Canadian blue grass IgE Ab RAST class [Presence] in Serum |
| 1574-3 | 17-Ketogenic steroids [Mass/time] in 24 hour Urine --24 hours post 40 ug corticotropin IM BID 3 day |
| 15740-4 | Brome IgE Ab RAST class [Presence] in Serum |
| 15741-2 | False oat grass IgE Ab RAST class [Presence] in Serum |
| 15742-0 | Gramma grass (Bouteloua gracilis) IgE Ab RAST class [Presence] in Serum |
| 15743-8 | Johnson grass IgE Ab RAST class [Presence] in Serum |
| 15744-6 | Kentucky blue grass IgE Ab RAST class [Presence] in Serum |
| 15745-3 | Koehlers grass IgE Ab RAST class [Presence] in Serum |
| 15746-1 | Cocksfoot IgE Ab RAST class [Presence] in Serum |
| 15747-9 | Quack grass IgE Ab RAST class [Presence] in Serum |
| 15748-7 | Red top grass IgE Ab RAST class [Presence] in Serum |
| 15749-5 | Perennial rye grass IgE Ab RAST class [Presence] in Serum |
| 1575-0 | 17-Ketogenic steroids [Mass/time] in 24 hour Urine --48 hours post 40 ug corticotropin IM BID 3 day |
| 15750-3 | Deprecated Grass rye Italian IgE Ab RAST class in Serum |
| 15751-1 | Wild rye grass IgE Ab RAST class [Presence] in Serum |
| 15752-9 | Salt grass IgE Ab RAST class [Presence] in Serum |
| 15753-7 | Sorghum grass IgE Ab RAST class [Presence] in Serum |
| 15754-5 | Sudan grass IgE Ab RAST class [Presence] in Serum |
| 15755-2 | Sweet Vernal grass IgE Ab RAST class [Presence] in Serum |
| 15756-0 | Velvet grass IgE Ab RAST class [Presence] in Serum |
| 15757-8 | Guar gum IgE Ab RAST class [Presence] in Serum |
| 15758-6 | Guava IgE Ab RAST class [Presence] in Serum |
| 15759-4 | Guinea pig epithelium IgE Ab RAST class [Presence] in Serum |
| 1576-8 | 17-Ketogenic steroids [Mass/time] in 24 hour Urine --48 hours post 500 ug dexamethasone PO 2.5 day low dose q6h |
| 15760-2 | Gum arabic IgE Ab RAST class [Presence] in Serum |
| 15761-0 | Sweet gum IgE Ab RAST class [Presence] in Serum |
| 15762-8 | Hackberry tree IgE Ab RAST class [Presence] in Serum |
| 15763-6 | Haddock IgE Ab RAST class [Presence] in Serum |
| 15764-4 | Halibut IgE Ab RAST class [Presence] in Serum |
| 15765-1 | Hamster epithelium IgE Ab RAST class [Presence] in Serum |
| 15766-9 | Hazelnut IgE Ab RAST class [Presence] in Serum |
| 15767-7 | Hazelnut Pollen IgE Ab RAST class [Presence] in Serum |
| 15768-5 | Helminthosporium sp IgE Ab RAST class [Presence] in Serum |
| 15769-3 | Setomelanomma rostrata IgE Ab RAST class [Presence] in Serum |
| 1577-6 | 17-Ketogenic steroids [Mass/time] in 24 hour Urine --48 hours post 2 mg dexamethasone PO 2.5 day high dose q6h |
| 15770-1 | Eastern Hemlock IgE Ab RAST class [Presence] in Serum |
| 15771-9 | Water Hemp IgE Ab RAST class [Presence] in Serum |
| 15772-7 | Herring IgE Ab RAST class [Presence] in Serum |
| 15773-5 | Pecan or Hickory Nut IgE Ab RAST class [Presence] in Serum |
| 15774-3 | Pecan or Hickory Tree IgE Ab RAST class [Presence] in Serum |
| 15775-0 | Shellbark Hickory IgE Ab RAST class [Presence] in Serum |
| 15776-8 | White Hickory IgE Ab RAST class [Presence] in Serum |
| 15777-6 | Honey IgE Ab RAST class [Presence] in Serum |
| 15778-4 | Honeysuckle IgE Ab RAST class [Presence] in Serum |
| 15779-2 | Hop IgE Ab RAST class [Presence] in Serum |
| 1578-4 | 17-Ketogenic steroids [Mass/time] in 24 hour Urine --72 hours post 40 ug corticotropin IM BID 3 day |
| 15780-0 | Horn beam IgE Ab RAST class [Presence] in Serum |
| 15781-8 | Hornet IgE Ab RAST class [Presence] in Serum |
| 15782-6 | Whitefaced Hornet IgE Ab RAST class [Presence] in Serum |
| 15783-4 | Yellow Hornet IgE Ab RAST class [Presence] in Serum |
| 15784-2 | Horse dander IgE Ab RAST class [Presence] in Serum |
| 15785-9 | Horse epithelium IgE Ab RAST class [Presence] in Serum |
| 15786-7 | Horse serum proteins IgE Ab RAST class [Presence] in Serum |
| 15787-5 | Horseradish IgE Ab RAST class [Presence] in Serum |
| 15788-3 | House dust IgE Ab RAST class [Presence] in Serum |
| 15789-1 | House dust Greer IgE Ab RAST class [Presence] in Serum |
| 1579-2 | 17-Ketogenic steroids [Mass/time] in 24 hour Urine --pre 50 ug corticotropin IM 3 day |
| 15790-9 | House dust Hausstaub IgE Ab RAST class [Presence] in Serum |
| 15791-7 | House dust Hollister Stier IgE Ab RAST class [Presence] in Serum |
| 15792-5 | Insulin bovine IgE Ab RAST class [Presence] in Serum |
| 15793-3 | Insulin human IgE Ab RAST class [Presence] in Serum |
| 15794-1 | Insulin porcine IgE Ab RAST class [Presence] in Serum |
| 15795-8 | Iodinebush IgE Ab RAST class [Presence] in Serum |
| 15796-6 | Isocyanate HDI IgE Ab RAST class [Presence] in Serum |
| 15797-4 | Isocyanate MDI IgE Ab RAST class [Presence] in Serum |
| 15798-2 | Isocyanate TDI IgE Ab RAST class [Presence] in Serum |
| 15799-0 | Ispaghula laxative IgE Ab RAST class [Presence] in Serum |
| 158-6 | Cephaloridine [Susceptibility] by Disk diffusion (KB) |
| 1580-0 | 17-Ketogenic steroids [Mass/time] in 24 hour Urine --pre 500 ug dexamethasone PO 2.5 day low dose q6h |
| 15800-6 | Juniper IgE Ab RAST class [Presence] in Serum |
| 15801-4 | Kapok IgE Ab RAST class [Presence] in Serum |
| 15802-2 | Kiwifruit IgE Ab RAST class [Presence] in Serum |
| 15803-0 | Lamb IgE Ab RAST class [Presence] in Serum |
| 15804-8 | Deprecated Mutton IgE Ab RAST class in Serum |
| 15805-5 | Goosefoot IgE Ab RAST class [Presence] in Serum |
| 15806-3 | Latex IgE Ab RAST class [Presence] in Serum |
| 15807-1 | Latex glove extract IgE Ab RAST class [Presence] in Serum |
| 15808-9 | Latex glove extract ammoniated IgE Ab RAST class [Presence] in Serum |
| 15809-7 | Latex glove extract buffered IgE Ab RAST class [Presence] in Serum |
| 1581-8 | 17-Ketogenic steroids [Mass/time] in 24 hour Urine --pre 2 mg dexamethasone PO 2.5 day high dose q6h |
| 15810-5 | Legume IgE Ab RAST class [Presence] in Serum |
| 15811-3 | Lemon IgE Ab RAST class [Presence] in Serum |
| 15812-1 | Lenscale IgE Ab RAST class [Presence] in Serum |
| 15813-9 | Lentils IgE Ab RAST class [Presence] in Serum |
| 15814-7 | Lepidoglyphus destructor IgE Ab RAST class [Presence] in Serum |
| 15815-4 | Lettuce IgE Ab RAST class [Presence] in Serum |
| 15816-2 | Lilac IgE Ab RAST class [Presence] in Serum |
| 15817-0 | Easter lily IgE Ab RAST class [Presence] in Serum |
| 15818-8 | Lime IgE Ab RAST class [Presence] in Serum |
| 15819-6 | Linden IgE Ab RAST class [Presence] in Serum |
| 1582-6 | Lactose [Mass/volume] in Serum or Plasma --1 hour post 50 g lactose PO |
| 15820-4 | Liver beef IgE Ab RAST class [Presence] in Serum |
| 15821-2 | Lobster IgE Ab RAST class [Presence] in Serum |
| 15822-0 | Spiny lobster IgE Ab RAST class [Presence] in Serum |
| 15823-8 | Black Locust IgE Ab RAST class [Presence] in Serum |
| 15824-6 | Lupin IgE Ab RAST class [Presence] in Serum |
| 15825-3 | Lycopodium spp IgE Ab RAST class [Presence] in Serum |
| 15826-1 | Lysozyme IgE Ab RAST class [Presence] in Serum |
| 15827-9 | Mackerel IgE Ab RAST class [Presence] in Serum |
| 15828-7 | Chub Mackerel IgE Ab RAST class [Presence] in Serum |
| 15829-5 | Scad IgE Ab RAST class [Presence] in Serum |
| 1583-4 | Lactose [Mass/volume] in Serum or Plasma --2 hours post 50 g lactose PO |
| 15830-3 | Deprecated Corn IgE Ab RAST class in Serum |
| 15831-1 | Malt IgE Ab RAST class [Presence] in Serum |
| 15832-9 | Mango IgE Ab RAST class [Presence] in Serum |
| 15833-7 | Coastal Maple IgE Ab RAST class [Presence] in Serum |
| 15834-5 | Red Maple IgE Ab RAST class [Presence] in Serum |
| 15835-2 | Silver Maple IgE Ab RAST class [Presence] in Serum |
| 15836-0 | Maple sugar IgE Ab RAST class [Presence] in Serum |
| 15837-8 | Mare milk IgE Ab RAST class [Presence] in Serum |
| 15838-6 | Marjoram IgE Ab RAST class [Presence] in Serum |
| 15839-4 | Maxatase IgE Ab RAST class [Presence] in Serum |
| 1584-2 | Lactose [Mass/volume] in Serum or Plasma --30 minutes post 50 g lactose PO |
| 15840-2 | Whiff IgE Ab RAST class [Presence] in Serum |
| 15841-0 | Cajeput tree IgE Ab RAST class [Presence] in Serum |
| 15842-8 | Deprecated Melon IgE Ab RAST class in Serum. |
| 15843-6 | Mesquite IgE Ab RAST class [Presence] in Serum |
| 15844-4 | Mexican tea IgE Ab RAST class [Presence] in Serum |
| 15845-1 | Green Nimitti IgE Ab RAST class [Presence] in Serum |
| 15846-9 | Milk IgE Ab RAST class [Presence] in Serum |
| 15847-7 | Cow milk boiled IgE Ab RAST class [Presence] in Serum |
| 15848-5 | Milk powder IgE Ab RAST class [Presence] in Serum |
| 15849-3 | Common Millet IgE Ab RAST class [Presence] in Serum |
| 1585-9 | Lactose [Mass/volume] in Serum or Plasma --pre 12 hour fast |
| 15850-1 | Foxtail Millet IgE Ab RAST class [Presence] in Serum |
| 15851-9 | Cockspur IgE Ab RAST class [Presence] in Serum |
| 15852-7 | Mink epithelium IgE Ab RAST class [Presence] in Serum |
| 15853-5 | Mint IgE Ab RAST class [Presence] in Serum |
| 15854-3 | Cheese mold type IgE Ab RAST class [Presence] in Serum |
| 15855-0 | Chrysonilia sitophila IgE Ab RAST class [Presence] in Serum |
| 15856-8 | Aedes mosquito IgE Ab RAST class [Presence] in Serum |
| 15857-6 | Moth IgE Ab RAST class [Presence] in Serum |
| 15858-4 | Mediterranean flour moth IgE Ab RAST class [Presence] in Serum |
| 15859-2 | Mouse epithelium IgE Ab RAST class [Presence] in Serum |
| 1586-7 | Lead [Mass/volume] in Urine --post EDTA therapy |
| 15860-0 | Mouse serum proteins IgE Ab RAST class [Presence] in Serum |
| 15861-8 | Mouse urine proteins IgE Ab RAST class [Presence] in Serum |
| 15862-6 | Mucor racemosus IgE Ab RAST class [Presence] in Serum |
| 15863-4 | Mugwort IgE Ab RAST class [Presence] in Serum |
| 15864-2 | White mulberry IgE Ab RAST class [Presence] in Serum |
| 15865-9 | Deprecated White mulberry IgE Ab RAST class in Serum |
| 15866-7 | Mushroom IgE Ab RAST class [Presence] in Serum |
| 15867-5 | Deprecated Melon IgE Ab Ab RAST class in Serum |
| 15868-3 | Deprecated Blue mussel IgE Ab RAST class in Serum |
| 15869-1 | Blue mussel IgE Ab RAST class [Presence] in Serum |
| 1587-5 | Deprecated Lutropin [Mass/volume] in Serum or Plasma --1.5 hours post 100 g lutropin IV |
| 15870-9 | Mustard IgE Ab RAST class [Presence] in Serum |
| 15871-7 | Nectarine IgE Ab RAST class [Presence] in Serum |
| 15872-5 | Nettle IgE Ab RAST class [Presence] in Serum |
| 15873-3 | Nigrospora sphaerica IgE Ab RAST class [Presence] in Serum |
| 15874-1 | Nutmeg IgE Ab RAST class [Presence] in Serum |
| 15875-8 | White Oak IgE Ab RAST class [Presence] in Serum |
| 15876-6 | California Black Oak IgE Ab RAST class [Presence] in Serum |
| 15877-4 | Coastal Oak IgE Ab RAST class [Presence] in Serum |
| 15878-2 | Gamble Oak IgE Ab RAST class [Presence] in Serum |
| 15879-0 | Jerusalem oak IgE Ab RAST class [Presence] in Serum |
| 1588-3 | Lutropin [Mass/volume] in Serum or Plasma --1.5 hours post dose gonadotropin releasing hormone |
| 15880-8 | Virginia Live Oak IgE Ab RAST class [Presence] in Serum |
| 15881-6 | Red Oak IgE Ab RAST class [Presence] in Serum |
| 15882-4 | Valley Oak IgE Ab RAST class [Presence] in Serum |
| 15883-2 | Deprecated Virginia Live Oak IgE Ab RAST class in Serum |
| 15884-0 | Deprecated White Oak IgE Ab RAST class in Serum |
| 15885-7 | Oat IgE Ab RAST class [Presence] in Serum |
| 15886-5 | Oat pollen IgE Ab RAST class [Presence] in Serum |
| 15887-3 | Deprecated Oat pollen IgE Ab RAST class in Serum |
| 15888-1 | Octopus IgE Ab RAST class [Presence] in Serum |
| 15889-9 | Oidiodendrum spp IgE Ab RAST class [Presence] in Serum |
| 1589-1 | Deprecated Lutropin [Mass/volume] in Serum or Plasma --105 minutes post 100 g lutropin IV |
| 15890-7 | Okra IgE Ab RAST class [Presence] in Serum |
| 15891-5 | Deprecated Olive IgE Ab RAST class [Presence] in Serum |
| 15892-3 | Olive Pollen IgE Ab RAST class [Presence] in Serum |
| 15893-1 | Onion IgE Ab RAST class [Presence] in Serum |
| 15894-9 | Orange IgE Ab RAST class [Presence] in Serum |
| 15895-6 | Oregano IgE Ab RAST class [Presence] in Serum |
| 15896-4 | Orris root IgE Ab RAST class [Presence] in Serum |
| 15897-2 | Ovalbumin IgE Ab RAST class [Presence] in Serum |
| 15898-0 | Ovomucoid IgE Ab RAST class [Presence] in Serum |
| 15899-8 | Oyster IgE Ab RAST class [Presence] in Serum |
| 159-4 | Cephaloridine [Susceptibility] by Serum bactericidal titer |
| 1590-9 | Deprecated Lutropin [Mass/volume] in Serum or Plasma --15 minutes post 100 g lutropin IV |
| 15900-4 | Queen Palm IgE Ab RAST class [Presence] in Serum |
| 15901-2 | Papaya (Carica papaya) IgE Ab RAST class [Presence] in Serum |
| 15902-0 | Paprika IgE Ab RAST class [Presence] in Serum |
| 15903-8 | Parakeet feather IgE Ab RAST class [Presence] in Serum |
| 15904-6 | Budgerigar droppings IgE Ab RAST class [Presence] in Serum |
| 15905-3 | Deprecated Budgerigar feather IgE Ab RAST class in Serum |
| 15906-1 | Budgerigar serum proteins IgE Ab RAST class [Presence] in Serum |
| 15907-9 | Parrot droppings IgE Ab RAST class [Presence] in Serum |
| 15908-7 | Parrot feather IgE Ab RAST class [Presence] in Serum |
| 15909-5 | Parrot serum proteins IgE Ab RAST class [Presence] in Serum |
| 1591-7 | Deprecated Lutropin [Mass/volume] in Serum or Plasma --1 hour post 100 g lutropin IV |
| 15910-3 | Parsley IgE Ab RAST class [Presence] in Serum |
| 15911-1 | Parsnip IgE Ab RAST class [Presence] in Serum |
| 15912-9 | Passion fruit IgE Ab RAST class [Presence] in Serum |
| 15913-7 | Pea IgE Ab RAST class [Presence] in Serum |
| 15914-5 | Black-eye pea IgE Ab RAST class [Presence] in Serum |
| 15915-2 | Chick Pea IgE Ab RAST class [Presence] in Serum |
| 15916-0 | Peach IgE Ab RAST class [Presence] in Serum |
| 15917-8 | Peanut IgE Ab RAST class [Presence] in Serum |
| 15918-6 | Pear IgE Ab RAST class [Presence] in Serum |
| 15919-4 | Deprecated Pecan or Hickory Nut IgE Ab RAST class in Serum |
| 1592-5 | Lutropin [Mass/volume] in Serum or Plasma --1 hour post dose gonadotropin releasing hormone |
| 15920-2 | Deprecated Pecan or Hickory Tree IgE Ab RAST class in Serum |
| 15921-0 | Penicillin G IgE Ab RAST class [Presence] in Serum |
| 15922-8 | Penicillin V IgE Ab RAST class [Presence] in Serum |
| 15923-6 | Penicillium frequentans IgE Ab RAST class [Presence] in Serum |
| 15924-4 | Penicillium notatum IgE Ab RAST class [Presence] in Serum |
| 15925-1 | Black Pepper IgE Ab RAST class [Presence] in Serum |
| 15926-9 | Cayenne IgE Ab RAST class [Presence] in Serum |
| 15927-7 | Chili Pepper IgE Ab RAST class [Presence] in Serum |
| 15928-5 | Green Pepper IgE Ab RAST class [Presence] in Serum |
| 15929-3 | Pepper tree IgE Ab RAST class [Presence] in Serum |
| 1593-3 | Deprecated Lutropin [Mass/volume] in Serum or Plasma --2 hours post 100 g lutropin IV |
| 15930-1 | Perch IgE Ab RAST class [Presence] in Serum |
| 15931-9 | Phoma betae IgE Ab RAST class [Presence] in Serum |
| 15932-7 | Phospholipase IgE Ab RAST class [Presence] in Serum |
| 15933-5 | Phthalic anhydride IgE Ab RAST class [Presence] in Serum |
| 15934-3 | Pigeon droppings IgE Ab RAST class [Presence] in Serum |
| 15935-0 | Pigeon feather IgE Ab RAST class [Presence] in Serum |
| 15936-8 | Common Pigweed IgE Ab RAST class [Presence] in Serum |
| 15937-6 | Rough Pigweed IgE Ab RAST class [Presence] in Serum |
| 15938-4 | Spiny Pigweed IgE Ab RAST class [Presence] in Serum |
| 15939-2 | Austrian Pine IgE Ab RAST class [Presence] in Serum |
| 1594-1 | Lutropin [Mass/volume] in Serum or Plasma --2 hours post dose gonadotropin releasing hormone |
| 15940-0 | Loblolly Pine IgE Ab RAST class [Presence] in Serum |
| 15941-8 | Long Leaf Pine IgE Ab RAST class [Presence] in Serum |
| 15942-6 | Pine IgE Ab RAST class [Presence] in Serum |
| 15943-4 | Pine Nut IgE Ab RAST class [Presence] in Serum |
| 15944-2 | Short Leaf Pine IgE Ab RAST class [Presence] in Serum |
| 15945-9 | Slash Pine IgE Ab RAST class [Presence] in Serum |
| 15946-7 | Virginia Scrub Pine IgE Ab RAST class [Presence] in Serum |
| 15947-5 | Eastern White Pine IgE Ab RAST class [Presence] in Serum |
| 15948-3 | Pineapple IgE Ab RAST class [Presence] in Serum |
| 15949-1 | Pistachio IgE Ab RAST class [Presence] in Serum |
| 1595-8 | Deprecated Lutropin [Mass/volume] in Serum or Plasma --30 minutes post 100 g lutropin IV |
| 15950-9 | Malassezia furfur IgE Ab RAST class [Presence] in Serum |
| 15951-7 | Plaice IgE Ab RAST class [Presence] in Serum |
| 15952-5 | English plantain IgE Ab RAST class [Presence] in Serum |
| 15953-3 | Plum IgE Ab RAST class [Presence] in Serum |
| 15954-1 | Black Cottonwood IgE Ab RAST class [Presence] in Serum |
| 15955-8 | Poppy Seed IgE Ab RAST class [Presence] in Serum |
| 15956-6 | Pork IgE Ab RAST class [Presence] in Serum |
| 15957-4 | Potato IgE Ab RAST class [Presence] in Serum |
| 15958-2 | Sweet potato IgE Ab RAST class [Presence] in Serum |
| 15959-0 | Povertyweed IgE Ab RAST class [Presence] in Serum |
| 1596-6 | Lutropin [Mass/volume] in Serum or Plasma --30 minutes post dose gonadotropin releasing hormone |
| 15960-8 | Privet IgE Ab RAST class [Presence] in Serum |
| 15961-6 | Protamine IgE Ab RAST class [Presence] in Serum |
| 15962-4 | Prune IgE Ab RAST class [Presence] in Serum |
| 15963-2 | Psyllium seed IgE Ab RAST class [Presence] in Serum |
| 15964-0 | Aureobasidium pullulans IgE Ab RAST class [Presence] in Serum |
| 15965-7 | Deprecated Pullularia pullulans IgE Ab RAST class in Serum |
| 15966-5 | Pumpkin IgE Ab RAST class [Presence] in Serum |
| 15967-3 | Pumpkin Seed IgE Ab RAST class [Presence] in Serum |
| 15968-1 | Pyrethrum IgE Ab RAST class [Presence] in Serum |
| 15969-9 | Rabbit meat IgE Ab RAST class [Presence] in Serum |
| 1597-4 | Deprecated Lutropin [Mass/volume] in Serum or Plasma --45 minutes post 100 g lutropin IV |
| 15970-7 | Rabbit Bush IgE Ab RAST class [Presence] in Serum |
| 15971-5 | Rabbit epithelium IgE Ab RAST class [Presence] in Serum |
| 15972-3 | Rabbit serum proteins IgE Ab RAST class [Presence] in Serum |
| 15973-1 | Rabbit urine proteins IgE Ab RAST class [Presence] in Serum |
| 15974-9 | Radish IgE Ab RAST class [Presence] in Serum |
| 15975-6 | Common Ragweed IgE Ab RAST class [Presence] in Serum |
| 15976-4 | Desert Ragweed IgE Ab RAST class [Presence] in Serum |
| 15977-2 | False ragweed IgE Ab RAST class [Presence] in Serum |
| 15978-0 | Giant Ragweed IgE Ab RAST class [Presence] in Serum |
| 15979-8 | Deprecated Common Ragweed IgE Ab RAST class in Serum |
| 1598-2 | Deprecated Lutropin [Mass/volume] in Serum or Plasma --75 minutes post 100 g lutropin IV |
| 15980-6 | Southern Ragweed IgE Ab RAST class [Presence] in Serum |
| 15981-4 | Western Ragweed IgE Ab RAST class [Presence] in Serum |
| 15982-2 | Rapeseed IgE Ab RAST class [Presence] in Serum |
| 15983-0 | Raspberry IgE Ab RAST class [Presence] in Serum |
| 15984-8 | Rat epithelium IgE Ab RAST class [Presence] in Serum |
| 15985-5 | Rat serum proteins IgE Ab RAST class [Presence] in Serum |
| 15986-3 | Rat urine proteins IgE Ab RAST class [Presence] in Serum |
| 15987-1 | Redwood IgE Ab RAST class [Presence] in Serum |
| 15988-9 | Canary grass IgE Ab RAST class [Presence] in Serum |
| 15989-7 | Common Reed IgE Ab RAST class [Presence] in Serum |
| 1599-0 | Lutropin [Mass/volume] in Serum or Plasma --baseline |
| 15990-5 | Reindeer epithelium IgE Ab RAST class [Presence] in Serum |
| 15991-3 | Rhizopus nigricans IgE Ab RAST class [Presence] in Serum |
| 15992-1 | Rhodotorula spp IgE Ab RAST class [Presence] in Serum |
| 15993-9 | Rhubarb IgE Ab RAST class [Presence] in Serum |
| 15994-7 | Rice IgE Ab RAST class [Presence] in Serum |
| 15995-4 | Wild Rice IgE Ab RAST class [Presence] in Serum |
| 15996-2 | Rose Hip IgE Ab RAST class [Presence] in Serum |
| 15997-0 | Cultivated Rye IgE Ab RAST class [Presence] in Serum |
| 15998-8 | Rye IgE Ab RAST class [Presence] in Serum |
| 15999-6 | Deprecated Cultivated Rye IgE Ab RAST class in Serum |
| 16-6 | Amoxicillin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 160-2 | Cephalothin [Susceptibility] by Minimum lethal concentration (MLC) |
| 1600-6 | Lutropin [Mass/volume] in Serum or Plasma --pre dose gonadotropin releasing hormone |
| 16000-2 | Deprecated rye Perennial IgE Ab RAST class in Serum |
| 16001-0 | Safflower IgE Ab RAST class [Presence] in Serum |
| 16002-8 | Sage IgE Ab RAST class [Presence] in Serum |
| 16003-6 | Common Sagebrush IgE Ab RAST class [Presence] in Serum |
| 16004-4 | Deprecated Sagebrush IgE Ab RAST class in Serum |
| 16005-1 | Saline fish feed IgE Ab RAST class [Presence] in Serum |
| 16006-9 | Salmon IgE Ab RAST class [Presence] in Serum |
| 16007-7 | Saltbush IgE Ab RAST class [Presence] in Serum |
| 16008-5 | Sardine (pilchard) IgE Ab RAST class [Presence] in Serum |
| 16009-3 | Savinase IgE Ab RAST class [Presence] in Serum |
| 1601-4 | Norepinephrine [Mass/volume] in Plasma --supine |
| 16010-1 | Deprecated Lenscale IgE Ab RAST class in Serum |
| 16011-9 | Scallop IgE Ab RAST class [Presence] in Serum |
| 16012-7 | Scotch broom IgE Ab RAST class [Presence] in Serum |
| 16013-5 | Sericin IgE Ab RAST class [Presence] in Serum |
| 16014-3 | Sesame Seed IgE Ab RAST class [Presence] in Serum |
| 16015-0 | Sheep epithelium IgE Ab RAST class [Presence] in Serum |
| 16016-8 | Sheep Sorrel IgE Ab RAST class [Presence] in Serum |
| 16017-6 | Sheep wool IgE Ab RAST class [Presence] in Serum |
| 16018-4 | Shrimp IgE Ab RAST class [Presence] in Serum |
| 16019-2 | Silk IgE Ab RAST class [Presence] in Serum |
| 1602-2 | Norepinephrine [Mass/volume] in Plasma --10 minutes post standing |
| 16020-0 | Silk waste IgE Ab RAST class [Presence] in Serum |
| 16021-8 | Silver IgE Ab RAST class [Presence] in Serum |
| 16022-6 | Bermuda grass smut IgE Ab RAST class [Presence] in Serum |
| 16023-4 | Johnson grass smut IgE Ab RAST class [Presence] in Serum |
| 16024-2 | Escargot IgE Ab RAST class [Presence] in Serum |
| 16025-9 | Red Snapper IgE Ab RAST class [Presence] in Serum |
| 16026-7 | Sole IgE Ab RAST class [Presence] in Serum |
| 16027-5 | Spinach IgE Ab RAST class [Presence] in Serum |
| 16028-3 | Spondylocladium citrovirens IgE Ab RAST class [Presence] in Serum |
| 16029-1 | Spruce IgE Ab RAST class [Presence] in Serum |
| 1603-0 | Norepinephrine [Mass/volume] in Plasma --1 hour post 300 ug clonidine PO |
| 16030-9 | Squash IgE Ab RAST class [Presence] in Serum |
| 16031-7 | Squid IgE Ab RAST class [Presence] in Serum |
| 16032-5 | Pacific Squid IgE Ab RAST class [Presence] in Serum |
| 16033-3 | Stemphylium botryosum IgE Ab RAST class [Presence] in Serum |
| 16034-1 | Stemphylium solani IgE Ab RAST class [Presence] in Serum |
| 16035-8 | Acarus siro IgE Ab RAST class [Presence] in Serum |
| 16037-4 | Tyrophagus putrescentiae IgE Ab RAST class [Presence] in Serum |
| 16038-2 | Strawberry IgE Ab RAST class [Presence] in Serum |
| 16039-0 | Succinylcholine IgE Ab RAST class [Presence] in Serum |
| 1604-8 | Norepinephrine [Mass/volume] in Plasma --2 hours post 300 ug clonidine PO |
| 16040-8 | Sugar Cane IgE Ab RAST class [Presence] in Serum |
| 16041-6 | Sunflower Pollen IgE Ab RAST class [Presence] in Serum |
| 16042-4 | Sunflower Seed IgE Ab RAST class [Presence] in Serum |
| 16043-2 | Swine epithelium IgE Ab RAST class [Presence] in Serum |
| 16044-0 | Swine urine proteins IgE Ab RAST class [Presence] in Serum |
| 16045-7 | Swordfish IgE Ab RAST class [Presence] in Serum |
| 16046-5 | American Sycamore IgE Ab RAST class [Presence] in Serum |
| 16047-3 | Mandarin IgE Ab RAST class [Presence] in Serum |
| 16048-1 | Tapioca IgE Ab RAST class [Presence] in Serum |
| 16049-9 | Tarragon IgE Ab RAST class [Presence] in Serum |
| 1605-5 | Norepinephrine [Mass/volume] in Plasma --3 hours post 300 ug clonidine PO |
| 16050-7 | Tea IgE Ab RAST class [Presence] in Serum |
| 16051-5 | Tetramin IgE Ab RAST class [Presence] in Serum |
| 16052-3 | Saltwort IgE Ab RAST class [Presence] in Serum |
| 16053-1 | Thyme IgE Ab RAST class [Presence] in Serum |
| 16054-9 | Timothy IgE Ab RAST class [Presence] in Serum |
| 16055-6 | Deprecated Tobacco IgE Ab RAST class in Serum |
| 16056-4 | Tobacco IgE Ab RAST class [Presence] in Serum |
| 16057-2 | Tomato IgE Ab RAST class [Presence] in Serum |
| 16058-0 | Tragacanth IgE Ab RAST class [Presence] in Serum |
| 16059-8 | Trichoderma viride IgE Ab RAST class [Presence] in Serum |
| 1606-3 | Norepinephrine [Mass/volume] in Plasma --pre 300 ug clonidine PO |
| 16060-6 | Trichophyton sp IgE Ab RAST class [Presence] in Serum |
| 16061-4 | Trichophyton rubrum IgE Ab RAST class [Presence] in Serum |
| 16062-2 | Trichosporon spp IgE Ab RAST class [Presence] in Serum |
| 16063-0 | Trimellitic anhydride (TMA) IgE Ab RAST class [Presence] in Serum |
| 16064-8 | Trout IgE Ab RAST class [Presence] in Serum |
| 16065-5 | Tuna IgE Ab RAST class [Presence] in Serum |
| 16066-3 | Turkey meat IgE Ab RAST class [Presence] in Serum |
| 16067-1 | Turnip IgE Ab RAST class [Presence] in Serum |
| 16069-7 | Ulocladium chartarum IgE Ab RAST class [Presence] in Serum |
| 1607-1 | Osmolality of Urine--12 hours post fluid fast |
| 16070-5 | Barley smut IgE Ab RAST class [Presence] in Serum |
| 16071-3 | Vanilla IgE Ab RAST class [Presence] in Serum |
| 16072-1 | Veal IgE Ab RAST class [Presence] in Serum |
| 16073-9 | Wall pellitory IgE Ab RAST class [Presence] in Serum |
| 16074-7 | Walnut IgE Ab RAST class [Presence] in Serum |
| 16075-4 | Black Walnut IgE Ab RAST class [Presence] in Serum |
| 16076-2 | Black Walnut Pollen IgE Ab RAST class [Presence] in Serum |
| 16077-0 | English Walnut Pollen IgE Ab RAST class [Presence] in Serum |
| 16078-8 | California Walnut Pollen IgE Ab RAST class [Presence] in Serum |
| 16079-6 | Deprecated California Walnut Pollen IgE Ab RAST class in Serum |
| 1608-9 | Osmolality of Urine--8 hours post fluid fast |
| 16080-4 | Paper wasp IgE Ab RAST class [Presence] in Serum |
| 16081-2 | Deprecated Paper Wasp IgE Ab RAST class in Serum |
| 16082-0 | Yellow Jacket IgE Ab RAST class [Presence] in Serum |
| 16083-8 | Watermelon IgE Ab RAST class [Presence] in Serum |
| 16084-6 | Grain weevel IgE Ab RAST class [Presence] in Serum |
| 16085-3 | Wheat IgE Ab RAST class [Presence] in Serum |
| 16086-1 | Cultivated Wheat IgE Ab RAST class [Presence] in Serum |
| 16087-9 | Deprecated Cultivated Wheat IgE Ab RAST class in Serum |
| 16088-7 | Wheat Stem Rust IgE Ab RAST class [Presence] in Serum |
| 16089-5 | Cow whey IgE Ab RAST class [Presence] in Serum |
| 1609-7 | Prolactin [Mass/volume] in Serum or Plasma --1.5 hours post dose insulin IV |
| 16090-3 | Whitefish IgE Ab RAST class [Presence] in Serum |
| 16091-1 | Willow IgE Ab RAST class [Presence] in Serum |
| 16092-9 | Black Willow IgE Ab RAST class [Presence] in Serum |
| 16093-7 | Pussy Willow IgE Ab RAST class [Presence] in Serum |
| 16094-5 | Wingscale IgE Ab RAST class [Presence] in Serum |
| 16095-2 | Wormwood IgE Ab RAST class [Presence] in Serum |
| 16096-0 | Baker's yeast IgE Ab RAST class [Presence] in Serum |
| 16097-8 | Deprecated Bakers Yeast IgE Ab RAST class in Serum |
| 16098-6 | Brewer's yeast IgE Ab RAST class [Presence] in Serum |
| 16099-4 | Ethionamide [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 161-0 | Cephalothin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 1610-5 | Prolactin [Mass/volume] in Serum or Plasma --1 hour post dose L-dopa PO |
| 16100-0 | Rifabutin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 16101-8 | Cumin IgE Ab [Units/volume] in Serum |
| 16102-6 | Bovine Gelatin IgE Ab [Units/volume] in Serum |
| 16103-4 | Porcine Gelatin IgE Ab [Units/volume] in Serum |
| 16104-2 | Paper Mulberry IgE Ab [Units/volume] in Serum |
| 16105-9 | Pheasant IgE Ab [Units/volume] in Serum |
| 16106-7 | CD8+CD28+ cells [#/volume] in Blood |
| 16107-5 | CD8+HLA-DR+ cells [#/volume] in Blood |
| 16108-3 | 17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --45 minutes post 250 ug corticotropin IM |
| 16109-1 | Prolactin [Mass/volume] in Serum or Plasma --2 hours post XXX challenge |
| 1611-3 | Prolactin [Mass/volume] in Serum or Plasma --1 hour post dose TRH IV |
| 16110-9 | 11-Deoxycorticosterone [Mass/time] in 24 hour Urine |
| 16111-7 | Epinephrine+Norepinephrine [Mass/time] in 24 hour Urine |
| 16112-5 | Estrogen receptor [Interpretation] in Tissue |
| 16113-3 | Progesterone receptor [Interpretation] in Tissue |
| 16114-1 | Amitriptyline [Mass/volume] in Urine |
| 16115-8 | Doxepin [Mass/mass] in Tissue |
| 16116-6 | Tetrahydrocortisone [Mass/time] in 24 hour Urine |
| 16117-4 | Babesia microti IgG Ab [Titer] in Serum |
| 16118-2 | Babesia microti IgM Ab [Titer] in Serum |
| 16119-0 | Brucella abortus IgG Ab [Titer] in Serum |
| 1612-1 | Prolactin [Mass/volume] in Serum or Plasma --1 hour post dose insulin IV |
| 16120-8 | Brucella abortus IgM Ab [Titer] in Serum |
| 16121-6 | Colorado tick fever virus IgG Ab [Titer] in Serum |
| 16122-4 | Colorado tick fever virus IgM Ab [Titer] in Serum |
| 16123-2 | Cryptococcus sp Ab [Titer] in Cerebral spinal fluid |
| 16124-0 | Cryptococcus sp Ab [Titer] in Serum |
| 16125-7 | Helicobacter pylori IgA Ab [Presence] in Serum |
| 16126-5 | Helicobacter pylori IgG Ab [Presence] in Serum |
| 16127-3 | Helicobacter pylori IgM Ab [Presence] in Serum |
| 16128-1 | Hepatitis C virus Ab [Presence] in Serum |
| 16129-9 | Hepatitis C virus IgG Ab [Presence] in Serum |
| 1613-9 | Prolactin [Mass/volume] in Serum or Plasma --2 hours post dose L-dopa PO |
| 16130-7 | Herpes simplex virus 1 DNA [Presence] in Unspecified specimen by Probe and target amplification method |
| 16131-5 | Herpes simplex virus 2 DNA [Presence] in Unspecified specimen by Probe and target amplification method |
| 16132-3 | HIV 1 p15+p18 Ab [Presence] in Serum by Immunoblot (IB) |
| 16133-1 | Legionella pneumophila IgM Ab [Titer] in Serum by Immunofluorescence |
| 16134-9 | Neisseria meningitidis [Presence] in Unspecified specimen by Organism specific culture |
| 16135-6 | Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum |
| 16136-4 | Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum |
| 16137-2 | Centromere Ab [Presence] in Serum |
| 16138-0 | Ganglioside GM1 IgA Ab [Titer] in Serum |
| 16139-8 | Neuronal nuclear Ab [Titer] in Cerebral spinal fluid |
| 1614-7 | Prolactin [Mass/volume] in Serum or Plasma --30 minutes post dose TRH IV |
| 16140-6 | Tellurium [Mass/volume] in Blood |
| 16141-4 | Nitrogen [Mass/time] in 24 hour Stool |
| 16142-2 | Fat [Mass/time] in 24 hour Stool |
| 16143-0 | Deprecated Butane [Mass/volume] in Blood |
| 16144-8 | Droperidol [Presence] in Serum or Plasma |
| 16145-5 | Mescaline [Mass/volume] in Serum or Plasma |
| 16146-3 | Psilocin [Mass/volume] in Serum or Plasma |
| 16147-1 | Aldosterone [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
| 16148-9 | Aldosterone [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
| 16149-7 | Aldosterone [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
| 1615-4 | Prolactin [Mass/volume] in Serum or Plasma --30 minutes post dose insulin IV |
| 16150-5 | Carboxy tetrahydrocannabinol [Mass/volume] in Serum or Plasma |
| 16151-3 | Dechlorane [Presence] in Serum or Plasma |
| 16152-1 | Gastrin [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
| 16153-9 | Gastrin [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
| 16154-7 | Gastrin [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
| 16155-4 | Gastrin [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
| 16156-2 | Gastrin [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
| 16157-0 | Gastrin [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
| 16158-8 | Gastrin [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge |
| 16159-6 | Gastrin [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge |
| 1616-2 | Deprecated Prolactin [Mass/volume] in Serum or Plasma --30 minutes post dose insulin IV |
| 16160-4 | Gastrin [Mass/volume] in Serum or Plasma --10th specimen post XXX challenge |
| 16161-2 | Gastrin [Mass/volume] in Serum or Plasma --post XXX challenge |
| 16162-0 | Parathyrin.intact [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge |
| 16163-8 | Parathyrin.intact [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
| 16164-6 | Parathyrin.intact [Mass/volume] in Serum or Plasma --2 hours post XXX challenge |
| 16165-3 | Glucose [Mass/volume] in Serum or Plasma --10 AM specimen |
| 16166-1 | Glucose [Mass/volume] in Serum or Plasma --11 AM specimen |
| 16167-9 | Glucose [Mass/volume] in Serum or Plasma --2 PM specimen |
| 16168-7 | Glucose [Mass/volume] in Serum or Plasma --3 PM specimen |
| 16169-5 | Glucose [Mass/volume] in Serum or Plasma --4 PM specimen |
| 1617-0 | Prolactin [Mass/volume] in Serum or Plasma --3 hours post dose L-dopa PO |
| 16170-3 | Glucose [Mass/volume] in Serum or Plasma --5 PM specimen |
| 16171-1 | Cocaethylene [Mass/mass] in Hair |
| 16172-9 | Magnesium [Mass/mass] in Hair |
| 16173-7 | Amyl ether [Mass/volume] in Blood |
| 16174-5 | Bartonella henselae IgG Ab [Presence] in Cerebral spinal fluid |
| 16175-2 | Bartonella henselae IgM Ab [Presence] in Cerebral spinal fluid |
| 16176-0 | Bartonella quintana IgG Ab [Units/volume] in Cerebral spinal fluid |
| 16177-8 | Bartonella quintana IgM Ab [Units/volume] in Cerebral spinal fluid |
| 16178-6 | Beryllium [Mass/mass] in Tissue |
| 16179-4 | Polychlorinated biphenyl (PCB) [Mass/mass] in Tissue |
| 1618-8 | Prolactin [Mass/volume] in Serum or Plasma --45 minutes post dose insulin IV |
| 16180-2 | Zinc [Mass/mass] in Tissue |
| 16181-0 | Tricyclic antidepressants [Mass/volume] in Urine by Confirmatory method |
| 16182-8 | Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability |
| 16183-6 | Phenolphthalein [Mass/volume] in Stool |
| 16184-4 | Temazepam [Mass/volume] in Stool |
| 16185-1 | Chlordiazepoxide [Mass/volume] in Stool |
| 16186-9 | Hydroxyalprazolam [Mass/volume] in Stool |
| 16187-7 | Alprazolam [Mass/volume] in Stool |
| 16188-5 | Creatinine [Mass/volume] in Serum or Plasma --2 hour specimen |
| 16189-3 | Creatinine [Mass/volume] in Serum or Plasma --4 hour specimen |
| 1619-6 | Prolactin [Mass/volume] in Serum or Plasma --pre dose L-dopa PO |
| 16190-1 | Amobarbital [Presence] in Urine by Confirmatory method |
| 16191-9 | Butabarbital [Presence] in Urine by Confirmatory method |
| 16192-7 | Phenobarbital [Presence] in Urine by Confirmatory method |
| 16193-5 | Pentobarbital [Presence] in Urine by Confirmatory method |
| 16194-3 | Secobarbital [Presence] in Urine by Confirmatory method |
| 16195-0 | Benzodiazepines [Presence] in Urine by Confirmatory method |
| 16196-8 | Morphine [Presence] in Urine by Confirmatory method |
| 16197-6 | Codeine [Presence] in Urine by Confirmatory method |
| 16198-4 | Diamorphine [Presence] in Urine by Confirmatory method |
| 16199-2 | Methadone [Presence] in Urine by Confirmatory method |
| 162-8 | Cephalothin [Susceptibility] by Disk diffusion (KB) |
| 1620-4 | Prolactin [Mass/volume] in Serum or Plasma --pre dose TRH IV |
| 16200-8 | Propoxyphene [Presence] in Urine by Confirmatory method |
| 16201-6 | Oxazepam [Mass/volume] in Urine by Confirmatory method |
| 16202-4 | Nordiazepam [Presence] in Urine by Confirmatory method |
| 16203-2 | Alprazolam [Presence] in Urine by Confirmatory method |
| 16204-0 | Clonazepam [Presence] in Urine by Confirmatory method |
| 16205-7 | Lorazepam [Presence] in Urine by Confirmatory method |
| 16206-5 | Temazepam [Presence] in Urine by Confirmatory method |
| 16207-3 | Meperidine [Presence] in Urine by Confirmatory method |
| 16208-1 | Buprenorphine [Presence] in Urine by Confirmatory method |
| 16209-9 | Chlorpheniramine [Presence] in Urine by Confirmatory method |
| 1621-2 | Prolactin [Mass/volume] in Serum or Plasma --pre dose insulin IV |
| 16210-7 | Diethylpropion [Presence] in Urine by Confirmatory method |
| 16211-5 | Dihydrocodeine [Presence] in Urine by Confirmatory method |
| 16212-3 | Ethylamphetamine [Presence] in Urine by Confirmatory method |
| 16213-1 | Levorphanol [Presence] in Urine by Confirmatory method |
| 16214-9 | Lysergate diethylamide [Presence] in Urine by Confirmatory method |
| 16215-6 | Mephobarbital [Mass/volume] in Serum or Plasma by Confirmatory method |
| 16216-4 | Methylephedrine [Presence] in Urine by Confirmatory method |
| 16217-2 | Methyprylon [Presence] in Urine by Confirmatory method |
| 16218-0 | Nalbuphine [Presence] in Urine by Confirmatory method |
| 16219-8 | Pentazocine [Presence] in Urine by Confirmatory method |
| 1622-0 | Renin [Enzymatic activity/volume] in Plasma --5 hours post 600 ug furosemide PO |
| 16220-6 | Phenmetrazine [Presence] in Urine by Confirmatory method |
| 16221-4 | Phenothiazines [Presence] in Urine by Confirmatory method |
| 16222-2 | Phentermine [Presence] in Urine by Confirmatory method |
| 16223-0 | Thiopental [Presence] in Urine by Confirmatory method |
| 16224-8 | Triazolam [Presence] in Urine by Confirmatory method |
| 16225-5 | Amitriptyline [Presence] in Urine by Confirmatory method |
| 16226-3 | Benzoylecgonine [Mass/volume] in Urine by Confirmatory method |
| 16227-1 | Diazepam [Mass/volume] in Urine by Confirmatory method |
| 16228-9 | Nordiazepam [Mass/volume] in Urine by Confirmatory method |
| 16229-7 | Clonazepam [Mass/volume] in Urine by Confirmatory method |
| 1623-8 | Renin [Enzymatic activity/volume] in Plasma --pre 600 ug furosemide PO |
| 16230-5 | N-desalkylflurazepam [Mass/volume] in Urine by Confirmatory method |
| 16231-3 | Flurazepam [Mass/volume] in Urine by Confirmatory method |
| 16232-1 | Triazolam [Mass/volume] in Urine by Confirmatory method |
| 16233-9 | Midazolam [Mass/volume] in Urine by Confirmatory method |
| 16234-7 | Amphetamine [Mass/volume] in Urine by Confirmatory method |
| 16235-4 | Methamphetamine [Mass/volume] in Urine by Confirmatory method |
| 16236-2 | Butabarbital [Mass/volume] in Urine by Confirmatory method |
| 16237-0 | Butalbital [Mass/volume] in Urine by Confirmatory method |
| 16238-8 | Secobarbital [Mass/volume] in Urine by Confirmatory method |
| 16239-6 | Amobarbital [Mass/volume] in Urine by Confirmatory method |
| 1624-6 | Retinol [Mass/volume] in Serum or Plasma --3 hours post 5000 units |
| 16240-4 | Pentobarbital [Mass/volume] in Urine by Confirmatory method |
| 16241-2 | Phenobarbital [Mass/volume] in Urine by Confirmatory method |
| 16242-0 | Propoxyphene [Mass/volume] in Urine by Confirmatory method |
| 16243-8 | Cannabinoids [Mass/volume] in Blood by Confirmatory method |
| 16244-6 | Methaqualone [Mass/volume] in Urine by Confirmatory method |
| 16245-3 | Hydroxyethylflurazepam [Mass/volume] in Serum or Plasma by Confirmatory method |
| 16246-1 | Methadone [Mass/volume] in Urine by Confirmatory method |
| 16247-9 | Dextromethorphan [Mass/volume] in Serum or Plasma by Confirmatory method |
| 16248-7 | 6-monoacetylmorphine free [Mass/volume] in Serum or Plasma by Confirmatory method |
| 16249-5 | Oxycodone [Mass/volume] in Urine by Confirmatory method |
| 1625-3 | Retinol [Mass/volume] in Serum or Plasma --6 hours post 5000 units |
| 16250-3 | Codeine [Mass/volume] in Urine by Confirmatory method |
| 16251-1 | Morphine [Mass/volume] in Urine by Confirmatory method |
| 16252-9 | Hydrocodone [Mass/volume] in Urine by Confirmatory method |
| 16253-7 | Meperidine [Mass/volume] in Urine by Confirmatory method |
| 16254-5 | Phencyclidine [Mass/volume] in Urine by Confirmatory method |
| 16255-2 | Troponin I.cardiac [Units/volume] in Serum or Plasma |
| 16257-8 | Sodium urate crystals [Presence] in Stone by Infrared spectroscopy |
| 16258-6 | Ammonium urate crystals [Presence] in Stone by Infrared spectroscopy |
| 16259-4 | Urate dihydrate crystals [Presence] in Stone by Infrared spectroscopy |
| 1626-1 | Retinol [Mass/volume] in Serum or Plasma --pre 5000 units |
| 16260-2 | Triamterene crystals [Presence] in Stone by Infrared spectroscopy |
| 16261-0 | Calcium bilirubinate crystals [Presence] in Stone by Infrared spectroscopy |
| 16262-8 | Newberyite crystals [Presence] in Stone by Infrared spectroscopy |
| 16263-6 | Calcium oxalate dihydrate crystals [Presence] in Stone by Infrared spectroscopy |
| 16264-4 | Calcium oxalate monohydrate crystals [Presence] in Stone by Infrared spectroscopy |
| 16265-1 | Triple phosphate crystals [Presence] in Stone by Infrared spectroscopy |
| 16266-9 | Calcium hydrogen phosphate crystals [Presence] in Stone by Infrared spectroscopy |
| 16267-7 | Calcium carbonate crystals [Presence] in Stone by Infrared spectroscopy |
| 16268-5 | Calcium phosphate crystals [Presence] in Stone by Infrared spectroscopy |
| 16269-3 | Urate crystals [Presence] in Stone by Infrared spectroscopy |
| 1627-9 | Somatotropin [Mass/volume] in Serum or Plasma --1.5 hours post dose insulin IV |
| 16270-1 | Calcium [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
| 16271-9 | Calcium [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge |
| 16272-7 | Calcium [Mass/volume] in Serum or Plasma --2 hours post XXX challenge |
| 16273-5 | Calcium [Mass/mass] in Red Blood Cells |
| 16274-3 | Deprecated Cells.CD4/Cells.C4 |
| 16275-0 | Bartonella sp DNA [Presence] in Blood by Probe and target amplification method |
| 16276-8 | Bartonella henselae DNA [Presence] in Blood by Probe and target amplification method |
| 16277-6 | Bartonella quintana DNA [Presence] in Blood by Probe and target amplification method |
| 16278-4 | Mycobacterium tuberculosis DNA [Presence] in Blood by Probe and target amplification method |
| 16279-2 | Toxoplasma gondii DNA [Presence] in Blood by Probe and target amplification method |
| 1628-7 | Somatotropin [Mass/volume] in Serum or Plasma --1 hour post 1 g/kg glucose PO |
| 16280-0 | Human papilloma virus DNA [Presence] in Unspecified specimen by Probe with amplification |
| 16281-8 | Trazodone [Units/volume] in Urine |
| 16282-6 | Acetaminophen [Units/volume] in Urine |
| 16283-4 | Escherichia coli verotoxin [Presence] in Unspecified specimen |
| 16284-2 | Polio virus Ab [Units/volume] in Serum |
| 16285-9 | Creatinine/Protein [Mass Ratio] in Urine |
| 16286-7 | Deprecated Testosterone Free/Testosterone.total in Serum or Plasma |
| 16287-5 | Deprecated Sulfatide Ab |
| 16288-3 | Deprecated Monosialoganglioside GM1 Ab.IgG+IgM |
| 16289-1 | Deprecated Monosialoganglioside GM1 Ab |
| 1629-5 | Somatotropin [Mass/volume] in Serum or Plasma --1 hour post dose insulin IV |
| 16290-9 | Neutrophils [Presence] in Stool |
| 16291-7 | Herpes simplex virus 1 [Presence] in Unspecified specimen by Organism specific culture |
| 16292-5 | 1,4-Dioxane [Mass/volume] in Urine |
| 16293-3 | 11-Deoxycorticosteroids [Mass/volume] in Plasma |
| 16294-1 | 11-Deoxycorticosterone [Mass/volume] in Serum or Plasma --post XXX challenge |
| 16295-8 | 11-Deoxycortisol [Mass/volume] in Serum or Plasma --post XXX challenge |
| 16296-6 | 11-Hydroxyandrosterone [Mass/volume] in Serum or Plasma |
| 16297-4 | 17-Hydroxypregnenolone [Mass/volume] in Urine |
| 16298-2 | 17-Hydroxypregnenolone [Mass/volume] in Serum or Plasma --45 minutes post XXX challenge |
| 16299-0 | 17-Hydroxypregnenolone [Mass/volume] in Serum or Plasma --6 hours post XXX challenge |
| 163-6 | Cephalothin [Susceptibility] by Serum bactericidal titer |
| 1630-3 | Somatotropin [Mass/volume] in Serum or Plasma --2 hours post 1 g/kg glucose PO |
| 16300-6 | 17-Ketogenic steroids [Mass/time] in 72 hour Urine |
| 16301-4 | 17-Ketogenic steroids [Mass/time] in 24 hour Urine --baseline |
| 16302-2 | 1-Methylhistidine [Presence] in Urine |
| 16303-0 | 2-Hexanol [Mass/volume] in Urine |
| 16304-8 | 2-Hexanol/Creatinine [Mass Ratio] in Urine |
| 16305-5 | 2-Methoxyethanol [Mass/volume] in Blood |
| 16306-3 | 3-Methylhistidine [Presence] in Urine |
| 16307-1 | Acetate [Mass/volume] in Dialysis fluid |
| 16308-9 | Acetazolamide [Units/volume] in Serum or Plasma |
| 16309-7 | Acetazolamide [Units/volume] in Urine |
| 1631-1 | Somatotropin [Mass/volume] in Serum or Plasma --30 minutes post dose insulin IV |
| 16310-5 | Acetone [Presence] in Body fluid |
| 16311-3 | Acetone [Mass/volume] in Body fluid |
| 16312-1 | Acetonitrile [Mass/volume] in Serum or Plasma |
| 16313-9 | Acetylene [Mass/volume] in Blood |
| 16314-7 | Acetylsalicylate [Presence] in Urine |
| 16315-4 | Acid phosphatase [Enzymatic activity/volume] in Blood by Tartrate inhibited |
| 16316-2 | Acid phosphatase tartrate resistant [Enzymatic activity/volume] in Blood |
| 16317-0 | Prostatic acid phosphatase [Presence] in Vaginal fluid |
| 16318-8 | Acrylamide [Mass/volume] in Urine |
| 16319-6 | Acrylamide [Mass/volume] in Serum or Plasma |
| 1632-9 | Somatotropin [Mass/volume] in Serum or Plasma --3 hours post 1 g/kg glucose PO |
| 16320-4 | Acyclovir [Susceptibility] by Serum bactericidal titer |
| 16321-2 | Deprecated Acyl carnitine [Mass/volume] in Serum or Plasma |
| 16322-0 | Biperiden [Mass/volume] in Serum or Plasma |
| 16323-8 | Alanine [Presence] in Urine |
| 16324-6 | Alanine aminotransferase [Enzymatic activity/volume] in Red Blood Cells |
| 16325-3 | Alanine aminotransferase/Aspartate aminotransferase [Enzymatic activity ratio] in Serum or Plasma |
| 16327-9 | Allyl alcohol [Mass/volume] in Blood |
| 16328-7 | Benzyl alcohol [Presence] in Blood |
| 16329-5 | Aldosterone [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
| 1633-7 | Somatotropin [Mass/volume] in Serum or Plasma --45 minutes post dose insulin IV |
| 16330-3 | Aldosterone [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
| 16331-1 | Aldosterone [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge |
| 16332-9 | Aldosterone [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge |
| 16333-7 | Aldrin [Mass/volume] in Blood |
| 16334-5 | Alfentanil [Mass/volume] in Urine |
| 16335-2 | Hydrocarbons Aliphatic [Identifier] in Blood |
| 16336-0 | Deprecated Alkaline phosphatase.placental [Enzymatic activity/volume] in Serum or Plasma |
| 16337-8 | Alkaline phosphatase [Enzymatic activity/volume] in Urine |
| 16338-6 | Alpha aminoadipate [Presence] in Urine |
| 16339-4 | Alpha aminoisobutyrate [Presence] in Urine |
| 1634-5 | Somatotropin [Mass/volume] in Serum or Plasma --52 hours post 250 ug L-dopa TID 2day PO |
| 16340-2 | Alpha aminoisobutyrate [Mass/volume] in Urine |
| 16341-0 | Alpha aminoisobutyrate [Presence] in Plasma |
| 16342-8 | Alpha aminoisobutyrate [Mass/volume] in Plasma |
| 16343-6 | Alpha aminoisobutyrate [Mass/volume] in Cerebral spinal fluid |
| 16344-4 | Alpha aminoisobutyrate [Mass/volume] in Amniotic fluid |
| 16345-1 | Alpha aminobutyrate [Presence] in Urine |
| 16346-9 | Alpha chlordane [Mass/volume] in Urine |
| 16347-7 | Alpha chlordane [Mass/volume] in Blood |
| 16348-5 | Alpha hydroxyalprazolam [Mass/volume] in Urine by Confirmatory method |
| 16349-3 | Aluminum [Mass/volume] in Body fluid |
| 1635-2 | Somatotropin [Mass/volume] in Serum or Plasma --pre 1 g/kg glucose PO |
| 16350-1 | Amantadine [Susceptibility] by Serum bactericidal titer |
| 16351-9 | Amiloride [Units/volume] in Serum or Plasma |
| 16352-7 | Amiloride [Units/volume] in Urine |
| 16353-5 | Amino beta guanidinopropionate [Presence] in Urine |
| 16354-3 | Deprecated Amino beta guanidinopropionate [Mass/volume] in Urine |
| 16355-0 | Amino beta guanidinopropionate [Presence] in Plasma |
| 16356-8 | Deprecated Amino beta guanidinopropionate [Mass/volume] in Plasma |
| 16357-6 | Deprecated Amino beta guanidinopropionate [Mass/volume] in Cerebral spinal fluid |
| 16358-4 | Deprecated Amino beta guanidinopropionate [Mass/volume] in Amniotic fluid |
| 16359-2 | Deprecated Amiodarone+Desethylamiodarone [Mass/volume] in Serum or Plasma |
| 1636-0 | Somatotropin [Mass/volume] in Serum or Plasma --pre 250 ug L-dopa TID 2day PO |
| 16360-0 | Amitriptyline [Mass/volume] in Serum or Plasma --peak |
| 16361-8 | Amitriptyline [Mass/volume] in Serum or Plasma --trough |
| 16362-6 | Ammonia [Moles/volume] in Plasma |
| 16363-4 | Ammonia [Moles/mass] in Tissue |
| 16364-2 | Amobarbital [Mass/volume] in Gastric fluid |
| 16365-9 | Amoxicillin+Clavulanate [Mass/volume] in Serum or Plasma |
| 16366-7 | Diethylpropion [Mass/volume] in Serum or Plasma |
| 16367-5 | Deprecated Amphetamine/Methamphetamine [Mass ratio] in Urine Qualitative |
| 16369-1 | Amphetamines [Presence] in Urine by Confirmatory method |
| 1637-8 | Somatotropin [Mass/volume] in Serum or Plasma --pre dose insulin IV |
| 16370-9 | Amphotericin B [Mass/volume] in Urine |
| 16373-3 | Amyl ether [Presence] in Blood |
| 16374-1 | Amyl nitrite [Mass/volume] in Serum or Plasma |
| 16378-2 | Androstenedione [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
| 16379-0 | Androstenedione [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
| 1638-6 | Testosterone [Mass/volume] in Serum or Plasma --96 hours post 5000 U HCG IM |
| 16380-8 | Androstenedione [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
| 16381-6 | Androstenedione [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
| 16382-4 | Androstenedione [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
| 16383-2 | Androstenedione [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
| 16384-0 | Androstenedione [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge |
| 16385-7 | Androstenedione [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge |
| 16386-5 | Deprecated Rifabutin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 16387-3 | Rifabutin+Ethambutol [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 16388-1 | Anticonvulsants [Identifier] in Urine |
| 16389-9 | Antidepressants [Identifier] in Serum or Plasma |
| 1639-4 | Testosterone [Mass/volume] in Serum or Plasma --pre 5000 U HCG IM |
| 16390-7 | Antidiuretics [Identifier] in Urine |
| 16391-5 | Antimony [Presence] in Urine |
| 16392-3 | Nuclear Ab [Presence] in Serum by Rodent substrate |
| 16393-1 | Nuclear Ab [Units/volume] in Serum by Rodent substrate |
| 16394-9 | Nuclear Ab [Presence] in Body fluid by Immunofluorescence |
| 16395-6 | Antipsychotics [Identifier] in Urine |
| 164-4 | Cephapirin [Susceptibility] by Minimum lethal concentration (MLC) |
| 1640-2 | Thyrotropin [Mass/volume] in Serum or Plasma --30 minutes post dose TRH IV |
| 16400-4 | Appearance of Seminal plasma |
| 16401-2 | Arginine [Presence] in Urine |
| 16402-0 | Aromatic solvents [Identifier] in Blood |
| 16403-8 | Arsenic [Presence] in Serum or Plasma |
| 16404-6 | Arsenic [Presence] in Urine |
| 16405-3 | Arylamidase [Presence] in Urine |
| 16406-1 | Arylamidase [Enzymatic activity/volume] in Urine |
| 16407-9 | Asbestos identified in Sputum by Light microscopy |
| 16408-7 | Ascorbate [Mass/volume] in Urine |
| 16409-5 | Ascorbate [Mass/volume] in Serum or Plasma --post dose |
| 1641-0 | Thyrotropin [Mass/volume] in Serum or Plasma --1 hour post dose TRH IV |
| 16410-3 | Asparagine [Presence] in Urine |
| 16411-1 | Aspartate [Presence] in Urine |
| 16412-9 | Aspartate aminotransferase [Enzymatic activity/volume] in Red Blood Cells |
| 16414-5 | Aspergillus amstelodami Ab [Units/volume] in Serum |
| 16415-2 | Aspergillus flavus Ab [Presence] in Cerebral spinal fluid |
| 16416-0 | Aspergillus terreus Ab [Units/volume] in Serum |
| 16417-8 | Aspergillus versicolor Ab [Units/volume] in Serum |
| 16418-6 | Azatadine [Presence] in Urine |
| 16419-4 | Azathioprine [Mass/volume] in Serum or Plasma |
| 1642-8 | Thyrotropin [Mass/volume] in Serum or Plasma --baseline |
| 16420-2 | Azithromycin [Mass/volume] in Serum or Plasma |
| 16421-0 | Azithromycin+Ethambutol [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 16422-8 | Azlocillin [Mass/volume] in Urine |
| 16423-6 | Aztreonam [Mass/volume] in Urine |
| 16424-4 | Deprecated Sulfasalazine [Mass/volume] in Serum or Plasma |
| 16425-1 | Babesia sp IgM Ab [Units/volume] in Serum by Immunofluorescence |
| 16426-9 | Babesia sp IgM Ab [Titer] in Serum |
| 16427-7 | Babesia microti Ab [Titer] in Serum |
| 16428-5 | Bacitracin [Mass/volume] in Serum or Plasma |
| 16429-3 | Barbiturates [Presence] in Urine by Confirmatory method |
| 1643-6 | Thyrotropin [Mass/volume] in Serum or Plasma --pre dose TRH IV |
| 16430-1 | Barbiturates [Units/volume] in Urine |
| 16431-9 | Barium [Presence] in Urine |
| 16432-7 | Barium [Mass/volume] in Blood |
| 16433-5 | Basement membrane Ab [Presence] in Serum |
| 16434-3 | Basement membrane Ab [Units/volume] in Serum by Immunofluorescence |
| 16435-0 | Deprecated White Bean IgE Ab [Units/volume] in Serum |
| 16436-8 | Deprecated Bean string IgE Ab [Units/volume] in Serum |
| 16437-6 | Bendroflumethiazide [Units/volume] in Urine |
| 16438-4 | Benzaldehyde [Presence] in Urine |
| 16439-2 | Benzene [Presence] in Blood |
| 1644-4 | Triglyceride [Mass/volume] in Serum or Plasma --12 hours fasting |
| 16440-0 | Benzene ring IgE Ab [Units/volume] in Serum |
| 16441-8 | Benzene ring IgG Ab [Units/volume] in Serum |
| 16442-6 | Benzene ring IgM Ab [Units/volume] in Serum |
| 16443-4 | Benzonatate [Mass/volume] in Serum |
| 16444-2 | Benzophenone [Mass/volume] in Serum or Plasma |
| 16446-7 | Benzoylecgonine [Presence] in Serum or Plasma by Confirmatory method |
| 16447-5 | Cocaine [Units/volume] in Serum or Plasma |
| 16448-3 | Cocaine [Units/volume] in Urine |
| 16449-1 | Benzthiazide [Mass/volume] in Serum or Plasma |
| 1645-1 | Xylose [Mass/volume] in Blood --2 hours post 25 g xylose PO |
| 16450-9 | Benzylhydrazine [Mass/volume] in Serum or Plasma |
| 16451-7 | Beryllium [Presence] in Urine |
| 16452-5 | Beta alanine [Presence] in Urine |
| 16453-3 | Beta aminoisobutyrate [Presence] in Urine |
| 16454-1 | Beta galactosidase [Enzymatic activity/volume] in Blood |
| 16455-8 | Beta hydroxybutyrate [Moles/volume] in Cerebral spinal fluid |
| 16456-6 | Beta hydroxybutyrate [Moles/volume] in Urine |
| 16457-4 | Beta-N-acetylhexosaminidase.A [Enzymatic activity/volume] in Leukocytes |
| 16458-2 | Bethanechol [Mass/volume] in Serum or Plasma |
| 16459-0 | Bicarbonate [Moles/volume] in Body fluid |
| 1646-9 | Xylose [Mass/time] in 5 hour Urine --post dose PO |
| 16460-8 | Bicarbonate [Moles/volume] in Cerebral spinal fluid |
| 16461-6 | Bicarbonate [Moles/volume] in Red Blood Cells |
| 16462-4 | Bicarbonate [Moles/volume] in Amniotic fluid |
| 16463-2 | Bile acid.dihydroxy [Mass/volume] in Serum |
| 16464-0 | Bile acid [Units/volume] in Exhaled gas |
| 16465-7 | Bile acid [Mass/volume] in Urine |
| 16466-5 | Bile acid.trihydroxy [Mass/volume] in Serum |
| 16467-3 | Bismuth [Presence] in Blood |
| 16468-1 | Bismuth [Presence] in Urine |
| 16469-9 | Bismuth/Creatinine [Mass Ratio] in Urine |
| 1647-7 | Tuberculosis reaction wheal [Diameter] --3 days post 25 TU intradermal |
| 16470-7 | Blastomyces dermatitidis Ab [Presence] in Serum by Complement fixation |
| 16471-5 | Blastomyces dermatitidis Ab [Units/volume] in Serum |
| 16472-3 | Blastomyces dermatitidis rRNA [Presence] in Serum by DNA probe |
| 16473-1 | Bordetella parapertussis Ab [Units/volume] in Serum |
| 16474-9 | Bordetella pertussis Ab [Units/volume] in Serum by Complement fixation |
| 16475-6 | Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid by Immunoassay |
| 16476-4 | Borrelia burgdorferi Ab [Presence] in Body fluid by Immunoassay |
| 16477-2 | Borrelia burgdorferi Ab [Presence] in Body fluid |
| 16478-0 | Borrelia burgdorferi IgA Ab [Presence] in Serum by Immunoassay |
| 16479-8 | Borrelia burgdorferi IgA Ab [Presence] in Cerebral spinal fluid by Immunoassay |
| 1648-5 | Tuberculosis reaction wheal [Diameter] --3 days post 5 TU intradermal |
| 16480-6 | Borrelia burgdorferi IgG Ab [Presence] in Serum by Immunoassay |
| 16481-4 | Borrelia burgdorferi IgG Ab [Units/volume] in Body fluid by Immunoassay |
| 16482-2 | Borrelia burgdorferi IgM Ab [Units/volume] in Body fluid by Immunoassay |
| 16483-0 | Borrelia hermsii [Presence] in Unspecified specimen by Organism specific culture |
| 16484-8 | Boysenberry IgE Ab [Units/volume] in Serum |
| 16485-5 | Bromodiphenhydramine [Mass/volume] in Urine |
| 16486-3 | Brucella abortus IgA+IgG+IgM Ab [Units/volume] in Serum |
| 16487-1 | Brucella abortus IgG Ab [Units/volume] in Serum by Agglutination |
| 16488-9 | Brucella abortus IgG Ab [Units/volume] in Serum by Complement fixation |
| 16489-7 | Brucella melitensis Ab [Units/volume] in Serum by Latex agglutination |
| 1649-3 | Calcitriol [Mass/volume] in Serum or Plasma |
| 16490-5 | Brucella suis Ab [Units/volume] in Serum by Latex agglutination |
| 16491-3 | Brush border Ab [Presence] in Serum by Immunofluorescence |
| 16492-1 | Bufotenine [Units/volume] in Urine |
| 16493-9 | Bufotenine [Units/volume] in Serum or Plasma |
| 16494-7 | Bumetanide [Units/volume] in Urine |
| 16495-4 | Buprenorphine [Units/volume] in Serum or Plasma |
| 16496-2 | Buprenorphine [Units/volume] in Urine |
| 16497-0 | Butabarbital [Mass/volume] in Gastric fluid |
| 16498-8 | Butalbital [Units/volume] in Gastric fluid |
| 16499-6 | Butorphanol [Mass/volume] in Urine by Confirmatory method |
| 165-1 | Cephapirin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 1650-1 | 1,4-Alpha glucan branching enzyme [Enzymatic activity/volume] in Leukocytes |
| 16500-1 | Butyrate (C4) [Mass/volume] in Stool |
| 16501-9 | C peptide [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
| 16502-7 | C peptide [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge |
| 16503-5 | C reactive protein [Mass/volume] in Body fluid |
| 16504-3 | Calcitonin [Mass/volume] in Serum or Plasma --1.5 minutes post XXX challenge |
| 16505-0 | Calcitonin [Mass/volume] in Serum or Plasma --10 minutes post XXX challenge |
| 16506-8 | Calcitonin [Mass/volume] in Serum or Plasma --3 hours post XXX challenge |
| 16507-6 | Calcitonin [Mass/volume] in Serum or Plasma --4 hours post XXX challenge |
| 16508-4 | Calcitonin [Mass/volume] in Serum or Plasma --5 minutes post XXX challenge |
| 16509-2 | Calcitonin [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
| 1651-9 | 1-Methylhistidine [Presence] in Serum or Plasma |
| 16510-0 | Calcitonin [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge |
| 16511-8 | Calcitonin [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge |
| 16512-6 | Calcium.ionized [Moles/volume] in Serum or Plasma --2nd specimen post XXX challenge |
| 16513-4 | Calcium.ionized [Moles/volume] in Serum or Plasma --3rd specimen post XXX challenge |
| 16514-2 | Calcium.ionized [Moles/volume] in Serum or Plasma --4th specimen post XXX challenge |
| 16515-9 | Calcium.ionized [Moles/volume] in Serum or Plasma --5th specimen post XXX challenge |
| 16516-7 | Calcium.ionized [Moles/volume] in Serum or Plasma --6th specimen post XXX challenge |
| 16517-5 | Calcium.ionized [Moles/volume] in Serum or Plasma --7th specimen post XXX challenge |
| 16518-3 | Calcium [Mass/time] in 2 hour Urine |
| 16519-1 | Calcium [Moles/volume] in Serum or Plasma --10 minutes post XXX challenge |
| 1652-7 | 1-Methylhistidine [Mass/volume] in Serum or Plasma |
| 16520-9 | Calcium [Moles/volume] in Urine --2nd specimen post XXX challenge |
| 16521-7 | Calcium [Moles/volume] in Urine --3rd specimen post XXX challenge |
| 16522-5 | Calcium [Moles/volume] in Urine --4th specimen post XXX challenge |
| 16523-3 | Calcium [Moles/volume] in Serum or Plasma --5 minutes post XXX challenge |
| 16524-1 | Calcium [Moles/volume] in Serum or Plasma --6 hours post XXX challenge |
| 16525-8 | Calcium/Phosphate [Mass Ratio] in Serum or Plasma |
| 16526-6 | Calcium/Protein [Mass Ratio] in Serum or Plasma |
| 16527-4 | Calcium/Sodium [Mass Ratio] in Serum or Plasma |
| 16528-2 | Campylobacter coli rRNA [Units/volume] in Serum by DNA probe |
| 16529-0 | Campylobacter jejuni rRNA [Units/volume] in Serum by DNA probe |
| 1653-5 | 1-Methylhistidine [Mass/volume] in Urine |
| 16530-8 | Campylobacter jejuni rRNA [Presence] in Serum by DNA probe |
| 16531-6 | Campylobacter lari rRNA [Units/volume] in Serum by DNA probe |
| 16532-4 | Campylobacter lari rRNA [Presence] in Serum by DNA probe |
| 16533-2 | Helicobacter pylori Ab [Titer] in Serum |
| 16534-0 | Campylobacter sp rRNA [Presence] in Serum by DNA probe |
| 16535-7 | Canary droppings IgE Ab [Units/volume] in Serum |
| 16536-5 | Canary serum proteins Ab [Units/volume] in Serum |
| 16537-3 | Candida albicans Ab [Units/volume] in Serum by Immune diffusion (ID) |
| 16538-1 | Candida sp IgA Ab [Units/volume] in Saliva (oral fluid) |
| 16539-9 | Candida sp Ag [Presence] in Serum |
| 1654-3 | 1-Naphthalene [Mass/volume] in Urine |
| 16540-7 | Deprecated Cannabinoids [Presence] in Serum or Plasma by Confirm method |
| 16542-3 | Cannabinoids [Mass/volume] in Serum or Plasma by Confirmatory method |
| 16543-1 | Cannabinoids [Mass/volume] in Unknown substance by Confirmatory method |
| 16544-9 | Canrenone [Units/volume] in Urine |
| 16545-6 | Capreomycin [Mass/volume] in Serum or Plasma |
| 16546-4 | Captopril [Mass/volume] in Serum or Plasma |
| 16547-2 | Carbamate pesticides [Type] in Urine |
| 16548-0 | Carbamazepine [Mass/volume] in Urine |
| 16549-8 | Carbinoxamine [Presence] in Urine |
| 1655-0 | Deprecated 11-Deoxy/11-Oxy steroids in Urine |
| 16550-6 | Carbohydrates [Identifier] in Urine |
| 16551-4 | Carbon dioxide, total [Moles/volume] in Capillary blood |
| 16553-0 | Carnitine [Mass/mass] in Tissue |
| 16555-5 | Carnitine [Mass/volume] in Cerebral spinal fluid |
| 16556-3 | Carnitine [Mass/volume] in Amniotic fluid |
| 16557-1 | Carnosine [Presence] in Urine |
| 16558-9 | Catecholamines [Mass/volume] in Plasma --2 hours post XXX challenge |
| 16559-7 | Catecholamines [Mass/volume] in Plasma --3 hours post XXX challenge |
| 1656-8 | 11-Deoxycorticosterone [Mass/volume] in Serum or Plasma |
| 16560-5 | Catecholamines [Mass/volume] in Plasma --5th specimen post XXX challenge |
| 16561-3 | Catecholamines [Mass/volume] in Plasma --6th specimen post XXX challenge |
| 16562-1 | Cathartic laxatives [Identifier] in Urine |
| 16563-9 | Cathepsin D in Serum or Plasma |
| 16564-7 | Cefaclor [Mass/volume] in Serum or Plasma |
| 16565-4 | Cefadroxil [Mass/volume] in Serum or Plasma |
| 16566-2 | Cefazolin [Mass/volume] in Urine |
| 16567-0 | Cefixime [Mass/volume] in Serum or Plasma |
| 16568-8 | Cefuroxime IgE Ab [Units/volume] in Serum |
| 16569-6 | Ceftriaxone IgE Ab [Mass/volume] in Serum |
| 1657-6 | 11-Deoxycortisol [Mass/volume] in Serum or Plasma |
| 16570-4 | Centromere Ab [Presence] in Serum by Immunofluorescence |
| 16571-2 | Cephadrine [Mass/volume] in Serum or Plasma |
| 16572-0 | Cephaloridine [Mass/volume] in Serum or Plasma |
| 16573-8 | Deprecated Cerebroside sulfatase [Presence] in Serum or Plasma |
| 16574-6 | Deprecated Cerebroside sulfatase [Enzymatic activity/mass] in Tissue |
| 16575-3 | Deprecated Cerebroside sulfatase B in urine |
| 16576-1 | Deprecated Cerebroside sulfatase B in amniotic fluid |
| 16577-9 | Deprecated Cerebroside sulfatase B in serum or plasma |
| 16578-7 | Deprecated Cerebroside sulfatase B in tissue |
| 16579-5 | Deprecated Cerebroside sulfatase B in blood |
| 1658-4 | 11-Hydroxyandrostenedione [Mass/volume] in Serum or Plasma |
| 16580-3 | Deprecated Cerebroside sulfatase B in leukocytes |
| 16581-1 | Chlamydophila pneumoniae IgA Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 16582-9 | Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 16583-7 | Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 16584-5 | Chlamydophila pneumoniae rRNA [Presence] in Sputum by DNA probe |
| 16585-2 | Chlamydophila pneumoniae rRNA [Presence] in Serum or Plasma by DNA probe |
| 16586-0 | Chlamydophila psittaci IgA Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 16587-8 | Chlamydophila psittaci IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 16588-6 | Chlamydophila psittaci IgM Ab [Units/volume] in Cerebral spinal fluid |
| 16589-4 | Chlamydia sp Ab [Units/volume] in Serum by Immunofluorescence |
| 1659-2 | 11-Hydroxyandrosterone [Mass/volume] in Urine |
| 16590-2 | Chlamydia sp Ab [Units/volume] in Serum by Complement fixation |
| 16591-0 | Chlamydia sp IgG Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence |
| 16592-8 | Chlamydia sp IgM Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence |
| 16593-6 | Chlamydia sp Ag [Presence] in Urine |
| 16594-4 | Chlamydia trachomatis IgA Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 16595-1 | Chlamydia trachomatis IgG Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence |
| 16596-9 | Chlamydia trachomatis IgM Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence |
| 16597-7 | Chlamydia trachomatis B IgG Ab [Units/volume] in Serum |
| 16598-5 | Chlamydia trachomatis C IgG Ab [Units/volume] in Serum |
| 16599-3 | Chlamydia trachomatis DNA [Presence] in Blood by Probe and target amplification method |
| 166-9 | Cephapirin [Susceptibility] by Disk diffusion (KB) |
| 1660-0 | 11-Hydroxyetiocholanolone [Mass/volume] in Serum |
| 16600-9 | Chlamydia trachomatis rRNA [Presence] in Genital specimen by DNA probe |
| 16601-7 | Chlamydia trachomatis rRNA [Presence] in Urine by DNA probe |
| 16602-5 | Deprecated Chlamydia trachomatis rRNA [Presence] in Urine by DNA probe |
| 16603-3 | Chloramphenicol [Mass/volume] in Serum or Plasma --peak |
| 16604-1 | Chloramphenicol [Mass/volume] in Serum or Plasma --trough |
| 16605-8 | Chlorocycline [Mass/volume] in Urine |
| 16606-6 | Chlorine [Mass/volume] in Dialysis fluid |
| 16607-4 | Chlorine [Mass/volume] in Water |
| 16608-2 | Chlorpheniramine [Units/volume] in Urine |
| 16609-0 | Chlorphentermine [Units/volume] in Blood |
| 1661-8 | 11-Ketoandrosterone [Mass/volume] in Serum |
| 16610-8 | Chlorphentermine [Units/volume] in Urine |
| 16611-6 | Chlorpyrifos [Mass/volume] in Urine |
| 16612-4 | Chlorthalidone [Mass/volume] in Serum or Plasma |
| 16613-2 | Cholesterol crystals [Presence] in Stone by Infrared spectroscopy |
| 16614-0 | Cholesterol crystals [Presence] in Body fluid by Light microscopy |
| 16615-7 | Cholesterol.total/Cholesterol in LDL [Mass Ratio] in Serum or Plasma |
| 16616-5 | Cholesterol in HDL/Cholesterol in LDL [Mass Ratio] in Serum or Plasma |
| 16617-3 | Choriogonadotropin.intact [Moles/volume] in Semen |
| 16618-1 | Cladosporium herbarum Ab [Units/volume] in Serum |
| 16619-9 | Clarithromycin [Mass/volume] in Serum or Plasma |
| 1662-6 | 11-Ketoetiocholanolone [Mass/volume] in Serum |
| 16620-7 | Clarithromycin+Ethambutol [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 16621-5 | Clindamycin [Mass/volume] in Serum or Plasma --peak |
| 16622-3 | Clindamycin [Mass/volume] in Serum or Plasma --trough |
| 16623-1 | Clofazimine [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 16624-9 | Clomipramine [Units/volume] in Milk |
| 16625-6 | Clomipramine [Mass/volume] in Milk |
| 16626-4 | Clostridium tetani Ab [Units/volume] in Serum --1st specimen |
| 16627-2 | Clostridium tetani Ab [Units/volume] in Serum --2nd specimen |
| 16628-0 | Cloxacillin [Mass/volume] in Serum or Plasma |
| 16629-8 | Deprecated Activated partial thrombplastin time (aPTT) in Blood from control by Coagulation assay |
| 1663-4 | 11-Oxycorticosterone [Mass/volume] in Serum |
| 16630-6 | aPTT in control Blood by Coagulation 1:1 saline |
| 16631-4 | aPTT in Blood by Coagulation 1:1 saline |
| 16632-2 | Cocaethylene [Mass/volume] in Urine by Confirmatory method |
| 16633-0 | Cocaine [Presence] in Blood |
| 16634-8 | Coccidioides immitis Ab [Units/volume] in Cerebral spinal fluid |
| 16635-5 | Coccidioides immitis IgA Ab [Units/volume] in Serum by Immunoassay |
| 16636-3 | Coccidioides immitis IgA Ab [Units/volume] in Cerebral spinal fluid |
| 16637-1 | Coccidioides immitis IgE Ab [Units/volume] in Serum |
| 16638-9 | Coccidioides immitis IgG Ab [Units/volume] in Cerebral spinal fluid |
| 16639-7 | Coccidioides immitis IgM Ab [Units/volume] in Cerebral spinal fluid |
| 1664-2 | 17-Hydroxycorticosteroids [Mass/volume] in Amniotic fluid |
| 16640-5 | Coccidioides reaction wheal [Diameter] |
| 16641-3 | Cockatiel droppings Ab [Units/volume] in Serum |
| 16642-1 | Cockatiel droppings IgG Ab [Units/volume] in Serum |
| 16643-9 | Cockatoo droppings Ab [Units/volume] in Serum |
| 16644-7 | Codeine Free [Presence] in Serum or Plasma by Confirmatory method |
| 16645-4 | Colistin [Mass/volume] in Serum or Plasma |
| 16647-0 | Collagen Ab [Units/volume] in Serum |
| 16648-8 | Copper [Mass/volume] in Body fluid |
| 16649-6 | Coproporphyrinogen oxidase [Enzymatic activity/volume] in Red Blood Cells |
| 1665-9 | 17-Hydroxycorticosteroids [Mass/volume] in Plasma |
| 16650-4 | Cilantro IgE Ab [Units/volume] in Serum |
| 16651-2 | Corticosterone [Mass/volume] in Serum or Plasma --post XXX challenge |
| 16652-0 | Corticotropin [Mass/volume] in Amniotic fluid by Radioimmunoassay (RIA) |
| 16653-8 | Corticotropin Canine [Mass/volume] in Plasma |
| 16654-6 | Corticotropin [Mass/volume] in Plasma by Radioimmunoassay (RIA) --1.5 hours post XXX challenge |
| 16655-3 | Corticotropin [Mass/volume] in Plasma by Radioimmunoassay (RIA) --10 minutes post XXX challenge |
| 16656-1 | Corticotropin [Mass/volume] in Plasma by Radioimmunoassay (RIA) --15 minutes post XXX challenge |
| 16657-9 | Corticotropin [Mass/volume] in Plasma by Radioimmunoassay (RIA) --1 hour post XXX challenge |
| 16658-7 | Corticotropin [Mass/volume] in Plasma by Radioimmunoassay (RIA) --1 minute post XXX challenge |
| 16659-5 | Corticotropin [Mass/volume] in Plasma by Radioimmunoassay (RIA) --2.5 hours post XXX challenge |
| 1666-7 | 17-Hydroxycorticosteroids [Mass/volume] in Urine |
| 16660-3 | Corticotropin [Mass/volume] in Plasma by Radioimmunoassay (RIA) --20 minutes post XXX challenge |
| 16661-1 | Corticotropin [Mass/volume] in Plasma by Radioimmunoassay (RIA) --2 hours post XXX challenge |
| 16662-9 | Corticotropin [Mass/volume] in Plasma by Radioimmunoassay (RIA) --30 minutes post XXX challenge |
| 16663-7 | Corticotropin [Mass/volume] in Plasma by Radioimmunoassay (RIA) --3 hours post XXX challenge |
| 16664-5 | Corticotropin [Mass/volume] in Plasma by Radioimmunoassay (RIA) --45 minutes post XXX challenge |
| 16665-2 | Corticotropin [Mass/volume] in Plasma by Radioimmunoassay (RIA) --5 minutes post XXX challenge |
| 16666-0 | Corticotropin [Mass/volume] in Plasma by Radioimmunoassay (RIA) --9th specimen post XXX challenge |
| 16667-8 | Cortisol Free [Mass/time] in 48 hour Urine |
| 16668-6 | Cortisol Free [Mass/time] in 72 hour Urine |
| 16669-4 | Cortisol [Mass/volume] in Serum or Plasma --10 minutes post XXX challenge |
| 1667-5 | 17-Hydroxyketosteroids [Mass/volume] in Urine |
| 16670-2 | Cortisol [Mass/volume] in Serum or Plasma --15 minutes post XXX challenge |
| 16671-0 | Cortisol [Mass/volume] in Serum or Plasma --1 minute post XXX challenge |
| 16672-8 | Cortisol [Mass/volume] in Serum or Plasma --40 minutes post XXX challenge |
| 16673-6 | Cortisol [Mass/volume] in Serum or Plasma --50 minutes post XXX challenge |
| 16674-4 | Cortisol [Mass/volume] in Serum or Plasma --70 minutes post XXX challenge |
| 16675-1 | Cortisol [Mass/volume] in Serum or Plasma --80 minutes post XXX challenge |
| 16676-9 | Corynebacterium diphtheriae [Presence] in Unspecified specimen by Organism specific culture |
| 16677-7 | Coxiella burnetii IgG Ab [Units/volume] in Serum |
| 16678-5 | Coxiella burnetii IgM Ab [Units/volume] in Serum |
| 16679-3 | Coxsackievirus A Ab [Units/volume] in Serum |
| 1668-3 | 17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma |
| 16680-1 | Coxsackievirus A IgG Ab [Units/volume] in Serum |
| 16681-9 | Coxsackievirus A IgM Ab [Units/volume] in Serum |
| 16682-7 | Coxsackievirus A2 Ab [Titer] in Cerebral spinal fluid |
| 16683-5 | Coxsackievirus A4 Ab [Titer] in Cerebral spinal fluid |
| 16684-3 | Coxsackievirus B Ab [Units/volume] in Serum |
| 16685-0 | Coxsackievirus B IgG Ab [Units/volume] in Serum by Neutralization test |
| 16686-8 | Coxsackievirus B IgM Ab [Units/volume] in Serum by Neutralization test |
| 16687-6 | Creatine [Mass/volume] in Vitreous fluid |
| 16688-4 | Creatine kinase [Enzymatic activity/volume] in Body fluid |
| 16689-2 | Creatinine [Mass/time] in 48 hour Urine |
| 1669-1 | Deprecated 17-Hydroxyprogesterone [Mass/volume] in Serum |
| 16690-0 | Creatinine [Mass/time] in 72 hour Urine |
| 16691-8 | Cresols [Identifier] in Unspecified specimen |
| 16692-6 | Cryptococcus sp Ag [Presence] in Body fluid |
| 16693-4 | Cryptococcus sp Ag [Presence] in Urine |
| 16694-2 | Cumene [Presence] in Blood |
| 16695-9 | Cobalamin (Vitamin B12) [Mass/volume] in Blood |
| 16696-7 | Cobalamin (Vitamin B12) [Mass/volume] in Urine --post XXX challenge |
| 16697-5 | Cyclohexane [Presence] in Blood |
| 16698-3 | Cyclohexanol [Mass/volume] in Blood |
| 16699-1 | Cyclohexanol [Mass/volume] in Urine |
| 167-7 | Cephapirin [Susceptibility] by Serum bactericidal titer |
| 1670-9 | 17-Hydroxyprogesterone [Mass/volume] in Urine |
| 16700-7 | Cyclohexanol/Creatinine [Mass Ratio] in Urine |
| 16701-5 | Cyclopropane [Presence] in Blood |
| 16702-3 | Cycloserine [Mass/volume] in Urine |
| 16703-1 | Cyclosporine [Mass/volume] in Plasma |
| 16704-9 | Cyproheptadine [Mass/volume] in Serum or Plasma |
| 16705-6 | Cystathionine [Presence] in Urine |
| 16706-4 | Taenia solium larva IgM Ab [Units/volume] in Cerebral spinal fluid |
| 16707-2 | Taenia solium larva IgM Ab [Units/volume] in Serum |
| 16708-0 | Taenia solium larva Ab [Units/volume] in Cerebral spinal fluid |
| 16709-8 | Cystine [Units/volume] in Urine |
| 1671-7 | 17-Ketogenic steroids [Mass/volume] in Blood |
| 16710-6 | Cystine crystals [Presence] in Stone by Infrared spectroscopy |
| 16711-4 | Cystine+Homocystine [Presence] in Urine |
| 16712-2 | Cytomegalovirus Ab [Units/volume] in Body fluid |
| 16713-0 | Cytomegalovirus Ab [Units/volume] in Cerebral spinal fluid |
| 16714-8 | Cytomegalovirus Ab [Units/volume] in Serum by Latex agglutination |
| 16715-5 | Cytomegalovirus IgG Ab [Units/volume] in Serum by Immunofluorescence |
| 16716-3 | Cytomegalovirus IgG Ab [Units/volume] in Serum by Immunoassay --2nd specimen |
| 16717-1 | Cytomegalovirus Ag [Presence] in Urine by Immunoassay |
| 16718-9 | Cytomegalovirus Ag [Presence] in Blood |
| 16719-7 | Cytomegalovirus inclusion bodies [Presence] in Urine by Microscopic observation |
| 1672-5 | Deprecated 17-Ketogenic steroids [Mass/volume] in Blood |
| 16720-5 | Dechlorane [Presence] in Blood |
| 16721-3 | Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Saliva (oral fluid) |
| 16722-1 | Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma --10th specimen post XXX challenge |
| 16723-9 | Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
| 16724-7 | Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
| 16725-4 | Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
| 16726-2 | Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
| 16727-0 | Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
| 16728-8 | Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
| 16729-6 | Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge |
| 1673-3 | 17-Ketogenic steroids [Mass/time] in 24 hour Urine |
| 16730-4 | Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge |
| 16731-2 | Deprecated Dehydroepiandrosterone.unconjugated [Mass/volume] in Serum or Plasma |
| 16732-0 | Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
| 16733-8 | Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge |
| 16734-6 | Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --baseline |
| 16735-3 | Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --post XXX challenge |
| 16736-1 | Dengue virus 1 Ab [Titer] in Serum |
| 16737-9 | Dengue virus 2 Ab [Titer] in Serum |
| 16738-7 | Dengue virus 3 Ab [Titer] in Serum |
| 16739-5 | Dengue virus 4 Ab [Titer] in Serum |
| 1674-1 | 18-Hydroxycorticosterone [Mass/volume] in Serum or Plasma |
| 16740-3 | Dengue virus Ab [Presence] in Serum |
| 16741-1 | American house dust mite IgG Ab [Presence] in Blood |
| 16742-9 | European house dust mite IgG Ab [Presence] in Blood |
| 16743-7 | Deprecated Nordiazepam [Presence] in Serum or Plasma |
| 16744-5 | Deprecated Nordiazepam [Presence] in Urine |
| 16745-2 | Deprecated Desmethylmethsuximide [Mass/volume] in Serum or Plasma |
| 16746-0 | Nortrimipramine [Mass/volume] in Serum or Plasma |
| 16747-8 | Dextromoramide [Presence] in Serum or Plasma |
| 16748-6 | Propoxyphene [Presence] in Serum or Plasma by Confirmatory method |
| 16749-4 | Propoxyphene + Norpropoxyphene [Units/volume] in Urine |
| 1675-8 | 2,3-Diphosphoglycerate [Mass/volume] in Red Blood Cells |
| 16750-2 | Dezocine [Mass/volume] in Serum or Plasma |
| 16751-0 | Dezocine [Mass/volume] in Blood |
| 16752-8 | Deprecated Diacetate [Presence] in Urine |
| 16753-6 | Deprecated Dialtrazene |
| 16754-4 | Diamorphine [Mass/volume] in Unknown substance |
| 16755-1 | Diamorphine [Mass/volume] in Urine by Confirmatory method |
| 16756-9 | Diamorphine [Mass/volume] in Serum or Plasma by Confirmatory method |
| 16757-7 | Diazepam+Nordiazepam [Mass/volume] in Serum or Plasma |
| 16758-5 | Dicamba [Mass/volume] in Serum or Plasma |
| 16759-3 | Dicamba [Mass/volume] in Urine |
| 1676-6 | 2,3-Diphosphoglycerate [Mass/volume] in Serum |
| 16760-1 | Deprecated Dicarboxylporphyrin [Mass/volume] in Blood |
| 16761-9 | Protoporphyrin [Mass/volume] in Stool |
| 16762-7 | Dichlorobenzene [Mass/volume] in Blood |
| 16763-5 | Dichlorodiphenyldichloroethylene [Mass/volume] in Urine |
| 16764-3 | Dichlorodiphenyldichloroethylene [Mass/volume] in Blood |
| 16765-0 | Dichlorodiphenyltrichloroethane [Mass/volume] in Milk |
| 16766-8 | Dichloroethane [Presence] in Blood |
| 16767-6 | Deprecated 2,4-Dichlorophenoxyacetate [Mass/volume] in Urine |
| 16768-4 | Dichlorvos [Mass/volume] in Urine |
| 16769-2 | Dicloxacillin [Mass/volume] in Urine |
| 1677-4 | Alpha hydroxybutyrate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma |
| 16770-0 | Dicoumarol [Mass/volume] in Urine |
| 16771-8 | Dicyclomine [Mass/volume] in Serum or Plasma |
| 16772-6 | Dieldrin [Mass/volume] in Urine |
| 16773-4 | Dieldrin [Mass/volume] in Blood |
| 16774-2 | Diethylcarbamazepine [Mass/volume] in Serum or Plasma |
| 16775-9 | Dihydrocodeine Free [Presence] in Serum or Plasma by Confirmatory method |
| 16776-7 | Diltiazem [Mass/volume] in Urine |
| 16777-5 | Dimethylacetamide [Presence] in Urine |
| 16778-3 | Dinitrophenol [Presence] in Serum or Plasma |
| 16779-1 | Dinitrophenol [Mass/volume] in Urine |
| 1678-2 | 20-Hydroxyprogesterone [Mass/volume] in Serum |
| 16780-9 | Disopyramide [Mass/volume] in Urine |
| 16781-7 | Disulfiram [Presence] in Urine |
| 16782-5 | Deprecated DNA double strand Ab [Presence] in Serum by Farr method |
| 16784-1 | Dopamine [Mass/volume] in Urine --2nd specimen post XXX challenge |
| 16785-8 | Dopamine [Mass/volume] in Urine --3rd specimen post XXX challenge |
| 16786-6 | Dopamine [Mass/volume] in Urine --4th specimen post XXX challenge |
| 16787-4 | Dopamine [Mass/volume] in Urine --5th specimen post XXX challenge |
| 16788-2 | Dopamine [Mass/volume] in Urine --6th specimen post XXX challenge |
| 16789-0 | Dopamine [Mass/volume] in Urine --7th specimen post XXX challenge |
| 1679-0 | 24r-Hydroxycalcidiol [Mass/volume] in Serum or Plasma |
| 16790-8 | Deprecated Doxepin+Desmethyldoxepin [Mass/volume] in Serum or Plasma |
| 16791-6 | Doxylamine [Mass/volume] in Serum or Plasma |
| 16792-4 | Doxylamine [Mass/volume] in Urine |
| 16793-2 | Drugs identified in Unknown substance by Screen method |
| 16794-0 | Echinococcus sp IgM Ab [Units/volume] in Serum |
| 16795-7 | Echovirus Ab [Units/volume] in Serum |
| 16796-5 | Echovirus Ab [Units/volume] in Serum by Complement fixation |
| 16797-3 | Echovirus 1 Ab [Units/volume] in Serum by Complement fixation |
| 16798-1 | Echovirus 14 Ab [Units/volume] in Serum |
| 16799-9 | Deprecated Echovirus 140 Ab by complement fixation |
| 168-5 | Cephradine [Susceptibility] by Minimum lethal concentration (MLC) |
| 1680-8 | 3-Alpha-Androstanediol glucuronide [Mass/volume] in Serum |
| 16800-5 | Echovirus 19 Ab [Units/volume] in Serum by Complement fixation |
| 16801-3 | Echovirus 3 Ab [Units/volume] in Serum by Complement fixation |
| 16802-1 | Echovirus 30 Ab [Units/volume] in Serum |
| 16803-9 | Echovirus 4 Ab [Units/volume] in Serum by Complement fixation |
| 16804-7 | Echovirus 40 Ab [Units/volume] in Serum |
| 16805-4 | Echovirus 6 Ab [Units/volume] in Serum by Complement fixation |
| 16806-2 | Echovirus 6+18+30 Ab [Units/volume] in Serum |
| 16807-0 | Echovirus 9 Ab [Units/volume] in Serum by Complement fixation |
| 16808-8 | Anaplasma phagocytophilum IgG Ab [Units/volume] in Serum |
| 16809-6 | Anaplasma phagocytophilum IgM Ab [Units/volume] in Serum |
| 1681-6 | Beta hydroxybutyrate dehydrogenase [Enzymatic activity/volume] in Blood |
| 16811-2 | Arachidate (C20:0) [Mass/volume] in Serum or Plasma |
| 16812-0 | Emetine [Presence] in Serum or Plasma |
| 16813-8 | Emetine [Units/volume] in Serum or Plasma |
| 16814-6 | Endomysium Ab [Presence] in Serum by Immunofluorescence |
| 16815-3 | Endomysium Ab [Units/volume] in Serum by Immunofluorescence |
| 16816-1 | Enoxacin [Mass/volume] in Urine |
| 16817-9 | Entamoeba histolytica Ab [Presence] in Serum by Immune diffusion (ID) |
| 16818-7 | Entamoeba histolytica Ab [Units/volume] in Cerebral spinal fluid |
| 16819-5 | Entamoeba histolytica Ab [Units/volume] in Serum by Immunofluorescence |
| 1682-4 | Beta hydroxybutyrate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma |
| 16820-3 | Entamoeba histolytica Ab [Units/volume] in Serum by Complement fixation |
| 16821-1 | Epinephrine [Mass/volume] in Plasma --4 hours post XXX challenge |
| 16822-9 | Epithelial cells [Presence] in Nose by Light microscopy |
| 16823-7 | Epstein Barr virus early Ab [Units/volume] in Serum by Immunoassay |
| 16824-5 | Epstein Barr virus nuclear Ab [Presence] in Cerebral spinal fluid |
| 16825-2 | Epstein Barr virus nuclear IgG Ab [Presence] in Body fluid |
| 16826-0 | Epstein Barr virus capsid IgG Ab [Units/volume] in Cerebral spinal fluid |
| 16827-8 | Epstein Barr virus capsid IgG Ab [Presence] in Cerebral spinal fluid |
| 16828-6 | Erythrocytes [#/volume] in Seminal plasma by Manual count |
| 16829-4 | Erythromycin [Mass/volume] in Urine |
| 1683-2 | 3-Hydroxyisovalerate [Mass/volume] in Urine |
| 16830-2 | Erythromycin+Ethambutol [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 16832-8 | Escherichia coli enterotoxic identified in Stool by Organism specific culture |
| 16833-6 | Escherichia coli K1 Ag [Presence] in Unspecified specimen by Immunoassay |
| 16834-4 | Escherichia coli K1 Ag [Presence] in Unspecified specimen by Latex agglutination |
| 16835-1 | Escherichia coli shiga-like identified in Stool by Organism specific culture |
| 16836-9 | Escherichia coli verotoxic identified in Stool by Organism specific culture |
| 16838-5 | Estriol (E3) [Mass/volume] in Body fluid |
| 1684-0 | 3-Methoxy-4-Hydroxyphenylglycol [Mass/volume] in Urine |
| 16840-1 | Ethacrynate [Mass/volume] in Serum or Plasma |
| 16841-9 | Ethambutol+Rifampin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 16842-7 | Ethanol [Mass/volume] in Unknown substance |
| 16843-5 | Ethanol [Mass/volume] in Body fluid |
| 16844-3 | Ethinamate [Presence] in Serum or Plasma by Confirmatory method |
| 16845-0 | Ethionamide [Mass/volume] in Serum or Plasma |
| 16847-6 | Ethoheptazine [Presence] in Serum or Plasma |
| 16848-4 | Ethoheptazine [Mass/volume] in Serum or Plasma |
| 16849-2 | Ethyl benzene [Mass/volume] in Urine |
| 1685-7 | 3-Methylhistidine [Presence] in Serum or Plasma |
| 16850-0 | Ethylene oxide [Mass/volume] in Blood |
| 16851-8 | Ethylmorphine [Units/volume] in Urine |
| 16852-6 | Etodolac [Mass/volume] in Serum or Plasma |
| 16853-4 | Fat [Mass] in Stool |
| 16855-9 | Fat [Mass/time] in 48 hour Stool |
| 16856-7 | Fat.microscopic observation [Identifier] in Synovial fluid by Sudan IV stain |
| 16857-5 | Fenclorvos [Presence] in Blood |
| 16858-3 | Fentanyl [Mass/volume] in Body fluid |
| 16859-1 | Fibrinogen [Presence] in Platelet poor plasma |
| 1686-5 | 3-Methylhistidine [Mass/volume] in Serum or Plasma |
| 16860-9 | Fibrinopeptide A Ag [Units/volume] in Peritoneal fluid by Immunologic method |
| 16861-7 | Fibrinopeptide A Ag [Units/volume] in Platelet poor plasma by Immunologic method |
| 16862-5 | Fibrinopeptide B Ag [Units/volume] in Platelet poor plasma by Immunologic method |
| 16863-3 | Fibrinopeptide B beta (1-14) Ag [Units/volume] in Platelet poor plasma by Immunologic method |
| 16864-1 | Fibrinopeptide B beta (1-42) Ag [Units/volume] in Platelet poor plasma by Immunologic method |
| 16865-8 | Fibrinopeptide B beta (15-42) Ag [Units/volume] in Platelet poor plasma by Immunologic method |
| 16866-6 | Fibrinopeptide B beta (43-47) Ag [Units/volume] in Platelet poor plasma by Immunologic method |
| 16867-4 | Fibronectin aggregate IgG Ab [Mass/volume] in Serum |
| 16868-2 | Finch droppings IgE Ab [Presence] in Serum |
| 16869-0 | Deprecated Flurbiprofen [Mass/volume] in Serum or Plasma |
| 1687-3 | 3-Methylhistidine [Mass/volume] in Urine |
| 16870-8 | Fluconazole [Mass/volume] in Urine |
| 16871-6 | Fluoride [Units/volume] in Bone |
| 16872-4 | Fluorocarbons [Identifier] in Serum or Plasma |
| 16873-2 | Follitropin [Moles/volume] in Serum or Plasma --105 minutes post XXX challenge |
| 16874-0 | Formate+Formaldehyde [Mass/volume] in Blood |
| 16875-7 | Francisella tularensis Ab [Titer] in Serum |
| 16876-5 | Francisella tularensis IgA Ab [Presence] in Serum by Latex agglutination |
| 16877-3 | Francisella tularensis IgG Ab [Presence] in Serum by Latex agglutination |
| 16878-1 | Francisella tularensis IgM Ab [Units/volume] in Serum |
| 16879-9 | Francisella tularensis Ag [Presence] in Serum by Immunofluorescence |
| 1688-1 | 4-Pyridoxate [Mass/volume] in Serum or Plasma |
| 16881-5 | Gallium [Mass/volume] in Blood |
| 16882-3 | Gamma aminobutyrate [Presence] in Urine |
| 16883-1 | Deprecated Gamma aminobutyrate [Mass/volume] in Urine |
| 16884-9 | Deprecated Gamma aminobutyrate [Presence] in Serum or Plasma |
| 16885-6 | Deprecated Gamma aminobutyrate [Mass/volume] in Serum or Plasma |
| 16886-4 | Deprecated Gamma aminobutyrate [Mass/volume] in Cerebral spinal fluid |
| 16887-2 | Gamma aminobutyrate [Mass/volume] in Amniotic fluid |
| 16888-0 | Gamma chlordane [Mass/volume] in Urine |
| 1689-9 | 5'-Nucleotidase [Enzymatic activity/volume] in Amniotic fluid |
| 16890-6 | Gastrin [Mass/volume] in Serum or Plasma --10 minutes post XXX challenge |
| 16891-4 | Gastrin [Mass/volume] in Serum or Plasma --11th specimen post XXX challenge |
| 16892-2 | Gastrin [Mass/volume] in Serum or Plasma --15 minutes post XXX challenge |
| 16893-0 | Gastrin [Mass/volume] in Serum or Plasma --20 minutes post XXX challenge |
| 16894-8 | Gastrin [Mass/volume] in Serum or Plasma --25 minutes post XXX challenge |
| 16895-5 | Gastrin [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge |
| 16896-3 | Gastrin [Mass/volume] in Serum or Plasma --5 minutes post XXX challenge |
| 16898-9 | Giardia lamblia 65 Ag [Presence] in Stool |
| 16899-7 | Giardia lamblia Ag [Presence] in Unspecified specimen |
| 169-3 | Cephradine [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 1690-7 | 5'-Nucleotidase [Enzymatic activity/volume] in Serum or Plasma |
| 16900-3 | Gliadin Ab [Units/volume] in Saliva (oral fluid) |
| 16901-1 | Gliadin IgA Ab [Presence] in Serum |
| 16902-9 | Gliadin IgG Ab [Presence] in Serum |
| 16903-7 | Glucose [Mass/volume] in Vitreous fluid |
| 16904-5 | Glucose [Presence] in Urine --1st specimen post XXX challenge |
| 16905-2 | Glucose [Presence] in Urine --2nd specimen post XXX challenge |
| 16906-0 | Glucose [Presence] in Urine --3rd specimen post XXX challenge |
| 16907-8 | Glucose [Presence] in Urine --4th specimen post XXX challenge |
| 16908-6 | Glucose [Presence] in Urine --5th specimen post XXX challenge |
| 16909-4 | Glucose [Presence] in Urine --6th specimen post XXX challenge |
| 1691-5 | 5,10-Methylenetetrahydrofolate reductase [Enzymatic activity/volume] in Serum |
| 16910-2 | Glucose [Presence] in Urine --7th specimen post XXX challenge |
| 16911-0 | Glucose [Presence] in Urine --8th specimen post XXX challenge |
| 16912-8 | Glucose [Presence] in Urine --9th specimen post XXX challenge |
| 16913-6 | Fasting glucose [Presence] in Urine |
| 16914-4 | Glucose [Mass/volume] in Serum or Plasma --post XXX challenge |
| 16915-1 | Glucose [Mass/volume] in Serum or Plasma --post meal |
| 16916-9 | Glutamate [Presence] in Urine |
| 16917-7 | Glutamine [Presence] in Urine |
| 16918-5 | Glutathione [Mass/volume] in Serum or Plasma |
| 16919-3 | Glycine [Presence] in Urine |
| 1692-3 | 5-Hydroxyindoleacetate [Mass/volume] in Cerebral spinal fluid |
| 16920-1 | Glycoproteins [Presence] in Serum or Plasma |
| 16921-9 | St. Augustine grass IgE Ab [Units/volume] in Serum |
| 16922-7 | Wild rye grass IgE Ab [Units/volume] in Serum |
| 16923-5 | Guaifenesin [Mass/volume] in Serum or Plasma |
| 16924-3 | Haemophilus influenzae IgG Ab [Units/volume] in Serum |
| 16925-0 | Haemophilus influenzae A Ag [Presence] in Urine |
| 16926-8 | Haemophilus influenzae A Ag [Presence] in Cerebral spinal fluid |
| 16927-6 | Haemophilus influenzae B IgG Ab [Units/volume] in Serum |
| 16928-4 | Hantavirus puumala IgG+IgM Ab [Units/volume] in Serum |
| 16929-2 | Helicobacter pylori Ab [Units/volume] in Serum by Immunofluorescence |
| 1693-1 | 5-Hydroxyindoleacetate [Mass/volume] in Serum |
| 16930-0 | Helminth IgE Ab [Units/volume] in Serum |
| 16931-8 | Hematocrit/Hemoglobin [Ratio] of Blood by Automated count |
| 16932-6 | Hemoglobin A3/Hemoglobin.total in Blood by Electrophoresis |
| 16933-4 | Hepatitis B virus core Ab [Presence] in Serum |
| 16934-2 | Hepatitis B virus polymerase DNA [Presence] in Blood by Probe and target amplification method |
| 16935-9 | Hepatitis B virus surface Ab [Units/volume] in Serum |
| 16936-7 | Hepatitis C virus IgG Ab [Units/volume] in Serum |
| 16937-5 | Hepatitis G virus RNA [Presence] in Serum by Probe and target amplification method |
| 16938-3 | Heptacarboxylporphyrin [Mass/volume] in Stool |
| 16939-1 | Heptachlor [Mass/volume] in Urine |
| 1694-9 | 5-Hydroxyindoleacetate [Mass/volume] in Urine |
| 16940-9 | Heptachlorepoxide [Mass/volume] in Urine |
| 16941-7 | Herbicide [Identifier] in Unspecified specimen |
| 16942-5 | Herpes simplex virus Ab [Presence] in Serum by Immunoblot (IB) |
| 16943-3 | Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid |
| 16944-1 | Herpes simplex virus IgM Ab [Units/volume] in Serum |
| 16945-8 | Herpes simplex virus Ag [Presence] in Unspecified specimen |
| 16947-4 | Herpes simplex virus 1 Ab [Presence] in Cerebral spinal fluid by Immunoblot (IB) |
| 16948-2 | Herpes simplex virus 1 IgG Ab [Units/volume] in Cerebral spinal fluid |
| 16949-0 | Herpes simplex virus 1 IgG Ab [Units/volume] in Serum --1st specimen |
| 1695-6 | 5-Hydroxyindoleacetate [Mass/time] in 24 hour Urine |
| 16950-8 | Herpes simplex virus 1 IgG Ab [Units/volume] in Serum --2nd specimen |
| 16952-4 | Herpes simplex virus 1 DNA [Presence] in Cerebral spinal fluid by Probe and target amplification method |
| 16953-2 | Herpes simplex virus 1 DNA [Presence] in Serum or Plasma by Probe and target amplification method |
| 16954-0 | Herpes simplex virus 2 Ab [Presence] in Serum |
| 16955-7 | Herpes simplex virus 2 IgG Ab [Presence] in Serum by Immunoblot (IB) |
| 16956-5 | Herpes simplex virus 2 IgG Ab [Units/volume] in Cerebral spinal fluid |
| 16957-3 | Herpes simplex virus 2 IgG Ab [Units/volume] in Serum --1st specimen |
| 16958-1 | Herpes simplex virus 2 IgG Ab [Units/volume] in Serum --2nd specimen |
| 16959-9 | Herpes simplex virus 2 DNA [Presence] in Serum or Plasma by Probe and target amplification method |
| 1696-4 | 5-Methyltetrahydrofolate homocysteine methyltransferase [Enzymatic activity/volume] in Serum |
| 16960-7 | Herpes simplex virus 2 DNA [Presence] in Cerebral spinal fluid by Probe and target amplification method |
| 16962-3 | Heterophile Ab [Presence] in Synovial fluid by Latex agglutination |
| 16963-1 | Hexacarboxylporphyrin [Mass/volume] in Blood |
| 16964-9 | Hexacarboxylporphyrin [Mass/volume] in Stool |
| 16965-6 | Lindane [Mass/volume] in Blood |
| 16966-4 | Hexachloroethane [Mass/volume] in Blood |
| 16967-2 | Hexokinase 1 [Enzymatic activity/volume] in Red Blood Cells |
| 16968-0 | Hexokinase 3 [Enzymatic activity/volume] in Red Blood Cells |
| 16969-8 | Histone H2a+H2b Ab [Units/volume] in Serum by Immunofluorescence |
| 1697-2 | 6-Phosphogluconate dehydrogenase [Enzymatic activity/volume] in Red Blood Cells |
| 16970-6 | Histoplasma capsulatum Ab [Presence] in Serum by Complement fixation |
| 16971-4 | Histoplasma capsulatum IgA Ab [Presence] in Serum by Immune diffusion (ID) |
| 16972-2 | Histoplasma capsulatum IgE Ab [Presence] in Serum by Immune diffusion (ID) |
| 16973-0 | Histoplasma capsulatum IgM Ab [Presence] in Serum by Immune diffusion (ID) |
| 16974-8 | HIV 1 Ab [Presence] in Cerebral spinal fluid |
| 16975-5 | HIV 1 IgG Ab [Presence] in Serum |
| 16976-3 | HIV 1 Ag [Units/volume] in Serum |
| 16977-1 | HIV 1 Ag [Presence] in Cerebral spinal fluid |
| 16978-9 | HIV 1 p24 Ab [Units/volume] in Serum |
| 16979-7 | HIV 1 p24 Ag [Units/volume] in Cerebral spinal fluid |
| 1698-0 | 8-Hydroxyamoxapine [Mass/volume] in Serum or Plasma |
| 16980-5 | HTLV II DNA [Presence] in Unspecified specimen by Probe and target amplification method |
| 16981-3 | HTLV I DNA [Presence] in Unspecified specimen by Probe and target amplification method |
| 16982-1 | HTLV I+II Ab [Presence] in Serum by Immunoblot (IB) |
| 16983-9 | Hydralazine [Presence] in Urine |
| 16984-7 | Hydrastine [Presence] in Urine |
| 16985-4 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --1.5 hours post dose glucose |
| 16986-2 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --1 hour post dose glucose |
| 16987-0 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --2.5 hours post dose glucose |
| 16988-8 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --2 hours post dose glucose |
| 16989-6 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --3.5 hours post dose glucose |
| 1699-8 | Alpha-L-iduronidase [Enzymatic activity/mass] in Tissue |
| 16990-4 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --3 hours post dose glucose |
| 16991-2 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --4.5 hours post dose glucose |
| 16992-0 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --4 hours post dose glucose |
| 16993-8 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --5.5 hours post dose glucose |
| 16994-6 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --5 hours post dose glucose |
| 16995-3 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --6 hours post dose glucose |
| 16996-1 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --pre dose glucose |
| 16997-9 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --post dose glucose |
| 16998-7 | Hydromorphone [Mass/volume] in Urine by Confirmatory method |
| 16999-5 | Hydroquinone [Mass/volume] in Urine |
| 17-4 | Amoxicillin [Susceptibility] by Disk diffusion (KB) |
| 170-1 | Cephradine [Susceptibility] by Disk diffusion (KB) |
| 1700-4 | Acetaldehyde [Mass/volume] in Blood |
| 17000-1 | Hydroxylysine [Presence] in Urine |
| 17001-9 | Hydroxyproline [Presence] in Urine |
| 17002-7 | Hydroxytriazolam [Mass/volume] in Serum or Plasma by Confirmatory method |
| 17003-5 | Serotonin [Mass/volume] in Urine |
| 17004-3 | Hypoxanthine [Mass/volume] in Urine |
| 17005-0 | IgA subclass 1 [Mass/volume] in Cerebral spinal fluid |
| 17006-8 | IgA subclass 2 [Mass/volume] in Cerebral spinal fluid |
| 17007-6 | IgG [Presence] in Serum |
| 17008-4 | IgG/Beta tubulin [Mass Ratio] in Serum |
| 17009-2 | IgM [Presence] in Serum |
| 1701-2 | Acetaldehyde [Mass/volume] in Serum or Plasma |
| 17010-0 | Imipenem [Mass/volume] in Serum or Plasma |
| 17012-6 | Influenza virus A Ab [Units/volume] in Cerebral spinal fluid |
| 17013-4 | Influenza virus A+B Ab [Units/volume] in Serum by Immunofluorescence |
| 17014-2 | Influenza virus B Ab [Units/volume] in Cerebral spinal fluid |
| 17015-9 | Influenza virus B IgG Ab [Units/volume] in Serum |
| 17016-7 | Influenza virus B IgM Ab [Units/volume] in Serum |
| 17017-5 | Insulin [Mass/volume] in Serum or Plasma --10 minutes post XXX challenge |
| 17018-3 | Insulin [Mass/volume] in Serum or Plasma --20 minutes post XXX challenge |
| 17019-1 | Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --2 hours post XXX challenge |
| 1702-0 | Acetoacetate [Mass/volume] in Urine |
| 17020-9 | Intercellular substance Ab [Presence] in Serum by Immunofluorescence |
| 17021-7 | Intercellular substance Ab [Units/volume] in Serum by Immunofluorescence |
| 17022-5 | Interleukin 1+2 [Units/volume] in Serum or Plasma |
| 17023-3 | Deprecated Interleukin 7 [Units/volume] in Serum or Plasma |
| 17024-1 | Iodine.inorganic [Mass/volume] in Serum or Plasma |
| 17025-8 | Iron [Mass/volume] in Water |
| 17026-6 | Isocyanate IgE Ab [Units/volume] in Serum |
| 17027-4 | Isocyanate IgG Ab [Units/volume] in Serum |
| 17028-2 | Isocyanate IgM Ab [Units/volume] in Serum |
| 17029-0 | Isoleucine [Presence] in Urine |
| 1703-8 | Acetoacetate [Mass/volume] in Cerebral spinal fluid |
| 17030-8 | Isopropyl ether [Presence] in Blood |
| 17031-6 | Jo-1 extractable nuclear Ab [Presence] in Serum by Immunofluorescence |
| 17032-4 | Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunofluorescence |
| 17033-2 | Ketamine [Presence] in Urine by Confirmatory method |
| 17034-0 | Ketoprofen [Mass/volume] in Serum or Plasma |
| 17035-7 | Ketorolac [Mass/volume] in Serum or Plasma |
| 17036-5 | La Crosse virus Ab [Titer] in Serum |
| 17037-3 | La Crosse virus Ab [Titer] in Cerebral spinal fluid |
| 17038-1 | La Crosse virus IgG Ab [Titer] in Serum |
| 17039-9 | La Crosse virus IgM Ab [Titer] in Serum |
| 1704-6 | Acetoacetate [Presence] in Serum or Plasma |
| 17040-7 | Labetalol [Presence] in Serum or Plasma |
| 17041-5 | Lactate dehydrogenase [Presence] in Urine |
| 17042-3 | Lactoglobulin IgE Ab [Units/volume] in Serum |
| 17043-1 | Lactose [Mass/volume] in Urine |
| 17044-9 | Lamellar bodies [Presence] in Amniotic fluid |
| 17045-6 | Latex IgE Ab [Units/volume] in Blood |
| 17046-4 | Latex IgG Ab [Units/volume] in Serum |
| 17047-2 | Latex Bencard IgE Ab [Units/volume] in Serum |
| 17048-0 | Latex glove extract IgE Ab [Units/volume] in Blood |
| 17049-8 | Latex glove extract ammoniated IgE Ab [Units/volume] in Blood |
| 1705-3 | Acetoacetate [Mass/volume] in Serum or Plasma |
| 17050-6 | Latex glove extract buffered IgE Ab [Units/volume] in Blood |
| 17051-4 | Laxatives [Identifier] in Urine |
| 17052-2 | Lead [Presence] in Blood |
| 17053-0 | Legionella longbeachae 1 IgG Ab [Presence] in Serum |
| 17054-8 | Legionella longbeachae 1 IgM Ab [Presence] in Serum |
| 17055-5 | Legionella longbeachae 2 IgG Ab [Presence] in Serum |
| 17056-3 | Legionella longbeachae 2 IgM Ab [Presence] in Serum |
| 17057-1 | Legionella pneumophila Ag [Presence] in Unspecified specimen |
| 17058-9 | Legionella pneumophila Ag [Presence] in Urine by Latex agglutination |
| 17059-7 | Legionella pneumophila Ag [Presence] in Urine by Immunofluorescence |
| 1706-1 | Acetonitrile [Mass/volume] in Blood |
| 17060-5 | Legionella pneumophila 1 Ab [Titer] in Serum |
| 17061-3 | Legionella pneumophila 1 IgM Ab [Units/volume] in Serum |
| 17062-1 | Legionella pneumophila 2 Ab [Titer] in Serum |
| 17063-9 | Legionella pneumophila 2 IgM Ab [Units/volume] in Serum |
| 17064-7 | Legionella pneumophila 3 Ab [Titer] in Serum |
| 17065-4 | Legionella pneumophila 3 IgM Ab [Units/volume] in Serum |
| 17066-2 | Legionella pneumophila 4 Ab [Titer] in Serum |
| 17067-0 | Legionella pneumophila 4 IgM Ab [Units/volume] in Serum |
| 17068-8 | Legionella pneumophila 5 Ab [Titer] in Serum |
| 17069-6 | Legionella pneumophila 5 IgM Ab [Units/volume] in Serum |
| 1707-9 | Acetylcholine [Mass/volume] in Serum |
| 17070-4 | Legionella pneumophila 6 Ab [Titer] in Serum |
| 17071-2 | Legionella pneumophila 7 Ab [Presence] in Serum |
| 17072-0 | Legionella pneumophila 8 Ab [Presence] in Serum |
| 17073-8 | Legionella pneumophila 9 Ab [Presence] in Serum |
| 17074-6 | Leucine [Units/volume] in Amniotic fluid |
| 17075-3 | Lidocaine [Mass/volume] in Urine |
| 17076-1 | Lidocaine [Mass/volume] in Body fluid |
| 17077-9 | Deprecated Lindane [Mass/volume] in Blood |
| 17078-7 | Fatty acids.esterified [Mass/volume] in Serum or Plasma |
| 17079-5 | Fatty acids.long chain [Identifier] in Serum or Plasma |
| 1708-7 | Acetylcholinesterase [Enzymatic activity/volume] in Amniotic fluid |
| 17080-3 | Fatty acids.very long chain [Identifier] in Serum or Plasma |
| 17081-1 | Deprecated Triglyceride [Mass/volume] in Serum or Plasma --post CFst |
| 17082-9 | Lipoprotein.alpha [Mass/volume] in Body fluid |
| 17083-7 | Lipoprotein.beta [Mass/volume] in Body fluid |
| 17084-5 | Lipoprotein.pre-beta [Mass/volume] in Body fluid |
| 17085-2 | Lipoproteins [Presence] in Serum or Plasma |
| 17086-0 | Lithium [Mass/volume] in Body fluid |
| 17087-8 | Loperamide [Mass/volume] in Serum or Plasma |
| 17088-6 | Lorazepam [Mass/volume] in Urine by Confirmatory method |
| 17089-4 | Lorcainide [Mass/volume] in Serum or Plasma |
| 1709-5 | Acetylcholinesterase [Enzymatic activity/volume] in Red Blood Cells |
| 17090-2 | Loxapine+8-Hydroxyloxapine [Mass/volume] in Serum or Plasma |
| 17091-0 | Lumpfish roe IgE Ab [Units/volume] in Serum |
| 17092-8 | Lupus erythematosus factor [Presence] in Serum by Latex agglutination |
| 17094-4 | Lutropin [Moles/volume] in Serum or Plasma --105 minutes post XXX challenge |
| 17095-1 | Lutropin [Moles/volume] in Serum or Plasma --75 minutes post XXX challenge |
| 17096-9 | Kappa lymphocytes/100 lymphocytes in Blood |
| 17097-7 | CD10+CD20+ cells/100 cells in Blood |
| 17098-5 | CD100 cells/100 cells in Blood |
| 17099-3 | CD102 cells/100 cells in Blood |
| 171-9 | Cephradine [Susceptibility] by Serum bactericidal titer |
| 1710-3 | Acetylcholinesterase [Enzymatic activity/volume] in Serum or Plasma |
| 17100-9 | CD103 cells/100 cells in Blood |
| 17101-7 | CD104 cells/100 cells in Blood |
| 17102-5 | CD105 cells/100 cells in Blood |
| 17103-3 | CD106 cells/100 cells in Blood |
| 17104-1 | CD107a cells/100 cells in Blood |
| 17105-8 | CD107b cells/100 cells in Blood |
| 17106-6 | CD115 cells/100 cells in Blood |
| 17107-4 | CD117 cells/100 cells in Blood |
| 17108-2 | CD118 cells/100 cells in Blood |
| 17109-0 | CD11a cells/100 cells in Blood |
| 1711-1 | Acid phosphatase [Enzymatic activity/volume] in Blood |
| 17110-8 | CD11b cells/100 cells in Blood |
| 17111-6 | CD12 cells/100 cells in Blood |
| 17112-4 | CD120A cells/100 cells in Blood |
| 17113-2 | CD120B cells/100 cells in Blood |
| 17114-0 | CD122 cells/100 cells in Blood |
| 17115-7 | CD126 cells/100 cells in Blood |
| 17116-5 | CD128 cells/100 cells in Blood |
| 17117-3 | CD15 cells/100 cells in Blood |
| 17118-1 | CD16B cells/100 cells in Blood |
| 17119-9 | CD16-CD34+ cells/100 cells in Blood |
| 1712-9 | Prostatic acid phosphatase [Enzymatic activity/volume] in Vaginal fluid |
| 17120-7 | CD17 cells/100 cells in Blood |
| 17121-5 | CD18 cells/100 cells in Blood |
| 17122-3 | CD19+Kappa+ cells/100 cells in Blood |
| 17123-1 | CD19+Lambda+ cells/100 cells in Blood |
| 17124-9 | CD2+CD20+ cells/100 cells in Blood |
| 17125-6 | CD22+CD19+ cells/100 cells in Blood |
| 17126-4 | CD24 cells/100 cells in Blood |
| 17127-2 | CD26 cells/100 cells in Blood |
| 17128-0 | CD27 cells/100 cells in Blood |
| 17129-8 | CD28 cells/100 cells in Blood |
| 1713-7 | Prostatic acid phosphatase [Enzymatic activity/volume] in Semen |
| 17130-6 | CD29 cells/100 cells in Blood |
| 17131-4 | CD3+CD69+ cells/100 cells in Blood |
| 17132-2 | CD3+IL2R1+ cells/100 cells in Blood |
| 17133-0 | CD3+CD16+ cells/100 cells in Blood |
| 17135-5 | CD3+CD56+ cells/100 cells in Blood |
| 17136-3 | CD3+DR+ cells/100 cells in Blood |
| 17137-1 | CD30 cells/100 cells in Blood |
| 17138-9 | CD31 cells/100 cells in Blood |
| 17139-7 | CD32 cells/100 cells in Blood |
| 1714-5 | Prostatic acid phosphatase [Enzymatic activity/volume] in Serum |
| 17140-5 | CD34+DR+ cells/100 cells in Blood |
| 17141-3 | CD36 cells/100 cells in Blood |
| 17142-1 | CD37 cells/100 cells in Blood |
| 17143-9 | CD39 cells/100 cells in Blood |
| 17144-7 | CD4+CD69+ cells/100 cells in Blood |
| 17145-4 | Deprecated CD4+2H4 cells/100 cells in Blood |
| 17146-2 | CD4+CD8+ cells/100 cells in Blood |
| 17147-0 | CD40 cells/100 cells in Blood |
| 17148-8 | CD41 cells/100 cells in Blood |
| 17149-6 | CD42a cells/100 cells in Blood |
| 1715-2 | Acid phosphatase [Enzymatic activity/volume] in Serum or Plasma |
| 17150-4 | CD42b cells/100 cells in Blood |
| 17151-2 | CD42c cells/100 cells in Blood |
| 17152-0 | CD42d cells/100 cells in Blood |
| 17153-8 | CD4+CD45RA+ cells/CD8 Cells [# Ratio] in Blood |
| 17154-6 | CD43 cells/100 cells in Blood |
| 17155-3 | CD44 cells/100 cells in Blood |
| 17156-1 | CD44R cells/100 cells in Blood |
| 17157-9 | CD45RA cells/100 cells in Blood |
| 17158-7 | CD45RB cells/100 cells in Blood |
| 17159-5 | CD45RO cells/100 cells in Blood |
| 1716-0 | Acidity.titratable [Mass/volume] in Urine |
| 17160-3 | CD46 cells/100 cells in Blood |
| 17161-1 | CD47 cells/100 cells in Blood |
| 17162-9 | CD48 cells/100 cells in Blood |
| 17163-7 | CD49a cells/100 cells in Blood |
| 17164-5 | CD49b cells/100 cells in Blood |
| 17165-2 | CD49c cells/100 cells in Blood |
| 17166-0 | CD49d cells/100 cells in Blood |
| 17167-8 | CD49e cells/100 cells in Blood |
| 17168-6 | CD49f cells/100 cells in Blood |
| 17169-4 | CD5+CD2- cells/100 cells in Blood |
| 1717-8 | Acylcarnitine [Mass/volume] in Serum or Plasma |
| 17170-2 | CD50 cells/100 cells in Blood |
| 17171-0 | CD51 cells/100 cells in Blood |
| 17172-8 | CD52 cells/100 cells in Blood |
| 17173-6 | CD53 cells/100 cells in Blood |
| 17174-4 | CD54 cells/100 cells in Blood |
| 17175-1 | CD55 cells/100 cells in Blood |
| 17176-9 | CD58 cells/100 cells in Blood |
| 17177-7 | CD59 cells/100 cells in Blood |
| 17178-5 | CD6 cells/100 cells in Blood |
| 17179-3 | CD62E cells/100 cells in Blood |
| 1718-6 | Acyl CoA dehydrogenase [Enzymatic activity/volume] in Serum |
| 17180-1 | CD62L cells/100 cells in Blood |
| 17181-9 | CD62P cells/100 cells in Blood |
| 17182-7 | CD63 cells/100 cells in Blood |
| 17183-5 | CD64 cells/100 cells in Blood |
| 17184-3 | CD66a cells/100 cells in Blood |
| 17185-0 | CD66b cells/100 cells in Blood |
| 17186-8 | CD66c cells/100 cells in Blood |
| 17187-6 | CD66d cells/100 cells in Blood |
| 17188-4 | CD66e cells/100 cells in Blood |
| 17189-2 | CD68 cells/100 cells in Blood |
| 1719-4 | Adenine [Mass/volume] in Serum |
| 17190-0 | CD69 cells/100 cells in Blood |
| 17191-8 | CD3-CD7+cells/100 cells in Blood |
| 17192-6 | CD72 cells/100 cells in Blood |
| 17193-4 | CD73 cells/100 cells in Blood |
| 17194-2 | CD74 cells/100 cells in Blood |
| 17195-9 | CD77 cells/100 cells in Blood |
| 17196-7 | CD79a cells/100 cells in Blood |
| 17197-5 | CD79b cells/100 cells in Blood |
| 17198-3 | CD8+CD28+ cells/100 cells in Blood |
| 17199-1 | CD80 cells/100 cells in Blood |
| 172-7 | Chloramphenicol [Susceptibility] by Minimum lethal concentration (MLC) |
| 1720-2 | Adenine phosphoribosyltransferase [Enzymatic activity/volume] in Red Blood Cells |
| 17200-7 | CD82 cells/100 cells in Blood |
| 17201-5 | CD83 cells/100 cells in Blood |
| 17202-3 | CD85 cells/100 cells in Blood |
| 17203-1 | CD86 cells/100 cells in Blood |
| 17204-9 | CD87 cells/100 cells in Blood |
| 17205-6 | CD88 cells/100 cells in Blood |
| 17206-4 | CD9 cells/100 cells in Blood |
| 17207-2 | CD91 cells/100 cells in Blood |
| 17208-0 | CD93 cells/100 cells in Blood |
| 17209-8 | CD94 cells/100 cells in Blood |
| 1721-0 | Adenosine triphosphate [Mass/volume] in Blood |
| 17210-6 | CD95 cells/100 cells in Blood |
| 17211-4 | CD96 cells/100 cells in Blood |
| 17212-2 | CD97 cells/100 cells in Blood |
| 17213-0 | CD98 cells/100 cells in Blood |
| 17214-8 | CD99 cells/100 cells in Blood |
| 17215-5 | CV lymphocytes/100 lymphocytes in Blood |
| 17216-3 | Cytoplasmic CD3 cells/100 cells in Blood |
| 17217-1 | Cytoplasmic CD79 cells/100 cells in Blood |
| 17218-9 | Cytoplasmic Ig mu cells/100 cells in Blood |
| 17219-7 | Cytoplasmic Ig cells/100 cells in Blood |
| 1722-8 | Adenosine deaminase [Enzymatic activity/volume] in Blood |
| 17220-5 | FMC7 cells/100 cells in Blood |
| 17221-3 | CD235a cells/100 cells in Blood |
| 17222-1 | HLE lymphocytes/100 lymphocytes in Blood |
| 17223-9 | Deprecated CD14 cells/100 cells in Blood |
| 17224-7 | Lambda lymphocytes/100 lymphocytes in Blood |
| 17225-4 | SMIg lymphocytes/100 lymphocytes in Blood |
| 17226-2 | SmIg-Cd79 cells/100 cells in Blood |
| 17227-0 | Lymphocytes/100 leukocytes in Synovial fluid by Automated count |
| 17228-8 | Lymphocytic choriomeningitis virus Ab [Titer] in Cerebral spinal fluid |
| 17229-6 | Lymphocytic choriomeningitis virus IgM Ab [Titer] in Cerebral spinal fluid |
| 1723-6 | Adenosine deaminase binding protein [Mass/volume] in Urine |
| 17230-4 | Lysine [Presence] in Urine |
| 17231-2 | Lysosomal enzymes [Identifier] in Plasma |
| 17232-0 | Lysozyme [Enzymatic activity/volume] in Tear |
| 17234-6 | Magnesium.plasma/Magnesium.RBC [Molar ratio] in Blood |
| 17235-3 | Magnesium [Moles/volume] in Leukocytes |
| 17236-1 | Magnesium [Moles/volume] in Stool |
| 17237-9 | Magnesium [Moles/mass] in Hair |
| 17238-7 | Malignin Ab [Units/volume] in Serum |
| 1724-4 | Adenosine diphosphate [Mass/volume] in Serum |
| 17241-1 | Prolactin [Mass/volume] in Serum or Plasma --3 hours post XXX challenge |
| 17242-9 | Prolactin [Mass/volume] in Serum or Plasma --40 minutes post XXX challenge |
| 17243-7 | Prolactin [Mass/volume] in Serum or Plasma --pre XXX challenge |
| 17244-5 | Manganese [Mass/mass] in Hair |
| 17245-2 | Deprecated Meclizine [Mass/volume] in Serum or Plasma |
| 17246-0 | Mefenamate [Mass/volume] in Serum or Plasma |
| 17247-8 | Melanin [Units/volume] in Urine |
| 17248-6 | Melanin [Units/volume] in Serum or Plasma |
| 17249-4 | Menthol [Mass/volume] in Blood |
| 1725-1 | Adenosine monophosphate deaminase [Enzymatic activity/volume] in Serum |
| 17250-2 | Mephobarbital [Mass/volume] in Urine by Confirmatory method |
| 17251-0 | Mepivacaine [Presence] in Serum or Plasma |
| 17252-8 | Mercaptopurine [Presence] in Serum or Plasma |
| 17253-6 | Mercury [Mass/volume] in Milk |
| 17254-4 | Mercury [Mass/volume] in Food |
| 17255-1 | Mercury [Mass/volume] in Dialysis fluid |
| 17256-9 | Mesoridazine [Mass/volume] in Urine |
| 17257-7 | Mesothelial cells [Presence] in Body fluid by Light microscopy |
| 17258-5 | Metandienone [Mass/volume] in Serum or Plasma |
| 17259-3 | Methadone.long acting metabolite [Mass/volume] in Serum or Plasma |
| 1726-9 | Adenosine monophosphate.cyclic [Mass/volume] in Serum or Plasma |
| 17260-1 | Methamphetamine [Mass/volume] in Serum or Plasma by Confirmatory method |
| 17261-9 | Methapyrilene [Mass/volume] in Urine |
| 17263-5 | Methemalbumin [Presence] in Serum or Plasma |
| 17264-3 | Methionine [Presence] in Urine |
| 17265-0 | Methocarbamol [Units/volume] in Serum or Plasma |
| 17266-8 | Methotrexate [Mass/volume] in Urine |
| 17267-6 | Methoxychlor [Mass/volume] in Urine |
| 17268-4 | Deprecated Methsuximide+Normethsuximide [Mass/volume] in Serum or Plasma |
| 17269-2 | Methyl isobutyl ketone [Mass/volume] in Urine |
| 1727-7 | Adenosine monophosphate.cyclic [Mass/time] in 24 hour Urine |
| 17270-0 | Methylacrylate [Mass/volume] in Serum or Plasma |
| 17271-8 | Deprecated 1,1,1-Trichloroethane [Mass/volume] in Serum or Plasma |
| 17272-6 | Methylenedianiline [Mass/volume] in Blood |
| 17273-4 | Methylephedrine [Units/volume] in Urine |
| 17274-2 | Methylergonovine [Mass/volume] in Serum or Plasma |
| 17275-9 | Methylfentanyl [Mass/volume] in Serum or Plasma |
| 17276-7 | 2-Methylpentane [Mass/volume] in Blood |
| 17277-5 | Metolazone [Mass/volume] in Serum or Plasma |
| 17278-3 | Miconazole [Mass/volume] in Serum or Plasma |
| 17279-1 | Bacteria identified in Pleural fluid by Aerobe culture |
| 1728-5 | Adenosine monophosphate.cyclic/Creatinine [Mass Ratio] in Serum or Plasma |
| 17280-9 | Microscopic observation [Identifier] in Tissue by Malaria thick smear |
| 17281-7 | Microscopic observation [Identifier] in Sputum by KOH preparation |
| 17282-5 | Minoxidil [Mass/volume] in Serum or Plasma |
| 17283-3 | Mirtazapine [Mass/volume] in Serum or Plasma |
| 17284-1 | Mitochondria Ab [Presence] in Serum by Immunofluorescence |
| 17285-8 | Mitochondria Ab [Units/volume] in Serum by Immunofluorescence |
| 17286-6 | Monocytes/100 leukocytes in Synovial fluid by Manual count |
| 17287-4 | Monocytes/100 leukocytes in Urine by Manual count |
| 17288-2 | Ganglioside GM1 Ab [Presence] in Serum by Immunofluorescence |
| 17289-0 | Monosodium glutamate (MSG) IgE Ab [Units/volume] in Serum |
| 1729-3 | Adenosine triphosphatase [Enzymatic activity/volume] in Red Blood Cells |
| 17290-8 | Morphine [Presence] in Serum or Plasma by Confirmatory method |
| 17291-6 | Deprecated Mulberry tree IgE Ab [Units/volume] in Serum |
| 17292-4 | Mumps virus Ab [Units/volume] in Cerebral spinal fluid |
| 17293-2 | Mumps virus IgG+IgM Ab [Units/volume] in Serum |
| 17294-0 | Mushroom toxins [Identifier] in Urine |
| 17296-5 | Mycobacterium tuberculosis complex rRNA [Presence] in Unspecified specimen by DNA probe |
| 17297-3 | Deprecated Mycobacterium tuberculosum rRNA [Presence] in Unspecified specimen by DNA probe |
| 17298-1 | Deprecated Mycobacterium tuberculosis rRNA [Presence] in Unspecified specimen by DNA probe |
| 17299-9 | Mycoplasma fermentans Ab [Presence] in Serum |
| 173-5 | Chloramphenicol [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 1730-1 | Adenosine triphosphatase [Enzymatic activity/volume] in Semen |
| 17300-5 | Mycoplasma hominis Ab [Titer] in Serum by Complement fixation |
| 17301-3 | Mycoplasma hominis Ab [Presence] in Serum |
| 17302-1 | Mycoplasma pneumoniae Ab [Presence] in Serum |
| 17303-9 | Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid |
| 17304-7 | Mycoplasma pneumoniae IgG+IgM Ab [Units/volume] in Serum |
| 17305-4 | Myelin IgA Ab [Presence] in Serum |
| 17306-2 | Myelin IgG Ab [Presence] in Serum |
| 17307-0 | Myelin IgM Ab [Presence] in Serum |
| 17308-8 | Myelin associated glycoprotein Ab [Units/volume] in Serum by Immunoblot (IB) |
| 1731-9 | Adenylate kinase [Enzymatic activity/volume] in Serum |
| 17310-4 | Myelin associated glycoprotein Ab [Presence] in Serum by Immunofluorescence |
| 17311-2 | Myelin associated glycoprotein IgA Ab [Units/volume] in Serum |
| 17312-0 | Myelin associated glycoprotein IgG Ab [Units/volume] in Serum |
| 17313-8 | Myelin associated glycoprotein IgG Ab [Units/volume] in Serum by Immunofluorescence |
| 17314-6 | Myelin associated glycoprotein IgM Ab [Units/volume] in Serum by Immunoassay |
| 17315-3 | Myelin basic protein Ab [Mass/volume] in Serum |
| 17316-1 | Myeloperoxidase Ab [Presence] in Serum |
| 17317-9 | N-acetylprocainamide [Mass/volume] in Urine |
| 17318-7 | Nalbuphine [Mass/volume] in Serum or Plasma |
| 17319-5 | Nalidixate [Mass/volume] in Serum or Plasma |
| 1732-7 | Adenylosuccinate lyase [Enzymatic activity/volume] in Serum |
| 17320-3 | Nefazodone [Mass/volume] in Urine |
| 17321-1 | Neisseria meningitidis A+Y Ag [Presence] in Urine |
| 17322-9 | Neisseria meningitidis Ab [Presence] in Serum |
| 17323-7 | Neisseria meningitidis Ag [Presence] in Urine |
| 17324-5 | Neisseria meningitidis Ag [Units/volume] in Cerebral spinal fluid by Latex agglutination |
| 17325-2 | Neisseria meningitidis C+w135 Ag [Presence] in Urine |
| 17326-0 | Neisseria meningitidis A Ag [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 17327-8 | Neisseria meningitidis B Ab [Units/volume] in Serum |
| 17328-6 | Neisseria meningitidis B Ag [Presence] in Urine by Latex agglutination |
| 17329-4 | Neisseria meningitidis C Ag [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 1733-5 | Adipate [Mass/volume] in Urine |
| 17330-2 | Neisseria meningitidis Y Ag [Presence] in Cerebral spinal fluid |
| 17331-0 | Neisseria meningitidis polyvalent Ab [Units/volume] in Serum |
| 17332-8 | Neisseria meningitidis polyvalent Ag [Presence] in Cerebral spinal fluid |
| 17333-6 | Neisseria meningitidis w135 Ag [Presence] in Serum or Plasma by Latex agglutination |
| 17334-4 | Neopterin/Creatinine [Mass Ratio] in Urine |
| 17335-1 | Neostigmine [Mass/volume] in Serum or Plasma |
| 17336-9 | Neuronal Ab [Presence] in Serum by Immunofluorescence |
| 17337-7 | Neuronal Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 17338-5 | Neuronal Ab [Units/volume] in Serum by Immunofluorescence |
| 17339-3 | Neuronal Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence |
| 1734-3 | Aldosterone renal clearance in 24 hour |
| 17340-1 | Neuronal IgG Ab [Presence] in Body fluid by Immunoassay |
| 17341-9 | Neuronal nuclear Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 17342-7 | Neuronal nuclear type 2 Ab [Units/volume] in Serum |
| 17343-5 | Neuronal nuclear type 2 Ab [Presence] in Cerebral spinal fluid |
| 17344-3 | Neuronal nuclear type 2 Ab [Units/volume] in Serum by Immunofluorescence |
| 17345-0 | Deprecated Neutrophil Ab [Units/volume] in Serum |
| 17346-8 | Neutrophil Ab [Presence] in Serum by Immunofluorescence |
| 17347-6 | Neutrophil Ab [Units/volume] in Serum by Immunofluorescence |
| 17348-4 | Neutrophil IgA Ab [Units/volume] in Serum |
| 17349-2 | Neutrophil IgG Ab [Units/volume] in Serum |
| 1735-0 | Alanine [Mass/volume] in Cerebral spinal fluid |
| 17350-0 | Neutrophil IgM Ab [Units/volume] in Serum |
| 17351-8 | Neutrophil cytoplasmic Ab [Presence] in Serum |
| 17352-6 | Neutrophil cytoplasmic Ab [Interpretation] in Serum |
| 17353-4 | Neutrophil cytoplasmic Ab.classic [Presence] in Serum by Immunofluorescence |
| 17354-2 | Neutrophil cytoplasmic IgA Ab [Presence] in Serum |
| 17355-9 | Neutrophil cytoplasmic IgG Ab [Presence] in Serum |
| 17356-7 | Neutrophil cytoplasmic IgM Ab [Presence] in Serum |
| 17357-5 | Neutrophil cytoplasmic Ab.perinuclear [Presence] in Serum by Immunofluorescence |
| 17358-3 | Neutrophil Cytoplasmic Ab atypical [Units/volume] in Serum |
| 17359-1 | Neutrophils [#/volume] in Semen by Manual count |
| 1736-8 | Alanine [Presence] in Serum or Plasma |
| 17360-9 | Heptane [Mass/volume] in Blood |
| 17361-7 | Deprecated Hexane [Mass/volume] in Blood |
| 17362-5 | Nicotinamide [Presence] in Urine |
| 17363-3 | Nitrazepam [Mass/volume] in Serum or Plasma by Confirmatory method |
| 17364-1 | Nitrophenol [Presence] in Urine |
| 17365-8 | Nitroprusside [Mass/volume] in Serum or Plasma |
| 17366-6 | Nizatidine [Mass/volume] in Serum or Plasma |
| 17367-4 | Nomifensine [Mass/volume] in Serum or Plasma |
| 17368-2 | Norepinephrine [Mass/volume] in Plasma --standing |
| 17369-0 | Norepinephrine [Mass/volume] in Urine --2nd specimen post XXX challenge |
| 1737-6 | Alanine [Mass/volume] in Serum or Plasma |
| 17370-8 | Norepinephrine [Mass/volume] in Urine --3rd specimen post XXX challenge |
| 17371-6 | Norepinephrine [Mass/volume] in Urine --4th specimen post XXX challenge |
| 17372-4 | Norepinephrine [Mass/volume] in Urine --5th specimen post XXX challenge |
| 17373-2 | Norepinephrine [Mass/volume] in Urine --6th specimen post XXX challenge |
| 17374-0 | Norepinephrine [Mass/volume] in Urine --7th specimen post XXX challenge |
| 17375-7 | Norflunitrazepam [Mass/volume] in Blood |
| 17376-5 | Norpropoxyphene [Presence] in Urine by Confirmatory method |
| 17377-3 | Norpropoxyphene [Mass/volume] in Urine by Confirmatory method |
| 17378-1 | Novobiocin [Mass/volume] in Serum or Plasma |
| 17379-9 | Propanol [Mass/volume] in Blood |
| 1738-4 | Alanine [Mass/volume] in Urine |
| 17380-7 | Nuclear Ab.histone reactive [Presence] in Serum |
| 17381-5 | Uroporphyrin [Mass/time] in 24 hour Stool |
| 17382-3 | Octadecanoate (C18:0) [Mass/volume] in Serum or Plasma |
| 17384-9 | Opiates [Mass/volume] in Urine by Confirmatory method |
| 17385-6 | Organic acids [Units/volume] in Urine |
| 17386-4 | Organic acids [Units/volume] in Blood |
| 17387-2 | Organic acids [Units/volume] in Serum or Plasma |
| 17388-0 | Organochlorine pesticides [Type] in Urine |
| 17389-8 | Ornithine [Presence] in Urine |
| 1739-2 | Alanine [Mass/time] in 24 hour Urine |
| 17390-6 | Orphenadrine [Mass/volume] in Urine |
| 17391-4 | Orthocresol [Mass/volume] in Blood |
| 17392-2 | Osmium [Mass/volume] in Urine |
| 17393-0 | Ovary Ab [Presence] in Serum |
| 17394-8 | Oxychlordane [Mass/volume] in Urine |
| 17395-5 | Oxymorphone [Mass/volume] in Urine by Confirmatory method |
| 17396-3 | Oxytetracycline [Mass/volume] in Serum or Plasma |
| 17397-1 | Oxytriphylline [Mass/volume] in Serum or Plasma |
| 17398-9 | Human papilloma virus 11 Ag [Presence] in Unspecified specimen |
| 17399-7 | Human papilloma virus 16 Ag [Presence] in Unspecified specimen |
| 174-3 | Chloramphenicol [Susceptibility] by Disk diffusion (KB) |
| 1740-0 | Alanine aminopeptidase [Mass/volume] in Serum |
| 17400-3 | Human papilloma virus 16+18 Ag [Presence] in Unspecified specimen |
| 17401-1 | Human papilloma virus 18 Ag [Presence] in Unspecified specimen |
| 17402-9 | Human papilloma virus 31 Ag [Presence] in Unspecified specimen |
| 17403-7 | Human papilloma virus 31+33+35 Ag [Presence] in Unspecified specimen |
| 17404-5 | Human papilloma virus 33 Ag [Presence] in Unspecified specimen |
| 17405-2 | Human papilloma virus 42 Ag [Presence] in Unspecified specimen |
| 17406-0 | Human papilloma virus 43 Ag [Presence] in Unspecified specimen |
| 17407-8 | Human papilloma virus 44 Ag [Presence] in Unspecified specimen |
| 17408-6 | Human papilloma virus 45 Ag [Presence] in Unspecified specimen |
| 17409-4 | Human papilloma virus 5 Ag [Presence] in Unspecified specimen |
| 1741-8 | Alanine aminotransferase [Enzymatic activity/volume] in Amniotic fluid |
| 17410-2 | Human papilloma virus 51 Ag [Presence] in Unspecified specimen |
| 17411-0 | Human papilloma virus 6 Ag [Presence] in Unspecified specimen |
| 17412-8 | Human papilloma virus 6+11 Ag [Presence] in Unspecified specimen |
| 17413-6 | Papova virus SV 40 Ab [Units/volume] in Serum |
| 17414-4 | Parainfluenza virus 1+2+3 Ag [Presence] in Unspecified specimen |
| 17415-1 | Parainfluenza virus A Ab [Units/volume] in Serum |
| 17416-9 | Parakeet droppings Ab [Units/volume] in Serum |
| 17417-7 | Parakeet droppings IgG Ab [Units/volume] in Serum |
| 17418-5 | Parakeet serum Ab [Units/volume] in Serum |
| 17419-3 | Parathion [Mass/volume] in Urine |
| 1742-6 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma |
| 17420-1 | Parrot droppings Ab [Units/volume] in Serum |
| 17421-9 | Parrot serum Ab [Units/volume] in Serum |
| 17422-7 | Parvovirus B19 IgG+IgM Ab [Units/volume] in Serum |
| 17423-5 | Deprecated Parvovirus B19 IgM Ab [Presence] in Serum |
| 17424-3 | 1,4-Dichlorobenzene [Mass/volume] in Blood |
| 17426-8 | Penicillium roqueforti IgE Ab [Units/volume] in Serum |
| 17427-6 | Penicillium sp Ab [Units/volume] in Serum |
| 17428-4 | Pentacarboxylporphyrins [Mass/time] in 24 hour Stool |
| 17429-2 | Pentachlorophenol [Mass/volume] in Blood |
| 1743-4 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P |
| 17430-0 | Pentane [Mass/volume] in Blood |
| 17431-8 | Pentobarbital [Mass/volume] in Gastric fluid |
| 17432-6 | Tetrachloroethylene [Mass/volume] in Serum or Plasma |
| 17433-4 | pH of Unspecified specimen |
| 17434-2 | Phenazopyridine [Mass/volume] in Serum or Plasma |
| 17435-9 | Pheniramine [Mass/volume] in Urine |
| 17436-7 | Phenobarbital [Mass/volume] in Gastric fluid |
| 17437-5 | Phenolphthalein [Mass/volume] in Urine |
| 17438-3 | Phenolphthalein [Mass/volume] in Blood |
| 17439-1 | Phenols [Mass/volume] in Blood |
| 1744-2 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by Without P-5'-P |
| 17440-9 | Phenothiazines [Units/volume] in Serum or Plasma |
| 17441-7 | Phenothiazines [Units/volume] in Urine |
| 17442-5 | Phenylephrine [Mass/volume] in Serum or Plasma |
| 17443-3 | Phenylpropanolamine [Mass/volume] in Urine |
| 17444-1 | Phenytoin [Mass/volume] in Urine |
| 17445-8 | Phoma herbarum IgG Ab [Units/volume] in Serum |
| 17446-6 | Phoma sp IgE Ab [Units/volume] in Serum |
| 17447-4 | Phosphate [Presence] in Stool |
| 17448-2 | Phosphatidylethanolamine IgA Ab [Presence] in Serum |
| 17449-0 | Phosphatidylethanolamine IgG Ab [Presence] in Serum |
| 1745-9 | Albumin [Mass/volume] in Amniotic fluid |
| 17450-8 | Phosphatidylethanolamine IgM Ab [Presence] in Serum |
| 17451-6 | Phosphatidylglycerol IgA Ab [Presence] in Serum |
| 17452-4 | Phosphatidylglycerol IgG Ab [Presence] in Serum |
| 17453-2 | Phosphatidylglycerol IgM Ab [Presence] in Serum |
| 17454-0 | Phosphatidylinositol IgA Ab [Presence] in Serum |
| 17455-7 | Phosphatidylinositol IgG Ab [Presence] in Serum |
| 17456-5 | Phosphatidylinositol IgM Ab [Presence] in Serum |
| 17457-3 | Phosphoethanolamine [Presence] in Urine |
| 17458-1 | Phosphoethanolamine [Presence] in Serum or Plasma |
| 17459-9 | Phospholipid IgA Ab [Units/volume] in Serum by Immunoassay |
| 1746-7 | Albumin [Mass/volume] in Cerebral spinal fluid |
| 17460-7 | Phosphoserine [Presence] in Urine |
| 17461-5 | Phosphoserine [Presence] in Serum or Plasma |
| 17462-3 | Picloram [Mass/volume] in Urine |
| 17463-1 | Pigeon droppings Ab [Units/volume] in Serum |
| 17464-9 | Pigeon feather IgE Ab [Presence] in Serum |
| 17465-6 | Pigeon serum IgE Ab [Presence] in Serum |
| 17466-4 | Deprecated Plasminogen activator inhibitor 1 Ag [Units/volume] in Platelet poor plasma by Immunologic method |
| 17467-2 | Plasminogen activator inhibitor 2 Ag [Units/volume] in Platelet poor plasma by Immunoassay |
| 17468-0 | Plutonium [Mass/volume] in Urine |
| 17469-8 | PM-1 Ab [Units/volume] in Serum |
| 1747-5 | Albumin [Mass/volume] in Body fluid |
| 17470-6 | PM-1 Ab [Presence] in Serum by Immunofluorescence |
| 17471-4 | PM-1 Ab [Units/volume] in Serum by Immunofluorescence |
| 17472-2 | Polybrominated biphenyl [Mass/volume] in Serum or Plasma |
| 17473-0 | Polymyxin B [Mass/volume] in Serum or Plasma |
| 17474-8 | Porphobilinogen [Moles/volume] in Serum or Plasma |
| 17475-5 | Porphyrins [Units/volume] in Urine |
| 17476-3 | Porphyrins [Units/volume] in Red Blood Cells |
| 17477-1 | Porphyrins [Units/volume] in Stool |
| 17478-9 | Porphyrins [Presence] in Body fluid |
| 17479-7 | Prazepam [Mass/volume] in Urine by Confirmatory method |
| 1748-3 | Albumin [Mass/volume] in Pleural fluid |
| 17480-5 | Pregnenolone [Mass/volume] in Urine |
| 17481-3 | Probenecid [Units/volume] in Urine |
| 17482-1 | Procainamide [Mass/volume] in Urine |
| 17483-9 | Progesterone [Mass/volume] in Urine |
| 17484-7 | Progesterone [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge |
| 17485-4 | Progesterone [Mass/volume] in Serum or Plasma --15 minutes post XXX challenge |
| 17486-2 | Progesterone [Mass/volume] in Serum or Plasma --2 hours post XXX challenge |
| 17487-0 | Progesterone [Mass/volume] in Serum or Plasma --45 minutes post XXX challenge |
| 17488-8 | Progesterone [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
| 17489-6 | Progesterone [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge |
| 1749-1 | Albumin [Mass/volume] in Peritoneal fluid |
| 17490-4 | Progesterone [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge |
| 17491-2 | Proinsulin [Mass/volume] in Serum or Plasma --baseline |
| 17492-0 | Proline [Presence] in Urine |
| 17493-8 | Prostaglandin E [Mass/volume] in Serum or Plasma |
| 17494-6 | Prostaglandin F2 alpha [Mass/volume] in Urine |
| 17495-3 | Prostaglandins [Mass/volume] in Urine |
| 17496-1 | Alpha 1 globulin [Mass/volume] in Body fluid by Electrophoresis |
| 17497-9 | Alpha 2 globulin [Mass/volume] in Body fluid by Electrophoresis |
| 17498-7 | Beta globulin [Mass/volume] in Body fluid by Electrophoresis |
| 17499-5 | Gamma globulin [Mass/volume] in Body fluid by Electrophoresis |
| 175-0 | Chloramphenicol [Susceptibility] by Serum bactericidal titer |
| 1750-9 | Albumin [Mass/volume] in Semen |
| 17501-8 | Protoporphyrin [Mass/volume] in Serum or Plasma |
| 17502-6 | Pseudomonas aeruginosa Ab [Units/volume] in Serum |
| 17504-2 | Psilocybin [Presence] in Urine |
| 17505-9 | Psilocybin/Psilocin [Mass Ratio] in Serum or Plasma |
| 17506-7 | Quinacrine [Mass/volume] in Serum or Plasma |
| 17507-5 | Quinidine [Mass/volume] in Urine |
| 17508-3 | Quinine [Units/volume] in Urine |
| 17509-1 | Marsh Ragweed IgE Ab [Units/volume] in Serum |
| 1751-7 | Albumin [Mass/volume] in Serum or Plasma |
| 17510-9 | Raisin IgE Ab [Units/volume] in Serum |
| 17511-7 | Red dye IgE Ab [Units/volume] in Serum |
| 17512-5 | Redfish IgE Ab [Units/volume] in Serum |
| 17513-3 | Renin [Enzymatic activity/volume] in Plasma --5 hours post XXX challenge |
| 17514-1 | Renin [Enzymatic activity/volume] in Plasma --9th specimen post XXX challenge |
| 17515-8 | Renin [Enzymatic activity/volume] in Plasma --baseline |
| 17516-6 | Renin [Enzymatic activity/volume] in Plasma --supine |
| 17517-4 | Respiratory syncytial virus IgG Ab [Titer] in Cerebral spinal fluid |
| 17518-2 | Respiratory syncytial virus IgG Ab [Titer] in Serum |
| 17519-0 | Respiratory syncytial virus IgM Ab [Titer] in Cerebral spinal fluid |
| 1752-5 | Albumin [Mass/volume] in Synovial fluid |
| 17520-8 | Respiratory syncytial virus identified in Unspecified specimen by Organism specific culture |
| 17521-6 | Reticulin Ab [Presence] in Serum |
| 17522-4 | Reticulin IgA Ab [Titer] in Serum by Immunofluorescence |
| 17523-2 | Reticulin IgG Ab [Titer] in Serum |
| 17524-0 | Reticulin IgG Ab [Titer] in Serum by Immunofluorescence |
| 17525-7 | Retinoate esters [Mass/volume] in Serum or Plasma |
| 17526-5 | Retinyl esters [Mass/volume] in Serum or Plasma |
| 17527-3 | Retinol Free [Mass/volume] in Serum or Plasma |
| 17528-1 | Retinol [Mass/volume] in Serum or Plasma --3 hours post dose |
| 17529-9 | Retinol [Mass/volume] in Serum or Plasma --6 hours post dose |
| 1753-3 | Albumin [Presence] in Urine |
| 17530-7 | Retrovirus identified in Unspecified specimen by Organism specific culture |
| 17531-5 | Rh [Type] in Amniotic fluid |
| 17532-3 | Rheumatoid arthritis nuclear Ab [Presence] in Serum |
| 17533-1 | Rheumatoid arthritis nuclear Ab [Presence] in Serum by Immunofluorescence |
| 17534-9 | Rheumatoid factor [Units/volume] in Body fluid by Immunoassay |
| 17535-6 | Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunofluorescence |
| 17536-4 | Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum by Immunofluorescence |
| 17537-2 | Rickettsia spotted fever group RNA [Presence] in Serum by Probe and target amplification method |
| 17538-0 | Rickettsia spotted fever group RNA [Presence] in Serum by DNA probe |
| 17539-8 | Rickettsia typhi Ab [Units/volume] in Serum by Latex agglutination |
| 1754-1 | Albumin [Mass/volume] in Urine |
| 17540-6 | Rickettsia typhi IgA Ab [Units/volume] in Serum by Immunofluorescence |
| 17541-4 | Rickettsia typhi IgG Ab [Presence] in Serum by Immunoassay |
| 17544-8 | Bartonella quintana IgG Ab [Presence] in Cerebral spinal fluid |
| 17545-5 | Bartonella quintana IgM Ab [Presence] in Cerebral spinal fluid |
| 17546-3 | Bartonella quintana rRNA [Presence] in Unspecified specimen by DNA probe |
| 17547-1 | Rotavirus Ag [Presence] in Stool |
| 17548-9 | Rotavirus RNA [Presence] in Unspecified specimen by DNA probe |
| 17549-7 | Rubella virus Ab [Units/volume] in Cerebral spinal fluid |
| 1755-8 | Albumin [Mass/time] in 24 hour Urine |
| 17550-5 | Rubella virus Ab [Units/volume] in Serum by Latex agglutination |
| 17551-3 | Rubella virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 17552-1 | Rubella virus IgM Ab [Presence] in Cerebral spinal fluid |
| 17553-9 | Measles virus Ab [Units/volume] in Cerebral spinal fluid |
| 17554-7 | Measles virus IgA Ab [Units/volume] in Serum |
| 17555-4 | Measles virus Ab [Units/volume] in Serum --1st specimen |
| 17556-2 | Measles virus Ab [Units/volume] in Serum --2nd specimen |
| 17557-0 | Saccharomonospora viridis IgG Ab [Units/volume] in Serum |
| 17558-8 | Saint Louis encephalitis virus Ab [Units/volume] in Cerebral spinal fluid |
| 17559-6 | Salicylates [Presence] in Blood |
| 1756-6 | Albumin in CSF/Albumin in Serum or Plasma |
| 17560-4 | Salicylates [Presence] in Gastric fluid |
| 17561-2 | Salmon roe IgE Ab [Units/volume] in Serum |
| 17562-0 | Salmonella sp Ab [Presence] in Serum |
| 17563-8 | Salmonella sp identified in Unspecified specimen by Organism specific culture |
| 17564-6 | Salmonella typhi O D Ab [Presence] in Serum by Latex agglutination |
| 17565-3 | Salmonella typhi H D Ab [Presence] in Serum by Latex agglutination |
| 17566-1 | Salmonella typhi O Ab [Presence] in Serum |
| 17567-9 | Sasapyrine [Mass/volume] in Serum or Plasma |
| 17568-7 | Sarcosine [Presence] in Urine |
| 17569-5 | SCL-70 extractable nuclear Ab [Presence] in Serum by Immunofluorescence |
| 1757-4 | Albumin renal clearance in 24 hour |
| 17570-3 | SCL-70 extractable nuclear IgG Ab [Presence] in Serum by Immunoassay |
| 17571-1 | Scopolamine [Mass/volume] in Urine |
| 17572-9 | 2-Butanol [Mass/volume] in Blood |
| 17573-7 | Secobarbital [Mass/volume] in Gastric fluid |
| 17574-5 | Selenium [Mass/volume] in Body fluid |
| 17575-2 | Serine [Presence] in Urine |
| 17576-0 | Shigella sp identified in Unspecified specimen by Organism specific culture |
| 17577-8 | Ganglioside GQ1a IgM Ab [Presence] in Serum |
| 17578-6 | Ganglioside GQ1b Ab [Presence] in Serum |
| 17579-4 | Ganglioside GQ1b IgG Ab [Presence] in Serum |
| 1758-2 | Albumin.glycated [Mass/volume] in Serum or Plasma |
| 17580-2 | Ganglioside GQ1b IgG Ab [Presence] in Cerebral spinal fluid |
| 17581-0 | Ganglioside GQ1b IgM Ab [Presence] in Serum |
| 17582-8 | Silver [Mass/volume] in Dialysis fluid |
| 17583-6 | Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunofluorescence |
| 17584-4 | Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum by Immunofluorescence |
| 17585-1 | Sjogrens syndrome-A extractable nuclear IgG Ab [Presence] in Serum by Immunoassay |
| 17586-9 | Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunofluorescence |
| 17587-7 | Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum by Immunofluorescence |
| 17588-5 | Sjogrens syndrome-B extractable nuclear IgG Ab [Presence] in Serum by Immunoassay |
| 17589-3 | Smith extractable nuclear Ab [Titer] in Serum by Immune diffusion (ID) |
| 1759-0 | Albumin/Globulin [Mass Ratio] in Serum or Plasma |
| 17590-1 | Smith extractable nuclear Ab [Titer] in Serum by Immunoassay |
| 17591-9 | Smith extractable nuclear Ab [Presence] in Serum by Immunofluorescence |
| 17592-7 | Smith extractable nuclear Ab [Units/volume] in Serum by Immunofluorescence |
| 17593-5 | Smooth muscle Ab [Presence] in Sweat |
| 17594-3 | Deprecated Somatotropin [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge |
| 17595-0 | Deprecated Somatotropin [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
| 17597-6 | Somatotropin [Mass/volume] in Serum or Plasma --52 hours post XXX challenge |
| 17598-4 | Specific gravity of Synovial fluid |
| 17599-2 | Volume of 24 hour Peritoneal dialysis fluid |
| 176-8 | Chlortetracycline [Susceptibility] by Minimum lethal concentration (MLC) |
| 1760-8 | Alcohol dehydrogenase [Enzymatic activity/volume] in Serum |
| 17600-8 | Volume of 6 hour Urine |
| 17601-6 | Volume of 24 hour Sputum |
| 17602-4 | Volume of Seminal plasma |
| 17603-2 | Volume of 24 hour Stool |
| 17604-0 | Volume of 24 hour Sweat |
| 17605-7 | Volume of 24 hour Unspecified specimen |
| 17606-5 | Volume of Stool |
| 17607-3 | Volume of Cerebral spinal fluid |
| 17608-1 | Weight [Mass/time] of 48 hour Stool |
| 17609-9 | Weight [Mass/time] of 72 hour Stool |
| 1761-6 | Aldolase [Enzymatic activity/volume] in Serum or Plasma |
| 17610-7 | Spermatozoa Motile [Presence] in Semen --30 minutes post collection |
| 17611-5 | Stimulants [Identifier] in Serum or Plasma |
| 17612-3 | Deprecated Streptococcus pneumoniae 1 Ab [Units/volume] in Serum --1st specimen |
| 17613-1 | Deprecated Streptococcus pneumoniae 1 Ab [Units/volume] in Serum --2nd specimen |
| 17614-9 | Streptococcus pneumoniae 12 Ab [Presence] in Serum |
| 17615-6 | Deprecated Streptococcus pneumoniae 12 Ab [Units/volume] in Serum --1st specimen |
| 17616-4 | Deprecated Streptococcus pneumoniae 12 Ab [Ratio] in Serum --2nd specimen/1st specimen |
| 17617-2 | Streptococcus pneumoniae 14 Ab [Units/volume] in Serum by Immunoassay --1st specimen |
| 17618-0 | Streptococcus pneumoniae 14 Ab [Units/volume] in Serum by Immunoassay --2nd specimen |
| 17619-8 | Streptococcus pneumoniae 14 Ab [Ratio] in Serum by Immunoassay --2nd specimen/1st specimen |
| 1762-4 | Aldosterone [Mass/volume] in Blood |
| 17620-6 | Deprecated Streptococcus pneumoniae 56 Ab [Units/volume] in Serum --1st specimen |
| 17621-4 | Deprecated Streptococcus pneumoniae 56 Ab [Units/volume] in Serum --2nd specimen |
| 17622-2 | Streptocuccus pneumoniae 18 Ab [Units/volume] in Serum --1st specimen |
| 17623-0 | Deprecated Streptococcus pneumoniae 19 Ab [Units/volume] in Serum --2nd specimen |
| 17624-8 | Deprecated Streptococcus pneumoniae 23 Ab [Units/volume] in Serum --1st specimen |
| 17625-5 | Deprecated Streptococcus pneumoniae 23 Ab [Units/volume] in Serum --2nd specimen |
| 17626-3 | Deprecated Streptococcus pneumoniae 3 Ab [Units/volume] in Serum --1st specimen |
| 17627-1 | Streptococcus pneumoniae 3 Ab [Units/volume] in Serum by Immunoassay --1st specimen |
| 17628-9 | Deprecated Streptococcus pneumoniae 3 Ab [Units/volume] in Serum --2nd specimen |
| 17629-7 | Streptococcus pneumoniae 3 Ab [Units/volume] in Serum by Immunoassay --2nd specimen |
| 1763-2 | Aldosterone [Mass/volume] in Serum or Plasma |
| 17630-5 | Streptococcus pneumoniae 3 Ab [Ratio] in Serum --2nd specimen/1st specimen |
| 17631-3 | Deprecated Streptococcus pneumoniae 36a+6b IgG Ab [Units/volume] in Serum |
| 17632-1 | Streptococcus pneumoniae 4 IgG Ab [Units/volume] in Serum |
| 17633-9 | Deprecated Streptococcus pneumoniae 4 Ab [Units/volume] in Serum --1st specimen |
| 17634-7 | Deprecated Streptococcus pneumoniae 4 Ab [Units/volume] in Serum --2nd specimen |
| 17635-4 | Streptococcus pneumoniae 56 IgG Ab [Units/volume] in Serum |
| 17636-2 | Deprecated Streptococcus pneumoniae 26 Ab [Units/volume] in Serum --1st specimen |
| 17637-0 | Deprecated Streptococcus pneumoniae 26 Ab [Units/volume] in Serum --2nd specimen |
| 17638-8 | Streptococcus pneumoniae 51 Ab [Units/volume] in Serum by Immunoassay --1st specimen |
| 17639-6 | Streptococcus pneumoniae 51 Ab [Units/volume] in Serum by Immunoassay --2nd specimen |
| 1764-0 | Aldosterone [Mass/volume] in Urine |
| 17640-4 | Streptococcus pneumoniae 51 Ab [Ratio] in Serum by Immunoassay --2nd specimen/1st specimen |
| 17641-2 | Streptococcus pneumoniae 8 Ab [Presence] in Serum |
| 17642-0 | Streptococcus pneumoniae 8 Ab [Presence] in Serum by Immunoassay |
| 17643-8 | Streptococcus pneumoniae 9 Ab [Presence] in Serum by Immunoassay |
| 17644-6 | Streptococcus pneumoniae 9 Ab [Ratio] in Serum by Immunoassay --1st specimen/2nd specimen |
| 17645-3 | Streptococcus pneumoniae 9 Ab [Units/volume] in Serum by Immunoassay --1st specimen |
| 17646-1 | Streptococcus pneumoniae 9 Ab [Units/volume] in Serum by Immunoassay --2nd specimen |
| 17647-9 | Streptococcus pneumoniae Ab [Units/volume] in Serum |
| 17648-7 | Streptococcus pneumoniae Ab [Units/volume] in Serum by Immunoassay |
| 17649-5 | Streptococcus pneumoniae IgG Ab [Ratio] in Serum by Immunoassay --1st specimen/2nd specimen |
| 1765-7 | Aldosterone [Mass/time] in 24 hour Urine |
| 17650-3 | Streptococcus pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay --1st specimen |
| 17651-1 | Streptococcus pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay --2nd specimen |
| 17652-9 | Streptococcus pneumoniae Ag [Presence] in Unspecified specimen by Latex agglutination |
| 17653-7 | Deprecated Streptococcus pneumoniae group A Ag |
| 17654-5 | Deprecated Streptococcus pneumoniae group B Ab by Immunoassay |
| 17655-2 | Deprecated Streptococcus pneumoniae group B Ag in urine by immunofluorescence |
| 17656-0 | Streptococcus pyogenes [Presence] in Unspecified specimen by Organism specific culture |
| 17657-8 | Streptolysin O Ab [Units/volume] in Synovial fluid |
| 17658-6 | Strontium/Creatinine [Mass Ratio] in Urine |
| 17659-4 | Strychnine [Units/volume] in Serum or Plasma |
| 1766-5 | Aldosterone receptors [#] in Leukocytes |
| 17660-2 | Strychnine [Units/volume] in Urine |
| 17661-0 | Succinylcholine [Mass/volume] in Serum or Plasma |
| 17662-8 | Succinylpurines [Presence] in Urine |
| 17663-6 | Sulfadiazine IgE Ab [Units/volume] in Serum |
| 17664-4 | Sulfalazine IgE Ab [Units/volume] in Serum |
| 17665-1 | Sulfamedraxozole IgE Ab [Units/volume] in Serum |
| 17666-9 | Sulfate [Mass/volume] in Dialysis fluid |
| 17667-7 | Sulfate.organic/Sulfate.total in Urine |
| 17668-5 | Sulfatide IgG Ab [Units/volume] in Serum by Immunofluorescence |
| 17669-3 | Sulfatide IgG Ab [Units/volume] in Serum by Immunoassay |
| 1767-3 | Aldosterone [Mass/volume] in Serum or Plasma --supine |
| 17670-1 | Sulfatide IgM Ab [Units/volume] in Serum by Immunofluorescence |
| 17671-9 | Sulfatide IgM Ab [Units/volume] in Serum by Immunoassay |
| 17672-7 | Sulfide [Mass/volume] in Urine |
| 17673-5 | Sulfisoxazole IgE Ab [Units/volume] in Serum |
| 17674-3 | Sulfonamide [Units/volume] in Serum or Plasma |
| 17675-0 | Sulfonamide [Units/volume] in Urine |
| 17676-8 | Sulindac sulfide metabolite [Mass/volume] in Serum or Plasma |
| 17677-6 | Deprecated Helianthus annuus Ab.IgE |
| 17678-4 | Taurine [Presence] in Urine |
| 17679-2 | Taurine [Presence] in Cerebral spinal fluid |
| 1768-1 | Aldosterone [Mass/volume] in Serum or Plasma --upright |
| 17681-8 | Tellurium [Presence] in Urine |
| 17682-6 | Terpineol [Presence] in Blood |
| 17683-4 | 2-Methyl-2-Propanol [Mass/volume] in Blood |
| 17685-9 | Testosterone Free [Mass/volume] in Dialysis fluid |
| 17686-7 | Testosterone.weakly bound [Mass/volume] in Serum or Plasma |
| 17687-5 | Testosterone/Epitestosterone [Mass Ratio] in Serum or Plasma |
| 17688-3 | Testosterone [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge |
| 17689-1 | Testosterone [Mass/volume] in Serum or Plasma --15 minutes post XXX challenge |
| 1769-9 | Fatty acids.nonesterified [Mass/volume] in Serum or Plasma |
| 17690-9 | Testosterone [Mass/volume] in Serum or Plasma --2 hours post XXX challenge |
| 17691-7 | Testosterone [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge |
| 17692-5 | Testosterone [Mass/volume] in Serum or Plasma --45 minutes post XXX challenge |
| 17693-3 | Testosterone [Mass/volume] in Serum or Plasma --4 days post XXX challenge |
| 17694-1 | Deprecated Coproporphyrin [Mass/time] in 24 hour Stool |
| 17695-8 | Tetrachlorodiphenylethane [Mass/volume] in Blood |
| 17696-6 | Tetrachlorodiphenylethane [Mass/volume] in Urine |
| 17697-4 | Tetrachloroethane [Mass/volume] in Blood |
| 17698-2 | Tetraethyl lead [Mass/volume] in Blood |
| 17699-0 | Thebaine [Mass/volume] in Serum or Plasma |
| 177-6 | Chlortetracycline [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 1770-7 | Aliphatic carboxylate, C14-C26.absorption [Mass/volume] in Serum or Plasma |
| 17700-6 | Theophylline [Mass/volume] in Urine |
| 17701-4 | Thiazides [Mass/volume] in Urine |
| 17703-0 | Thorium [Mass/volume] in Urine |
| 17704-8 | Threonine [Presence] in Urine |
| 17705-5 | Thyroglobulin IgM Ab [Units/volume] in Serum |
| 17706-3 | Thyroperoxidase Ab [Titer] in Cerebral spinal fluid by Latex agglutination |
| 17707-1 | Thyroperoxidase IgM Ab [Units/volume] in Serum or Plasma |
| 17708-9 | Thyroid stimulating immunoglobulins [Presence] in Serum |
| 17709-7 | Ticlopidine [Presence] in Urine |
| 1771-5 | Aliphatic carboxylate, C14-C26.esters [Mass/volume] in Serum or Plasma |
| 17710-5 | Tin/Creatinine [Mass Ratio] in Urine |
| 17712-1 | Toluene diisocyanate [Mass/volume] in Blood |
| 17713-9 | Topiramate [Mass/volume] in Serum or Plasma |
| 17714-7 | Toxaphene [Mass/volume] in Serum or Plasma |
| 17715-4 | Toxocara canis Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 17716-2 | Toxoplasma gondii IgE Ab [Units/volume] in Serum |
| 17717-0 | Toxoplasma gondii IgG+IgM Ab [Presence] in Serum |
| 17718-8 | Tramadol [Presence] in Urine by Confirmatory method |
| 17719-6 | Tramadol [Mass/volume] in Urine |
| 1772-3 | Aliphatic carboxylate, C14-C26.esters [Mass/volume] in Stool |
| 17720-4 | Trans nonachlor [Mass/volume] in Urine |
| 17721-2 | Trans nonachlor [Mass/volume] in Blood |
| 17723-8 | Treponema pallidum Ab [Presence] in Serum by Immobilization |
| 17724-6 | Treponema pallidum Ab [Units/volume] in Serum by Immunofluorescence |
| 17725-3 | Treponema pallidum Ab [Units/volume] in Serum by Latex agglutination |
| 17726-1 | Treponema pallidum IgG Ab [Presence] in Serum by Immunofluorescence |
| 17727-9 | Treponema pallidum IgG Ab [Units/volume] in Serum by Immunofluorescence |
| 17728-7 | Treponema pallidum IgM Ab [Units/volume] in Serum by Immunofluorescence |
| 17729-5 | Treponema pallidum IgM Ab [Presence] in Serum by Immunofluorescence |
| 1773-1 | Fatty acids.very long chain C24:0 (Tetracosanoate)/C22:0 (Docosanoate) [Mass Ratio] in Serum or Plasma |
| 17730-3 | Triamterene [Units/volume] in Urine |
| 17732-9 | Trichinella spiralis Ab [Presence] in Serum by Latex agglutination |
| 17733-7 | Trichinella spiralis IgA Ab [Presence] in Serum |
| 17734-5 | Trichinella spiralis IgG Ab [Units/volume] in Serum |
| 17735-2 | Trichinella spiralis IgM Ab [Presence] in Serum |
| 17736-0 | Trichloroacetate [Mass/volume] in Blood |
| 17737-8 | Trichloroethane [Mass/volume] in Urine |
| 17738-6 | Chloral hydrate [Presence] in Urine |
| 17739-4 | Chloral hydrate [Presence] in Urine by Confirmatory method |
| 1774-9 | Fatty acids.very long chain C26:0 (Hexacosanoate)/C22:0 (Docosanoate) [Mass Ratio] in Serum or Plasma |
| 17740-2 | Trichlorophenoxyacetate [Presence] in Blood |
| 17741-0 | Trichlorophenoxyacetate [Mass/volume] in Serum or Plasma |
| 17742-8 | Trichlorothiazide [Presence] in Urine |
| 17743-6 | Triiodothyronine resin uptake (T3RU) in Serum or Plasma --1 hour post XXX challenge |
| 17744-4 | Trimellitic anhydride (TMA) IgG Ab [Units/volume] in Serum |
| 17745-1 | Trimellitic anhydride (TMA) IgM Ab [Units/volume] in Serum |
| 17746-9 | Trimeprazine [Presence] in Serum or Plasma |
| 17747-7 | Trimethoprim [Mass/volume] in Urine |
| 17748-5 | Trimethylamine [Presence] in Urine |
| 17749-3 | Tromethamine [Mass/volume] in Serum or Plasma |
| 1775-6 | Alkaline phosphatase [Mass/volume] in Body fluid |
| 17750-1 | Trypsinogen [Enzymatic activity/volume] in Serum or Plasma |
| 17751-9 | Tryptamine [Mass/volume] in Serum or Plasma |
| 17752-7 | Tryptophan [Presence] in Urine |
| 17753-5 | Tungsten [Mass/volume] in Serum or Plasma |
| 17754-3 | Tyrosine [Presence] in Blood |
| 17755-0 | Urate [Mass/time] in 2 hour Urine |
| 17756-8 | Urate [Mass/time] in 4 hour Urine |
| 17757-6 | Urea nitrogen [Mass/volume] in Peritoneal dialysis fluid |
| 17758-4 | Urea nitrogen [Mass/volume] in Vitreous fluid |
| 17759-2 | Urea nitrogen [Mass/volume] in Arterial blood --post dialysis |
| 1776-4 | Alkaline phosphatase [Mass/volume] in Urine |
| 17760-0 | Urea nitrogen [Mass/volume] in Venous blood --pre dialysis |
| 17761-8 | Urobilinogen [Mass/time] in 48 hour Stool |
| 17762-6 | Valproate [Mass/volume] in Urine |
| 17763-4 | Varicella zoster virus IgG Ab [Units/volume] in Serum by Immunofluorescence |
| 17764-2 | Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid |
| 17765-9 | Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence |
| 17766-7 | Varicella zoster virus IgM Ab [Units/volume] in Serum by Immunofluorescence |
| 17767-5 | Verapamil [Mass/volume] in Urine |
| 17768-3 | Vinyl chloride [Mass/volume] in Blood |
| 17769-1 | Western equine encephalitis virus Ab [Titer] in Cerebral spinal fluid |
| 1777-2 | Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma |
| 17770-9 | Western equine encephalitis virus Ab [Titer] in Serum |
| 17771-7 | Whitefish roe IgE Ab [Units/volume] in Serum |
| 17772-5 | Dimethylbenzene [Mass/volume] in Urine |
| 17773-3 | Yeast [Presence] in Stool by Light microscopy |
| 17774-1 | Yellow dye IgE Ab [Units/volume] in Serum |
| 17775-8 | Yersinia sp IgA Ab [Units/volume] in Serum |
| 17776-6 | Yersinia sp IgG Ab [Units/volume] in Serum |
| 17777-4 | Yersinia sp IgM Ab [Units/volume] in Serum |
| 17778-2 | Zinc [Mass/volume] in Leukocytes |
| 1778-0 | Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma |
| 17780-8 | Helicobacter pylori Ag [Presence] in Stool by Immunoassay |
| 17781-6 | 21-Hydroxylase Ab [Units/volume] in Serum |
| 17782-4 | Lipoprotein.beta.subparticle [Entitic length] in Serum or Plasma |
| 17783-2 | Hemosiderin [Presence] in Urine by Light microscopy |
| 17784-0 | Parasites in Blood by Light microscopy |
| 17785-7 | Radioactive iodine.thyroid/Radioactive iodine dose [Ratio] |
| 17786-5 | Thyrotropin [Interpretation] in Unspecified specimen--post dose TRH |
| 17787-3 | Thyroid gland NM Study report |
| 17788-1 | Large unstained cells/100 leukocytes in Blood by Automated count |
| 17789-9 | Large unstained cells [#/volume] in Blood by Automated count |
| 1779-8 | Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma |
| 17790-7 | Leukocytes Left Shift [Presence] in Blood by Automated count |
| 17791-5 | Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum |
| 17792-3 | Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum |
| 17793-1 | Immunoglobulin light chains [Mass/volume] in 24 hour Urine |
| 17794-9 | Osmolality of Hyperal solution |
| 17795-6 | Potassium [Moles/volume] in Hyperal solution |
| 17796-4 | Sodium [Moles/volume] in Hyperal solution |
| 17797-2 | Thyroid colloidal Ab [Units/volume] in Serum |
| 17798-0 | Amikacin [Mass/volume] in Cerebral spinal fluid |
| 17799-8 | Promyelocytes/100 leukocytes in Body fluid |
| 178-4 | Chlortetracycline [Susceptibility] by Disk diffusion (KB) |
| 1780-6 | Alkaline phosphatase.placental [Enzymatic activity/volume] in Serum or Plasma |
| 17800-4 | Myelocytes/100 leukocytes in Body fluid |
| 17801-2 | Metamyelocytes/100 leukocytes in Body fluid |
| 17802-0 | Prolymphocytes/100 leukocytes in Body fluid |
| 17803-8 | Plasma cells/100 leukocytes in Body fluid |
| 17804-6 | Promonocytes/100 leukocytes in Body fluid |
| 17805-3 | Procainamide [Mass/volume] in Body fluid |
| 17806-1 | N-acetylprocainamide [Mass/volume] in Body fluid |
| 17807-9 | Cyclosporine [Mass/volume] in Body fluid |
| 17808-7 | Tobramycin [Mass/volume] in Urine |
| 17809-5 | Hematocrit [Volume Fraction] of Urine |
| 1781-4 | Alkaline phosphatase.regan [Enzymatic activity/volume] in Serum or Plasma |
| 17810-3 | Prealbumin/Protein.total in Body fluid by Electrophoresis |
| 17811-1 | Alpha 1 globulin/Protein.total by Electrophoresis in Urine collected for unspecified duration |
| 17812-9 | Alpha 1 globulin/Protein.total in Body fluid by Electrophoresis |
| 17813-7 | Alpha 2 globulin/Protein.total by Electrophoresis in Urine collected for unspecified duration |
| 17814-5 | Alpha 2 globulin/Protein.total in Body fluid by Electrophoresis |
| 17815-2 | Beta globulin/Protein.total by Electrophoresis in Urine collected for unspecified duration |
| 17816-0 | Beta globulin/Protein.total in Body fluid by Electrophoresis |
| 17817-8 | Gamma globulin/Protein.total by Electrophoresis in Urine collected for unspecified duration |
| 17818-6 | Gamma globulin/Protein.total in Body fluid by Electrophoresis |
| 17819-4 | Albumin/Protein.total by Electrophoresis in Urine collected for unspecified duration |
| 1782-2 | Alkaline phosphatase.renal [Enzymatic activity/volume] in Serum or Plasma |
| 17820-2 | Albumin/Protein.total in Body fluid by Electrophoresis |
| 17821-0 | Oligoclonal bands [Interpretation] in Body fluid by Electrophoresis Narrative |
| 17822-8 | CD3+CD4+ (T4 helper) cells/100 cells in Body fluid |
| 17823-6 | CD45 (Lymphs) cells/100 cells in Body fluid |
| 17824-4 | CD3+CD8+ (T8 suppressor cells) cells/100 cells in Body fluid |
| 17825-1 | CD41a cells/100 cells in Blood |
| 17826-9 | CD3 cells/100 cells in Body fluid |
| 17827-7 | CD2 cells/100 cells in Body fluid |
| 17828-5 | CD16 cells/100 cells in Body fluid |
| 17829-3 | CD19 cells/100 cells in Body fluid |
| 1783-0 | Alkaline phosphatase [Enzymatic activity/volume] in Blood |
| 17830-1 | Centromere Ab [Units/volume] in Body fluid |
| 17831-9 | Deprecated 5-Fluorocytosine [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 17832-7 | Deprecated 5-Fluorocytosine [Susceptibility] by Minimum lethal concentration (MLC) |
| 17833-5 | Basophils/100 leukocytes in Synovial fluid |
| 17834-3 | Eosinophils/100 leukocytes in Synovial fluid |
| 17835-0 | Monocytes/100 leukocytes in Synovial fluid |
| 17836-8 | Neutrophils/100 leukocytes in Synovial fluid |
| 17837-6 | Acid phosphatase tartrate resistant [Enzymatic activity/volume] in Serum |
| 17838-4 | Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma |
| 17839-2 | Alpha fucosidase [Enzymatic activity/volume] in Blood |
| 1784-8 | Alpha amino acid nitrogen [Mass/volume] in Plasma |
| 17840-0 | Alpha-L-iduronidase [Enzymatic activity/volume] in Blood |
| 17841-8 | Amylase [Enzymatic activity/time] in 12 hour Urine |
| 17842-6 | Cancer Ag 27-29 [Units/volume] in Serum or Plasma |
| 17843-4 | Cancer Ag 72-4 [Units/volume] in Serum or Plasma |
| 17844-2 | Estradiol (E2).albumin bound [Mass/volume] in Serum or Plasma |
| 17845-9 | Lipoprotein.alpha [Presence] in Serum or Plasma |
| 17846-7 | Lipoprotein.beta [Presence] in Serum or Plasma |
| 17847-5 | Lipoprotein.pre-beta [Presence] in Serum or Plasma |
| 17848-3 | Reticulocytes/1000 erythrocytes in Blood by Manual |
| 17849-1 | Reticulocytes/100 erythrocytes in Blood by Automated count |
| 1785-5 | Alpha amino acid nitrogen [Mass/time] in 24 hour Urine |
| 17850-9 | Herpes simplex virus 1 IgG Ab [Presence] in Serum |
| 17851-7 | Herpes simplex virus 2 IgG Ab [Presence] in Serum |
| 17852-5 | Ureaplasma urealyticum [Presence] in Unspecified specimen by Organism specific culture |
| 17853-3 | Ganglioside GM1b IgG Ab [Titer] in Serum |
| 17854-1 | Ganglioside GM1b IgM Ab [Titer] in Serum |
| 17855-8 | Hemoglobin A1c/Hemoglobin.total in Blood by calculation |
| 17856-6 | Hemoglobin A1c/Hemoglobin.total in Blood by HPLC |
| 17857-4 | Rheumatoid factor [Titer] in Serum |
| 17858-2 | Gamma glutamyl transferase [Enzymatic activity/volume] in Body fluid |
| 17859-0 | Helicobacter pylori IgG Ab [Presence] in Serum or Plasma by Immunoassay |
| 1786-3 | Alpha aminobutyrate [Mass/volume] in Cerebral spinal fluid |
| 17860-8 | 3-Methylhistidine [Mass/volume] in 24 hour Urine |
| 17861-6 | Calcium [Mass/volume] in Serum or Plasma |
| 17862-4 | Calcium [Mass/volume] in Urine |
| 17863-2 | Calcium.ionized [Mass/volume] in Serum or Plasma |
| 17864-0 | Calcium.ionized [Mass/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE) |
| 17865-7 | Glucose [Mass/volume] in Serum or Plasma --8 hours fasting |
| 17866-5 | Carnitine/Creatinine [Ratio] in Urine |
| 17867-3 | Carnitine free (C0)/Creatinine [Ratio] in Urine |
| 17868-1 | Acylcarnitine/Creatinine [Ratio] in Urine |
| 17869-9 | Orotate/Creatinine [Molar ratio] in Urine |
| 1787-1 | Alpha aminobutyrate [Presence] in Serum or Plasma |
| 17870-7 | Orotidine/Creatinine [Molar ratio] in Urine |
| 17871-5 | Hemoglobin H [Presence] in Blood by Heat denaturation |
| 17872-3 | Tetrahydrocannabinol [Presence] in Urine by Confirm method >25 ng/mL |
| 17873-1 | Bacteria # 2 identified in Bone by Aerobe culture |
| 17874-9 | Bacteria # 3 identified in Bone by Aerobe culture |
| 17875-6 | Bacteria # 4 identified in Bone by Aerobe culture |
| 17876-4 | Bacteria # 5 identified in Bone by Aerobe culture |
| 17877-2 | Bacteria # 6 identified in Bone by Aerobe culture |
| 17878-0 | Bacteria # 2 identified in Bronchial specimen by Aerobe culture |
| 17879-8 | Bacteria # 3 identified in Bronchial specimen by Aerobe culture |
| 1788-9 | Alpha aminobutyrate [Mass/volume] in Serum or Plasma |
| 17880-6 | Bacteria # 4 identified in Bronchial specimen by Aerobe culture |
| 17881-4 | Bacteria # 5 identified in Bronchial specimen by Aerobe culture |
| 17882-2 | Bacteria # 6 identified in Bronchial specimen by Aerobe culture |
| 17883-0 | Bacteria # 2 identified in Genital specimen by Aerobe culture |
| 17884-8 | Bacteria # 3 identified in Genital specimen by Aerobe culture |
| 17885-5 | Bacteria # 4 identified in Genital specimen by Aerobe culture |
| 17886-3 | Bacteria # 5 identified in Genital specimen by Aerobe culture |
| 17887-1 | Bacteria # 6 identified in Genital specimen by Aerobe culture |
| 17888-9 | Bacteria # 2 identified in Nose by Aerobe culture |
| 17889-7 | Bacteria # 3 identified in Nose by Aerobe culture |
| 1789-7 | Deprecated Alpha aminobutyrate [Mass/volume] in Serum |
| 17890-5 | Bacteria # 4 identified in Nose by Aerobe culture |
| 17891-3 | Bacteria # 5 identified in Nose by Aerobe culture |
| 17892-1 | Bacteria # 6 identified in Nose by Aerobe culture |
| 17893-9 | Bacteria # 2 identified in Sputum by Aerobe culture |
| 17894-7 | Bacteria # 3 identified in Sputum by Aerobe culture |
| 17895-4 | Bacteria # 4 identified in Sputum by Aerobe culture |
| 17896-2 | Bacteria # 5 identified in Sputum by Aerobe culture |
| 17897-0 | Bacteria # 6 identified in Sputum by Aerobe culture |
| 17898-8 | Bacteria identified in Throat by Aerobe culture |
| 17899-6 | Bacteria # 2 identified in Throat by Aerobe culture |
| 179-2 | Chlortetracycline [Susceptibility] by Serum bactericidal titer |
| 1790-5 | Alpha aminobutyrate [Mass/volume] in Urine |
| 17900-2 | Bacteria # 3 identified in Throat by Aerobe culture |
| 17901-0 | Bacteria # 4 identified in Throat by Aerobe culture |
| 17902-8 | Bacteria # 5 identified in Throat by Aerobe culture |
| 17903-6 | Bacteria # 6 identified in Throat by Aerobe culture |
| 17904-4 | Bacteria # 2 identified in Tissue by Aerobe culture |
| 17905-1 | Bacteria # 3 identified in Tissue by Aerobe culture |
| 17906-9 | Bacteria # 4 identified in Tissue by Aerobe culture |
| 17907-7 | Bacteria # 5 identified in Tissue by Aerobe culture |
| 17908-5 | Bacteria # 6 identified in Tissue by Aerobe culture |
| 17909-3 | Bacteria identified in Wound deep by Aerobe culture |
| 1791-3 | Alpha aminoadipate [Presence] in Plasma |
| 17910-1 | Bacteria # 2 identified in Wound deep by Aerobe culture |
| 17911-9 | Bacteria # 3 identified in Wound deep by Aerobe culture |
| 17912-7 | Bacteria # 4 identified in Wound deep by Aerobe culture |
| 17913-5 | Bacteria # 5 identified in Wound deep by Aerobe culture |
| 17914-3 | Bacteria # 6 identified in Wound deep by Aerobe culture |
| 17915-0 | Bacteria identified in Wound shallow by Aerobe culture |
| 17916-8 | Bacteria # 2 identified in Wound shallow by Aerobe culture |
| 17917-6 | Bacteria # 3 identified in Wound shallow by Aerobe culture |
| 17918-4 | Bacteria # 4 identified in Wound shallow by Aerobe culture |
| 17919-2 | Bacteria # 5 identified in Wound shallow by Aerobe culture |
| 1792-1 | Alpha aminoadipate [Mass/volume] in Plasma |
| 17920-0 | Bacteria # 6 identified in Wound shallow by Aerobe culture |
| 17921-8 | Bacteria # 2 identified in Nose by Anaerobe culture |
| 17922-6 | Bacteria # 3 identified in Nose by Anaerobe culture |
| 17923-4 | Bacteria # 2 identified in Tissue by Anaerobe culture |
| 17924-2 | Bacteria # 3 identified in Tissue by Anaerobe culture |
| 17925-9 | Bacteria identified in Wound deep by Anaerobe culture |
| 17926-7 | Bacteria # 2 identified in Wound deep by Anaerobe culture |
| 17927-5 | Bacteria # 3 identified in Wound deep by Anaerobe culture |
| 17928-3 | Bacteria identified in Blood by Aerobe culture |
| 17929-1 | Bacteria # 2 identified in Blood by Aerobe culture |
| 1793-9 | Alpha aminoadipate [Mass/volume] in Urine |
| 17930-9 | Bacteria # 3 identified in Blood by Aerobe culture |
| 17931-7 | Bacteria # 4 identified in Blood by Aerobe culture |
| 17932-5 | Bacteria # 5 identified in Blood by Aerobe culture |
| 17933-3 | Bacteria # 6 identified in Blood by Aerobe culture |
| 17934-1 | Bacteria identified in Blood by Anaerobe culture |
| 17935-8 | Bacteria # 2 identified in Blood by Anaerobe culture |
| 17936-6 | Bacteria # 3 identified in Blood by Anaerobe culture |
| 17937-4 | Bacteria # 2 identified in Burn by Culture |
| 17938-2 | Bacteria # 3 identified in Burn by Culture |
| 17939-0 | Bacteria # 4 identified in Burn by Culture |
| 1794-7 | Amylase [Enzymatic activity/volume] in Duodenal fluid |
| 17940-8 | Bacteria # 5 identified in Burn by Culture |
| 17941-6 | Bacteria # 6 identified in Burn by Culture |
| 17942-4 | Bacteria # 2 identified in Line specimen by IV Line culture |
| 17943-2 | Bacteria # 3 identified in Line specimen by IV Line culture |
| 17944-0 | Bacteria # 4 identified in Line specimen by IV Line culture |
| 17945-7 | Bacteria # 5 identified in Line specimen by IV Line culture |
| 17946-5 | Bacteria # 6 identified in Line specimen by IV Line culture |
| 17947-3 | Fungus # 2 identified in Unspecified specimen by Culture |
| 17948-1 | Fungus # 3 identified in Unspecified specimen by Culture |
| 17949-9 | Fungus # 4 identified in Unspecified specimen by Culture |
| 1795-4 | Amylase [Enzymatic activity/volume] in Body fluid |
| 17950-7 | Deprecated Bacteria identified in Body fluid by Aerobe culture |
| 17951-5 | Bacteria # 2 identified in Body fluid by Aerobe culture |
| 17952-3 | Bacteria # 3 identified in Body fluid by Aerobe culture |
| 17953-1 | Bacteria # 4 identified in Body fluid by Aerobe culture |
| 17954-9 | Bacteria # 5 identified in Body fluid by Aerobe culture |
| 17955-6 | Bacteria # 6 identified in Body fluid by Aerobe culture |
| 17956-4 | Bacteria identified in Body fluid by Anaerobe culture |
| 17957-2 | Bacteria # 2 identified in Body fluid by Anaerobe culture |
| 17958-0 | Bacteria # 3 identified in Body fluid by Anaerobe culture |
| 17959-8 | Bacteria # 2 identified in Peritoneal fluid by Culture |
| 1796-2 | Amylase [Enzymatic activity/volume] in Pleural fluid |
| 17960-6 | Bacteria # 3 identified in Peritoneal fluid by Culture |
| 17961-4 | Bacteria # 4 identified in Peritoneal fluid by Culture |
| 17962-2 | Bacteria # 5 identified in Peritoneal fluid by Culture |
| 17963-0 | Bacteria # 6 identified in Peritoneal fluid by Culture |
| 17964-8 | Bacteria # 2 identified in Stool by Culture |
| 17965-5 | Bacteria # 3 identified in Stool by Culture |
| 17966-3 | Bacteria # 4 identified in Stool by Culture |
| 17967-1 | Bacteria # 5 identified in Stool by Culture |
| 17968-9 | Bacteria # 6 identified in Stool by Culture |
| 17969-7 | Deprecated Bacteria identified in Urine by Aerobe culture |
| 1797-0 | Amylase [Enzymatic activity/volume] in Peritoneal fluid |
| 17970-5 | Bacteria # 2 identified in Urine by Culture |
| 17971-3 | Bacteria # 3 identified in Urine by Culture |
| 17972-1 | Bacteria # 4 identified in Urine by Culture |
| 17973-9 | Bacteria # 5 identified in Urine by Culture |
| 17974-7 | Bacteria # 6 identified in Urine by Culture |
| 17975-4 | Virus # 2 identified in Unspecified specimen by Culture |
| 17976-2 | Virus # 3 identified in Unspecified specimen by Culture |
| 17977-0 | Left atrial Apical 4 chamber [Area] by US 2D |
| 17978-8 | Mitral valve Peak A wave by US.doppler |
| 17979-6 | Anterior mitral valve leaflet A-C interval by US.M-mode |
| 1798-8 | Amylase [Enzymatic activity/volume] in Serum or Plasma |
| 17980-4 | Anterior mitral valve leaflet A-C slope [Velocity] by US.M-mode |
| 17981-2 | Aortic valve Acceleration by US.doppler |
| 17982-0 | Pulmonic valve Acceleration by US.doppler |
| 17983-8 | Tricuspid valve Acceleration by US.doppler |
| 17984-6 | Aortic valve area method |
| 17985-3 | Left atrial AP dimension.left atrium/AP dimension.aorta root by US |
| 17986-1 | Left ventricular Maximum Apical 2 chamber.diastole [Volume] by US 2D modified |
| 17987-9 | Left ventricular Apical 2 chamber.systole.minimum [Volume] by US 2D modified |
| 17988-7 | Right atrial Apical 4 chamber [Area] by US 2D |
| 17989-5 | Left ventricular Maximum Apical 4 chamber.diastole [Volume] by US 2D modified |
| 1799-6 | Amylase [Enzymatic activity/volume] in Urine |
| 17990-3 | Left ventricular Apical 4 chamber.systole.minimum [Volume] by US 2D modified |
| 17991-1 | Left ventricular Cardiac echo volume method |
| 17992-9 | Aorta root Cardiac output by US.doppler |
| 17993-7 | Mitral valve Cardiac output by US.doppler |
| 17994-5 | Pulmonary artery Cardiac output by US |
| 17995-2 | Aorta Maximum coarctation gradient [Pressure] by US.doppler |
| 17996-0 | Aortic valve Maximum cusp separation [Length] by US |
| 17997-8 | Anterior mitral valve leaflet D-E excursion [Length] by US.M-mode |
| 17998-6 | Aortic valve regurgitant jet Deceleration [Time] by US.doppler |
| 17999-4 | Mitral valve Deceleration [Time] by US.doppler |
| 18-2 | Amoxicillin [Susceptibility] by Serum bactericidal titer |
| 180-0 | Cinoxacin [Susceptibility] by Minimum lethal concentration (MLC) |
| 1800-2 | Amylase [Enzymatic activity/time] in 24 hour Urine |
| 18000-0 | Tricuspid valve Deceleration [Time] by US.doppler |
| 18001-8 | Mitral valve Deceleration.pressure.half time by US.doppler |
| 18002-6 | Mitral valve Deceleration slope [Acceleration] by US.doppler |
| 18003-4 | Aortic valve regurgitant jet Deceleration time slope by US.doppler |
| 18004-2 | Atrial septum Defect diameter by US |
| 18005-9 | Ventricular septal Defect diameter by US |
| 18006-7 | Inferior vena cava Diameter by US |
| 18007-5 | Superior vena cava Diameter by US |
| 18008-3 | Ventricular septal Defect.gradient.systole.maximum [Pressure] by US.doppler |
| 18009-1 | Ventricular septal Defect.gradient.systole.mean [Pressure] by US.doppler |
| 1801-0 | Amylase renal clearance in 24 hour |
| 18010-9 | Aorta Diameter by US |
| 18011-7 | Aorta arch and Neck Diameter by US |
| 18012-5 | Ascending thoracic aorta Diameter by US |
| 18013-3 | Descending thoracic aorta Diameter by US |
| 18014-1 | Aorta isthmus Diameter by US |
| 18015-8 | Aorta root annulo-aortic junction Diameter by US |
| 18016-6 | Aortic valve annulus Diameter by US |
| 18017-4 | Mitral valve annulus Diameter by US |
| 18018-2 | Left ventricular outflow tract Diameter by US |
| 18019-0 | Left pulmonary artery Diameter by US |
| 1802-8 | Amylase.P1 [Enzymatic activity/volume] in Serum or Plasma |
| 18020-8 | Main pulmonary artery Diameter by US |
| 18021-6 | Right pulmonary artery Diameter by US |
| 18022-4 | Pulmonic valve annulus Diameter by US |
| 18023-2 | Tricuspid valve annulus Diameter by US |
| 18024-0 | Left atrial Diameter anterior-posterior systole by US.M-mode |
| 18025-7 | Heart Diameter anterior-posterior systole/Aortic root diameter by US |
| 18026-5 | Left ventricular End-diastolic volume by US |
| 18027-3 | Left ventricular End-diastolic volume by US.2D+Calculated by single-plane ellipse method |
| 18028-1 | Left ventricular End-diastolic volume by US.2D+Calculated by biplane ellipse method |
| 18029-9 | Left ventricular End-diastolic volume by US 2D modified |
| 1803-6 | Amylase.P2 [Enzymatic activity/volume] in Serum or Plasma |
| 18030-7 | Tricuspid valve Peak A wave by US.doppler |
| 18031-5 | Tricuspid valve Peak E wave by US.doppler |
| 18032-3 | Tricuspid valve Pressure half time during diastole by US.doppler |
| 18033-1 | Left ventricular Diastole-systole [Volume] by US |
| 18034-9 | Tricuspid valve regurgitant jet dP/dT (1 M/S to 3 M/S).systole [Pressure rate] by US.doppler |
| 18035-6 | Mitral valve regurgitant jet dP/dT (1M/S to 3 M/S) [Pressure rate] by US.doppler continuous wave |
| 18036-4 | Anterior mitral valve leaflet E point to septal separation [Time] by US.M-mode |
| 18037-2 | Mitral valve Peak E wave by US.doppler |
| 18038-0 | Mitral valve Peak E wave/Peak A wave by US.doppler |
| 18039-8 | Tricuspid valve Peak E wave/Peak A wave by US.doppler |
| 1804-4 | Amylase.P3 [Enzymatic activity/volume] in Serum or Plasma |
| 18040-6 | Anterior mitral valve leaflet E-F slope [Velocity] by US.M-mode |
| 18041-4 | Aortic valve Ejection time by US.doppler |
| 18042-2 | Pulmonic valve Ejection time by US.doppler |
| 18043-0 | Left ventricular Ejection fraction by US |
| 18044-8 | Left ventricular Ejection fraction by US.2D+Calculated by single-plane ellipse method |
| 18045-5 | Left ventricular Ejection fraction by US.2D+Calculated by biplane ellipse method |
| 18046-3 | Left ventricular Ejection fraction by US 2D modified |
| 18047-1 | Left ventricular Ejection fraction by US 2D modified biplane |
| 18048-9 | Left ventricular Ejection fraction by US 2D modified single-plane |
| 18049-7 | Left ventricular Ejection fraction by US.M-mode+Calculated by Teichholz method |
| 1805-1 | Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma |
| 18050-5 | Inferior vena cava Fractional collapse by US --inspiration |
| 18051-3 | Left ventricular Fractional shortening minor axis by US |
| 18052-1 | Right ventricular anterior wall Fractional thickening freewall by US |
| 18053-9 | Left ventricular posterior wall Thickening.fractional change by US |
| 18054-7 | Interventricular septum Fractional thickness; fractional change by US 2D |
| 18055-4 | Tricuspid valve Maximum gradient during diastole [Pressure] by US.doppler |
| 18056-2 | Tricuspid valve Mean gradient during diastole [Pressure] by US.doppler |
| 18057-0 | Mitral valve Peak gradient [Pressure] by US.doppler |
| 18058-8 | Pulmonic valve Peak gradient [Pressure] by US.doppler |
| 18059-6 | Mitral valve Mean gradient [Pressure] by US.doppler |
| 1806-9 | Amylase S1 [Enzymatic activity/volume] in Serum or Plasma |
| 18060-4 | Pulmonic valve Mean gradient [Pressure] by US.doppler |
| 18061-2 | Aortic valve Maximum gradient during systole [Pressure] by US.doppler derived full Bernoulli |
| 18062-0 | Aortic valve Maximum gradient during systole [Pressure] by US.doppler+Calculated by simplified Bernoulli |
| 18063-8 | Aortic valve Mean systole gradient [Pressure] by US.doppler+Calculated by simplified Bernoulli |
| 18064-6 | Left ventricular outflow tract Maximum gradient during systole [Pressure] by US.doppler |
| 18065-3 | Tricuspid valve regurgitant jet Maximum gradient during systole [Pressure] by US.doppler |
| 18066-1 | Aortic valve Mean systole gradient [Pressure] by US.doppler derived full Bernoulli |
| 18067-9 | Cardiac echo imaging device Image quality by US |
| 18068-7 | Left ventricular Pre ejection time by US |
| 18069-5 | Right atrial Intrachamber mean systole pressure by Estimated from jugular venous distention |
| 1807-7 | Amylase S2 [Enzymatic activity/volume] in Serum or Plasma |
| 18070-3 | Right atrial Intrachamber mean systole pressure by US |
| 18071-1 | Left ventricular Isovolumic relaxation time by US.doppler |
| 18072-9 | Left ventricular Major axis apical 2 chamber diastole [Length] by US 2D |
| 18073-7 | Left ventricular Major axis apical 2 chamber systole [Length] by US 2D |
| 18074-5 | Left ventricular Major axis apical 4 chamber diastole [Length] by US 2D |
| 18075-2 | Left ventricular Major axis apical 4 chamber systole [Length] by US 2D |
| 18076-0 | Left ventricular Major axis apical systole [Length] by US 2D |
| 18077-8 | Left ventricular Major axis apical diastole [Length] by US 2D |
| 18078-6 | Right ventricular Major axis diastole maximum [Length] by US 2D |
| 18079-4 | Right ventricular Minimum major axis during systole [Length] by US 2D |
| 1808-5 | Amylase S3 [Enzymatic activity/volume] in Serum or Plasma |
| 18080-2 | Right ventricular outflow tract Peak systolic flow by US.doppler |
| 18081-0 | Left ventricular Minor axis at end diastole.apical 4 chamber [Length] by US 2D |
| 18082-8 | Left ventricular Minor axis at end systole.apical 4 chamber [Length] by US.M-mode |
| 18083-6 | Left ventricular Internal diameter minor axis diastole by US 2D |
| 18084-4 | Right ventricular Minor axis at end diastole [Length] by US 2D |
| 18085-1 | Left ventricular Internal diameter minor axis systole by US 2D |
| 18086-9 | Right ventricular Minor axis at end systole [Length] by US 2D |
| 18087-7 | Left ventricular Myocardial mass by US |
| 18088-5 | Left ventricular Myocardial mass by US.M-mode |
| 18089-3 | Aortic valve Orifice [Area] by US |
| 1809-3 | Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma |
| 18090-1 | Aortic valve Orifice [Area] by US.continuity |
| 18091-9 | Aortic valve Orifice [Area] by US.continuity.VTI+Area |
| 18092-7 | Aortic valve Orifice [Area] by US.continuity.VTI+Diameter |
| 18093-5 | Aortic valve Orifice [Area] by US.continuity.Vmax+Area |
| 18094-3 | Aortic valve Orifice [Area] by US.continuity.Vmax+Diameter |
| 18095-0 | Main pulmonary artery Crossection [Area] by US |
| 18096-8 | Pulmonic valve Orifice [Area] by US.continuity |
| 18097-6 | Mitral valve Minimum orifice [Area] by US.doppler pressure half time |
| 18098-4 | Mitral valve Minimum orifice minor axis [Area] by US 2D |
| 18099-2 | Left ventricular Apical plane 2 chamber diastole [Area] by US 2D |
| 181-8 | Cinoxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 1810-1 | Amylase/Creatinine [Mass Ratio] in Serum or Plasma |
| 18100-8 | Left ventricular Apical plane 2 chamber systole [Area] by US 2D |
| 18101-6 | Left ventricular Apical plane 4 chamber diastole [Area] by US 2D |
| 18102-4 | Left ventricular Apical plane 4 chamber systole [Area] by US 2D |
| 18103-2 | Left ventricular outflow tract Planimetry parasternal short axis [Area] by US 2D |
| 18104-0 | Aortic valve Pressure half time by US.doppler |
| 18105-7 | Aortic valve regurgitant jet Pressure half time by US.doppler |
| 18106-5 | Cardiac Echo Study Procedure |
| 18107-3 | Cardiac echo study Procedure stress method |
| 18108-1 | Aortic valve Prosthetic valve type by US |
| 18109-9 | Mitral valve Prosthetic valve type by US |
| 1811-9 | Amylase/Creatinine renal clearance [Ratio] in 24 hour Urine and Serum or Plasma |
| 18110-7 | Pulmonic valve Prosthetic valve type by US |
| 18111-5 | Tricuspid valve Prosthetic valve type by US |
| 18112-3 | Aortic valve Regurgitation degree by US.doppler |
| 18113-1 | Mitral valve Regurgitation degree by US.doppler |
| 18114-9 | Pulmonic valve Regurgitation degree by US.doppler |
| 18115-6 | Tricuspid valve Regurgitation degree by US.doppler |
| 18116-4 | Left ventricular Segmental wall appearance by US |
| 18117-2 | Left ventricular Segmental wall motion by US score |
| 18118-0 | Left ventricular Segmental wall motion Narrative by US |
| 18119-8 | Left ventricular apical anterior Segmental wall motion by US |
| 1812-7 | Alpha fucosidase [Enzymatic activity/mass] in Tissue |
| 18120-6 | Left ventricular apical septum Segmental wall motion by US |
| 18121-4 | Left ventricular basal anterior Segmental wall motion by US |
| 18122-2 | Left ventricular basal anterior septum Segmental wall motion by US |
| 18123-0 | Left ventricular basal inferior Segmental wall motion by US |
| 18124-8 | Left ventricular basal lateral Segmental wall motion by US |
| 18125-5 | Left ventricular basal posterior Segmental wall motion by US |
| 18126-3 | Left ventricular basal septum Segmental wall motion by US |
| 18127-1 | Left ventricular inferior apical Segmental wall motion by US |
| 18128-9 | Left ventricular lateral apical Segmental wall motion by US |
| 18129-7 | Left ventricular mid anterior Segmental wall motion by US |
| 1813-5 | Alpha galactosidase A [Enzymatic activity/volume] in Serum or Plasma |
| 18130-5 | Left ventricular mid anterior septum Segmental wall motion by US |
| 18131-3 | Left ventricular mid inferior Segmental wall motion by US |
| 18132-1 | Left ventricular mid lateral Segmental wall motion by US |
| 18133-9 | Left ventricular mid posterior Segmental wall motion by US |
| 18134-7 | Left ventricular mid septum Segmental wall motion by US |
| 18135-4 | Left ventricular Minor axis.mitral level.diastole [Area] by US 2D |
| 18136-2 | Left ventricular Minor axis.mitral level.systole [Area] by US 2D |
| 18137-0 | Left ventricular Minor axis.papillary level.diastole [Area] by US 2D |
| 18138-8 | Left ventricular Minor axis.papillary level.systole [Area] by US 2D |
| 18139-6 | Stress study Stage by US |
| 1814-3 | Acid alpha glucosidase [Enzymatic activity/volume] in Semen |
| 18140-4 | Central cardiovascular Study observation by US |
| 18141-2 | Central cardiovascular Study observation Narrative by US |
| 18142-0 | Heart chambers Study observation by US |
| 18143-8 | Heart chambers Study observation Narrative by US |
| 18144-6 | Heart valves Study observation Narrative by US |
| 18145-3 | Heart valves Study observation by US |
| 18146-1 | Central cardiovascular Overall Study observation Narrative by US |
| 18147-9 | Central cardiovascular Overall Study observation by US |
| 18148-7 | Left ventricular End-systolic volume by US |
| 18149-5 | Left ventricular End-systolic volume by US.2D+Calculated by single-plane ellipse method |
| 1815-0 | Acid alpha glucosidase [Enzymatic activity/mass] in Tissue |
| 18150-3 | Left ventricular End-systolic volume by US.2D+Calculated by biplane ellipse method |
| 18151-1 | Left ventricular End-systolic volume by US 2D modified |
| 18152-9 | Left ventricular posterior wall Thickness during diastole by US |
| 18153-7 | Right ventricular anterior wall Thickness during diastole by US |
| 18154-5 | Interventricular septum Thickness during diastole by US |
| 18155-2 | Left ventricular Thickness septal wall/Thickness posterior wall by US |
| 18156-0 | Left ventricular posterior wall Thickness during systole by US |
| 18157-8 | Right ventricular anterior wall Thickness during systole by US |
| 18158-6 | Interventricular septum Thickness during systole by US |
| 18159-4 | Cardiac Echo Study Transducer site |
| 1816-8 | Acid alpha glucosidase [Enzymatic activity/volume] in Leukocytes |
| 18160-2 | Cardiac echo imaging device Class |
| 18161-0 | Tricuspid valve Maximum blood flow by US.doppler |
| 18162-8 | Pulmonic valve Maximum blood flow by US.doppler |
| 18163-6 | Aorta root Peak systolic flow by US.doppler |
| 18164-4 | Left ventricular outflow tract Peak systolic flow by US.doppler |
| 18165-1 | Pulmonic valve regurgitant jet Peak diastole flow by US.doppler |
| 18166-9 | Tricuspid valve regurgitant jet Peak systolic flow by US.doppler |
| 18167-7 | Aorta root Mean systolic flow by US.doppler |
| 18168-5 | Aorta root Blood velocity-time integral by US.doppler |
| 18169-3 | Aortic valve Blood velocity-time integral by US.doppler |
| 1817-6 | Alpha ketoglutarate [Mass/volume] in Serum or Plasma |
| 18170-1 | Left ventricular outflow tract Blood velocity-time integral by US.doppler |
| 18171-9 | Right ventricular outflow tract Blood velocity-time integral by US.doppler |
| 18172-7 | Mitral valve Blood velocity-time integral by US.doppler |
| 18173-5 | Pulmonary artery Blood velocity-time integral by US.doppler |
| 18174-3 | Pulmonic valve Blood velocity-time integral by US.doppler |
| 18175-0 | Tricuspid valve Velocity-time integral during diastole by US.doppler |
| 18176-8 | Cardiac echo imaging device Vendor model number |
| 18177-6 | Cardiac echo imaging device Vendor serial number |
| 18178-4 | Left ventricular Wall motion index by US |
| 18179-2 | Left ventricular Wall segment [Identifier] by US |
| 1818-4 | Alpha mannosidase [Enzymatic activity/volume] in Serum or Plasma |
| 18180-0 | Deprecated Albumin |
| 18182-6 | Osmolality of Serum or Plasma by calculation |
| 18183-4 | Melatonin [Mass/time] in 24 hour Urine |
| 18184-2 | Erythrocyte sedimentation rate by 2H Westergren method |
| 18185-9 | Gestational age |
| 18186-7 | Calcium [Mass/time] in 12 hour Urine |
| 18187-5 | Lorazepam [Presence] in Urine |
| 18188-3 | Acebutolol [Mass/volume] in Unspecified specimen |
| 18189-1 | Acetone [Mass/time] in 24 hour Urine |
| 1819-2 | Alpha mannosidase [Enzymatic activity/mass] in Tissue |
| 18190-9 | Acid phosphatase tartrate resistant [Presence] in Unspecified specimen |
| 18191-7 | Amino acids [Identifier] in 24 hour Urine |
| 18192-5 | Bacteria [Presence] in Nose by Light microscopy |
| 18194-1 | Barium [Mass/time] in 24 hour Urine |
| 18195-8 | Acid beta glucosidase [Presence] in Tissue |
| 18196-6 | Beta-N-acetylhexosaminidase.A [Presence] in Tissue |
| 18197-4 | Blastomyces dermatitidis Ab [Presence] in Cerebral spinal fluid |
| 18198-2 | Blastomyces dermatitidis IgE Ab [Presence] in Serum |
| 18199-0 | Blastomyces dermatitidis IgG Ab [Presence] in Serum |
| 182-6 | Cinoxacin [Susceptibility] by Disk diffusion (KB) |
| 1820-0 | Alpha melanocyte stimulating hormone [Mass/volume] in Serum or Plasma |
| 18200-6 | Blastomyces dermatitidis IgM Ab [Presence] in Serum |
| 18201-4 | Borrelia burgdorferi IgA Ab [Presence] in Serum by Immunoblot (IB) |
| 18202-2 | Borrelia burgdorferi IgA Ab [Presence] in Cerebral spinal fluid by Immunoblot (IB) |
| 18203-0 | Borrelia burgdorferi IgG+IgM Ab [Presence] in Serum by Immunoblot (IB) |
| 18204-8 | Caffeine renal clearance in 24 hour |
| 18205-5 | Carbon disulfide [Presence] in Urine |
| 18206-3 | Catecholamines [Mass/volume] in Plasma --7th specimen post XXX challenge |
| 18208-9 | Cocaine [Mass/volume] in Unspecified specimen |
| 18209-7 | Coenzyme Q10 [Units/volume] in Serum or Plasma |
| 1821-8 | Alpha naphthylesterase [Enzymatic activity/volume] in Serum |
| 18210-5 | Complement C1 esterase inhibitor bound IgG Ab [Mass/volume] in Serum or Plasma |
| 18211-3 | Complement C1 esterase inhibitor bound IgM Ab [Mass/volume] in Serum or Plasma |
| 18212-1 | Complement C1 esterase inhibitor free IgG Ab [Mass/volume] in Serum or Plasma |
| 18213-9 | Complement C1 esterase inhibitor free IgM Ab [Mass/volume] in Serum or Plasma |
| 18214-7 | Delta 5-Pregnanetriol [Mass/volume] in Urine |
| 18215-4 | Delta alanine [Mass/volume] in Urine |
| 18216-2 | Dezocine [Presence] in Urine by Confirmatory method |
| 18217-0 | Epidermis IgA Ab [Presence] in Tissue |
| 18218-8 | Epidermis IgM Ab [Presence] in Tissue |
| 18219-6 | Epinephrine [Mass/volume] in Urine --2nd specimen post XXX challenge |
| 1822-6 | Alpha thymosin [Mass/volume] in Serum |
| 18220-4 | Epinephrine [Mass/volume] in Urine --3rd specimen post XXX challenge |
| 18221-2 | Epinephrine [Mass/volume] in Urine --4th specimen post XXX challenge |
| 18222-0 | Epinephrine [Mass/volume] in Urine --5th specimen post XXX challenge |
| 18223-8 | Epinephrine [Mass/volume] in Urine --6th specimen post XXX challenge |
| 18224-6 | Epinephrine [Mass/volume] in Urine --7th specimen post XXX challenge |
| 18225-3 | Erythrocyte shape [Morphology] in Blood |
| 18226-1 | Erythrocyte size [Morphology] in Blood |
| 18227-9 | Glucose [Mass/time] in 6 hour Urine |
| 18228-7 | Glucose-6-Phosphate dehydrogenase [Presence] in Tissue |
| 18229-5 | Heparan sulfate [Presence] in Serum or Plasma |
| 1823-4 | Alpha tocopherol [Mass/volume] in Serum or Plasma |
| 18230-3 | Histone H2a+H2b Ab [Units/volume] in Serum |
| 18231-1 | Histone H2a+H2b Ab [Presence] in Serum by Immunofluorescence |
| 18232-9 | Hydrocorticosterone [Presence] in Urine |
| 18233-7 | Influenza virus Ab [Units/volume] in Cerebral spinal fluid |
| 18234-5 | Insulin [Presence] in Unknown substance |
| 18235-2 | Ketone solvents [Identifier] in Blood |
| 18236-0 | Lead [Presence] in Tissue |
| 18237-8 | Legionella pneumophila atypical IgM Ab [Presence] in Serum |
| 18238-6 | Lithium [Mass/mass] in Tissue |
| 18239-4 | Lupus erythematosus factor [Mass/volume] in Blood by Latex agglutination |
| 1824-2 | Alpha-1-Antichymotrypsin [Mass/volume] in Serum |
| 18240-2 | 1,3-Dichlorobenzene [Mass/volume] in Blood |
| 18241-0 | Cefoxitin IgE Ab [Units/volume] in Serum |
| 18242-8 | Methyprylon [Mass/time] in 24 hour Urine |
| 18243-6 | Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid |
| 18244-4 | Niacin [Mass/volume] in Serum or Plasma |
| 18245-1 | Nickel [Mass/volume] in Unspecified specimen |
| 18246-9 | Nitrogen [Mass/volume] in Stool |
| 18247-7 | Nitrogen [Mass/volume] in Dialysis fluid |
| 18248-5 | Nordiazepam [Mass/volume] in Stool |
| 18249-3 | Para aminobenzoate [Mass/volume] in Serum or Plasma |
| 1825-9 | Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma |
| 18250-1 | Pentacarboxylporphyrins [Mass/volume] in Blood |
| 18251-9 | Polychlorinated biphenyl (PCB) [Presence] in Tissue |
| 18252-7 | Prednisone [Mass/time] in 24 hour Urine |
| 18253-5 | Serotonin [Mass/time] in 24 hour Urine |
| 18254-3 | Silicate [Mass/volume] in Body fluid |
| 18255-0 | Sulfonylurea [Mass/volume] in Serum or Plasma |
| 18256-8 | Sulfonylurea [Mass/volume] in Urine |
| 18257-6 | Coproporphyrin [Mass/volume] in Blood |
| 18258-4 | Trimethoprim IgE Ab [Units/volume] in Serum |
| 18259-2 | Vasoactive intestinal peptide [Mass/time] in 24 hour Urine |
| 1826-7 | Alpha 1 antitrypsin MM [Mass/volume] in Serum or Plasma |
| 18260-0 | Zinc [Presence] in Tissue |
| 18261-8 | Cholesterol in LDL [Mass/volume] in Serum or Plasma ultracentrifugate |
| 18262-6 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay |
| 18263-4 | Cholesterol in HDL [Mass/volume] in Serum or Plasma ultracentrifugate |
| 18264-2 | Deprecated Direct bilirubin [Mass/volume] in Serum or Plasma |
| 18265-9 | Acetaminophen [Presence] in Body fluid |
| 18266-7 | CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Body fluid |
| 18267-5 | CD16+CD56+ cells/100 cells in Blood |
| 18268-3 | CD16+CD56+ cells/100 cells in Body fluid |
| 18269-1 | Immune complex [Units/volume] in Body fluid |
| 1827-5 | Alpha 1 antitrypsin MS [Mass/volume] in Serum or Plasma |
| 18270-9 | Carbamazepine 10,11-Epoxide [Moles/volume] in Serum or Plasma |
| 18271-7 | Alpha 1 antitrypsin fecal clearance in 24 hour |
| 18272-5 | RNA Ab [Units/volume] in Serum |
| 18273-3 | Blood group antibody screen [Presence] in Serum or Plasma from Blood product unit |
| 18274-1 | Blood group antibody screen [Presence] in Serum or Plasma from donor |
| 18275-8 | Blood group antigens present [Identifier] on Red Blood Cells from donor |
| 18276-6 | Blood group antigens absent [Identifier] on Red Blood Cells from donor |
| 18277-4 | Hemoglobin F [Presence] in Gastric fluid by Apt-Downey method |
| 18278-2 | Hemoglobin F [Presence] in Meconium by Apt-Downey method |
| 18279-0 | Deprecated Hemoglobin F [Presence] in Stool by Apt-Downey method |
| 1828-3 | Alpha 1 antitrypsin MZ [Mass/volume] in Serum or Plasma |
| 18280-8 | Background stain [Presence] in Blood by Light microscopy |
| 18281-6 | Calcium [Moles/volume] corrected for total protein in Serum or Plasma |
| 18282-4 | Cannabinoids [Presence] in Urine by Screen method |
| 18283-2 | CD11 cells/100 cells in Blood |
| 18284-0 | CD198 cells/100 cells in Blood |
| 18285-7 | CDA cells/100 cells in Blood |
| 18286-5 | Donath Landsteiner Ab [Presence] in Blood |
| 18287-3 | Donath Landsteiner Ab [Presence] in control Serum and RBC |
| 18288-1 | Donath Landsteiner Ab [Titer] in control Serum and RBC |
| 18289-9 | Erythrocytes [Morphology] in Cerebral spinal fluid by Light microscopy |
| 1829-1 | Alpha 1 antitrypsin SS [Mass/volume] in Serum or Plasma |
| 18290-7 | Erythrocytes [Morphology] in Synovial fluid by Light microscopy |
| 18291-5 | Hemoglobin F/Hemoglobin.total in Blood from newborn |
| 18292-3 | Deprecated Hemoglobin.fetal/Hemoglobin.total^post amniocentesis |
| 18293-1 | Deprecated Hemoglobin.fetal/Hemoglobin.total^post partum |
| 18294-9 | Deprecated Hemoglobin.fetal/Hemoglobin.total^pre amniocentesis |
| 18295-6 | Deprecated Hemoglobin.fetal/Hemoglobin.total^pre partum |
| 18296-4 | Glucose [Interpretation] in Serum or Plasma--post dose glucose |
| 18297-2 | Acid hemolysis [Mass/volume] of Red Blood Cells |
| 18298-0 | High titer low avidity Ab [Presence] in Serum or Plasma |
| 18299-8 | IgA [Presence] in Serum by Immunofixation |
| 183-4 | Cinoxacin [Susceptibility] by Serum bactericidal titer |
| 1830-9 | Alpha 1 antitrypsin SZ [Mass/volume] in Serum or Plasma |
| 18300-4 | IgA [Presence] in Urine by Immunofixation |
| 18301-2 | IgG [Presence] in Serum by Immunofixation |
| 18302-0 | IgG [Presence] in Urine by Immunofixation |
| 18303-8 | IgM [Presence] in Serum by Immunofixation |
| 18304-6 | IgM [Presence] in Urine by Immunofixation |
| 18305-3 | Amoeba identified in Aspirate by Iron hematoxylin stain |
| 18306-1 | Hydatid cyst identified in Aspirate by Iron hematoxylin stain |
| 18307-9 | Ova and parasites identified in Stool by Iron hematoxylin stain |
| 18308-7 | Pneumocystis sp identified in Lung tissue by Immunohistochemical |
| 18309-5 | Nucleated erythrocytes/100 leukocytes [Ratio] in Blood by Manual count |
| 1831-7 | Alpha 1 antitrypsin ZZ [Mass/volume] in Serum or Plasma |
| 18310-3 | Deprecated Hemoglobin.other/Hemoglobin.total [interpretation] in Blood |
| 18311-1 | Pelger Huet cells [Presence] in Blood by Light microscopy |
| 18312-9 | Platelet satellitism [Presence] in Blood by Light microscopy |
| 18313-7 | Coagulation of Semen by Visual observation |
| 18314-5 | Morphology [Interpretation] in Blood Narrative |
| 18319-4 | Neutrophils.vacuolated [Presence] in Blood by Light microscopy |
| 1832-5 | Alpha-1-Fetoprotein [Mass/volume] in Amniotic fluid |
| 18320-2 | Globulin [Mass/volume] in Urine by calculation |
| 18321-0 | Benzidine [Mass/volume] in Serum or Plasma |
| 18322-8 | Norketamine [Mass/volume] in Urine |
| 18323-6 | Smith extractable nuclear IgG Ab [Units/volume] in Serum |
| 18324-4 | Cockatiel serum IgE Ab [Units/volume] in Serum |
| 18325-1 | Oxymorphone [Presence] in Urine by Confirmatory method |
| 18326-9 | Microscopic observation [Identifier] in Cervix by Other stain |
| 18327-7 | Microscopic observation [Identifier] in Duodenal fluid by Other stain |
| 18328-5 | Microscopic observation [Identifier] in Body fluid by Other stain |
| 18329-3 | Neutrophil cytoplasmic IgA Ab [Units/volume] in Serum |
| 1833-3 | Alpha-1-Fetoprotein [Mass/volume] in Cerebral spinal fluid |
| 18330-1 | Neutrophil cytoplasmic IgG Ab [Units/volume] in Serum |
| 18331-9 | Neutrophil cytoplasmic IgM Ab [Units/volume] in Serum |
| 18332-7 | Thyroperoxidase IgG Ab [Units/volume] in Serum or Plasma |
| 18333-5 | Echovirus 7 Ab [Units/volume] in Cerebral spinal fluid |
| 18334-3 | Naltrexone [Presence] in Urine by Confirmatory method |
| 18335-0 | Antihistamines [Presence] in Urine by Confirmatory method |
| 18336-8 | Methyl tert-butyl ether [Mass/volume] in Blood |
| 18337-6 | Hydroxyitraconazole [Mass/volume] in Serum or Plasma |
| 18338-4 | Nortramadol [Mass/volume] in Urine |
| 18339-2 | Nortramadol [Presence] in Serum or Plasma by Confirmatory method |
| 1834-1 | Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma |
| 18340-0 | Nortramadol [Mass/volume] in Serum or Plasma by Confirmatory method |
| 18341-8 | Propylene glycol [Mass/volume] in Urine |
| 18342-6 | Glucose [Mass/volume] in Serum or Plasma --3 hours post XXX challenge |
| 18343-4 | 6-Monoacetylmorphine (6-MAM) [Presence] in Serum or Plasma by Screen method |
| 18344-2 | Beta-N-acetylhexosaminidase [Enzymatic activity/volume] in Platelets |
| 18345-9 | Protein S Ag/Coagulation factor VII Ag Ag [Mass Ratio] in Platelet poor plasma by Coagulation assay |
| 18346-7 | Deprecated Streptococcus pneumoniae 56 IgG Ab [Units/volume] in Serum |
| 18347-5 | Streptococcus pneumoniae 12 Ab [Units/volume] in Serum --2nd specimen |
| 18348-3 | Toxoplasma gondii IgM Ab [Units/volume] in Cerebral spinal fluid |
| 18349-1 | CD8+CD25+ cells [#/volume] in Blood |
| 1835-8 | Alpha-2-Macroglobulin [Mass/volume] in Serum or Plasma |
| 18350-9 | CD8+CD57+ cells [#/volume] in Blood |
| 18351-7 | 11-Deoxycortisol [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
| 18352-5 | Volume of 4 hour Urine |
| 18353-3 | Glucose [Mass/volume] in Serum or Plasma --6 hours post 50 g lactose PO |
| 18354-1 | Glucose [Mass/volume] in Serum or Plasma --12 hours post 50 g lactose PO |
| 18355-8 | Methylenedioxyamphetamine [Mass/volume] in Urine |
| 18356-6 | Methylenedioxymethamphetamine [Mass/volume] in Serum or Plasma |
| 18357-4 | Methylenedioxymethamphetamine [Mass/volume] in Blood |
| 18358-2 | Methylenedioxymethamphetamine [Mass/volume] in Urine by Confirmatory method |
| 18359-0 | Methylenedioxyamphetamine [Mass/volume] in Blood |
| 1836-6 | Alpha-2-Retinol binding protein [Mass/volume] in Serum or Plasma |
| 18360-8 | 8-Hydroxyamoxapine [Mass/volume] in Urine |
| 18361-6 | Adenosine monophosphate.cyclic/Creatinine [Mass Ratio] in Urine |
| 18362-4 | Alpha-2-Retinol binding protein [Mass/time] in 24 hour Urine |
| 18363-2 | Carnitine free (C0) [Units/mass] in Tissue |
| 18364-0 | Chondroitin sulfate [Mass/volume] in Serum |
| 18365-7 | Cortisol Free [Mass/volume] in Saliva (oral fluid) |
| 18366-5 | Cytochrome C oxidase [Enzymatic activity/mass] in Tissue |
| 18367-3 | Iodine Free [Mass/volume] in Serum or Plasma |
| 18368-1 | Magnesium [Moles/time] in 2 hour Urine |
| 18369-9 | Magnesium [Moles/time] in 4 hour Urine |
| 1837-4 | Alpha-N-acetylglucosaminidase [Enzymatic activity/volume] in Serum or Plasma |
| 18370-7 | Nitrite [Mass/volume] in Blood |
| 18371-5 | Methyl parathion [Mass/volume] in Urine |
| 18372-3 | Potassium [Moles/time] in 6 hour Urine |
| 18373-1 | Protein [Mass/time] in 6 hour Urine |
| 18374-9 | Riboflavin [Mass/volume] in 24 hour Urine |
| 18375-6 | Deprecated Serotonin [Mass/volume] in Urine |
| 18376-4 | Sodium [Moles/time] in 6 hour Urine |
| 18377-2 | Sodium [Moles/time] in 12 hour Urine |
| 18378-0 | Transcortin [Mass/volume] in Cerebral spinal fluid |
| 18379-8 | Urate [Mass/time] in 6 hour Urine |
| 1838-2 | Alpha-N-acetylglucosaminidase [Enzymatic activity/mass] in Tissue |
| 18380-6 | Uroporphyrinogen decarboxylase [Entitic Catalytic Activity] in Red Blood Cells |
| 18381-4 | Uroporphyrinogen decarboxylase [Enzymatic activity/volume] in Blood |
| 18382-2 | Dry weight [Mass/time] of 24 hour Stool |
| 18383-0 | Alfentanil [Presence] in Urine |
| 18384-8 | Butabarbital [Mass/volume] in Serum or Plasma by Confirmatory method |
| 18385-5 | Butalbital [Presence] in Urine by Confirmatory method |
| 18386-3 | Chlorothiazide [Presence] in Serum or Plasma |
| 18387-1 | Diamorphine [Mass/volume] in Serum or Plasma |
| 18388-9 | Diazepam [Presence] in Urine by Confirmatory method |
| 18389-7 | Methaqualone [Presence] in Urine by Confirmatory method |
| 1839-0 | Ammonia [Moles/volume] in Blood |
| 18390-5 | Opiates [Presence] in Urine by Confirmatory method |
| 18391-3 | Paraldehyde [Mass/volume] in Urine |
| 18392-1 | Phencyclidine [Presence] in Urine by Confirmatory method |
| 18393-9 | Quinidine+Quinine [Presence] in Urine |
| 18394-7 | HLA-A24(9) [Presence] |
| 18395-4 | Aspergillus niger Ab [Presence] in Cerebral spinal fluid |
| 18396-2 | HIV 1 p24 Ag [Presence] in Serum or Plasma by Immunoassay |
| 18397-0 | Polio virus 1 Ab [Titer] in Cerebral spinal fluid by Complement fixation |
| 18398-8 | Polio virus 2 Ab [Titer] in Cerebral spinal fluid by Complement fixation |
| 18399-6 | Polio virus 3 Ab [Titer] in Cerebral spinal fluid by Complement fixation |
| 184-2 | Ciprofloxacin [Susceptibility] by Minimum lethal concentration (MLC) |
| 1840-8 | Ammonia [Moles/volume] in Cerebral spinal fluid |
| 18400-2 | Spermatozoa IgA Ab [Units/volume] in Cervical mucus |
| 18401-0 | Spermatozoa IgG Ab [Units/volume] in Cervical mucus |
| 18402-8 | Spermatozoa IgA Ab [Units/volume] in Semen |
| 18403-6 | Spermatozoa IgG Ab [Units/volume] in Semen |
| 18404-4 | Spermatozoa IgM Ab [Units/volume] in Semen |
| 18405-1 | Arsenate [Mass/volume] in Urine |
| 18406-9 | Arsenic trioxide [Mass/volume] in Urine |
| 18407-7 | Leukocytes in 12 hour Urine sediment by Light microscopy |
| 18408-5 | CD3+HLA-DR+ cells/100 cells in Blood |
| 18409-3 | Curvularia lunata IgG Ab [Units/volume] in Serum |
| 1841-6 | Ammonia [Moles/volume] in Serum |
| 18410-1 | Epicoccum purpurascens IgG Ab [Units/volume] in Serum |
| 18411-9 | Rhizopus nigricans IgG Ab [Units/volume] in Serum |
| 18412-7 | Stemphylium botryosum IgG Ab [Units/volume] in Serum |
| 18413-5 | HLA-DR16 [Presence] |
| 18414-3 | Psilocin [Presence] in Urine |
| 18415-0 | Psilocin [Mass/volume] in Urine |
| 18416-8 | Aspergillus nidulans IgG Ab [Units/volume] in Serum |
| 18417-6 | Black Bean IgG Ab [Units/volume] in Serum |
| 18418-4 | Casein IgA Ab [Units/volume] in Serum |
| 18419-2 | Cephalosporine mold IgG Ab [Units/volume] in Serum |
| 1842-4 | Ammonia [Moles/volume] in Urine |
| 18420-0 | Chaetomium globosum IgG Ab [Units/volume] in Serum |
| 18421-8 | Fusarium oxysporum IgG Ab [Units/volume] in Serum |
| 18422-6 | Microcytes [Presence] in Urine by Light microscopy |
| 18423-4 | Phthalic anhydride IgG Ab [Units/volume] in Serum |
| 18424-2 | Phthalic anhydride IgM Ab [Units/volume] in Serum |
| 18425-9 | Zucchini IgG Ab [Units/volume] in Serum |
| 18426-7 | Aspergillus sp Ab [Presence] in Cerebral spinal fluid |
| 18427-5 | Epstein Barr virus early Ab [Presence] in Body fluid |
| 18428-3 | Epstein Barr virus nuclear IgG Ab [Presence] in Cerebral spinal fluid |
| 18429-1 | Rickettsia rickettsii IgG Ab [Units/volume] in Cerebral spinal fluid |
| 1843-2 | Ammonia nitrogen [Mass/time] in 24 hour Urine |
| 18430-9 | Rickettsia rickettsii IgM Ab [Units/volume] in Cerebral spinal fluid |
| 18431-7 | Amphetamines [Presence] in Stool by Screen method |
| 18432-5 | Tetrahydrocannabinol [Presence] in Stool by Screen method |
| 18433-3 | Deprecated 1,3-Dichlorobenzene [Mass/volume] in Blood |
| 18434-1 | 1,2-Dichlorobenzene [Mass/volume] in Blood |
| 18435-8 | Sufentanil [Presence] in Urine |
| 18436-6 | Acetylcarnitine (C2) [Mass/volume] in Serum or Plasma |
| 18437-4 | Acrylylcarnitine (C3:1) [Mass/volume] in Serum or Plasma |
| 18438-2 | Propionylcarnitine (C3) [Mass/volume] in Serum or Plasma |
| 18439-0 | Butyrylcarnitine (C4) [Mass/volume] in Serum or Plasma |
| 1844-0 | Ammonium ion [Moles/volume] in Arterial blood |
| 18440-8 | Crotonylcarnitine (C4:1) [Mass/volume] in Serum or Plasma |
| 18441-6 | Isovalerylcarnitine (C5) [Mass/volume] in Serum or Plasma |
| 18442-4 | 3-Hydroxybutyrylcarnitine (C4-OH) [Mass/volume] in Serum or Plasma |
| 18443-2 | Hexanoylcarnitine (C6) [Mass/volume] in Serum or Plasma |
| 18444-0 | 3-Hydroxyisovalerylcarnitine (C5-OH) [Mass/volume] in Serum or Plasma |
| 18445-7 | Benzoylcarnitine (BzCn) [Mass/volume] in Serum or Plasma |
| 18446-5 | Methylmalonylcarnitine (C4-DC) [Mass/volume] in Serum or Plasma |
| 18447-3 | Octenoylcarnitine (C8:1) [Mass/volume] in Serum or Plasma |
| 18448-1 | Octanoylcarnitine (C8) [Mass/volume] in Serum or Plasma |
| 18449-9 | Glutarylcarnitine (C5-DC) [Mass/volume] in Serum or Plasma |
| 1845-7 | Ammonium ion [Moles/volume] in Plasma |
| 18450-7 | Adipoylcarnitine (C6-DC) [Mass/volume] in Serum or Plasma |
| 18451-5 | cis-4-Decenoylcarnitine (Cis 4 C10:1) [Mass/volume] in Serum or Plasma |
| 18452-3 | Decanoylcarnitine (C10) [Mass/volume] in Serum or Plasma |
| 18453-1 | Suberylcarnitine (C8-DC) [Mass/volume] in Serum or Plasma |
| 18454-9 | Dodecenoylcarnitine (C12:1) [Mass/volume] in Serum or Plasma |
| 18455-6 | Dodecanoylcarnitine (C12) [Mass/volume] in Serum or Plasma |
| 18456-4 | Tetradecadienoylcarnitine (C14:2) [Mass/volume] in Serum or Plasma |
| 18457-2 | Tetradecenoylcarnitine (C14:1) [Mass/volume] in Serum or Plasma |
| 18458-0 | 3-Hydroxytetradecadienoylcarnitine (C14:2-OH) [Mass/volume] in Serum or Plasma |
| 18459-8 | 3-Hydroxytetradecenoylcarnitine (C14:1-OH) [Mass/volume] in Serum or Plasma |
| 1846-5 | Amylo-alpha-1,6-glucosidase [Enzymatic activity/volume] in Red Blood Cells |
| 18460-6 | Palmitoylcarnitine (C16) [Mass/volume] in Serum or Plasma |
| 18461-4 | 3-Hydroxypalmitoylcarnitine (C16-OH) [Mass/volume] in Serum or Plasma |
| 18462-2 | Linoleoylcarnitine (C18:2) [Mass/volume] in Serum or Plasma |
| 18463-0 | Oleoylcarnitine (C18:1) [Mass/volume] in Serum or Plasma |
| 18464-8 | 3-Hydroxylinoleoylcarnitine (C18:2-OH) [Mass/volume] in Serum or Plasma |
| 18465-5 | 3-Hydroxyoleoylcarnitine (C18:1-OH) [Mass/volume] in Serum or Plasma |
| 18466-3 | Dicarboxyoleylcarnitine (C18:1-DC) [Mass/volume] in Serum or Plasma |
| 18467-1 | Venlafaxine [Mass/volume] in Urine |
| 18468-9 | Aspergillus fumigatus Ab [Presence] in Cerebral spinal fluid |
| 18469-7 | Methyclothiazide [Mass/volume] in Serum or Plasma |
| 1847-3 | Amyloid associated protein [Mass/volume] in Serum |
| 18470-5 | Norclomipramine [Mass/volume] in Urine |
| 18471-3 | Metoclopramide [Mass/volume] in Urine |
| 18472-1 | Organophosphate pesticides [Identifier] in Urine |
| 18473-9 | Hydromorphone [Presence] in Urine by Confirmatory method |
| 18474-7 | HER2 Ag [Presence] in Tissue by Immune stain |
| 18475-4 | Phenylalanine/Creatinine [Molar ratio] in Urine |
| 18476-2 | Uroporphyrinogen decarboxylase [Presence] in Red Blood Cells |
| 18477-0 | Lithium [Moles/time] in 24 hour Urine |
| 18478-8 | Human papilloma virus 16+18 DNA [Presence] in Tissue by DNA probe |
| 18479-6 | Human papilloma virus 31+35+51 DNA [Presence] in Tissue by DNA probe |
| 1848-1 | Androstanolone [Mass/volume] in Serum or Plasma |
| 18480-4 | Human papilloma virus 6+11 DNA [Presence] in Tissue by DNA probe |
| 18481-2 | Streptococcus pyogenes Ag [Presence] in Throat |
| 18482-0 | Yeast [Presence] in Unspecified specimen by Organism specific culture |
| 18483-8 | Yeast [Presence] in Genital specimen by Organism specific culture |
| 18484-6 | Ku Ab [Presence] in Serum |
| 18485-3 | Mi-2 Ab [Presence] in Serum |
| 18486-1 | Methylenediamine [Presence] in Urine |
| 18487-9 | Broad casts [#/area] in Urine sediment by Microscopy low power field |
| 18488-7 | Calcium [Mass/volume] in 24 hour Urine |
| 18489-5 | Valproate.protein bound [Mass/volume] in Serum or Plasma |
| 1849-9 | Androstanolone [Mass/volume] in Semen |
| 18490-3 | Chlamydia trachomatis G+F+K IgA Ab [Titer] in Serum by Immunofluorescence |
| 18491-1 | Chlamydia trachomatis G+F+K IgG Ab [Titer] in Serum by Immunofluorescence |
| 18492-9 | Chlamydia trachomatis G+F+K IgM Ab [Titer] in Serum by Immunofluorescence |
| 18493-7 | Ova and parasites identified in Stool by Concentration--3rd specimen |
| 18494-5 | Ova and parasites identified in Stool by Concentration--2nd specimen |
| 18495-2 | Ova and parasites identified in Stool by Trichrome stain--3rd specimen |
| 18496-0 | Ova and parasites identified in Stool by Trichrome stain--2nd specimen |
| 18497-8 | Microscopic observation [Identifier] in Thyroid fine needle aspirate by Cyto stain |
| 18498-6 | Microscopic observation [Identifier] in Breast fine needle aspirate by Cyto stain |
| 18499-4 | Microscopic observation [Identifier] in Nipple discharge by Cyto stain |
| 185-9 | Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 1850-7 | Androstanediol [Mass/volume] in Urine |
| 18500-9 | Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep |
| 18501-7 | Microscopic observation [Identifier] in Buccal smear by Cyto stain |
| 18502-5 | Microscopic observation [Identifier] in Deep tissue fine needle aspirate by Cyto stain |
| 18503-3 | Microscopic observation [Identifier] in Superficial tissue fine needle aspirate by Cyto stain |
| 18504-1 | PP interval mean |
| 18505-8 | R-R interval (Mean value during study) by EKG |
| 18506-6 | P wave axis horizontal plane Reference beat |
| 18507-4 | QRS axis.horizontal plane Reference beat |
| 18508-2 | R wave axis.horizontal plane |
| 18509-0 | T wave axis.horizontal plane Reference beat |
| 1851-5 | Androstenedione [Mass/volume] in Amniotic fluid |
| 18510-8 | ST segment axis.horizontal plane |
| 18511-6 | P wave onset [Time] Reference beat |
| 18512-4 | P wave offset [Time] Reference beat |
| 18513-2 | QRS onset [Time] Reference beat |
| 18514-0 | QRS offset [Time] Reference beat |
| 18515-7 | T wave offset [Time] Reference beat |
| 18516-5 | P wave axis frontal plane Reference beat |
| 18517-3 | QRS axis.frontal plane Reference beat |
| 18518-1 | T wave axis.frontal plane Reference beat |
| 18519-9 | Reference beat |
| 1852-3 | Androstenedione [Mass/volume] in Capillary blood |
| 18520-7 | P-R Interval Lead AVF |
| 18521-5 | P-R Interval Lead AVL |
| 18522-3 | P-R Interval Lead AVR |
| 18523-1 | P-R Interval Lead I |
| 18524-9 | P-R Interval Lead II |
| 18525-6 | P-R Interval Lead III |
| 18526-4 | P-R Interval Lead V1 |
| 18527-2 | P-R Interval Lead V2 |
| 18528-0 | P-R Interval Lead V3 |
| 18529-8 | P-R Interval Lead V4 |
| 1853-1 | Androstenedione [Mass/volume] in Semen |
| 18530-6 | P-R Interval Lead V5 |
| 18531-4 | P-R Interval Lead V6 |
| 18532-2 | Q-T interval Lead AVF |
| 18533-0 | Q-T interval Lead AVL |
| 18534-8 | Q-T interval Lead AVR |
| 18535-5 | Q-T interval Lead I |
| 18536-3 | Q-T interval Lead II |
| 18537-1 | Q-T interval Lead III |
| 18538-9 | Q-T interval Lead V1 |
| 18539-7 | Q-T interval Lead V2 |
| 1854-9 | Androstenedione [Mass/volume] in Serum or Plasma |
| 18540-5 | Q-T interval Lead V3 |
| 18541-3 | Q-T interval Lead V4 |
| 18542-1 | Q-T interval Lead V5 |
| 18543-9 | Q-T interval Lead V6 |
| 18544-7 | ST amplitude.J point+20 ms Lead AVF |
| 18545-4 | ST amplitude.J point+20 ms Lead AVL |
| 18546-2 | ST amplitude.J point+20 ms Lead AVR |
| 18547-0 | ST amplitude.J point+20 ms Lead I |
| 18548-8 | ST amplitude.J point+20 ms Lead II |
| 18549-6 | ST amplitude.J point+20 ms Lead III |
| 1855-6 | Androstenedione [Mass/volume] in Urine |
| 18550-4 | ST amplitude.J point+20 ms Lead V1 |
| 18551-2 | ST amplitude.J point+20 ms Lead V2 |
| 18552-0 | ST amplitude.J point+20 ms Lead V3 |
| 18553-8 | ST amplitude.J point+20 ms Lead V4 |
| 18554-6 | ST amplitude.J point+20 ms Lead V5 |
| 18555-3 | ST amplitude.J point+20 ms Lead V6 |
| 18556-1 | ST amplitude.J point+60 ms Lead AVF |
| 18557-9 | ST amplitude.J point+60 ms Lead AVL |
| 18558-7 | ST amplitude.J point+60 ms Lead AVR |
| 18559-5 | ST amplitude.J point+60 ms Lead I |
| 1856-4 | Androsterone [Mass/volume] in Serum or Plasma |
| 18560-3 | ST amplitude.J point+60 ms Lead II |
| 18561-1 | ST amplitude.J point+60 ms Lead III |
| 18562-9 | ST amplitude.J point+60 ms Lead V1 |
| 18563-7 | ST amplitude.J point+60 ms Lead V2 |
| 18564-5 | ST amplitude.J point+60 ms Lead V3 |
| 18565-2 | ST amplitude.J point+60 ms Lead V4 |
| 18566-0 | ST amplitude.J point+60 ms Lead V5 |
| 18567-8 | ST amplitude.J point+60 ms Lead V6 |
| 18568-6 | ST amplitude.J point+80 ms Lead AVF |
| 18569-4 | ST amplitude.J point+80 ms Lead AVL |
| 1857-2 | Angiotensin converting enzyme [Enzymatic activity/volume] in Blood |
| 18570-2 | ST amplitude.J point+80 ms Lead AVR |
| 18571-0 | ST amplitude.J point+80 ms Lead I |
| 18572-8 | ST amplitude.J point+80 ms Lead II |
| 18573-6 | ST amplitude.J point+80 ms Lead III |
| 18574-4 | ST amplitude.J point+80 ms Lead V1 |
| 18575-1 | ST amplitude.J point+80 ms Lead V2 |
| 18576-9 | ST amplitude.J point+80 ms Lead V3 |
| 18577-7 | ST amplitude.J point+80 ms Lead V4 |
| 18578-5 | ST amplitude.J point+80 ms Lead V5 |
| 18579-3 | ST amplitude.J point+80 ms Lead V6 |
| 1858-0 | Angiotensin I [Mass/volume] in Plasma |
| 18580-1 | Ambulance transport, Origination site |
| 18581-9 | Ambulance transport, Origination site Address |
| 18582-7 | Ambulance transport, Destination site Name |
| 18583-5 | Ambulance transport, Destination site Address |
| 18584-3 | Body weight at ambulance transport Set |
| 18588-4 | Ambulance transport, Purpose of stretcher (narrative) |
| 18589-2 | Ambulance transport, Admitted at destination facility |
| 1859-8 | Angiotensin II [Mass/volume] in Cerebral spinal fluid |
| 18591-8 | Confined to bed before ambulance transport |
| 18592-6 | Confined to bed after ambulance transport |
| 18593-4 | Ambulance transport, Discharged from origin institution |
| 18594-2 | Psychiatric service attachment |
| 18598-3 | Control number identification.claims attachment |
| 186-7 | Ciprofloxacin [Susceptibility] by Disk diffusion (KB) |
| 1860-6 | Angiotensin II [Mass/volume] in Plasma |
| 18600-7 | Primary practitioner identifier |
| 18601-5 | Primary practitioner profession |
| 18602-3 | ED practitioner identifier |
| 18605-6 | Medication current Set |
| 18606-4 | Current medication, Name and Identifier |
| 18607-2 | Current medication Dose |
| 18608-0 | Current medication, Timing + Quantity |
| 18609-8 | Current medication, Route |
| 1861-4 | Angiotensinogen [Mass/volume] in Plasma |
| 18610-6 | Medication administered Set |
| 18611-4 | Administered medication, Name and Identifier |
| 18612-2 | Administered medication, Route |
| 18614-8 | Administered medication, Timing |
| 18615-5 | Medication administered Dose |
| 18616-3 | Administered medication, Strength |
| 18617-1 | Medication discharge Set |
| 18618-9 | Discharge medication, Name and Identifier |
| 18619-7 | Discharge medication Dose |
| 1862-2 | Aniline [Mass/volume] in Serum or Plasma |
| 18620-5 | Discharge medication, Timing + Quantity |
| 18621-3 | Discharge medication, Route |
| 18622-1 | Discharge medication, Amount dispensed |
| 18623-9 | Discharge medication, Refills |
| 18624-7 | ED problem (narrative) |
| 18626-2 | Psychiatric rehabilitation treatment plan, New/revised |
| 18627-0 | Psychiatric rehabilitation treatment plan, Date onset or exacerbation of primary diagnosis |
| 18628-8 | Deprecated Psychiatric rehabilitation treatment plan, start date |
| 18629-6 | Deprecated Clinical discipline - Psychiatric rehabilitation treatment plan |
| 1863-0 | Anion gap 4 in Serum or Plasma |
| 18630-4 | Primary diagnosis |
| 18631-2 | Psychiatric rehabilitation treatment plan, Diagnosis addressed by plan Set |
| 18632-0 | Psychiatric rehabilitation treatment plan, Author of treatment plan Set |
| 18633-8 | Psychiatric rehabilitation treatment plan, Author name |
| 18634-6 | Psychiatric rehabilitation treatment plan, Author profession Identifier |
| 18635-3 | Psychiatric rehabilitation treatment plan, Signature date Date and time |
| 18637-9 | Psychiatric rehabilitation treatment plan, Visit frequency TQ2 |
| 18638-7 | Psychiatric rehabilitation treatment plan, Visit duration Time |
| 18639-5 | Psychiatric rehabilitation treatment plan, Date range (from/through) described by plan Set |
| 1864-8 | Anserine [Mass/volume] in Cerebral spinal fluid |
| 18640-3 | Psychiatric rehabilitation treatment plan, Start date |
| 18641-1 | Psychiatric rehabilitation treatment plan, End date |
| 18642-9 | Psychiatric rehabilitation treatment plan, Date range (from/through) Set |
| 18643-7 | Psychiatric rehabilitation treatment plan, Start date of hospitalization leading to treatment |
| 18644-5 | Psychiatric rehabilitation treatment plan, End date of hospitalization leading to treatment |
| 18645-2 | Psychiatric rehabilitation treatment plan, Continuation status |
| 18646-0 | Psychiatric rehabilitation treatment plan, Date attending MD referred patient for Date |
| 18647-8 | Psychiatric rehabilitation treatment plan, Date attending MD signed Date and time |
| 18648-6 | Psychiatric rehabilitation treatment plan, Date rehabilitation professional signed Date and time |
| 18649-4 | Psychiatric rehabilitation treatment plan, Signature of responsible attending physician on file |
| 1865-5 | Anserine [Presence] in Serum or Plasma |
| 18650-2 | Psychiatric rehabilitation treatment plan, Signature of responsible rehabilitation professional on file |
| 18651-0 | Psychiatric rehabilitation treatment plan, Medication administered Set |
| 18652-8 | Psychiatric rehabilitation treatment plan, Prognosis for rehabilitation |
| 18653-6 | Psychiatric rehabilitation treatment plan, Estimated date of completion Date |
| 18654-4 | Psychiatric rehabilitation treatment plan, Date of last plan of treatment certification |
| 18655-1 | Psychiatric rehabilitation treatment plan, Past medical history and Level of function (narrative) |
| 18656-9 | Psychiatric rehabilitation treatment plan Initial evaluation note (narrative) |
| 18657-7 | Psychiatric rehabilitation treatment plan, Plan of treatment (narrative) |
| 18658-5 | Psychiatric rehabilitation treatment plan Progress note and attainment of goals (narrative) |
| 18659-3 | Psychiatric rehabilitation treatment plan, Reason to continue (narrative) |
| 1866-3 | Anserine [Mass/volume] in Serum or Plasma |
| 18660-1 | Psychiatric rehabilitation treatment plan, Justification (narrative) |
| 18661-9 | Psychiatric rehabilitation treatment plan, Psychiatric symptoms (narrative) |
| 18662-7 | Alcohol-substance abuse rehabilitation treatment plan, Chief complaint+Reason for referral+Reason for relapse if known (narrative) |
| 18663-5 | Alcohol-substance abuse, rehabilitation plan, History of present alcohol/substance abuse (narrative) |
| 18664-3 | Rehabilitation treatment plan, Follow-up approach Set |
| 18665-0 | Alcohol-substance abuse rehabilitation treatment plan, Agency that will follow up Identifier |
| 18666-8 | Alcohol-substance abuse rehabilitation treatment plan, Person that will follow up after Identifier |
| 18667-6 | Alcohol-substance abuse rehabilitation treatment plan, Methodology for follow up (narrative) Text |
| 18668-4 | Alcohol-substance abuse rehabilitation treatment plan, Frequency of assessments for follow up # |
| 18669-2 | Rehabilitation treatment plan, Level of patient participation Text |
| 1867-1 | Anserine [Mass/volume] in Urine |
| 18670-0 | Rehabilitation treatment plan, Date of next planned rehabilitation treatment Set |
| 18671-8 | Psychiatric rehabilitation treatment plan, Next plan of treatment (narrative) Text |
| 18672-6 | Alcohol or substance abuse symptoms with physiological dependence indicator |
| 18673-4 | Alcohol-substance abuse rehabilitation treatment plan, rehabilitation problem remission status |
| 18674-2 | Alcohol-substance abuse rehabilitation treatment plan, longest period of sobriety for abused substance (composite) |
| 18675-9 | Alcohol-substance abuse rehabilitation treatment plan, abused substance |
| 18676-7 | Alcohol-substance abuse rehabilitation treatment plan, longest period of sobriety |
| 18677-5 | Service claims attachment |
| 18679-1 | ED claims attachment (composite) |
| 1868-9 | Antithrombin Ag [Mass/volume] in Platelet poor plasma by Immunologic method |
| 18682-5 | Ambulance claims attachment |
| 18684-1 | First Blood pressure Set |
| 18685-8 | First Blood pressure special circumstances |
| 18686-6 | First Respiration rate Set |
| 18687-4 | First Respiration rate special circumstances |
| 18688-2 | First Body temperature Set |
| 18689-0 | First Body temperature special circumstances |
| 1869-7 | Apolipoprotein A-I [Mass/volume] in Serum or Plasma |
| 18690-8 | First Body weight Set |
| 18692-4 | First Body weight special circumstances |
| 18693-2 | ED consultant practitioner Set |
| 18694-0 | ED consultant practitioner name |
| 18695-7 | ED clinical finding type |
| 18696-5 | ED clinical finding (narrative) |
| 18697-3 | ED clinical finding data source |
| 18698-1 | ED clinical finding (composite) |
| 18699-9 | ED practitioner Set |
| 187-5 | Ciprofloxacin [Susceptibility] by Serum bactericidal titer |
| 1870-5 | Apolipoprotein A-II [Mass/volume] in Serum or Plasma |
| 18700-5 | ED practitioner name |
| 18701-3 | ED practitioner profession |
| 18702-1 | ED practitioner role |
| 18703-9 | ED diagnostic procedure results Set |
| 18704-7 | ED referring practitioner Set |
| 18705-4 | ED referring practitioner name |
| 18706-2 | ED referring practitioner identifier |
| 18707-0 | ED referring practitioner profession |
| 18708-8 | First Heart rate Set |
| 18709-6 | First Heart rate special circumstances |
| 1871-3 | Apolipoprotein B-100 [Mass/volume] in Serum or Plasma |
| 18710-4 | Primary practitioner Set |
| 18711-2 | Primary practitioner name |
| 18716-1 | Allergy studies (set) |
| 18717-9 | Blood bank studies (set) |
| 18718-7 | Cell marker studies (set) |
| 18719-5 | Chemistry studies (set) |
| 1872-1 | Apolipoprotein B-150 [Mass/volume] in Serum or Plasma |
| 18720-3 | Coagulation studies (set) |
| 18721-1 | Therapeutic drug monitoring studies (set) |
| 18722-9 | Fertility studies (set) |
| 18723-7 | Hematology studies (set) |
| 18724-5 | HLA studies (set) |
| 18725-2 | Microbiology studies (set) |
| 18726-0 | Radiology studies (set) |
| 18727-8 | Serology studies (set) |
| 18728-6 | Toxicology studies (set) |
| 18729-4 | Urinalysis studies (set) |
| 1873-9 | Apolipoprotein B-48 [Mass/volume] in Serum or Plasma |
| 18730-2 | Psychiatric rehabilitation treatment plan, Author ID Identifier |
| 18733-6 | Physician attending Progress note |
| 18734-4 | Occupational therapy Initial evaluation note |
| 18735-1 | Physical therapy Initial evaluation note |
| 18736-9 | Physician Initial evaluation note |
| 18737-7 | Podiatry Initial evaluation note |
| 18738-5 | Psychology Initial evaluation note |
| 18739-3 | Social work Initial evaluation note |
| 1874-7 | Apolipoprotein B/Apolipoprotein A-I [Mass Ratio] in Serum or Plasma |
| 18740-1 | Speech-language pathology Initial evaluation note |
| 18741-9 | Deprecated Attending physician progress note |
| 18742-7 | Arthroscopy study |
| 18743-5 | Autopsy report |
| 18744-3 | Bronchoscopy study |
| 18745-0 | Cardiac catheterization study |
| 18746-8 | Colonoscopy Study |
| 18747-6 | Deprecated CT Unspecified system Study |
| 18748-4 | Diagnostic imaging study |
| 18749-2 | Electromyogram study |
| 1875-4 | Apolipoprotein C-I [Mass/volume] in Serum or Plasma |
| 18750-0 | Electrophysiology study |
| 18751-8 | Endoscopy study |
| 18752-6 | Exercise stress test study |
| 18753-4 | Flexible sigmoidoscopy study |
| 18754-2 | Holter monitor study |
| 18755-9 | Deprecated MRI Unspecified site study |
| 18756-7 | MR Spine study |
| 18757-5 | Deprecated Nuclear medicine study |
| 18758-3 | Deprecated PET scan Unspecified system Study |
| 18759-1 | Spirometry study |
| 1876-2 | Apolipoprotein C-II [Mass/volume] in Serum or Plasma |
| 18760-9 | Deprecated US Unspecified system Study |
| 18761-7 | Provider-unspecified Transfer summary |
| 18762-5 | Deprecated Chiropractor Progress note |
| 18763-3 | Physician consulting Initial evaluation note |
| 18764-1 | Deprecated Nurse practitioner Progress note |
| 18765-8 | Deprecated Podiatry visit note |
| 18766-6 | Deprecated Psychology visit note |
| 18767-4 | Blood gas studies (set) |
| 18768-2 | Cell counts+Differential studies (set) |
| 18769-0 | Microbial susceptibility tests Set |
| 1877-0 | Apolipoprotein C-III [Mass/volume] in Serum or Plasma |
| 18770-8 | Dictating practitioner name |
| 18771-6 | Provider signing name |
| 18772-4 | Surgeon.resident name |
| 18773-2 | Surgeon.staff name |
| 18774-0 | Staff practitioner name |
| 18775-7 | Staff practitioner identifier |
| 18776-5 | Plan of care |
| 18777-3 | Psychiatric rehabilitation treatment plan, Primary diagnosis (narrative) |
| 18779-9 | Radiology Comparison study - date and time |
| 1878-8 | Apolipoprotein A-III [Mass/volume] in Serum or Plasma |
| 18780-7 | Ordering practitioner identifier |
| 18781-5 | Ordering practitioner name |
| 18782-3 | Radiology Study observation (narrative) |
| 18783-1 | Radiology Study recommendation (narrative) |
| 18785-6 | Radiology Reason for study (narrative) |
| 18789-8 | Include all data of the selected type within the date window associated with the service |
| 1879-6 | Apolipoprotein E2 [Mass/volume] in Serum or Plasma |
| 18790-6 | Include all data of the selected type on or before the date of service |
| 18791-4 | Include all data of the selected type within or aligned to an encounter by the same service or encounter |
| 18792-2 | Include all data of the selected type on or after the date of service |
| 18793-0 | Use no fixed time limit on data (any of the selected type are relevant no matter when obtained) |
| 18794-8 | Send all items of the specified type within the time window |
| 18795-5 | Send all items of the specified type within the time window relevant to the service |
| 18796-3 | Send all abnormals within the time window |
| 18797-1 | Send the first abnormals within the time window |
| 18798-9 | Send the last abnormals within the time window |
| 18799-7 | Send the first (i.e., oldest) result for each kind of observation in the time window |
| 188-3 | Clarithromycin [Susceptibility] by Minimum lethal concentration (MLC) |
| 1880-4 | Beta 2 glycoprotein 1 [Mass/volume] in Serum or Plasma |
| 18800-3 | Send the worst abnormal result for each kind of observation in the time window |
| 18802-9 | Send the last (most recent) within the time window |
| 18803-7 | Include all data of the selected type that represents observations made 30 days or fewer before the starting date of service |
| 18804-5 | Include all data of the selected type that represents observations made 3 months or fewer before the starting date of service |
| 18805-2 | Include all data of the selected type that represents observations made six months or fewer before the starting date of service |
| 18806-0 | Include all data of the selected type that represents observations made nine months or fewer before the starting date of service |
| 18807-8 | Include all data of the selected type that represents observations made one year or less before the starting date of service |
| 1881-2 | Apolipoprotein LPA [Mass/volume] in Serum or Plasma |
| 18810-2 | EKG Study observation overall (narrative) |
| 18812-8 | Ambulance transport, Ordering practitioner Identifier |
| 18813-6 | Ambulance transport, Ordering practitioner name |
| 18814-4 | Ambulance transport, Reason for scheduled trip |
| 18815-1 | Ambulance transport, Reason for scheduled trip additional service information (narrative) |
| 18816-9 | Medication name + identifier |
| 18817-7 | Medication dose |
| 18818-5 | Medication timing + Quantity |
| 18819-3 | Psychiatric rehabilitation treatment plan, Medication route Identifier |
| 1882-0 | Apolipoprotein LPQ [Mass/volume] in Serum or Plasma |
| 18820-1 | Psychiatric rehabilitation treatment plan, Primary diagnosis Identifier |
| 18821-9 | Diagnosis addressed by plan |
| 18822-7 | Diagnosis addressed by plan (narrative) |
| 18823-5 | Alcohol and/or substance abuse service attachment |
| 18824-3 | Cardiac service attachment |
| 18825-0 | Medical social services attachment |
| 18826-8 | Occupational therapy service attachment |
| 1883-8 | Apolipoprotein A [Mass/volume] in Serum or Plasma |
| 18833-4 | First Body weight |
| 18834-2 | Radiology Comparison study (narrative) |
| 18835-9 | Aortic valve area method Narrative |
| 18836-7 | Cardiac stress study Procedure |
| 18837-5 | Left ventricle Segmental wall appearance by US Narrative |
| 18838-3 | Cardiac echo study Transducer site Narrative |
| 18839-1 | Cardiac echo imaging device Class Narrative |
| 1884-6 | Apolipoprotein B [Mass/volume] in Serum or Plasma |
| 18840-9 | Left ventricular Wall motion index by US Narrative |
| 18841-7 | Hospital consultations Document |
| 18842-5 | Discharge summary |
| 18843-3 | EKG Comparison study (narrative) |
| 18844-1 | EKG impression Narrative |
| 18845-8 | Reference beat type (narrative) by EKG |
| 18846-6 | Examination level ultrasound (narrative) |
| 18847-4 | Narrative Fetal position palpation |
| 18848-2 | Narrative Fetal position US |
| 18849-0 | Narrative Fetal presentation palpation |
| 1885-3 | Apolipoprotein C [Mass/volume] in Serum or Plasma |
| 18850-8 | Narrative Fetal presentation US |
| 18851-6 | Fetal Placenta Grade US (narrative) |
| 18852-4 | Deprecated Operative note - surgical drains (narrative) |
| 18855-7 | 5-Fluorocytosine [Susceptibility] |
| 18857-3 | Almecillin [Susceptibility] |
| 18859-9 | Amdinocillin [Susceptibility] |
| 1886-1 | Apolipoprotein E [Mass/volume] in Serum or Plasma |
| 18860-7 | Amikacin [Susceptibility] |
| 18861-5 | Amoxicillin [Susceptibility] |
| 18862-3 | Amoxicillin+Clavulanate [Susceptibility] |
| 18863-1 | Amphotericin B [Susceptibility] |
| 18864-9 | Ampicillin [Susceptibility] |
| 18865-6 | Ampicillin+Sulbactam [Susceptibility] |
| 18866-4 | Azithromycin [Susceptibility] |
| 18867-2 | Azlocillin [Susceptibility] |
| 18868-0 | Aztreonam [Susceptibility] |
| 18869-8 | Bacampicillin [Susceptibility] |
| 1887-9 | Appearance of Amniotic fluid |
| 18870-6 | Bacitracin [Susceptibility] |
| 18871-4 | Butirosin [Susceptibility] |
| 18872-2 | Capreomycin [Susceptibility] |
| 18873-0 | Carbenicillin [Susceptibility] |
| 18874-8 | Cefaclor [Susceptibility] |
| 18875-5 | Cefadroxil [Susceptibility] |
| 18876-3 | Cefamandole [Susceptibility] |
| 18877-1 | Cefatrizine [Susceptibility] |
| 18878-9 | Cefazolin [Susceptibility] |
| 18879-7 | Cefepime [Susceptibility] |
| 1888-7 | Aquacobalamin [Mass/volume] in Serum or Plasma |
| 18880-5 | Cefixime [Susceptibility] |
| 18881-3 | Cefmetazole [Susceptibility] |
| 18882-1 | Cefodizime [Susceptibility] |
| 18883-9 | Cefonicid [Susceptibility] |
| 18884-7 | Cefoperazone [Susceptibility] |
| 18885-4 | Ceforanide [Susceptibility] |
| 18886-2 | Cefotaxime [Susceptibility] |
| 18887-0 | Cefotetan [Susceptibility] |
| 18888-8 | Cefoxitin [Susceptibility] |
| 18889-6 | Cefpirome [Susceptibility] |
| 1889-5 | Arachidonate (C20:4w6) [Mass/volume] in Serum or Plasma |
| 18890-4 | Cefpodoxime [Susceptibility] |
| 18891-2 | Cefprozil [Susceptibility] |
| 18892-0 | Cefsulodin [Susceptibility] |
| 18893-8 | Ceftazidime [Susceptibility] |
| 18894-6 | Ceftizoxime [Susceptibility] |
| 18895-3 | Ceftriaxone [Susceptibility] |
| 18896-1 | Cefuroxime Parenteral [Susceptibility] |
| 18897-9 | Cephalexin [Susceptibility] |
| 18898-7 | Cephaloglycin [Susceptibility] |
| 18899-5 | Cephaloridine [Susceptibility] |
| 189-1 | Clarithromycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 1890-3 | Arginase [Enzymatic activity/volume] in Red Blood Cells |
| 18900-1 | Cephalothin [Susceptibility] |
| 18901-9 | Cephapirin [Susceptibility] |
| 18902-7 | Cephradine [Susceptibility] |
| 18903-5 | Chloramphenicol [Susceptibility] |
| 18904-3 | Chlortetracycline [Susceptibility] |
| 18905-0 | Cinoxacin [Susceptibility] |
| 18906-8 | Ciprofloxacin [Susceptibility] |
| 18907-6 | Clarithromycin [Susceptibility] |
| 18908-4 | Clindamycin [Susceptibility] |
| 18909-2 | Clotrimazole [Susceptibility] |
| 1891-1 | Arginine [Mass/volume] in Cerebral spinal fluid |
| 18910-0 | Cloxacillin [Susceptibility] |
| 18911-8 | Colistimethate |
| 18912-6 | Colistin [Susceptibility] |
| 18913-4 | Cyclacillin [Susceptibility] |
| 18914-2 | Cycloserine [Susceptibility] |
| 18915-9 | Demeclocycline [Susceptibility] |
| 18916-7 | Dicloxacillin [Susceptibility] |
| 18917-5 | Doxycycline [Susceptibility] |
| 18918-3 | Enoxacin [Susceptibility] |
| 18919-1 | Erythromycin [Susceptibility] |
| 1892-9 | Arginine [Presence] in Serum or Plasma |
| 18920-9 | Erythromycin+Sulfisoxazole [Susceptibility] |
| 18921-7 | Ethambutol [Susceptibility] |
| 18922-5 | Ethionamide [Susceptibility] |
| 18923-3 | Floxacillin [Susceptibility] |
| 18924-1 | Fluconazole [Susceptibility] |
| 18925-8 | Deprecated 5-Fluorocytosine [Susceptibility] |
| 18926-6 | Framycetin [Susceptibility] |
| 18927-4 | Fusidate [Susceptibility] |
| 18928-2 | Gentamicin [Susceptibility] |
| 18929-0 | Gentamicin.high potency [Susceptibility] |
| 1893-7 | Arginine [Mass/volume] in Serum or Plasma |
| 18930-8 | Gramicidin D [Susceptibility] |
| 18931-6 | Hetacillin [Susceptibility] |
| 18932-4 | Imipenem [Susceptibility] |
| 18933-2 | Deprecated Imipenem+Cilastatin [Susceptibility] |
| 18934-0 | Isoniazid [Susceptibility] |
| 18935-7 | Kanamycin [Susceptibility] |
| 18936-5 | Kanamycin.high potency [Susceptibility] |
| 18937-3 | Ketoconazole [Susceptibility] |
| 18938-1 | Lincomycin [Susceptibility] |
| 18939-9 | Lomefloxacin [Susceptibility] |
| 1894-5 | Arginine [Mass/volume] in Urine |
| 18940-7 | Loracarbef [Susceptibility] |
| 18941-5 | Lymecycline [Susceptibility] |
| 18942-3 | Meclocycline [Susceptibility] |
| 18943-1 | Meropenem [Susceptibility] |
| 18944-9 | Methacycline [Susceptibility] |
| 18945-6 | Methicillin [Susceptibility] |
| 18946-4 | Metronidazole [Susceptibility] |
| 18947-2 | Mezlocillin [Susceptibility] |
| 18948-0 | Minocycline [Susceptibility] |
| 18949-8 | Miocamycin [Susceptibility] |
| 1895-2 | Arginine [Mass/time] in 24 hour Urine |
| 18950-6 | Moxalactam [Susceptibility] |
| 18951-4 | Nafcillin [Susceptibility] |
| 18952-2 | Nalidixate [Susceptibility] |
| 18953-0 | Neomycin [Susceptibility] |
| 18954-8 | Netilmicin [Susceptibility] |
| 18955-5 | Nitrofurantoin [Susceptibility] |
| 18956-3 | Norfloxacin [Susceptibility] |
| 18957-1 | Novobiocin [Susceptibility] |
| 18958-9 | Nystatin [Susceptibility] |
| 18959-7 | Ofloxacin [Susceptibility] |
| 1896-0 | Argininosuccinate [Mass/volume] in Serum or Plasma |
| 18960-5 | Oleandomycin [Susceptibility] |
| 18961-3 | Oxacillin [Susceptibility] |
| 18962-1 | Oxytetracycline [Susceptibility] |
| 18963-9 | Pefloxacin [Susceptibility] |
| 18964-7 | Penicillin [Susceptibility] |
| 18965-4 | Penicillin G [Susceptibility] |
| 18966-2 | Penicillin V [Susceptibility] |
| 18967-0 | Phenethicillin [Susceptibility] |
| 18968-8 | Pipemidate [Susceptibility] |
| 18969-6 | Piperacillin [Susceptibility] |
| 1897-8 | Argininosuccinate [Mass/volume] in Urine |
| 18970-4 | Piperacillin+Tazobactam [Susceptibility] |
| 18971-2 | Pivampicillin [Susceptibility] |
| 18972-0 | Polymyxin B [Susceptibility] |
| 18973-8 | Pyrazinamide [Susceptibility] |
| 18974-6 | Rifampin [Susceptibility] |
| 18975-3 | Ristocetin [Susceptibility] |
| 18976-1 | Rolitetracycline [Susceptibility] |
| 18977-9 | Rosoxacin [Susceptibility] |
| 18978-7 | Roxithromycin [Susceptibility] |
| 18979-5 | Sisomicin [Susceptibility] |
| 1898-6 | Argininosuccinate lyase [Enzymatic activity/volume] in Serum |
| 18980-3 | Spectinomycin [Susceptibility] |
| 18981-1 | Spiramycin [Susceptibility] |
| 18982-9 | Streptomycin [Susceptibility] |
| 18983-7 | Streptomycin.high potency [Susceptibility] |
| 18984-5 | Sulfadiazine [Susceptibility] |
| 18985-2 | Sulfamethoxazole [Susceptibility] |
| 18986-0 | Sulfisoxazole [Susceptibility] |
| 18987-8 | Sulfonamide [Susceptibility] |
| 18988-6 | Talampicillin [Susceptibility] |
| 18989-4 | Teicoplanin [Susceptibility] |
| 1899-4 | Argininosuccinate synthase [Enzymatic activity/mass] in Tissue |
| 18990-2 | Temafloxacin [Susceptibility] |
| 18991-0 | Temocillin [Susceptibility] |
| 18992-8 | Terbinafine [Susceptibility] |
| 18993-6 | Tetracycline [Susceptibility] |
| 18994-4 | Ticarcillin [Susceptibility] |
| 18995-1 | Ticarcillin+Clavulanate [Susceptibility] |
| 18996-9 | Tobramycin [Susceptibility] |
| 18997-7 | Trimethoprim [Susceptibility] |
| 18998-5 | Trimethoprim+Sulfamethoxazole [Susceptibility] |
| 18999-3 | Troleandomycin [Susceptibility] |
| 19-0 | Amoxicillin+Clavulanate [Susceptibility] by Minimum lethal concentration (MLC) |
| 190-9 | Clarithromycin [Susceptibility] by Disk diffusion (KB) |
| 1900-0 | Arylamidase [Enzymatic activity/volume] in Serum |
| 19000-9 | Vancomycin [Susceptibility] |
| 19001-7 | Viomycin [Susceptibility] |
| 19002-5 | Physical therapy service attachment |
| 19003-3 | Respiratory therapy service attachment |
| 19004-1 | Skilled nursing service attachment |
| 19005-8 | Radiology Imaging study [Impression] (narrative) |
| 19006-6 | Cardiac echo imaging device Image quality Narrative by US |
| 19007-4 | Psychiatric rehabilitation treatment plan, Primary diagnosis Set |
| 19008-2 | Transducer site Narrative |
| 19009-0 | Medication current (narrative) |
| 1901-8 | Arylsulfatase [Enzymatic activity/volume] in Serum or Plasma |
| 19010-8 | Medication discharge (narrative) |
| 19011-6 | Medication administered (narrative) |
| 19012-4 | Discharge medication, Substitution instruction |
| 19013-2 | Medications current report request |
| 19014-0 | Medications discharge report request |
| 19015-7 | Medications administered report request |
| 19016-5 | X12 277, all requests for information that are included in this transaction are stated for individual services |
| 1902-6 | Ascorbate [Mass/volume] in Blood |
| 19021-5 | Palpitation Cervix Study observation (narrative) |
| 19022-3 | Neisseria meningitidis C+w135 Ag [Presence] in Cerebral spinal fluid |
| 19023-1 | Granulocytes/100 leukocytes in Blood by Automated count |
| 1903-4 | Ascorbate [Mass/volume] in Serum or Plasma |
| 1904-2 | Ascorbate [Presence] in Urine |
| 19044-7 | Fish Feed IgE Ab RAST class [Presence] in Serum |
| 19045-4 | Salmon IgG Ab RAST class [Presence] in Serum |
| 19046-2 | Deprecated Bovine serum albumin (BSA) IgE Ab RAST class in Serum |
| 19047-0 | Tuna IgG Ab RAST class [Presence] in Serum |
| 19048-8 | Nucleated erythrocytes/100 leukocytes [Ratio] in Blood |
| 19049-6 | Metanephrine [Mass/time] in 24 hour Urine |
| 1905-9 | Ascorbate [Mass/time] in 24 hour Urine |
| 19050-4 | Metanephrines [Mass/volume] in 24 hour Urine |
| 19051-2 | Saquinavir [Mass/volume] in Serum or Plasma |
| 19052-0 | Borrelia burgdorferi DNA [Presence] in Urine by Probe with amplification |
| 19053-8 | Brucella sp Ab [Titer] in Serum by Agglutination |
| 19054-6 | Mycoplasma pneumoniae [Presence] in Unspecified specimen by Organism specific culture |
| 19055-3 | Carboxy tetrahydrocannabinol/Creatinine [Mass Ratio] in Urine |
| 19056-1 | Mercury [Presence] in Urine |
| 19057-9 | ABO and Rh group [Type] in Blood from newborn |
| 19058-7 | Allergens identified in Serum |
| 19059-5 | Amphetamines cutoff [Mass/volume] in Urine |
| 1906-7 | Asparagine [Mass/volume] in Cerebral spinal fluid |
| 19060-3 | Deprecated Blood group antibodies identified in Serum or Plasma |
| 19064-5 | Benzodiazepines cutoff [Mass/volume] in Urine |
| 19065-2 | Benzoylecgonine cutoff [Mass/volume] in Urine |
| 19066-0 | Blood bank comment |
| 1907-5 | Asparagine [Presence] in Serum or Plasma |
| 19071-0 | Blood removed from patient [Volume] |
| 19072-8 | Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma |
| 19073-6 | Cannabinoids cutoff [Mass/volume] in Urine |
| 19074-4 | Carnitine esters [Moles/volume] in Serum or Plasma |
| 19075-1 | Cells Counted Total [#] in Cerebral spinal fluid |
| 19076-9 | Cells Counted Total [#] in Unspecified specimen |
| 19077-7 | Cells identified in Body fluid |
| 19078-5 | CD23 cells/100 cells in Unspecified specimen |
| 19079-3 | CD43 cells/100 cells in Unspecified specimen |
| 1908-3 | Asparagine [Mass/volume] in Serum or Plasma |
| 19080-1 | Choriogonadotropin [Units/volume] in Serum or Plasma |
| 19085-0 | Deprecated Collection duration of Urine - time unspecified |
| 19086-8 | Collection of urine specimen end date |
| 19087-6 | Collection of urine specimen end time |
| 19088-4 | Collection of urine specimen start date |
| 19089-2 | Collection of urine specimen start time |
| 1909-1 | Asparagine [Mass/volume] in Urine |
| 19090-0 | Colony count [#/volume] in Urine |
| 19091-8 | Colony count [#] in Urine by Visual count |
| 19092-6 | Cotinine cutoff [Mass/volume] in Urine |
| 19096-7 | Electrolytes - single valence [Interpretation] in 24 hour Urine Narrative |
| 19098-3 | Erythrocytes [Presence] in Amniotic fluid |
| 19099-1 | Events counted [#] in Unspecified specimen |
| 191-7 | Clarithromycin [Susceptibility] by Serum bactericidal titer |
| 1910-9 | Asparagine [Mass/time] in 24 hour Urine |
| 19101-5 | Fungus colony count [#/volume] in Unspecified specimen by Culture |
| 19102-3 | Genetic screen in Unspecified specimen by Molecular genetics method Narrative |
| 19104-9 | Glucose [Interpretation] in Serum or Plasma--1 hour post dose glucose |
| 19105-6 | Glucose [Interpretation] in Serum or Plasma--3 hours post dose glucose |
| 19106-4 | Herpes simplex virus IgG Ab [Presence] in Serum |
| 19107-2 | Histoplasma capsulatum Ag [Units/volume] in Serum by Radioimmunoassay (RIA) |
| 19108-0 | Histoplasma capsulatum Ag [Presence] in Serum |
| 19109-8 | Histoplasma capsulatum Ag [Presence] in Unspecified specimen |
| 1911-7 | Aspartate [Mass/volume] in Cerebral spinal fluid |
| 19110-6 | HIV 1 gp41+gp43 Ab [Presence] in Serum by Immunoblot (IB) |
| 19111-4 | Mother's hospital number |
| 19113-0 | IgE [Units/volume] in Serum or Plasma |
| 19114-8 | Lamellar bodies [#/volume] in Amniotic fluid |
| 1912-5 | Aspartate [Presence] in Serum or Plasma |
| 19122-1 | CD42 cells/100 cells in Blood |
| 19123-9 | Magnesium [Mass/volume] in Serum or Plasma |
| 19124-7 | Magnesium [Mass/volume] in Urine |
| 19125-4 | Meconium [Presence] in Amniotic fluid |
| 19126-2 | Bacteria identified in Bone marrow by Aerobe culture |
| 19127-0 | Bacteria identified in Sputum by Acute Respiratoy Distress (ARDS) culture |
| 19128-8 | Bacteria identified in Catheter tip by Culture |
| 19129-6 | Microscopic observation [Identifier] in Tissue by Biopsy culture |
| 1913-3 | Aspartate [Mass/volume] in Serum or Plasma |
| 19132-0 | Mother's name |
| 19133-8 | Neisseria meningitidis A+C+w135+Y Ag [Presence] in Cerebral spinal fluid by Latex agglutination |
| 19134-6 | Neisseria meningitidis B+Escherichia coli K1 Ag [Presence] in Cerebral spinal fluid by Latex agglutination |
| 19137-9 | Neuronal nuclear Ab [Units/volume] in Serum by Immunoblot (IB) |
| 19138-7 | Opiates cutoff [Mass/volume] in Urine |
| 19139-5 | Pathologist name |
| 1914-1 | Aspartate [Mass/volume] in Urine |
| 19140-3 | Phospholipid Ab [Presence] in Serum |
| 19141-1 | Propoxyphene [Presence] in Urine |
| 19144-5 | Reason for drug test [Interpretation] |
| 19145-2 | Reference lab test name |
| 19146-0 | Reference lab test results |
| 19147-8 | Reference lab test reference range |
| 19148-6 | RhoGam candidate (yes/no) |
| 19149-4 | Rifabutin [Susceptibility] |
| 1915-8 | Aspartate [Mass/time] in 24 hour Urine |
| 19150-2 | Specimen creatinine acceptable [Presence] in Urine |
| 19151-0 | Specimen drawn [Date and time] of Serum or Plasma |
| 19152-8 | Specimen specific gravity acceptable [Presence] in Urine |
| 19153-6 | Volume in Urine collected for unspecified duration |
| 19156-9 | Susceptibility method - Unspecified specimen |
| 19157-7 | Tube number of Cerebral spinal fluid |
Terminology
|
Version History |
Table of Contents |
Compare to DSTU2 
|
Propose a change